assays_ss_ctgr,assays_rltnshp_tp,assays_td,assays_cll_d,assays_ss_sbclllr_frctn,assays_ss_tst_tp,assays_ss_tp,assays_tss_d,assays_chmbl_d,assays_cnfdnc_scr,assays_vrnt_d,assays_b_frmt,assays_dc_d,assays_dscrptn,assays_src_d,assays_src_ss_d,assays_ss_tss,assays_ss_rgnsm,assays_crtd_b,assays_ss_cll_tp,assays_ss_strn,assays_ss_d,assays_ss_tx_d
,N,50597,,,In vivo,A,2113.0,CHEMBL618647,1,,BAO_0000218,9866,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,Kidney,Rattus norvegicus,Intermediate,,,7524,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL618648,1,,BAO_0000218,9866,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,1,,Kidney,Rattus norvegicus,Intermediate,,,7525,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL618649,1,,BAO_0000218,9866,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,1,,Kidney,Rattus norvegicus,Intermediate,,,7526,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL618650,1,,BAO_0000218,9866,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,Liver,Rattus norvegicus,Intermediate,,,7527,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL618651,1,,BAO_0000218,9866,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,1,,Liver,Rattus norvegicus,Intermediate,,,7528,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL876497,1,,BAO_0000218,9866,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,1,,Liver,Rattus norvegicus,Intermediate,,,7529,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL618652,1,,BAO_0000218,9866,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,Lung,Rattus norvegicus,Intermediate,,,7530,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL618653,1,,BAO_0000218,9866,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,1,,Lung,Rattus norvegicus,Intermediate,,,7531,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL618654,1,,BAO_0000218,9866,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,1,,Lung,Rattus norvegicus,Intermediate,,,7532,10116.0
,N,50597,,,,A,,CHEMBL618655,1,,BAO_0000218,6351,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,1,,,Rattus norvegicus,Intermediate,,,7533,10116.0
,N,50597,,,,A,,CHEMBL618656,1,,BAO_0000218,1465,Compound was tested for solubility in water,1,,,Rattus norvegicus,Intermediate,,,7534,10116.0
,U,22229,,,,P,,CHEMBL618657,0,,BAO_0000100,5182,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),1,,,,Intermediate,,,7535,
,N,50597,,,,A,,CHEMBL618658,1,,BAO_0000218,17847,Solubility was determined,1,,,Rattus norvegicus,Intermediate,,,7536,10116.0
,N,50597,,,,A,,CHEMBL618659,1,,BAO_0000218,15339,solubility in water (ug/mL) at 37 degree C.,1,,,Rattus norvegicus,Intermediate,,,7537,10116.0
,N,50597,,,,A,,CHEMBL618660,1,,BAO_0000218,5202,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,1,,,Rattus norvegicus,Intermediate,,,7538,10116.0
,N,50597,,,,A,,CHEMBL618661,1,,BAO_0000218,1088,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,1,,,Rattus norvegicus,Intermediate,,,7539,10116.0
,N,50597,,,,A,,CHEMBL873807,1,,BAO_0000218,3169,Half life in rats,1,,,Rattus norvegicus,Intermediate,,,7540,10116.0
,N,50597,,,,A,,CHEMBL618662,1,,BAO_0000218,5353,Half life in Dawley rat,1,,,Rattus norvegicus,Intermediate,,,7541,10116.0
,N,50597,,,In vivo,A,,CHEMBL618663,1,,BAO_0000218,2864,Half life period after 3 mg/kg iv administration,1,,,Rattus norvegicus,Intermediate,,,7542,10116.0
,N,50597,,,In vivo,A,,CHEMBL618664,1,,BAO_0000218,2864,Half life period after 3 mg/kg iv administration in rat,1,,,Rattus norvegicus,Intermediate,,,7543,10116.0
,N,50597,,,In vivo,A,,CHEMBL618665,1,,BAO_0000218,2864,Half life period after 3 mg/kg iv administration in the rat,1,,,Rattus norvegicus,Intermediate,,,7544,10116.0
,N,50597,,,,A,,CHEMBL876498,1,,BAO_0000218,6362,Half life period in female Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,7545,10116.0
,N,50597,,,,A,,CHEMBL618666,1,,BAO_0000218,6249,Half life period in rat,1,,,Rattus norvegicus,Intermediate,,,7546,10116.0
,N,50597,,,,A,,CHEMBL620440,1,,BAO_0000218,3169,Half-life in rats was determined,1,,,Rattus norvegicus,Intermediate,,,7547,10116.0
,N,50597,,,,A,,CHEMBL620441,1,,BAO_0000218,3169,Half-life in rats with metabolic oxidation,1,,,Rattus norvegicus,Intermediate,,,7548,10116.0
,N,50597,,,,A,,CHEMBL620442,1,,BAO_0000218,3169,Half-life in rats,1,,,Rattus norvegicus,Intermediate,,,7549,10116.0
,N,50597,,,In vivo,A,,CHEMBL620443,1,,BAO_0000218,17260,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,,Rattus norvegicus,Intermediate,,,7550,10116.0
,N,50597,,,In vivo,A,,CHEMBL620444,1,,BAO_0000218,17260,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,,Rattus norvegicus,Intermediate,,,7551,10116.0
,N,50597,,,In vivo,A,,CHEMBL620445,1,,BAO_0000218,17260,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,,Rattus norvegicus,Intermediate,,,7552,10116.0
,N,50597,,,In vivo,A,,CHEMBL620446,1,,BAO_0000218,17260,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,,Rattus norvegicus,Intermediate,,,7553,10116.0
,N,50597,,,,A,1969.0,CHEMBL620447,1,,BAO_0000218,2879,Biological half-life measured in plasma of rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7554,10116.0
,N,50597,,,,A,1969.0,CHEMBL621129,1,,BAO_0000218,2879,Biological half-life measured in plasma of rat; 22-25,1,,Plasma,Rattus norvegicus,Intermediate,,,7555,10116.0
,N,50597,,,,A,1969.0,CHEMBL621130,1,,BAO_0000218,2879,Biological half-life measured in plasma of rat; 9-16,1,,Plasma,Rattus norvegicus,Intermediate,,,7556,10116.0
,N,50597,,,In vivo,A,,CHEMBL873808,1,,BAO_0000218,3184,Compound was evaluated for its half life when administered intravenously in rat,1,,,Rattus norvegicus,Intermediate,,,7557,10116.0
,N,50597,,,In vivo,A,,CHEMBL876598,1,,BAO_0000218,4891,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,1,,,Rattus norvegicus,Intermediate,,,7558,10116.0
,N,50597,,,In vivo,A,,CHEMBL621131,1,,BAO_0000218,429,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7559,10116.0
,N,50597,,,In vivo,A,,CHEMBL621132,1,,BAO_0000218,5656,Half life (T1/2) after oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,7560,10116.0
,N,50597,,,In vivo,A,,CHEMBL621133,1,,BAO_0000218,4413,Half life of compound after iv administration of 20 mg/kg dose in rat,1,,,Rattus norvegicus,Intermediate,,,7561,10116.0
,N,50597,,,In vivo,A,,CHEMBL621312,1,,BAO_0000218,3598,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Expert,,,7562,10116.0
,N,50597,,,,A,,CHEMBL621313,1,,BAO_0000218,17267,Half life of compound was determined in rat,1,,,Rattus norvegicus,Intermediate,,,7563,10116.0
,N,50597,,,,A,178.0,CHEMBL621314,1,,BAO_0000218,4727,Half life of compound was determined in rat blood,1,,Blood,Rattus norvegicus,Intermediate,,,7564,10116.0
,N,50597,,,In vivo,A,,CHEMBL621315,1,,BAO_0000218,17651,Half life at 1 mg/kg was determined in rat,1,,,Rattus norvegicus,Intermediate,,,7565,10116.0
,N,50597,,,In vivo,A,,CHEMBL621316,1,,BAO_0000218,17651,Half life at 10 mg/kg was determined in rat,1,,,Rattus norvegicus,Intermediate,,,7566,10116.0
,N,50597,,,,A,,CHEMBL621317,1,,BAO_0000218,401,Half life in rats,1,,,Rattus norvegicus,Intermediate,,,7567,10116.0
,N,50597,,,,A,,CHEMBL621318,1,,BAO_0000218,4942,Half life in rats in hours,1,,,Rattus norvegicus,Intermediate,,,7568,10116.0
,N,50597,,,In vivo,A,,CHEMBL621319,1,,BAO_0000218,17735,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,,,Rattus norvegicus,Intermediate,,,7569,10116.0
,N,50597,,,In vivo,A,,CHEMBL621377,1,,BAO_0000218,6056,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,7570,10116.0
,N,50597,,,,A,,CHEMBL621378,1,,BAO_0000218,5213,Half life was determined,1,,,Rattus norvegicus,Intermediate,,,7571,10116.0
,N,50597,,,In vivo,A,,CHEMBL876599,1,,BAO_0000218,6616,Half life after i.v. administration,1,,,Rattus norvegicus,Intermediate,,,7572,10116.0
,N,50597,,,In vivo,A,,CHEMBL621379,1,,BAO_0000218,5937,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7573,10116.0
,N,50597,,,,A,1969.0,CHEMBL621380,1,,BAO_0000218,5819,Half life in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,7574,10116.0
,N,50597,,,,A,1969.0,CHEMBL621381,1,,BAO_0000218,5819,Half life in rat plasma; Not detected,1,,Plasma,Rattus norvegicus,Intermediate,,,7575,10116.0
,N,50597,,,,A,,CHEMBL618515,1,,BAO_0000218,6803,Half life in rats,1,,,Rattus norvegicus,Intermediate,,,7576,10116.0
,N,50597,,,In vivo,A,,CHEMBL618516,1,,BAO_0000218,17804,Half life period of compound was determined after peroral administration,1,,,Rattus norvegicus,Intermediate,,,7577,10116.0
,N,50597,,,In vivo,A,,CHEMBL618517,1,,BAO_0000218,17804,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,1,,,Rattus norvegicus,Intermediate,,,7578,10116.0
,N,50597,,,,A,,CHEMBL618518,1,,BAO_0000218,5948,Half life period in rat,1,,,Rattus norvegicus,Intermediate,,,7579,10116.0
,N,50597,,,In vivo,A,,CHEMBL618519,1,,BAO_0000218,1916,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,,,Rattus norvegicus,Intermediate,,,7580,10116.0
,N,50597,,,In vivo,A,,CHEMBL618698,1,,BAO_0000218,1916,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,,,Rattus norvegicus,Intermediate,,,7581,10116.0
,N,50597,,,In vivo,A,,CHEMBL618862,1,,BAO_0000218,1916,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,1,,,Rattus norvegicus,Intermediate,,,7582,10116.0
,N,50597,,,In vivo,A,,CHEMBL618863,1,,BAO_0000218,4890,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,7583,10116.0
,N,50597,,,In vivo,A,,CHEMBL618864,1,,BAO_0000218,17764,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,1,,,Rattus norvegicus,Intermediate,,,7584,10116.0
,N,50597,,,In vivo,A,,CHEMBL618865,1,,BAO_0000218,4727,Half life time in rat the dose of 2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7585,10116.0
,N,50597,,,In vivo,A,,CHEMBL618866,1,,BAO_0000218,17509,Half-life 24 hr after 10 mg/kg iv administration in rats,1,,,Rattus norvegicus,Intermediate,,,7586,10116.0
,N,50597,,,In vivo,A,,CHEMBL618867,1,,BAO_0000218,17509,Half-life 24 hr after 2 mg/kg iv administration in rats,1,,,Rattus norvegicus,Intermediate,,,7587,10116.0
,N,50597,,,,A,,CHEMBL875828,1,,BAO_0000218,6597,Half-life consistent with the observed metabolic steady state in rats,1,,,Rattus norvegicus,Intermediate,,,7588,10116.0
,N,50597,,,In vivo,A,,CHEMBL618868,1,,BAO_0000218,17735,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,,,Rattus norvegicus,Intermediate,,,7589,10116.0
,N,50597,,,,A,,CHEMBL618869,1,,BAO_0000218,6597,Half-life for oxidative metabolic stability was determined using male human,1,,,Rattus norvegicus,Intermediate,,,7590,10116.0
,N,50597,,,In vivo,A,,CHEMBL618870,1,,BAO_0000218,17670,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",1,,,Rattus norvegicus,Intermediate,,,7591,10116.0
,N,50597,,,,A,1969.0,CHEMBL618871,1,,BAO_0000218,1696,Half-life in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,7592,10116.0
,N,50597,,,,A,1969.0,CHEMBL618872,1,,BAO_0000218,1742,Half-life in rat plasma was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,7593,10116.0
,N,50597,,,,A,,CHEMBL873816,1,,BAO_0000218,17800,Half-life in rats was determined,1,,,Rattus norvegicus,Intermediate,,,7594,10116.0
,U,22224,,,,A,,CHEMBL618873,0,,BAO_0000218,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,1,,,,Autocuration,,,7595,
,U,22224,,,,A,,CHEMBL621602,0,,BAO_0000019,11954,Area under curve after oral dose of 0.1 mg//kg,1,,,,Autocuration,,,7596,
,U,22224,,,,A,,CHEMBL621603,0,,BAO_0000218,11954,Area under curve after oral dose of 0.3 mg/kg,1,,,,Autocuration,,,7597,
,U,22224,,,,A,,CHEMBL621604,0,,BAO_0000218,11954,Area under curve after oral dose of 1 mg/kg,1,,,,Autocuration,,,7598,
,U,22224,,,,A,,CHEMBL621605,0,,BAO_0000218,11954,Area under curve after oral dose of 10 mg/kg,1,,,,Autocuration,,,7599,
,U,22224,,,,A,,CHEMBL621606,0,,BAO_0000218,11954,Area under curve after oral dose of 23.4 mg/kg,1,,,,Autocuration,,,7600,
,U,22224,,,,A,,CHEMBL621607,0,,BAO_0000218,11954,Area under curve after oral dose of 3 mg/kg,1,,,,Autocuration,,,7601,
,U,22224,,,,A,,CHEMBL621608,0,,BAO_0000218,11954,Area under curve after oral dose of 3.87 mg/kg,1,,,,Autocuration,,,7602,
,U,22224,,,,A,,CHEMBL621609,0,,BAO_0000019,5237,Area under curve was determined,1,,,,Autocuration,,,7603,
,U,22224,,,,A,,CHEMBL621610,0,,BAO_0000218,4026,Area under curve at a dose of 10 mg/kg,1,,,,Autocuration,,,7604,
,N,50597,,,,A,,CHEMBL621611,1,,BAO_0000218,5237,Area under curve was determined; ND=No data,1,,,Rattus norvegicus,Intermediate,,,7605,10116.0
,N,50597,,,,A,,CHEMBL621612,1,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,1,,,Rattus norvegicus,Intermediate,,,7606,10116.0
,N,50597,,,,A,,CHEMBL622308,1,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,1,,,Rattus norvegicus,Intermediate,,,7607,10116.0
,N,50597,,,,A,,CHEMBL622309,1,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,1,,,Rattus norvegicus,Intermediate,,,7608,10116.0
,N,50597,,,,A,,CHEMBL622310,1,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,1,,,Rattus norvegicus,Intermediate,,,7609,10116.0
,N,50597,,,,A,,CHEMBL622311,1,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,1,,,Rattus norvegicus,Intermediate,,,7610,10116.0
,N,50597,,,,A,,CHEMBL622312,1,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,1,,,Rattus norvegicus,Intermediate,,,7611,10116.0
,N,50597,,,,A,,CHEMBL622931,1,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,1,,,Rattus norvegicus,Intermediate,,,7612,10116.0
,N,50597,,,,A,,CHEMBL622932,1,,BAO_0000218,14793,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,1,,,Rattus norvegicus,Intermediate,,,7613,10116.0
,N,50597,,,,A,1969.0,CHEMBL622736,1,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,1,,Plasma,Rattus norvegicus,Intermediate,,,7614,10116.0
,N,50597,,,,A,1969.0,CHEMBL622737,1,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,1,,Plasma,Rattus norvegicus,Intermediate,,,7615,10116.0
,N,50597,,,,A,1969.0,CHEMBL622738,1,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,1,,Plasma,Rattus norvegicus,Intermediate,,,7616,10116.0
,N,50597,,,,A,1969.0,CHEMBL622739,1,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,1,,Plasma,Rattus norvegicus,Intermediate,,,7617,10116.0
,N,50597,,,,A,1969.0,CHEMBL622740,1,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,1,,Plasma,Rattus norvegicus,Intermediate,,,7618,10116.0
,N,50597,,,,A,1969.0,CHEMBL622741,1,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,1,,Plasma,Rattus norvegicus,Intermediate,,,7619,10116.0
,N,50597,,,,A,1969.0,CHEMBL622742,1,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,1,,Plasma,Rattus norvegicus,Intermediate,,,7620,10116.0
,N,50597,,,,A,1969.0,CHEMBL622743,1,,BAO_0000218,14793,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,1,,Plasma,Rattus norvegicus,Intermediate,,,7621,10116.0
,N,50594,,,,A,1969.0,CHEMBL622744,1,,BAO_0000218,11637,AUC in mice,1,,Plasma,Mus musculus,Intermediate,,,7622,10090.0
,U,22224,,,,A,,CHEMBL624134,0,,BAO_0000019,11149,Area under curve was measured from the graph obtained from concentration Vs time,1,,,,Autocuration,,,7623,
,U,22224,,,,A,,CHEMBL624135,0,,BAO_0000019,10016,Area under curve value of compound per hour after oral administration,1,,,,Autocuration,,,7624,
,N,50597,,,,A,,CHEMBL624136,1,,BAO_0000218,17796,Area under curve was determined after oral administration in rats,1,,,Rattus norvegicus,Intermediate,,,7625,10116.0
,N,50597,,,,A,,CHEMBL624137,1,,BAO_0000218,17796,Area under curve was determined after oral administration in rats; No data,1,,,Rattus norvegicus,Intermediate,,,7626,10116.0
,N,50597,,,,A,,CHEMBL624320,1,,BAO_0000218,17796,Area under curve was determined after oral administration in rats;No data,1,,,Rattus norvegicus,Intermediate,,,7627,10116.0
,N,50588,,,,A,,CHEMBL624321,1,,BAO_0000218,12923,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,1,,,Canis lupus familiaris,Intermediate,,,7628,9615.0
,N,50597,,,,A,,CHEMBL624322,1,,BAO_0000218,15372,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,7629,10116.0
,N,50597,,,,A,,CHEMBL624323,1,,BAO_0000218,15372,Area under curve was determined for the compound after iv dose of 5.06 in rats,1,,,Rattus norvegicus,Intermediate,,,7630,10116.0
,N,50597,,,,A,,CHEMBL624324,1,,BAO_0000218,15372,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,7631,10116.0
,N,50597,,,,A,,CHEMBL624325,1,,BAO_0000218,15372,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,7632,10116.0
,N,50597,,,,A,,CHEMBL624326,1,,BAO_0000218,15372,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,7633,10116.0
,N,50597,,,,A,,CHEMBL624327,1,,BAO_0000218,15372,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,7634,10116.0
,N,50597,,,,A,,CHEMBL624328,1,,BAO_0000218,15372,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,7635,10116.0
,N,50588,,,,A,,CHEMBL627848,1,,BAO_0000218,14169,Area under curve was determined in Dogs after peroral administration,1,,,Canis lupus familiaris,Intermediate,,,7636,9615.0
,N,50597,,,,A,,CHEMBL627849,1,,BAO_0000218,14169,Area under curve was determined in Rats after peroral administration,1,,,Rattus norvegicus,Intermediate,,,7637,10116.0
,N,50597,,,,A,,CHEMBL627850,1,,BAO_0000218,14258,Area under curve was determined in carotid blood of rat when administered intradermally,1,,,Rattus norvegicus,Intermediate,,,7638,10116.0
,N,50597,,,,A,,CHEMBL627851,1,,BAO_0000218,14258,Area under curve was determined in portal blood of rat when administered intradermally,1,,,Rattus norvegicus,Intermediate,,,7639,10116.0
,N,50594,,,,A,,CHEMBL627852,1,,BAO_0000218,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,,Mus musculus,Intermediate,,,7640,10090.0
,N,50594,,,,A,,CHEMBL627853,1,,BAO_0000218,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,1,,,Mus musculus,Intermediate,,,7641,10090.0
,N,50594,,,,A,,CHEMBL627854,1,,BAO_0000218,15011,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),1,,,Mus musculus,Intermediate,,,7642,10090.0
,N,50594,,,,A,,CHEMBL627855,1,,BAO_0000218,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,,Mus musculus,Intermediate,,,7643,10090.0
,N,50594,,,,A,,CHEMBL627856,1,,BAO_0000218,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),1,,,Mus musculus,Intermediate,,,7644,10090.0
,N,50594,,,,A,,CHEMBL875339,1,,BAO_0000218,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,1,,,Mus musculus,Intermediate,,,7645,10090.0
,N,50594,,,,A,,CHEMBL627857,1,,BAO_0000218,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),1,,,Mus musculus,Intermediate,,,7646,10090.0
,N,50597,,,In vivo,A,2106.0,CHEMBL627858,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,1,,Spleen,Rattus norvegicus,Intermediate,,,7647,10116.0
,N,50597,,,,A,178.0,CHEMBL627859,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,1,,Blood,Rattus norvegicus,Intermediate,,,7648,10116.0
,N,50597,,,,A,955.0,CHEMBL627860,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,1,,Brain,Rattus norvegicus,Intermediate,,,7649,10116.0
,N,50597,,,,A,948.0,CHEMBL627019,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,1,,Heart,Rattus norvegicus,Intermediate,,,7650,10116.0
,N,50597,,,,A,2107.0,CHEMBL627020,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,1,,Liver,Rattus norvegicus,Intermediate,,,7651,10116.0
,N,50597,,,,A,2048.0,CHEMBL627021,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,1,,Lung,Rattus norvegicus,Intermediate,,,7652,10116.0
,N,50597,,,,A,2385.0,CHEMBL627022,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,7653,10116.0
,N,50597,,,,A,,CHEMBL627023,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,1,,,Rattus norvegicus,Intermediate,,,7654,10116.0
,N,50597,,,,A,2106.0,CHEMBL627024,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,1,,Spleen,Rattus norvegicus,Intermediate,,,7655,10116.0
,N,50597,,,,A,2046.0,CHEMBL627025,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,7656,10116.0
,N,50597,,,,A,2113.0,CHEMBL627026,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,1,,Kidney,Rattus norvegicus,Intermediate,,,7657,10116.0
,N,50597,,,,A,178.0,CHEMBL627027,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,1,,Blood,Rattus norvegicus,Intermediate,,,7658,10116.0
,N,50597,,,,A,955.0,CHEMBL627028,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,1,,Brain,Rattus norvegicus,Intermediate,,,7659,10116.0
,N,50597,,,,A,948.0,CHEMBL627029,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,1,,Heart,Rattus norvegicus,Intermediate,,,7660,10116.0
,N,50597,,,,A,2113.0,CHEMBL627030,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,1,,Kidney,Rattus norvegicus,Intermediate,,,7661,10116.0
,N,50597,,,,A,2107.0,CHEMBL627031,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,1,,Liver,Rattus norvegicus,Intermediate,,,7662,10116.0
,N,50597,,,,A,2048.0,CHEMBL627032,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,1,,Lung,Rattus norvegicus,Intermediate,,,7663,10116.0
,N,50597,,,,A,2385.0,CHEMBL627033,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,7664,10116.0
,N,50597,,,,A,,CHEMBL627034,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,1,,,Rattus norvegicus,Intermediate,,,7665,10116.0
,N,50597,,,,A,2106.0,CHEMBL627035,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,1,,Spleen,Rattus norvegicus,Intermediate,,,7666,10116.0
,N,50597,,,,A,2046.0,CHEMBL627036,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,7667,10116.0
,N,50597,,,,A,178.0,CHEMBL875340,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,1,,Blood,Rattus norvegicus,Intermediate,,,7668,10116.0
,N,50597,,,,A,948.0,CHEMBL627037,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,1,,Heart,Rattus norvegicus,Intermediate,,,7669,10116.0
,N,50597,,,,A,2113.0,CHEMBL627038,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,1,,Kidney,Rattus norvegicus,Intermediate,,,7670,10116.0
,N,50597,,,,A,2107.0,CHEMBL627039,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,1,,Liver,Rattus norvegicus,Intermediate,,,7671,10116.0
,N,50597,,,,A,2385.0,CHEMBL627040,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,7672,10116.0
,N,50597,,,,A,2106.0,CHEMBL624663,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,1,,Spleen,Rattus norvegicus,Intermediate,,,7673,10116.0
,N,50597,,,,A,2046.0,CHEMBL625963,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,7674,10116.0
,N,50597,,,,A,955.0,CHEMBL876799,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,1,,Brain,Rattus norvegicus,Intermediate,,,7675,10116.0
,N,50597,,,,A,2048.0,CHEMBL626133,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,1,,Lung,Rattus norvegicus,Intermediate,,,7676,10116.0
,N,50597,,,,A,,CHEMBL626134,1,,BAO_0000218,10130,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,1,,,Rattus norvegicus,Intermediate,,,7677,10116.0
,N,50597,,,,A,,CHEMBL626135,1,,BAO_0000218,6295,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7678,10116.0
,N,50597,,,,A,,CHEMBL626136,1,,BAO_0000218,6296,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7679,10116.0
,N,50597,,,,A,,CHEMBL626137,1,,BAO_0000218,6296,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,1,,,Rattus norvegicus,Intermediate,,,7680,10116.0
,N,50597,,,,A,,CHEMBL626138,1,,BAO_0000218,6295,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7681,10116.0
,N,50597,,,,A,,CHEMBL626139,1,,BAO_0000218,6296,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7682,10116.0
,N,50597,,,In vivo,A,,CHEMBL626140,1,,BAO_0000218,17260,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,,Rattus norvegicus,Intermediate,,,7683,10116.0
,N,50597,,,In vivo,A,,CHEMBL626141,1,,BAO_0000218,17260,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,,Rattus norvegicus,Intermediate,,,7684,10116.0
,N,50597,,,,A,,CHEMBL626142,1,,BAO_0000218,17686,C24h in rat p.o. at 20 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,7685,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627930,1,,BAO_0000218,9866,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,7686,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627931,1,,BAO_0000218,9866,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,7687,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627932,1,,BAO_0000218,9866,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,7688,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL627933,1,,BAO_0000218,9866,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,1,,Spleen,Rattus norvegicus,Intermediate,,,7689,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL627934,1,,BAO_0000218,9866,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,1,,Spleen,Rattus norvegicus,Intermediate,,,7690,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL627935,1,,BAO_0000218,9866,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,1,,Spleen,Rattus norvegicus,Intermediate,,,7691,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627936,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,1,,Blood,Rattus norvegicus,Intermediate,,,7692,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627937,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,1,,Blood,Rattus norvegicus,Intermediate,,,7693,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627938,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,Blood,Rattus norvegicus,Intermediate,,,7694,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627939,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,1,,Blood,Rattus norvegicus,Intermediate,,,7695,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627940,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,1,,Blood,Rattus norvegicus,Intermediate,,,7696,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627941,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,Blood,Rattus norvegicus,Intermediate,,,7697,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL876800,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,Blood,Rattus norvegicus,Intermediate,,,7698,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627942,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,1,,Blood,Rattus norvegicus,Intermediate,,,7699,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627943,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,,Blood,Rattus norvegicus,Intermediate,,,7700,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627944,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,1,,Blood,Rattus norvegicus,Intermediate,,,7701,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627945,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,1,,Blood,Rattus norvegicus,Intermediate,,,7702,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628584,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,1,,Blood,Rattus norvegicus,Intermediate,,,7703,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628585,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA at 15 min,1,,Blood,Rattus norvegicus,Intermediate,,,7704,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628586,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,1,,Blood,Rattus norvegicus,Intermediate,,,7705,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628587,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA at 30 min,1,,Blood,Rattus norvegicus,Intermediate,,,7706,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628588,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,1,,Blood,Rattus norvegicus,Intermediate,,,7707,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628589,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,1,,Blood,Rattus norvegicus,Intermediate,,,7708,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625304,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,1,,Blood,Rattus norvegicus,Intermediate,,,7709,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625305,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,1,,Blood,Rattus norvegicus,Intermediate,,,7710,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625306,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,1,,Blood,Rattus norvegicus,Intermediate,,,7711,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625307,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,1,,Blood,Rattus norvegicus,Intermediate,,,7712,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625308,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,1,,Blood,Rattus norvegicus,Intermediate,,,7713,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627740,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,1,,Blood,Rattus norvegicus,Intermediate,,,7714,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627741,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,1,,Blood,Rattus norvegicus,Intermediate,,,7715,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627742,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,Blood,Rattus norvegicus,Intermediate,,,7716,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627743,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,1,,Blood,Rattus norvegicus,Intermediate,,,7717,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627744,1,,BAO_0000218,9866,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,1,,Blood,Rattus norvegicus,Intermediate,,,7718,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL627745,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,1,,Bone,Rattus norvegicus,Intermediate,,,7719,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL627746,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,Bone,Rattus norvegicus,Intermediate,,,7720,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL627747,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,,Bone,Rattus norvegicus,Intermediate,,,7721,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL876810,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,1,,Bone,Rattus norvegicus,Intermediate,,,7722,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL627748,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,1,,Bone,Rattus norvegicus,Intermediate,,,7723,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL627749,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,Bone,Rattus norvegicus,Intermediate,,,7724,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL627750,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,Bone,Rattus norvegicus,Intermediate,,,7725,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618728,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,1,,Bone,Rattus norvegicus,Intermediate,,,7726,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618729,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,,Bone,Rattus norvegicus,Intermediate,,,7727,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618730,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA at 15 min,1,,Bone,Rattus norvegicus,Intermediate,,,7728,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618731,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,1,,Bone,Rattus norvegicus,Intermediate,,,7729,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618732,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA at 30 min,1,,Bone,Rattus norvegicus,Intermediate,,,7730,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618733,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,1,,Bone,Rattus norvegicus,Intermediate,,,7731,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618734,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,1,,Bone,Rattus norvegicus,Intermediate,,,7732,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618735,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,1,,Bone,Rattus norvegicus,Intermediate,,,7733,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL876602,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,1,,Bone,Rattus norvegicus,Intermediate,,,7734,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618736,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,1,,Bone,Rattus norvegicus,Intermediate,,,7735,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618737,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,1,,Bone,Rattus norvegicus,Intermediate,,,7736,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618738,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,1,,Bone,Rattus norvegicus,Intermediate,,,7737,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618739,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,1,,Bone,Rattus norvegicus,Intermediate,,,7738,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618740,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,1,,Bone,Rattus norvegicus,Intermediate,,,7739,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618741,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,Bone,Rattus norvegicus,Intermediate,,,7740,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618742,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,1,,Bone,Rattus norvegicus,Intermediate,,,7741,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL618743,1,,BAO_0000218,9866,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,1,,Bone,Rattus norvegicus,Intermediate,,,7742,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL618744,1,,BAO_0000218,17752,Half-life from rat plasma at a single oral dose of 25 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,7743,10116.0
,N,50597,,,,A,,CHEMBL618745,1,,BAO_0000218,5610,Half-life in male rat,1,,,Rattus norvegicus,Intermediate,,,7744,10116.0
,N,50597,,,In vivo,A,,CHEMBL620479,1,,BAO_0000218,5939,Half-life in rat after peroral administration at 10 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,7745,10116.0
,N,50597,,,In vivo,A,,CHEMBL620480,1,,BAO_0000218,5939,Half-life in rat after peroral administration at 5 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,7746,10116.0
,N,50597,,,In vivo,A,,CHEMBL620481,1,,BAO_0000218,17771,Half-life in rat at a dose of 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7747,10116.0
,N,50597,,,,A,,CHEMBL620482,1,,BAO_0000218,1974,Half-life was evaluated in rats,1,,,Rattus norvegicus,Intermediate,,,7748,10116.0
,N,50597,,,,A,,CHEMBL876603,1,,BAO_0000218,4239,Half-life was measured in rat,1,,,Rattus norvegicus,Intermediate,,,7749,10116.0
,N,50597,,,In vivo,A,,CHEMBL620483,1,,BAO_0000218,6681,Half-life period for the compound was determined in rats at 50 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,7750,10116.0
,N,50597,,,In vivo,A,,CHEMBL620484,1,,BAO_0000218,17752,Half-life period in rats after intravenous administration at 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7751,10116.0
,N,50597,,,In vivo,A,,CHEMBL620485,1,,BAO_0000218,6046,Half-life period in rat at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7752,10116.0
,N,50597,,,In vivo,A,,CHEMBL620486,1,,BAO_0000218,6685,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,7753,10116.0
,N,50597,,,In vivo,A,,CHEMBL620487,1,,BAO_0000218,6685,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",1,,,Rattus norvegicus,Intermediate,,,7754,10116.0
,N,50597,,,In vivo,A,,CHEMBL620488,1,,BAO_0000218,6685,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",1,,,Rattus norvegicus,Intermediate,,,7755,10116.0
,N,50597,,,In vivo,A,,CHEMBL620489,1,,BAO_0000218,4727,Half-life time in rat the dose of 2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7756,10116.0
,N,50597,,,In vivo,A,,CHEMBL620490,1,,BAO_0000218,1088,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,1,,,Rattus norvegicus,Intermediate,,,7757,10116.0
,N,50597,,,In vivo,A,,CHEMBL620491,1,,BAO_0000218,5610,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7758,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL876604,1,,BAO_0000218,3032,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",1,,Plasma,Rattus norvegicus,Intermediate,,,7759,10116.0
,N,50597,,,In vivo,A,,CHEMBL620492,1,,BAO_0000218,5199,Oral half life was determined,1,,,Rattus norvegicus,Intermediate,,,7760,10116.0
,N,50597,,,In vivo,A,,CHEMBL620493,1,,BAO_0000218,14941,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",1,,,Rattus norvegicus,Intermediate,,,7761,10116.0
,N,50597,,,In vivo,A,,CHEMBL620494,1,,BAO_0000218,4408,Pharmacokinetic property (t1/2) in rat,1,,,Rattus norvegicus,Intermediate,,,7762,10116.0
,N,50597,,,,A,1969.0,CHEMBL620495,1,,BAO_0000218,2552,Plasma elimination half-life was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,7763,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL620496,1,,BAO_0000218,5199,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,,Plasma,Rattus norvegicus,Intermediate,,,7764,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL620497,1,,BAO_0000218,15662,Plasma half life was observed after intravenous administration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7765,10116.0
,N,50597,,,,A,1969.0,CHEMBL620498,1,,BAO_0000218,1465,Plasma half-life was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,7766,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL620499,1,,BAO_0000218,1446,Plasma half-life following oral administration in Fisher rats,1,,Plasma,Rattus norvegicus,Intermediate,,,7767,10116.0
,N,50597,,,,A,1969.0,CHEMBL620500,1,,BAO_0000218,6824,Plasma half-life in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7768,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL873809,1,,BAO_0000218,17533,Plasmatic Half-life after intravenous administration to rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7769,10116.0
,N,50597,,,In vivo,A,,CHEMBL620501,1,,BAO_0000218,5979,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,1,,,Rattus norvegicus,Intermediate,,,7770,10116.0
,N,50597,,,In vivo,A,,CHEMBL620502,1,,BAO_0000218,4689,Terminal half life after intravenous administration (1 mg/kg) in rat,1,,,Rattus norvegicus,Intermediate,,,7771,10116.0
,N,50597,,,In vivo,A,,CHEMBL620503,1,,BAO_0000218,4689,Terminal half life in Rat at a oral dose of 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7772,10116.0
,N,50597,,,In vivo,A,,CHEMBL620504,1,,BAO_0000218,2463,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,1,,,Rattus norvegicus,Intermediate,,,7773,10116.0
,N,50597,,,In vivo,A,,CHEMBL876605,1,,BAO_0000218,4883,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,7774,10116.0
,N,50597,,,In vivo,A,,CHEMBL620505,1,,BAO_0000218,4883,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,7775,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL873811,1,,BAO_0000218,15662,plasma half life was observed after intravenous administration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7776,10116.0
,N,50597,,,In vivo,A,,CHEMBL624016,1,,BAO_0000218,3598,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Expert,,,7777,10116.0
,N,50597,,,,A,,CHEMBL624017,1,,BAO_0000218,4576,Half life of compound determined in rat,1,,,Rattus norvegicus,Intermediate,,,7778,10116.0
,N,50597,,,,A,,CHEMBL624018,1,,BAO_0000218,4576,Mean residence time determined in rat,1,,,Rattus norvegicus,Intermediate,,,7779,10116.0
,N,50597,,,,A,,CHEMBL624019,1,,BAO_0000218,4576,Plasma half life determined in rat,1,,,Rattus norvegicus,Intermediate,,,7780,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL624020,1,,BAO_0000218,4910,Compound was evaluated for Tmax in brain after intravenous administration in male rats,1,,Brain,Rattus norvegicus,Intermediate,,,7781,10116.0
,N,50597,,,In vivo,A,,CHEMBL624201,1,,BAO_0000218,4891,Compound was evaluated for pharmacokinetic parameter maximum time period,1,,,Rattus norvegicus,Intermediate,,,7782,10116.0
,N,50597,,,In vivo,A,,CHEMBL872528,1,,BAO_0000218,429,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7783,10116.0
,N,50597,,,In vivo,A,,CHEMBL624202,1,,BAO_0000218,5974,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,7784,10116.0
,N,50597,,,In vivo,A,,CHEMBL624203,1,,BAO_0000218,5974,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,7785,10116.0
,N,50597,,,In vivo,A,,CHEMBL624350,1,,BAO_0000218,5974,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,7786,10116.0
,N,50597,,,In vivo,A,,CHEMBL621320,1,,BAO_0000218,5974,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,7787,10116.0
,N,50597,,,In vivo,A,,CHEMBL621321,1,,BAO_0000218,17582,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,,,Rattus norvegicus,Intermediate,,,7788,10116.0
,N,50597,,,,A,,CHEMBL621322,1,,BAO_0000218,4026,Maximum time (Tmax) required to reach Cmax in rats,1,,,Rattus norvegicus,Intermediate,,,7789,10116.0
,N,50597,,,In vivo,A,,CHEMBL621323,1,,BAO_0000218,4890,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,7790,10116.0
,N,50597,,,In vivo,A,,CHEMBL621324,1,,BAO_0000218,6571,Maximum time of clearance of compound in rats after peroral administration,1,,,Rattus norvegicus,Intermediate,,,7791,10116.0
,N,50597,,,,A,,CHEMBL621325,1,,BAO_0000218,4727,Maximum time at the dose of 2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,7792,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL875837,1,,BAO_0000218,17651,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,7793,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621326,1,,BAO_0000218,17651,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,7794,10116.0
,N,50597,,,In vivo,A,,CHEMBL621327,1,,BAO_0000218,14465,Tmax in Guinea pig (PO dose),1,,,Rattus norvegicus,Intermediate,,,7795,10116.0
,N,50597,,,In vivo,A,,CHEMBL621328,1,,BAO_0000218,14941,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",1,,,Rattus norvegicus,Intermediate,,,7796,10116.0
,N,50597,,,In vivo,A,,CHEMBL621329,1,,BAO_0000218,5960,Pharmacokinetic parameter (Tmax) in rat,1,,,Rattus norvegicus,Intermediate,,,7797,10116.0
,N,50597,,,In vivo,A,,CHEMBL621330,1,,BAO_0000218,5022,Pharmacokinetic parameter (Tmax) was estimated,1,,,Rattus norvegicus,Intermediate,,,7798,10116.0
,N,50597,,,In vivo,A,,CHEMBL621331,1,,BAO_0000218,4408,Pharmacokinetic property (Tmax) in rat,1,,,Rattus norvegicus,Intermediate,,,7799,10116.0
,N,50597,,,In vivo,A,,CHEMBL621332,1,,BAO_0000218,5983,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,1,,,Rattus norvegicus,Intermediate,,,7800,10116.0
,N,50597,,,In vivo,A,,CHEMBL621333,1,,BAO_0000218,4689,T max in Rat at a oral dose of 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7801,10116.0
,N,50597,,,In vivo,A,,CHEMBL621334,1,,BAO_0000218,2792,T max was determined at 10 mg/kg po dose in rats,1,,,Rattus norvegicus,Intermediate,,,7802,10116.0
,N,50594,,,,A,,CHEMBL621335,1,,BAO_0000218,15011,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),1,,,Mus musculus,Intermediate,,,7803,10090.0
,N,50588,,,,A,,CHEMBL621336,1,,BAO_0000218,14180,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,1,,,Canis lupus familiaris,Intermediate,,,7804,9615.0
,N,50597,,,,A,,CHEMBL621337,1,,BAO_0000218,14180,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,1,,,Rattus norvegicus,Intermediate,,,7805,10116.0
,N,50588,,,,A,,CHEMBL621338,1,,BAO_0000218,14599,Area under curve was measured after i.v. administration into Beagle dog.,1,,,Canis lupus familiaris,Intermediate,,,7806,9615.0
,N,50588,,,,A,,CHEMBL875838,1,,BAO_0000218,14599,Area under curve was measured after iv administration into Beagle dog,1,,,Canis lupus familiaris,Intermediate,,,7807,9615.0
,N,50588,,,,A,,CHEMBL621339,1,,BAO_0000218,14599,Area under curve was measured after po administration into Beagle dog,1,,,Canis lupus familiaris,Intermediate,,,7808,9615.0
,N,50588,,,,A,,CHEMBL621340,1,,BAO_0000218,14599,Area under curve was measured after po administration into Beagle dog.,1,,,Canis lupus familiaris,Intermediate,,,7809,9615.0
,U,22224,,,,A,,CHEMBL621341,0,,BAO_0000218,15675,Area under curve was measured at peroral dose of 3 mg/kg,1,,,,Autocuration,,,7810,
,U,22224,,,,A,,CHEMBL621342,0,,BAO_0000019,12706,Area under curve was measured by using concentration Vs time,1,,,,Autocuration,,,7811,
,U,22224,,,,A,,CHEMBL621343,0,,BAO_0000019,12706,Area under curve was measured by using concentration Vs time; not tested,1,,,,Autocuration,,,7812,
,N,50594,,,,A,,CHEMBL621344,1,,BAO_0000218,9750,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),1,,,Mus musculus,Intermediate,,,7813,10090.0
,N,50594,,,,A,,CHEMBL621345,1,,BAO_0000218,9750,Area under curve(AUC) was measured in mice after oral administration.,1,,,Mus musculus,Intermediate,,,7814,10090.0
,U,22224,,,,A,,CHEMBL621346,0,,BAO_0000019,14691,Area under curve(AUC) value of the compound,1,,,,Autocuration,,,7815,
,U,22224,,,,A,,CHEMBL621347,0,,BAO_0000218,14691,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,1,,,,Autocuration,,,7816,
,N,50588,,,,A,,CHEMBL621348,1,,BAO_0000218,14691,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,1,,,Canis lupus familiaris,Intermediate,,,7817,9615.0
,U,22224,,,,A,178.0,CHEMBL621349,0,,BAO_0000019,2939,Area under curve(carotid artery) was determined by the availability in blood,1,,Blood,,Autocuration,,,7818,
,U,22224,,,,A,178.0,CHEMBL621350,0,,BAO_0000019,2939,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,1,,Blood,,Autocuration,,,7819,
,U,22224,,,,A,178.0,CHEMBL875839,0,,BAO_0000019,2939,Area under curve(carotid artery) was determined by the availability in blood; No data,1,,Blood,,Autocuration,,,7820,
,U,22224,,,,A,178.0,CHEMBL620211,0,,BAO_0000019,2939,Area under curve(portal vein) was determined by the availability in blood,1,,Blood,,Autocuration,,,7821,
,U,22224,,,,A,178.0,CHEMBL620212,0,,BAO_0000019,2939,Area under curve(portal vein) was determined by the availability in blood; ND means no data,1,,Blood,,Autocuration,,,7822,
,U,22224,,,,A,178.0,CHEMBL620213,0,,BAO_0000019,2939,Area under curve(portal vein) was determined by the availability in blood; No data,1,,Blood,,Autocuration,,,7823,
,N,50797,,,,A,1969.0,CHEMBL620214,1,,BAO_0000218,9552,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",1,,Plasma,Macaca mulatta,Intermediate,,,7824,9544.0
,N,50797,,,,A,1969.0,CHEMBL620215,1,,BAO_0000218,9552,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",1,,Plasma,Macaca mulatta,Intermediate,,,7825,9544.0
,N,50797,,,,A,1969.0,CHEMBL620216,1,,BAO_0000218,9552,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,1,,Plasma,Macaca mulatta,Intermediate,,,7826,9544.0
,N,50588,,,,A,1969.0,CHEMBL620888,1,,BAO_0000218,9552,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",1,,Plasma,Canis lupus familiaris,Intermediate,,,7827,9615.0
,N,50588,,,,A,1969.0,CHEMBL620889,1,,BAO_0000218,9552,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",1,,Plasma,Canis lupus familiaris,Intermediate,,,7828,9615.0
,U,22224,,,,A,1969.0,CHEMBL620890,0,,BAO_0000019,9552,Area under plasma concentration vs time curve observed in rats for 0-3 h,1,,Plasma,,Autocuration,,,7829,
,N,50597,,,,A,1969.0,CHEMBL620891,1,,BAO_0000218,11911,Area under plasma time curve determined in male rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7830,10116.0
,U,22224,,,,A,,CHEMBL620892,0,,BAO_0000019,16618,Area under the MAP curve measured over 5 min.,1,,,,Autocuration,,,7831,
,N,50594,,,,A,,CHEMBL621079,1,,BAO_0000218,14387,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,1,,,Mus musculus,Intermediate,,,7832,10090.0
,N,50594,,,,A,,CHEMBL621080,1,,BAO_0000218,14387,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,1,,,Mus musculus,Intermediate,,,7833,10090.0
,N,50588,,,,A,,CHEMBL621081,1,,BAO_0000218,12836,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,1,,,Canis lupus familiaris,Intermediate,,,7834,9615.0
,N,100712,,,,A,,CHEMBL621082,1,,BAO_0000218,12836,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,1,,,Cricetinae,Intermediate,,,7835,10026.0
,N,50597,,,,A,,CHEMBL621083,1,,BAO_0000218,12836,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,1,,,Rattus norvegicus,Intermediate,,,7836,10116.0
,N,50588,,,,A,,CHEMBL621084,1,,BAO_0000218,14339,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,1,,,Canis lupus familiaris,Intermediate,,,7837,9615.0
,N,50588,,,,A,,CHEMBL621085,1,,BAO_0000218,14339,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,1,,,Canis lupus familiaris,Intermediate,,,7838,9615.0
,N,50588,,,,A,,CHEMBL621086,1,,BAO_0000218,14339,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,1,,,Canis lupus familiaris,Intermediate,,,7839,9615.0
,N,50588,,,,A,,CHEMBL621087,1,,BAO_0000218,10524,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),1,,,Canis lupus familiaris,Intermediate,,,7840,9615.0
,N,50588,,,,A,,CHEMBL622607,1,,BAO_0000218,9994,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),1,,,Canis lupus familiaris,Intermediate,,,7841,9615.0
,N,50588,,,,A,,CHEMBL622608,1,,BAO_0000218,11325,Serum AUC in marmosets (IV dose),1,,,Canis lupus familiaris,Intermediate,,,7842,9615.0
,U,22224,,,,A,,CHEMBL624481,0,,BAO_0000019,12536,Area under the curve after intravenous administration at a dose of 10 umol/kg,1,,,,Autocuration,,,7843,
,U,22224,,,,A,,CHEMBL624482,0,,BAO_0000019,12536,Area under the curve after intravenous administration at a dose of 2 umol/kg,1,,,,Autocuration,,,7844,
,U,22224,,,,A,,CHEMBL624483,0,,BAO_0000019,12536,Area under the curve after intravenous administration at a dose of 4 umol/kg,1,,,,Autocuration,,,7845,
,U,22224,,,,A,,CHEMBL624484,0,,BAO_0000019,12536,Area under the curve after intravenous administration at a dose of 40 umol/kg,1,,,,Autocuration,,,7846,
,U,22224,,,,A,,CHEMBL624485,0,,BAO_0000019,12536,Area under the curve after intravenous administration at a dose of 5 umol/kg,1,,,,Autocuration,,,7847,
,N,50597,,,,A,,CHEMBL624486,1,,BAO_0000218,15556,Area under the curve for fumarate salt was evaluated in F344 Rats.,1,,,Rattus norvegicus,Intermediate,,,7848,10116.0
,U,22224,,,,A,,CHEMBL624487,0,,BAO_0000019,2809,Area under the curve for the compound was calculated.,1,,,,Autocuration,,,7849,
,U,22224,,,,A,,CHEMBL624488,0,,BAO_0000019,9511,Area under the curve in concentration/ time,1,,,,Autocuration,,,7850,
,N,50597,,,,A,,CHEMBL624489,1,,BAO_0000218,12818,Area under the curve administered intraintestinal in rats.,1,,,Rattus norvegicus,Intermediate,,,7851,10116.0
,N,50597,,,,A,,CHEMBL625184,1,,BAO_0000218,12818,Area under the curve administered intravenously in rats.,1,,,Rattus norvegicus,Intermediate,,,7852,10116.0
,U,22224,,,,A,,CHEMBL625185,0,,BAO_0000019,15118,Area under the curve during intravenous administration,1,,,,Autocuration,,,7853,
,U,22224,,,,A,,CHEMBL875954,0,,BAO_0000019,15118,Area under the curve during intravenous administration; Not determined,1,,,,Autocuration,,,7854,
,U,22224,,,,A,,CHEMBL625186,0,,BAO_0000019,15118,Area under the curve during systemic administration,1,,,,Autocuration,,,7855,
,U,22224,,,,A,,CHEMBL625187,0,,BAO_0000019,15118,Area under the curve during systemic administration; Not determined,1,,,,Autocuration,,,7856,
,U,22224,,,,A,,CHEMBL625188,0,,BAO_0000019,2632,Area under the curve was calculated for the compound.,1,,,,Autocuration,,,7857,
,N,50588,,,,A,,CHEMBL625189,1,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,1,,,Canis lupus familiaris,Intermediate,,,7858,9615.0
,N,50588,,,,A,,CHEMBL625190,1,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,1,,,Canis lupus familiaris,Intermediate,,,7859,9615.0
,N,50597,,,,A,,CHEMBL621733,1,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,7860,10116.0
,N,50597,,,,A,,CHEMBL621734,1,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,7861,10116.0
,N,50597,,,,A,,CHEMBL621735,1,,BAO_0000218,11149,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,1,,,Rattus norvegicus,Intermediate,,,7862,10116.0
,N,50597,,,,A,1969.0,CHEMBL621736,1,,BAO_0000218,17796,Clearance of the drug was measured in the plasma of rat; No data,1,,Plasma,Rattus norvegicus,Intermediate,,,7863,10116.0
,N,50597,,,,A,1969.0,CHEMBL621737,1,,BAO_0000218,5247,The pharmacokinetic parameter plasma clearance in vivo in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,7864,10116.0
,N,50597,,,,A,,CHEMBL621738,1,,BAO_0000218,4727,Plasma clearance at the dose of 2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,7865,10116.0
,N,50597,,,In vivo,A,,CHEMBL622806,1,,BAO_0000218,5654,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,7866,10116.0
,N,50597,,,In vivo,A,,CHEMBL623519,1,,BAO_0000218,5654,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,7867,10116.0
,N,50597,,,In vivo,A,,CHEMBL623520,1,,BAO_0000218,17260,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,,Rattus norvegicus,Intermediate,,,7868,10116.0
,N,50597,,,In vivo,A,,CHEMBL623521,1,,BAO_0000218,17065,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,,Rattus norvegicus,Intermediate,,,7869,10116.0
,N,50597,,,In vivo,A,,CHEMBL623522,1,,BAO_0000218,17671,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7870,10116.0
,N,50597,,,In vivo,A,,CHEMBL623523,1,,BAO_0000218,6672,Clearance rate in rat,1,,,Rattus norvegicus,Intermediate,,,7871,10116.0
,N,50597,,,In vivo,A,,CHEMBL623690,1,,BAO_0000218,6673,Clearance rate in rat,1,,,Rattus norvegicus,Intermediate,,,7872,10116.0
,N,50597,,,In vivo,A,,CHEMBL623691,1,,BAO_0000218,5978,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,7873,10116.0
,N,50597,,,In vivo,A,,CHEMBL623692,1,,BAO_0000218,5978,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,7874,10116.0
,N,50597,,,In vivo,A,,CHEMBL623693,1,,BAO_0000218,5978,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,7875,10116.0
,N,50597,,,In vivo,A,,CHEMBL623694,1,,BAO_0000218,5978,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,7876,10116.0
,N,50597,,,In vivo,A,,CHEMBL623695,1,,BAO_0000218,4413,Clearance of compound after iv administration of 20 mg/kg dose in rat,1,,,Rattus norvegicus,Intermediate,,,7877,10116.0
,N,50597,,,In vivo,A,,CHEMBL623696,1,,BAO_0000218,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,1,,,Rattus norvegicus,Intermediate,,,7878,10116.0
,N,50597,,,In vivo,A,,CHEMBL623697,1,,BAO_0000218,2661,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,1,,,Rattus norvegicus,Intermediate,,,7879,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL623698,0,,BAO_0000218,5005,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,1,,Plasma,Macaca mulatta,Intermediate,,,7880,9544.0
,U,22224,,,In vivo,A,1969.0,CHEMBL623699,0,,BAO_0000218,5005,Compound was tested for its plasma clearance rate in Sprague Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,7881,10116.0
,N,50597,,,In vivo,A,,CHEMBL623700,1,,BAO_0000218,15765,Mean (%CV) PK parameters for CL(mL/min/kg).,1,,,Rattus norvegicus,Intermediate,,,7882,10116.0
,N,50597,,,In vivo,A,,CHEMBL623701,1,,BAO_0000218,3747,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,1,,,Rattus norvegicus,Intermediate,,,7883,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623702,1,,BAO_0000218,16366,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,1,,Plasma,Rattus norvegicus,Intermediate,,,7884,10116.0
,N,50597,,,In vivo,A,,CHEMBL623703,1,,BAO_0000218,4199,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,1,,,Rattus norvegicus,Intermediate,,,7885,10116.0
,N,50597,,,In vivo,A,,CHEMBL623704,1,,BAO_0000218,17267,Plasma clearance in rat was determined,1,,,Rattus norvegicus,Intermediate,,,7886,10116.0
,N,50597,,,In vivo,A,,CHEMBL623705,1,,BAO_0000218,6535,Plasma clearance in rat after administration of 2 mg/kg iv,1,,,Rattus norvegicus,Intermediate,,,7887,10116.0
,N,50597,,,In vivo,A,,CHEMBL623706,1,,BAO_0000218,6535,Plasma clearance in rat after administration of 2 mg/kg iv,1,,,Rattus norvegicus,Intermediate,,,7888,10116.0
,N,50597,,,In vivo,A,,CHEMBL623707,1,,BAO_0000218,5041,Plasma clearance was determined,1,,,Rattus norvegicus,Intermediate,,,7889,10116.0
,N,50597,,,In vivo,A,,CHEMBL623708,1,,BAO_0000218,5960,Plasma clearance in rat,1,,,Rattus norvegicus,Intermediate,,,7890,10116.0
,N,50597,,,In vivo,A,,CHEMBL623709,1,,BAO_0000218,5937,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7891,10116.0
,N,50597,,,In vivo,A,,CHEMBL623710,1,,BAO_0000218,5871,Plasma clearance in rat by iv administration,1,,,Rattus norvegicus,Intermediate,,,7892,10116.0
,N,50597,,,In vivo,A,,CHEMBL623711,1,,BAO_0000218,5874,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7893,10116.0
,N,50597,,,In vivo,A,,CHEMBL623712,1,,BAO_0000218,6504,Plasma clearance in rat p.o.,1,,,Rattus norvegicus,Intermediate,,,7894,10116.0
,N,50597,,,In vivo,A,,CHEMBL623713,1,,BAO_0000218,6803,Plasma clearance in rats,1,,,Rattus norvegicus,Intermediate,,,7895,10116.0
,N,50597,,,In vivo,A,,CHEMBL623714,1,,BAO_0000218,5041,Plasma clearance was determined; ND denotes no data,1,,,Rattus norvegicus,Intermediate,,,7896,10116.0
,N,50597,,,In vivo,A,,CHEMBL623715,1,,BAO_0000218,5041,Plasma clearance was determined; ND denotes not determined,1,,,Rattus norvegicus,Intermediate,,,7897,10116.0
,N,50597,,,In vivo,A,,CHEMBL623716,1,,BAO_0000218,1916,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,,,Rattus norvegicus,Intermediate,,,7898,10116.0
,N,50597,,,In vivo,A,,CHEMBL622980,1,,BAO_0000218,5199,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,,,Rattus norvegicus,Intermediate,,,7899,10116.0
,N,50597,,,In vivo,A,,CHEMBL622981,1,,BAO_0000218,16367,Plasma administration to rats,1,,,Rattus norvegicus,Intermediate,,,7900,10116.0
,N,50597,,,In vivo,A,,CHEMBL622982,1,,BAO_0000218,6362,Plasma clearance of the compound in female Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,7901,10116.0
,N,50597,,,In vivo,A,,CHEMBL622983,1,,BAO_0000218,15662,Plasma clearance was observed after intravenous administration in rat,1,,,Rattus norvegicus,Intermediate,,,7902,10116.0
,N,50597,,,In vivo,A,,CHEMBL622984,1,,BAO_0000218,6215,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,1,,,Rattus norvegicus,Intermediate,,,7903,10116.0
,N,50597,,,In vivo,A,,CHEMBL622985,1,,BAO_0000218,1466,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,1,,,Rattus norvegicus,Intermediate,,,7904,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623631,1,,BAO_0000218,15662,plasma clearance was observed after intravenous administration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7905,10116.0
,N,50597,,,In vivo,A,,CHEMBL623632,1,,BAO_0000218,4723,In vivo CL/F determined,1,,,Rattus norvegicus,Intermediate,,,7906,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623633,1,,BAO_0000218,2792,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,7907,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623634,1,,BAO_0000218,2792,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,7908,10116.0
,N,50597,,,In vivo,A,,CHEMBL623635,1,,BAO_0000218,5213,Compound was tested for the lower blood clearance in rat,1,,,Rattus norvegicus,Intermediate,,,7909,10116.0
,N,50597,,,In vivo,A,,CHEMBL621195,1,,BAO_0000218,4687,Evaluated for the low clearance in rat (in vivo),1,,,Rattus norvegicus,Intermediate,,,7910,10116.0
,N,50597,,,In vivo,A,,CHEMBL621196,1,,BAO_0000218,3371,Pharmacokinetic property (CLb)of the compound was determined in rat,1,,,Rattus norvegicus,Intermediate,,,7911,10116.0
,N,50597,,,In vivo,A,,CHEMBL875287,1,,BAO_0000218,4690,Rapid clearance after intravenous administration in rat was determined,1,,,Rattus norvegicus,Intermediate,,,7912,10116.0
,N,50597,,,In vivo,A,,CHEMBL621197,1,,BAO_0000218,5702,Clearance measured in rat,1,,,Rattus norvegicus,Intermediate,,,7913,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621198,1,,BAO_0000218,740,Compound was evaluated for plasma clearance in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7914,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621199,1,,BAO_0000218,4853,Low plasma clearance was calculated in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7915,10116.0
,N,50597,,,In vivo,A,,CHEMBL621200,1,,BAO_0000218,5789,Pharmacokinetic property (Clp) in rat,1,,,Rattus norvegicus,Intermediate,,,7916,10116.0
,N,50597,,,In vivo,A,,CHEMBL621201,1,,BAO_0000218,4527,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,1,,,Rattus norvegicus,Intermediate,,,7917,10116.0
,N,50597,,,In vivo,A,,CHEMBL621202,1,,BAO_0000218,4527,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,1,,,Rattus norvegicus,Intermediate,,,7918,10116.0
,N,50597,,,In vivo,A,,CHEMBL621203,1,,BAO_0000218,6518,Plasma clearance after IV dosing at 0.5 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,7919,10116.0
,N,50597,,,In vivo,A,,CHEMBL621204,1,,BAO_0000218,6518,Plasma clearance after IV dosing at 1 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,7920,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621205,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,1,,Heart,Rattus norvegicus,Intermediate,,,7921,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621206,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,1,,Heart,Rattus norvegicus,Intermediate,,,7922,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621207,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,,Heart,Rattus norvegicus,Intermediate,,,7923,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621208,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,1,,Heart,Rattus norvegicus,Intermediate,,,7924,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621209,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,1,,Heart,Rattus norvegicus,Intermediate,,,7925,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL876484,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,1,,Heart,Rattus norvegicus,Intermediate,,,7926,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621210,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,Heart,Rattus norvegicus,Intermediate,,,7927,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621211,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,1,,Heart,Rattus norvegicus,Intermediate,,,7928,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621212,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,1,,Heart,Rattus norvegicus,Intermediate,,,7929,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621213,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA at 15 min,1,,Heart,Rattus norvegicus,Intermediate,,,7930,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621214,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,1,,Heart,Rattus norvegicus,Intermediate,,,7931,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621215,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA at 30 min,1,,Heart,Rattus norvegicus,Intermediate,,,7932,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621216,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,1,,Heart,Rattus norvegicus,Intermediate,,,7933,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621217,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,1,,Heart,Rattus norvegicus,Intermediate,,,7934,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621218,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,1,,Heart,Rattus norvegicus,Intermediate,,,7935,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621219,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,1,,Heart,Rattus norvegicus,Intermediate,,,7936,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621220,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,1,,Heart,Rattus norvegicus,Intermediate,,,7937,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621221,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,1,,Heart,Rattus norvegicus,Intermediate,,,7938,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621222,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,1,,Heart,Rattus norvegicus,Intermediate,,,7939,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621223,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,1,,Heart,Rattus norvegicus,Intermediate,,,7940,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL876485,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,1,,Heart,Rattus norvegicus,Intermediate,,,7941,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621224,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,Heart,Rattus norvegicus,Intermediate,,,7942,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621225,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,1,,Heart,Rattus norvegicus,Intermediate,,,7943,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621226,1,,BAO_0000218,9866,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,1,,Heart,Rattus norvegicus,Intermediate,,,7944,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621227,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,1,,Kidney,Rattus norvegicus,Intermediate,,,7945,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621228,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,Kidney,Rattus norvegicus,Intermediate,,,7946,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621229,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,1,,Kidney,Rattus norvegicus,Intermediate,,,7947,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621230,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,1,,Kidney,Rattus norvegicus,Intermediate,,,7948,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621231,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,1,,Kidney,Rattus norvegicus,Intermediate,,,7949,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621232,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,Kidney,Rattus norvegicus,Intermediate,,,7950,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621233,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,Kidney,Rattus norvegicus,Intermediate,,,7951,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621234,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,1,,Kidney,Rattus norvegicus,Intermediate,,,7952,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621235,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,1,,Kidney,Rattus norvegicus,Intermediate,,,7953,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621236,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,Kidney,Rattus norvegicus,Intermediate,,,7954,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621237,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,1,,Kidney,Rattus norvegicus,Intermediate,,,7955,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL876486,1,,BAO_0000218,9866,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,1,,Kidney,Rattus norvegicus,Intermediate,,,7956,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL622436,1,,BAO_0000218,9866,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,1,,Intestine,Rattus norvegicus,Intermediate,,,7957,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL622437,1,,BAO_0000218,9866,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,1,,Intestine,Rattus norvegicus,Intermediate,,,7958,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL622438,1,,BAO_0000218,9866,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,1,,Intestine,Rattus norvegicus,Intermediate,,,7959,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622439,1,,BAO_0000218,9866,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,1,,Liver,Rattus norvegicus,Intermediate,,,7960,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622440,1,,BAO_0000218,9866,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,1,,Liver,Rattus norvegicus,Intermediate,,,7961,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622441,1,,BAO_0000218,9866,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,1,,Liver,Rattus norvegicus,Intermediate,,,7962,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622442,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,1,,Liver,Rattus norvegicus,Intermediate,,,7963,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622443,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,1,,Liver,Rattus norvegicus,Intermediate,,,7964,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622444,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,1,,Liver,Rattus norvegicus,Intermediate,,,7965,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622445,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,1,,Liver,Rattus norvegicus,Intermediate,,,7966,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622446,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,1,,Liver,Rattus norvegicus,Intermediate,,,7967,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622447,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,1,,Liver,Rattus norvegicus,Intermediate,,,7968,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622448,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,1,,Liver,Rattus norvegicus,Intermediate,,,7969,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622449,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,1,,Liver,Rattus norvegicus,Intermediate,,,7970,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622450,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,1,,Liver,Rattus norvegicus,Intermediate,,,7971,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622451,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,1,,Liver,Rattus norvegicus,Intermediate,,,7972,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622452,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA at 15 min,1,,Liver,Rattus norvegicus,Intermediate,,,7973,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622453,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,1,,Liver,Rattus norvegicus,Intermediate,,,7974,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622454,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA at 30 min,1,,Liver,Rattus norvegicus,Intermediate,,,7975,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622455,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,1,,Liver,Rattus norvegicus,Intermediate,,,7976,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL876024,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,1,,Liver,Rattus norvegicus,Intermediate,,,7977,10116.0
,N,50597,,,In vivo,A,,CHEMBL622456,1,,BAO_0000218,2792,T max was determined at 3 mg/kg po dose in rats,1,,,Rattus norvegicus,Intermediate,,,7978,10116.0
,N,50597,,,In vivo,A,,CHEMBL622457,1,,BAO_0000218,15078,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,7979,10116.0
,N,50597,,,In vivo,A,,CHEMBL622458,1,,BAO_0000218,15078,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,7980,10116.0
,N,50597,,,,A,,CHEMBL622459,1,,BAO_0000218,15022,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,1,,,Rattus norvegicus,Intermediate,,,7981,10116.0
,N,50597,,,,A,,CHEMBL873343,1,,BAO_0000218,15022,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,1,,,Rattus norvegicus,Intermediate,,,7982,10116.0
,N,50597,,,,A,,CHEMBL622460,1,,BAO_0000218,15022,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,1,,,Rattus norvegicus,Intermediate,,,7983,10116.0
,N,50597,,,,A,1969.0,CHEMBL622461,1,,BAO_0000218,4576,Time for maximum plasma concentration determined in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7984,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622462,1,,BAO_0000218,6681,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,1,,Plasma,Rattus norvegicus,Intermediate,,,7985,10116.0
,N,50597,,,In vivo,A,,CHEMBL622463,1,,BAO_0000218,16365,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,1,,,Rattus norvegicus,Intermediate,,,7986,10116.0
,N,50597,,,In vivo,A,,CHEMBL622464,1,,BAO_0000218,16365,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,1,,,Rattus norvegicus,Intermediate,,,7987,10116.0
,N,50597,,,In vivo,A,,CHEMBL622465,1,,BAO_0000218,16365,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7988,10116.0
,N,50597,,,In vivo,A,,CHEMBL622466,1,,BAO_0000218,16365,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,1,,,Rattus norvegicus,Intermediate,,,7989,10116.0
,N,50597,,,In vivo,A,,CHEMBL622467,1,,BAO_0000218,16365,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,7990,10116.0
,N,50597,,,,A,1969.0,CHEMBL622468,1,,BAO_0000218,6824,Time of maximum plasma concentration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,7991,10116.0
,N,50597,,,,A,1969.0,CHEMBL876025,1,,BAO_0000218,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",1,,Plasma,Rattus norvegicus,Intermediate,,,7992,10116.0
,N,50597,,,,A,1969.0,CHEMBL622469,1,,BAO_0000218,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",1,,Plasma,Rattus norvegicus,Intermediate,,,7993,10116.0
,N,50597,,,,A,1969.0,CHEMBL622470,1,,BAO_0000218,6685,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,,Plasma,Rattus norvegicus,Intermediate,,,7994,10116.0
,N,50597,,,In vivo,A,,CHEMBL622471,1,,BAO_0000218,15662,Time required to reach maximum concentration (Cmax) after oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,7995,10116.0
,N,50597,,,,A,1969.0,CHEMBL622472,1,,BAO_0000218,1742,Time required to reach maximum concentration in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,7996,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622473,1,,BAO_0000218,2774,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,1,,Plasma,Rattus norvegicus,Intermediate,,,7997,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624282,1,,BAO_0000218,5199,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,7998,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624283,1,,BAO_0000218,12873,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,7999,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624284,1,,BAO_0000218,12873,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,8000,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624285,1,,BAO_0000218,1916,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,,Plasma,Rattus norvegicus,Intermediate,,,8001,10116.0
,N,50597,,,In vivo,A,,CHEMBL624286,1,,BAO_0000218,16367,Time to reach Cmax after oral administration to rats,1,,,Rattus norvegicus,Intermediate,,,8002,10116.0
,N,50597,,,In vivo,A,,CHEMBL624287,1,,BAO_0000218,16366,Time to reach Cmax when a dose of 1 mg/kg is administered orally,1,,,Rattus norvegicus,Intermediate,,,8003,10116.0
,N,50597,,,,A,,CHEMBL624288,1,,BAO_0000218,216,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,1,,,Rattus norvegicus,Intermediate,,,8004,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624289,1,,BAO_0000218,6410,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,1,,Plasma,Rattus norvegicus,Intermediate,,,8005,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL873344,1,,BAO_0000218,6410,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,8006,10116.0
,N,50597,,,In vivo,A,,CHEMBL619623,1,,BAO_0000218,6215,Tmax after peroral administration (10 mg/kg) was determined in rat,1,,,Rattus norvegicus,Intermediate,,,8007,10116.0
,N,50597,,,In vivo,A,,CHEMBL621399,1,,BAO_0000218,3598,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Expert,,,8008,10116.0
,N,50597,,,In vivo,A,,CHEMBL621400,1,,BAO_0000218,4527,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,1,,,Rattus norvegicus,Intermediate,,,8009,10116.0
,N,50597,,,In vivo,A,,CHEMBL621401,1,,BAO_0000218,17670,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",1,,,Rattus norvegicus,Intermediate,,,8010,10116.0
,N,50597,,,,A,,CHEMBL621402,1,,BAO_0000218,1465,Tmax was determined,1,,,Rattus norvegicus,Intermediate,,,8011,10116.0
,N,50597,,,,A,,CHEMBL621403,1,,BAO_0000218,2552,Tmax was determined,1,,,Rattus norvegicus,Intermediate,,,8012,10116.0
,N,50597,,,In vivo,A,,CHEMBL621121,1,,BAO_0000218,5656,Tmax after oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,8013,10116.0
,N,50597,,,In vivo,A,,CHEMBL872525,1,,BAO_0000218,17764,Tmax after peroral administration in rats at 2.4 uM/kg,1,,,Rattus norvegicus,Intermediate,,,8014,10116.0
,N,50597,,,,A,,CHEMBL621122,1,,BAO_0000218,5610,Tmax in male rat,1,,,Rattus norvegicus,Intermediate,,,8015,10116.0
,N,50597,,,In vivo,A,,CHEMBL621123,1,,BAO_0000218,6046,Tmax in rat at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8016,10116.0
,N,50597,,,In vivo,A,,CHEMBL621124,1,,BAO_0000218,5874,Tmax in rat by po administration at a dose of 40 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8017,10116.0
,N,50597,,,,A,,CHEMBL621125,1,,BAO_0000218,17596,Tmax in rats,1,,,Rattus norvegicus,Intermediate,,,8018,10116.0
,N,50597,,,In vivo,A,,CHEMBL621126,1,,BAO_0000218,17804,Tmax was measured in rats after peroral administration at 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8019,10116.0
,N,50597,,,In vivo,A,,CHEMBL621127,1,,BAO_0000218,1908,Tmax value after oral dose at a dose of 10 mg/kg in rats.,1,,,Rattus norvegicus,Intermediate,,,8020,10116.0
,N,50597,,,In vivo,A,,CHEMBL621128,1,,BAO_0000218,2959,Tmax value after administration of 20 mg/Kg oral dose in rat,1,,,Rattus norvegicus,Intermediate,,,8021,10116.0
,N,50597,,,In vivo,A,,CHEMBL618263,1,,BAO_0000218,6757,Tmax value at a dose of 10 mg/kg in male SD rats,1,,,Rattus norvegicus,Intermediate,,,8022,10116.0
,N,50597,,,In vivo,A,,CHEMBL618264,1,,BAO_0000218,6757,Tmax value at a dose of 100 mg/kg in male SD rats,1,,,Rattus norvegicus,Intermediate,,,8023,10116.0
,N,50597,,,In vivo,A,,CHEMBL618265,1,,BAO_0000218,6757,Tmax value at a dose of 50 mg/kg in male SD rats,1,,,Rattus norvegicus,Intermediate,,,8024,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL618266,1,,BAO_0000218,4186,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,Plasma,Rattus norvegicus,Intermediate,,,8025,10116.0
,N,50597,,,In vivo,A,,CHEMBL618267,1,,BAO_0000218,15662,time required to reach maximum concentration (Cmax) after oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,8026,10116.0
,N,50597,,,,A,1088.0,CHEMBL618450,1,,BAO_0000218,429,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),1,,Urine,Rattus norvegicus,Intermediate,,,8027,10116.0
,N,50597,,,,A,1088.0,CHEMBL618451,1,,BAO_0000218,429,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),1,,Urine,Rattus norvegicus,Intermediate,,,8028,10116.0
,N,50597,,,,A,,CHEMBL618452,1,,BAO_0000218,5546,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,,,Rattus norvegicus,Intermediate,,,8029,10116.0
,N,50597,,,,A,1088.0,CHEMBL618453,1,,BAO_0000218,3173,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,1,,Urine,Rattus norvegicus,Intermediate,,,8030,10116.0
,N,50597,,,,A,1088.0,CHEMBL618454,1,,BAO_0000218,3173,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,1,,Urine,Rattus norvegicus,Intermediate,,,8031,10116.0
,N,50597,,,,A,1088.0,CHEMBL618455,1,,BAO_0000218,3173,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,1,,Urine,Rattus norvegicus,Intermediate,,,8032,10116.0
,N,50597,,,In vivo,A,,CHEMBL618456,1,,BAO_0000218,4257,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,1,,,Rattus norvegicus,Intermediate,,,8033,10116.0
,N,50597,,,In vivo,A,,CHEMBL618457,1,,BAO_0000218,6011,Compound distribution in rat tissues was determined,1,,,Rattus norvegicus,Intermediate,,,8034,10116.0
,N,50597,,,In vivo,A,,CHEMBL618458,1,,BAO_0000218,5472,Volume of distribution was evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,8035,10116.0
,N,50597,,,,A,,CHEMBL618459,1,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8036,10116.0
,N,50597,,,,A,,CHEMBL876733,1,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8037,10116.0
,N,50588,,,,A,,CHEMBL618460,1,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,1,,,Canis lupus familiaris,Intermediate,,,8038,9615.0
,N,50597,,,,A,,CHEMBL618461,1,,BAO_0000218,14346,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8039,10116.0
,U,22224,,,,A,,CHEMBL618462,0,,BAO_0000019,15469,Area under the curve was determined after oral administration (300 uM/Kg),1,,,,Autocuration,,,8040,
,N,50597,,,,A,,CHEMBL618463,1,,BAO_0000218,14346,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8041,10116.0
,N,50597,,,,A,,CHEMBL618464,1,,BAO_0000218,14346,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8042,10116.0
,N,50597,,,,A,,CHEMBL618465,1,,BAO_0000218,14346,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8043,10116.0
,N,50597,,,,A,,CHEMBL618466,1,,BAO_0000218,14346,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8044,10116.0
,N,50597,,,,A,,CHEMBL618467,1,,BAO_0000218,14346,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8045,10116.0
,N,50597,,,,A,,CHEMBL618468,1,,BAO_0000218,15372,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,8046,10116.0
,N,50588,,,,A,1969.0,CHEMBL618469,1,,BAO_0000218,12935,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,1,,Plasma,Canis lupus familiaris,Intermediate,,,8047,9615.0
,N,50588,,,,A,1969.0,CHEMBL618470,1,,BAO_0000218,12935,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,1,,Plasma,Canis lupus familiaris,Intermediate,,,8048,9615.0
,U,22224,,,,A,,CHEMBL618471,0,,BAO_0000218,14813,Plasma drug AUC in rat (PO dose),1,,,,Autocuration,,,8049,
,N,50594,,,,A,,CHEMBL618472,1,,BAO_0000218,15792,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,1,,,Mus musculus,Intermediate,,,8050,10090.0
,U,22224,,,,A,,CHEMBL618473,0,,BAO_0000218,3579,Area under was determined at a dose of 30 mg/kg,1,,,,Autocuration,,,8051,
,N,50506,,,,A,,CHEMBL621699,1,,BAO_0000218,12487,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,1,,,Mustela putorius furo,Intermediate,,,8052,9669.0
,N,50597,,,,A,,CHEMBL621700,1,,BAO_0000218,12487,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,1,,,Rattus norvegicus,Intermediate,,,8053,10116.0
,N,50597,,,,A,,CHEMBL621701,1,,BAO_0000218,12487,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,1,,,Rattus norvegicus,Intermediate,,,8054,10116.0
,N,50506,,,,A,,CHEMBL621702,1,,BAO_0000218,12487,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,1,,,Mustela putorius furo,Intermediate,,,8055,9669.0
,N,50588,,,,A,,CHEMBL621703,1,,BAO_0000218,12487,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,1,,,Canis lupus familiaris,Intermediate,,,8056,9615.0
,N,50588,,,,A,,CHEMBL621704,1,,BAO_0000218,12487,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,1,,,Canis lupus familiaris,Intermediate,,,8057,9615.0
,N,50597,,,,A,,CHEMBL624259,1,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",1,,,Rattus norvegicus,Intermediate,,,8058,10116.0
,N,50597,,,,A,,CHEMBL624260,1,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",1,,,Rattus norvegicus,Intermediate,,,8059,10116.0
,N,50597,,,,A,,CHEMBL624430,1,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",1,,,Rattus norvegicus,Intermediate,,,8060,10116.0
,N,50597,,,,A,,CHEMBL624431,1,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",1,,,Rattus norvegicus,Intermediate,,,8061,10116.0
,N,50597,,,,A,,CHEMBL624432,1,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",1,,,Rattus norvegicus,Intermediate,,,8062,10116.0
,N,50597,,,,A,,CHEMBL624433,1,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",1,,,Rattus norvegicus,Intermediate,,,8063,10116.0
,N,50597,,,,A,,CHEMBL624434,1,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",1,,,Rattus norvegicus,Intermediate,,,8064,10116.0
,N,50597,,,,A,,CHEMBL624435,1,,BAO_0000218,12902,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",1,,,Rattus norvegicus,Intermediate,,,8065,10116.0
,N,50594,,,,A,,CHEMBL618570,1,,BAO_0000218,12745,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,1,,,Mus musculus,Intermediate,,,8066,10090.0
,N,50594,,,,A,,CHEMBL618571,1,,BAO_0000218,12745,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,,Mus musculus,Intermediate,,,8067,10090.0
,N,50594,,,,A,,CHEMBL618572,1,,BAO_0000218,12745,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,1,,,Mus musculus,Intermediate,,,8068,10090.0
,N,50594,,,,A,,CHEMBL618573,1,,BAO_0000218,12745,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,,Mus musculus,Intermediate,,,8069,10090.0
,N,50594,,,,A,,CHEMBL619267,1,,BAO_0000218,12745,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,1,,,Mus musculus,Intermediate,,,8070,10090.0
,N,50594,,,,A,,CHEMBL619431,1,,BAO_0000218,12745,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,,Mus musculus,Intermediate,,,8071,10090.0
,N,50594,,,,A,,CHEMBL619432,1,,BAO_0000218,12745,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,1,,,Mus musculus,Intermediate,,,8072,10090.0
,N,50594,,,,A,,CHEMBL619433,1,,BAO_0000218,12745,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),1,,,Mus musculus,Intermediate,,,8073,10090.0
,U,22224,,,,A,1969.0,CHEMBL619434,0,,BAO_0000218,13298,AUC in mice after oral dose (50 mg/kg),1,,Plasma,,Autocuration,,,8074,
,N,50594,,,,A,1977.0,CHEMBL619435,1,,BAO_0000218,12226,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,1,,Serum,Mus musculus,Intermediate,,,8075,10090.0
,U,22224,,,,A,1969.0,CHEMBL619436,0,,BAO_0000019,12634,AUC (0-4 hr) ug/ml/h,1,,Plasma,,Autocuration,,,8076,
,N,50597,,,,A,,CHEMBL619437,1,,BAO_0000218,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,1,,,Rattus norvegicus,Intermediate,,,8077,10116.0
,U,22224,,,,A,,CHEMBL619438,0,,BAO_0000218,13889,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,1,,,,Autocuration,,,8078,
,N,50594,,,,A,,CHEMBL619439,1,,BAO_0000218,10018,Compound was evaluated for Area under curve in mice,1,,,Mus musculus,Intermediate,,,8079,10090.0
,N,50597,,,,A,,CHEMBL619440,1,,BAO_0000218,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,,,Rattus norvegicus,Intermediate,,,8080,10116.0
,U,22224,,,,F,,CHEMBL619441,0,,BAO_0000218,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,,,,Autocuration,,,8081,
,N,50597,,,,A,,CHEMBL619442,1,,BAO_0000218,8758,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,1,,,Rattus norvegicus,Intermediate,,,8082,10116.0
,U,22224,,,,A,,CHEMBL875156,0,,BAO_0000019,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,1,,,,Autocuration,,,8083,
,U,22224,,,,A,,CHEMBL619443,0,,BAO_0000019,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,1,,,,Autocuration,,,8084,
,U,22224,,,,A,,CHEMBL619444,0,,BAO_0000019,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,1,,,,Autocuration,,,8085,
,U,22224,,,,A,,CHEMBL623464,0,,BAO_0000019,2249,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,1,,,,Autocuration,,,8086,
,N,50594,,,,A,,CHEMBL623465,1,,BAO_0000218,15115,Compound was evaluated for area under curve when administered through oral route in mouse,1,,,Mus musculus,Intermediate,,,8087,10090.0
,N,50597,,,In vivo,A,,CHEMBL623466,1,,BAO_0000218,6518,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,1,,,Rattus norvegicus,Intermediate,,,8088,10116.0
,N,50597,,,In vivo,A,,CHEMBL623467,1,,BAO_0000218,6518,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,1,,,Rattus norvegicus,Intermediate,,,8089,10116.0
,N,50597,,,In vivo,A,,CHEMBL623468,1,,BAO_0000218,6249,Plasma clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8090,10116.0
,N,50597,,,In vivo,A,,CHEMBL622660,1,,BAO_0000218,2463,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,1,,,Rattus norvegicus,Intermediate,,,8091,10116.0
,N,50597,,,In vivo,A,,CHEMBL622661,1,,BAO_0000218,4969,Plasma clearance rate in Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8092,10116.0
,N,50597,,,In vivo,F,,CHEMBL622662,1,,BAO_0000218,17720,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,,Rattus norvegicus,Intermediate,,,8093,10116.0
,N,50597,,,In vivo,A,,CHEMBL622663,1,,BAO_0000218,3457,Pharmacokinetic property (total body clearance) in rat,1,,,Rattus norvegicus,Intermediate,,,8094,10116.0
,N,50597,,,In vivo,A,,CHEMBL622664,1,,BAO_0000218,5983,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,1,,,Rattus norvegicus,Intermediate,,,8095,10116.0
,N,50597,,,,A,,CHEMBL622665,1,,BAO_0000218,6295,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8096,10116.0
,N,50597,,,,A,,CHEMBL622666,1,,BAO_0000218,6296,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8097,10116.0
,N,50597,,,In vivo,A,,CHEMBL621615,1,,BAO_0000218,17686,Cl in rat i.v. at 2 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,8098,10116.0
,N,50597,,,In vivo,A,,CHEMBL621616,1,,BAO_0000218,17764,Clearance of compound after intravenous administration in rats at 24 uM/kg,1,,,Rattus norvegicus,Intermediate,,,8099,10116.0
,N,50597,,,In vivo,A,,CHEMBL621617,1,,BAO_0000218,5503,Clearance was determined,1,,,Rattus norvegicus,Intermediate,,,8100,10116.0
,N,50597,,,In vivo,A,,CHEMBL621618,1,,BAO_0000218,4368,Clearance by intravenous administration of 3.4 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,8101,10116.0
,N,50597,,,In vivo,A,,CHEMBL621619,1,,BAO_0000218,6005,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8102,10116.0
,N,50597,,,In vivo,A,,CHEMBL621620,1,,BAO_0000218,5031,Clearance rate after i.v. administration in rats,1,,,Rattus norvegicus,Intermediate,,,8103,10116.0
,N,50597,,,In vivo,A,,CHEMBL621786,1,,BAO_0000218,4890,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8104,10116.0
,N,50597,,,In vivo,A,,CHEMBL621787,1,,BAO_0000218,5182,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,,,Rattus norvegicus,Intermediate,,,8105,10116.0
,N,50597,,,In vivo,A,,CHEMBL621788,1,,BAO_0000218,5979,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,1,,,Rattus norvegicus,Intermediate,,,8106,10116.0
,N,50597,,,In vivo,A,,CHEMBL621789,1,,BAO_0000218,5656,Clearance (Cl) after oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,8107,10116.0
,N,50597,,,In vivo,A,,CHEMBL621790,1,,BAO_0000218,17804,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8108,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621791,1,,BAO_0000218,4839,Compound was tested for plasma clearance in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8109,10116.0
,N,50597,,Microsomes,In vitro,A,,CHEMBL621792,1,,BAO_0000218,5041,In vitro microsome metabolism clearance in rat was determined,1,,,Rattus norvegicus,Intermediate,,,8110,10116.0
,N,50597,,Microsomes,In vitro,A,,CHEMBL621793,1,,BAO_0000218,5041,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,1,,,Rattus norvegicus,Intermediate,,,8111,10116.0
,N,50597,,,In vivo,A,,CHEMBL621794,1,,BAO_0000218,5974,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8112,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621795,1,,BAO_0000218,5496,In vivo plasma clearance was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,8113,10116.0
,N,50597,,,In vivo,A,,CHEMBL621796,1,,BAO_0000218,5739,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,1,,,Rattus norvegicus,Intermediate,,,8114,10116.0
,N,50597,401.0,,In vivo,A,2107.0,CHEMBL621797,1,,BAO_0000218,5676,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,1,,Liver,Rattus norvegicus,Intermediate,Hepatocyte,,8115,10116.0
,N,50597,,,In vivo,A,,CHEMBL621798,1,,BAO_0000218,4239,Pharmacokinetic property (Plasma clearance) was measured in rat,1,,,Rattus norvegicus,Intermediate,,,8116,10116.0
,N,50597,,,In vivo,A,,CHEMBL621799,1,,BAO_0000218,5676,Pharmacokinetic property (clearance) in rat i.v.,1,,,Rattus norvegicus,Intermediate,,,8117,10116.0
,N,50597,,,In vivo,A,,CHEMBL621800,1,,BAO_0000218,1918,"Plasma Clearance was evaluated in rats, iv",1,,,Rattus norvegicus,Intermediate,,,8118,10116.0
,N,50597,,,In vivo,A,,CHEMBL621801,1,,BAO_0000218,17800,Plasma clearance (in vivo) in rats was determined,1,,,Rattus norvegicus,Intermediate,,,8119,10116.0
,N,50597,,,In vivo,A,,CHEMBL621802,1,,BAO_0000218,6056,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,8120,10116.0
,N,50597,,,In vivo,A,,CHEMBL618596,1,,BAO_0000218,5496,Plasma clearance was determined,1,,,Rattus norvegicus,Intermediate,,,8121,10116.0
,N,50597,,,In vivo,A,,CHEMBL618597,1,,BAO_0000218,5939,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,8122,10116.0
,N,50597,,,In vivo,A,,CHEMBL618598,1,,BAO_0000218,5939,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,8123,10116.0
,N,50597,,,In vivo,A,,CHEMBL618599,1,,BAO_0000218,17752,Plasma clearance in rats,1,,,Rattus norvegicus,Intermediate,,,8124,10116.0
,N,50597,,,In vivo,A,,CHEMBL618600,1,,BAO_0000218,4576,Plasma clearance rate determined in rat,1,,,Rattus norvegicus,Intermediate,,,8125,10116.0
,N,50597,,,In vivo,A,,CHEMBL618601,1,,BAO_0000218,6011,Plasma clearance was determined in rat,1,,,Rattus norvegicus,Intermediate,,,8126,10116.0
,N,50597,,,In vivo,A,,CHEMBL618602,1,,BAO_0000218,5510,Plasma clearance was determined,1,,,Rattus norvegicus,Intermediate,,,8127,10116.0
,N,50597,,,In vivo,A,,CHEMBL618603,1,,BAO_0000218,5948,Plasma clearance value in rat,1,,,Rattus norvegicus,Intermediate,,,8128,10116.0
,N,50597,,,Ex vivo,A,2107.0,CHEMBL618604,1,,BAO_0000218,6125,Clearance rate constant using isolated perfused rat liver (IPRL) assay,1,,Liver,Rattus norvegicus,Intermediate,,,8129,10116.0
,N,50597,,,In vivo,A,,CHEMBL618605,1,,BAO_0000218,4839,Clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8130,10116.0
,N,50597,,,In vivo,A,,CHEMBL618606,1,,BAO_0000218,17686,Total body clearance in rat i.v. at 2 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,8131,10116.0
,N,50597,,,In vivo,A,,CHEMBL618607,1,,BAO_0000218,6571,Clearance of compound in rats after intravenous administration,1,,,Rattus norvegicus,Intermediate,,,8132,10116.0
,N,50597,,,In vivo,A,,CHEMBL618608,1,,BAO_0000218,3364,Clearance after iv administration to rats,1,,,Rattus norvegicus,Intermediate,,,8133,10116.0
,N,50597,,,In vivo,A,,CHEMBL618609,1,,BAO_0000218,13569,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8134,10116.0
,N,50597,,,In vivo,A,,CHEMBL618610,1,,BAO_0000218,13569,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8135,10116.0
,N,50597,,,In vivo,A,,CHEMBL618611,1,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8136,10116.0
,N,50597,,,In vivo,A,,CHEMBL618612,1,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8137,10116.0
,N,50597,,,In vivo,A,,CHEMBL618613,1,,BAO_0000218,13569,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8138,10116.0
,N,50597,,,In vivo,A,,CHEMBL621076,1,,BAO_0000218,13569,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8139,10116.0
,N,50597,,,In vivo,A,,CHEMBL621077,1,,BAO_0000218,13569,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8140,10116.0
,N,50597,,,In vivo,A,,CHEMBL621078,1,,BAO_0000218,17670,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",1,,,Rattus norvegicus,Intermediate,,,8141,10116.0
,N,50597,,,In vivo,A,,CHEMBL621251,1,,BAO_0000218,5970,Clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8142,10116.0
,N,50597,,,In vivo,A,,CHEMBL621252,1,,BAO_0000218,6495,Clearance in rat after oral administration at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8143,10116.0
,N,50597,,,In vivo,A,,CHEMBL621253,1,,BAO_0000218,4590,Clearance in rat.,1,,,Rattus norvegicus,Intermediate,,,8144,10116.0
,N,50597,,,In vivo,A,,CHEMBL621254,1,,BAO_0000218,6193,Clearance rate following an oral dose of 20 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,8145,10116.0
,N,50597,,,In vivo,A,,CHEMBL621255,1,,BAO_0000218,2832,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,1,,,Rattus norvegicus,Intermediate,,,8146,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621256,1,,BAO_0000218,1052,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,1,,Plasma,Rattus norvegicus,Intermediate,,,8147,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621257,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,1,,Liver,Rattus norvegicus,Intermediate,,,8148,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621258,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,1,,Liver,Rattus norvegicus,Intermediate,,,8149,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621259,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,1,,Liver,Rattus norvegicus,Intermediate,,,8150,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621260,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,1,,Liver,Rattus norvegicus,Intermediate,,,8151,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL876494,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,1,,Liver,Rattus norvegicus,Intermediate,,,8152,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621261,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,1,,Liver,Rattus norvegicus,Intermediate,,,8153,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621262,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,1,,Liver,Rattus norvegicus,Intermediate,,,8154,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621263,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,1,,Liver,Rattus norvegicus,Intermediate,,,8155,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621264,1,,BAO_0000218,9866,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,1,,Liver,Rattus norvegicus,Intermediate,,,8156,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621265,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8157,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621266,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8158,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621267,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8159,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621268,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8160,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621269,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8161,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621270,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8162,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621271,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8163,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621272,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8164,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621273,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8165,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621274,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8166,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL876495,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8167,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621275,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8168,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621276,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8169,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621277,1,,BAO_0000218,9866,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8170,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL621278,1,,BAO_0000218,9866,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,1,,Intestine,Rattus norvegicus,Intermediate,,,8171,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL621279,1,,BAO_0000218,9866,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,1,,Intestine,Rattus norvegicus,Intermediate,,,8172,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL621280,1,,BAO_0000218,9866,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),1,,Intestine,Rattus norvegicus,Intermediate,,,8173,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL621281,1,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,1,,Spleen,Rattus norvegicus,Intermediate,,,8174,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL621282,1,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,1,,Spleen,Rattus norvegicus,Intermediate,,,8175,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL621283,1,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,1,,Spleen,Rattus norvegicus,Intermediate,,,8176,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL621284,1,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,1,,Spleen,Rattus norvegicus,Intermediate,,,8177,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL621285,1,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,1,,Spleen,Rattus norvegicus,Intermediate,,,8178,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL621286,1,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,1,,Spleen,Rattus norvegicus,Intermediate,,,8179,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL623220,1,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,1,,Spleen,Rattus norvegicus,Intermediate,,,8180,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL623221,1,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,1,,Spleen,Rattus norvegicus,Intermediate,,,8181,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL876029,1,,BAO_0000218,9866,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,1,,Spleen,Rattus norvegicus,Intermediate,,,8182,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL623222,1,,BAO_0000218,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,1,,Stomach,Rattus norvegicus,Intermediate,,,8183,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL623223,1,,BAO_0000218,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,1,,Stomach,Rattus norvegicus,Intermediate,,,8184,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL621445,1,,BAO_0000218,9866,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,1,,Stomach,Rattus norvegicus,Intermediate,,,8185,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL621446,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,Blood,Rattus norvegicus,Intermediate,,,8186,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL621447,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,Blood,Rattus norvegicus,Intermediate,,,8187,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL619681,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,Blood,Rattus norvegicus,Intermediate,,,8188,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL619682,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,Blood,Rattus norvegicus,Intermediate,,,8189,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL619683,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,Blood,Rattus norvegicus,Intermediate,,,8190,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL619684,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,Brain,Rattus norvegicus,Intermediate,,,8191,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL619685,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,Brain,Rattus norvegicus,Intermediate,,,8192,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL619686,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,Brain,Rattus norvegicus,Intermediate,,,8193,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL619687,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,Brain,Rattus norvegicus,Intermediate,,,8194,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL619688,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,Brain,Rattus norvegicus,Intermediate,,,8195,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL619689,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,Heart,Rattus norvegicus,Intermediate,,,8196,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL619690,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,Heart,Rattus norvegicus,Intermediate,,,8197,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL619691,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,Heart,Rattus norvegicus,Intermediate,,,8198,10116.0
,N,50597,,,In vivo,A,,CHEMBL619692,1,,BAO_0000218,6062,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8199,10116.0
,N,50597,,,,A,,CHEMBL619693,1,,BAO_0000218,3598,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Expert,,,8200,10116.0
,N,50597,,,In vivo,A,,CHEMBL619694,1,,BAO_0000218,1908,Vc value after IV dose at a dose of 5 mg/kg in rats.,1,,,Rattus norvegicus,Intermediate,,,8201,10116.0
,N,50597,,,In vivo,A,,CHEMBL619695,1,,BAO_0000218,17596,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,1,,,Rattus norvegicus,Intermediate,,,8202,10116.0
,N,50597,,,In vivo,A,,CHEMBL619696,1,,BAO_0000218,4891,Compound was evaluated for pharmacokinetic parameter volume of distribution,1,,,Rattus norvegicus,Intermediate,,,8203,10116.0
,N,50597,,,In vivo,A,,CHEMBL619697,1,,BAO_0000218,740,Compound was evaluated for volume of distribution in rat,1,,,Rattus norvegicus,Intermediate,,,8204,10116.0
,N,50597,,,In vivo,A,,CHEMBL619698,1,,BAO_0000218,16366,Steady state volume distribution was determined; steady state(ss),1,,,Rattus norvegicus,Intermediate,,,8205,10116.0
,N,50597,,,In vivo,A,,CHEMBL619699,1,,BAO_0000218,3364,Steady state volume of distribution after iv administration to rats,1,,,Rattus norvegicus,Intermediate,,,8206,10116.0
,N,50597,,,In vivo,A,,CHEMBL619700,1,,BAO_0000218,2552,Steady state volume of distribution dosing at 3 mg/kg iv,1,,,Rattus norvegicus,Intermediate,,,8207,10116.0
,N,50597,,,In vivo,A,,CHEMBL619701,1,,BAO_0000218,406,The compound was evaluated for volume of distribution in rat,1,,,Rattus norvegicus,Intermediate,,,8208,10116.0
,N,50597,,,In vivo,A,,CHEMBL619702,1,,BAO_0000218,12500,The compound was tested for volume of distribution in rat,1,,,Rattus norvegicus,Intermediate,,,8209,10116.0
,N,50597,,,In vivo,A,,CHEMBL620335,1,,BAO_0000218,12500,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,1,,,Rattus norvegicus,Intermediate,,,8210,10116.0
,N,50597,,,In vivo,A,,CHEMBL620336,1,,BAO_0000218,5656,Volume distribution (VD) after oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,8211,10116.0
,N,50597,,,In vivo,A,,CHEMBL620337,1,,BAO_0000218,17671,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8212,10116.0
,N,50597,,,In vivo,A,,CHEMBL620520,1,,BAO_0000218,1094,Volume distribution in rat,1,,,Rattus norvegicus,Intermediate,,,8213,10116.0
,N,50597,,,In vivo,A,,CHEMBL620521,1,,BAO_0000218,5833,Volume distribution in rat,1,,,Rattus norvegicus,Intermediate,,,8214,10116.0
,N,50597,,,In vivo,A,,CHEMBL875825,1,,BAO_0000218,5939,Volume distribution in rat after peroral administration at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8215,10116.0
,N,50597,,,In vivo,A,,CHEMBL620522,1,,BAO_0000218,5939,Volume distribution in rat after peroral administration at 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8216,10116.0
,N,50597,,,In vivo,A,,CHEMBL620523,1,,BAO_0000218,6005,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8217,10116.0
,N,50597,,,In vivo,A,,CHEMBL620524,1,,BAO_0000218,1696,Volume of distribution in rat.,1,,,Rattus norvegicus,Intermediate,,,8218,10116.0
,N,50597,,,In vivo,A,,CHEMBL620525,1,,BAO_0000218,6672,Volume of distribution in rat,1,,,Rattus norvegicus,Intermediate,,,8219,10116.0
,N,50597,,,In vivo,A,,CHEMBL620526,1,,BAO_0000218,6673,Volume of distribution in rat,1,,,Rattus norvegicus,Intermediate,,,8220,10116.0
,N,50597,,,In vivo,A,,CHEMBL620527,1,,BAO_0000218,5871,Volume of distribution in rat by iv administration,1,,,Rattus norvegicus,Intermediate,,,8221,10116.0
,N,50597,,,In vivo,A,,CHEMBL620528,1,,BAO_0000218,6803,Volume of distribution in rats,1,,,Rattus norvegicus,Intermediate,,,8222,10116.0
,N,50597,,,In vivo,A,,CHEMBL620529,1,,BAO_0000218,5199,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,1,,,Rattus norvegicus,Intermediate,,,8223,10116.0
,N,50597,,,,A,,CHEMBL620530,1,,BAO_0000218,4727,Volume distribution at the dose of 2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,8224,10116.0
,N,50597,,,In vivo,A,,CHEMBL620531,1,,BAO_0000218,16367,Steady state volume of distribution was determined,1,,,Rattus norvegicus,Intermediate,,,8225,10116.0
,U,22224,,,In vivo,A,,CHEMBL620532,0,,BAO_0000218,5005,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,1,,,Macaca mulatta,Intermediate,,,8226,9544.0
,U,22224,,,In vivo,A,,CHEMBL620533,0,,BAO_0000218,5005,Compound was tested for its plasma volume distribution in Sprague Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8227,10116.0
,U,22224,,,In vivo,A,,CHEMBL620534,0,,BAO_0000218,5005,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,1,,,Rattus norvegicus,Intermediate,,,8228,10116.0
,N,50597,,,In vivo,A,,CHEMBL620535,1,,BAO_0000218,15765,Mean (%CV) PK parameters for Vdss(mL/kg).,1,,,Rattus norvegicus,Intermediate,,,8229,10116.0
,N,50597,,,In vivo,A,,CHEMBL875826,1,,BAO_0000218,2792,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,1,,,Rattus norvegicus,Intermediate,,,8230,10116.0
,N,50597,,,In vivo,A,,CHEMBL620536,1,,BAO_0000218,2792,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,1,,,Rattus norvegicus,Intermediate,,,8231,10116.0
,N,50597,,,In vivo,A,,CHEMBL620537,1,,BAO_0000218,5334,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8232,10116.0
,N,50597,,,In vivo,A,,CHEMBL618526,1,,BAO_0000218,5334,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,1,,,Rattus norvegicus,Intermediate,,,8233,10116.0
,N,50597,,,In vivo,A,,CHEMBL618527,1,,BAO_0000218,5739,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,1,,,Rattus norvegicus,Intermediate,,,8234,10116.0
,N,50597,,,In vivo,A,,CHEMBL618528,1,,BAO_0000218,5789,Pharmacokinetic property (Vdss) in rat,1,,,Rattus norvegicus,Intermediate,,,8235,10116.0
,N,50597,,,In vivo,A,,CHEMBL618529,1,,BAO_0000218,4239,Pharmacokinetic property (vdss) was measured in rat,1,,,Rattus norvegicus,Intermediate,,,8236,10116.0
,N,50597,,,In vivo,A,,CHEMBL618530,1,,BAO_0000218,4709,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,8237,10116.0
,N,50597,,,In vivo,A,,CHEMBL618531,1,,BAO_0000218,6642,Volume of distribution in rat,1,,,Rattus norvegicus,Intermediate,,,8238,10116.0
,N,50597,,,In vivo,A,,CHEMBL618532,1,,BAO_0000218,5247,The pharmacokinetic parameter volume of distribution in vivo in rats,1,,,Rattus norvegicus,Intermediate,,,8239,10116.0
,N,50597,,,In vivo,F,,CHEMBL618533,1,,BAO_0000218,17720,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,,Rattus norvegicus,Intermediate,,,8240,10116.0
,N,50597,,,In vivo,A,,CHEMBL618534,1,,BAO_0000218,17686,Vdss in rat i.v. at 2 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,8241,10116.0
,N,50597,,,In vivo,A,,CHEMBL618535,1,,BAO_0000218,4689,Volume distribution after intravenous administration (1 mg/kg) in rat,1,,,Rattus norvegicus,Intermediate,,,8242,10116.0
,N,50597,,,In vivo,A,,CHEMBL618536,1,,BAO_0000218,5654,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,8243,10116.0
,N,50597,,,In vivo,A,,CHEMBL618537,1,,BAO_0000218,5654,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,8244,10116.0
,N,50597,,,In vivo,A,,CHEMBL618538,1,,BAO_0000218,4527,Volume distribution at a dose of 10 uM/kg in rat was determined,1,,,Rattus norvegicus,Intermediate,,,8245,10116.0
,N,50597,,,In vivo,A,,CHEMBL618539,1,,BAO_0000218,4521,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,,Rattus norvegicus,Intermediate,,,8246,10116.0
,N,50597,,,In vivo,A,,CHEMBL618540,1,,BAO_0000218,6057,Volume distribution was calculated in rat,1,,,Rattus norvegicus,Intermediate,,,8247,10116.0
,N,50597,,,In vivo,A,,CHEMBL618541,1,,BAO_0000218,5510,Volume distribution was determined,1,,,Rattus norvegicus,Intermediate,,,8248,10116.0
,N,50597,,,In vivo,A,,CHEMBL618542,1,,BAO_0000218,2938,Volume of distribution after intravenous administration was evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,8249,10116.0
,N,50597,,,In vivo,A,,CHEMBL622544,1,,BAO_0000218,6679,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,,Rattus norvegicus,Intermediate,,,8250,10116.0
,N,50597,,,In vivo,A,,CHEMBL622545,1,,BAO_0000218,6685,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",1,,,Rattus norvegicus,Intermediate,,,8251,10116.0
,N,50597,,,In vivo,A,,CHEMBL622546,1,,BAO_0000218,6685,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,,,Rattus norvegicus,Intermediate,,,8252,10116.0
,N,50597,,,In vivo,A,,CHEMBL622547,1,,BAO_0000218,6685,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",1,,,Rattus norvegicus,Intermediate,,,8253,10116.0
,N,50597,,,In vivo,A,,CHEMBL622548,1,,BAO_0000218,5145,Volume of distribution in steady state was determined in rat,1,,,Rattus norvegicus,Intermediate,,,8254,10116.0
,N,50597,,,In vivo,A,,CHEMBL622549,1,,BAO_0000218,6467,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,1,,,Rattus norvegicus,Intermediate,,,8255,10116.0
,N,50597,,,In vivo,A,,CHEMBL622550,1,,BAO_0000218,6467,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,,,Rattus norvegicus,Intermediate,,,8256,10116.0
,N,50594,,,,A,,CHEMBL622551,1,,BAO_0000218,15115,Compound was evaluated for area under curve when administered through oral route to mouse,1,,,Mus musculus,Intermediate,,,8257,10090.0
,N,50597,,,,A,,CHEMBL622552,1,,BAO_0000218,8758,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,1,,,Rattus norvegicus,Intermediate,,,8258,10116.0
,N,50597,,,,A,,CHEMBL622553,1,,BAO_0000218,8758,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,1,,,Rattus norvegicus,Intermediate,,,8259,10116.0
,U,22224,,,In vivo,F,,CHEMBL622554,0,,BAO_0000218,8267,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,1,,,,Autocuration,,,8260,
,N,50588,,,,A,,CHEMBL622555,1,,BAO_0000218,8267,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,1,,,Canis lupus familiaris,Intermediate,,,8261,9615.0
,N,50594,,,,A,,CHEMBL622556,1,,BAO_0000218,14239,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,1,,,Mus musculus,Intermediate,,,8262,10090.0
,N,50594,,,,A,,CHEMBL622557,1,,BAO_0000218,14239,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,1,,,Mus musculus,Intermediate,,,8263,10090.0
,N,50594,,,,A,178.0,CHEMBL622558,1,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,1,,Blood,Mus musculus,Intermediate,,,8264,10090.0
,N,50594,,,,A,178.0,CHEMBL622559,1,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,1,,Blood,Mus musculus,Intermediate,,,8265,10090.0
,N,50588,,,,A,,CHEMBL622560,1,,BAO_0000218,10754,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,1,,,Canis lupus familiaris,Intermediate,,,8266,9615.0
,N,50597,,,,A,,CHEMBL622561,1,,BAO_0000218,14681,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,,,Rattus norvegicus,Intermediate,,,8267,10116.0
,N,50597,,,,A,,CHEMBL622562,1,,BAO_0000218,14681,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,1,,,Rattus norvegicus,Intermediate,,,8268,10116.0
,N,50597,,,,A,,CHEMBL622563,1,,BAO_0000218,14681,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,,,Rattus norvegicus,Intermediate,,,8269,10116.0
,U,22224,,,,A,,CHEMBL622564,0,,BAO_0000019,13118,Concentration of compound in Central nervous system,1,,,,Autocuration,,,8270,
,U,22224,,,,A,,CHEMBL622565,0,,BAO_0000019,13118,Concentration of compound in Central nervous system; Not detectable,1,,,,Autocuration,,,8271,
,N,50594,,,,A,,CHEMBL622566,1,,BAO_0000218,13318,"Concentration of diester in the blood, following oral administration in mice",1,,,Mus musculus,Intermediate,,,8272,10090.0
,N,50594,,,,A,,CHEMBL624515,1,,BAO_0000218,13318,"Concentration of monoester in the blood, following oral administration in mice",1,,,Mus musculus,Intermediate,,,8273,10090.0
,N,50594,,,,A,,CHEMBL624516,1,,BAO_0000218,13318,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,1,,,Mus musculus,Intermediate,,,8274,10090.0
,U,22224,,,,A,,CHEMBL624517,0,,BAO_0000019,15692,Evaluated for Pharmacokinetic property: Area under the curve,1,,,,Autocuration,,,8275,
,N,50594,,,,A,,CHEMBL624518,1,,BAO_0000218,14839,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,1,,,Mus musculus,Intermediate,,,8276,10090.0
,N,100710,,,,A,,CHEMBL624519,1,,BAO_0000218,14839,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,1,,,Macaca fascicularis,Intermediate,,,8277,9541.0
,N,100710,,,,A,,CHEMBL624520,1,,BAO_0000218,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,1,,,Macaca fascicularis,Intermediate,,,8278,9541.0
,N,100710,,,,A,,CHEMBL624521,1,,BAO_0000218,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,1,,,Macaca fascicularis,Intermediate,,,8279,9541.0
,N,100710,,,,A,,CHEMBL624522,1,,BAO_0000218,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,1,,,Macaca fascicularis,Intermediate,,,8280,9541.0
,N,100710,,,,A,,CHEMBL624523,1,,BAO_0000218,14839,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,1,,,Macaca fascicularis,Intermediate,,,8281,9541.0
,N,100710,,,,A,,CHEMBL624409,1,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,,,Macaca fascicularis,Intermediate,,,8282,9541.0
,N,100710,,,,A,,CHEMBL624410,1,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",1,,,Macaca fascicularis,Intermediate,,,8283,9541.0
,N,100710,,,,A,,CHEMBL624411,1,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,,,Macaca fascicularis,Intermediate,,,8284,9541.0
,N,100710,,,,A,,CHEMBL623531,1,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",1,,,Macaca fascicularis,Intermediate,,,8285,9541.0
,N,100710,,,,A,,CHEMBL623532,1,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",1,,,Macaca fascicularis,Intermediate,,,8286,9541.0
,N,100710,,,,A,,CHEMBL623533,1,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",1,,,Macaca fascicularis,Intermediate,,,8287,9541.0
,N,100710,,,,A,,CHEMBL623534,1,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",1,,,Macaca fascicularis,Intermediate,,,8288,9541.0
,N,50594,,,,A,,CHEMBL623535,1,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,1,,,Mus musculus,Intermediate,,,8289,10090.0
,N,50594,,,,A,,CHEMBL623536,1,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,1,,,Mus musculus,Intermediate,,,8290,10090.0
,N,50594,,,,A,,CHEMBL623537,1,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,1,,,Mus musculus,Intermediate,,,8291,10090.0
,N,50594,,,,A,,CHEMBL623538,1,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,1,,,Mus musculus,Intermediate,,,8292,10090.0
,N,50594,,,,A,,CHEMBL623539,1,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,1,,,Mus musculus,Intermediate,,,8293,10090.0
,N,50594,,,,A,,CHEMBL623540,1,,BAO_0000218,14839,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,1,,,Mus musculus,Intermediate,,,8294,10090.0
,N,50594,,,,A,,CHEMBL623541,1,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",1,,,Mus musculus,Intermediate,,,8295,10090.0
,N,50594,,,,A,,CHEMBL623542,1,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",1,,,Mus musculus,Intermediate,,,8296,10090.0
,N,50594,,,,A,,CHEMBL623543,1,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",1,,,Mus musculus,Intermediate,,,8297,10090.0
,N,50594,,,,A,,CHEMBL623544,1,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",1,,,Mus musculus,Intermediate,,,8298,10090.0
,N,50594,,,,A,,CHEMBL623545,1,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",1,,,Mus musculus,Intermediate,,,8299,10090.0
,N,50594,,,,A,,CHEMBL623546,1,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",1,,,Mus musculus,Intermediate,,,8300,10090.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623547,1,,BAO_0000218,5408,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,8301,10116.0
,N,50597,,,In vivo,A,,CHEMBL623548,1,,BAO_0000218,6827,High i.v. clearance in Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8302,10116.0
,N,50597,,Microsomes,In vitro,A,2107.0,CHEMBL623549,1,,BAO_0000218,17538,In vitro clearance in rat liver microsomes,1,,Liver,Rattus norvegicus,Intermediate,,,8303,10116.0
,N,50597,,Microsomes,In vitro,A,2107.0,CHEMBL623550,1,,BAO_0000218,6331,Intrinsic clearance in rat liver microsomes was determined,1,,Liver,Rattus norvegicus,Intermediate,,,8304,10116.0
,N,50597,401.0,,In vitro,A,2107.0,CHEMBL875276,1,,BAO_0000218,5948,Intrinsic clearance in rat hepatocytes was determined,1,,Liver,Rattus norvegicus,Intermediate,Hepatocyte,,8305,10116.0
,N,50597,,,In vivo,A,,CHEMBL621872,1,,BAO_0000218,4026,Plasma Clearance was determined,1,,,Rattus norvegicus,Intermediate,,,8306,10116.0
,N,50597,,,In vivo,A,,CHEMBL621873,1,,BAO_0000218,6647,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,1,,,Rattus norvegicus,Intermediate,,,8307,10116.0
,N,50597,,,In vivo,A,,CHEMBL621874,1,,BAO_0000218,1696,Plasma clearance in rat.,1,,,Rattus norvegicus,Intermediate,,,8308,10116.0
,N,50597,,,In vivo,A,,CHEMBL621875,1,,BAO_0000218,6597,Plasma clearance in rats,1,,,Rattus norvegicus,Intermediate,,,8309,10116.0
,N,50597,,,In vivo,A,,CHEMBL621876,1,,BAO_0000218,347,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,1,,,Rattus norvegicus,Intermediate,,,8310,10116.0
,N,50597,,,In vivo,A,,CHEMBL621877,1,,BAO_0000218,16423,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,1,,,Rattus norvegicus,Intermediate,,,8311,10116.0
,N,50597,,,In vivo,A,,CHEMBL621878,1,,BAO_0000218,2879,Plasma clearance was measured in rat,1,,,Rattus norvegicus,Intermediate,,,8312,10116.0
,N,50597,,,In vivo,A,,CHEMBL621879,1,,BAO_0000218,4883,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8313,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621880,1,,BAO_0000218,5328,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",1,,Plasma,Rattus norvegicus,Intermediate,,,8314,10116.0
,N,50597,,,In vivo,A,,CHEMBL621881,1,,BAO_0000218,5160,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8315,10116.0
,N,50597,,,In vivo,A,,CHEMBL621882,1,,BAO_0000218,17582,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,,Rattus norvegicus,Intermediate,,,8316,10116.0
,N,50597,,,In vivo,A,,CHEMBL875283,1,,BAO_0000218,17651,Total clearance at 1 mg/kg was determined in rat,1,,,Rattus norvegicus,Intermediate,,,8317,10116.0
,N,50597,,,In vivo,A,,CHEMBL621883,1,,BAO_0000218,17651,Total clearance at 10 mg/kg was determined in rat,1,,,Rattus norvegicus,Intermediate,,,8318,10116.0
,N,50597,,,In vivo,A,,CHEMBL621884,1,,BAO_0000218,6596,Clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8319,10116.0
,N,50597,,,In vivo,A,,CHEMBL621885,1,,BAO_0000218,4796,Plasma clearance rate determined in rats,1,,,Rattus norvegicus,Intermediate,,,8320,10116.0
,N,50597,,,In vivo,A,,CHEMBL621886,1,,BAO_0000218,6850,Clearance of compound in rat was evaluated,1,,,Rattus norvegicus,Intermediate,,,8321,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621887,1,,BAO_0000218,5932,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,1,,Plasma,Rattus norvegicus,Intermediate,,,8322,10116.0
,N,50597,,,In vivo,A,,CHEMBL621888,1,,BAO_0000218,3371,Pharmacokinetic property (blood clearance) in rat,1,,,Rattus norvegicus,Intermediate,,,8323,10116.0
,N,50597,,,In vivo,A,,CHEMBL621889,1,,BAO_0000218,2083,Plasma clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8324,10116.0
,N,50597,,,In vivo,A,,CHEMBL621890,1,,BAO_0000218,4942,Plasma clearance in rats,1,,,Rattus norvegicus,Intermediate,,,8325,10116.0
,N,50597,,Microsomes,In vitro,A,2107.0,CHEMBL621891,1,,BAO_0000218,6838,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,1,,Liver,Rattus norvegicus,Intermediate,,,8326,10116.0
,N,50597,,,In vivo,A,,CHEMBL621892,1,,BAO_0000218,5353,Clearance in Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8327,10116.0
,N,50597,,,In vivo,A,,CHEMBL621893,1,,BAO_0000218,6641,Clearance rat,1,,,Rattus norvegicus,Intermediate,,,8328,10116.0
,N,50597,,,In vivo,A,,CHEMBL621894,1,,BAO_0000218,6641,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),1,,,Rattus norvegicus,Intermediate,,,8329,10116.0
,N,50597,,,In vivo,A,,CHEMBL621895,1,,BAO_0000218,6641,Clearance rat; Not determined,1,,,Rattus norvegicus,Intermediate,,,8330,10116.0
,N,50597,,,In vivo,A,,CHEMBL875284,1,,BAO_0000218,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.,1,,,Rattus norvegicus,Intermediate,,,8331,10116.0
,N,50597,,,In vivo,A,,CHEMBL618699,1,,BAO_0000218,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,,,Rattus norvegicus,Intermediate,,,8332,10116.0
,N,50597,,,In vivo,A,,CHEMBL618700,1,,BAO_0000218,6444,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,,,Rattus norvegicus,Intermediate,,,8333,10116.0
,N,50597,,,In vivo,A,,CHEMBL618701,1,,BAO_0000218,6211,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8334,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL876600,1,,BAO_0000218,12873,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",1,,Plasma,Rattus norvegicus,Intermediate,,,8335,10116.0
,N,50597,,,In vivo,A,,CHEMBL618702,1,,BAO_0000218,6570,Clearance of compound in rat after 1 mg/kg i.v. administration,1,,,Rattus norvegicus,Intermediate,,,8336,10116.0
,N,50597,,,In vivo,A,,CHEMBL618703,1,,BAO_0000218,3341,Compound was evaluated for Hepatic clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8337,10116.0
,N,50597,,,In vivo,A,,CHEMBL618704,1,,BAO_0000218,4891,In vivo clearance after 5 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,8338,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL618705,1,,BAO_0000218,1094,Compound was tested for plasma clearance in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,8339,10116.0
,N,50597,,,In vivo,A,,CHEMBL618706,1,,BAO_0000218,2938,Hepatic clearance after intravenous administration was evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,8340,10116.0
,N,50597,,,In vivo,A,,CHEMBL618707,1,,BAO_0000218,17853,Lower clearance in rat (i.v.) at 0.5 mpk,1,,,Rattus norvegicus,Intermediate,,,8341,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL618708,1,,BAO_0000218,6049,Pharmacokinetic parameter expressed as plasma clearance in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8342,10116.0
,N,50597,,,In vivo,A,,CHEMBL618709,1,,BAO_0000218,5789,Pharmacokinetic property (Clp) in rat,1,,,Rattus norvegicus,Intermediate,,,8343,10116.0
,N,50597,,,In vivo,A,,CHEMBL618710,1,,BAO_0000218,4514,Plasma clearance in Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8344,10116.0
,N,50597,,,In vivo,A,,CHEMBL618711,1,,BAO_0000218,6448,Plasma clearance (Clp) in rat,1,,,Rattus norvegicus,Intermediate,,,8345,10116.0
,N,50597,,,In vivo,A,,CHEMBL618712,1,,BAO_0000218,6062,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8346,10116.0
,N,50597,,,In vivo,A,,CHEMBL618713,1,,BAO_0000218,5710,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,1,,,Rattus norvegicus,Intermediate,,,8347,10116.0
,N,50597,,,In vivo,A,,CHEMBL618714,1,,BAO_0000218,4709,Plasma clearance after intravenous administration of 1 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,8348,10116.0
,N,50597,,,In vivo,A,,CHEMBL618715,1,,BAO_0000218,4521,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,,Rattus norvegicus,Intermediate,,,8349,10116.0
,N,50597,,,In vivo,A,,CHEMBL618716,1,,BAO_0000218,1742,Plasma clearance in rat was determined,1,,,Rattus norvegicus,Intermediate,,,8350,10116.0
,N,50597,,,In vivo,A,,CHEMBL876601,1,,BAO_0000218,6057,Plasma clearance measured in rat,1,,,Rattus norvegicus,Intermediate,,,8351,10116.0
,N,50597,,,In vivo,A,,CHEMBL618717,1,,BAO_0000218,6057,Plasma clearance was calculated in rat,1,,,Rattus norvegicus,Intermediate,,,8352,10116.0
,N,50597,,,In vivo,A,,CHEMBL618718,1,,BAO_0000218,5145,Plasma clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8353,10116.0
,N,50597,,,In vivo,A,,CHEMBL618719,1,,BAO_0000218,5833,Plasma clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8354,10116.0
,N,50597,,,In vivo,A,,CHEMBL618720,1,,BAO_0000218,6453,Plasma clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8355,10116.0
,N,50597,,,In vivo,A,,CHEMBL618721,1,,BAO_0000218,6640,Plasma clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8356,10116.0
,N,50597,,,In vivo,A,,CHEMBL621477,1,,BAO_0000218,6305,Plasma clearance in rats,1,,,Rattus norvegicus,Intermediate,,,8357,10116.0
,N,50597,,,In vivo,A,,CHEMBL621478,1,,BAO_0000218,6642,Plasma clearance in rat,1,,,Rattus norvegicus,Intermediate,,,8358,10116.0
,N,50597,,,In vivo,A,,CHEMBL621479,1,,BAO_0000218,5472,Plasma clearance was evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,8359,10116.0
,N,50597,,,In vivo,A,,CHEMBL621480,1,,BAO_0000218,5472,Plasma clearance was evaluated in rat; Not tested,1,,,Rattus norvegicus,Intermediate,,,8360,10116.0
,N,50597,,,In vivo,A,,CHEMBL621481,1,,BAO_0000218,5144,Plasma clearance rate was determined for the compound in rat,1,,,Rattus norvegicus,Intermediate,,,8361,10116.0
,N,50597,,,In vivo,A,,CHEMBL621482,1,,BAO_0000218,6685,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",1,,,Rattus norvegicus,Intermediate,,,8362,10116.0
,N,50597,,,In vivo,A,,CHEMBL621483,1,,BAO_0000218,6685,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,,,Rattus norvegicus,Intermediate,,,8363,10116.0
,N,50597,,,In vivo,A,,CHEMBL621484,1,,BAO_0000218,6685,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",1,,,Rattus norvegicus,Intermediate,,,8364,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621485,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,Heart,Rattus norvegicus,Intermediate,,,8365,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL621486,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,Heart,Rattus norvegicus,Intermediate,,,8366,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL621487,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,Intestine,Rattus norvegicus,Intermediate,,,8367,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL621488,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,Intestine,Rattus norvegicus,Intermediate,,,8368,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL621489,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,Intestine,Rattus norvegicus,Intermediate,,,8369,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL621490,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,Intestine,Rattus norvegicus,Intermediate,,,8370,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL621491,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,Intestine,Rattus norvegicus,Intermediate,,,8371,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621492,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,Kidney,Rattus norvegicus,Intermediate,,,8372,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621493,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,1,,Kidney,Rattus norvegicus,Intermediate,,,8373,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621494,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,Kidney,Rattus norvegicus,Intermediate,,,8374,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621495,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,Kidney,Rattus norvegicus,Intermediate,,,8375,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621496,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,Kidney,Rattus norvegicus,Intermediate,,,8376,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621497,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,Liver,Rattus norvegicus,Intermediate,,,8377,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621498,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,Liver,Rattus norvegicus,Intermediate,,,8378,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621499,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,Liver,Rattus norvegicus,Intermediate,,,8379,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL618634,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,1,,Liver,Rattus norvegicus,Intermediate,,,8380,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL618635,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,Liver,Rattus norvegicus,Intermediate,,,8381,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL618636,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,Lung,Rattus norvegicus,Intermediate,,,8382,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL619737,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,Lung,Rattus norvegicus,Intermediate,,,8383,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL619738,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,Lung,Rattus norvegicus,Intermediate,,,8384,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624329,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,Lung,Rattus norvegicus,Intermediate,,,8385,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624330,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,Lung,Rattus norvegicus,Intermediate,,,8386,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624331,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8387,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624332,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8388,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624333,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8389,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624334,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8390,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624335,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8391,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL620016,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,Spleen,Rattus norvegicus,Intermediate,,,8392,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL620169,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,1,,Spleen,Rattus norvegicus,Intermediate,,,8393,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL620170,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,Spleen,Rattus norvegicus,Intermediate,,,8394,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL620171,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,1,,Spleen,Rattus norvegicus,Intermediate,,,8395,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL620172,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,Spleen,Rattus norvegicus,Intermediate,,,8396,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL620173,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,1,,Stomach,Rattus norvegicus,Intermediate,,,8397,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL620174,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,1,,Stomach,Rattus norvegicus,Intermediate,,,8398,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL620175,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,1,,Stomach,Rattus norvegicus,Intermediate,,,8399,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL620176,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,1,,Stomach,Rattus norvegicus,Intermediate,,,8400,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL620177,1,,BAO_0000218,13950,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,1,,Stomach,Rattus norvegicus,Intermediate,,,8401,10116.0
,N,50597,,,,A,2037.0,CHEMBL620178,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,Cerebellum,Rattus norvegicus,Intermediate,,,8402,10116.0
,N,50597,,,,A,2037.0,CHEMBL620179,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,Cerebellum,Rattus norvegicus,Intermediate,,,8403,10116.0
,N,50597,,,,A,,CHEMBL620180,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,Rattus norvegicus,Intermediate,,,8404,10116.0
,N,50597,,,In vivo,A,,CHEMBL620181,1,,BAO_0000218,6570,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,1,,,Rattus norvegicus,Intermediate,,,8405,10116.0
,N,50597,,,In vivo,A,,CHEMBL620182,1,,BAO_0000218,6571,Volume of distribution of compound in rats after intravenous administration,1,,,Rattus norvegicus,Intermediate,,,8406,10116.0
,N,50597,,,In vivo,A,,CHEMBL620183,1,,BAO_0000218,6453,Volume of distribution in rat,1,,,Rattus norvegicus,Intermediate,,,8407,10116.0
,N,50597,,,In vivo,A,,CHEMBL620184,1,,BAO_0000218,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,1,,,Rattus norvegicus,Intermediate,,,8408,10116.0
,N,50597,,,In vivo,A,,CHEMBL620185,1,,BAO_0000218,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,,,Rattus norvegicus,Intermediate,,,8409,10116.0
,N,50597,,,In vivo,A,,CHEMBL620186,1,,BAO_0000218,6444,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,,,Rattus norvegicus,Intermediate,,,8410,10116.0
,N,50597,,,In vivo,A,,CHEMBL620187,1,,BAO_0000218,5353,Volume of distribution was determined in Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8411,10116.0
,N,50597,,,In vivo,A,,CHEMBL620188,1,,BAO_0000218,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8412,10116.0
,N,50597,,,In vivo,A,,CHEMBL620189,1,,BAO_0000218,5334,Volume of distribution was reported in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8413,10116.0
,N,50597,,,In vivo,A,,CHEMBL620190,1,,BAO_0000218,6641,Volumes of distribution in rat after peroral administration,1,,,Rattus norvegicus,Intermediate,,,8414,10116.0
,N,50597,,,In vivo,A,,CHEMBL620191,1,,BAO_0000218,6641,Volumes of distribution in rat after po administration,1,,,Rattus norvegicus,Intermediate,,,8415,10116.0
,N,50597,,,In vivo,A,,CHEMBL620192,1,,BAO_0000218,6641,Volumes of distribution in rat after po administration; Not determined,1,,,Rattus norvegicus,Intermediate,,,8416,10116.0
,N,50597,,,In vivo,A,,CHEMBL620193,1,,BAO_0000218,5676,Pharmacokinetic property (Volume) in rat i.v.,1,,,Rattus norvegicus,Intermediate,,,8417,10116.0
,N,50597,,,In vivo,A,,CHEMBL620194,1,,BAO_0000218,6410,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,1,,,Rattus norvegicus,Intermediate,,,8418,10116.0
,N,50597,,,In vivo,A,,CHEMBL876730,1,,BAO_0000218,17670,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",1,,,Rattus norvegicus,Intermediate,,,8419,10116.0
,N,50597,,,In vivo,A,,CHEMBL620195,1,,BAO_0000218,6495,Volume distribution in rat after oral administration at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8420,10116.0
,N,50597,,,In vivo,A,,CHEMBL620196,1,,BAO_0000218,5408,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8421,10116.0
,N,50597,,,In vivo,A,,CHEMBL620197,1,,BAO_0000218,4883,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8422,10116.0
,N,50597,,,In vivo,A,,CHEMBL620198,1,,BAO_0000218,6647,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,1,,,Rattus norvegicus,Intermediate,,,8423,10116.0
,N,50597,,,In vivo,A,,CHEMBL620199,1,,BAO_0000218,6495,Volume of distribution in rats,1,,,Rattus norvegicus,Intermediate,,,8424,10116.0
,N,50597,,,In vivo,A,,CHEMBL620200,1,,BAO_0000218,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,1,,,Rattus norvegicus,Intermediate,,,8425,10116.0
,N,50597,,,In vivo,A,,CHEMBL620201,1,,BAO_0000218,2661,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,1,,,Rattus norvegicus,Intermediate,,,8426,10116.0
,N,50597,,,In vivo,A,,CHEMBL620202,1,,BAO_0000218,5974,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8427,10116.0
,N,50597,,,In vivo,A,,CHEMBL620203,1,,BAO_0000218,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8428,10116.0
,N,50597,,,In vivo,A,,CHEMBL620204,1,,BAO_0000218,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,1,,,Rattus norvegicus,Intermediate,,,8429,10116.0
,N,50597,,,In vivo,A,,CHEMBL620205,1,,BAO_0000218,5974,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8430,10116.0
,N,50597,,,In vivo,A,,CHEMBL624664,1,,BAO_0000218,5960,Pharmacokinetic parameter (Vss) in rat,1,,,Rattus norvegicus,Intermediate,,,8431,10116.0
,N,50597,,,In vivo,A,,CHEMBL624665,1,,BAO_0000218,5676,Pharmacokinetic property (Volume) in rat i.v.,1,,,Rattus norvegicus,Intermediate,,,8432,10116.0
,N,50597,,,,A,,CHEMBL624666,1,,BAO_0000218,5948,Pharmacokinetic property (Vss) in rat,1,,,Rattus norvegicus,Intermediate,,,8433,10116.0
,N,50597,,,In vivo,A,,CHEMBL624667,1,,BAO_0000218,5979,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,1,,,Rattus norvegicus,Intermediate,,,8434,10116.0
,N,50597,,,In vivo,A,,CHEMBL624668,1,,BAO_0000218,5978,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8435,10116.0
,N,50597,,,In vivo,A,,CHEMBL624669,1,,BAO_0000218,5978,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8436,10116.0
,N,50597,,,In vivo,A,,CHEMBL624670,1,,BAO_0000218,5978,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8437,10116.0
,N,50597,,,In vivo,A,,CHEMBL624671,1,,BAO_0000218,5978,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8438,10116.0
,N,50597,,,In vivo,A,,CHEMBL624672,1,,BAO_0000218,6448,Steady state volume distribution in rat,1,,,Rattus norvegicus,Intermediate,,,8439,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624673,1,,BAO_0000218,12873,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",1,,Plasma,Rattus norvegicus,Intermediate,,,8440,10116.0
,N,50597,,,In vivo,A,,CHEMBL624674,1,,BAO_0000218,4576,Steady state volume of distribution determined in rat,1,,,Rattus norvegicus,Intermediate,,,8441,10116.0
,N,50597,,,In vivo,A,,CHEMBL624675,1,,BAO_0000218,17582,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,,Rattus norvegicus,Intermediate,,,8442,10116.0
,N,50597,,,In vivo,A,,CHEMBL621728,1,,BAO_0000218,1466,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,1,,,Rattus norvegicus,Intermediate,,,8443,10116.0
,N,50597,,,,A,,CHEMBL621729,1,,BAO_0000218,5182,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,1,,,Rattus norvegicus,Intermediate,,,8444,10116.0
,N,50597,,,,A,,CHEMBL621730,1,,BAO_0000218,5182,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,1,,,Rattus norvegicus,Intermediate,,,8445,10116.0
,N,50597,,,In vivo,A,,CHEMBL621731,1,,BAO_0000218,6535,Volume distribution in rat after administration of 2 mg/kg iv,1,,,Rattus norvegicus,Intermediate,,,8446,10116.0
,N,50597,,,In vivo,A,,CHEMBL621732,1,,BAO_0000218,6535,Volume distribution in rat after administration of 2 mg/kg iv,1,,,Rattus norvegicus,Intermediate,,,8447,10116.0
,N,50597,,,In vivo,A,,CHEMBL621908,1,,BAO_0000218,5041,Volume in steady state distribution value was determined,1,,,Rattus norvegicus,Intermediate,,,8448,10116.0
,N,50597,,,In vivo,A,,CHEMBL875347,1,,BAO_0000218,5041,Volume in steady state distribution value was determined; ND denotes no data,1,,,Rattus norvegicus,Intermediate,,,8449,10116.0
,N,50597,,,In vivo,A,,CHEMBL621909,1,,BAO_0000218,5041,Volume in steady state distribution value was determined; ND denotes not determined,1,,,Rattus norvegicus,Intermediate,,,8450,10116.0
,N,50597,,,In vivo,A,,CHEMBL621910,1,,BAO_0000218,17065,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,,Rattus norvegicus,Intermediate,,,8451,10116.0
,N,50597,,,In vivo,A,,CHEMBL621911,1,,BAO_0000218,6597,Volume of distribution at steady state was evaluated in rats,1,,,Rattus norvegicus,Intermediate,,,8452,10116.0
,N,50597,,,In vivo,A,,CHEMBL621912,1,,BAO_0000218,15662,Volume of distribution at steady state was observed after intravenous administration in rat,1,,,Rattus norvegicus,Intermediate,,,8453,10116.0
,N,50597,,,In vivo,A,,CHEMBL621913,1,,BAO_0000218,6485,Volume of distribution in steady state was determined in rat,1,,,Rattus norvegicus,Intermediate,,,8454,10116.0
,N,50597,,,In vivo,A,,CHEMBL621914,1,,BAO_0000218,17655,Volume of distribution in steady state was determined in rat,1,,,Rattus norvegicus,Intermediate,,,8455,10116.0
,N,50597,,,In vivo,A,,CHEMBL621915,1,,BAO_0000218,6616,Volume of distribution after i.v. administration,1,,,Rattus norvegicus,Intermediate,,,8456,10116.0
,N,50597,,,In vivo,A,,CHEMBL621916,1,,BAO_0000218,1916,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1,,,Rattus norvegicus,Intermediate,,,8457,10116.0
,N,50594,,,In vivo,A,2107.0,CHEMBL621917,1,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",1,,Liver,Mus musculus,Intermediate,,,8458,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL621918,1,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",1,,Liver,Mus musculus,Intermediate,,,8459,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL621919,1,,BAO_0000218,16438,Biodistribution of compound (oxidized form) in spleen tissue,1,,Spleen,Mus musculus,Intermediate,,,8460,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL621920,1,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",1,,Spleen,Mus musculus,Intermediate,,,8461,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL621921,1,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",1,,Spleen,Mus musculus,Intermediate,,,8462,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL622401,1,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,Spleen,Mus musculus,Intermediate,,,8463,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL875348,1,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",1,,Spleen,Mus musculus,Intermediate,,,8464,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL622402,1,,BAO_0000218,16438,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",1,,Spleen,Mus musculus,Intermediate,,,8465,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL622403,1,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,1,,Blood,Mus musculus,Intermediate,,,8466,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL622404,1,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,Blood,Mus musculus,Intermediate,,,8467,10090.0
,N,50594,,,In vivo,A,955.0,CHEMBL622405,1,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,1,,Brain,Mus musculus,Intermediate,,,8468,10090.0
,N,50594,,,In vivo,A,955.0,CHEMBL622406,1,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",1,,Brain,Mus musculus,Intermediate,,,8469,10090.0
,N,50594,,,In vivo,A,955.0,CHEMBL622407,1,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,Brain,Mus musculus,Intermediate,,,8470,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL622408,1,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,1,,Heart,Mus musculus,Intermediate,,,8471,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL622409,1,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",1,,Heart,Mus musculus,Intermediate,,,8472,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL622410,1,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,Heart,Mus musculus,Intermediate,,,8473,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL622411,1,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,1,,Kidney,Mus musculus,Intermediate,,,8474,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL627864,1,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",1,,Kidney,Mus musculus,Intermediate,,,8475,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL627865,1,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,Kidney,Mus musculus,Intermediate,,,8476,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL627866,1,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,1,,Liver,Mus musculus,Intermediate,,,8477,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL627751,1,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,Liver,Mus musculus,Intermediate,,,8478,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL627752,1,,BAO_0000218,16438,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,1,,Spleen,Mus musculus,Intermediate,,,8479,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL627753,1,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",1,,Spleen,Mus musculus,Intermediate,,,8480,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL627754,1,,BAO_0000218,16438,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",1,,Spleen,Mus musculus,Intermediate,,,8481,10090.0
,N,50594,,,,A,,CHEMBL627755,1,,BAO_0000218,12467,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,1,,,Mus musculus,Intermediate,,,8482,10090.0
,N,50594,,,In vivo,A,955.0,CHEMBL627756,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),1,,Brain,Mus musculus,Intermediate,,,8483,10090.0
,N,50594,,,In vivo,A,955.0,CHEMBL627757,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),1,,Brain,Mus musculus,Intermediate,,,8484,10090.0
,N,50594,,,In vivo,A,955.0,CHEMBL627758,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,Brain,Mus musculus,Intermediate,,,8485,10090.0
,N,50594,,,In vivo,A,955.0,CHEMBL627759,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),1,,Brain,Mus musculus,Intermediate,,,8486,10090.0
,N,50594,,,In vivo,A,955.0,CHEMBL627760,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,Brain,Mus musculus,Intermediate,,,8487,10090.0
,N,50594,,,In vivo,A,955.0,CHEMBL627761,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),1,,Brain,Mus musculus,Intermediate,,,8488,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL876811,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),1,,Heart,Mus musculus,Intermediate,,,8489,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL627762,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),1,,Heart,Mus musculus,Intermediate,,,8490,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL627763,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,Heart,Mus musculus,Intermediate,,,8491,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL627764,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),1,,Heart,Mus musculus,Intermediate,,,8492,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL627765,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,Heart,Mus musculus,Intermediate,,,8493,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL627766,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),1,,Heart,Mus musculus,Intermediate,,,8494,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL627767,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),1,,Kidney,Mus musculus,Intermediate,,,8495,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL627768,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),1,,Kidney,Mus musculus,Intermediate,,,8496,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL628422,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,Kidney,Mus musculus,Intermediate,,,8497,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL628423,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),1,,Kidney,Mus musculus,Intermediate,,,8498,10090.0
,N,50597,,,In vivo,A,,CHEMBL628424,1,,BAO_0000218,5089,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8499,10116.0
,N,50597,,,In vivo,A,,CHEMBL628425,1,,BAO_0000218,5089,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8500,10116.0
,N,50597,,,In vivo,A,,CHEMBL628426,1,,BAO_0000218,4257,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,1,,,Rattus norvegicus,Intermediate,,,8501,10116.0
,N,50597,,,In vivo,A,,CHEMBL628427,1,,BAO_0000218,6679,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,,Rattus norvegicus,Intermediate,,,8502,10116.0
,N,50597,,,In vivo,A,,CHEMBL626938,1,,BAO_0000218,5546,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,,,Rattus norvegicus,Intermediate,,,8503,10116.0
,N,50597,,,In vivo,A,,CHEMBL626939,1,,BAO_0000218,6141,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8504,10116.0
,N,50597,,,In vivo,A,,CHEMBL626940,1,,BAO_0000218,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8505,10116.0
,N,50597,,,In vivo,A,,CHEMBL626941,1,,BAO_0000218,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8506,10116.0
,N,50597,,,In vivo,A,,CHEMBL626942,1,,BAO_0000218,5334,Plasma clearance was reported in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8507,10116.0
,N,50597,,,In vivo,A,,CHEMBL876812,1,,BAO_0000218,4689,Plasma clearance after intravenous administration (1 mg/kg) in rat,1,,,Rattus norvegicus,Intermediate,,,8508,10116.0
,N,50597,,,In vivo,A,,CHEMBL626943,1,,BAO_0000218,6848,Plasma clearance of compound in rats was evaluated,1,,,Rattus norvegicus,Intermediate,,,8509,10116.0
,N,50597,,,In vivo,A,,CHEMBL626944,1,,BAO_0000218,6848,Plasma clearance of compound in rats was evaluated; ND indicates not determined,1,,,Rattus norvegicus,Intermediate,,,8510,10116.0
,N,50597,,,In vivo,A,,CHEMBL626945,1,,BAO_0000218,6467,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,1,,,Rattus norvegicus,Intermediate,,,8511,10116.0
,N,50597,,,In vivo,A,,CHEMBL626946,1,,BAO_0000218,6467,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,,,Rattus norvegicus,Intermediate,,,8512,10116.0
,N,50597,,,In vivo,A,,CHEMBL626856,1,,BAO_0000218,4956,Plasma clearance rate in Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8513,10116.0
,N,50597,,,In vivo,A,,CHEMBL626857,1,,BAO_0000218,5529,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),1,,,Rattus norvegicus,Intermediate,,,8514,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626858,1,,BAO_0000218,406,The compound was evaluated for plasma clearance in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8515,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627018,1,,BAO_0000218,17655,Total plasma clearance in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8516,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625331,1,,BAO_0000218,3293,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,1,,Blood,Rattus norvegicus,Intermediate,,,8517,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625332,1,,BAO_0000218,4075,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,1,,Blood,Rattus norvegicus,Intermediate,,,8518,10116.0
,N,50597,,,In vivo,A,,CHEMBL877590,1,,BAO_0000218,2792,C max was determined at 10 mg/kg po dose in rats,1,,,Rattus norvegicus,Intermediate,,,8519,10116.0
,N,50597,,,In vivo,A,,CHEMBL625333,1,,BAO_0000218,2792,C max was determined at 3 mg/kg po dose in rats,1,,,Rattus norvegicus,Intermediate,,,8520,10116.0
,N,50597,,,In vivo,A,,CHEMBL625334,1,,BAO_0000218,17594,Cmax after repeated oral dose of compound at 1 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,8521,10116.0
,N,50597,,,In vivo,A,,CHEMBL625335,1,,BAO_0000218,17594,Cmax after single intravenous bolus of 1 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,8522,10116.0
,N,50597,,,In vivo,A,,CHEMBL625336,1,,BAO_0000218,4762,Cmax of compound at 5 mg/kg after po administration was determined in rat,1,,,Rattus norvegicus,Intermediate,,,8523,10116.0
,N,50597,,,In vivo,A,,CHEMBL625337,1,,BAO_0000218,17509,Cmax 24 hr after 10 mg/kg oral administration in rats,1,,,Rattus norvegicus,Intermediate,,,8524,10116.0
,N,50597,,,In vivo,A,,CHEMBL625338,1,,BAO_0000218,17509,Cmax 24 hr after 2 mg/kg oral administration in rats,1,,,Rattus norvegicus,Intermediate,,,8525,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625339,1,,BAO_0000218,1466,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8526,10116.0
,N,50597,,,In vivo,A,,CHEMBL625340,1,,BAO_0000218,6535,Cmax in rat after administration of 2 mg/kg iv,1,,,Rattus norvegicus,Intermediate,,,8527,10116.0
,N,50597,,,In vivo,A,,CHEMBL625341,1,,BAO_0000218,6535,Cmax in rat after administration of 2 mg/kg iv,1,,,Rattus norvegicus,Intermediate,,,8528,10116.0
,N,50597,,,In vivo,A,,CHEMBL622687,1,,BAO_0000218,3169,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8529,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622688,1,,BAO_0000218,6515,Cmax wa determined in rat plasma at 30 mg/kg after po administration,1,,Plasma,Rattus norvegicus,Intermediate,,,8530,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL622689,1,,BAO_0000218,11149,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,1,,Blood,Rattus norvegicus,Intermediate,,,8531,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL620295,1,,BAO_0000218,11149,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,1,,Blood,Rattus norvegicus,Intermediate,,,8532,10116.0
,N,50597,,,In vivo,A,,CHEMBL620296,1,,BAO_0000218,17858,Cmax after 10 mg/kg oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,8533,10116.0
,N,50597,,,In vivo,A,,CHEMBL620297,1,,BAO_0000218,6518,Cmax after IV dosing at 0.5 mg/kg in rat; no data,1,,,Rattus norvegicus,Intermediate,,,8534,10116.0
,N,50597,,,In vivo,A,,CHEMBL620298,1,,BAO_0000218,6518,Cmax after IV dosing at 1 mg/kg in rat; no data,1,,,Rattus norvegicus,Intermediate,,,8535,10116.0
,N,50597,,,In vivo,A,,CHEMBL620299,1,,BAO_0000218,4426,Cmax after oral administration at 20 mpk in rats,1,,,Rattus norvegicus,Intermediate,,,8536,10116.0
,N,50597,,,In vivo,A,,CHEMBL620300,1,,BAO_0000218,4426,Cmax after oral administration at 20 mpk in rats; Not performed.,1,,,Rattus norvegicus,Intermediate,,,8537,10116.0
,N,50597,,,In vivo,A,,CHEMBL620301,1,,BAO_0000218,4426,Cmax after oral administration at 20 mpk in rats d; Not performed.,1,,,Rattus norvegicus,Intermediate,,,8538,10116.0
,N,50597,,,In vivo,A,,CHEMBL620302,1,,BAO_0000218,5656,Cmax after oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,8539,10116.0
,N,50597,,,In vivo,A,,CHEMBL620303,1,,BAO_0000218,6518,Cmax after oral administration at a dose of 2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,8540,10116.0
,N,50597,,,In vivo,A,,CHEMBL620304,1,,BAO_0000218,6518,Cmax after oral administration at a dose of 4 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,8541,10116.0
,N,50597,,,In vivo,A,,CHEMBL620305,1,,BAO_0000218,6113,Cmax in rats after 20 mg/kg oral dose,1,,,Rattus norvegicus,Intermediate,,,8542,10116.0
,N,50597,,,In vivo,A,,CHEMBL620306,1,,BAO_0000218,17764,Cmax after peroral administration in rats at 2.4 uM/kg,1,,,Rattus norvegicus,Intermediate,,,8543,10116.0
,N,50597,,,In vivo,A,,CHEMBL620307,1,,BAO_0000218,4756,Cmax at the dose of 2 mg/Kg administered perorally in rats,1,,,Rattus norvegicus,Intermediate,,,8544,10116.0
,N,50597,,,In vivo,A,,CHEMBL620308,1,,BAO_0000218,4756,Cmax at the dose of 5 mg/Kg administered perorally in rats,1,,,Rattus norvegicus,Intermediate,,,8545,10116.0
,N,50597,,,In vivo,A,,CHEMBL620309,1,,BAO_0000218,6402,Cmax by administering at 20 mg/kg p.o. in rats,1,,,Rattus norvegicus,Intermediate,,,8546,10116.0
,N,50597,,,In vivo,A,,CHEMBL620310,1,,BAO_0000218,5610,Cmax in male rat,1,,,Rattus norvegicus,Intermediate,,,8547,10116.0
,N,50597,,,In vivo,A,,CHEMBL620311,1,,BAO_0000218,5207,Cmax in rat,1,,,Rattus norvegicus,Intermediate,,,8548,10116.0
,N,50597,,,In vivo,A,,CHEMBL620312,1,,BAO_0000218,6011,Cmax in rat,1,,,Rattus norvegicus,Intermediate,,,8549,10116.0
,N,50597,,,In vivo,A,,CHEMBL620313,1,,BAO_0000218,6504,Cmax in rat,1,,,Rattus norvegicus,Intermediate,,,8550,10116.0
,N,50597,,,In vivo,A,,CHEMBL620314,1,,BAO_0000218,6046,Cmax in rat at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8551,10116.0
,N,50597,,,In vivo,A,,CHEMBL620315,1,,BAO_0000218,6504,Cmax in rat at the dose of 1 mg/kg i.v.,1,,,Rattus norvegicus,Intermediate,,,8552,10116.0
,N,50597,,,In vivo,A,,CHEMBL620316,1,,BAO_0000218,5874,Cmax in rat by po administration at a dose of 40 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8553,10116.0
,N,50597,,,In vivo,A,,CHEMBL620317,1,,BAO_0000218,17686,Cmax in rat p.o. at 20 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,8554,10116.0
,N,50597,,,In vivo,A,,CHEMBL620318,1,,BAO_0000218,5836,Cmax in rats,1,,,Rattus norvegicus,Intermediate,,,8555,10116.0
,N,50597,,,In vivo,A,,CHEMBL620319,1,,BAO_0000218,17596,Cmax in rats,1,,,Rattus norvegicus,Intermediate,,,8556,10116.0
,N,50597,,,In vivo,A,,CHEMBL620320,1,,BAO_0000218,16423,Cmax was evaluated after 20 uM/kg of peroral administration,1,,,Rattus norvegicus,Intermediate,,,8557,10116.0
,N,50597,,,In vivo,A,,CHEMBL620321,1,,BAO_0000218,17804,Cmax was measured in rats after peroral administration at 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8558,10116.0
,N,50597,,,In vivo,A,,CHEMBL620322,1,,BAO_0000218,1908,Cmax value after oral dose at a dose of 10 mg/kg in rats.,1,,,Rattus norvegicus,Intermediate,,,8559,10116.0
,N,50597,,,,A,,CHEMBL620323,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,Rattus norvegicus,Intermediate,,,8560,10116.0
,N,50597,,,,A,1870.0,CHEMBL620324,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,Frontal cortex,Rattus norvegicus,Intermediate,,,8561,10116.0
,N,50597,,,,A,1870.0,CHEMBL620325,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,Frontal cortex,Rattus norvegicus,Intermediate,,,8562,10116.0
,N,50597,,,,A,10000000.0,CHEMBL620326,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,Hippocampus,Rattus norvegicus,Intermediate,,,8563,10116.0
,N,50597,,,,A,10000000.0,CHEMBL620327,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,Hippocampus,Rattus norvegicus,Intermediate,,,8564,10116.0
,N,50597,,,,A,,CHEMBL620328,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,Rattus norvegicus,Intermediate,,,8565,10116.0
,N,50597,,,,A,,CHEMBL620329,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,Rattus norvegicus,Intermediate,,,8566,10116.0
,N,50597,,,,A,1891.0,CHEMBL620330,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,Midbrain,Rattus norvegicus,Intermediate,,,8567,10116.0
,N,50597,,,,A,1891.0,CHEMBL875286,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,Midbrain,Rattus norvegicus,Intermediate,,,8568,10116.0
,N,50597,,,,A,,CHEMBL620331,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,,Rattus norvegicus,Intermediate,,,8569,10116.0
,N,50597,,,,A,,CHEMBL620332,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,,Rattus norvegicus,Intermediate,,,8570,10116.0
,N,50597,,,,A,2435.0,CHEMBL620333,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,1,,Striatum,Rattus norvegicus,Intermediate,,,8571,10116.0
,N,50597,,,,A,2435.0,CHEMBL620334,1,,BAO_0000218,13950,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,1,,Striatum,Rattus norvegicus,Intermediate,,,8572,10116.0
,N,50597,,,,A,178.0,CHEMBL621015,1,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8573,10116.0
,N,50597,,,,A,178.0,CHEMBL621016,1,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8574,10116.0
,N,50597,,,,A,178.0,CHEMBL621191,1,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8575,10116.0
,N,50597,,,,A,178.0,CHEMBL621192,1,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8576,10116.0
,N,50597,,,,A,178.0,CHEMBL621193,1,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8577,10116.0
,N,50597,,,,A,178.0,CHEMBL621194,1,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8578,10116.0
,N,50597,,,,A,178.0,CHEMBL624204,1,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8579,10116.0
,N,50597,,,,A,178.0,CHEMBL624205,1,,BAO_0000218,16434,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8580,10116.0
,N,50597,,,,A,178.0,CHEMBL624206,1,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8581,10116.0
,N,50597,,,,A,178.0,CHEMBL624207,1,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8582,10116.0
,N,50597,,,,A,178.0,CHEMBL624208,1,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8583,10116.0
,N,50597,,,,A,178.0,CHEMBL624209,1,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8584,10116.0
,N,50597,,,,A,178.0,CHEMBL624210,1,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8585,10116.0
,N,50597,,,,A,178.0,CHEMBL624211,1,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8586,10116.0
,N,50597,,,,A,178.0,CHEMBL624212,1,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8587,10116.0
,N,50597,,,,A,178.0,CHEMBL624213,1,,BAO_0000218,16435,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,Blood,Rattus norvegicus,Intermediate,,,8588,10116.0
,N,50597,,,,A,178.0,CHEMBL876611,1,,BAO_0000218,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,Blood,Rattus norvegicus,Intermediate,,,8589,10116.0
,N,50597,,,,A,178.0,CHEMBL624214,1,,BAO_0000218,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,Blood,Rattus norvegicus,Intermediate,,,8590,10116.0
,N,50597,,,,A,178.0,CHEMBL624215,1,,BAO_0000218,16434,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,Blood,Rattus norvegicus,Intermediate,,,8591,10116.0
,N,50597,,,,A,178.0,CHEMBL624216,1,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,Blood,Rattus norvegicus,Intermediate,,,8592,10116.0
,N,50597,,,,A,178.0,CHEMBL624217,1,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,Blood,Rattus norvegicus,Intermediate,,,8593,10116.0
,N,50597,,,,A,178.0,CHEMBL624218,1,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,Blood,Rattus norvegicus,Intermediate,,,8594,10116.0
,N,50597,,,,A,178.0,CHEMBL624219,1,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,Blood,Rattus norvegicus,Intermediate,,,8595,10116.0
,N,50597,,,,A,178.0,CHEMBL624220,1,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,Blood,Rattus norvegicus,Intermediate,,,8596,10116.0
,N,50597,,,,A,178.0,CHEMBL624221,1,,BAO_0000218,16435,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,Blood,Rattus norvegicus,Intermediate,,,8597,10116.0
,N,50597,,,,A,,CHEMBL624222,1,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,Rattus norvegicus,Intermediate,,,8598,10116.0
,N,50597,,,,A,,CHEMBL624223,1,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,Rattus norvegicus,Intermediate,,,8599,10116.0
,N,50597,,,,A,,CHEMBL624224,1,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,Rattus norvegicus,Intermediate,,,8600,10116.0
,N,50597,,,,A,,CHEMBL624225,1,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,Rattus norvegicus,Intermediate,,,8601,10116.0
,N,50597,,,In vivo,A,,CHEMBL622420,1,,BAO_0000218,17764,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,1,,,Rattus norvegicus,Intermediate,,,8602,10116.0
,N,50597,,,In vivo,A,,CHEMBL622421,1,,BAO_0000218,5031,Volume of steady state distribution after i.v. administration in rats,1,,,Rattus norvegicus,Intermediate,,,8603,10116.0
,N,50597,,,In vivo,A,,CHEMBL622422,1,,BAO_0000218,6215,Vss after intravenous administration (5.0 mg/kg) was determined in rat,1,,,Rattus norvegicus,Intermediate,,,8604,10116.0
,N,50597,,,In vivo,A,,CHEMBL622423,1,,BAO_0000218,17671,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8605,10116.0
,N,50597,,,In vivo,A,,CHEMBL622424,1,,BAO_0000218,17752,Vss was determined,1,,,Rattus norvegicus,Intermediate,,,8606,10116.0
,N,50597,,,In vivo,A,,CHEMBL622425,1,,BAO_0000218,6596,Vss in rat,1,,,Rattus norvegicus,Intermediate,,,8607,10116.0
,N,50597,,,In vivo,A,,CHEMBL876612,1,,BAO_0000218,16423,Vss was evaluated after 10 uM/kg of intra arterial administration,1,,,Rattus norvegicus,Intermediate,,,8608,10116.0
,N,50597,,,In vivo,A,,CHEMBL622426,1,,BAO_0000218,15662,volume of distribution at steady state was observed after intravenous administration in rat,1,,,Rattus norvegicus,Intermediate,,,8609,10116.0
,N,50597,,,In vivo,A,,CHEMBL622427,1,,BAO_0000218,6062,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8610,10116.0
,N,50597,,,In vivo,A,,CHEMBL622428,1,,BAO_0000218,5874,Pharmacokinetic (PK) parameter Vz in rat,1,,,Rattus norvegicus,Intermediate,,,8611,10116.0
,N,50597,,,In vivo,A,,CHEMBL622429,1,,BAO_0000218,4942,Volume distribution in rats,1,,,Rattus norvegicus,Intermediate,,,8612,10116.0
,N,50597,,,In vivo,A,,CHEMBL622430,1,,BAO_0000218,17796,Volume of distribution in rat; No data,1,,,Rattus norvegicus,Intermediate,,,8613,10116.0
,N,50597,,,In vivo,A,,CHEMBL622431,1,,BAO_0000218,4890,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,8614,10116.0
,N,50597,,,,A,2116.0,CHEMBL622432,1,,BAO_0000218,15765,% absorption predicted from in vitro rat ileum transport studies,1,,Ileum,Rattus norvegicus,Intermediate,,,8615,10116.0
,N,50597,,,In vivo,A,,CHEMBL622433,1,,BAO_0000218,13569,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8616,10116.0
,N,50597,,,In vivo,A,,CHEMBL622434,1,,BAO_0000218,13569,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8617,10116.0
,N,50597,,,In vivo,A,,CHEMBL622435,1,,BAO_0000218,13569,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8618,10116.0
,N,50597,,,In vivo,A,,CHEMBL618748,1,,BAO_0000218,13569,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,8619,10116.0
,N,50597,,,In vivo,A,,CHEMBL618749,1,,BAO_0000218,13569,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8620,10116.0
,N,50597,,,In vivo,A,,CHEMBL618750,1,,BAO_0000218,13569,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8621,10116.0
,N,50597,,,In vivo,A,,CHEMBL618751,1,,BAO_0000218,13569,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8622,10116.0
,N,50597,,,In vivo,A,,CHEMBL618752,1,,BAO_0000218,13569,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,8623,10116.0
,N,50597,,,In vivo,A,,CHEMBL618753,1,,BAO_0000218,4576,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,8624,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL618754,1,,BAO_0000218,750,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,1,,Plasma,Rattus norvegicus,Intermediate,,,8625,10116.0
,N,50597,,,In vivo,A,,CHEMBL618755,1,,BAO_0000218,750,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,8626,10116.0
,N,50597,,,In vivo,A,,CHEMBL618756,1,,BAO_0000218,4590,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,8627,10116.0
,N,50597,,,In vivo,A,,CHEMBL618757,1,,BAO_0000218,1716,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,8628,10116.0
,N,50597,,,In vivo,A,,CHEMBL618758,1,,BAO_0000218,1974,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,8629,10116.0
,N,50597,,,In vivo,A,,CHEMBL621088,1,,BAO_0000218,4502,Oral bioavailability in rat (dose 30 mg/kg),1,,,Rattus norvegicus,Intermediate,,,8630,10116.0
,N,50597,,,,A,,CHEMBL621089,1,,BAO_0000218,3371,Pharmacokinetic property (cLogP) in rat,1,,,Rattus norvegicus,Intermediate,,,8631,10116.0
,N,50597,,,,F,178.0,CHEMBL621090,1,,BAO_0000218,9099,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,1,,Blood,Rattus norvegicus,Intermediate,,,8632,10116.0
,N,50597,,,,F,178.0,CHEMBL621091,1,,BAO_0000218,9099,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,1,,Blood,Rattus norvegicus,Intermediate,,,8633,10116.0
,N,50597,,,In vivo,A,,CHEMBL876731,1,,BAO_0000218,4590,Clearance in rat.,1,,,Rattus norvegicus,Intermediate,,,8634,10116.0
,N,50597,,,In vivo,A,,CHEMBL621092,1,,BAO_0000218,3184,Compound was evaluated for its clearance when administered intravenously in rat,1,,,Rattus norvegicus,Intermediate,,,8635,10116.0
,N,50597,,,In vivo,A,,CHEMBL621093,1,,BAO_0000218,16456,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8636,10116.0
,N,50597,,,,A,,CHEMBL621094,1,,BAO_0000218,4199,Blood: Brain distribution ratio is determined in rat,1,,,Rattus norvegicus,Intermediate,,,8637,10116.0
,N,50597,,,,A,,CHEMBL621095,1,,BAO_0000218,4199,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,1,,,Rattus norvegicus,Intermediate,,,8638,10116.0
,N,50597,,,,A,,CHEMBL621096,1,,BAO_0000218,4199,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,1,,,Rattus norvegicus,Intermediate,,,8639,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL621097,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Kidney,Rattus norvegicus,Intermediate,,,8640,10116.0
,N,50597,,,,F,,CHEMBL621098,1,,BAO_0000218,7449,Percent dose excreted in 0-48 hours administered ip to male rat,1,,,Rattus norvegicus,Intermediate,,,8641,10116.0
,N,50597,,,,A,2037.0,CHEMBL621099,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Cerebellum,Rattus norvegicus,Intermediate,,,8642,10116.0
,N,50597,,,,A,2037.0,CHEMBL621100,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Cerebellum,Rattus norvegicus,Intermediate,,,8643,10116.0
,N,50597,,,,A,2037.0,CHEMBL621101,1,,BAO_0000218,11977,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,Cerebellum,Rattus norvegicus,Intermediate,,,8644,10116.0
,N,50597,,,,A,2037.0,CHEMBL621102,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Cerebellum,Rattus norvegicus,Intermediate,,,8645,10116.0
,N,50597,,,,A,2037.0,CHEMBL876732,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Cerebellum,Rattus norvegicus,Intermediate,,,8646,10116.0
,N,50597,,,,A,,CHEMBL621103,1,,BAO_0000218,11977,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,Rattus norvegicus,Intermediate,,,8647,10116.0
,N,50597,,,,A,,CHEMBL621104,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,Rattus norvegicus,Intermediate,,,8648,10116.0
,N,50597,,,,A,,CHEMBL621105,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,Rattus norvegicus,Intermediate,,,8649,10116.0
,N,50597,,,,A,,CHEMBL621106,1,,BAO_0000218,11977,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,,Rattus norvegicus,Intermediate,,,8650,10116.0
,N,50597,,,,A,,CHEMBL621107,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,Rattus norvegicus,Intermediate,,,8651,10116.0
,N,50597,,,,A,,CHEMBL621108,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,,Rattus norvegicus,Intermediate,,,8652,10116.0
,N,50597,,,,A,,CHEMBL621109,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,,Rattus norvegicus,Intermediate,,,8653,10116.0
,N,50594,,,In vivo,A,2113.0,CHEMBL621110,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,Kidney,Mus musculus,Intermediate,,,8654,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL621111,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),1,,Kidney,Mus musculus,Intermediate,,,8655,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL622541,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),1,,Liver,Mus musculus,Intermediate,,,8656,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL622542,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),1,,Liver,Mus musculus,Intermediate,,,8657,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL622543,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,Liver,Mus musculus,Intermediate,,,8658,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL624412,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),1,,Liver,Mus musculus,Intermediate,,,8659,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL624413,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,Liver,Mus musculus,Intermediate,,,8660,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL624414,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),1,,Liver,Mus musculus,Intermediate,,,8661,10090.0
,N,50594,,,In vivo,A,2048.0,CHEMBL624415,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),1,,Lung,Mus musculus,Intermediate,,,8662,10090.0
,N,50594,,,In vivo,A,2048.0,CHEMBL624416,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),1,,Lung,Mus musculus,Intermediate,,,8663,10090.0
,N,50594,,,In vivo,A,2048.0,CHEMBL624417,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,Lung,Mus musculus,Intermediate,,,8664,10090.0
,N,50594,,,In vivo,A,2048.0,CHEMBL624418,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),1,,Lung,Mus musculus,Intermediate,,,8665,10090.0
,N,50594,,,In vivo,A,2048.0,CHEMBL624419,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,Lung,Mus musculus,Intermediate,,,8666,10090.0
,N,50594,,,In vivo,A,2048.0,CHEMBL624420,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),1,,Lung,Mus musculus,Intermediate,,,8667,10090.0
,N,50594,,,In vivo,A,2385.0,CHEMBL624421,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),1,,Muscle tissue,Mus musculus,Intermediate,,,8668,10090.0
,N,50594,,,In vivo,A,2385.0,CHEMBL624422,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),1,,Muscle tissue,Mus musculus,Intermediate,,,8669,10090.0
,N,50594,,,In vivo,A,2385.0,CHEMBL624423,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,Muscle tissue,Mus musculus,Intermediate,,,8670,10090.0
,N,50594,,,In vivo,A,2385.0,CHEMBL625123,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),1,,Muscle tissue,Mus musculus,Intermediate,,,8671,10090.0
,N,50594,,,In vivo,A,2385.0,CHEMBL625124,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,Muscle tissue,Mus musculus,Intermediate,,,8672,10090.0
,N,50594,,,In vivo,A,2385.0,CHEMBL625125,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),1,,Muscle tissue,Mus musculus,Intermediate,,,8673,10090.0
,N,50594,,,In vivo,A,14.0,CHEMBL625126,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),1,,Zone of skin,Mus musculus,Intermediate,,,8674,10090.0
,N,50594,,,In vivo,A,14.0,CHEMBL626947,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),1,,Zone of skin,Mus musculus,Intermediate,,,8675,10090.0
,N,50594,,,In vivo,A,14.0,CHEMBL626948,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,Zone of skin,Mus musculus,Intermediate,,,8676,10090.0
,N,50594,,,In vivo,A,14.0,CHEMBL626949,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),1,,Zone of skin,Mus musculus,Intermediate,,,8677,10090.0
,N,50594,,,In vivo,A,14.0,CHEMBL626950,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,Zone of skin,Mus musculus,Intermediate,,,8678,10090.0
,N,50594,,,In vivo,A,14.0,CHEMBL626951,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),1,,Zone of skin,Mus musculus,Intermediate,,,8679,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL626952,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),1,,Spleen,Mus musculus,Intermediate,,,8680,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL626953,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),1,,Spleen,Mus musculus,Intermediate,,,8681,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL626954,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,Spleen,Mus musculus,Intermediate,,,8682,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL626955,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),1,,Spleen,Mus musculus,Intermediate,,,8683,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL626956,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,Spleen,Mus musculus,Intermediate,,,8684,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL626957,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),1,,Spleen,Mus musculus,Intermediate,,,8685,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL626958,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),1,,Blood,Mus musculus,Intermediate,,,8686,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL626959,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),1,,Blood,Mus musculus,Intermediate,,,8687,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL626960,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),1,,Blood,Mus musculus,Intermediate,,,8688,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL626961,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),1,,Blood,Mus musculus,Intermediate,,,8689,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL627589,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),1,,Blood,Mus musculus,Intermediate,,,8690,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL627590,1,,BAO_0000218,17208,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),1,,Blood,Mus musculus,Intermediate,,,8691,10090.0
,N,50594,,,,A,,CHEMBL627591,1,,BAO_0000218,3132,Time taken for EC90 was determined when tested in mouse,1,,,Mus musculus,Intermediate,,,8692,10090.0
,N,50594,,,,A,,CHEMBL627592,1,,BAO_0000218,3132,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,1,,,Mus musculus,Intermediate,,,8693,10090.0
,N,50594,,,In vivo,A,,CHEMBL627593,1,,BAO_0000218,16597,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),1,,,Mus musculus,Intermediate,,,8694,10090.0
,N,50594,,,,A,,CHEMBL627594,1,,BAO_0000218,5727,Half life in mice,1,,,Mus musculus,Intermediate,,,8695,10090.0
,N,50594,,,In vivo,A,,CHEMBL876813,1,,BAO_0000218,5302,Half life period in mouse after 10 mg/Kg dose,1,,,Mus musculus,Intermediate,,,8696,10090.0
,N,50594,,,In vivo,A,,CHEMBL627595,1,,BAO_0000218,5302,Half life period in mouse after 10 mg/kg dose,1,,,Mus musculus,Intermediate,,,8697,10090.0
,N,50594,,,In vivo,A,,CHEMBL627596,1,,BAO_0000218,6348,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,1,,,Mus musculus,Intermediate,,,8698,10090.0
,N,50597,,,In vivo,A,,CHEMBL627597,1,,BAO_0000218,5964,Cmax value at 5 mg/kg po was determined in rat,1,,,Rattus norvegicus,Intermediate,,,8699,10116.0
,N,50597,,,In vivo,A,,CHEMBL627598,1,,BAO_0000218,6078,Cmax value evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,8700,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL627599,1,,BAO_0000218,5206,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,1,,Brain,Rattus norvegicus,Intermediate,,,8701,10116.0
,N,50597,,,In vivo,A,,CHEMBL627600,1,,BAO_0000218,2959,Cmax value after administration of 20 mg/Kg oral dose in rat,1,,,Rattus norvegicus,Intermediate,,,8702,10116.0
,N,50597,,,In vivo,A,,CHEMBL627601,1,,BAO_0000218,5964,Cmax value at 1 mg/kg po in rat,1,,,Rattus norvegicus,Intermediate,,,8703,10116.0
,N,50597,,,In vivo,A,,CHEMBL627776,1,,BAO_0000218,5964,Cmax value at 5 mg/kg po in rat,1,,,Rattus norvegicus,Intermediate,,,8704,10116.0
,N,50597,,,In vivo,A,,CHEMBL627777,1,,BAO_0000218,6757,Cmax value at a dose of 10 mg/kg in male SD rats,1,,,Rattus norvegicus,Intermediate,,,8705,10116.0
,N,50597,,,In vivo,A,,CHEMBL627778,1,,BAO_0000218,6757,Cmax value at a dose of 100 mg/kg in male SD rats,1,,,Rattus norvegicus,Intermediate,,,8706,10116.0
,N,50597,,,In vivo,A,,CHEMBL627779,1,,BAO_0000218,6757,Cmax value at a dose of 50 mg/kg in male SD rats,1,,,Rattus norvegicus,Intermediate,,,8707,10116.0
,N,50597,,,In vivo,A,,CHEMBL876814,1,,BAO_0000218,17617,Cmax value in rats at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8708,10116.0
,N,50597,,,In vivo,A,,CHEMBL627780,1,,BAO_0000218,1445,Cmax value was evaluated in rats at a dose of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8709,10116.0
,N,50597,,,In vivo,A,,CHEMBL627781,1,,BAO_0000218,6082,Cmax value was determined after peroral administration of 20 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,8710,10116.0
,N,50597,,,In vivo,A,,CHEMBL627782,1,,BAO_0000218,1446,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1,,,Rattus norvegicus,Intermediate,,,8711,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627783,1,,BAO_0000218,5407,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,1,,Plasma,Rattus norvegicus,Intermediate,,,8712,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627784,1,,BAO_0000218,2690,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,1,,Plasma,Rattus norvegicus,Intermediate,,,8713,10116.0
,N,50597,,,In vivo,A,,CHEMBL627785,1,,BAO_0000218,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,1,,,Rattus norvegicus,Intermediate,,,8714,10116.0
,N,50597,,,In vivo,A,,CHEMBL627786,1,,BAO_0000218,2661,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,1,,,Rattus norvegicus,Intermediate,,,8715,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627787,1,,BAO_0000218,4891,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,1,,Plasma,Rattus norvegicus,Intermediate,,,8716,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627788,1,,BAO_0000218,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,1,,Plasma,Rattus norvegicus,Intermediate,,,8717,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626579,1,,BAO_0000218,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,1,,Plasma,Rattus norvegicus,Intermediate,,,8718,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626580,1,,BAO_0000218,2807,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,1,,Plasma,Rattus norvegicus,Intermediate,,,8719,10116.0
,N,50597,,,In vivo,A,,CHEMBL876815,1,,BAO_0000218,3634,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8720,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626581,1,,BAO_0000218,1881,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,1,,Plasma,Rattus norvegicus,Intermediate,,,8721,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626582,1,,BAO_0000218,1881,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,1,,Plasma,Rattus norvegicus,Intermediate,,,8722,10116.0
,N,50597,,,In vivo,A,,CHEMBL626583,1,,BAO_0000218,429,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,8723,10116.0
,N,50597,,,In vivo,A,,CHEMBL626205,1,,BAO_0000218,5974,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8724,10116.0
,N,50597,,,In vivo,A,,CHEMBL626206,1,,BAO_0000218,5974,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8725,10116.0
,N,50597,,,In vivo,A,,CHEMBL626207,1,,BAO_0000218,5974,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8726,10116.0
,N,50597,,,In vivo,A,,CHEMBL623882,1,,BAO_0000218,5974,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,8727,10116.0
,N,50597,,,In vivo,A,,CHEMBL623883,1,,BAO_0000218,17582,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,1,,,Rattus norvegicus,Intermediate,,,8728,10116.0
,N,50597,,,In vivo,A,,CHEMBL623884,1,,BAO_0000218,17582,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,1,,,Rattus norvegicus,Intermediate,,,8729,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623885,1,,BAO_0000218,3032,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",1,,Plasma,Rattus norvegicus,Intermediate,,,8730,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623886,1,,BAO_0000218,6295,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,8731,10116.0
,N,50597,,,In vivo,A,,CHEMBL623887,1,,BAO_0000218,6619,Maximal concentration in rat was determined,1,,,Rattus norvegicus,Intermediate,,,8732,10116.0
,N,50597,,,In vivo,A,,CHEMBL623888,1,,BAO_0000218,6616,Maximal concentration after i.v. administration,1,,,Rattus norvegicus,Intermediate,,,8733,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623889,1,,BAO_0000218,3249,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,8734,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623890,1,,BAO_0000218,17791,Maximal plasma concentration in rat after oral administration at 50 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,8735,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623891,1,,BAO_0000218,17791,Cmax in rat plasma after oral dose (50 mg/Kg),1,,Plasma,Rattus norvegicus,Intermediate,,,8736,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623892,1,,BAO_0000218,1360,Maximal plasma concentration was determined.,1,,Plasma,Rattus norvegicus,Intermediate,,,8737,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623893,1,,BAO_0000218,2552,Maximal plasma drug concentration was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,8738,10116.0
,N,50597,,,In vivo,A,,CHEMBL877616,1,,BAO_0000218,6571,Maximal concentration in rats after peroral administration,1,,,Rattus norvegicus,Intermediate,,,8739,10116.0
,N,50597,,,In vivo,A,,CHEMBL623894,1,,BAO_0000218,6570,Maximum concentration in rat after 2 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,8740,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623895,1,,BAO_0000218,6567,Maximum concentration in rat plasma after 5 mg/kg oral gavage,1,,Plasma,Rattus norvegicus,Intermediate,,,8741,10116.0
,N,50597,,,In vivo,A,,CHEMBL623896,1,,BAO_0000218,3031,Maximum concentration of compound in rat was evaluated.,1,,,Rattus norvegicus,Intermediate,,,8742,10116.0
,N,50597,,,In vivo,A,,CHEMBL623897,1,,BAO_0000218,3436,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,8743,10116.0
,N,50597,,,In vivo,A,,CHEMBL623898,1,,BAO_0000218,3436,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,8744,10116.0
,N,50597,,,In vivo,A,,CHEMBL623899,1,,BAO_0000218,2083,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,1,,,Rattus norvegicus,Intermediate,,,8745,10116.0
,N,50597,,,In vivo,A,,CHEMBL623900,1,,BAO_0000218,3436,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,8746,10116.0
,N,50597,,,In vivo,A,,CHEMBL623901,1,,BAO_0000218,4527,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,1,,,Rattus norvegicus,Intermediate,,,8747,10116.0
,N,50597,,,In vivo,A,,CHEMBL623902,1,,BAO_0000218,1974,Maximum concentration was evaluated in rats,1,,,Rattus norvegicus,Intermediate,,,8748,10116.0
,N,50597,,,In vivo,A,1359.0,CHEMBL623903,1,,BAO_0000218,3307,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,1,,Cerebrospinal fluid,Rattus norvegicus,Intermediate,,,8749,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623904,1,,BAO_0000218,3307,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,8750,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL877617,1,,BAO_0000218,1916,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1,,Plasma,Rattus norvegicus,Intermediate,,,8751,10116.0
,N,50597,,,In vivo,A,,CHEMBL623905,1,,BAO_0000218,1500,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,8752,10116.0
,N,50597,,,In vivo,A,,CHEMBL623906,1,,BAO_0000218,1500,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,8753,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623907,1,,BAO_0000218,4186,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,Plasma,Rattus norvegicus,Intermediate,,,8754,10116.0
,N,50597,,,,A,,CHEMBL623908,1,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,Rattus norvegicus,Intermediate,,,8755,10116.0
,N,50597,,,,A,,CHEMBL623909,1,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,1,,,Rattus norvegicus,Intermediate,,,8756,10116.0
,N,50597,,,,A,,CHEMBL623910,1,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,Rattus norvegicus,Intermediate,,,8757,10116.0
,N,50597,,,,A,,CHEMBL623911,1,,BAO_0000218,16434,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,Rattus norvegicus,Intermediate,,,8758,10116.0
,N,50597,,,,A,,CHEMBL623912,1,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,Rattus norvegicus,Intermediate,,,8759,10116.0
,N,50597,,,,A,,CHEMBL624616,1,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,Rattus norvegicus,Intermediate,,,8760,10116.0
,N,50597,,,,A,,CHEMBL624617,1,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,Rattus norvegicus,Intermediate,,,8761,10116.0
,N,50597,,,,A,,CHEMBL624618,1,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,Rattus norvegicus,Intermediate,,,8762,10116.0
,N,50597,,,,A,,CHEMBL624619,1,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,Rattus norvegicus,Intermediate,,,8763,10116.0
,N,50597,,,,A,,CHEMBL624794,1,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,Rattus norvegicus,Intermediate,,,8764,10116.0
,N,50597,,,,A,,CHEMBL624795,1,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,Rattus norvegicus,Intermediate,,,8765,10116.0
,N,50597,,,,A,,CHEMBL623921,1,,BAO_0000218,16435,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,Rattus norvegicus,Intermediate,,,8766,10116.0
,N,50597,,,,A,,CHEMBL623922,1,,BAO_0000218,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,Rattus norvegicus,Intermediate,,,8767,10116.0
,N,50597,,,,A,,CHEMBL623923,1,,BAO_0000218,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,Rattus norvegicus,Intermediate,,,8768,10116.0
,N,50597,,,,A,,CHEMBL623924,1,,BAO_0000218,16434,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,Rattus norvegicus,Intermediate,,,8769,10116.0
,N,50597,,,,A,,CHEMBL623925,1,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,Rattus norvegicus,Intermediate,,,8770,10116.0
,N,50597,,,,A,,CHEMBL623926,1,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,Rattus norvegicus,Intermediate,,,8771,10116.0
,N,50597,,,,A,,CHEMBL623927,1,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,Rattus norvegicus,Intermediate,,,8772,10116.0
,N,50597,,,,A,,CHEMBL623928,1,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,Rattus norvegicus,Intermediate,,,8773,10116.0
,N,50597,,,,A,,CHEMBL623929,1,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,Rattus norvegicus,Intermediate,,,8774,10116.0
,N,50597,,,,A,,CHEMBL623930,1,,BAO_0000218,16435,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,Rattus norvegicus,Intermediate,,,8775,10116.0
,N,50597,,,,A,955.0,CHEMBL623931,1,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8776,10116.0
,N,50597,,,,A,955.0,CHEMBL622165,1,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8777,10116.0
,N,50597,,,,A,955.0,CHEMBL621249,1,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8778,10116.0
,N,50597,,,,A,955.0,CHEMBL621250,1,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8779,10116.0
,N,50597,,,,A,955.0,CHEMBL621448,1,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8780,10116.0
,N,50597,,,,A,955.0,CHEMBL621449,1,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8781,10116.0
,N,50597,,,,A,955.0,CHEMBL621450,1,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8782,10116.0
,N,50597,,,,A,955.0,CHEMBL621451,1,,BAO_0000218,16434,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8783,10116.0
,N,50597,,,,A,955.0,CHEMBL621452,1,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8784,10116.0
,N,50597,,,,A,955.0,CHEMBL621453,1,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8785,10116.0
,N,50597,,,,A,955.0,CHEMBL621454,1,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8786,10116.0
,N,50597,,,,A,955.0,CHEMBL621455,1,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8787,10116.0
,N,50597,,,,A,955.0,CHEMBL621456,1,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8788,10116.0
,N,50597,,,,A,955.0,CHEMBL625145,1,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8789,10116.0
,N,50597,,,,A,955.0,CHEMBL875847,1,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8790,10116.0
,N,50597,,,,A,955.0,CHEMBL625146,1,,BAO_0000218,16435,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,Brain,Rattus norvegicus,Intermediate,,,8791,10116.0
,N,50597,,,,A,955.0,CHEMBL625147,1,,BAO_0000218,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,Brain,Rattus norvegicus,Intermediate,,,8792,10116.0
,N,50597,,,,A,955.0,CHEMBL625148,1,,BAO_0000218,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,Brain,Rattus norvegicus,Intermediate,,,8793,10116.0
,N,50597,,,,A,955.0,CHEMBL625149,1,,BAO_0000218,16434,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,Brain,Rattus norvegicus,Intermediate,,,8794,10116.0
,N,50597,,,,A,955.0,CHEMBL625150,1,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,Brain,Rattus norvegicus,Intermediate,,,8795,10116.0
,N,50597,,,,A,955.0,CHEMBL625151,1,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,Brain,Rattus norvegicus,Intermediate,,,8796,10116.0
,N,50597,,,,A,955.0,CHEMBL625152,1,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,Brain,Rattus norvegicus,Intermediate,,,8797,10116.0
,N,50597,,,,A,955.0,CHEMBL625153,1,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,Brain,Rattus norvegicus,Intermediate,,,8798,10116.0
,N,50597,,,,A,955.0,CHEMBL625154,1,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,Brain,Rattus norvegicus,Intermediate,,,8799,10116.0
,N,50597,,,,A,955.0,CHEMBL625155,1,,BAO_0000218,16435,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,Brain,Rattus norvegicus,Intermediate,,,8800,10116.0
,N,50597,,,,A,,CHEMBL625156,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,,Rattus norvegicus,Intermediate,,,8801,10116.0
,N,50597,,,,A,,CHEMBL624354,1,,BAO_0000218,11977,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,,Rattus norvegicus,Intermediate,,,8802,10116.0
,N,50597,,,,A,10000000.0,CHEMBL624355,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Hippocampus,Rattus norvegicus,Intermediate,,,8803,10116.0
,N,50597,,,,A,10000000.0,CHEMBL624356,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Hippocampus,Rattus norvegicus,Intermediate,,,8804,10116.0
,N,50597,,,,A,10000000.0,CHEMBL624357,1,,BAO_0000218,11977,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Hippocampus,Rattus norvegicus,Intermediate,,,8805,10116.0
,N,50597,,,,A,10000000.0,CHEMBL624358,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Hippocampus,Rattus norvegicus,Intermediate,,,8806,10116.0
,N,50597,,,,A,2435.0,CHEMBL624359,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Striatum,Rattus norvegicus,Intermediate,,,8807,10116.0
,N,50597,,,,A,2435.0,CHEMBL624360,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Striatum,Rattus norvegicus,Intermediate,,,8808,10116.0
,N,50597,,,,A,2435.0,CHEMBL624361,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,Striatum,Rattus norvegicus,Intermediate,,,8809,10116.0
,N,50597,,,,A,2435.0,CHEMBL624362,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Striatum,Rattus norvegicus,Intermediate,,,8810,10116.0
,N,50597,,,,A,2435.0,CHEMBL624363,1,,BAO_0000218,11977,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Striatum,Rattus norvegicus,Intermediate,,,8811,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL624364,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Blood,Rattus norvegicus,Intermediate,,,8812,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL624365,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Blood,Rattus norvegicus,Intermediate,,,8813,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL624366,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Blood,Rattus norvegicus,Intermediate,,,8814,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL624367,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Blood,Rattus norvegicus,Intermediate,,,8815,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL624368,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Brain,Rattus norvegicus,Intermediate,,,8816,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL624369,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Brain,Rattus norvegicus,Intermediate,,,8817,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL624370,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,Brain,Rattus norvegicus,Intermediate,,,8818,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL625069,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Brain,Rattus norvegicus,Intermediate,,,8819,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL625070,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Brain,Rattus norvegicus,Intermediate,,,8820,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL626051,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Heart,Rattus norvegicus,Intermediate,,,8821,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL626052,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Heart,Rattus norvegicus,Intermediate,,,8822,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL626053,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,Heart,Rattus norvegicus,Intermediate,,,8823,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL626054,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Heart,Rattus norvegicus,Intermediate,,,8824,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL626055,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Heart,Rattus norvegicus,Intermediate,,,8825,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL626056,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Kidney,Rattus norvegicus,Intermediate,,,8826,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL626057,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Kidney,Rattus norvegicus,Intermediate,,,8827,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL625193,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Kidney,Rattus norvegicus,Intermediate,,,8828,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL625194,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Kidney,Rattus norvegicus,Intermediate,,,8829,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625195,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Liver,Rattus norvegicus,Intermediate,,,8830,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625196,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Liver,Rattus norvegicus,Intermediate,,,8831,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625197,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,Liver,Rattus norvegicus,Intermediate,,,8832,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625198,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Liver,Rattus norvegicus,Intermediate,,,8833,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627929,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Liver,Rattus norvegicus,Intermediate,,,8834,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627074,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Lung,Rattus norvegicus,Intermediate,,,8835,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627075,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Lung,Rattus norvegicus,Intermediate,,,8836,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627076,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,Lung,Rattus norvegicus,Intermediate,,,8837,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627077,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Lung,Rattus norvegicus,Intermediate,,,8838,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627078,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Lung,Rattus norvegicus,Intermediate,,,8839,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627079,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8840,10116.0
,N,50594,,,In vivo,A,,CHEMBL873824,1,,BAO_0000218,4573,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,1,,,Mus musculus,Intermediate,,,8841,10090.0
,N,50594,,,In vivo,A,1969.0,CHEMBL627080,1,,BAO_0000218,3132,Half life in mouse plasma was determined at dose 25 mg/kg,1,,Plasma,Mus musculus,Intermediate,,,8842,10090.0
,N,50594,,,,A,,CHEMBL627081,1,,BAO_0000218,17718,Half life was determined,1,,,Mus musculus,Intermediate,,,8843,10090.0
,N,50594,,,In vivo,A,,CHEMBL627082,1,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,1,,,Mus musculus,Intermediate,,,8844,10090.0
,N,50594,,,In vivo,A,,CHEMBL627083,1,,BAO_0000218,5961,Half-life in male mice after 1 mg/kg intravenous dose,1,,,Mus musculus,Intermediate,,,8845,10090.0
,N,50594,,,,A,1969.0,CHEMBL627085,1,,BAO_0000218,17731,Half life in mice plasma,1,,Plasma,Mus musculus,Intermediate,,,8847,10090.0
,N,50594,,,,A,,CHEMBL627086,1,,BAO_0000218,17592,Half life in mouse,1,,,Mus musculus,Intermediate,,,8848,10090.0
,N,50594,,,In vivo,A,1969.0,CHEMBL627087,1,,BAO_0000218,3132,Half life in mouse plasma at dose 25 mg/kg,1,,Plasma,Mus musculus,Intermediate,,,8849,10090.0
,N,50594,,,In vivo,A,,CHEMBL627088,1,,BAO_0000218,17729,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,1,,,Mus musculus,Intermediate,,,8850,10090.0
,N,50594,,,In vivo,A,,CHEMBL627089,1,,BAO_0000218,17729,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,1,,,Mus musculus,Intermediate,,,8851,10090.0
,N,50594,,,In vivo,A,,CHEMBL627090,1,,BAO_0000218,17729,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,1,,,Mus musculus,Intermediate,,,8852,10090.0
,N,50594,,,In vivo,A,,CHEMBL627091,1,,BAO_0000218,3277,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),1,,,Mus musculus,Intermediate,,,8853,10090.0
,N,50594,,,In vivo,A,,CHEMBL627092,1,,BAO_0000218,3760,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",1,,,Mus musculus,Intermediate,,,8854,10090.0
,N,50594,,,In vivo,A,,CHEMBL876785,1,,BAO_0000218,3760,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",1,,,Mus musculus,Intermediate,,,8855,10090.0
,N,50594,,,In vivo,A,,CHEMBL627093,1,,BAO_0000218,2862,Half-life by iv administration in mouse,1,,,Mus musculus,Intermediate,,,8856,10090.0
,N,50594,,,In vivo,A,,CHEMBL627094,1,,BAO_0000218,2862,Half-life by oral administration in mouse,1,,,Mus musculus,Intermediate,,,8857,10090.0
,N,50594,,,,A,,CHEMBL627095,1,,BAO_0000218,5980,Half-life in mice,1,,,Mus musculus,Intermediate,,,8858,10090.0
,N,50594,,,,A,955.0,CHEMBL627096,1,,BAO_0000218,6159,Half-life using mouse brain homogenate,1,,Brain,Mus musculus,Intermediate,,,8859,10090.0
,N,50594,,,,A,,CHEMBL627097,1,,BAO_0000218,6254,Half-life was measured in mice,1,,,Mus musculus,Intermediate,,,8860,10090.0
,N,50594,,,In vivo,A,,CHEMBL627098,1,,BAO_0000218,6062,Half-life was measured in mouse after an iv dose of 1 mg/kg,1,,,Mus musculus,Intermediate,,,8861,10090.0
,N,50594,,,,A,178.0,CHEMBL627099,1,,BAO_0000218,1574,Half-life period was determined in mouse blood,1,,Blood,Mus musculus,Intermediate,,,8862,10090.0
,N,50594,,,,A,955.0,CHEMBL627100,1,,BAO_0000218,56,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",1,,Brain,Mus musculus,Intermediate,,,8863,10090.0
,N,50594,,,,A,1969.0,CHEMBL627101,1,,BAO_0000218,993,Plasma half life in mouse,1,,Plasma,Mus musculus,Intermediate,,,8864,10090.0
,N,50594,,,,A,,CHEMBL627102,1,,BAO_0000218,6652,Stability of the peptide in the presence of mouse serum,1,,,Mus musculus,Intermediate,,,8865,10090.0
,N,50594,,,,A,,CHEMBL627103,1,,BAO_0000218,17852,Terminal half life of compound was determined in mouse,1,,,Mus musculus,Intermediate,,,8866,10090.0
,N,50594,,,In vivo,A,,CHEMBL627104,1,,BAO_0000218,2675,Terminal half life was evaluated in mice after intravenous administration,1,,,Mus musculus,Intermediate,,,8867,10090.0
,N,50594,,,In vivo,A,,CHEMBL627105,1,,BAO_0000218,2675,Terminal half life was evaluated in mice after oral administration,1,,,Mus musculus,Intermediate,,,8868,10090.0
,N,50594,,,,A,,CHEMBL876786,1,,BAO_0000218,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,1,,,Mus musculus,Intermediate,,,8869,10090.0
,N,50594,,,,A,,CHEMBL873825,1,,BAO_0000218,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,1,,,Mus musculus,Intermediate,,,8870,10090.0
,N,50594,,,,A,,CHEMBL627106,1,,BAO_0000218,499,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,1,,,Mus musculus,Intermediate,,,8871,10090.0
,N,50594,,,In vivo,A,,CHEMBL626336,1,,BAO_0000218,14239,half life period is evaluated by administering intravenously at 25 mg/kg in mice,1,,,Mus musculus,Intermediate,,,8872,10090.0
,N,50594,,,In vivo,A,,CHEMBL877462,1,,BAO_0000218,5506,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",1,,,Mus musculus,Intermediate,,,8873,10090.0
,N,50594,,,In vivo,A,,CHEMBL626337,1,,BAO_0000218,5506,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",1,,,Mus musculus,Intermediate,,,8874,10090.0
,N,50594,,,,A,,CHEMBL626338,1,,BAO_0000218,17734,Half life after intraperitoneal administration of 100 mg/kg in mice,1,,,Mus musculus,Intermediate,,,8875,10090.0
,N,50594,,,In vivo,A,,CHEMBL626339,1,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,1,,,Mus musculus,Intermediate,,,8876,10090.0
,N,50594,,,In vivo,A,,CHEMBL626340,1,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,1,,,Mus musculus,Intermediate,,,8877,10090.0
,N,50594,,,In vivo,A,,CHEMBL625377,1,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,1,,,Mus musculus,Intermediate,,,8878,10090.0
,N,50594,,,In vivo,A,,CHEMBL625378,1,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,1,,,Mus musculus,Intermediate,,,8879,10090.0
,N,50594,,,In vivo,A,,CHEMBL625379,1,,BAO_0000218,17728,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,1,,,Mus musculus,Intermediate,,,8880,10090.0
,U,22224,,Microsomes,,A,,CHEMBL625380,0,,BAO_0000251,14294,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),1,,,Sus scrofa,Autocuration,,,8881,9823.0
,U,22224,,Microsomes,,A,,CHEMBL625381,0,,BAO_0000251,14294,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),1,,,Sus scrofa,Autocuration,,,8882,9823.0
,U,22224,,,,A,,CHEMBL625382,0,,BAO_0000019,6056,Stability to porcine renal DHP-I,1,,,Sus scrofa,Autocuration,,,8883,9823.0
,U,22224,,,In vivo,A,,CHEMBL873828,0,,BAO_0000218,1317,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,1,,,Sus scrofa,Autocuration,,,8884,9823.0
,U,22224,,,In vivo,A,,CHEMBL625383,0,,BAO_0000218,1317,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,1,,,Sus scrofa,Autocuration,,,8885,9823.0
,U,22224,,,,A,,CHEMBL625384,0,,BAO_0000019,5229,Half-life of the parent prodrug in porcine esterase solution,1,,,Sus scrofa,Autocuration,,,8886,9823.0
,U,22224,,,,A,,CHEMBL625385,0,,BAO_0000019,4231,"First order rate constant, k was determined in in pig liver Esterase",1,,,Sus scrofa,Autocuration,,,8887,9823.0
,U,22224,,,,A,2107.0,CHEMBL625386,0,,BAO_0000221,4231,Half life of the in pig liver Esterase,1,,Liver,Sus scrofa,Autocuration,,,8888,9823.0
,U,22224,,,,A,2107.0,CHEMBL623571,0,,BAO_0000221,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,1,,Liver,Sus scrofa,Autocuration,,,8889,9823.0
,U,22224,,,,A,2107.0,CHEMBL623572,0,,BAO_0000221,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,1,,Liver,Sus scrofa,Autocuration,,,8890,9823.0
,U,22224,,,,A,2107.0,CHEMBL623573,0,,BAO_0000221,5318,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,1,,Liver,Sus scrofa,Autocuration,,,8891,9823.0
,U,22224,,,,A,2107.0,CHEMBL623574,0,,BAO_0000221,3305,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,1,,Liver,Sus scrofa,Autocuration,,,8892,9823.0
,U,22224,,,,A,2107.0,CHEMBL623575,0,,BAO_0000221,3305,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,1,,Liver,Sus scrofa,Autocuration,,,8893,9823.0
,U,22224,,,,A,2107.0,CHEMBL623749,0,,BAO_0000221,2842,Half-life in the presence of pig liver esterase(PLE) was evaluated.,1,,Liver,Sus scrofa,Autocuration,,,8894,9823.0
,U,22224,,,,A,2107.0,CHEMBL623750,0,,BAO_0000221,2842,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,1,,Liver,Sus scrofa,Autocuration,,,8895,9823.0
,U,22224,,,In vitro,A,2107.0,CHEMBL623751,0,,BAO_0000221,889,Half-life in vitro in pig liver,1,,Liver,Sus scrofa,Autocuration,,,8896,9823.0
,U,22224,,,,A,2107.0,CHEMBL623752,0,,BAO_0000221,1904,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,1,,Liver,Sus scrofa,Autocuration,,,8897,9823.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623753,1,,BAO_0000218,4186,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,1,,Plasma,Rattus norvegicus,Intermediate,,,8898,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623754,1,,BAO_0000218,2774,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,1,,Plasma,Rattus norvegicus,Intermediate,,,8899,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623755,1,,BAO_0000218,1742,Maximum concentration in rat plasma was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,8900,10116.0
,N,50597,,,In vivo,A,,CHEMBL623756,1,,BAO_0000218,3169,Maximum concentration in rats,1,,,Rattus norvegicus,Intermediate,,,8901,10116.0
,N,50597,,,In vivo,A,,CHEMBL623757,1,,BAO_0000218,3169,Maximum concentration in rats at 1-2 hours,1,,,Rattus norvegicus,Intermediate,,,8902,10116.0
,N,50597,,,In vivo,A,,CHEMBL623758,1,,BAO_0000218,2081,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,1,,,Rattus norvegicus,Intermediate,,,8903,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL623759,1,,BAO_0000218,3307,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,1,,Brain,Rattus norvegicus,Intermediate,,,8904,10116.0
,N,50597,,,In vivo,A,,CHEMBL623760,1,,BAO_0000218,4727,Maximum concentration at the dose of 2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,8905,10116.0
,N,50597,,,In vivo,A,,CHEMBL623761,1,,BAO_0000218,6597,Maximum concentration was evaluated in rats,1,,,Rattus norvegicus,Intermediate,,,8906,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623762,1,,BAO_0000218,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8907,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL877594,1,,BAO_0000218,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8908,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623763,1,,BAO_0000218,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,8909,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623764,1,,BAO_0000218,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,8910,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623765,1,,BAO_0000218,16365,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8911,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL623766,1,,BAO_0000218,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,1,,Blood,Rattus norvegicus,Intermediate,,,8912,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL623767,1,,BAO_0000218,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,1,,Blood,Rattus norvegicus,Intermediate,,,8913,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL623768,1,,BAO_0000218,2591,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,1,,Blood,Rattus norvegicus,Intermediate,,,8914,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623769,1,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8915,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623770,1,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8916,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623771,1,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8917,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623772,1,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8918,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623773,1,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8919,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623774,1,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8920,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623775,1,,BAO_0000218,5978,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8921,10116.0
,N,50597,,,In vivo,A,,CHEMBL623776,1,,BAO_0000218,14465,Cmax in rat (PO dose),1,,,Rattus norvegicus,Intermediate,,,8922,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622191,1,,BAO_0000218,4723,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,Plasma,Rattus norvegicus,Intermediate,,,8923,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622192,1,,BAO_0000218,4723,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,Plasma,Rattus norvegicus,Intermediate,,,8924,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622193,1,,BAO_0000218,4576,Maximum plasma concentration determined in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8925,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622194,1,,BAO_0000218,12873,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,8926,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622195,1,,BAO_0000218,12873,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,8927,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622196,1,,BAO_0000218,6824,Maximum plasma concentration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8928,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622197,1,,BAO_0000218,17065,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,Plasma,Rattus norvegicus,Intermediate,,,8929,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622198,1,,BAO_0000218,2932,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,1,,Plasma,Rattus norvegicus,Intermediate,,,8930,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622199,1,,BAO_0000218,2932,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,1,,Plasma,Rattus norvegicus,Intermediate,,,8931,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622200,1,,BAO_0000218,2879,Maximum plasma concentration of compound was measured in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8932,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622201,1,,BAO_0000218,2864,Maximum plasma concentration after 20 mg/kg oral administration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,8933,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623990,1,,BAO_0000218,16367,Maximum plasma concentration after oral administration to rats,1,,Plasma,Rattus norvegicus,Intermediate,,,8934,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623991,1,,BAO_0000218,17717,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,Plasma,Rattus norvegicus,Intermediate,,,8935,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623992,1,,BAO_0000218,17717,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",1,,Plasma,Rattus norvegicus,Intermediate,,,8936,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623993,1,,BAO_0000218,17717,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,Plasma,Rattus norvegicus,Intermediate,,,8937,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623994,1,,BAO_0000218,17717,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,1,,Plasma,Rattus norvegicus,Intermediate,,,8938,10116.0
,N,50597,,,In vivo,F,1969.0,CHEMBL623995,1,,BAO_0000218,17720,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,1,,Plasma,Rattus norvegicus,Intermediate,,,8939,10116.0
,N,50597,,,In vivo,F,1969.0,CHEMBL623996,1,,BAO_0000218,17720,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,Plasma,Rattus norvegicus,Intermediate,,,8940,10116.0
,N,50597,,,In vivo,F,1969.0,CHEMBL623997,1,,BAO_0000218,17720,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,1,,Plasma,Rattus norvegicus,Intermediate,,,8941,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623998,1,,BAO_0000218,4516,Maximum plasma concentration dosed orally in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,8942,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623999,1,,BAO_0000218,4516,Maximum plasma concentration dosed orally in rats after 6 hours,1,,Plasma,Rattus norvegicus,Intermediate,,,8943,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624000,1,,BAO_0000218,4516,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,1,,Plasma,Rattus norvegicus,Intermediate,,,8944,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624001,1,,BAO_0000218,5199,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,8945,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624002,1,,BAO_0000218,17538,Maximum plasma concentration in rat after po administration,1,,Plasma,Rattus norvegicus,Intermediate,,,8946,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624003,1,,BAO_0000218,6685,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",1,,Plasma,Rattus norvegicus,Intermediate,,,8947,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL624004,1,,BAO_0000218,6685,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",1,,Plasma,Rattus norvegicus,Intermediate,,,8948,10116.0
,N,50597,,,,A,948.0,CHEMBL624005,1,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8949,10116.0
,N,50597,,,,A,948.0,CHEMBL624006,1,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8950,10116.0
,N,50597,,,,A,948.0,CHEMBL624007,1,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8951,10116.0
,N,50597,,,,A,948.0,CHEMBL624008,1,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8952,10116.0
,N,50597,,,,A,948.0,CHEMBL624009,1,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8953,10116.0
,N,50597,,,,A,948.0,CHEMBL874387,1,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8954,10116.0
,N,50597,,,,A,948.0,CHEMBL624010,1,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8955,10116.0
,N,50597,,,,A,948.0,CHEMBL624011,1,,BAO_0000218,16434,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8956,10116.0
,N,50597,,,,A,948.0,CHEMBL624012,1,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8957,10116.0
,N,50597,,,,A,948.0,CHEMBL624013,1,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8958,10116.0
,N,50597,,,,A,948.0,CHEMBL624736,1,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8959,10116.0
,N,50597,,,,A,948.0,CHEMBL624737,1,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8960,10116.0
,N,50597,,,,A,948.0,CHEMBL624738,1,,BAO_0000218,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,Heart,Rattus norvegicus,Intermediate,,,8961,10116.0
,N,50597,,,,A,948.0,CHEMBL624739,1,,BAO_0000218,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,Heart,Rattus norvegicus,Intermediate,,,8962,10116.0
,N,50597,,,,A,948.0,CHEMBL624740,1,,BAO_0000218,16434,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,Heart,Rattus norvegicus,Intermediate,,,8963,10116.0
,N,50597,,,,A,948.0,CHEMBL624896,1,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,Heart,Rattus norvegicus,Intermediate,,,8964,10116.0
,N,50597,,,,A,948.0,CHEMBL624897,1,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,Heart,Rattus norvegicus,Intermediate,,,8965,10116.0
,N,50597,,,,A,948.0,CHEMBL624108,1,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,Heart,Rattus norvegicus,Intermediate,,,8966,10116.0
,N,50597,,,,A,948.0,CHEMBL624109,1,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,Heart,Rattus norvegicus,Intermediate,,,8967,10116.0
,N,50597,,,,A,948.0,CHEMBL624110,1,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,Heart,Rattus norvegicus,Intermediate,,,8968,10116.0
,N,50597,,,,A,948.0,CHEMBL624111,1,,BAO_0000218,16435,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,Heart,Rattus norvegicus,Intermediate,,,8969,10116.0
,N,50597,,,,A,948.0,CHEMBL624112,1,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8970,10116.0
,N,50597,,,,A,948.0,CHEMBL624113,1,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8971,10116.0
,N,50597,,,,A,948.0,CHEMBL619709,1,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8972,10116.0
,N,50597,,,,A,948.0,CHEMBL619710,1,,BAO_0000218,16435,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,Heart,Rattus norvegicus,Intermediate,,,8973,10116.0
,N,50597,,,,A,2113.0,CHEMBL619711,1,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8974,10116.0
,N,50597,,,,A,2113.0,CHEMBL619712,1,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8975,10116.0
,N,50597,,,,A,2113.0,CHEMBL619713,1,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8976,10116.0
,N,50597,,,,A,2113.0,CHEMBL619714,1,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8977,10116.0
,N,50597,,,,A,2113.0,CHEMBL619715,1,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8978,10116.0
,N,50597,,,,A,2113.0,CHEMBL619716,1,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8979,10116.0
,N,50597,,,,A,2113.0,CHEMBL619717,1,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8980,10116.0
,N,50597,,,,A,2113.0,CHEMBL619718,1,,BAO_0000218,16434,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8981,10116.0
,N,50597,,,,A,2113.0,CHEMBL619719,1,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8982,10116.0
,N,50597,,,,A,2113.0,CHEMBL875329,1,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8983,10116.0
,N,50597,,,,A,2113.0,CHEMBL619720,1,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8984,10116.0
,N,50597,,,,A,2113.0,CHEMBL619721,1,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8985,10116.0
,N,50597,,,,A,2113.0,CHEMBL619722,1,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8986,10116.0
,N,50597,,,,A,2113.0,CHEMBL619723,1,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8987,10116.0
,N,50597,,,,A,2113.0,CHEMBL619724,1,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8988,10116.0
,N,50597,,,,A,2113.0,CHEMBL619725,1,,BAO_0000218,16435,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,Kidney,Rattus norvegicus,Intermediate,,,8989,10116.0
,N,50597,,,,A,2113.0,CHEMBL619726,1,,BAO_0000218,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,Kidney,Rattus norvegicus,Intermediate,,,8990,10116.0
,N,50597,,,,A,2113.0,CHEMBL619727,1,,BAO_0000218,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,Kidney,Rattus norvegicus,Intermediate,,,8991,10116.0
,N,50597,,,,A,2113.0,CHEMBL619728,1,,BAO_0000218,16434,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,Kidney,Rattus norvegicus,Intermediate,,,8992,10116.0
,N,50597,,,,A,2113.0,CHEMBL619729,1,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,Kidney,Rattus norvegicus,Intermediate,,,8993,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL619730,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8994,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL619731,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8995,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL619732,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8996,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL619733,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8997,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL619734,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Muscle tissue,Rattus norvegicus,Intermediate,,,8998,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL619735,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Zone of skin,Rattus norvegicus,Intermediate,,,8999,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL875330,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Zone of skin,Rattus norvegicus,Intermediate,,,9000,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL628465,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,Zone of skin,Rattus norvegicus,Intermediate,,,9001,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL628466,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Zone of skin,Rattus norvegicus,Intermediate,,,9002,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL628467,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Zone of skin,Rattus norvegicus,Intermediate,,,9003,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL628468,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Spleen,Rattus norvegicus,Intermediate,,,9004,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL628469,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Spleen,Rattus norvegicus,Intermediate,,,9005,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL628470,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,Spleen,Rattus norvegicus,Intermediate,,,9006,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL628471,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Spleen,Rattus norvegicus,Intermediate,,,9007,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL628472,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Spleen,Rattus norvegicus,Intermediate,,,9008,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL625191,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9009,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL625192,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9010,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL875337,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9011,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL626341,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9012,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL626342,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9013,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL621943,1,,BAO_0000218,11977,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),1,,Liver,Rattus norvegicus,Intermediate,,,9014,10116.0
,N,50597,,,,A,,CHEMBL621944,1,,BAO_0000218,3748,Half life in rats,1,,,Rattus norvegicus,Intermediate,,,9015,10116.0
,N,50597,,,,A,,CHEMBL621945,1,,BAO_0000218,15765,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,1,,,Rattus norvegicus,Intermediate,,,9016,10116.0
,N,50597,,,,A,,CHEMBL621946,1,,BAO_0000218,4871,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),1,,,Rattus norvegicus,Intermediate,,,9017,10116.0
,N,50597,,,,A,,CHEMBL621947,1,,BAO_0000218,4871,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,1,,,Rattus norvegicus,Intermediate,,,9018,10116.0
,N,50597,,,,A,,CHEMBL621948,1,,BAO_0000218,4872,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),1,,,Rattus norvegicus,Intermediate,,,9019,10116.0
,N,50597,,,,A,,CHEMBL621949,1,,BAO_0000218,4872,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,1,,,Rattus norvegicus,Intermediate,,,9020,10116.0
,N,50597,,,,A,,CHEMBL621950,1,,BAO_0000218,5413,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),1,,,Rattus norvegicus,Intermediate,,,9021,10116.0
,N,50597,,,,A,,CHEMBL621951,1,,BAO_0000218,5413,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,1,,,Rattus norvegicus,Intermediate,,,9022,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL621952,1,,BAO_0000218,15272,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,1,,Blood,Rattus norvegicus,Intermediate,,,9023,10116.0
,N,50597,,,,A,2107.0,CHEMBL621953,1,,BAO_0000218,4689,Stability (%) in rat liver microsomes,1,,Liver,Rattus norvegicus,Intermediate,,,9024,10116.0
,N,50597,,,,A,,CHEMBL621954,1,,BAO_0000218,6057,Area under curve was calculated after intravenous administration,1,,,Rattus norvegicus,Intermediate,,,9025,10116.0
,N,50597,,,,A,,CHEMBL621955,1,,BAO_0000218,6057,Area under the curve was calculated after iv administration in rat,1,,,Rattus norvegicus,Intermediate,,,9026,10116.0
,N,50597,,,,A,,CHEMBL621956,1,,BAO_0000218,6057,Area under the curve was calculated in rat after peroral administration,1,,,Rattus norvegicus,Intermediate,,,9027,10116.0
,N,50597,,,,A,,CHEMBL621957,1,,BAO_0000218,6211,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,9028,10116.0
,N,50597,,,,A,,CHEMBL621958,1,,BAO_0000218,5710,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,9029,10116.0
,N,50597,,,,A,,CHEMBL621959,1,,BAO_0000218,5710,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,9030,10116.0
,N,50597,,,,A,,CHEMBL621960,1,,BAO_0000218,17853,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,1,,,Rattus norvegicus,Intermediate,,,9031,10116.0
,N,50597,,,,A,,CHEMBL621961,1,,BAO_0000218,17853,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,1,,,Rattus norvegicus,Intermediate,,,9032,10116.0
,N,50597,,,,A,,CHEMBL621962,1,,BAO_0000218,15765,p value of the compound,1,,,Rattus norvegicus,Intermediate,,,9033,10116.0
,N,50597,,,,F,,CHEMBL876787,1,,BAO_0000218,15765,p value of the compound,1,,,Rattus norvegicus,Intermediate,,,9034,10116.0
,N,50597,,,,A,,CHEMBL621963,1,,BAO_0000218,15765,p value of the compound,1,,,Rattus norvegicus,Intermediate,,,9035,10116.0
,N,50597,,,,A,945.0,CHEMBL622637,1,,BAO_0000218,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,Stomach,Rattus norvegicus,Intermediate,,,9036,10116.0
,N,50597,,,,A,945.0,CHEMBL622638,1,,BAO_0000218,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,Stomach,Rattus norvegicus,Intermediate,,,9037,10116.0
,N,50597,,,,A,945.0,CHEMBL626561,1,,BAO_0000218,6175,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,Stomach,Rattus norvegicus,Intermediate,,,9038,10116.0
,U,22224,,,,F,,CHEMBL626562,0,,BAO_0000019,7991,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),1,,,Oryctolagus cuniculus,Autocuration,,,9039,9986.0
,U,22224,,,,A,,CHEMBL626563,0,,BAO_0000218,429,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),1,,,Oryctolagus cuniculus,Autocuration,,,9040,9986.0
,U,22224,,,,A,,CHEMBL626564,0,,BAO_0000218,429,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),1,,,Oryctolagus cuniculus,Autocuration,,,9041,9986.0
,U,22224,,,In vivo,A,,CHEMBL626565,0,,BAO_0000218,6253,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,1,,,Oryctolagus cuniculus,Autocuration,,,9042,9986.0
,U,22224,,,In vivo,A,,CHEMBL626566,0,,BAO_0000218,6253,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,1,,,Oryctolagus cuniculus,Autocuration,,,9043,9986.0
,U,22224,,,In vivo,A,,CHEMBL626567,0,,BAO_0000218,3615,Clearance rate in rabbits,1,,,Oryctolagus cuniculus,Autocuration,,,9044,9986.0
,U,22224,,,In vivo,A,,CHEMBL626568,0,,BAO_0000218,4059,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,1,,,Oryctolagus cuniculus,Autocuration,,,9045,9986.0
,U,22224,,,In vivo,A,,CHEMBL626569,0,,BAO_0000218,5124,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,1,,,Oryctolagus cuniculus,Autocuration,,,9046,9986.0
,U,22224,,,In vivo,A,,CHEMBL626570,0,,BAO_0000218,5124,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,1,,,Oryctolagus cuniculus,Autocuration,,,9047,9986.0
,U,22224,,,In vivo,A,,CHEMBL626571,0,,BAO_0000218,5124,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,1,,,Oryctolagus cuniculus,Autocuration,,,9048,9986.0
,U,22224,,,In vivo,A,,CHEMBL626572,0,,BAO_0000218,429,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,1,,,Oryctolagus cuniculus,Autocuration,,,9049,9986.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626573,0,,BAO_0000218,4059,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,1,,Plasma,Oryctolagus cuniculus,Autocuration,,,9050,9986.0
,U,22224,,Microsomes,,A,2107.0,CHEMBL626574,0,,BAO_0000251,9659,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,1,,Liver,Oryctolagus cuniculus,Autocuration,,,9051,9986.0
,U,22224,,Microsomes,,A,2107.0,CHEMBL626575,0,,BAO_0000251,9659,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,1,,Liver,Oryctolagus cuniculus,Autocuration,,,9052,9986.0
,U,22224,,,,A,,CHEMBL626576,0,,BAO_0000218,3639,Dose at which bioavailability of intravenously administered compound was tested in rabbit,1,,,Oryctolagus cuniculus,Autocuration,,,9053,9986.0
,U,22224,,,,A,,CHEMBL626577,0,,BAO_0000218,3639,Dose at which bioavailability of perorally administered compound was tested in rabbit,1,,,Oryctolagus cuniculus,Autocuration,,,9054,9986.0
,U,22224,,,In vivo,A,,CHEMBL626578,0,,BAO_0000218,3639,The compound was tested for its bioavailability in rabbit (by oral dosage).,1,,,Oryctolagus cuniculus,Autocuration,,,9055,9986.0
,U,22224,,,In vivo,A,,CHEMBL625263,0,,BAO_0000218,5124,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,1,,,Oryctolagus cuniculus,Autocuration,,,9056,9986.0
,U,22224,,,In vivo,A,,CHEMBL625264,0,,BAO_0000218,5124,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,1,,,Oryctolagus cuniculus,Autocuration,,,9057,9986.0
,U,22224,,,In vivo,A,,CHEMBL625265,0,,BAO_0000218,5124,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,1,,,Oryctolagus cuniculus,Autocuration,,,9058,9986.0
,U,22224,,Microsomes,,A,,CHEMBL625266,0,,BAO_0000251,14294,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),1,,,Oryctolagus cuniculus,Autocuration,,,9059,9986.0
,U,22224,,Microsomes,,A,,CHEMBL876796,0,,BAO_0000251,14294,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),1,,,Oryctolagus cuniculus,Autocuration,,,9060,9986.0
,U,22224,,,In vivo,A,,CHEMBL625267,0,,BAO_0000218,429,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,1,,,Oryctolagus cuniculus,Autocuration,,,9061,9986.0
,U,22224,,,In vivo,A,1969.0,CHEMBL625268,0,,BAO_0000218,5124,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,1,,Plasma,Oryctolagus cuniculus,Autocuration,,,9062,9986.0
,U,22224,,,In vivo,A,1969.0,CHEMBL625269,0,,BAO_0000218,5124,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,1,,Plasma,Oryctolagus cuniculus,Autocuration,,,9063,9986.0
,U,22224,,,In vivo,A,1969.0,CHEMBL624689,0,,BAO_0000218,5124,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,1,,Plasma,Oryctolagus cuniculus,Autocuration,,,9064,9986.0
,U,22224,,,In vivo,A,,CHEMBL624690,0,,BAO_0000218,429,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,1,,,Oryctolagus cuniculus,Autocuration,,,9065,9986.0
,U,22224,,,,A,1088.0,CHEMBL624691,0,,BAO_0000218,429,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),1,,Urine,Oryctolagus cuniculus,Autocuration,,,9066,9986.0
,U,22224,,,,A,1088.0,CHEMBL624692,0,,BAO_0000218,429,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),1,,Urine,Oryctolagus cuniculus,Autocuration,,,9067,9986.0
,U,22224,,,In vivo,A,,CHEMBL624693,0,,BAO_0000218,4059,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,1,,,Oryctolagus cuniculus,Autocuration,,,9068,9986.0
,U,22224,,,In vivo,A,,CHEMBL624694,0,,BAO_0000218,4137,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,1,,,Oryctolagus cuniculus,Autocuration,,,9069,9986.0
,U,22224,,,In vitro,A,,CHEMBL877596,0,,BAO_0000221,11672,In vitro Biological half-life in crude homogenate of rabbit renal cortex,1,,,Oryctolagus cuniculus,Autocuration,,,9070,9986.0
,U,22224,,,,A,,CHEMBL624695,0,,BAO_0000019,12886,Time within which only 10% of the drug was degraded,1,,,Oryctolagus cuniculus,Autocuration,,,9071,9986.0
,U,22224,,,,A,2107.0,CHEMBL624696,0,,BAO_0000221,3853,Half life period in rabbit liver homogenate,1,,Liver,Oryctolagus cuniculus,Autocuration,,,9072,9986.0
,U,22224,,,,A,,CHEMBL624697,0,,BAO_0000019,3615,Half life value in rabbits,1,,,Oryctolagus cuniculus,Autocuration,,,9073,9986.0
,U,22224,,,In vivo,A,178.0,CHEMBL624698,0,,BAO_0000218,6253,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,1,,Blood,Oryctolagus cuniculus,Autocuration,,,9074,9986.0
,U,22224,,,In vivo,A,178.0,CHEMBL624699,0,,BAO_0000218,6253,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,1,,Blood,Oryctolagus cuniculus,Autocuration,,,9075,9986.0
,U,22224,,,In vivo,A,,CHEMBL624700,0,,BAO_0000218,6077,Half-life period in rabbits following intravenous administration at 2 mg/kg,1,,,Oryctolagus cuniculus,Autocuration,,,9076,9986.0
,N,50597,,,,A,1969.0,CHEMBL622903,1,,BAO_0000218,17617,AUC 0-8 hr value in rats at 10 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9077,10116.0
,N,50597,,,,A,1969.0,CHEMBL622904,1,,BAO_0000218,17594,AUC after administration at 2000 mg/kg/day in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9078,10116.0
,N,50597,,,,A,1969.0,CHEMBL622905,1,,BAO_0000218,6149,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,1,,Plasma,Rattus norvegicus,Intermediate,,,9079,10116.0
,N,50597,,,,A,1969.0,CHEMBL622906,1,,BAO_0000218,17260,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9080,10116.0
,N,50597,,,,A,1969.0,CHEMBL622907,1,,BAO_0000218,17260,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9081,10116.0
,N,50597,,,,A,1969.0,CHEMBL622908,1,,BAO_0000218,6644,AUC in rat after oral administration at 10.5 mg/kg dose,1,,Plasma,Rattus norvegicus,Intermediate,,,9082,10116.0
,N,50597,,,,A,1969.0,CHEMBL622909,1,,BAO_0000218,6644,AUC in rat after oral administration at 11.2 mg/kg dose,1,,Plasma,Rattus norvegicus,Intermediate,,,9083,10116.0
,N,50597,,,,A,1969.0,CHEMBL622910,1,,BAO_0000218,6644,AUC in rat after oral administration at 9.7 mg/kg dose,1,,Plasma,Rattus norvegicus,Intermediate,,,9084,10116.0
,N,50597,,,,A,955.0,CHEMBL622911,1,,BAO_0000218,6495,AUC in rat brain after oral administration at 10 mg/kg,1,,Brain,Rattus norvegicus,Intermediate,,,9085,10116.0
,N,50597,,,,A,1969.0,CHEMBL622912,1,,BAO_0000218,6504,AUC in rat p.o.,1,,Plasma,Rattus norvegicus,Intermediate,,,9086,10116.0
,N,50597,,,,A,1969.0,CHEMBL622913,1,,BAO_0000218,17686,AUC in rat p.o. at 20 mg/kg concentration,1,,Plasma,Rattus norvegicus,Intermediate,,,9087,10116.0
,N,50597,,,,A,1969.0,CHEMBL622914,1,,BAO_0000218,6495,AUC in rat plasma after oral administration at 10 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9088,10116.0
,N,50597,,,,A,1969.0,CHEMBL622915,1,,BAO_0000218,216,AUC in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9089,10116.0
,N,50597,,,,A,1969.0,CHEMBL622916,1,,BAO_0000218,1908,AUC value after IV dose at a dose of 5 mg/kg in rats.,1,,Plasma,Rattus norvegicus,Intermediate,,,9090,10116.0
,N,50597,,,,A,1969.0,CHEMBL622917,1,,BAO_0000218,1908,AUC value after oral dose at a dose of 10 mg/kg in rats.,1,,Plasma,Rattus norvegicus,Intermediate,,,9091,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622918,1,,BAO_0000218,6685,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,,Plasma,Rattus norvegicus,Intermediate,,,9092,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622919,1,,BAO_0000218,216,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,1,,Plasma,Rattus norvegicus,Intermediate,,,9093,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622920,1,,BAO_0000218,6049,Maximum plasma concentration was evaluated in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9094,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622921,1,,BAO_0000218,2463,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,1,,Plasma,Rattus norvegicus,Intermediate,,,9095,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622922,1,,BAO_0000218,6679,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,1,,Plasma,Rattus norvegicus,Intermediate,,,9096,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622923,1,,BAO_0000218,6681,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,1,,Plasma,Rattus norvegicus,Intermediate,,,9097,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL877604,1,,BAO_0000218,4890,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9098,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622924,1,,BAO_0000218,6410,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9099,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622925,1,,BAO_0000218,6410,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9100,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622926,1,,BAO_0000218,16366,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,1,,Plasma,Rattus norvegicus,Intermediate,,,9101,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623625,1,,BAO_0000218,6227,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9102,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623626,1,,BAO_0000218,3598,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,Plasma,Rattus norvegicus,Expert,,,9103,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623627,1,,BAO_0000218,1465,Maximum plasma drug concentration was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,9104,10116.0
,N,50597,,,In vivo,A,,CHEMBL623628,1,,BAO_0000218,4368,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9105,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623629,1,,BAO_0000218,15662,Mean peak plasma concentration was observed after intravenous administration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9106,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623630,1,,BAO_0000218,15662,Mean peak plasma concentration was observed after oral administration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9107,10116.0
,N,50597,,,In vivo,A,,CHEMBL623804,1,,BAO_0000218,5355,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9108,10116.0
,N,50597,,,In vivo,A,,CHEMBL623805,1,,BAO_0000218,5355,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9109,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623806,1,,BAO_0000218,1567,Peak oral plasma concentration was determined in rats by oral administration,1,,Plasma,Rattus norvegicus,Intermediate,,,9110,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623807,1,,BAO_0000218,4026,Peak plasma concentration (Cmax) was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,9111,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623808,1,,BAO_0000218,6193,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9112,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623809,1,,BAO_0000218,4026,Peak plasma concentration (Cmax) in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9113,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623810,1,,BAO_0000218,6485,Peak plasma concentration at 1 mg/kg peroral administration,1,,Plasma,Rattus norvegicus,Intermediate,,,9114,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623811,1,,BAO_0000218,17655,Peak plasma concentration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9115,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623812,1,,BAO_0000218,14941,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",1,,Plasma,Rattus norvegicus,Intermediate,,,9116,10116.0
,N,50597,,,In vivo,A,,CHEMBL877605,1,,BAO_0000218,5394,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9117,10116.0
,N,50597,,,In vivo,A,,CHEMBL623813,1,,BAO_0000218,4408,Pharmacokinetic property (Cmax) in rat,1,,,Rattus norvegicus,Intermediate,,,9118,10116.0
,N,50597,,,In vivo,A,,CHEMBL623814,1,,BAO_0000218,5983,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,1,,,Rattus norvegicus,Intermediate,,,9119,10116.0
,N,50597,,,In vivo,A,,CHEMBL623815,1,,BAO_0000218,4878,Cmax in rat after 3mg/kg oral dose,1,,,Rattus norvegicus,Intermediate,,,9120,10116.0
,N,50597,,,In vivo,A,,CHEMBL623816,1,,BAO_0000218,5862,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,1,,,Rattus norvegicus,Intermediate,,Sprague-Dawley,9121,10116.0
,N,50597,,,In vivo,A,,CHEMBL623145,1,,BAO_0000218,4517,Cmax in rats after 20 mg/kg oral dose,1,,,Rattus norvegicus,Intermediate,,,9122,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623146,1,,BAO_0000218,5932,Cmax in rat plasma after 30mg/kg oral dose,1,,Plasma,Rattus norvegicus,Intermediate,,,9123,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623147,1,,BAO_0000218,5436,Plasma concentration after oral administration of 100 mg/kg to rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9124,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL623042,1,,BAO_0000218,4910,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,1,,Brain,Rattus norvegicus,Intermediate,,,9125,10116.0
,N,50597,,,In vivo,A,,CHEMBL623043,1,,BAO_0000218,4950,Tested for the Cmax in rat at 10 mg/kg per orally,1,,,Rattus norvegicus,Intermediate,,,9126,10116.0
,N,50597,,,In vivo,A,,CHEMBL623044,1,,BAO_0000218,15078,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,9127,10116.0
,N,50597,,,In vivo,A,,CHEMBL623045,1,,BAO_0000218,15078,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,9128,10116.0
,N,50597,,,In vivo,A,,CHEMBL623046,1,,BAO_0000218,3360,Bioavailability as oral Cmax in rats at 30 mins,1,,,Rattus norvegicus,Intermediate,,,9129,10116.0
,N,50597,,,In vivo,A,,CHEMBL623226,1,,BAO_0000218,3360,Bioavailability as oral Cmax in rats at 6hr,1,,,Rattus norvegicus,Intermediate,,,9130,10116.0
,N,50597,,,In vivo,A,,CHEMBL623227,1,,BAO_0000218,15022,The maximum concentration of compound was measured at the dose of 100 umol/kg,1,,,Rattus norvegicus,Intermediate,,,9131,10116.0
,N,50597,,,In vivo,A,,CHEMBL623228,1,,BAO_0000218,15022,The maximum concentration of compound was measured at the dose of 300 umol/kg,1,,,Rattus norvegicus,Intermediate,,,9132,10116.0
,N,50597,,,In vivo,A,,CHEMBL623229,1,,BAO_0000218,15022,The maximum concentration of compound was measured at the dose of 30 umol/kg,1,,,Rattus norvegicus,Intermediate,,,9133,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623230,1,,BAO_0000218,5160,The maximum plasma levels for the compounds were determined by LC-MS.,1,,Plasma,Rattus norvegicus,Intermediate,,,9134,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623231,1,,BAO_0000218,15662,mean peak plasma concentration was observed after intravenous administration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9135,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623232,1,,BAO_0000218,15662,mean peak plasma concentration was observed after oral administration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9136,10116.0
,N,50597,,,,A,,CHEMBL623233,1,,BAO_0000218,4709,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9137,10116.0
,N,50597,,,,A,,CHEMBL623234,1,,BAO_0000218,3535,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,1,,,Rattus norvegicus,Intermediate,,,9138,10116.0
,N,50597,,,,A,,CHEMBL623235,1,,BAO_0000218,3535,Concentration in plasma (portal) following oral dose in rats at 1 hr,1,,,Rattus norvegicus,Intermediate,,,9139,10116.0
,N,50597,,,,A,,CHEMBL623236,1,,BAO_0000218,3535,Concentration in plasma (portal) following oral dose in rats at 2 hr,1,,,Rattus norvegicus,Intermediate,,,9140,10116.0
,N,50597,,,,A,,CHEMBL623237,1,,BAO_0000218,3535,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,1,,,Rattus norvegicus,Intermediate,,,9141,10116.0
,N,50597,,,,A,,CHEMBL623238,1,,BAO_0000218,3535,Concentration in plasma (systemic) following oral dose in rats at 1 hr,1,,,Rattus norvegicus,Intermediate,,,9142,10116.0
,N,50597,,,,A,,CHEMBL623239,1,,BAO_0000218,3535,Concentration in plasma (systemic) following oral dose in rats at 2 hr,1,,,Rattus norvegicus,Intermediate,,,9143,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL623240,0,,BAO_0000218,5005,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,1,,Plasma,Rattus norvegicus,Intermediate,,,9144,10116.0
,N,50597,,,,A,1898.0,CHEMBL623241,1,,BAO_0000218,6326,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",1,,Hypothalamus,Rattus norvegicus,Intermediate,,,9145,10116.0
,N,50597,,,,A,1898.0,CHEMBL623242,1,,BAO_0000218,6326,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",1,,Hypothalamus,Rattus norvegicus,Intermediate,,,9146,10116.0
,N,50597,,,,A,,CHEMBL874394,1,,BAO_0000218,6326,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",1,,,Rattus norvegicus,Intermediate,,,9147,10116.0
,N,50597,,,,A,,CHEMBL623243,1,,BAO_0000218,6326,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",1,,,Rattus norvegicus,Intermediate,,,9148,10116.0
,N,50597,,,,A,,CHEMBL623244,1,,BAO_0000218,17411,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9149,10116.0
,N,50597,,,,A,2113.0,CHEMBL623245,1,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,Kidney,Rattus norvegicus,Intermediate,,,9150,10116.0
,N,50597,,,,A,2113.0,CHEMBL623246,1,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,Kidney,Rattus norvegicus,Intermediate,,,9151,10116.0
,N,50597,,,,A,2113.0,CHEMBL623247,1,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,Kidney,Rattus norvegicus,Intermediate,,,9152,10116.0
,N,50597,,,,A,2113.0,CHEMBL623248,1,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,Kidney,Rattus norvegicus,Intermediate,,,9153,10116.0
,N,50597,,,,A,2113.0,CHEMBL623249,1,,BAO_0000218,16435,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,Kidney,Rattus norvegicus,Intermediate,,,9154,10116.0
,N,50597,,,,A,2107.0,CHEMBL625072,1,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9155,10116.0
,N,50597,,,,A,2107.0,CHEMBL625073,1,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9156,10116.0
,N,50597,,,,A,2107.0,CHEMBL625074,1,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9157,10116.0
,N,50597,,,,A,2107.0,CHEMBL625075,1,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9158,10116.0
,N,50597,,,,A,2107.0,CHEMBL625076,1,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9159,10116.0
,N,50597,,,,A,2107.0,CHEMBL625077,1,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9160,10116.0
,N,50597,,,,A,2107.0,CHEMBL625078,1,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9161,10116.0
,N,50597,,,,A,2107.0,CHEMBL874395,1,,BAO_0000218,16434,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9162,10116.0
,N,50597,,,,A,2107.0,CHEMBL625079,1,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9163,10116.0
,N,50597,,,,A,2107.0,CHEMBL625080,1,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9164,10116.0
,N,50597,,,,A,2107.0,CHEMBL625081,1,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9165,10116.0
,N,50597,,,,A,2107.0,CHEMBL625082,1,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9166,10116.0
,N,50597,,,,A,2107.0,CHEMBL625083,1,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9167,10116.0
,N,50597,,,,A,2107.0,CHEMBL625084,1,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9168,10116.0
,N,50597,,,,A,2107.0,CHEMBL625085,1,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9169,10116.0
,N,50597,,,,A,2107.0,CHEMBL625086,1,,BAO_0000218,16435,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,Liver,Rattus norvegicus,Intermediate,,,9170,10116.0
,N,50597,,,,A,2107.0,CHEMBL625087,1,,BAO_0000218,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,Liver,Rattus norvegicus,Intermediate,,,9171,10116.0
,N,50597,,,,A,2107.0,CHEMBL625088,1,,BAO_0000218,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,Liver,Rattus norvegicus,Intermediate,,,9172,10116.0
,N,50597,,,,A,2107.0,CHEMBL622205,1,,BAO_0000218,16434,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,Liver,Rattus norvegicus,Intermediate,,,9173,10116.0
,N,50597,,,,A,2107.0,CHEMBL622206,1,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,Liver,Rattus norvegicus,Intermediate,,,9174,10116.0
,N,50597,,,,A,2107.0,CHEMBL622207,1,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,Liver,Rattus norvegicus,Intermediate,,,9175,10116.0
,N,50597,,,,A,2107.0,CHEMBL622366,1,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,Liver,Rattus norvegicus,Intermediate,,,9176,10116.0
,N,50597,,,,A,2107.0,CHEMBL622367,1,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,Liver,Rattus norvegicus,Intermediate,,,9177,10116.0
,N,50597,,,,A,2107.0,CHEMBL875331,1,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,Liver,Rattus norvegicus,Intermediate,,,9178,10116.0
,N,50597,,,,A,2107.0,CHEMBL622368,1,,BAO_0000218,16435,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,Liver,Rattus norvegicus,Intermediate,,,9179,10116.0
,N,50597,,,,A,2048.0,CHEMBL622369,1,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9180,10116.0
,N,50597,,,,A,2048.0,CHEMBL622370,1,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9181,10116.0
,N,50597,,,,A,2048.0,CHEMBL622371,1,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9182,10116.0
,N,50597,,,,A,2048.0,CHEMBL622372,1,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9183,10116.0
,N,50597,,,,A,2048.0,CHEMBL622373,1,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9184,10116.0
,N,50597,,,,A,2048.0,CHEMBL622374,1,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9185,10116.0
,N,50597,,,,A,2048.0,CHEMBL622375,1,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9186,10116.0
,N,50597,,,,A,2048.0,CHEMBL622376,1,,BAO_0000218,16434,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9187,10116.0
,N,50597,,,,A,2048.0,CHEMBL622377,1,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9188,10116.0
,N,50597,,,,A,2048.0,CHEMBL622378,1,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9189,10116.0
,N,50597,,,,A,2048.0,CHEMBL622379,1,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9190,10116.0
,N,50597,,,,A,2048.0,CHEMBL622380,1,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9191,10116.0
,N,50597,,,,A,2048.0,CHEMBL622381,1,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9192,10116.0
,N,50597,,,,A,2048.0,CHEMBL622382,1,,BAO_0000218,16435,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9193,10116.0
,N,50597,,,,A,2048.0,CHEMBL622383,1,,BAO_0000218,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,1,,Lung,Rattus norvegicus,Intermediate,,,9194,10116.0
,N,50597,,,,A,945.0,CHEMBL875332,1,,BAO_0000218,6175,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,Stomach,Rattus norvegicus,Intermediate,,,9195,10116.0
,N,50597,,,,A,945.0,CHEMBL622384,1,,BAO_0000218,6175,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,Stomach,Rattus norvegicus,Intermediate,,,9196,10116.0
,N,50597,,,,A,945.0,CHEMBL622385,1,,BAO_0000218,6175,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,Stomach,Rattus norvegicus,Intermediate,,,9197,10116.0
,N,50597,,,,A,945.0,CHEMBL622386,1,,BAO_0000218,6175,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),1,,Stomach,Rattus norvegicus,Intermediate,,,9198,10116.0
,N,50597,,,,A,,CHEMBL622387,1,,BAO_0000218,10839,The compound was tested for the plasma binding in rat,1,,,Rattus norvegicus,Intermediate,,,9199,10116.0
,N,50597,,,,A,,CHEMBL622388,1,,BAO_0000218,16459,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",1,,,Rattus norvegicus,Intermediate,,,9200,10116.0
,N,50597,,,,A,,CHEMBL622389,1,,BAO_0000218,16459,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",1,,,Rattus norvegicus,Intermediate,,,9201,10116.0
,N,50597,,,,A,,CHEMBL622390,1,,BAO_0000218,16459,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",1,,,Rattus norvegicus,Intermediate,,,9202,10116.0
,N,50597,,,,A,,CHEMBL622391,1,,BAO_0000218,16459,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),1,,,Rattus norvegicus,Intermediate,,,9203,10116.0
,N,50597,,,,A,,CHEMBL622392,1,,BAO_0000218,16459,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),1,,,Rattus norvegicus,Intermediate,,,9204,10116.0
,N,50597,,,,A,,CHEMBL622393,1,,BAO_0000218,16459,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),1,,,Rattus norvegicus,Intermediate,,,9205,10116.0
,N,50597,,,,A,,CHEMBL622394,1,,BAO_0000218,3278,Plasma level at 2 hr after administration of the compound,1,,,Rattus norvegicus,Intermediate,,,9206,10116.0
,N,50597,,,,A,,CHEMBL622395,1,,BAO_0000218,3278,plasma level at 2 hr after administration of the compound,1,,,Rattus norvegicus,Intermediate,,,9207,10116.0
,N,50597,,,,A,1977.0,CHEMBL622396,1,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 1 min,1,,Serum,Rattus norvegicus,Intermediate,,,9208,10116.0
,N,50597,,,,A,1977.0,CHEMBL624894,1,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 10 min,1,,Serum,Rattus norvegicus,Intermediate,,,9209,10116.0
,N,50597,,,,A,1977.0,CHEMBL624895,1,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 10 mins,1,,Serum,Rattus norvegicus,Intermediate,,,9210,10116.0
,N,50597,,,,A,1977.0,CHEMBL624058,1,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 2 hr,1,,Serum,Rattus norvegicus,Intermediate,,,9211,10116.0
,N,50597,,,,A,1977.0,CHEMBL624059,1,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 3 min,1,,Serum,Rattus norvegicus,Intermediate,,,9212,10116.0
,N,50597,,,,A,1977.0,CHEMBL624060,1,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 3 mins,1,,Serum,Rattus norvegicus,Intermediate,,,9213,10116.0
,N,50597,,,,A,1977.0,CHEMBL624061,1,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 5 min,1,,Serum,Rattus norvegicus,Intermediate,,,9214,10116.0
,N,50597,,,,A,1977.0,CHEMBL624062,1,,BAO_0000218,4684,Stability in rat serum measured as % recovery at 5 mins,1,,Serum,Rattus norvegicus,Intermediate,,,9215,10116.0
,N,50597,,,In vivo,A,,CHEMBL624063,1,,BAO_0000218,16456,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9216,10116.0
,N,50597,,,In vivo,A,,CHEMBL624064,1,,BAO_0000218,16456,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9217,10116.0
,N,50597,,,,A,1969.0,CHEMBL624065,1,,BAO_0000218,723,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9218,10116.0
,N,50597,,,,A,1969.0,CHEMBL624066,1,,BAO_0000218,723,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,1,,Plasma,Rattus norvegicus,Intermediate,,,9219,10116.0
,N,50597,,,In vivo,A,,CHEMBL877490,1,,BAO_0000218,5160,Half life tested in mature male rat at a dose of 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9220,10116.0
,N,50597,,,In vivo,A,,CHEMBL874442,1,,BAO_0000218,4709,Half life after intravenous administration of 1 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9221,10116.0
,N,50597,,,In vivo,A,,CHEMBL626890,1,,BAO_0000218,5633,Half life period after administration (30 mg/kg) in rat,1,,,Rattus norvegicus,Intermediate,,,9222,10116.0
,N,50597,,,In vivo,A,,CHEMBL626891,1,,BAO_0000218,5302,Half life period in rat after 5 mg/Kg dose,1,,,Rattus norvegicus,Intermediate,,,9223,10116.0
,N,50597,,,In vivo,A,,CHEMBL626892,1,,BAO_0000218,5302,Half life period in rat after 5 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,9224,10116.0
,N,50597,,,,A,,CHEMBL626893,1,,BAO_0000218,17791,Half life period was determined,1,,,Rattus norvegicus,Intermediate,,,9225,10116.0
,N,50597,,,,A,,CHEMBL626894,1,,BAO_0000218,17791,Half life period was evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,9226,10116.0
,N,50597,,,,A,,CHEMBL626895,1,,BAO_0000218,17791,Half life period was evaluated in rat; 0.5-1.0,1,,,Rattus norvegicus,Intermediate,,,9227,10116.0
,N,50597,,,,A,,CHEMBL626896,1,,BAO_0000218,17791,Half life period was evaluated in rat; 5.9-7.5,1,,,Rattus norvegicus,Intermediate,,,9228,10116.0
,N,50597,,,,A,1969.0,CHEMBL626897,1,,BAO_0000218,14512,Half-life in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9229,10116.0
,N,50597,,,,A,,CHEMBL626898,1,,BAO_0000218,6230,Half-life time in rat was determined,1,,,Rattus norvegicus,Intermediate,,,9230,10116.0
,N,50597,,,In vivo,A,,CHEMBL626899,1,,BAO_0000218,3364,Terminal half-life after iv administration to rats,1,,,Rattus norvegicus,Intermediate,,,9231,10116.0
,N,50597,,,In vivo,A,,CHEMBL626900,1,,BAO_0000218,6874,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,1,,,Rattus norvegicus,Intermediate,,,9232,10116.0
,N,50597,,,,A,,CHEMBL626901,1,,BAO_0000218,857,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,1,,,Rattus norvegicus,Intermediate,,,9233,10116.0
,N,50597,,,In vivo,A,,CHEMBL626902,1,,BAO_0000218,858,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),1,,,Rattus norvegicus,Intermediate,,,9234,10116.0
,N,50597,,,In vivo,A,,CHEMBL626903,1,,BAO_0000218,858,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),1,,,Rattus norvegicus,Intermediate,,,9235,10116.0
,N,50597,,,In vivo,A,,CHEMBL874443,1,,BAO_0000218,5355,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9236,10116.0
,N,50597,,,In vivo,A,,CHEMBL626904,1,,BAO_0000218,5355,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9237,10116.0
,N,50597,,,,A,,CHEMBL626905,1,,BAO_0000218,6305,Half life in rats,1,,,Rattus norvegicus,Intermediate,,,9238,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL873830,1,,BAO_0000218,13501,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9239,10116.0
,N,50597,,,In vivo,A,,CHEMBL626906,1,,BAO_0000218,17594,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9240,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL631076,1,,BAO_0000218,4186,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,Plasma,Rattus norvegicus,Intermediate,,,9241,10116.0
,N,50597,,,,A,1969.0,CHEMBL631077,1,,BAO_0000218,2932,Biological half-life was measured in plasma of rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9242,10116.0
,N,50597,,,In vivo,A,,CHEMBL631078,1,,BAO_0000218,17065,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,,Rattus norvegicus,Intermediate,,,9243,10116.0
,N,50597,,,In vivo,A,,CHEMBL631079,1,,BAO_0000218,15765,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,1,,,Rattus norvegicus,Intermediate,,,9244,10116.0
,N,50597,,,In vivo,A,,CHEMBL631080,1,,BAO_0000218,2713,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,1,,,Rattus norvegicus,Intermediate,,,9245,10116.0
,N,50597,,,In vivo,A,,CHEMBL631081,1,,BAO_0000218,2661,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,1,,,Rattus norvegicus,Intermediate,,,9246,10116.0
,N,50597,,,In vivo,A,,CHEMBL631239,1,,BAO_0000218,2661,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,1,,,Rattus norvegicus,Intermediate,,,9247,10116.0
,N,50597,,,,A,1969.0,CHEMBL631240,1,,BAO_0000218,740,Compound was evaluated for plasma half life in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9248,10116.0
,N,50597,,,,A,1969.0,CHEMBL631241,1,,BAO_0000218,6597,AUC value at a dose of 5 mg/kg (p.o.) in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9249,10116.0
,N,50597,,,,A,1969.0,CHEMBL631242,1,,BAO_0000218,2959,AUC value after administration of 20 mg/Kg oral dose in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9250,10116.0
,N,50597,,,,A,1969.0,CHEMBL631243,1,,BAO_0000218,17594,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9251,10116.0
,N,50597,,,,A,1969.0,CHEMBL874444,1,,BAO_0000218,17596,AUC0-96 after administration at 50 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9252,10116.0
,N,50597,,,,A,1969.0,CHEMBL631244,1,,BAO_0000218,17594,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9253,10116.0
,N,50597,,,,A,,CHEMBL631245,1,,BAO_0000218,3293,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",1,,,Rattus norvegicus,Intermediate,,,9254,10116.0
,N,50597,,,,A,,CHEMBL627162,1,,BAO_0000218,6757,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,1,,,Rattus norvegicus,Intermediate,,,9255,10116.0
,N,50597,,,,A,,CHEMBL627163,1,,BAO_0000218,6757,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,1,,,Rattus norvegicus,Intermediate,,,9256,10116.0
,N,50597,,,,A,,CHEMBL627164,1,,BAO_0000218,6757,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,1,,,Rattus norvegicus,Intermediate,,,9257,10116.0
,N,50597,,,,A,2113.0,CHEMBL627165,1,,BAO_0000218,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,1,,Kidney,Rattus norvegicus,Intermediate,,,9258,10116.0
,N,50597,,,,A,,CHEMBL627166,1,,BAO_0000218,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,1,,,Rattus norvegicus,Intermediate,,,9259,10116.0
,N,50597,,,,A,,CHEMBL627167,1,,BAO_0000218,5979,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,1,,,Rattus norvegicus,Intermediate,,,9260,10116.0
,N,50597,,,,A,,CHEMBL627822,1,,BAO_0000218,4026,Area under curve (AUC) at a dose of 30 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9261,10116.0
,N,50597,,,,A,,CHEMBL627823,1,,BAO_0000218,5355,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9262,10116.0
,N,50597,,,,A,,CHEMBL627824,1,,BAO_0000218,5355,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9263,10116.0
,N,50597,,,,A,,CHEMBL627825,1,,BAO_0000218,5355,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9264,10116.0
,N,50597,,,,A,,CHEMBL627826,1,,BAO_0000218,5633,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,1,,,Rattus norvegicus,Intermediate,,,9265,10116.0
,N,50597,,,,A,,CHEMBL627827,1,,BAO_0000218,1716,Area under curve (Pharmacokinetic property) was determined,1,,,Rattus norvegicus,Intermediate,,,9266,10116.0
,N,50597,,,,A,,CHEMBL627828,1,,BAO_0000218,1716,Area under curve (Pharmacokinetic property) of the compound; Not determined,1,,,Rattus norvegicus,Intermediate,,,9267,10116.0
,N,50597,,,,A,,CHEMBL627829,1,,BAO_0000218,4689,Area under curve after intravenous administration (1 mg/kg) in rat,1,,,Rattus norvegicus,Intermediate,,,9268,10116.0
,N,50597,,,,A,,CHEMBL627830,1,,BAO_0000218,4527,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,1,,,Rattus norvegicus,Intermediate,,,9269,10116.0
,N,50597,,,,A,,CHEMBL627831,1,,BAO_0000218,4527,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,1,,,Rattus norvegicus,Intermediate,,,9270,10116.0
,N,50597,,,,A,,CHEMBL627832,1,,BAO_0000218,15662,Area under curve in male SD rats was observed after oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,9271,10116.0
,N,50597,,,,A,,CHEMBL627833,1,,BAO_0000218,4413,Area under curve of compound after iv administration of 20 mg/kg dose in rat,1,,,Rattus norvegicus,Intermediate,,,9272,10116.0
,N,50597,,,,A,,CHEMBL627834,1,,BAO_0000218,3598,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Expert,,,9273,10116.0
,N,50597,,,,A,,CHEMBL628004,1,,BAO_0000218,3598,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Expert,,,9274,10116.0
,N,50597,,,,A,,CHEMBL628005,1,,BAO_0000218,5964,Area under curve at 5 mg/kg po was determined in rat,1,,,Rattus norvegicus,Intermediate,,,9275,10116.0
,N,50597,,,,A,,CHEMBL628006,1,,BAO_0000218,4689,Area under curve in Rat at a oral dose of 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9276,10116.0
,N,50597,,,,A,,CHEMBL628007,1,,BAO_0000218,4186,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,1,,,Rattus norvegicus,Intermediate,,,9277,10116.0
,N,50597,,,,A,,CHEMBL625676,1,,BAO_0000218,5510,Area under curve was determined,1,,,Rattus norvegicus,Intermediate,,,9278,10116.0
,N,50597,,,,A,,CHEMBL631309,1,,BAO_0000218,17858,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,1,,,Rattus norvegicus,Intermediate,,,9279,10116.0
,N,50597,,,,A,,CHEMBL631310,1,,BAO_0000218,17804,Area under curve after intravenous administration at 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9280,10116.0
,N,50597,,,,A,,CHEMBL631311,1,,BAO_0000218,6106,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,1,,,Rattus norvegicus,Intermediate,,,9281,10116.0
,N,50597,,,,A,,CHEMBL631312,1,,BAO_0000218,5964,Area under curve at 4 hr in rat,1,,,Rattus norvegicus,Intermediate,,,9282,10116.0
,N,50597,,,,A,,CHEMBL631313,1,,BAO_0000218,4026,Area under curve at a dose of 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9283,10116.0
,N,50597,,,,A,,CHEMBL631314,1,,BAO_0000218,4756,Area under curve at the dose of 2 mg/Kg administered perorally in rats,1,,,Rattus norvegicus,Intermediate,,,9284,10116.0
,N,50597,,,,A,,CHEMBL631315,1,,BAO_0000218,4756,Area under curve at the dose of 5 mg/Kg administered perorally in rats,1,,,Rattus norvegicus,Intermediate,,,9285,10116.0
,N,50597,,,,A,,CHEMBL631316,1,,BAO_0000218,5862,Area under curve for a 2-mpk po dose in SD rats,1,,,Rattus norvegicus,Intermediate,,,9286,10116.0
,N,50597,,,,A,,CHEMBL631317,1,,BAO_0000218,5862,Area under curve in SD rats,1,,,Rattus norvegicus,Intermediate,,,9287,10116.0
,N,50597,,,,A,,CHEMBL874471,1,,BAO_0000218,6644,Area under curve in rat after oral administration at 13 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,9288,10116.0
,N,50597,,,,A,,CHEMBL631318,1,,BAO_0000218,5871,Area under curve in rat by po administration at 0-24 hr,1,,,Rattus norvegicus,Intermediate,,,9289,10116.0
,N,50597,,,,A,1969.0,CHEMBL631319,1,,BAO_0000218,5919,Area under curve in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9290,10116.0
,N,50597,,,,A,,CHEMBL631320,1,,BAO_0000218,5939,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9291,10116.0
,N,50597,,,,A,,CHEMBL631321,1,,BAO_0000218,5939,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9292,10116.0
,N,50597,,,,A,,CHEMBL631322,1,,BAO_0000218,10,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,1,,,Rattus norvegicus,Intermediate,,,9293,10116.0
,N,50597,,,,A,,CHEMBL631323,1,,BAO_0000218,11149,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,1,,,Rattus norvegicus,Intermediate,,,9294,10116.0
,N,50597,,,,A,,CHEMBL631324,1,,BAO_0000218,5302,Area under curve value in rat at a dose of 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9295,10116.0
,N,50597,,,,A,,CHEMBL631325,1,,BAO_0000218,17796,Area under curve was determined after oral administration in rats,1,,,Rattus norvegicus,Intermediate,,,9296,10116.0
,N,50597,,,,A,,CHEMBL631326,1,,BAO_0000218,4890,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,9297,10116.0
,N,50597,,,,A,,CHEMBL631327,1,,BAO_0000218,6011,Area under curve was determined after peroral administration in rat,1,,,Rattus norvegicus,Intermediate,,,9298,10116.0
,N,50597,,,,A,,CHEMBL631328,1,,BAO_0000218,5375,Area under curve was determined at a dose 30 mpk administered orally.,1,,,Rattus norvegicus,Intermediate,,,9299,10116.0
,N,50597,,,,A,,CHEMBL631329,1,,BAO_0000218,17764,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,1,,,Rattus norvegicus,Intermediate,,,9300,10116.0
,N,50597,,,,A,,CHEMBL627217,1,,BAO_0000218,4368,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9301,10116.0
,N,50597,,,,A,,CHEMBL626352,1,,BAO_0000218,5610,Area under curve was determined in male rat,1,,,Rattus norvegicus,Intermediate,,,9302,10116.0
,N,50597,,,,A,,CHEMBL626353,1,,BAO_0000218,5833,Area under curve was determined in rat after PO administration,1,,,Rattus norvegicus,Intermediate,,,9303,10116.0
,N,50597,,,,A,,CHEMBL626354,1,,BAO_0000218,4257,Area under curve was determined in rat after a 3 mg/kg of oral dose,1,,,Rattus norvegicus,Intermediate,,,9304,10116.0
,N,50597,,,,A,,CHEMBL626355,1,,BAO_0000218,5937,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9305,10116.0
,N,50597,,,,A,,CHEMBL626356,1,,BAO_0000218,5932,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9306,10116.0
,N,50597,,,,A,,CHEMBL626357,1,,BAO_0000218,5932,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,1,,,Rattus norvegicus,Intermediate,,,9307,10116.0
,N,50597,,,,A,,CHEMBL626358,1,,BAO_0000218,17411,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9308,10116.0
,N,50597,,,,A,,CHEMBL626359,1,,BAO_0000218,17411,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9309,10116.0
,N,50597,,,,A,1969.0,CHEMBL626360,1,,BAO_0000218,17771,Peak plasma concentration in rat at a dose of 3 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9310,10116.0
,N,50597,,,,A,,CHEMBL626361,1,,BAO_0000218,1628,Plasma concentration at 2 hr in rats was evaluated.,1,,,Rattus norvegicus,Intermediate,,,9311,10116.0
,N,50597,,,,A,,CHEMBL626362,1,,BAO_0000218,1628,Plasma concentration at 2 hr in rats was evaluated; Not available,1,,,Rattus norvegicus,Intermediate,,,9312,10116.0
,N,50597,,,,A,,CHEMBL626363,1,,BAO_0000218,17411,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9313,10116.0
,N,50597,,,,A,,CHEMBL626970,1,,BAO_0000218,4910,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,,Rattus norvegicus,Intermediate,,,9314,10116.0
,N,50597,,,,A,,CHEMBL626971,1,,BAO_0000218,4910,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,,Rattus norvegicus,Intermediate,,,9315,10116.0
,N,50597,,,,A,1969.0,CHEMBL626972,1,,BAO_0000218,4910,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9316,10116.0
,N,50597,,,,A,1969.0,CHEMBL626973,1,,BAO_0000218,4910,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9317,10116.0
,N,50597,,,,A,1969.0,CHEMBL626974,1,,BAO_0000218,4910,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9318,10116.0
,N,50597,,,,A,1969.0,CHEMBL874592,1,,BAO_0000218,4910,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9319,10116.0
,N,50597,,,,A,,CHEMBL626975,1,,BAO_0000218,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,1,,,Rattus norvegicus,Intermediate,,,9320,10116.0
,N,50597,,,,A,,CHEMBL626976,1,,BAO_0000218,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,1,,,Rattus norvegicus,Intermediate,,,9321,10116.0
,N,50597,,,,A,,CHEMBL626977,1,,BAO_0000218,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,1,,,Rattus norvegicus,Intermediate,,,9322,10116.0
,N,50597,,,,A,,CHEMBL626978,1,,BAO_0000218,5510,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,1,,,Rattus norvegicus,Intermediate,,,9323,10116.0
,N,50597,,,,A,,CHEMBL626979,1,,BAO_0000218,16427,PK study was carried to determine the relative absorption ranking in rat.,1,,,Rattus norvegicus,Intermediate,,,9324,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626980,1,,BAO_0000218,4689,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9325,10116.0
,N,50597,,,,A,178.0,CHEMBL626981,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,9326,10116.0
,N,50597,,,,A,178.0,CHEMBL626982,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,9327,10116.0
,N,50597,,,,A,178.0,CHEMBL626983,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,9328,10116.0
,N,50597,,,,A,178.0,CHEMBL622522,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,9329,10116.0
,N,50597,,,,A,178.0,CHEMBL622523,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,9330,10116.0
,N,50597,,,,A,178.0,CHEMBL622524,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,9331,10116.0
,N,50597,,,,A,955.0,CHEMBL622525,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,9332,10116.0
,N,50597,,,,A,955.0,CHEMBL622526,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,9333,10116.0
,N,50597,,,,A,955.0,CHEMBL619849,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,9334,10116.0
,N,50597,,,,A,955.0,CHEMBL619850,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,9335,10116.0
,N,50597,,,,A,955.0,CHEMBL623864,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,9336,10116.0
,N,50597,,,,A,955.0,CHEMBL623865,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,9337,10116.0
,N,50597,,,,A,948.0,CHEMBL623866,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,9338,10116.0
,N,50597,,,,A,948.0,CHEMBL623867,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,9339,10116.0
,N,50597,,,,A,948.0,CHEMBL877615,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,9340,10116.0
,N,50597,,,,A,948.0,CHEMBL623868,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,9341,10116.0
,N,50597,,,,A,948.0,CHEMBL623869,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,9342,10116.0
,N,50597,,,,A,948.0,CHEMBL623870,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,9343,10116.0
,N,50597,,,,A,2048.0,CHEMBL623871,1,,BAO_0000218,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,,Lung,Rattus norvegicus,Intermediate,,,9344,10116.0
,N,50597,,,,A,2048.0,CHEMBL623872,1,,BAO_0000218,16434,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,Lung,Rattus norvegicus,Intermediate,,,9345,10116.0
,N,50597,,,,A,2048.0,CHEMBL622129,1,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,Lung,Rattus norvegicus,Intermediate,,,9346,10116.0
,N,50597,,,,A,2048.0,CHEMBL622130,1,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,Lung,Rattus norvegicus,Intermediate,,,9347,10116.0
,N,50597,,,,A,2048.0,CHEMBL622131,1,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,Lung,Rattus norvegicus,Intermediate,,,9348,10116.0
,N,50597,,,,A,2048.0,CHEMBL622132,1,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,Lung,Rattus norvegicus,Intermediate,,,9349,10116.0
,N,50597,,,,A,2048.0,CHEMBL622133,1,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,Lung,Rattus norvegicus,Intermediate,,,9350,10116.0
,N,50597,,,,A,2048.0,CHEMBL622134,1,,BAO_0000218,16435,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,Lung,Rattus norvegicus,Intermediate,,,9351,10116.0
,N,50597,,,,A,2048.0,CHEMBL622135,1,,BAO_0000218,16435,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9352,10116.0
,N,50597,,,,A,2048.0,CHEMBL622136,1,,BAO_0000218,16435,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,Lung,Rattus norvegicus,Intermediate,,,9353,10116.0
,N,50597,,,,A,2385.0,CHEMBL622137,1,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9354,10116.0
,N,50597,,,,A,2385.0,CHEMBL622138,1,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9355,10116.0
,N,50597,,,,A,2385.0,CHEMBL623017,1,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9356,10116.0
,N,50597,,,,A,2385.0,CHEMBL623018,1,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9357,10116.0
,N,50597,,,,A,2385.0,CHEMBL623019,1,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9358,10116.0
,N,50597,,,,A,2385.0,CHEMBL623020,1,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9359,10116.0
,N,50597,,,,A,2385.0,CHEMBL623021,1,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9360,10116.0
,N,50597,,,,A,2385.0,CHEMBL623022,1,,BAO_0000218,16434,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9361,10116.0
,N,50597,,,,A,2385.0,CHEMBL623023,1,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9362,10116.0
,N,50597,,,,A,2385.0,CHEMBL623024,1,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9363,10116.0
,N,50597,,,,A,2385.0,CHEMBL623025,1,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9364,10116.0
,N,50597,,,,A,2385.0,CHEMBL620545,1,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9365,10116.0
,N,50597,,,,A,2385.0,CHEMBL620546,1,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9366,10116.0
,N,50597,,,,A,2385.0,CHEMBL620547,1,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9367,10116.0
,N,50597,,,,A,2385.0,CHEMBL620548,1,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9368,10116.0
,N,50597,,,,A,2385.0,CHEMBL620549,1,,BAO_0000218,16435,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9369,10116.0
,N,50597,,,,A,2385.0,CHEMBL620550,1,,BAO_0000218,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9370,10116.0
,N,50597,,,,A,2385.0,CHEMBL620551,1,,BAO_0000218,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9371,10116.0
,N,50597,,,,A,2385.0,CHEMBL620552,1,,BAO_0000218,16434,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9372,10116.0
,N,50597,,,,A,2385.0,CHEMBL620553,1,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9373,10116.0
,N,50597,,,,A,2385.0,CHEMBL620554,1,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9374,10116.0
,N,50597,,,,A,2385.0,CHEMBL875845,1,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9375,10116.0
,N,50597,,,,A,2385.0,CHEMBL620555,1,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9376,10116.0
,N,50597,,,,A,2385.0,CHEMBL620556,1,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9377,10116.0
,N,50597,,,,A,2385.0,CHEMBL620557,1,,BAO_0000218,16435,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9378,10116.0
,N,50597,,,,A,,CHEMBL620558,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,Rattus norvegicus,Intermediate,,,9379,10116.0
,N,50597,,,,A,,CHEMBL620559,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,Rattus norvegicus,Intermediate,,,9380,10116.0
,N,50597,,,,A,,CHEMBL622939,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,Rattus norvegicus,Intermediate,,,9381,10116.0
,N,50597,,,,A,,CHEMBL622940,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,Rattus norvegicus,Intermediate,,,9382,10116.0
,N,50597,,,,A,,CHEMBL622941,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,Rattus norvegicus,Intermediate,,,9383,10116.0
,N,50597,,,,A,,CHEMBL622942,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,Rattus norvegicus,Intermediate,,,9384,10116.0
,N,50597,,,,A,,CHEMBL622943,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,Rattus norvegicus,Intermediate,,,9385,10116.0
,N,50597,,,,A,,CHEMBL622944,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,Rattus norvegicus,Intermediate,,,9386,10116.0
,N,50597,,,,A,,CHEMBL622945,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,Rattus norvegicus,Intermediate,,,9387,10116.0
,N,50597,,,,A,,CHEMBL622946,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,Rattus norvegicus,Intermediate,,,9388,10116.0
,N,50597,,,,A,,CHEMBL622947,1,,BAO_0000218,3341,Compound was evaluated for terminal half life in rat,1,,,Rattus norvegicus,Intermediate,,,9389,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622948,1,,BAO_0000218,3634,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,1,,Plasma,Rattus norvegicus,Intermediate,,,9390,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622949,1,,BAO_0000218,3634,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,1,,Plasma,Rattus norvegicus,Intermediate,,,9391,10116.0
,N,50597,,,,A,,CHEMBL622950,1,,BAO_0000218,4839,Compound was tested for its half life in rat,1,,,Rattus norvegicus,Intermediate,,,9392,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL622951,0,,BAO_0000218,5005,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,1,,Plasma,Macaca mulatta,Intermediate,,,9393,9544.0
,U,22224,,,,A,1969.0,CHEMBL622952,0,,BAO_0000366,5005,Compound was tested for its plasma half life in Sprague Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9394,10116.0
,U,22224,,,,A,1969.0,CHEMBL622953,0,,BAO_0000366,5005,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,9395,10116.0
,N,50597,,,,A,1969.0,CHEMBL873818,1,,BAO_0000218,1094,Compound was tested for plasma half-life period in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9396,10116.0
,N,50597,,,In vivo,A,,CHEMBL622954,1,,BAO_0000218,5031,Elimination half life after i.v. administration of compound in rats,1,,,Rattus norvegicus,Intermediate,,,9397,10116.0
,N,50597,,,In vivo,A,,CHEMBL622955,1,,BAO_0000218,6518,Elimination half-life after IV dosing at 0.5 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9398,10116.0
,N,50597,,,In vivo,A,,CHEMBL875229,1,,BAO_0000218,6518,Elimination half-life after IV dosing at 1 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9399,10116.0
,N,50597,,,In vivo,A,,CHEMBL622956,1,,BAO_0000218,6518,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9400,10116.0
,N,50597,,,In vivo,A,,CHEMBL622957,1,,BAO_0000218,6518,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9401,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622958,1,,BAO_0000218,5408,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,1,,Brain,Rattus norvegicus,Intermediate,,,9402,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622959,1,,BAO_0000218,5408,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9403,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622960,1,,BAO_0000218,5408,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,1,,Brain,Rattus norvegicus,Intermediate,,,9404,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622961,1,,BAO_0000218,5408,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9405,10116.0
,N,50597,,,In vivo,A,,CHEMBL622962,1,,BAO_0000218,4687,Evaluated for the half life in rat (in vivo),1,,,Rattus norvegicus,Intermediate,,,9406,10116.0
,N,50597,,,,A,,CHEMBL622963,1,,BAO_0000218,6640,Hafl life in rat,1,,,Rattus norvegicus,Intermediate,,,9407,10116.0
,N,50597,,,,A,,CHEMBL622964,1,,BAO_0000218,6640,Hafl life rat,1,,,Rattus norvegicus,Intermediate,,,9408,10116.0
,N,50597,,,,A,,CHEMBL622965,1,,BAO_0000218,6641,Hafl life rat,1,,,Rattus norvegicus,Intermediate,,,9409,10116.0
,N,50597,,,,A,,CHEMBL622966,1,,BAO_0000218,6640,Hafl life rat; Not determined,1,,,Rattus norvegicus,Intermediate,,,9410,10116.0
,N,50597,,,,A,,CHEMBL622967,1,,BAO_0000218,6641,Hafl life rat; Not determined,1,,,Rattus norvegicus,Intermediate,,,9411,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL622968,1,,BAO_0000218,17411,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,Kidney,Rattus norvegicus,Intermediate,,,9412,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622969,1,,BAO_0000218,17411,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,Liver,Rattus norvegicus,Intermediate,,,9413,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL875327,1,,BAO_0000218,17411,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,Lung,Rattus norvegicus,Intermediate,,,9414,10116.0
,N,50597,,,In vivo,A,,CHEMBL628638,1,,BAO_0000218,6570,Half life in rat after 1 mg/kg i.v. administration,1,,,Rattus norvegicus,Intermediate,,,9415,10116.0
,N,50597,,,In vivo,A,,CHEMBL628639,1,,BAO_0000218,6570,Half life in rat after 2 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,9416,10116.0
,N,50597,,,In vivo,A,,CHEMBL625840,1,,BAO_0000218,17411,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9417,10116.0
,N,50597,,,In vivo,A,,CHEMBL625841,1,,BAO_0000218,4722,Half life of 10 mg/kg oral dose determined in rats,1,,,Rattus norvegicus,Intermediate,,,9418,10116.0
,N,50597,,,In vivo,A,,CHEMBL625842,1,,BAO_0000218,5978,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9419,10116.0
,N,50597,,,In vivo,A,,CHEMBL625843,1,,BAO_0000218,5978,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9420,10116.0
,N,50597,,,In vivo,A,,CHEMBL625844,1,,BAO_0000218,5978,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9421,10116.0
,N,50597,,,In vivo,A,,CHEMBL873822,1,,BAO_0000218,5978,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9422,10116.0
,N,50597,,,In vivo,A,,CHEMBL625845,1,,BAO_0000218,5978,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9423,10116.0
,N,50597,,,In vivo,A,,CHEMBL627059,1,,BAO_0000218,5978,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9424,10116.0
,N,50597,,,In vivo,A,,CHEMBL627060,1,,BAO_0000218,5978,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9425,10116.0
,N,50597,,,In vivo,A,,CHEMBL627061,1,,BAO_0000218,5978,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9426,10116.0
,N,50597,,,In vivo,A,,CHEMBL627709,1,,BAO_0000218,4762,Half life of compound at 5 mg/kg after po administration was determined in rat,1,,,Rattus norvegicus,Intermediate,,,9427,10116.0
,N,50597,,,In vivo,A,,CHEMBL627710,1,,BAO_0000218,5327,Half life of compound determined after intravenous administration to rat,1,,,Rattus norvegicus,Intermediate,,,9428,10116.0
,N,50597,,,,A,,CHEMBL627711,1,,BAO_0000218,4847,Half life of compound was determined in rat,1,,,Rattus norvegicus,Intermediate,,,9429,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627712,1,,BAO_0000218,17720,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,Plasma,Rattus norvegicus,Intermediate,,,9430,10116.0
,N,50597,,,In vivo,A,,CHEMBL627713,1,,BAO_0000218,4723,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,Rattus norvegicus,Intermediate,,,9431,10116.0
,N,50597,,,In vivo,A,,CHEMBL627714,1,,BAO_0000218,4723,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,Rattus norvegicus,Intermediate,,,9432,10116.0
,U,22224,,,In vivo,A,,CHEMBL627889,0,,BAO_0000218,4256,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,1,,,Macaca fascicularis,Intermediate,,,9433,9541.0
,U,22224,,,In vivo,A,,CHEMBL627890,0,,BAO_0000218,4256,Half life determined in rat by intravenous administration,1,,,Rattus norvegicus,Intermediate,,,9434,10116.0
,N,50597,,,In vivo,A,,CHEMBL627891,1,,BAO_0000218,4722,Half life determined in rats after iv administration,1,,,Rattus norvegicus,Intermediate,,,9435,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627892,1,,BAO_0000218,6535,Half life in rat plasma after administration of 2 mg/kg iv,1,,Plasma,Rattus norvegicus,Intermediate,,,9436,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627893,1,,BAO_0000218,6535,Half life in rat plasma after administration of 2 mg/kg iv,1,,Plasma,Rattus norvegicus,Intermediate,,,9437,10116.0
,N,50597,,,,A,1969.0,CHEMBL627894,1,,BAO_0000218,1435,Half life in rat plasma was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,9438,10116.0
,N,50597,,,,A,1969.0,CHEMBL627895,1,,BAO_0000218,1435,Half life in rat plasma was determined; NA means not applicable,1,,Plasma,Rattus norvegicus,Intermediate,,,9439,10116.0
,N,50597,,,,A,,CHEMBL627896,1,,BAO_0000218,5206,Half life in rat was tested,1,,,Rattus norvegicus,Intermediate,,,9440,10116.0
,N,50597,,,,A,1969.0,CHEMBL627897,1,,BAO_0000218,6080,Half life measured in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9441,10116.0
,N,50597,,,,A,,CHEMBL627898,1,,BAO_0000218,4449,Half life recorded in rats,1,,,Rattus norvegicus,Intermediate,,,9442,10116.0
,N,50597,,,,A,,CHEMBL627899,1,,BAO_0000218,6057,Half life was calculated,1,,,Rattus norvegicus,Intermediate,,,9443,10116.0
,N,50597,,,,A,,CHEMBL873823,1,,BAO_0000218,6057,Half life was calculated in rat,1,,,Rattus norvegicus,Intermediate,,,9444,10116.0
,N,50597,,,,A,,CHEMBL627900,1,,BAO_0000218,3747,Half life was determined,1,,,Rattus norvegicus,Intermediate,,,9445,10116.0
,N,50597,,,In vivo,A,,CHEMBL627901,1,,BAO_0000218,17858,Half life after 10 mg/kg oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,9446,10116.0
,N,50597,,,In vivo,A,,CHEMBL627902,1,,BAO_0000218,16365,Half life after administering orally a dose of 10 mg/kg to a fasting rat,1,,,Rattus norvegicus,Intermediate,,,9447,10116.0
,N,50597,,,In vivo,A,,CHEMBL627903,1,,BAO_0000218,16365,Half life after administering orally a dose of 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9448,10116.0
,N,50597,,,,A,,CHEMBL627904,1,,BAO_0000218,5031,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,1,,,Rattus norvegicus,Intermediate,,,9449,10116.0
,N,50597,,,,A,,CHEMBL627905,1,,BAO_0000218,4722,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,1,,,Rattus norvegicus,Intermediate,,,9450,10116.0
,N,50597,,,,A,,CHEMBL627906,1,,BAO_0000218,6078,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9451,10116.0
,N,50597,,,,A,,CHEMBL627907,1,,BAO_0000218,6078,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9452,10116.0
,N,50597,,,,A,,CHEMBL876783,1,,BAO_0000218,6078,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9453,10116.0
,N,50597,,,,A,,CHEMBL627908,1,,BAO_0000218,6078,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,1,,,Rattus norvegicus,Intermediate,,,9454,10116.0
,N,50597,,,,A,,CHEMBL627909,1,,BAO_0000218,17065,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,1,,,Rattus norvegicus,Intermediate,,,9455,10116.0
,N,50597,,,,A,,CHEMBL627910,1,,BAO_0000218,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,1,,,Rattus norvegicus,Intermediate,,,9456,10116.0
,N,50597,,,,A,,CHEMBL627911,1,,BAO_0000218,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),1,,,Rattus norvegicus,Intermediate,,,9457,10116.0
,N,50597,,,,A,,CHEMBL627912,1,,BAO_0000218,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),1,,,Rattus norvegicus,Intermediate,,,9458,10116.0
,N,50597,,,,A,,CHEMBL627913,1,,BAO_0000218,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),1,,,Rattus norvegicus,Intermediate,,,9459,10116.0
,N,50597,,,,A,,CHEMBL627914,1,,BAO_0000218,1353,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),1,,,Rattus norvegicus,Intermediate,,,9460,10116.0
,N,50597,,,,A,,CHEMBL627915,1,,BAO_0000218,16423,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,1,,,Rattus norvegicus,Intermediate,,,9461,10116.0
,N,50597,,,,A,,CHEMBL627916,1,,BAO_0000218,16423,Area under the curve was evaluated after 20 uM/kg of peroral administration,1,,,Rattus norvegicus,Intermediate,,,9462,10116.0
,N,50597,,,,A,,CHEMBL627917,1,,BAO_0000218,6062,Area under the curve was measured in rat after an iv dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9463,10116.0
,N,50597,,,,A,,CHEMBL627918,1,,BAO_0000218,6056,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9464,10116.0
,N,50597,,,,A,,CHEMBL627919,1,,BAO_0000218,5182,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,1,,,Rattus norvegicus,Intermediate,,,9465,10116.0
,N,50597,,,,A,,CHEMBL627920,1,,BAO_0000218,6410,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9466,10116.0
,N,50597,,,,A,,CHEMBL627921,1,,BAO_0000218,6410,Area under the curve was evaluated at an oral dose of 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9467,10116.0
,N,50597,,,,A,,CHEMBL627922,1,,BAO_0000218,4723,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,Rattus norvegicus,Intermediate,,,9468,10116.0
,N,50597,,,,A,,CHEMBL876784,1,,BAO_0000218,4723,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,Rattus norvegicus,Intermediate,,,9469,10116.0
,N,50597,,,,A,,CHEMBL627923,1,,BAO_0000218,4723,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,Rattus norvegicus,Intermediate,,,9470,10116.0
,N,50597,,,,A,,CHEMBL626208,1,,BAO_0000218,4723,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,Rattus norvegicus,Intermediate,,,9471,10116.0
,N,50597,,,,A,,CHEMBL626209,1,,BAO_0000218,4723,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,Rattus norvegicus,Intermediate,,,9472,10116.0
,N,50597,,,,A,,CHEMBL626210,1,,BAO_0000218,4723,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,Rattus norvegicus,Intermediate,,,9473,10116.0
,N,50597,,,,A,1969.0,CHEMBL627994,1,,BAO_0000218,2463,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,1,,Plasma,Rattus norvegicus,Intermediate,,,9474,10116.0
,N,50597,,,,A,,CHEMBL627995,1,,BAO_0000218,4709,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9475,10116.0
,N,50597,,,,A,,CHEMBL627996,1,,BAO_0000218,4075,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,1,,,Rattus norvegicus,Intermediate,,,9476,10116.0
,N,50597,,,,A,,CHEMBL627997,1,,BAO_0000218,5394,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,1,,,Rattus norvegicus,Intermediate,,,9477,10116.0
,N,50597,,,,A,,CHEMBL627998,1,,BAO_0000218,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,1,,,Rattus norvegicus,Intermediate,,,9478,10116.0
,N,50597,,,,A,,CHEMBL628640,1,,BAO_0000218,2661,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,1,,,Rattus norvegicus,Intermediate,,,9479,10116.0
,N,50597,,,,A,,CHEMBL628641,1,,BAO_0000218,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,1,,,Rattus norvegicus,Intermediate,,,9480,10116.0
,N,50597,,,,A,,CHEMBL628642,1,,BAO_0000218,2661,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,1,,,Rattus norvegicus,Intermediate,,,9481,10116.0
,N,50597,,,,A,,CHEMBL628643,1,,BAO_0000218,17791,Compound was evaluated for area under the curve expressed as (h*ug/ml),1,,,Rattus norvegicus,Intermediate,,,9482,10116.0
,N,50597,,,,A,,CHEMBL628644,1,,BAO_0000218,2591,Compound was tested for area under curve in rat,1,,,Rattus norvegicus,Intermediate,,,9483,10116.0
,N,50597,,,,A,,CHEMBL628645,1,,BAO_0000218,6567,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,1,,,Rattus norvegicus,Intermediate,,,9484,10116.0
,N,50597,,,,A,,CHEMBL628646,1,,BAO_0000218,6211,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,9485,10116.0
,N,50597,,,,A,,CHEMBL628647,1,,BAO_0000218,5529,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),1,,,Rattus norvegicus,Intermediate,,,9486,10116.0
,N,50597,,,,A,,CHEMBL628648,1,,BAO_0000218,5408,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,1,,,Rattus norvegicus,Intermediate,,,9487,10116.0
,N,50597,,,,A,,CHEMBL625358,1,,BAO_0000218,5408,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,1,,,Rattus norvegicus,Intermediate,,,9488,10116.0
,N,50597,,,,A,,CHEMBL625359,1,,BAO_0000218,5408,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,1,,,Rattus norvegicus,Intermediate,,,9489,10116.0
,N,50597,,,,A,,CHEMBL625360,1,,BAO_0000218,5408,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,1,,,Rattus norvegicus,Intermediate,,,9490,10116.0
,N,50597,,,,A,,CHEMBL625361,1,,BAO_0000218,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),1,,,Rattus norvegicus,Intermediate,,,9491,10116.0
,N,50597,,,,A,,CHEMBL625362,1,,BAO_0000218,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),1,,,Rattus norvegicus,Intermediate,,,9492,10116.0
,N,50597,,,,A,,CHEMBL625363,1,,BAO_0000218,429,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),1,,,Rattus norvegicus,Intermediate,,,9493,10116.0
,N,50597,,,,A,,CHEMBL625364,1,,BAO_0000218,4796,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,1,,,Rattus norvegicus,Intermediate,,,9494,10116.0
,N,50597,,,,A,,CHEMBL625365,1,,BAO_0000218,5974,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9495,10116.0
,N,50597,,,,A,,CHEMBL625366,1,,BAO_0000218,5974,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9496,10116.0
,N,50597,,,,A,,CHEMBL625367,1,,BAO_0000218,5974,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9497,10116.0
,N,50597,,,,A,2113.0,CHEMBL625368,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,9498,10116.0
,N,50597,,,,A,2113.0,CHEMBL625369,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,9499,10116.0
,N,50597,,,,A,2113.0,CHEMBL625370,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,9500,10116.0
,N,50597,,,,A,2113.0,CHEMBL625371,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,9501,10116.0
,N,50597,,,,A,2113.0,CHEMBL625372,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,9502,10116.0
,N,50597,,,,A,2113.0,CHEMBL625373,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,9503,10116.0
,N,50597,,,,A,2107.0,CHEMBL625374,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,9504,10116.0
,N,50597,,,,A,2107.0,CHEMBL877593,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,9505,10116.0
,N,50597,,,,A,2107.0,CHEMBL625375,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,9506,10116.0
,N,50597,,,,A,2107.0,CHEMBL625376,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,9507,10116.0
,N,50597,,,,A,2107.0,CHEMBL621973,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,9508,10116.0
,N,50597,,,,A,2107.0,CHEMBL621974,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,9509,10116.0
,N,50597,,,,A,2048.0,CHEMBL621975,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,9510,10116.0
,N,50597,,,,A,2048.0,CHEMBL622166,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,9511,10116.0
,N,50597,,,,A,2048.0,CHEMBL622167,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,9512,10116.0
,N,50597,,,,A,2048.0,CHEMBL622168,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,9513,10116.0
,N,50597,,,,A,2048.0,CHEMBL622169,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,9514,10116.0
,N,50597,,,,A,2048.0,CHEMBL622170,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,9515,10116.0
,N,50597,,,,A,2046.0,CHEMBL622171,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9516,10116.0
,N,50597,,,,A,2046.0,CHEMBL622172,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9517,10116.0
,N,50597,,,,A,2046.0,CHEMBL622173,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9518,10116.0
,N,50597,,,,A,2046.0,CHEMBL622174,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9519,10116.0
,N,50597,,,,A,2046.0,CHEMBL622175,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9520,10116.0
,N,50597,,,,A,2046.0,CHEMBL622176,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9521,10116.0
,N,50597,,,,A,2046.0,CHEMBL622177,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9522,10116.0
,N,50597,,,,A,2046.0,CHEMBL622178,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9523,10116.0
,N,50597,,,,A,2046.0,CHEMBL622179,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9524,10116.0
,N,50597,,,,A,2046.0,CHEMBL622180,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9525,10116.0
,N,50597,,,,A,,CHEMBL622181,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,Rattus norvegicus,Intermediate,,,9526,10116.0
,N,50597,,,,A,,CHEMBL622182,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,Rattus norvegicus,Intermediate,,,9527,10116.0
,N,50597,,,,A,,CHEMBL622183,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,Rattus norvegicus,Intermediate,,,9528,10116.0
,N,50597,,,,A,,CHEMBL622184,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,Rattus norvegicus,Intermediate,,,9529,10116.0
,N,50597,,,,A,,CHEMBL622185,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,Rattus norvegicus,Intermediate,,,9530,10116.0
,N,50597,,,,A,,CHEMBL622186,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,Rattus norvegicus,Intermediate,,,9531,10116.0
,N,50597,,,,A,,CHEMBL622187,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,Rattus norvegicus,Intermediate,,,9532,10116.0
,N,50597,,,,A,,CHEMBL625002,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,1,,,Rattus norvegicus,Intermediate,,,9533,10116.0
,N,50597,,,,A,,CHEMBL622090,1,,BAO_0000218,16434,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,1,,,Rattus norvegicus,Intermediate,,,9534,10116.0
,N,50597,,,,A,,CHEMBL622091,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,Rattus norvegicus,Intermediate,,,9535,10116.0
,N,50597,,,,A,,CHEMBL622092,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,Rattus norvegicus,Intermediate,,,9536,10116.0
,N,50597,,,,A,,CHEMBL622093,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,Rattus norvegicus,Intermediate,,,9537,10116.0
,N,50597,,,,A,,CHEMBL622094,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,Rattus norvegicus,Intermediate,,,9538,10116.0
,N,50597,,,,A,,CHEMBL622095,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,Rattus norvegicus,Intermediate,,,9539,10116.0
,N,50597,,,,A,,CHEMBL622264,1,,BAO_0000218,16435,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,Rattus norvegicus,Intermediate,,,9540,10116.0
,N,50597,,,,A,2106.0,CHEMBL622265,1,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9541,10116.0
,N,50597,,,,A,2106.0,CHEMBL622266,1,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9542,10116.0
,N,50597,,,,A,2106.0,CHEMBL622267,1,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9543,10116.0
,N,50597,,,,A,2106.0,CHEMBL622268,1,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9544,10116.0
,N,50597,,,,A,2106.0,CHEMBL622269,1,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9545,10116.0
,N,50597,,,,A,2106.0,CHEMBL625071,1,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9546,10116.0
,N,50597,,,,A,2106.0,CHEMBL621621,1,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9547,10116.0
,N,50597,,,,A,2106.0,CHEMBL621622,1,,BAO_0000218,16434,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9548,10116.0
,N,50597,,,,A,2106.0,CHEMBL621623,1,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9549,10116.0
,N,50597,,,,A,2106.0,CHEMBL621624,1,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9550,10116.0
,N,50597,,,,A,2106.0,CHEMBL621625,1,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9551,10116.0
,N,50597,,,,A,2106.0,CHEMBL621626,1,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9552,10116.0
,N,50597,,,,A,2106.0,CHEMBL621627,1,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9553,10116.0
,N,50597,,,,A,2106.0,CHEMBL621628,1,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9554,10116.0
,N,50597,,,,A,2106.0,CHEMBL875328,1,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9555,10116.0
,N,50597,,,,A,2106.0,CHEMBL621629,1,,BAO_0000218,16435,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,Spleen,Rattus norvegicus,Intermediate,,,9556,10116.0
,N,50597,,,,A,2106.0,CHEMBL621630,1,,BAO_0000218,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,Spleen,Rattus norvegicus,Intermediate,,,9557,10116.0
,N,50597,,,,A,2106.0,CHEMBL621631,1,,BAO_0000218,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,Spleen,Rattus norvegicus,Intermediate,,,9558,10116.0
,N,50597,,,,A,2106.0,CHEMBL621632,1,,BAO_0000218,16434,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,Spleen,Rattus norvegicus,Intermediate,,,9559,10116.0
,N,50597,,,,A,2106.0,CHEMBL621633,1,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,Spleen,Rattus norvegicus,Intermediate,,,9560,10116.0
,N,50597,,,,A,2106.0,CHEMBL621634,1,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,Spleen,Rattus norvegicus,Intermediate,,,9561,10116.0
,N,50597,,,,A,2106.0,CHEMBL621635,1,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,Spleen,Rattus norvegicus,Intermediate,,,9562,10116.0
,N,50597,,,,A,2106.0,CHEMBL621636,1,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,Spleen,Rattus norvegicus,Intermediate,,,9563,10116.0
,N,50597,,,,A,2106.0,CHEMBL621637,1,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,Spleen,Rattus norvegicus,Intermediate,,,9564,10116.0
,N,50597,,,,A,2106.0,CHEMBL621638,1,,BAO_0000218,16435,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,Spleen,Rattus norvegicus,Intermediate,,,9565,10116.0
,N,50597,,,,A,,CHEMBL618883,1,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,Rattus norvegicus,Intermediate,,,9566,10116.0
,N,50597,,,,A,,CHEMBL618884,1,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,1,,,Rattus norvegicus,Intermediate,,,9567,10116.0
,N,50597,,,,A,,CHEMBL628627,1,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,Rattus norvegicus,Intermediate,,,9568,10116.0
,N,50597,,,,A,,CHEMBL628628,1,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,Rattus norvegicus,Intermediate,,,9569,10116.0
,N,50597,,,,A,,CHEMBL628629,1,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,1,,,Rattus norvegicus,Intermediate,,,9570,10116.0
,N,50597,,,In vivo,A,,CHEMBL628630,1,,BAO_0000218,16365,Half life after administering orally a dose of 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9571,10116.0
,N,50597,,,In vivo,A,,CHEMBL628631,1,,BAO_0000218,16365,Half life after administering orally a dose of 3 mg/kg to a fasting rat,1,,,Rattus norvegicus,Intermediate,,,9572,10116.0
,N,50597,,,In vivo,A,,CHEMBL628632,1,,BAO_0000218,16365,Half life after administering intravenously a dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9573,10116.0
,N,50597,,,In vivo,A,,CHEMBL628633,1,,BAO_0000218,526,Half life after oral dosing in rats,1,,,Rattus norvegicus,Intermediate,,,9574,10116.0
,N,50597,,,In vivo,A,,CHEMBL628634,1,,BAO_0000218,16365,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,1,,,Rattus norvegicus,Intermediate,,,9575,10116.0
,N,50597,,,In vivo,A,,CHEMBL627789,1,,BAO_0000218,4368,Half life by intravenous administration of 3.4 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9576,10116.0
,N,50597,,,,A,,CHEMBL627790,1,,BAO_0000218,3371,Half life in rat,1,,,Rattus norvegicus,Intermediate,,,9577,10116.0
,N,50597,,,,A,,CHEMBL627791,1,,BAO_0000218,6448,Half life in rat,1,,,Rattus norvegicus,Intermediate,,,9578,10116.0
,N,50597,,,,A,,CHEMBL627792,1,,BAO_0000218,6453,Half life in rat,1,,,Rattus norvegicus,Intermediate,,,9579,10116.0
,N,50597,,,In vivo,A,,CHEMBL627793,1,,BAO_0000218,4353,Half life in rat after intravenous administration of the compound,1,,,Rattus norvegicus,Intermediate,,,9580,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627794,1,,BAO_0000218,4353,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,1,,Plasma,Rattus norvegicus,Intermediate,,,9581,10116.0
,N,50597,,,In vivo,A,,CHEMBL627795,1,,BAO_0000218,4353,Half life in rat after po administration of the compound,1,,,Rattus norvegicus,Intermediate,,,9582,10116.0
,N,50597,,,In vivo,A,,CHEMBL627796,1,,BAO_0000218,4353,Half life in rat after po administration of the compound; ND means Not determined,1,,,Rattus norvegicus,Intermediate,,,9583,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL875335,1,,BAO_0000218,4353,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,1,,Plasma,Rattus norvegicus,Intermediate,,,9584,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627797,1,,BAO_0000218,4353,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,1,,Plasma,Rattus norvegicus,Intermediate,,,9585,10116.0
,N,50597,,,In vivo,A,,CHEMBL627798,1,,BAO_0000218,5789,Half life in rat i.v.,1,,,Rattus norvegicus,Intermediate,,,9586,10116.0
,N,50597,,,In vivo,A,,CHEMBL627799,1,,BAO_0000218,17686,Half life in rat i.v. at 2 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,9587,10116.0
,N,50597,,,,A,,CHEMBL627800,1,,BAO_0000218,6495,Half life in rats,1,,,Rattus norvegicus,Intermediate,,,9588,10116.0
,N,50597,,,In vivo,A,,CHEMBL627801,1,,BAO_0000218,484,Half life in rats after intravenous administration,1,,,Rattus norvegicus,Intermediate,,,9589,10116.0
,N,50597,,,In vivo,A,,CHEMBL627802,1,,BAO_0000218,6467,Half life in rats at the dose of 1.0 mpk by i.v. administration,1,,,Rattus norvegicus,Intermediate,,,9590,10116.0
,N,50597,,,,A,,CHEMBL627803,1,,BAO_0000218,6642,Half life in rat,1,,,Rattus norvegicus,Expert,,,9591,10116.0
,N,50597,,,In vivo,A,,CHEMBL873820,1,,BAO_0000218,16367,Half life was evaluated after intravenous administration to rats,1,,,Rattus norvegicus,Intermediate,,,9592,10116.0
,N,50597,,,,A,,CHEMBL627804,1,,BAO_0000218,1369,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),1,,,Rattus norvegicus,Intermediate,,,9593,10116.0
,N,50597,,,,A,,CHEMBL627805,1,,BAO_0000218,5472,Half life was evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,9594,10116.0
,N,50597,,,,A,,CHEMBL627806,1,,BAO_0000218,6049,Half life was evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,9595,10116.0
,N,50597,,,,A,,CHEMBL627107,1,,BAO_0000218,5472,Half life was evaluated in rat; Not tested,1,,,Rattus norvegicus,Intermediate,,,9596,10116.0
,N,50597,,,In vivo,A,,CHEMBL627108,1,,BAO_0000218,16366,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,1,,,Rattus norvegicus,Intermediate,,,9597,10116.0
,N,50597,,,In vivo,A,,CHEMBL627109,1,,BAO_0000218,11149,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,1,,,Rattus norvegicus,Intermediate,,,9598,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627110,1,,BAO_0000218,11149,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,1,,Blood,Rattus norvegicus,Intermediate,,,9599,10116.0
,U,22224,,,In vivo,A,,CHEMBL627111,0,,BAO_0000218,2891,Half life was measured in monkey at dose of 10 mg/kg by po administration,1,,,Primates,Intermediate,,,9600,9443.0
,U,22224,,,In vivo,A,,CHEMBL627112,0,,BAO_0000218,2891,Half life was measured in monkey at dose of 10 mg/kg by po administration,1,,,Primates,Intermediate,,,9601,9443.0
,U,22224,,,In vivo,A,,CHEMBL627113,0,,BAO_0000218,2891,Half life was measured in rat at dose of 30 mg/kg by iv administration,1,,,Rattus norvegicus,Intermediate,,,9602,10116.0
,U,22224,,,In vivo,A,,CHEMBL627114,0,,BAO_0000218,2891,Half life was measured in rat at dose of 30 mg/kg by po administration,1,,,Rattus norvegicus,Intermediate,,,9603,10116.0
,N,50597,,,,A,,CHEMBL627115,1,,BAO_0000218,4026,Half life (t1/2) was determined,1,,,Rattus norvegicus,Intermediate,,,9604,10116.0
,N,50597,,,,A,,CHEMBL627116,1,,BAO_0000218,4527,Half life period at a dose of 10 uM/kg in rat was determined,1,,,Rattus norvegicus,Intermediate,,,9605,10116.0
,N,50597,,,In vivo,A,,CHEMBL627117,1,,BAO_0000218,4527,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,1,,,Rattus norvegicus,Intermediate,,,9606,10116.0
,N,50597,,,,A,,CHEMBL627118,1,,BAO_0000218,5503,Half life period was determined,1,,,Rattus norvegicus,Intermediate,,,9607,10116.0
,N,50597,,,In vivo,A,,CHEMBL627119,1,,BAO_0000218,4426,Half life period after intravenous administration at 20 mpk in rats,1,,,Rattus norvegicus,Intermediate,,,9608,10116.0
,N,50597,,,In vivo,A,,CHEMBL627120,1,,BAO_0000218,4426,Half life period after intravenous administration at 20 mpk in rats; Not performed.,1,,,Rattus norvegicus,Intermediate,,,9609,10116.0
,N,50597,,,In vivo,A,,CHEMBL626922,1,,BAO_0000218,6109,Half life period after intravenous administration in rat,1,,,Rattus norvegicus,Intermediate,,,9610,10116.0
,N,50597,,,In vivo,A,,CHEMBL626923,1,,BAO_0000218,5654,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,9611,10116.0
,N,50597,,,In vivo,A,,CHEMBL626924,1,,BAO_0000218,5654,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,9612,10116.0
,N,50597,,,,A,1969.0,CHEMBL626925,1,,BAO_0000218,4755,Half life period in 80% rat plasma at 37 degree Centigrade,1,,Plasma,Rattus norvegicus,Intermediate,,,9613,10116.0
,N,50597,,,,A,,CHEMBL626926,1,,BAO_0000218,5862,Half life period in SD rats,1,,,Rattus norvegicus,Intermediate,,,9614,10116.0
,N,50597,,,,A,1969.0,CHEMBL626927,1,,BAO_0000218,1515,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),1,,Plasma,Rattus norvegicus,Intermediate,,,9615,10116.0
,N,50597,,,,A,1969.0,CHEMBL626928,1,,BAO_0000218,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),1,,Plasma,Rattus norvegicus,Intermediate,,,9616,10116.0
,N,50597,,,,A,1969.0,CHEMBL626929,1,,BAO_0000218,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,Plasma,Rattus norvegicus,Intermediate,,,9617,10116.0
,N,50597,,,,A,1969.0,CHEMBL626930,1,,BAO_0000218,1515,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,Plasma,Rattus norvegicus,Intermediate,,,9618,10116.0
,N,50597,,,,A,,CHEMBL626931,1,,BAO_0000218,5960,Half life period in rat,1,,,Rattus norvegicus,Intermediate,,,9619,10116.0
,N,50597,,,,A,,CHEMBL626932,1,,BAO_0000218,6103,Half life period in rat,1,,,Rattus norvegicus,Intermediate,,,9620,10116.0
,N,50597,,,,A,,CHEMBL626933,1,,BAO_0000218,6317,Half life period in rat,1,,,Rattus norvegicus,Intermediate,,,9621,10116.0
,N,50597,,,In vivo,A,,CHEMBL873826,1,,BAO_0000218,6644,Half life period in rat after oral administration at 10.5 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,9622,10116.0
,N,50597,,,In vivo,A,,CHEMBL626934,1,,BAO_0000218,6644,Half life period in rat after oral administration at 11.2 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,9623,10116.0
,N,50597,,,In vivo,A,,CHEMBL626935,1,,BAO_0000218,6644,Half life period in rat after oral administration at 13 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,9624,10116.0
,N,50597,,,In vivo,A,,CHEMBL626936,1,,BAO_0000218,6644,Half life period in rat after oral administration at 9.7 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,9625,10116.0
,N,50597,,,,A,,CHEMBL626937,1,,BAO_0000218,5974,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,9626,10116.0
,N,50597,,,,A,,CHEMBL625906,1,,BAO_0000218,6295,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9627,10116.0
,N,50597,,,,A,,CHEMBL625907,1,,BAO_0000218,6296,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9628,10116.0
,N,50597,,,,A,,CHEMBL625908,1,,BAO_0000218,16427,PK study was carried to determine AUC (area under curve) value in rat,1,,,Rattus norvegicus,Intermediate,,,9629,10116.0
,N,50597,,,,A,,CHEMBL625909,1,,BAO_0000218,16367,Pharmacokinetic parameter AUC after intravenous administration to rats,1,,,Rattus norvegicus,Intermediate,,,9630,10116.0
,N,50597,,,,A,,CHEMBL625910,1,,BAO_0000218,16367,Pharmacokinetic parameter AUC after oral administration to rats,1,,,Rattus norvegicus,Intermediate,,,9631,10116.0
,N,50597,,,,A,,CHEMBL625911,1,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9632,10116.0
,N,50597,,,,A,,CHEMBL625912,1,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,1,,,Rattus norvegicus,Intermediate,,,9633,10116.0
,N,50597,,,,A,,CHEMBL626538,1,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,1,,,Rattus norvegicus,Intermediate,,,9634,10116.0
,N,50597,,,,A,,CHEMBL876794,1,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,1,,,Rattus norvegicus,Intermediate,,,9635,10116.0
,N,50597,,,,A,,CHEMBL626539,1,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,1,,,Rattus norvegicus,Intermediate,,,9636,10116.0
,N,50597,,,,A,,CHEMBL626540,1,,BAO_0000218,16365,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,1,,,Rattus norvegicus,Intermediate,,,9637,10116.0
,N,50597,,,,A,,CHEMBL626541,1,,BAO_0000218,5394,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9638,10116.0
,N,50597,,,,A,,CHEMBL626542,1,,BAO_0000218,5394,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9639,10116.0
,N,50597,,,,A,,CHEMBL626543,1,,BAO_0000218,2792,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,1,,,Rattus norvegicus,Intermediate,,,9640,10116.0
,N,50597,,,,A,,CHEMBL626544,1,,BAO_0000218,2792,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,1,,,Rattus norvegicus,Intermediate,,,9641,10116.0
,N,50597,,,,A,,CHEMBL626545,1,,BAO_0000218,2792,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,1,,,Rattus norvegicus,Intermediate,,,9642,10116.0
,N,50597,,,,A,,CHEMBL626546,1,,BAO_0000218,2792,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,1,,,Rattus norvegicus,Intermediate,,,9643,10116.0
,N,50597,,,,A,,CHEMBL626547,1,,BAO_0000218,5334,Pharmacokinetic parameter area under curve was reported,1,,,Rattus norvegicus,Intermediate,,,9644,10116.0
,N,50597,,,,A,,CHEMBL626548,1,,BAO_0000218,4408,Pharmacokinetic property (AUC) in rat,1,,,Rattus norvegicus,Intermediate,,,9645,10116.0
,N,50597,,,,A,,CHEMBL626549,1,,BAO_0000218,5983,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,1,,,Rattus norvegicus,Intermediate,,,9646,10116.0
,N,50597,,,,A,,CHEMBL626550,1,,BAO_0000218,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,1,,,Rattus norvegicus,Intermediate,,,9647,10116.0
,N,50597,,,,A,,CHEMBL626551,1,,BAO_0000218,4397,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,1,,,Rattus norvegicus,Intermediate,,,9648,10116.0
,N,50597,,,,A,,CHEMBL623777,1,,BAO_0000218,5491,Pharmacokinetic property was determined,1,,,Rattus norvegicus,Intermediate,,,9649,10116.0
,N,50597,,,,A,,CHEMBL623778,1,,BAO_0000218,5491,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9650,10116.0
,N,50597,,,,A,,CHEMBL623779,1,,BAO_0000218,5491,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,1,,,Rattus norvegicus,Intermediate,,,9651,10116.0
,N,50597,,,,A,1969.0,CHEMBL623780,1,,BAO_0000218,4199,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9652,10116.0
,N,50597,,,,A,1969.0,CHEMBL622015,1,,BAO_0000218,4199,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9653,10116.0
,N,50597,,,,A,1969.0,CHEMBL622016,1,,BAO_0000218,4199,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9654,10116.0
,N,50597,,,,A,,CHEMBL622017,1,,BAO_0000218,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",1,,,Rattus norvegicus,Intermediate,,,9655,10116.0
,N,50597,,,,A,,CHEMBL622018,1,,BAO_0000218,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",1,,,Rattus norvegicus,Intermediate,,,9656,10116.0
,N,50597,,,,A,,CHEMBL622019,1,,BAO_0000218,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",1,,,Rattus norvegicus,Intermediate,,,9657,10116.0
,N,50597,,,,A,,CHEMBL622020,1,,BAO_0000218,5173,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",1,,,Rattus norvegicus,Intermediate,,,9658,10116.0
,N,50597,,,,A,,CHEMBL622021,1,,BAO_0000218,16366,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,1,,,Rattus norvegicus,Intermediate,,,9659,10116.0
,N,50597,,,,A,,CHEMBL622022,1,,BAO_0000218,16366,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,1,,,Rattus norvegicus,Intermediate,,,9660,10116.0
,N,50597,,,,A,,CHEMBL622023,1,,BAO_0000218,5327,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,1,,,Rattus norvegicus,Intermediate,,,9661,10116.0
,N,50597,,,,A,,CHEMBL622024,1,,BAO_0000218,6681,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,9662,10116.0
,N,50597,,,,A,,CHEMBL622693,1,,BAO_0000218,12873,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),1,,,Rattus norvegicus,Intermediate,,,9663,10116.0
,N,50597,,,,A,,CHEMBL622694,1,,BAO_0000218,12873,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),1,,,Rattus norvegicus,Intermediate,,,9664,10116.0
,N,50597,,,,A,,CHEMBL622695,1,,BAO_0000218,6685,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,9665,10116.0
,N,50597,,,,A,,CHEMBL622696,1,,BAO_0000218,6685,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",1,,,Rattus norvegicus,Intermediate,,,9666,10116.0
,N,50597,,,,A,,CHEMBL622697,1,,BAO_0000218,6685,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",1,,,Rattus norvegicus,Intermediate,,,9667,10116.0
,N,50597,,,,A,,CHEMBL622874,1,,BAO_0000218,6619,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",1,,,Rattus norvegicus,Intermediate,,,9668,10116.0
,N,50597,,,,A,,CHEMBL622875,1,,BAO_0000218,6619,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",1,,,Rattus norvegicus,Intermediate,,,9669,10116.0
,N,50597,,,,A,,CHEMBL622876,1,,BAO_0000218,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,1,,,Rattus norvegicus,Intermediate,,,9670,10116.0
,N,50597,,,,A,,CHEMBL622877,1,,BAO_0000218,4796,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,1,,,Rattus norvegicus,Intermediate,,,9671,10116.0
,N,50597,,,,A,,CHEMBL622878,1,,BAO_0000218,4910,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,1,,,Rattus norvegicus,Intermediate,,,9672,10116.0
,N,50597,,,,A,1969.0,CHEMBL622879,1,,BAO_0000218,4910,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9673,10116.0
,N,50597,,,,A,,CHEMBL877602,1,,BAO_0000218,4839,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,1,,,Rattus norvegicus,Intermediate,,,9674,10116.0
,N,50597,,,,A,,CHEMBL622880,1,,BAO_0000218,15078,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,9675,10116.0
,N,50597,,,,A,,CHEMBL622881,1,,BAO_0000218,15078,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,9676,10116.0
,N,50597,,,,A,,CHEMBL622882,1,,BAO_0000218,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,9677,10116.0
,N,50597,,,,A,,CHEMBL622883,1,,BAO_0000218,15078,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,9678,10116.0
,N,50597,,,,A,2046.0,CHEMBL622884,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9679,10116.0
,N,50597,,,,A,2046.0,CHEMBL622885,1,,BAO_0000218,11450,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9680,10116.0
,N,50597,,,,A,,CHEMBL622886,1,,BAO_0000218,8151,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,,,Rattus norvegicus,Intermediate,,,9681,10116.0
,N,50597,,,,A,,CHEMBL622887,1,,BAO_0000218,8151,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,9682,10116.0
,N,50597,,,,A,1088.0,CHEMBL622888,1,,BAO_0000218,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,,Urine,Rattus norvegicus,Intermediate,,,9683,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL622889,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Blood,Rattus norvegicus,Intermediate,,,9684,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL622890,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Blood,Rattus norvegicus,Intermediate,,,9685,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL622891,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Blood,Rattus norvegicus,Intermediate,,,9686,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL877603,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Blood,Rattus norvegicus,Intermediate,,,9687,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622892,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Brain,Rattus norvegicus,Intermediate,,,9688,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622893,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Brain,Rattus norvegicus,Intermediate,,,9689,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622894,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Brain,Rattus norvegicus,Intermediate,,,9690,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622895,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Brain,Rattus norvegicus,Intermediate,,,9691,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622896,1,,BAO_0000218,8677,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,1,,Brain,Rattus norvegicus,Intermediate,,,9692,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL622897,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Heart,Rattus norvegicus,Intermediate,,,9693,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL622898,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Heart,Rattus norvegicus,Intermediate,,,9694,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL622899,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Heart,Rattus norvegicus,Intermediate,,,9695,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL622900,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Kidney,Rattus norvegicus,Intermediate,,,9696,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL624114,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Kidney,Rattus norvegicus,Intermediate,,,9697,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL624115,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Kidney,Rattus norvegicus,Intermediate,,,9698,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL624116,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Kidney,Rattus norvegicus,Intermediate,,,9699,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL624117,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Liver,Rattus norvegicus,Intermediate,,,9700,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL624118,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Liver,Rattus norvegicus,Intermediate,,,9701,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL624119,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Liver,Rattus norvegicus,Intermediate,,,9702,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL624120,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Liver,Rattus norvegicus,Intermediate,,,9703,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624121,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Lung,Rattus norvegicus,Intermediate,,,9704,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624122,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Lung,Rattus norvegicus,Intermediate,,,9705,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624123,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Lung,Rattus norvegicus,Intermediate,,,9706,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624124,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Lung,Rattus norvegicus,Intermediate,,,9707,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624125,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9708,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624126,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9709,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624127,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9710,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624128,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9711,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL624129,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Zone of skin,Rattus norvegicus,Intermediate,,,9712,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL624130,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Zone of skin,Rattus norvegicus,Intermediate,,,9713,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL622340,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Zone of skin,Rattus norvegicus,Intermediate,,,9714,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL622341,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Zone of skin,Rattus norvegicus,Intermediate,,,9715,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL622342,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Intestine,Rattus norvegicus,Intermediate,,,9716,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL622343,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Intestine,Rattus norvegicus,Intermediate,,,9717,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL622344,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Intestine,Rattus norvegicus,Intermediate,,,9718,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL622345,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Intestine,Rattus norvegicus,Intermediate,,,9719,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL622346,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Spleen,Rattus norvegicus,Intermediate,,,9720,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL622347,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Spleen,Rattus norvegicus,Intermediate,,,9721,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL622348,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Spleen,Rattus norvegicus,Intermediate,,,9722,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL622349,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Spleen,Rattus norvegicus,Intermediate,,,9723,10116.0
,N,50597,,,,A,,CHEMBL622350,1,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,1,,,Rattus norvegicus,Intermediate,,,9724,10116.0
,N,50597,,,,A,,CHEMBL622351,1,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,1,,,Rattus norvegicus,Intermediate,,,9725,10116.0
,N,50597,,,,A,,CHEMBL622352,1,,BAO_0000218,16434,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,1,,,Rattus norvegicus,Intermediate,,,9726,10116.0
,N,50597,,,,A,,CHEMBL622353,1,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,1,,,Rattus norvegicus,Intermediate,,,9727,10116.0
,N,50597,,,,A,,CHEMBL622354,1,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,1,,,Rattus norvegicus,Intermediate,,,9728,10116.0
,N,50597,,,,A,,CHEMBL622355,1,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,1,,,Rattus norvegicus,Intermediate,,,9729,10116.0
,N,50597,,,,A,,CHEMBL622356,1,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,1,,,Rattus norvegicus,Intermediate,,,9730,10116.0
,N,50597,,,,A,,CHEMBL622357,1,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,1,,,Rattus norvegicus,Intermediate,,,9731,10116.0
,N,50597,,,,A,,CHEMBL622358,1,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,1,,,Rattus norvegicus,Intermediate,,,9732,10116.0
,N,50597,,,,A,,CHEMBL622359,1,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,1,,,Rattus norvegicus,Intermediate,,,9733,10116.0
,N,50597,,,,A,,CHEMBL874393,1,,BAO_0000218,16435,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,1,,,Rattus norvegicus,Intermediate,,,9734,10116.0
,N,50597,,,,A,,CHEMBL622872,1,,BAO_0000218,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,Rattus norvegicus,Intermediate,,,9735,10116.0
,N,50597,,,,A,,CHEMBL622873,1,,BAO_0000218,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,Rattus norvegicus,Intermediate,,,9736,10116.0
,N,50597,,,,A,,CHEMBL623047,1,,BAO_0000218,16434,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,Rattus norvegicus,Intermediate,,,9737,10116.0
,N,50597,,,,A,,CHEMBL623048,1,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,Rattus norvegicus,Intermediate,,,9738,10116.0
,N,50597,,,,A,,CHEMBL623049,1,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,Rattus norvegicus,Intermediate,,,9739,10116.0
,N,50597,,,,A,,CHEMBL623050,1,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,Rattus norvegicus,Intermediate,,,9740,10116.0
,N,50597,,,,A,,CHEMBL623051,1,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,Rattus norvegicus,Intermediate,,,9741,10116.0
,N,50597,,,,A,,CHEMBL623052,1,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,Rattus norvegicus,Intermediate,,,9742,10116.0
,N,50597,,,,A,,CHEMBL626343,1,,BAO_0000218,16435,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,Rattus norvegicus,Intermediate,,,9743,10116.0
,N,50597,,,,A,,CHEMBL626344,1,,BAO_0000218,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,1,,,Rattus norvegicus,Intermediate,,,9744,10116.0
,N,50597,,,,A,,CHEMBL626345,1,,BAO_0000218,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,1,,,Rattus norvegicus,Intermediate,,,9745,10116.0
,N,50597,,,,A,,CHEMBL626346,1,,BAO_0000218,16434,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,1,,,Rattus norvegicus,Intermediate,,,9746,10116.0
,N,50597,,,,A,,CHEMBL626347,1,,BAO_0000218,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,1,,,Rattus norvegicus,Intermediate,,,9747,10116.0
,N,50597,,,,A,,CHEMBL626348,1,,BAO_0000218,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,1,,,Rattus norvegicus,Intermediate,,,9748,10116.0
,N,50597,,,,A,,CHEMBL626349,1,,BAO_0000218,16434,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,1,,,Rattus norvegicus,Intermediate,,,9749,10116.0
,N,50597,,,,F,,CHEMBL626350,1,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,1,,,Rattus norvegicus,Intermediate,,,9750,10116.0
,N,50597,,,,A,,CHEMBL626351,1,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,1,,,Rattus norvegicus,Intermediate,,,9751,10116.0
,N,50597,,,,A,,CHEMBL627650,1,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,1,,,Rattus norvegicus,Intermediate,,,9752,10116.0
,N,50597,,,,F,,CHEMBL627651,1,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,1,,,Rattus norvegicus,Intermediate,,,9753,10116.0
,N,50597,,,,A,,CHEMBL627652,1,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,1,,,Rattus norvegicus,Intermediate,,,9754,10116.0
,N,50597,,,,A,,CHEMBL627653,1,,BAO_0000218,16435,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,1,,,Rattus norvegicus,Intermediate,,,9755,10116.0
,N,50597,,,,A,,CHEMBL627654,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,1,,,Rattus norvegicus,Intermediate,,,9756,10116.0
,N,50597,,,,A,,CHEMBL627835,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,1,,,Rattus norvegicus,Intermediate,,,9757,10116.0
,N,50597,,,,A,,CHEMBL627836,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9758,10116.0
,N,50597,,,,A,,CHEMBL627837,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9759,10116.0
,N,50597,,,,A,,CHEMBL627838,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,1,,,Rattus norvegicus,Intermediate,,,9760,10116.0
,N,50597,,,,A,,CHEMBL875338,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,1,,,Rattus norvegicus,Intermediate,,,9761,10116.0
,N,50597,,,,A,,CHEMBL627839,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9762,10116.0
,N,50597,,,,A,,CHEMBL627840,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9763,10116.0
,N,50597,,,,A,,CHEMBL627841,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,1,,,Rattus norvegicus,Intermediate,,,9764,10116.0
,N,50597,,,,A,,CHEMBL627842,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,1,,,Rattus norvegicus,Intermediate,,,9765,10116.0
,N,50597,,,,A,,CHEMBL627843,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9766,10116.0
,N,50597,,,,A,,CHEMBL627844,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9767,10116.0
,N,50597,,,,A,,CHEMBL627845,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,1,,,Rattus norvegicus,Intermediate,,,9768,10116.0
,N,50597,,,In vivo,A,,CHEMBL627846,1,,BAO_0000218,5874,Half life period in rat by iv administration at a dose of 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9769,10116.0
,N,50597,,,,A,1969.0,CHEMBL627847,1,,BAO_0000218,1515,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),1,,Plasma,Rattus norvegicus,Intermediate,,,9770,10116.0
,N,50597,,,,A,1969.0,CHEMBL873821,1,,BAO_0000218,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),1,,Plasma,Rattus norvegicus,Intermediate,,,9771,10116.0
,N,50597,,,,A,1969.0,CHEMBL626079,1,,BAO_0000218,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,Plasma,Rattus norvegicus,Intermediate,,,9772,10116.0
,N,50597,,,,A,1969.0,CHEMBL626080,1,,BAO_0000218,1515,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1,,Plasma,Rattus norvegicus,Intermediate,,,9773,10116.0
,N,50597,,,,A,1969.0,CHEMBL626081,1,,BAO_0000218,5491,Half life period was evaluated in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9774,10116.0
,N,50597,,,,A,1969.0,CHEMBL875344,1,,BAO_0000218,5491,Half life period was evaluated in rat plasma; Not tested,1,,Plasma,Rattus norvegicus,Intermediate,,,9775,10116.0
,N,50597,,,,A,,CHEMBL626082,1,,BAO_0000218,1918,Half life period was evaluated in rats,1,,,Rattus norvegicus,Intermediate,,,9776,10116.0
,N,50597,,,In vivo,A,,CHEMBL626250,1,,BAO_0000218,1918,"Half life period was evaluated in rats, iv",1,,,Rattus norvegicus,Intermediate,,,9777,10116.0
,N,50597,,,In vivo,A,,CHEMBL626251,1,,BAO_0000218,6113,Half life period after intravenous administration at 5 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,9778,10116.0
,N,50597,,,In vivo,A,,CHEMBL626252,1,,BAO_0000218,5546,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,1,,,Rattus norvegicus,Intermediate,,,9779,10116.0
,N,50597,,,In vivo,A,,CHEMBL626253,1,,BAO_0000218,5553,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9780,10116.0
,N,50597,,,,A,1969.0,CHEMBL626254,1,,BAO_0000218,4188,Half life stability of compound was evaluated in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9781,10116.0
,N,50597,,,In vivo,A,,CHEMBL626255,1,,BAO_0000218,6215,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,1,,,Rattus norvegicus,Intermediate,,,9782,10116.0
,N,50597,,,In vivo,A,,CHEMBL626256,1,,BAO_0000218,6141,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,9783,10116.0
,N,50597,,,In vivo,A,,CHEMBL626257,1,,BAO_0000218,5182,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,,,Rattus norvegicus,Intermediate,,,9784,10116.0
,N,50597,,,In vivo,A,,CHEMBL626258,1,,BAO_0000218,5182,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,1,,,Rattus norvegicus,Intermediate,,,9785,10116.0
,N,50597,,,In vivo,A,,CHEMBL626259,1,,BAO_0000218,5710,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,1,,,Rattus norvegicus,Intermediate,,,9786,10116.0
,N,50597,,,In vivo,A,,CHEMBL626260,1,,BAO_0000218,5789,Half in rat i.v.,1,,,Rattus norvegicus,Intermediate,,,9787,10116.0
,N,50597,,,In vivo,A,,CHEMBL875345,1,,BAO_0000218,6011,Half period in rat after intravenous administration,1,,,Rattus norvegicus,Intermediate,,,9788,10116.0
,N,50597,,,In vivo,A,,CHEMBL626261,1,,BAO_0000218,17594,Half-life after repeated oral dose of compound at 1 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9789,10116.0
,N,50597,,,In vitro,A,2107.0,CHEMBL626262,1,,BAO_0000218,12357,Half-life measured in in vitro Cathepsin B assay in rat liver,1,,Liver,Rattus norvegicus,Intermediate,,,9790,10116.0
,N,50597,,,,A,,CHEMBL626263,1,,BAO_0000218,5210,Half-life of compound was determined in rats,1,,,Rattus norvegicus,Intermediate,,,9791,10116.0
,N,50597,,,In vivo,A,,CHEMBL625270,1,,BAO_0000218,17596,Half-life at 10 mg/kg in rat upon intravenous administration,1,,,Rattus norvegicus,Intermediate,,,9792,10116.0
,N,50597,,,,A,,CHEMBL625271,1,,BAO_0000218,6672,Half-life determined in rat,1,,,Rattus norvegicus,Intermediate,,,9793,10116.0
,N,50597,,,,A,,CHEMBL625272,1,,BAO_0000218,6673,Half-life determined in rat,1,,,Rattus norvegicus,Intermediate,,,9794,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL625273,1,,BAO_0000218,4910,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,1,,Brain,Rattus norvegicus,Intermediate,,,9795,10116.0
,N,50597,,,,A,1969.0,CHEMBL625274,1,,BAO_0000218,3741,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",1,,Plasma,Rattus norvegicus,Intermediate,,,9796,10116.0
,N,50597,,,In vivo,A,,CHEMBL625275,1,,BAO_0000218,17671,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9797,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625276,1,,BAO_0000218,4910,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,1,,Plasma,Rattus norvegicus,Intermediate,,,9798,10116.0
,N,50597,,,,A,1969.0,CHEMBL625277,1,,BAO_0000218,17537,Half-life in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9799,10116.0
,N,50597,,,,A,1969.0,CHEMBL625278,1,,BAO_0000218,4965,Half-life in rat plasma was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,9800,10116.0
,N,50597,,,,A,1969.0,CHEMBL625279,1,,BAO_0000218,17537,Half-life in rat plasma; Not tested,1,,Plasma,Rattus norvegicus,Intermediate,,,9801,10116.0
,N,50597,,,,A,1977.0,CHEMBL625280,1,,BAO_0000218,6124,Half-life in rat serum,1,,Serum,Rattus norvegicus,Intermediate,,,9802,10116.0
,N,50597,,,,A,1977.0,CHEMBL876797,1,,BAO_0000218,6124,Half-life in rat serum; na is not available,1,,Serum,Rattus norvegicus,Intermediate,,,9803,10116.0
,N,50597,,,,A,,CHEMBL625281,1,,BAO_0000218,6078,Half-life was calculated in rat,1,,,Rattus norvegicus,Intermediate,,,9804,10116.0
,N,50597,,,,A,1969.0,CHEMBL873827,1,,BAO_0000218,17668,Half-life was calculated in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9805,10116.0
,N,50597,,,,A,,CHEMBL625282,1,,BAO_0000218,3185,Half-life was determined,1,,,Rattus norvegicus,Intermediate,,,9806,10116.0
,N,50597,,,,A,,CHEMBL625283,1,,BAO_0000218,4883,Half-life was determined,1,,,Rattus norvegicus,Intermediate,,,9807,10116.0
,N,50597,,,In vivo,A,,CHEMBL625284,1,,BAO_0000218,2959,Half-life after administration of 20 mg/Kg oral dose in rat,1,,,Rattus norvegicus,Intermediate,,,9808,10116.0
,N,50597,,,In vivo,A,,CHEMBL625285,1,,BAO_0000218,4029,Half-life after administration of 3.2 mg/kg intravenously in male rat,1,,,Rattus norvegicus,Intermediate,,,9809,10116.0
,N,50597,,,In vivo,A,,CHEMBL625286,1,,BAO_0000218,4029,Half-life after intravenous administration in female rat,1,,,Rattus norvegicus,Intermediate,,,9810,10116.0
,N,50597,,,In vivo,A,,CHEMBL625287,1,,BAO_0000218,4029,Half-life after intravenous administration in male rat,1,,,Rattus norvegicus,Intermediate,,,9811,10116.0
,N,50597,,,In vivo,A,,CHEMBL625288,1,,BAO_0000218,6180,Half-life after intravenous dose in rat,1,,,Rattus norvegicus,Intermediate,,,9812,10116.0
,N,50597,,,,A,2107.0,CHEMBL625289,1,,BAO_0000218,1557,Half-life in a rat liver homogenate preparation,1,,Liver,Rattus norvegicus,Intermediate,,,9813,10116.0
,N,50597,,,,A,1969.0,CHEMBL625290,1,,BAO_0000218,12500,Half-life in plasma of rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9814,10116.0
,N,50597,,,,A,1969.0,CHEMBL876798,1,,BAO_0000218,12500,Half-life in plasma of rat at dose of 3-10 mgkg,1,,Plasma,Rattus norvegicus,Intermediate,,,9815,10116.0
,N,50597,,,,A,,CHEMBL625291,1,,BAO_0000218,5064,Half-life in rat,1,,,Rattus norvegicus,Intermediate,,,9816,10116.0
,N,50597,,,,A,,CHEMBL625292,1,,BAO_0000218,5145,Half-life in rat,1,,,Rattus norvegicus,Intermediate,,,9817,10116.0
,N,50597,,,,A,,CHEMBL625293,1,,BAO_0000218,5147,Half-life in rat,1,,,Rattus norvegicus,Intermediate,,,9818,10116.0
,N,50597,,,,A,,CHEMBL622832,1,,BAO_0000218,5833,Half-life in rat,1,,,Rattus norvegicus,Intermediate,,,9819,10116.0
,N,50597,,,,A,,CHEMBL622833,1,,BAO_0000218,6596,Half-life in rat,1,,,Rattus norvegicus,Intermediate,,,9820,10116.0
,N,50597,,,,A,,CHEMBL622834,1,,BAO_0000218,17655,Half-life in rat,1,,,Rattus norvegicus,Intermediate,,,9821,10116.0
,N,50597,,,In vivo,A,,CHEMBL622835,1,,BAO_0000218,6495,Half-life in rat after oral administration at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9822,10116.0
,N,50597,,,In vivo,A,,CHEMBL622836,1,,BAO_0000218,17538,Half-life in rat after po administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9823,10116.0
,N,50597,,,In vivo,A,,CHEMBL622837,1,,BAO_0000218,17538,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,1,,,Rattus norvegicus,Intermediate,,,9824,10116.0
,N,50597,,,In vivo,A,,CHEMBL622838,1,,BAO_0000218,10,Half-life in rat at 3 mg/kg dose administered intravenously,1,,,Rattus norvegicus,Intermediate,,,9825,10116.0
,N,50597,,,,A,955.0,CHEMBL622839,1,,BAO_0000218,17669,Half-life in rat brain homogenate,1,,Brain,Rattus norvegicus,Intermediate,,,9826,10116.0
,N,50597,,,,A,1969.0,CHEMBL622840,1,,BAO_0000218,17065,Half-life in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9827,10116.0
,N,50597,,,,A,,CHEMBL622841,1,,BAO_0000218,4333,Half-life in rats,1,,,Rattus norvegicus,Intermediate,,,9828,10116.0
,N,50597,,,,A,,CHEMBL622842,1,,BAO_0000218,6827,Half-life in Dawley rats,1,,,Rattus norvegicus,Intermediate,,,9829,10116.0
,N,50597,,,In vitro,A,1969.0,CHEMBL622843,1,,BAO_0000218,889,Half-life in vitro in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,9830,10116.0
,N,50597,,,In vitro,A,1969.0,CHEMBL622844,1,,BAO_0000218,889,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,1,,Plasma,Rattus norvegicus,Intermediate,,,9831,10116.0
,N,50597,,,,A,,CHEMBL622845,1,,BAO_0000218,3747,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",1,,,Rattus norvegicus,Intermediate,,,9832,10116.0
,N,50597,,,,A,,CHEMBL622846,1,,BAO_0000218,15022,The area under the curve of compound was measured at the dose of 100 umol/kg,1,,,Rattus norvegicus,Intermediate,,,9833,10116.0
,N,50597,,,,A,,CHEMBL622847,1,,BAO_0000218,15022,The area under the curve of compound was measured at the dose of 300 umol/kg,1,,,Rattus norvegicus,Intermediate,,,9834,10116.0
,N,50597,,,,A,,CHEMBL622848,1,,BAO_0000218,15022,The area under the curve of compound was measured at the dose of 30 umol/kg,1,,,Rattus norvegicus,Intermediate,,,9835,10116.0
,N,50597,,,In vivo,A,,CHEMBL622849,1,,BAO_0000218,3360,Bioavailability as oral AUC in rats,1,,,Rattus norvegicus,Intermediate,,,9836,10116.0
,N,50597,,,,A,1969.0,CHEMBL622850,1,,BAO_0000218,5334,The plasma concentration versus time curve (AUC) was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,9837,10116.0
,N,50597,,,,A,,CHEMBL876807,1,,BAO_0000218,17411,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9838,10116.0
,N,50597,,,,A,,CHEMBL622851,1,,BAO_0000218,17411,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9839,10116.0
,N,50597,,,,A,,CHEMBL622852,1,,BAO_0000218,17411,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9840,10116.0
,N,50597,,,,A,,CHEMBL622853,1,,BAO_0000218,6570,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,1,,,Rattus norvegicus,Intermediate,,,9841,10116.0
,N,50597,,,,A,,CHEMBL622854,1,,BAO_0000218,6570,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,1,,,Rattus norvegicus,Intermediate,,,9842,10116.0
,N,50597,,,,A,,CHEMBL622855,1,,BAO_0000218,17411,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9843,10116.0
,N,50597,,,,A,1969.0,CHEMBL622856,1,,BAO_0000218,14941,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",1,,Plasma,Rattus norvegicus,Intermediate,,,9844,10116.0
,N,50597,,,,A,1969.0,CHEMBL622857,1,,BAO_0000218,14941,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",1,,Plasma,Rattus norvegicus,Intermediate,,,9845,10116.0
,N,50597,,,,A,1969.0,CHEMBL622858,1,,BAO_0000218,17538,AUC in rat after po administration at a dose of 10 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9846,10116.0
,N,50597,,,,A,1969.0,CHEMBL622859,1,,BAO_0000218,17752,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9847,10116.0
,N,50597,,,,A,,CHEMBL622860,1,,BAO_0000218,17509,Area under curve value 24 hr after 10 mg/kg iv administration in rats,1,,,Rattus norvegicus,Intermediate,,,9848,10116.0
,N,50597,,,,A,,CHEMBL622861,1,,BAO_0000218,17509,Area under curve value 24 hr after 10 mg/kg oral administration in rats,1,,,Rattus norvegicus,Intermediate,,,9849,10116.0
,N,50597,,,,A,,CHEMBL622862,1,,BAO_0000218,17509,Area under curve value 24 hr after 2 mg/kg iv administration in rats,1,,,Rattus norvegicus,Intermediate,,,9850,10116.0
,N,50597,,,,A,,CHEMBL622863,1,,BAO_0000218,17509,Area under curve value 24 hr after 2 mg/kg oral administration in rats,1,,,Rattus norvegicus,Intermediate,,,9851,10116.0
,N,50597,,,,A,,CHEMBL623817,1,,BAO_0000218,17509,Area under curve value 6 hr after po administration in rat,1,,,Rattus norvegicus,Intermediate,,,9852,10116.0
,N,50597,,,,A,,CHEMBL623818,1,,BAO_0000218,17717,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,,Rattus norvegicus,Intermediate,,,9853,10116.0
,N,50597,,,,A,,CHEMBL623819,1,,BAO_0000218,17717,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",1,,,Rattus norvegicus,Intermediate,,,9854,10116.0
,N,50597,,,,A,,CHEMBL623820,1,,BAO_0000218,17717,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,,Rattus norvegicus,Intermediate,,,9855,10116.0
,N,50597,,,,A,,CHEMBL623821,1,,BAO_0000218,17717,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,1,,,Rattus norvegicus,Intermediate,,,9856,10116.0
,N,50597,,,,A,1969.0,CHEMBL623822,1,,BAO_0000218,6642,AUC normalized for dose (AUCN) in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9857,10116.0
,N,50597,,,,A,,CHEMBL623823,1,,BAO_0000218,6640,Area under curve in rat after p.o. administration,1,,,Rattus norvegicus,Intermediate,,,9858,10116.0
,N,50597,,,,A,,CHEMBL623824,1,,BAO_0000218,6641,Area under curve in rat after p.o. administration,1,,,Rattus norvegicus,Intermediate,,,9859,10116.0
,N,50597,,,,A,,CHEMBL623825,1,,BAO_0000218,6641,Area under curve in rat after p.o. administration; Not determined,1,,,Rattus norvegicus,Intermediate,,,9860,10116.0
,N,50597,,,,A,,CHEMBL622070,1,,BAO_0000218,6641,Area under curve in rat after peroral administration,1,,,Rattus norvegicus,Intermediate,,,9861,10116.0
,N,50597,,,,A,,CHEMBL622071,1,,BAO_0000218,3603,Area under curve (carotid artery) value of the compound,1,,,Rattus norvegicus,Intermediate,,,9862,10116.0
,N,50597,,,,A,,CHEMBL622072,1,,BAO_0000218,3550,Bioavailability expressed as the area under curve of rat carotid artery,1,,,Rattus norvegicus,Intermediate,,,9863,10116.0
,N,50597,,,,A,,CHEMBL622073,1,,BAO_0000218,15662,Area under curve in male SD rats was observed after intravenous administration in rat,1,,,Rattus norvegicus,Intermediate,,,9864,10116.0
,N,50597,,,,A,,CHEMBL622074,1,,BAO_0000218,17720,Area under curve of the compound was determined,1,,,Rattus norvegicus,Intermediate,,,9865,10116.0
,N,50597,,,,A,,CHEMBL622075,1,,BAO_0000218,5407,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,1,,,Rattus norvegicus,Intermediate,,,9866,10116.0
,N,50597,,,,A,1969.0,CHEMBL622076,1,,BAO_0000218,17752,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9867,10116.0
,N,50597,,,,A,1969.0,CHEMBL622077,1,,BAO_0000218,17752,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,9868,10116.0
,N,50597,,,,A,,CHEMBL622078,1,,BAO_0000218,3603,Area under curve (portal vein) value of the compound,1,,,Rattus norvegicus,Intermediate,,,9869,10116.0
,N,50597,,,,A,,CHEMBL622079,1,,BAO_0000218,3550,Bioavailability expressed as the area under curve of rat portal vein,1,,,Rattus norvegicus,Intermediate,,,9870,10116.0
,N,50597,,,,A,1969.0,CHEMBL622080,1,,BAO_0000218,17655,Area Under plasma concentration time curve in rat upon peroral administration,1,,Plasma,Rattus norvegicus,Intermediate,,,9871,10116.0
,N,50597,,,,A,,CHEMBL877612,1,,BAO_0000218,17582,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9872,10116.0
,N,50597,,,,A,,CHEMBL622081,1,,BAO_0000218,17582,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,9873,10116.0
,N,50597,,,,A,,CHEMBL622082,1,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats,1,,,Rattus norvegicus,Intermediate,,,9874,10116.0
,N,50597,,,,A,,CHEMBL622083,1,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats after iv administration,1,,,Rattus norvegicus,Intermediate,,,9875,10116.0
,N,50597,,,,A,,CHEMBL622084,1,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats; 30-80,1,,,Rattus norvegicus,Intermediate,,,9876,10116.0
,N,50597,,,,A,,CHEMBL622085,1,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats; 50-60,1,,,Rattus norvegicus,Intermediate,,,9877,10116.0
,N,50597,,,,A,,CHEMBL622086,1,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats; no data,1,,,Rattus norvegicus,Intermediate,,,9878,10116.0
,N,50597,,,,A,,CHEMBL622087,1,,BAO_0000218,17791,Compound was evaluated for oral bioavailability in rats; peptide,1,,,Rattus norvegicus,Intermediate,,,9879,10116.0
,N,50597,,,,A,178.0,CHEMBL622088,1,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",1,,Blood,Rattus norvegicus,Intermediate,,,9880,10116.0
,N,50597,,,,A,178.0,CHEMBL622089,1,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",1,,Blood,Rattus norvegicus,Intermediate,,,9881,10116.0
,N,50597,,,,A,178.0,CHEMBL623685,1,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",1,,Blood,Rattus norvegicus,Intermediate,,,9882,10116.0
,N,50597,,,,A,178.0,CHEMBL623686,1,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",1,,Blood,Rattus norvegicus,Intermediate,,,9883,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL623687,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Stomach,Rattus norvegicus,Intermediate,,,9884,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL623688,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Stomach,Rattus norvegicus,Intermediate,,,9885,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL623689,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Stomach,Rattus norvegicus,Intermediate,,,9886,10116.0
,N,50597,,,In vivo,A,945.0,CHEMBL622485,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Stomach,Rattus norvegicus,Intermediate,,,9887,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL622486,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9888,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL877613,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9889,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL622487,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9890,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL622488,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,9891,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL622489,1,,BAO_0000218,8677,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",1,,Heart,Rattus norvegicus,Intermediate,,,9892,10116.0
,N,50597,,,,A,1088.0,CHEMBL622490,1,,BAO_0000218,6899,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,,Urine,Rattus norvegicus,Intermediate,,,9893,10116.0
,N,50597,,,,A,1088.0,CHEMBL622491,1,,BAO_0000218,6899,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,1,,Urine,Rattus norvegicus,Intermediate,,,9894,10116.0
,N,50597,,,,A,2107.0,CHEMBL622492,1,,BAO_0000218,6899,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,1,,Liver,Rattus norvegicus,Intermediate,,,9895,10116.0
,N,50597,,,,A,1088.0,CHEMBL622493,1,,BAO_0000218,6899,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,,Urine,Rattus norvegicus,Intermediate,,,9896,10116.0
,N,50597,,,,A,1088.0,CHEMBL622494,1,,BAO_0000218,6899,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,1,,Urine,Rattus norvegicus,Intermediate,,,9897,10116.0
,N,50597,,,,A,2385.0,CHEMBL622495,1,,BAO_0000218,8677,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9898,10116.0
,N,50597,,,,A,,CHEMBL622496,1,,BAO_0000218,6899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,1,,,Rattus norvegicus,Intermediate,,,9899,10116.0
,N,50597,,,,A,1088.0,CHEMBL622497,1,,BAO_0000218,6899,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,1,,Urine,Rattus norvegicus,Intermediate,,,9900,10116.0
,N,50597,,,,A,,CHEMBL622498,1,,BAO_0000218,2189,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,1,,,Rattus norvegicus,Intermediate,,,9901,10116.0
,N,50597,,,,A,1088.0,CHEMBL624918,1,,BAO_0000218,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,1,,Urine,Rattus norvegicus,Intermediate,,,9902,10116.0
,N,50597,,,,A,1088.0,CHEMBL624919,1,,BAO_0000218,2189,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,1,,Urine,Rattus norvegicus,Intermediate,,,9903,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL624920,1,,BAO_0000218,10839,Biodistribution of compound in rat blood after 5 min of administration,1,,Blood,Rattus norvegicus,Intermediate,,,9904,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL624921,1,,BAO_0000218,10839,Biodistribution of compound in rat blood after 5 min of administration.,1,,Blood,Rattus norvegicus,Intermediate,,,9905,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL624922,1,,BAO_0000218,10839,Biodistribution of compound in rat brain after 5 min of administration,1,,Brain,Rattus norvegicus,Intermediate,,,9906,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL624923,1,,BAO_0000218,10839,Biodistribution of compound in rat heart after 5 min of administration,1,,Heart,Rattus norvegicus,Intermediate,,,9907,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL624924,1,,BAO_0000218,10839,Biodistribution of compound in rat heart after 5 min of administration.,1,,Heart,Rattus norvegicus,Intermediate,,,9908,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL624925,1,,BAO_0000218,10839,Biodistribution of compound in rat kidney after 5 min of administration,1,,Kidney,Rattus norvegicus,Intermediate,,,9909,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL624926,1,,BAO_0000218,10839,Biodistribution of compound in rat kidney after 5 min of administration.,1,,Kidney,Rattus norvegicus,Intermediate,,,9910,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL624927,1,,BAO_0000218,10839,Biodistribution of compound in rat liver after 5 min of administration,1,,Liver,Rattus norvegicus,Intermediate,,,9911,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL874402,1,,BAO_0000218,10839,Biodistribution of compound in rat liver after 5 min of administration.,1,,Liver,Rattus norvegicus,Intermediate,,,9912,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624928,1,,BAO_0000218,10839,Biodistribution of compound in rat lung after 5 min of administration,1,,Lung,Rattus norvegicus,Intermediate,,,9913,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624929,1,,BAO_0000218,10839,Biodistribution of compound in rat lung after 5 min of administration.,1,,Lung,Rattus norvegicus,Intermediate,,,9914,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624930,1,,BAO_0000218,10839,Biodistribution of compound in rat muscle after 5 min of administration,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9915,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624931,1,,BAO_0000218,10839,Biodistribution of compound in rat muscle after 5 min of administration.,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9916,10116.0
,N,50597,,,,A,948.0,CHEMBL624932,1,,BAO_0000218,4043,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,Heart,Rattus norvegicus,Intermediate,,,9917,10116.0
,N,50597,,,,A,948.0,CHEMBL624933,1,,BAO_0000218,4043,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,Heart,Rattus norvegicus,Intermediate,,,9918,10116.0
,N,50597,,,,A,2107.0,CHEMBL624934,1,,BAO_0000218,4043,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,Liver,Rattus norvegicus,Intermediate,,,9919,10116.0
,N,50597,,,,A,2107.0,CHEMBL624935,1,,BAO_0000218,4043,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,Liver,Rattus norvegicus,Intermediate,,,9920,10116.0
,N,50597,,,,A,,CHEMBL624936,1,,BAO_0000218,4043,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,Rattus norvegicus,Intermediate,,,9921,10116.0
,N,50597,,,,A,,CHEMBL624937,1,,BAO_0000218,4043,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,Rattus norvegicus,Intermediate,,,9922,10116.0
,N,50597,,,,A,2106.0,CHEMBL624938,1,,BAO_0000218,4043,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,Spleen,Rattus norvegicus,Intermediate,,,9923,10116.0
,N,50597,,,,A,2106.0,CHEMBL624939,1,,BAO_0000218,4043,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,Spleen,Rattus norvegicus,Intermediate,,,9924,10116.0
,N,50597,,,,A,,CHEMBL624940,1,,BAO_0000218,4043,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,Rattus norvegicus,Intermediate,,,9925,10116.0
,N,50597,,,,A,,CHEMBL874403,1,,BAO_0000218,4043,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,1,,,Rattus norvegicus,Intermediate,,,9926,10116.0
,N,50597,,,,A,,CHEMBL624941,1,,BAO_0000218,1446,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,1,,,Rattus norvegicus,Intermediate,,,9927,10116.0
,N,50597,,,,A,1088.0,CHEMBL624942,1,,BAO_0000218,9971,Dose required to lower urine osmolality to 300 mOsm/kg in rat,1,,Urine,Rattus norvegicus,Intermediate,,,9928,10116.0
,N,50597,,,,A,1088.0,CHEMBL624943,1,,BAO_0000218,9971,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,1,,Urine,Rattus norvegicus,Intermediate,,,9929,10116.0
,N,50597,,,In vivo,A,,CHEMBL624944,1,,BAO_0000218,5765,% Bioavailability after 1 day of the drug administration in rats,1,,,Rattus norvegicus,Intermediate,,,9930,10116.0
,N,50597,,,In vivo,A,,CHEMBL624945,1,,BAO_0000218,5765,% Bioavailability after 4 day of the drug administration in rats,1,,,Rattus norvegicus,Intermediate,,,9931,10116.0
,N,50597,,,In vivo,A,,CHEMBL624946,1,,BAO_0000218,4257,Absolute bioavailability was evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,9932,10116.0
,N,50597,,,,A,,CHEMBL624947,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,1,,,Rattus norvegicus,Intermediate,,,9933,10116.0
,N,50597,,,,A,,CHEMBL624948,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9934,10116.0
,N,50597,,,,A,,CHEMBL624949,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9935,10116.0
,N,50597,,,,A,2113.0,CHEMBL622025,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,1,,Kidney,Rattus norvegicus,Intermediate,,,9936,10116.0
,N,50597,,,,A,2113.0,CHEMBL622026,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,1,,Kidney,Rattus norvegicus,Intermediate,,,9937,10116.0
,N,50597,,,,A,2113.0,CHEMBL622027,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,1,,Kidney,Rattus norvegicus,Intermediate,,,9938,10116.0
,N,50597,,,,A,2113.0,CHEMBL622028,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,1,,Kidney,Rattus norvegicus,Intermediate,,,9939,10116.0
,N,50597,,,,A,2107.0,CHEMBL622029,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,1,,Liver,Rattus norvegicus,Intermediate,,,9940,10116.0
,N,50597,,,,A,2107.0,CHEMBL622208,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,1,,Liver,Rattus norvegicus,Intermediate,,,9941,10116.0
,N,50597,,,,A,2107.0,CHEMBL622209,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,1,,Liver,Rattus norvegicus,Intermediate,,,9942,10116.0
,N,50597,,,,A,2107.0,CHEMBL622210,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,1,,Liver,Rattus norvegicus,Intermediate,,,9943,10116.0
,N,50597,,,,A,,CHEMBL622211,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,1,,,Rattus norvegicus,Intermediate,,,9944,10116.0
,N,50597,,,,A,,CHEMBL622212,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,1,,,Rattus norvegicus,Intermediate,,,9945,10116.0
,N,50597,,,,A,,CHEMBL622213,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9946,10116.0
,N,50597,,,,A,,CHEMBL874404,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9947,10116.0
,N,50597,,,,A,2385.0,CHEMBL620452,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9948,10116.0
,N,50597,,,,A,2385.0,CHEMBL620453,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9949,10116.0
,N,50597,,,,A,2385.0,CHEMBL620454,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9950,10116.0
,N,50597,,,,A,2385.0,CHEMBL624067,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9951,10116.0
,N,50597,,,,A,,CHEMBL624068,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,1,,,Rattus norvegicus,Intermediate,,,9952,10116.0
,N,50597,,,,A,992.0,CHEMBL624069,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,1,,Female gonad,Rattus norvegicus,Intermediate,,,9953,10116.0
,N,50597,,,,A,992.0,CHEMBL624070,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,1,,Female gonad,Rattus norvegicus,Intermediate,,,9954,10116.0
,N,50597,,,,A,992.0,CHEMBL624071,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,1,,Female gonad,Rattus norvegicus,Intermediate,,,9955,10116.0
,N,50597,,,,A,995.0,CHEMBL624072,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,1,,Uterus,Rattus norvegicus,Intermediate,,,9956,10116.0
,N,50597,,,,A,995.0,CHEMBL624073,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,1,,Uterus,Rattus norvegicus,Intermediate,,,9957,10116.0
,N,50597,,,,A,995.0,CHEMBL624788,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,1,,Uterus,Rattus norvegicus,Intermediate,,,9958,10116.0
,N,50597,,,,A,995.0,CHEMBL624789,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,1,,Uterus,Rattus norvegicus,Intermediate,,,9959,10116.0
,N,50597,,,,A,,CHEMBL624790,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,1,,,Rattus norvegicus,Intermediate,,,9960,10116.0
,N,50597,,,,A,,CHEMBL624791,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,1,,,Rattus norvegicus,Intermediate,,,9961,10116.0
,N,50597,,,,A,,CHEMBL624792,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9962,10116.0
,N,50597,,,,A,,CHEMBL624793,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,1,,,Rattus norvegicus,Intermediate,,,9963,10116.0
,N,50597,,,,A,2385.0,CHEMBL877491,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9964,10116.0
,N,50597,,,,A,2385.0,CHEMBL624957,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9965,10116.0
,N,50597,,,,A,2385.0,CHEMBL624958,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9966,10116.0
,N,50597,,,,A,2385.0,CHEMBL624959,1,,BAO_0000218,13091,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,9967,10116.0
,N,50597,,,,A,,CHEMBL624960,1,,BAO_0000218,11977,Dissociation constant was determined,1,,,Rattus norvegicus,Intermediate,,,9968,10116.0
,N,50597,,,,A,,CHEMBL624961,1,,BAO_0000218,14941,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",1,,,Rattus norvegicus,Intermediate,,,9969,10116.0
,N,50597,,,,A,,CHEMBL624962,1,,BAO_0000218,15078,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,9970,10116.0
,N,50597,,,,A,,CHEMBL624963,1,,BAO_0000218,15078,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,9971,10116.0
,N,50597,,,,A,,CHEMBL624964,1,,BAO_0000218,4755,Observed rate constant in 80% rat plasma at 37 degree Centigrade,1,,,Rattus norvegicus,Intermediate,,,9972,10116.0
,N,50597,,,,A,,CHEMBL624965,1,,BAO_0000218,589,LogP value was evaluated in the in situ rat gut perfusion assay,1,,,Rattus norvegicus,Intermediate,,,9973,10116.0
,N,50597,,,In vivo,A,,CHEMBL624966,1,,BAO_0000218,17582,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,,Rattus norvegicus,Intermediate,,,9974,10116.0
,N,50597,,,In vivo,A,,CHEMBL624967,1,,BAO_0000218,5031,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,1,,,Rattus norvegicus,Intermediate,,,9975,10116.0
,N,50597,,,In vivo,A,,CHEMBL624968,1,,BAO_0000218,17764,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,1,,,Rattus norvegicus,Intermediate,,,9976,10116.0
,N,50597,,,,A,,CHEMBL624969,1,,BAO_0000218,17720,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,,Rattus norvegicus,Intermediate,,,9977,10116.0
,N,50597,,,,F,,CHEMBL624970,1,,BAO_0000218,2862,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,1,,,Rattus norvegicus,Expert,,,9978,10116.0
,N,50597,,,,A,,CHEMBL624971,1,,BAO_0000218,16423,Half-life was evaluated after 10 uM/kg of intra arterial administration,1,,,Rattus norvegicus,Intermediate,,,9979,10116.0
,N,50597,,,In vivo,A,,CHEMBL624972,1,,BAO_0000218,16423,Half-life was evaluated after 20 uM/kg of peroral administration,1,,,Rattus norvegicus,Intermediate,,,9980,10116.0
,N,50597,,,In vivo,A,,CHEMBL624973,1,,BAO_0000218,6005,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9981,10116.0
,N,50597,,,,A,1969.0,CHEMBL624974,1,,BAO_0000218,2938,Half-life was evaluated in plasma of rat,1,,Plasma,Rattus norvegicus,Intermediate,,,9982,10116.0
,N,50597,,,In vivo,A,,CHEMBL624975,1,,BAO_0000218,6410,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9983,10116.0
,N,50597,,,In vivo,A,,CHEMBL877492,1,,BAO_0000218,6410,Half-life was evaluated in rats at an oral dose of 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9984,10116.0
,N,50597,,,In vivo,A,,CHEMBL624976,1,,BAO_0000218,6062,Half-life was measured in rat after an iv dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9985,10116.0
,N,50597,,,In vivo,A,,CHEMBL624977,1,,BAO_0000218,6571,Half-life period of compound in rats after peroral administration,1,,,Rattus norvegicus,Intermediate,,,9986,10116.0
,N,50597,,,,A,1969.0,CHEMBL626848,1,,BAO_0000218,3136,Half-life period of compound was measured in rat plasma.,1,,Plasma,Rattus norvegicus,Intermediate,,,9987,10116.0
,N,50597,,,,A,1969.0,CHEMBL626849,1,,BAO_0000218,3136,Half-life period of compound was measured in rat plasma; ND is not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,9988,10116.0
,N,50597,,,,A,1969.0,CHEMBL626850,1,,BAO_0000218,3136,Half-life period of compound was measured in rat plasma; not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,9989,10116.0
,N,50597,,,In vivo,A,,CHEMBL626851,1,,BAO_0000218,4521,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,,Rattus norvegicus,Intermediate,,,9990,10116.0
,N,50597,,,In vivo,A,,CHEMBL626852,1,,BAO_0000218,5871,Half-life period in rat by iv administration,1,,,Rattus norvegicus,Intermediate,,,9991,10116.0
,N,50597,,,In vivo,A,,CHEMBL626853,1,,BAO_0000218,6077,Half-life period in rats following intravenous administration at 2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,9992,10116.0
,N,50597,,,In vivo,A,,CHEMBL626854,1,,BAO_0000218,6679,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,,Rattus norvegicus,Intermediate,,,9993,10116.0
,N,50597,,,,A,,CHEMBL627486,1,,BAO_0000218,5144,Half-life period was determined for the compound in rat,1,,,Rattus norvegicus,Intermediate,,,9994,10116.0
,N,50597,,,In vivo,A,,CHEMBL627487,1,,BAO_0000218,4498,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",1,,,Rattus norvegicus,Intermediate,,,9995,10116.0
,N,50597,,,In vivo,A,,CHEMBL627488,1,,BAO_0000218,4498,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",1,,,Rattus norvegicus,Intermediate,,,9996,10116.0
,N,50597,,,In vivo,A,,CHEMBL627489,1,,BAO_0000218,1908,Half-life value after IV dose at a dose of 5 mg/kg in rats.,1,,,Rattus norvegicus,Intermediate,,,9997,10116.0
,N,50597,,,In vivo,A,,CHEMBL627490,1,,BAO_0000218,6211,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,9998,10116.0
,N,50597,,,In vivo,A,,CHEMBL873829,1,,BAO_0000218,5529,Half-life was determined in rat after intravenous administration (0.5 mg/kg),1,,,Rattus norvegicus,Intermediate,,,9999,10116.0
,N,50597,,,In vivo,A,,CHEMBL627655,1,,BAO_0000218,6444,Half-life was determined in rat at a dose of 1 mpk i.v.,1,,,Rattus norvegicus,Intermediate,,,10000,10116.0
,N,50597,,,In vivo,A,,CHEMBL625994,1,,BAO_0000218,6444,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,1,,,Rattus norvegicus,Intermediate,,,10001,10116.0
,N,50597,,,In vivo,A,,CHEMBL625995,1,,BAO_0000218,6444,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,1,,,Rattus norvegicus,Intermediate,,,10002,10116.0
,N,50597,,,,A,,CHEMBL625996,1,,BAO_0000218,5207,Half-life in rat,1,,,Rattus norvegicus,Intermediate,,,10003,10116.0
,N,50597,,,In vitro,A,1969.0,CHEMBL625850,1,,BAO_0000218,530,In vitro half life in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,10004,10116.0
,N,50597,,,In vitro,A,1969.0,CHEMBL625851,1,,BAO_0000218,1116,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",1,,Plasma,Rattus norvegicus,Intermediate,,,10005,10116.0
,N,50597,,,In vitro,A,,CHEMBL625852,1,,BAO_0000218,3219,In vitro half life in rat,1,,,Rattus norvegicus,Intermediate,,,10006,10116.0
,N,50597,,,In vivo,A,,CHEMBL625853,1,,BAO_0000218,6109,In vivo half life period after intravenous administration in rat,1,,,Rattus norvegicus,Intermediate,,,10007,10116.0
,N,50597,,,In vivo,A,,CHEMBL625854,1,,BAO_0000218,17582,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,1,,,Rattus norvegicus,Intermediate,,,10008,10116.0
,N,50597,,,In vivo,A,,CHEMBL874450,1,,BAO_0000218,17582,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,,,Rattus norvegicus,Intermediate,,,10009,10116.0
,N,50597,,,In vivo,A,,CHEMBL625855,1,,BAO_0000218,5974,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10010,10116.0
,N,50597,,,In vivo,A,,CHEMBL625856,1,,BAO_0000218,5974,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10011,10116.0
,N,50597,,,In vivo,A,,CHEMBL625857,1,,BAO_0000218,5974,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10012,10116.0
,N,50597,,,In vivo,A,,CHEMBL873831,1,,BAO_0000218,5974,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10013,10116.0
,N,50597,,,In vivo,A,,CHEMBL625858,1,,BAO_0000218,17853,Longer half-life in rat (i.v.) at 0.5 mpk,1,,,Rattus norvegicus,Intermediate,,,10014,10116.0
,N,50597,,,In vivo,A,,CHEMBL625859,1,,BAO_0000218,17853,Longer half-life in rat (p.o.) at 2.0 mpk,1,,,Rattus norvegicus,Intermediate,,,10015,10116.0
,N,50597,,,,A,,CHEMBL625860,1,,BAO_0000218,3457,Pharmacokinetic property (half life) in rat,1,,,Rattus norvegicus,Intermediate,,,10016,10116.0
,N,50597,,,In vivo,A,,CHEMBL625861,1,,BAO_0000218,2792,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,1,,,Rattus norvegicus,Intermediate,,,10017,10116.0
,N,50597,,,In vivo,A,,CHEMBL625862,1,,BAO_0000218,2792,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,1,,,Rattus norvegicus,Intermediate,,,10018,10116.0
,N,50597,,,In vivo,A,,CHEMBL625863,1,,BAO_0000218,2792,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,1,,,Rattus norvegicus,Intermediate,,,10019,10116.0
,N,50597,,,In vivo,A,,CHEMBL625864,1,,BAO_0000218,2792,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,1,,,Rattus norvegicus,Intermediate,,,10020,10116.0
,N,50597,,,In vivo,A,,CHEMBL625865,1,,BAO_0000218,5739,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,1,,,Rattus norvegicus,Intermediate,,,10021,10116.0
,N,50597,,,In vivo,A,,CHEMBL625866,1,,BAO_0000218,15765,Pharmacokinetic half time was determined intravenously in rats.,1,,,Rattus norvegicus,Intermediate,,,10022,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625867,1,,BAO_0000218,6567,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,1,,Plasma,Rattus norvegicus,Intermediate,,,10023,10116.0
,N,50597,,,,A,1969.0,CHEMBL625868,1,,BAO_0000218,2448,Plasma half life of hydrolysis of the compound,1,,Plasma,Rattus norvegicus,Intermediate,,,10024,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625869,1,,BAO_0000218,5423,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,10025,10116.0
,N,50597,,,,A,1969.0,CHEMBL874451,1,,BAO_0000218,4853,Plasma half life period was calculated in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,10026,10116.0
,N,50597,,,,A,1969.0,CHEMBL625870,1,,BAO_0000218,4514,Plasma half-life in Sprague-Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,10027,10116.0
,N,50597,,,,A,1969.0,CHEMBL625871,1,,BAO_0000218,4514,Plasma half-life in Sprague-Dawley rats; Not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,10028,10116.0
,N,50597,,,,A,1969.0,CHEMBL625872,1,,BAO_0000218,1500,Plasma half-life in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,10029,10116.0
,N,50597,,,,A,1969.0,CHEMBL625873,1,,BAO_0000218,1500,Plasma half-life in rats; <MQL,1,,Plasma,Rattus norvegicus,Intermediate,,,10030,10116.0
,N,50597,,,,A,1969.0,CHEMBL625874,1,,BAO_0000218,5334,Plasma half-life period (0-8 h) was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,10031,10116.0
,N,50597,,,,A,1969.0,CHEMBL625875,1,,BAO_0000218,5334,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,10032,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625876,1,,BAO_0000218,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,10033,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL631258,1,,BAO_0000218,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,1,,Plasma,Rattus norvegicus,Intermediate,,,10034,10116.0
,N,50597,,,,A,1969.0,CHEMBL631259,1,,BAO_0000218,4956,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,1,,Plasma,Rattus norvegicus,Intermediate,,,10035,10116.0
,N,50597,,,,A,1969.0,CHEMBL631260,1,,BAO_0000218,4956,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,10036,10116.0
,N,50597,,,,A,178.0,CHEMBL631261,1,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",1,,Blood,Rattus norvegicus,Intermediate,,,10037,10116.0
,N,50597,,,,A,178.0,CHEMBL631262,1,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",1,,Blood,Rattus norvegicus,Intermediate,,,10038,10116.0
,N,50597,,,,A,178.0,CHEMBL631263,1,,BAO_0000218,7768,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",1,,Blood,Rattus norvegicus,Intermediate,,,10039,10116.0
,N,50597,,,,A,,CHEMBL631264,1,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",1,,,Rattus norvegicus,Intermediate,,,10040,10116.0
,N,50597,,,,A,,CHEMBL631265,1,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",1,,,Rattus norvegicus,Intermediate,,,10041,10116.0
,N,50597,,,,A,,CHEMBL631266,1,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",1,,,Rattus norvegicus,Intermediate,,,10042,10116.0
,N,50597,,,,A,,CHEMBL631267,1,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",1,,,Rattus norvegicus,Intermediate,,,10043,10116.0
,N,50597,,,,A,,CHEMBL631268,1,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",1,,,Rattus norvegicus,Intermediate,,,10044,10116.0
,N,50597,,,,A,,CHEMBL631269,1,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",1,,,Rattus norvegicus,Intermediate,,,10045,10116.0
,N,50597,,,,A,,CHEMBL631270,1,,BAO_0000218,7768,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",1,,,Rattus norvegicus,Intermediate,,,10046,10116.0
,N,50597,,,,A,948.0,CHEMBL631271,1,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",1,,Heart,Rattus norvegicus,Intermediate,,,10047,10116.0
,N,50597,,,,A,948.0,CHEMBL631272,1,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",1,,Heart,Rattus norvegicus,Intermediate,,,10048,10116.0
,N,50597,,,,A,948.0,CHEMBL631273,1,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",1,,Heart,Rattus norvegicus,Intermediate,,,10049,10116.0
,N,50597,,,,A,948.0,CHEMBL631274,1,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",1,,Heart,Rattus norvegicus,Intermediate,,,10050,10116.0
,N,50597,,,,A,948.0,CHEMBL631275,1,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",1,,Heart,Rattus norvegicus,Intermediate,,,10051,10116.0
,N,50597,,,,A,948.0,CHEMBL626984,1,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",1,,Heart,Rattus norvegicus,Intermediate,,,10052,10116.0
,N,50597,,,,A,948.0,CHEMBL626985,1,,BAO_0000218,7768,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",1,,Heart,Rattus norvegicus,Intermediate,,,10053,10116.0
,N,50597,,,,A,2107.0,CHEMBL626986,1,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",1,,Liver,Rattus norvegicus,Intermediate,,,10054,10116.0
,N,50597,,,,A,2107.0,CHEMBL626987,1,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",1,,Liver,Rattus norvegicus,Intermediate,,,10055,10116.0
,N,50597,,,,A,2107.0,CHEMBL626988,1,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",1,,Liver,Rattus norvegicus,Intermediate,,,10056,10116.0
,N,50597,,,,A,2107.0,CHEMBL626989,1,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",1,,Liver,Rattus norvegicus,Intermediate,,,10057,10116.0
,N,50597,,,,A,2107.0,CHEMBL626990,1,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",1,,Liver,Rattus norvegicus,Intermediate,,,10058,10116.0
,N,50597,,,,A,2107.0,CHEMBL626991,1,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",1,,Liver,Rattus norvegicus,Intermediate,,,10059,10116.0
,N,50597,,,,A,2107.0,CHEMBL626992,1,,BAO_0000218,7768,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",1,,Liver,Rattus norvegicus,Intermediate,,,10060,10116.0
,N,50597,,,,A,2048.0,CHEMBL626993,1,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",1,,Lung,Rattus norvegicus,Intermediate,,,10061,10116.0
,N,50597,,,,A,2048.0,CHEMBL874593,1,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",1,,Lung,Rattus norvegicus,Intermediate,,,10062,10116.0
,N,50597,,,,A,2048.0,CHEMBL626994,1,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",1,,Lung,Rattus norvegicus,Intermediate,,,10063,10116.0
,N,50597,,,,A,2048.0,CHEMBL626995,1,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",1,,Lung,Rattus norvegicus,Intermediate,,,10064,10116.0
,N,50597,,,,A,2048.0,CHEMBL626190,1,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",1,,Lung,Rattus norvegicus,Intermediate,,,10065,10116.0
,N,50597,,,,A,2048.0,CHEMBL626191,1,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",1,,Lung,Rattus norvegicus,Intermediate,,,10066,10116.0
,N,50597,,,,A,2048.0,CHEMBL626364,1,,BAO_0000218,7768,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",1,,Lung,Rattus norvegicus,Intermediate,,,10067,10116.0
,N,50597,,,,A,2046.0,CHEMBL626365,1,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,10068,10116.0
,N,50597,,,,A,2046.0,CHEMBL626366,1,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,10069,10116.0
,N,50597,,,,A,2046.0,CHEMBL626367,1,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,10070,10116.0
,N,50597,,,,A,2046.0,CHEMBL626368,1,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,10071,10116.0
,N,50597,,,,A,2046.0,CHEMBL626369,1,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,10072,10116.0
,N,50597,,,,A,2046.0,CHEMBL626370,1,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,10073,10116.0
,N,50597,,,In vivo,A,,CHEMBL626371,1,,BAO_0000218,4498,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",1,,,Rattus norvegicus,Intermediate,,,10074,10116.0
,N,50597,,,In vivo,A,,CHEMBL626372,1,,BAO_0000218,4498,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",1,,,Rattus norvegicus,Intermediate,,,10075,10116.0
,N,50597,,,In vivo,A,,CHEMBL626373,1,,BAO_0000218,3603,Bioavailability after a dose of 10 mg/kg p.o.,1,,,Rattus norvegicus,Intermediate,,,10076,10116.0
,N,50597,,,In vivo,A,,CHEMBL626374,1,,BAO_0000218,6215,Bioavailability after peroral administration (10 mg/kg) was determined in rat,1,,,Rattus norvegicus,Intermediate,,,10077,10116.0
,N,50597,,,In vivo,A,,CHEMBL626375,1,,BAO_0000218,5710,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,1,,,Rattus norvegicus,Intermediate,,,10078,10116.0
,N,50597,,,In vivo,A,,CHEMBL626376,1,,BAO_0000218,5710,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10079,10116.0
,N,50597,,,In vivo,A,,CHEMBL626377,1,,BAO_0000218,5676,Bioavailability in rat po was determined,1,,,Rattus norvegicus,Intermediate,,,10080,10116.0
,N,50597,,,In vivo,A,,CHEMBL626378,1,,BAO_0000218,17667,Bioavailability of compound at 10 mg/kg in rat after oral administration,1,,,Rattus norvegicus,Intermediate,,,10081,10116.0
,N,50597,,,In vivo,A,,CHEMBL626379,1,,BAO_0000218,17667,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,1,,,Rattus norvegicus,Intermediate,,,10082,10116.0
,N,50597,,,In vivo,A,,CHEMBL626380,1,,BAO_0000218,6848,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10083,10116.0
,N,50597,,,In vivo,A,,CHEMBL626381,1,,BAO_0000218,6848,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10084,10116.0
,N,50597,,,In vivo,A,,CHEMBL626382,1,,BAO_0000218,17267,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10085,10116.0
,N,50597,,,In vivo,A,,CHEMBL626383,1,,BAO_0000218,6362,Bioavailability in rat (Sprague-Dawley) (female),1,,,Rattus norvegicus,Intermediate,,,10086,10116.0
,N,50597,,,In vivo,A,,CHEMBL874652,1,,BAO_0000218,17671,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10087,10116.0
,N,50597,,,In vivo,A,,CHEMBL626384,1,,BAO_0000218,17671,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10088,10116.0
,N,50597,,,In vivo,A,,CHEMBL626385,1,,BAO_0000218,4333,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,1,,,Rattus norvegicus,Intermediate,,,10089,10116.0
,N,50597,,,In vivo,A,,CHEMBL626386,1,,BAO_0000218,6077,Bioavailability in rat at an oral dose of 2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10090,10116.0
,N,50597,,,In vivo,A,,CHEMBL626387,1,,BAO_0000218,3278,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10091,10116.0
,N,50597,,,In vivo,A,,CHEMBL626388,1,,BAO_0000218,5964,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10092,10116.0
,N,50597,,,In vivo,A,,CHEMBL626389,1,,BAO_0000218,4884,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10093,10116.0
,N,50597,,,In vivo,A,,CHEMBL626390,1,,BAO_0000218,4905,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10094,10116.0
,N,50597,,,In vivo,A,,CHEMBL626391,1,,BAO_0000218,4884,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,1,,,Rattus norvegicus,Intermediate,,,10095,10116.0
,N,50597,,,In vivo,A,,CHEMBL626392,1,,BAO_0000218,6850,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10096,10116.0
,N,50597,,,In vivo,A,,CHEMBL626393,1,,BAO_0000218,2864,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10097,10116.0
,N,50597,,,In vivo,A,,CHEMBL623026,1,,BAO_0000218,5780,Bioavailability was determined in rat,1,,,Rattus norvegicus,Intermediate,,,10098,10116.0
,N,50597,,,In vivo,A,,CHEMBL623027,1,,BAO_0000218,1465,Bioavailability,1,,,Rattus norvegicus,Intermediate,,,10099,10116.0
,N,50597,,,In vivo,A,,CHEMBL623028,1,,BAO_0000218,5199,Bioavailability,1,,,Rattus norvegicus,Intermediate,,,10100,10116.0
,N,50597,,,In vivo,A,,CHEMBL623029,1,,BAO_0000218,5765,Bioavailability in rat after 1 day dosing,1,,,Rattus norvegicus,Intermediate,,,10101,10116.0
,N,50597,,,In vivo,A,,CHEMBL623030,1,,BAO_0000218,5765,Bioavailability in rat after 4 day dosing,1,,,Rattus norvegicus,Intermediate,,,10102,10116.0
,N,50597,,,In vivo,A,,CHEMBL623031,1,,BAO_0000218,6518,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,1,,,Rattus norvegicus,Intermediate,,,10103,10116.0
,N,50597,,,In vivo,A,,CHEMBL623032,1,,BAO_0000218,6518,Bioavailability after IV dosing at 1 mg/kg in rat; no data,1,,,Rattus norvegicus,Intermediate,,,10104,10116.0
,N,50597,,,In vivo,A,,CHEMBL623033,1,,BAO_0000218,6518,Bioavailability after oral administration at a dose of 2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10105,10116.0
,N,50597,,,In vivo,A,,CHEMBL623034,1,,BAO_0000218,6518,Bioavailability after oral administration at a dose of 4 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10106,10116.0
,N,50597,,,In vivo,A,,CHEMBL623035,1,,BAO_0000218,2083,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,1,,,Rattus norvegicus,Intermediate,,,10107,10116.0
,N,50597,,,In vivo,A,,CHEMBL623036,1,,BAO_0000218,17260,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,1,,,Rattus norvegicus,Intermediate,,,10108,10116.0
,N,50597,,,In vivo,A,,CHEMBL623037,1,,BAO_0000218,4956,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10109,10116.0
,N,50597,,,In vivo,A,,CHEMBL623038,1,,BAO_0000218,4368,Bioavailability by intravenous administration of 3.4 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10110,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL874385,1,,BAO_0000218,17752,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,10111,10116.0
,N,50597,,,In vivo,A,,CHEMBL623039,1,,BAO_0000218,1446,Bioavailability in rat (Fisher) (fasted),1,,,Rattus norvegicus,Intermediate,,,10112,10116.0
,U,22224,,,In vivo,A,,CHEMBL623040,0,,BAO_0000218,2891,Bioavailability in monkey after po administration of 10 mg/kg dose,1,,,Primates,Intermediate,,,10113,9443.0
,U,22224,,,In vivo,A,,CHEMBL623041,0,,BAO_0000218,2891,Oral bioavailability in monkey (dose 10 mg/kg),1,,,Primates,Intermediate,,,10114,9443.0
,N,50597,,,In vivo,A,,CHEMBL623741,1,,BAO_0000218,6672,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10115,10116.0
,N,50597,,,In vivo,A,,CHEMBL623742,1,,BAO_0000218,6673,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10116,10116.0
,N,50597,,,In vivo,A,,CHEMBL623743,1,,BAO_0000218,17655,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10117,10116.0
,N,50597,,,In vivo,A,,CHEMBL623744,1,,BAO_0000218,17796,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10118,10116.0
,N,50597,,,In vivo,A,,CHEMBL623745,1,,BAO_0000218,17853,Bioavailability in rat (dose 2.0 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10119,10116.0
,N,50597,,,In vivo,A,,CHEMBL623746,1,,BAO_0000218,4521,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10120,10116.0
,N,50597,,,In vivo,A,,CHEMBL623747,1,,BAO_0000218,4940,Oral bioavailability in rat (dose 5 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10121,10116.0
,U,22224,,,In vivo,A,,CHEMBL623748,0,,BAO_0000218,2891,Bioavailability in rat after po administration of 30 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,10122,10116.0
,U,22224,,,In vivo,A,,CHEMBL623916,0,,BAO_0000218,2891,Bioavailability in rat after po administration of 30 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,10123,10116.0
,N,50597,,,In vivo,A,,CHEMBL623917,1,,BAO_0000218,4521,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,1,,,Rattus norvegicus,Intermediate,,,10124,10116.0
,N,50597,,,In vivo,A,,CHEMBL623918,1,,BAO_0000218,17686,Bioavailability in rat (dose 2 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10125,10116.0
,N,50597,,,In vivo,A,,CHEMBL874386,1,,BAO_0000218,17796,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10126,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623919,1,,BAO_0000218,17796,Bioavailability in rat; Only traces detected in rat plasma,1,,Plasma,Rattus norvegicus,Intermediate,,,10127,10116.0
,N,50597,,,In vivo,A,,CHEMBL623920,1,,BAO_0000218,5064,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10128,10116.0
,N,50597,,,In vivo,A,,CHEMBL623148,1,,BAO_0000218,5147,Bioavailability upon oral administration of compound,1,,,Rattus norvegicus,Intermediate,,,10129,10116.0
,N,50597,,,In vivo,A,,CHEMBL623149,1,,BAO_0000218,1916,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10130,10116.0
,N,50597,,,In vivo,A,,CHEMBL623150,1,,BAO_0000218,6049,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10131,10116.0
,N,50597,,,In vivo,A,,CHEMBL623151,1,,BAO_0000218,1445,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",1,,,Rattus norvegicus,Intermediate,,,10132,10116.0
,N,50597,,,In vivo,A,,CHEMBL623152,1,,BAO_0000218,1445,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",1,,,Rattus norvegicus,Intermediate,,,10133,10116.0
,N,50597,,,,F,,CHEMBL623153,1,,BAO_0000218,2862,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,1,,,Rattus norvegicus,Expert,,,10134,10116.0
,N,50597,,,,F,,CHEMBL623154,1,,BAO_0000218,2862,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,1,,,Rattus norvegicus,Expert,,,10135,10116.0
,N,50597,,,,A,,CHEMBL623155,1,,BAO_0000218,4194,In vitro and metabolic stability was determined,1,,,Rattus norvegicus,Intermediate,,,10136,10116.0
,N,50597,,,,A,,CHEMBL623156,1,,BAO_0000218,4194,In vitro metabolic stability in rat hepatocytes,1,,,Rattus norvegicus,Intermediate,,,10137,10116.0
,N,50597,,,,A,,CHEMBL623157,1,,BAO_0000218,5486,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,1,,,Rattus norvegicus,Intermediate,,,10138,10116.0
,N,50597,401.0,,In vitro,A,2107.0,CHEMBL623158,1,,BAO_0000218,17582,Metabolic rate for compound was observed in rat hepatocytes,1,,Liver,Rattus norvegicus,Intermediate,Hepatocyte,,10139,10116.0
,N,50597,,,,A,,CHEMBL623159,1,,BAO_0000218,5600,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,1,,,Rattus norvegicus,Intermediate,,,10140,10116.0
,N,50597,,,,A,,CHEMBL874390,1,,BAO_0000218,14294,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),1,,,Rattus norvegicus,Intermediate,,,10141,10116.0
,N,50597,,,,A,,CHEMBL623160,1,,BAO_0000218,14294,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),1,,,Rattus norvegicus,Intermediate,,,10142,10116.0
,N,50597,,,,A,,CHEMBL623161,1,,BAO_0000218,14294,Metabolism of compound in rat S9 microsomes; Trace,1,,,Rattus norvegicus,Intermediate,,,10143,10116.0
,N,50597,,,,A,,CHEMBL623162,1,,BAO_0000218,17847,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,1,,,Rattus norvegicus,Intermediate,,,10144,10116.0
,N,50597,,,,A,,CHEMBL623163,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,1,,,Rattus norvegicus,Intermediate,,,10145,10116.0
,N,50597,,,,A,,CHEMBL623164,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,1,,,Rattus norvegicus,Intermediate,,,10146,10116.0
,N,50597,,,,A,,CHEMBL623165,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,1,,,Rattus norvegicus,Intermediate,,,10147,10116.0
,N,50597,,,,A,,CHEMBL623166,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,1,,,Rattus norvegicus,Intermediate,,,10148,10116.0
,N,50597,,,,A,,CHEMBL624983,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,1,,,Rattus norvegicus,Intermediate,,,10149,10116.0
,N,50597,,,,A,,CHEMBL624984,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,1,,,Rattus norvegicus,Intermediate,,,10150,10116.0
,N,50597,,,,A,,CHEMBL624985,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,1,,,Rattus norvegicus,Intermediate,,,10151,10116.0
,N,50597,,,,A,,CHEMBL622970,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,1,,,Rattus norvegicus,Intermediate,,,10152,10116.0
,N,50597,,,,A,,CHEMBL622971,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10153,10116.0
,N,50597,,,,A,,CHEMBL622972,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,1,,,Rattus norvegicus,Intermediate,,,10154,10116.0
,N,50597,,,,A,,CHEMBL622973,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10155,10116.0
,N,50597,,,,A,,CHEMBL622974,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,1,,,Rattus norvegicus,Intermediate,,,10156,10116.0
,N,50597,,,,A,,CHEMBL622975,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10157,10116.0
,N,50597,,,,A,,CHEMBL622976,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,1,,,Rattus norvegicus,Intermediate,,,10158,10116.0
,N,50597,,,,A,,CHEMBL622977,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,1,,,Rattus norvegicus,Intermediate,,,10159,10116.0
,N,50597,,,,A,,CHEMBL624351,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,1,,,Rattus norvegicus,Intermediate,,,10160,10116.0
,N,50597,,,,A,,CHEMBL624352,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,1,,,Rattus norvegicus,Intermediate,,,10161,10116.0
,N,50597,,,,A,,CHEMBL624353,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,1,,,Rattus norvegicus,Intermediate,,,10162,10116.0
,N,50597,,,,A,,CHEMBL622397,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,1,,,Rattus norvegicus,Intermediate,,,10163,10116.0
,N,50597,,,,A,,CHEMBL622398,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,1,,,Rattus norvegicus,Intermediate,,,10164,10116.0
,N,50597,,,,A,,CHEMBL622399,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,1,,,Rattus norvegicus,Intermediate,,,10165,10116.0
,N,50597,,,,A,,CHEMBL622400,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,1,,,Rattus norvegicus,Intermediate,,,10166,10116.0
,N,50597,,,,A,,CHEMBL628428,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,1,,,Rattus norvegicus,Intermediate,,,10167,10116.0
,N,50597,,,,A,,CHEMBL628590,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,1,,,Rattus norvegicus,Intermediate,,,10168,10116.0
,N,50597,,,,A,,CHEMBL628591,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10169,10116.0
,N,50597,,,,A,,CHEMBL628592,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,1,,,Rattus norvegicus,Intermediate,,,10170,10116.0
,N,50597,,,,A,,CHEMBL628593,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10171,10116.0
,N,50597,,,,A,,CHEMBL875333,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,1,,,Rattus norvegicus,Intermediate,,,10172,10116.0
,N,50597,,,,A,,CHEMBL628594,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10173,10116.0
,N,50597,,,,A,1969.0,CHEMBL628595,1,,BAO_0000218,4969,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,1,,Plasma,Rattus norvegicus,Intermediate,,,10174,10116.0
,N,50597,,,,A,1969.0,CHEMBL628596,1,,BAO_0000218,6737,Stability in rat plasma was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,10175,10116.0
,N,50597,,,,A,1969.0,CHEMBL628597,1,,BAO_0000218,6737,Stability in rat plasma was determined; ND= no data,1,,Plasma,Rattus norvegicus,Intermediate,,,10176,10116.0
,N,50597,,,,A,1969.0,CHEMBL628598,1,,BAO_0000218,5089,Tested for plasma half life period in rat (0-8 hr),1,,Plasma,Rattus norvegicus,Intermediate,,,10177,10116.0
,N,50597,,,,A,1969.0,CHEMBL628599,1,,BAO_0000218,5089,Tested for plasma half life period in rat (0-8 hr); Not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,10178,10116.0
,N,50597,,,In vivo,A,,CHEMBL628600,1,,BAO_0000218,1466,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,1,,,Rattus norvegicus,Intermediate,,,10179,10116.0
,N,50597,,,In vivo,A,,CHEMBL628601,1,,BAO_0000218,1466,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,1,,,Rattus norvegicus,Intermediate,,,10180,10116.0
,N,50597,,,,A,,CHEMBL628602,1,,BAO_0000218,4950,Tested for the half life in rat,1,,,Rattus norvegicus,Intermediate,,,10181,10116.0
,N,50597,,,In vitro,A,,CHEMBL628603,1,,BAO_0000218,2412,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,1,,,Rattus norvegicus,Intermediate,,,10182,10116.0
,N,50597,,,In vitro,A,,CHEMBL628604,1,,BAO_0000218,2412,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,1,,,Rattus norvegicus,Intermediate,,,10183,10116.0
,N,50597,,,In vitro,A,,CHEMBL628605,1,,BAO_0000218,2412,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,1,,,Rattus norvegicus,Intermediate,,,10184,10116.0
,N,50597,,,In vitro,A,,CHEMBL628606,1,,BAO_0000218,2412,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,1,,,Rattus norvegicus,Intermediate,,,10185,10116.0
,N,50597,,,In vitro,A,,CHEMBL628607,1,,BAO_0000218,2412,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,1,,,Rattus norvegicus,Intermediate,,,10186,10116.0
,N,50597,,,,A,,CHEMBL628608,1,,BAO_0000218,15022,The biological half life the compound was measured at the dose of 100 umol/kg,1,,,Rattus norvegicus,Intermediate,,,10187,10116.0
,N,50597,,,,A,,CHEMBL628609,1,,BAO_0000218,15022,The biological half life the compound was measured at the dose of 30 umol/kg,1,,,Rattus norvegicus,Intermediate,,,10188,10116.0
,N,50597,,,,A,1969.0,CHEMBL628610,1,,BAO_0000218,406,The compound was evaluated for plasma half life period in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,10189,10116.0
,N,50597,,,In vivo,A,,CHEMBL873819,1,,BAO_0000218,15078,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,10190,10116.0
,N,50597,,,In vivo,A,,CHEMBL628611,1,,BAO_0000218,15078,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,10191,10116.0
,N,50597,,,In vivo,A,,CHEMBL628612,1,,BAO_0000218,5247,The pharmacokinetic parameter half-life period in vivo in rats,1,,,Rattus norvegicus,Intermediate,,,10192,10116.0
,N,50597,,,In vivo,A,,CHEMBL628613,1,,BAO_0000218,5041,"The pharmacokinetic property, Half-life was determined",1,,,Rattus norvegicus,Intermediate,,,10193,10116.0
,N,50597,,,In vivo,A,,CHEMBL628614,1,,BAO_0000218,5041,"The pharmacokinetic property, Half-life in rat in vivo",1,,,Rattus norvegicus,Intermediate,,,10194,10116.0
,N,50597,,,In vivo,A,,CHEMBL628615,1,,BAO_0000218,5041,"The pharmacokinetic property, Half-life was determined; ND denotes no data",1,,,Rattus norvegicus,Intermediate,,,10195,10116.0
,N,50597,,,In vivo,A,,CHEMBL628616,1,,BAO_0000218,5041,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",1,,,Rattus norvegicus,Intermediate,,,10196,10116.0
,N,50597,,,,A,1969.0,CHEMBL627924,1,,BAO_0000218,3918,The plasma half life period in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,10197,10116.0
,N,50597,,,,A,2107.0,CHEMBL627925,1,,BAO_0000218,2906,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,1,,Liver,Rattus norvegicus,Intermediate,,,10198,10116.0
,N,50597,,,In vivo,A,,CHEMBL627926,1,,BAO_0000218,6467,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,1,,,Rattus norvegicus,Intermediate,,,10199,10116.0
,N,50597,,,,A,,CHEMBL627927,1,,BAO_0000218,5510,t1/2 (apparent elimination)of the compound was determined,1,,,Rattus norvegicus,Intermediate,,,10200,10116.0
,N,50597,,,,A,,CHEMBL627928,1,,BAO_0000218,3788,t1/2 value in rat,1,,,Rattus norvegicus,Intermediate,,,10201,10116.0
,N,50597,,,,A,,CHEMBL627539,1,,BAO_0000218,17796,Half life in rat,1,,,Rattus norvegicus,Intermediate,,,10202,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL876790,1,,BAO_0000218,12873,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",1,,Plasma,Rattus norvegicus,Intermediate,,,10203,10116.0
,N,50597,,,In vivo,A,,CHEMBL858186,1,,BAO_0000218,5983,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,1,,,Rattus norvegicus,Intermediate,,,10204,10116.0
,N,50597,,,,A,,CHEMBL627540,1,,BAO_0000218,15765,Half-life period in fasted rats,1,,,Rattus norvegicus,Intermediate,,,10205,10116.0
,N,50597,,,In vivo,A,,CHEMBL627541,1,,BAO_0000218,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,1,,,Rattus norvegicus,Intermediate,,,10206,10116.0
,N,50597,,,In vivo,A,,CHEMBL627715,1,,BAO_0000218,2661,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,1,,,Rattus norvegicus,Intermediate,,,10207,10116.0
,N,50597,,,In vivo,A,,CHEMBL627716,1,,BAO_0000218,429,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10208,10116.0
,N,50597,,,,A,,CHEMBL627717,1,,BAO_0000218,17655,Maximum time required to achieve Cmax was determined in rat,1,,,Rattus norvegicus,Intermediate,,,10209,10116.0
,N,50597,,,In vivo,A,,CHEMBL627718,1,,BAO_0000218,17717,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,,Rattus norvegicus,Intermediate,,,10210,10116.0
,N,50597,,,In vivo,A,,CHEMBL627719,1,,BAO_0000218,17717,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,1,,,Rattus norvegicus,Intermediate,,,10211,10116.0
,N,50597,,,In vivo,A,,CHEMBL627720,1,,BAO_0000218,17717,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,1,,,Rattus norvegicus,Intermediate,,,10212,10116.0
,N,50597,,,In vivo,A,,CHEMBL627721,1,,BAO_0000218,6570,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,10213,10116.0
,N,50597,,,In vivo,A,,CHEMBL627722,1,,BAO_0000218,6570,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,1,,,Rattus norvegicus,Intermediate,,,10214,10116.0
,N,50597,,,In vivo,A,,CHEMBL627723,1,,BAO_0000218,5978,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10215,10116.0
,N,50597,,,In vivo,A,,CHEMBL626058,1,,BAO_0000218,5978,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10216,10116.0
,N,50597,,,In vivo,A,,CHEMBL626059,1,,BAO_0000218,5978,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10217,10116.0
,N,50597,,,In vivo,A,,CHEMBL626060,1,,BAO_0000218,5978,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10218,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626061,1,,BAO_0000218,17720,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,1,,Plasma,Rattus norvegicus,Intermediate,,,10219,10116.0
,N,50597,,,In vivo,A,,CHEMBL876791,1,,BAO_0000218,4723,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,1,,,Rattus norvegicus,Intermediate,,,10220,10116.0
,N,50597,,,In vivo,A,,CHEMBL626062,1,,BAO_0000218,4723,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,1,,,Rattus norvegicus,Intermediate,,,10221,10116.0
,N,50597,,,In vivo,A,,CHEMBL626063,1,,BAO_0000218,4756,Tmax at the dose of 2 mg/Kg administered perorally in rats,1,,,Rattus norvegicus,Intermediate,,,10222,10116.0
,N,50597,,,In vivo,A,,CHEMBL626064,1,,BAO_0000218,4756,Tmax at the dose of 5 mg/Kg administered perorally in rats,1,,,Rattus norvegicus,Intermediate,,,10223,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626065,1,,BAO_0000218,17720,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,1,,Plasma,Rattus norvegicus,Intermediate,,,10224,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626066,1,,BAO_0000218,17720,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,1,,Plasma,Rattus norvegicus,Intermediate,,,10225,10116.0
,N,50597,,,In vivo,A,,CHEMBL626067,1,,BAO_0000218,1466,tmax upon peroral administration of 10.0 mg/Kg dose in rat,1,,,Rattus norvegicus,Intermediate,,,10226,10116.0
,N,50597,,,,F,,CHEMBL626068,1,,BAO_0000218,7449,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,1,,,Rattus norvegicus,Intermediate,,,10227,10116.0
,N,50597,,,,F,,CHEMBL626069,1,,BAO_0000218,7449,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,1,,,Rattus norvegicus,Intermediate,,,10228,10116.0
,N,50597,,,,F,,CHEMBL626070,1,,BAO_0000218,7449,Percent total excretion of 3-methoxyacetaminophen glucuronide,1,,,Rattus norvegicus,Intermediate,,,10229,10116.0
,N,50597,,,,F,,CHEMBL626071,1,,BAO_0000218,7449,Percent total excretion of N-methoxyacetaminophen glucuronide,1,,,Rattus norvegicus,Intermediate,,,10230,10116.0
,N,50597,,,,F,,CHEMBL626072,1,,BAO_0000218,7449,Percent total excretion of N-methoxyacetaminophen sulfate,1,,,Rattus norvegicus,Intermediate,,,10231,10116.0
,N,50597,,,,F,,CHEMBL626073,1,,BAO_0000218,7449,Percent total excretion of acetaminophen,1,,,Rattus norvegicus,Intermediate,,,10232,10116.0
,N,50597,,,,A,2046.0,CHEMBL626741,1,,BAO_0000218,7768,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,10233,10116.0
,N,50597,,,,A,,CHEMBL626742,1,,BAO_0000218,17655,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",1,,,Rattus norvegicus,Intermediate,,,10234,10116.0
,N,50597,,,,A,,CHEMBL626743,1,,BAO_0000218,17735,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,1,,,Rattus norvegicus,Intermediate,,,10235,10116.0
,N,50597,,,,A,,CHEMBL876792,1,,BAO_0000218,5960,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,1,,,Rattus norvegicus,Intermediate,,,10236,10116.0
,N,50597,,,,A,,CHEMBL626744,1,,BAO_0000218,17735,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,1,,,Rattus norvegicus,Intermediate,,,10237,10116.0
,N,50597,,,,A,,CHEMBL626745,1,,BAO_0000218,7116,Compound was tested for antidiuretic activity in rats,1,,,Rattus norvegicus,Intermediate,,,10238,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626746,1,,BAO_0000218,4878,AUC in rat after 3mg/kg oral dose,1,,Plasma,Rattus norvegicus,Intermediate,,,10239,10116.0
,N,50597,,,,A,,CHEMBL626747,1,,BAO_0000218,5939,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10240,10116.0
,N,50597,,,,A,,CHEMBL626748,1,,BAO_0000218,5939,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10241,10116.0
,N,50597,,,,A,,CHEMBL626749,1,,BAO_0000218,16367,Bioavailability administered orally at a dose of 10 mg/kg to rats,1,,,Rattus norvegicus,Intermediate,,,10242,10116.0
,N,50597,,,,A,,CHEMBL626750,1,,BAO_0000218,16366,Oral Bioavailability was determined,1,,,Rattus norvegicus,Intermediate,,,10243,10116.0
,N,50597,,,,A,,CHEMBL626751,1,,BAO_0000218,4426,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10244,10116.0
,N,50597,,,,A,,CHEMBL626913,1,,BAO_0000218,4426,Oral bioavailability in rat; Not performed.,1,,,Rattus norvegicus,Intermediate,,,10245,10116.0
,N,50597,,,,A,,CHEMBL626914,1,,BAO_0000218,5041,Bioavailability,1,,,Rattus norvegicus,Intermediate,,,10246,10116.0
,N,50597,,,,A,,CHEMBL626915,1,,BAO_0000218,5041,Bioavailability was determined; ND denotes no data,1,,,Rattus norvegicus,Intermediate,,,10247,10116.0
,N,50597,,,,A,,CHEMBL626916,1,,BAO_0000218,1500,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,10248,10116.0
,N,50597,,,,A,,CHEMBL626917,1,,BAO_0000218,1500,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,10249,10116.0
,N,50597,,,,A,,CHEMBL626918,1,,BAO_0000218,17409,Binding towards rat plasma protein at 10 uM,1,,,Rattus norvegicus,Intermediate,,,10250,10116.0
,N,50597,,,,A,,CHEMBL626919,1,,BAO_0000218,17409,Binding towards rat plasma protein at 100 uM,1,,,Rattus norvegicus,Intermediate,,,10251,10116.0
,N,50597,,,In vivo,A,,CHEMBL626920,1,,BAO_0000218,2959,Bioavailability in rat (dose 20 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10252,10116.0
,N,50597,,,In vivo,A,,CHEMBL621976,1,,BAO_0000218,13501,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,1,,,Rattus norvegicus,Intermediate,,,10253,10116.0
,N,50597,,,In vivo,A,,CHEMBL877599,1,,BAO_0000218,6567,Bioavailability in rat after 5 mg/kg oral gavage,1,,,Rattus norvegicus,Intermediate,,,10254,10116.0
,N,50597,,,In vivo,A,,CHEMBL621977,1,,BAO_0000218,6571,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10255,10116.0
,N,50597,,,In vivo,A,,CHEMBL621978,1,,BAO_0000218,6715,Bioavailability in rat (dose 1 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10256,10116.0
,N,50597,,,In vivo,A,,CHEMBL621979,1,,BAO_0000218,6715,Bioavailability in rat (dose 3 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10257,10116.0
,N,50597,,,In vivo,A,,CHEMBL621980,1,,BAO_0000218,2932,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10258,10116.0
,N,50597,,,In vivo,A,,CHEMBL621981,1,,BAO_0000218,4171,Bioavailability of the compound in rats after administration of 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10259,10116.0
,N,50597,,,In vivo,A,,CHEMBL621982,1,,BAO_0000218,17509,Bioavailability after administration of 10 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,10260,10116.0
,N,50597,,,In vivo,A,,CHEMBL882953,1,,BAO_0000218,17509,Bioavailability after administration of 2 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,10261,10116.0
,N,50597,,,In vivo,A,,CHEMBL621983,1,,BAO_0000218,4527,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,1,,,Rattus norvegicus,Intermediate,,,10262,10116.0
,N,50597,,,In vivo,A,,CHEMBL621984,1,,BAO_0000218,4026,Bioavailability in dogs was determined; high,1,,,Rattus norvegicus,Intermediate,,,10263,10116.0
,N,50597,,,In vivo,A,,CHEMBL621985,1,,BAO_0000218,6659,Bioavailability in monkey after intravenous administration at 1 mpk,1,,,Rattus norvegicus,Intermediate,,,10264,10116.0
,N,50597,,,In vivo,A,,CHEMBL621986,1,,BAO_0000218,6659,Bioavailability in monkey after peroral administration at 10 mpk,1,,,Rattus norvegicus,Intermediate,,,10265,10116.0
,N,50597,,,In vivo,A,,CHEMBL621987,1,,BAO_0000218,6659,Bioavailability in rat after intravenous administration at 1 mpk,1,,,Rattus norvegicus,Intermediate,,,10266,10116.0
,N,50597,,,In vivo,F,,CHEMBL877600,1,,BAO_0000218,6659,Bioavailability in rat after intravenous administration at 2 mpk,1,,,Rattus norvegicus,Intermediate,,,10267,10116.0
,N,50597,,,In vivo,A,,CHEMBL621988,1,,BAO_0000218,6659,Bioavailability in rat after peroral administration at 30 mpk,1,,,Rattus norvegicus,Intermediate,,,10268,10116.0
,N,50597,,,In vivo,F,,CHEMBL621989,1,,BAO_0000218,6659,Bioavailability in rat after peroral administration at at 100 mpk,1,,,Rattus norvegicus,Intermediate,,,10269,10116.0
,N,50597,,,In vivo,A,,CHEMBL621990,1,,BAO_0000218,6597,Bioavailability in rats was evaluated,1,,,Rattus norvegicus,Intermediate,,,10270,10116.0
,N,50597,,,In vivo,A,,CHEMBL621991,1,,BAO_0000218,1202,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,1,,,Rattus norvegicus,Intermediate,,,10271,10116.0
,N,50597,,,In vivo,A,,CHEMBL621992,1,,BAO_0000218,1202,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,1,,,Rattus norvegicus,Intermediate,,,10272,10116.0
,N,50597,,,In vivo,A,,CHEMBL621993,1,,BAO_0000218,1202,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,1,,,Rattus norvegicus,Intermediate,,,10273,10116.0
,N,50597,,,In vivo,A,,CHEMBL621994,1,,BAO_0000218,1202,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,1,,,Rattus norvegicus,Intermediate,,,10274,10116.0
,N,50597,,,In vivo,A,,CHEMBL621995,1,,BAO_0000218,5207,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10275,10116.0
,N,50597,,,In vivo,A,,CHEMBL621996,1,,BAO_0000218,5970,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10276,10116.0
,N,50597,,,In vivo,A,,CHEMBL621997,1,,BAO_0000218,17538,Oral bioavailability in rat (dose 10 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10277,10116.0
,N,50597,,,In vivo,A,,CHEMBL621998,1,,BAO_0000218,17538,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,1,,,Rattus norvegicus,Intermediate,,,10278,10116.0
,N,50597,,,In vivo,A,,CHEMBL621999,1,,BAO_0000218,1466,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,1,,,Rattus norvegicus,Intermediate,,,10279,10116.0
,N,50597,,,In vivo,A,,CHEMBL622000,1,,BAO_0000218,2879,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10280,10116.0
,N,50597,,,In vivo,A,,CHEMBL622001,1,,BAO_0000218,2879,Bioavailability was measured in rat after oral administration; 2-4,1,,,Rattus norvegicus,Intermediate,,,10281,10116.0
,N,50597,,,In vivo,A,,CHEMBL622002,1,,BAO_0000218,2879,Bioavailability was measured in rat after oral administration; 3-7,1,,,Rattus norvegicus,Intermediate,,,10282,10116.0
,N,50597,,,In vivo,A,,CHEMBL622003,1,,BAO_0000218,3777,Bioavailability in rat (intraduodenal administration),1,,,Rattus norvegicus,Intermediate,,,10283,10116.0
,N,50597,,,In vivo,A,,CHEMBL877601,1,,BAO_0000218,3777,Bioavailability in rat (intraduodenal administration),1,,,Rattus norvegicus,Intermediate,,,10284,10116.0
,N,50597,,,In vivo,A,,CHEMBL624871,1,,BAO_0000218,3777,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10285,10116.0
,N,50597,,,In vivo,A,,CHEMBL622004,1,,BAO_0000218,3777,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10286,10116.0
,N,50597,,,In vivo,A,,CHEMBL882954,1,,BAO_0000218,5423,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10287,10116.0
,N,50597,,,In vivo,A,,CHEMBL622005,1,,BAO_0000218,16365,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,1,,,Rattus norvegicus,Intermediate,,,10288,10116.0
,N,50597,,,In vivo,A,,CHEMBL622006,1,,BAO_0000218,16365,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,1,,,Rattus norvegicus,Intermediate,,,10289,10116.0
,N,50597,,,In vivo,A,,CHEMBL622007,1,,BAO_0000218,4239,Bioavailability was measured in rat,1,,,Rattus norvegicus,Intermediate,,,10290,10116.0
,N,50597,,,In vivo,A,,CHEMBL622008,1,,BAO_0000218,5438,Bioavailability was reported,1,,,Rattus norvegicus,Intermediate,,,10291,10116.0
,N,50597,,,In vivo,A,,CHEMBL622009,1,,BAO_0000218,5334,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10292,10116.0
,N,50597,,,In vivo,A,,CHEMBL622010,1,,BAO_0000218,5334,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10293,10116.0
,N,50597,,,In vivo,A,,CHEMBL622011,1,,BAO_0000218,4199,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,1,,,Rattus norvegicus,Intermediate,,,10294,10116.0
,N,50597,,,In vivo,A,,CHEMBL622012,1,,BAO_0000218,4199,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),1,,,Rattus norvegicus,Intermediate,,,10295,10116.0
,N,50597,,,In vivo,A,,CHEMBL622013,1,,BAO_0000218,4199,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),1,,,Rattus norvegicus,Intermediate,,,10296,10116.0
,N,50597,,,In vivo,A,,CHEMBL622014,1,,BAO_0000218,4890,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,10297,10116.0
,N,50597,,,In vivo,A,,CHEMBL624749,1,,BAO_0000218,2792,Bioavailability was determined at 3 mg/kg po dose in rats,1,,,Rattus norvegicus,Intermediate,,,10298,10116.0
,N,50597,,,In vivo,A,,CHEMBL624750,1,,BAO_0000218,5529,Oral bioavailability in rat (dose 2 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10299,10116.0
,N,50597,,,In vivo,A,,CHEMBL624751,1,,BAO_0000218,6685,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,10300,10116.0
,N,50597,,,In vivo,A,,CHEMBL624752,1,,BAO_0000218,6685,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",1,,,Rattus norvegicus,Intermediate,,,10301,10116.0
,N,50597,,,In vivo,A,,CHEMBL624753,1,,BAO_0000218,6685,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",1,,,Rattus norvegicus,Intermediate,,,10302,10116.0
,N,50597,,,In vivo,A,,CHEMBL624754,1,,BAO_0000218,6005,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10303,10116.0
,N,50597,,,In vivo,A,,CHEMBL624755,1,,BAO_0000218,6410,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,1,,,Rattus norvegicus,Intermediate,,,10304,10116.0
,N,50597,,,In vivo,A,,CHEMBL624756,1,,BAO_0000218,6410,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10305,10116.0
,N,50597,,,In vivo,A,,CHEMBL624757,1,,BAO_0000218,6103,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10306,10116.0
,N,50597,,,In vivo,A,,CHEMBL624758,1,,BAO_0000218,6410,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,1,,,Rattus norvegicus,Intermediate,,,10307,10116.0
,N,50597,,,In vivo,A,,CHEMBL622270,1,,BAO_0000218,6410,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10308,10116.0
,N,50597,,,In vivo,A,,CHEMBL622271,1,,BAO_0000218,5353,Bioavailability in rat (Sprague-Dawley),1,,,Rattus norvegicus,Intermediate,,,10309,10116.0
,N,50597,,,In vivo,A,,CHEMBL622272,1,,BAO_0000218,4727,Bioavailability in rat at the dose of 2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10310,10116.0
,N,50597,,,In vivo,A,,CHEMBL622273,1,,BAO_0000218,17804,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10311,10116.0
,N,50597,,,In vivo,A,,CHEMBL622274,1,,BAO_0000218,5809,Bioavailability in rat (cannulated) (dose 2 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10312,10116.0
,N,50597,,,In vivo,A,,CHEMBL622275,1,,BAO_0000218,17804,Bioavailability value of compound in rats was determined after peroral administration,1,,,Rattus norvegicus,Intermediate,,,10313,10116.0
,N,50597,,,In vivo,A,,CHEMBL622276,1,,BAO_0000218,3634,Oral bioavailability in rat (dose 20 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10314,10116.0
,N,50597,,,In vivo,A,,CHEMBL622277,1,,BAO_0000218,3341,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10315,10116.0
,N,50597,,,In vivo,A,,CHEMBL622278,1,,BAO_0000218,2690,Oral bioavailability in rat (dose 5 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10316,10116.0
,N,50597,,,In vivo,A,,CHEMBL622279,1,,BAO_0000218,3184,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10317,10116.0
,N,50597,,,In vivo,A,,CHEMBL622280,1,,BAO_0000218,740,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10318,10116.0
,N,50597,,,In vivo,A,,CHEMBL624083,1,,BAO_0000218,1806,Compound was evaluated for oral bioavailability in rats; 15-27 %,1,,,Rattus norvegicus,Intermediate,,,10319,10116.0
,N,50597,,,In vivo,A,,CHEMBL624084,1,,BAO_0000218,4891,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,1,,,Rattus norvegicus,Intermediate,,,10320,10116.0
,N,50597,,,In vivo,A,,CHEMBL624085,1,,BAO_0000218,3634,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),1,,,Rattus norvegicus,Intermediate,,,10321,10116.0
,N,50597,,,In vivo,A,,CHEMBL624086,1,,BAO_0000218,64,Compound was tested for bioavailability in rats,1,,,Rattus norvegicus,Intermediate,,,10322,10116.0
,N,50597,,,In vivo,A,,CHEMBL624087,1,,BAO_0000218,4839,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10323,10116.0
,N,50597,,,In vivo,A,,CHEMBL624088,1,,BAO_0000218,1094,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10324,10116.0
,U,22224,,,In vivo,A,,CHEMBL624089,0,,BAO_0000218,5005,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,1,,,Macaca mulatta,Intermediate,,,10325,9544.0
,U,22224,,,In vivo,A,,CHEMBL624090,0,,BAO_0000218,5005,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10326,10116.0
,N,50597,,,In vivo,A,,CHEMBL624091,1,,BAO_0000218,4687,Evaluated for the bioavailability in rat (in vivo),1,,,Rattus norvegicus,Intermediate,,,10327,10116.0
,N,50597,,,In vivo,A,,CHEMBL624092,1,,BAO_0000218,17804,F value of compound in rats was determined after peroral administration,1,,,Rattus norvegicus,Intermediate,,,10328,10116.0
,N,50597,,,In vivo,A,,CHEMBL624093,1,,BAO_0000218,5974,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10329,10116.0
,N,50597,,,In vivo,A,,CHEMBL624094,1,,BAO_0000218,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10330,10116.0
,N,50597,,,In vivo,A,,CHEMBL624095,1,,BAO_0000218,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10331,10116.0
,N,50597,,,In vivo,A,,CHEMBL624096,1,,BAO_0000218,5974,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10332,10116.0
,N,50597,,,In vivo,A,,CHEMBL624097,1,,BAO_0000218,1088,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",1,,,Rattus norvegicus,Intermediate,,,10333,10116.0
,N,50597,,,In vivo,A,,CHEMBL624098,1,,BAO_0000218,1742,Maximum fall in carotid flow in rat,1,,,Rattus norvegicus,Intermediate,,,10334,10116.0
,N,50597,,,In vivo,A,,CHEMBL874392,1,,BAO_0000218,4689,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,1,,,Rattus norvegicus,Intermediate,,,10335,10116.0
,N,50597,,,In vivo,A,,CHEMBL624099,1,,BAO_0000218,2463,Oral bioavailability in rat (dose 5 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10336,10116.0
,N,50597,,,In vivo,A,,CHEMBL624100,1,,BAO_0000218,5654,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,10337,10116.0
,N,50597,,,In vivo,A,,CHEMBL624101,1,,BAO_0000218,5654,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,1,,,Rattus norvegicus,Intermediate,,,10338,10116.0
,N,50597,,,In vivo,A,,CHEMBL624102,1,,BAO_0000218,6874,Oral bioavailability in rat (male Wistar),1,,,Rattus norvegicus,Intermediate,,,10339,10116.0
,N,50597,,,In vivo,A,,CHEMBL624103,1,,BAO_0000218,5633,Oral bioavailability after administration (30 mg/kg) in rat; good,1,,,Rattus norvegicus,Intermediate,,,10340,10116.0
,N,50597,,,In vivo,A,,CHEMBL624104,1,,BAO_0000218,5496,Oral bioavailability at the dose of 2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10341,10116.0
,N,50597,,,In vivo,A,,CHEMBL624105,1,,BAO_0000218,2358,Oral bioavailability determined in rats,1,,,Rattus norvegicus,Intermediate,,,10342,10116.0
,N,50597,,,In vivo,A,,CHEMBL624106,1,,BAO_0000218,16456,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10343,10116.0
,N,50597,,,In vivo,A,,CHEMBL624107,1,,BAO_0000218,5302,Oral bioavailability in rat (dose single 10 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10344,10116.0
,N,50597,,,In vivo,A,,CHEMBL623943,1,,BAO_0000218,5302,Oral bioavailability in rat (dose single 10 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10345,10116.0
,N,50597,,,In vivo,A,,CHEMBL623944,1,,BAO_0000218,5302,Oral bioavailability in rat (dose 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10346,10116.0
,N,50597,,,,A,,CHEMBL623945,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,1,,,Rattus norvegicus,Intermediate,,,10347,10116.0
,N,50597,,,,A,,CHEMBL623946,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,1,,,Rattus norvegicus,Intermediate,,,10348,10116.0
,N,50597,,,,A,,CHEMBL623947,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,1,,,Rattus norvegicus,Intermediate,,,10349,10116.0
,N,50597,,,,A,,CHEMBL623948,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,1,,,Rattus norvegicus,Intermediate,,,10350,10116.0
,N,50597,,,,A,,CHEMBL623949,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,1,,,Rattus norvegicus,Intermediate,,,10351,10116.0
,N,50597,,,,A,,CHEMBL623950,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,1,,,Rattus norvegicus,Intermediate,,,10352,10116.0
,N,50597,,,,A,,CHEMBL874398,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,1,,,Rattus norvegicus,Intermediate,,,10353,10116.0
,N,50597,,,,A,,CHEMBL623951,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,1,,,Rattus norvegicus,Intermediate,,,10354,10116.0
,N,50597,,,,A,,CHEMBL623952,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,1,,,Rattus norvegicus,Intermediate,,,10355,10116.0
,N,50597,,,,A,,CHEMBL623953,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,1,,,Rattus norvegicus,Intermediate,,,10356,10116.0
,N,50597,,,,A,,CHEMBL623954,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10357,10116.0
,N,50597,,,,A,,CHEMBL623955,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,1,,,Rattus norvegicus,Intermediate,,,10358,10116.0
,N,50597,,,,A,,CHEMBL623956,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10359,10116.0
,N,50597,,,,A,,CHEMBL627807,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,1,,,Rattus norvegicus,Intermediate,,,10360,10116.0
,N,50597,,,,A,,CHEMBL627808,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10361,10116.0
,N,50597,,,,A,,CHEMBL627809,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,1,,,Rattus norvegicus,Intermediate,,,10362,10116.0
,N,50597,,,,A,,CHEMBL627810,1,,BAO_0000218,11020,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,1,,,Rattus norvegicus,Intermediate,,,10363,10116.0
,N,50597,,,,A,,CHEMBL627811,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",1,,,Rattus norvegicus,Intermediate,,,10364,10116.0
,N,50597,,,,A,,CHEMBL627812,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",1,,,Rattus norvegicus,Intermediate,,,10365,10116.0
,N,50597,,,,A,,CHEMBL627813,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",1,,,Rattus norvegicus,Intermediate,,,10366,10116.0
,N,50597,,,,A,,CHEMBL627814,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",1,,,Rattus norvegicus,Intermediate,,,10367,10116.0
,N,50597,,,,A,,CHEMBL875336,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",1,,,Rattus norvegicus,Intermediate,,,10368,10116.0
,N,50597,,,,A,,CHEMBL627815,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",1,,,Rattus norvegicus,Intermediate,,,10369,10116.0
,N,50597,,,,A,,CHEMBL627816,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",1,,,Rattus norvegicus,Intermediate,,,10370,10116.0
,N,50597,,,,A,,CHEMBL627817,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",1,,,Rattus norvegicus,Intermediate,,,10371,10116.0
,N,50597,,,,A,,CHEMBL627818,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",1,,,Rattus norvegicus,Intermediate,,,10372,10116.0
,N,50597,,,,A,,CHEMBL627819,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",1,,,Rattus norvegicus,Intermediate,,,10373,10116.0
,N,50597,,,,A,,CHEMBL627820,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",1,,,Rattus norvegicus,Intermediate,,,10374,10116.0
,N,50597,,,,A,,CHEMBL627821,1,,BAO_0000218,11020,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",1,,,Rattus norvegicus,Intermediate,,,10375,10116.0
,N,50597,,,,A,,CHEMBL628464,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,1,,,Rattus norvegicus,Intermediate,,,10376,10116.0
,N,50597,,,,A,,CHEMBL626239,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,1,,,Rattus norvegicus,Intermediate,,,10377,10116.0
,N,50597,,,,A,,CHEMBL626240,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,1,,,Rattus norvegicus,Intermediate,,,10378,10116.0
,N,50597,,,,A,,CHEMBL626241,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,1,,,Rattus norvegicus,Intermediate,,,10379,10116.0
,N,50597,,,,A,,CHEMBL626242,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,1,,,Rattus norvegicus,Intermediate,,,10380,10116.0
,N,50597,,,,A,,CHEMBL626243,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,1,,,Rattus norvegicus,Intermediate,,,10381,10116.0
,N,50597,,,,A,,CHEMBL626244,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,1,,,Rattus norvegicus,Intermediate,,,10382,10116.0
,N,50597,,,,A,,CHEMBL626907,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10383,10116.0
,N,50597,,,,A,,CHEMBL626908,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10384,10116.0
,N,50597,,,,A,,CHEMBL626909,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10385,10116.0
,N,50597,,,,A,,CHEMBL626910,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,1,,,Rattus norvegicus,Intermediate,,,10386,10116.0
,N,50597,,,,F,,CHEMBL875342,1,,BAO_0000218,7449,Percent total excretion of acetaminophen cysteine conjugate,1,,,Rattus norvegicus,Intermediate,,,10387,10116.0
,N,50597,,,,F,,CHEMBL626911,1,,BAO_0000218,7449,Percent total excretion of acetaminophen glucuronide,1,,,Rattus norvegicus,Intermediate,,,10388,10116.0
,N,50597,,,,F,,CHEMBL626912,1,,BAO_0000218,7449,Percent total excretion of acetaminophen sulfate,1,,,Rattus norvegicus,Intermediate,,,10389,10116.0
,N,50597,,,,F,,CHEMBL627065,1,,BAO_0000218,7449,Percent total excretion of acetaminophen-mercapturic acid,1,,,Rattus norvegicus,Intermediate,,,10390,10116.0
,N,50597,,,,A,1088.0,CHEMBL627066,1,,BAO_0000218,3172,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,1,,Urine,Rattus norvegicus,Intermediate,,,10391,10116.0
,N,50597,,,In vivo,A,,CHEMBL627067,1,,BAO_0000218,16456,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10392,10116.0
,U,22224,,,In vivo,A,2385.0,CHEMBL627068,0,,BAO_0000218,10839,Biodistribution of compound in rat muscle after 5 min of administration,1,,Muscle tissue,ratrat,Autocuration,,,10393,8656.0
,U,22224,,,In vivo,A,2385.0,CHEMBL627069,0,,BAO_0000218,10839,Biodistribution of compound in rat muscle after 5 min of administration.,1,,Muscle tissue,ratrat,Autocuration,,,10394,8656.0
,U,22224,,,In vivo,A,,CHEMBL627070,0,,BAO_0000218,5334,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,,,Ovis aries,Autocuration,,,10395,9940.0
,U,22224,,,In vivo,A,,CHEMBL627071,0,,BAO_0000218,5334,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,,,Ovis aries,Autocuration,,,10396,9940.0
,U,22224,,,In vivo,A,,CHEMBL627072,0,,BAO_0000218,5334,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,,,Ovis aries,Autocuration,,,10397,9940.0
,U,22224,,,In vivo,A,,CHEMBL627073,0,,BAO_0000218,5334,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,,,Ovis aries,Autocuration,,,10398,9940.0
,U,22224,,,In vivo,A,,CHEMBL625387,0,,BAO_0000218,5334,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,,,Ovis aries,Autocuration,,,10399,9940.0
,U,22224,,,In vivo,A,,CHEMBL625388,0,,BAO_0000218,5334,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,,,Ovis aries,Autocuration,,,10400,9940.0
,U,22224,,,In vivo,A,1969.0,CHEMBL625389,0,,BAO_0000218,5334,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),1,,Plasma,Ovis aries,Autocuration,,,10401,9940.0
,U,22224,,,In vivo,A,1969.0,CHEMBL875343,0,,BAO_0000218,5334,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),1,,Plasma,Ovis aries,Autocuration,,,10402,9940.0
,N,50497,,,,A,,CHEMBL876795,1,,BAO_0000218,1735,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),1,,,Serpentes,Intermediate,,,10403,8570.0
,N,50497,,,,A,,CHEMBL626552,1,,BAO_0000218,1469,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,1,,,Serpentes,Intermediate,,,10404,8570.0
,N,50497,,,,A,,CHEMBL626553,1,,BAO_0000218,1336,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,1,,,Serpentes,Intermediate,,,10405,8570.0
,U,22224,,,,A,1969.0,CHEMBL626554,0,,BAO_0000366,12403,The human biological plasma half life of the compound,1,,Plasma,Homo sapiens,Autocuration,,,10406,9606.0
,N,50597,,,,A,1088.0,CHEMBL626555,1,,BAO_0000218,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,,Urine,Rattus norvegicus,Intermediate,,,10407,10116.0
,N,50597,,,,A,,CHEMBL626556,1,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,1,,,Rattus norvegicus,Intermediate,,,10408,10116.0
,N,50597,,,,A,,CHEMBL626557,1,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,1,,,Rattus norvegicus,Intermediate,,,10409,10116.0
,N,50597,,,,A,,CHEMBL626558,1,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,1,,,Rattus norvegicus,Intermediate,,,10410,10116.0
,N,50597,,,,A,,CHEMBL626559,1,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,1,,,Rattus norvegicus,Intermediate,,,10411,10116.0
,N,50597,,,,A,,CHEMBL626560,1,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,1,,,Rattus norvegicus,Intermediate,,,10412,10116.0
,N,50597,,,,A,,CHEMBL876803,1,,BAO_0000218,8004,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,1,,,Rattus norvegicus,Intermediate,,,10413,10116.0
,N,50597,,,,A,,CHEMBL627964,1,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,1,,,Rattus norvegicus,Intermediate,,,10414,10116.0
,N,50597,,,,A,,CHEMBL627965,1,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,1,,,Rattus norvegicus,Intermediate,,,10415,10116.0
,N,50597,,,,A,,CHEMBL627966,1,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,1,,,Rattus norvegicus,Intermediate,,,10416,10116.0
,N,50597,,,,A,,CHEMBL627967,1,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,1,,,Rattus norvegicus,Intermediate,,,10417,10116.0
,N,50597,,,,A,,CHEMBL627968,1,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,1,,,Rattus norvegicus,Intermediate,,,10418,10116.0
,N,50597,,,,A,,CHEMBL627969,1,,BAO_0000218,8004,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,1,,,Rattus norvegicus,Intermediate,,,10419,10116.0
,N,50597,,,,A,,CHEMBL627970,1,,BAO_0000218,8004,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,1,,,Rattus norvegicus,Intermediate,,,10420,10116.0
,N,50597,,,,A,178.0,CHEMBL627971,1,,BAO_0000218,8004,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,1,,Blood,Rattus norvegicus,Intermediate,,,10421,10116.0
,N,50597,,,,A,178.0,CHEMBL627972,1,,BAO_0000218,8004,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,1,,Blood,Rattus norvegicus,Intermediate,,,10422,10116.0
,D,180,,,,B,,CHEMBL856029,9,,BAO_0000357,15917,Dissociation constant against binding to human cyclophilin A,1,,,Homo sapiens,Expert,,,10423,9606.0
,H,11591,,,,B,,CHEMBL627973,8,,BAO_0000019,12396,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,1,,,Bos taurus,Expert,,,10424,9913.0
,U,22224,,,,A,,CHEMBL627974,0,,BAO_0000019,7065,-Log C was determined by performing the electroshock minimum test,1,,,,Autocuration,,,10425,
,U,22224,,,,A,,CHEMBL627975,0,,BAO_0000019,7065,-Log C was determined by performing the foot shock test,1,,,,Autocuration,,,10426,
,U,22224,,,,A,,CHEMBL627976,0,,BAO_0000019,7065,-Log C was determined by performing the incl screen test,1,,,,Autocuration,,,10427,
,U,22224,,,,A,,CHEMBL627977,0,,BAO_0000019,7065,-Log C was determined by performing the maximum electroshock test,1,,,,Autocuration,,,10428,
,U,22224,,,,A,,CHEMBL627978,0,,BAO_0000019,7065,-Log C was determined by performing the pentylenetetrazole test,1,,,,Autocuration,,,10429,
,U,22224,,,,A,,CHEMBL627979,0,,BAO_0000019,12415,Tested for experimental arotinoid inhibitory dose,1,,,,Autocuration,,,10430,
,U,22224,,,,A,,CHEMBL876804,0,,BAO_0000019,10256,Negative log transformed activity,1,,,,Autocuration,,,10431,
,U,22224,,,,A,,CHEMBL627980,0,,BAO_0000019,7991,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",1,,,,Autocuration,,,10432,
,N,50512,,,,A,,CHEMBL627981,1,,BAO_0000218,14342,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,1,,,Cavia porcellus,Intermediate,,,10433,10141.0
,N,50512,,,,A,,CHEMBL627982,1,,BAO_0000218,14342,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,1,,,Cavia porcellus,Intermediate,,,10434,10141.0
,N,50512,,,,A,,CHEMBL627983,1,,BAO_0000218,14342,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,1,,,Cavia porcellus,Intermediate,,,10435,10141.0
,N,50512,,,,A,2116.0,CHEMBL627984,1,,BAO_0000218,14342,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,1,,Ileum,Cavia porcellus,Intermediate,,,10436,10141.0
,U,22229,,,,P,,CHEMBL627985,0,,BAO_0000100,6047,Solubility in water was determined; values expressed as -log,1,,,,Autocuration,,,10437,
,U,22224,,,,A,,CHEMBL627986,0,,BAO_0000019,17269,Ratio of Kcat to that of Km was determined,1,,,,Autocuration,,,10438,
,U,22224,,,,A,,CHEMBL627987,0,,BAO_0000019,10026,Observed first order rate constant,1,,,,Autocuration,,,10439,
,U,22224,,,,A,,CHEMBL627988,0,,BAO_0000019,14583,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,1,,,,Autocuration,,,10440,
,N,50597,,,In vivo,A,,CHEMBL627989,1,,BAO_0000218,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,1,,,Rattus norvegicus,Intermediate,,,10441,10116.0
,N,50597,,,In vivo,A,,CHEMBL627990,1,,BAO_0000218,2661,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,1,,,Rattus norvegicus,Intermediate,,,10442,10116.0
,N,50597,,,In vivo,A,,CHEMBL876805,1,,BAO_0000218,4029,Oral Bioavailability after administration of 10 mg/kg in male rat,1,,,Rattus norvegicus,Intermediate,,,10443,10116.0
,N,50597,,,In vivo,A,,CHEMBL627991,1,,BAO_0000218,17735,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10444,10116.0
,N,50597,,,In vivo,A,,CHEMBL627992,1,,BAO_0000218,4576,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10445,10116.0
,N,50597,,,In vivo,A,,CHEMBL627993,1,,BAO_0000218,17582,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,1,,,Rattus norvegicus,Intermediate,,,10446,10116.0
,N,50597,,,In vivo,A,,CHEMBL622817,1,,BAO_0000218,17651,Oral bioavailability at 1 mg/kg was determined in rat,1,,,Rattus norvegicus,Intermediate,,,10447,10116.0
,N,50597,,,In vivo,A,,CHEMBL622818,1,,BAO_0000218,17651,Oral bioavailability at 10 mg/kg was determined in rat,1,,,Rattus norvegicus,Intermediate,,,10448,10116.0
,N,50597,,,In vivo,A,,CHEMBL622819,1,,BAO_0000218,17670,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",1,,,Rattus norvegicus,Intermediate,,,10449,10116.0
,N,50597,,,In vivo,A,,CHEMBL872267,1,,BAO_0000218,5045,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10450,10116.0
,N,50597,,,In vivo,A,,CHEMBL622820,1,,BAO_0000218,1696,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10451,10116.0
,N,50597,,,In vivo,A,,CHEMBL622821,1,,BAO_0000218,17764,Oral bioavailability after intravenous administration in rats at 24 uM/kg,1,,,Rattus norvegicus,Intermediate,,,10452,10116.0
,N,50597,,,In vivo,A,,CHEMBL622822,1,,BAO_0000218,6448,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10453,10116.0
,N,50597,,,In vivo,A,,CHEMBL622823,1,,BAO_0000218,6596,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10454,10116.0
,N,50597,,,In vivo,A,,CHEMBL622824,1,,BAO_0000218,17547,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10455,10116.0
,N,50597,,,In vivo,A,,CHEMBL622825,1,,BAO_0000218,17771,Oral bioavailability in rat at a dose of 3 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10456,10116.0
,N,50597,,,In vivo,A,,CHEMBL622901,1,,BAO_0000218,6495,Oral bioavailability in rat after oral administration at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10457,10116.0
,N,50597,,,In vivo,A,,CHEMBL622902,1,,BAO_0000218,4558,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10458,10116.0
,N,50597,,,In vivo,A,,CHEMBL621844,1,,BAO_0000218,17596,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10459,10116.0
,N,50597,,,In vivo,A,,CHEMBL621845,1,,BAO_0000218,6827,Oral bioavailability in Dawley rats,1,,,Rattus norvegicus,Intermediate,,,10460,10116.0
,N,50597,,,In vivo,A,,CHEMBL621846,1,,BAO_0000218,4026,Oral bioavailability,1,,,Rattus norvegicus,Intermediate,,,10461,10116.0
,N,50597,,,In vivo,A,,CHEMBL621847,1,,BAO_0000218,10,Oral bioavailability in rat (dose 30 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10462,10116.0
,N,50597,,,In vivo,A,,CHEMBL877609,1,,BAO_0000218,17717,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,1,,,Rattus norvegicus,Intermediate,,,10463,10116.0
,N,50597,,,In vivo,A,,CHEMBL621848,1,,BAO_0000218,17717,Bioavailability in rat (dose 3 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10464,10116.0
,N,50597,,,In vivo,A,,CHEMBL621849,1,,BAO_0000218,17717,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,1,,,Rattus norvegicus,Intermediate,,,10465,10116.0
,N,50597,,,In vivo,A,,CHEMBL622030,1,,BAO_0000218,17717,Oral bioavailability in rat (dose 60 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10466,10116.0
,N,50597,,,In vivo,A,,CHEMBL622031,1,,BAO_0000218,4796,Percent oral bioavailability determined in rats,1,,,Rattus norvegicus,Intermediate,,,10467,10116.0
,N,50597,,,In vivo,A,,CHEMBL622032,1,,BAO_0000218,4883,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10468,10116.0
,N,50597,,,In vivo,A,,CHEMBL622033,1,,BAO_0000218,2137,The compound was evaluated for bioavailability in rats; 32-51,1,,,Rattus norvegicus,Intermediate,,,10469,10116.0
,N,50597,,,In vivo,A,,CHEMBL622034,1,,BAO_0000218,2959,Bioavailability in rat (dose 20 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10470,10116.0
,N,50597,,,In vivo,A,,CHEMBL622035,1,,BAO_0000218,1361,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10471,10116.0
,N,50597,,,In vivo,A,,CHEMBL882966,1,,BAO_0000218,4727,Bioavailability percent in rat at the dose of 2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10472,10116.0
,N,50597,,,In vivo,A,,CHEMBL622036,1,,BAO_0000218,16423,Bioavailability was evaluated after 20 uM/kg of peroral administration,1,,,Rattus norvegicus,Intermediate,,,10473,10116.0
,N,50597,,,In vivo,A,,CHEMBL622037,1,,BAO_0000218,5206,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10474,10116.0
,N,50597,,,In vivo,A,,CHEMBL622038,1,,BAO_0000218,6448,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10475,10116.0
,N,50597,,,In vivo,A,,CHEMBL622039,1,,BAO_0000218,17723,Bioavailability in rats,1,,,Rattus norvegicus,Intermediate,,,10476,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL622040,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,1,,Blood,Rattus norvegicus,Intermediate,,,10477,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL622041,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,1,,Blood,Rattus norvegicus,Intermediate,,,10478,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL622042,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,1,,Blood,Rattus norvegicus,Intermediate,,,10479,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL622043,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,1,,Blood,Rattus norvegicus,Intermediate,,,10480,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL622044,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,1,,Blood,Rattus norvegicus,Intermediate,,,10481,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL622045,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,1,,Bone,Rattus norvegicus,Intermediate,,,10482,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL622046,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,1,,Bone,Rattus norvegicus,Intermediate,,,10483,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL622047,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,1,,Bone,Rattus norvegicus,Intermediate,,,10484,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL877610,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,1,,Bone,Rattus norvegicus,Intermediate,,,10485,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622048,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,1,,Brain,Rattus norvegicus,Intermediate,,,10486,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622049,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,1,,Brain,Rattus norvegicus,Intermediate,,,10487,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622050,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,1,,Brain,Rattus norvegicus,Intermediate,,,10488,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622051,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,1,,Brain,Rattus norvegicus,Intermediate,,,10489,10116.0
,N,50597,,,In vivo,A,,CHEMBL622052,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,1,,,Rattus norvegicus,Intermediate,,,10490,10116.0
,N,50597,,,In vivo,A,,CHEMBL622053,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,1,,,Rattus norvegicus,Intermediate,,,10491,10116.0
,N,50597,,,In vivo,A,,CHEMBL622054,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,1,,,Rattus norvegicus,Intermediate,,,10492,10116.0
,N,50597,,,In vivo,A,,CHEMBL622055,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,1,,,Rattus norvegicus,Intermediate,,,10493,10116.0
,N,50597,,,In vivo,A,,CHEMBL622056,1,,BAO_0000218,5237,Oral bioavailability in rats was determined; High,1,,,Rattus norvegicus,Intermediate,,,10494,10116.0
,N,50597,,,In vivo,A,,CHEMBL622057,1,,BAO_0000218,5503,Oral bioavailability in the rat was determined,1,,,Rattus norvegicus,Intermediate,,,10495,10116.0
,N,50597,,,In vivo,A,,CHEMBL628008,1,,BAO_0000218,15765,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,1,,,Rattus norvegicus,Intermediate,,,10496,10116.0
,N,50597,,,In vivo,A,,CHEMBL622058,1,,BAO_0000218,15660,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10497,10116.0
,N,50597,,,In vivo,A,,CHEMBL622059,1,,BAO_0000218,5978,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10498,10116.0
,N,50597,,,In vivo,A,,CHEMBL622060,1,,BAO_0000218,5978,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10499,10116.0
,N,50597,,,In vivo,A,,CHEMBL622061,1,,BAO_0000218,5978,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10500,10116.0
,N,50597,,,In vivo,A,,CHEMBL622062,1,,BAO_0000218,5978,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,1,,,Rattus norvegicus,Intermediate,,,10501,10116.0
,N,50597,,,In vivo,A,,CHEMBL622063,1,,BAO_0000218,5656,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,1,,,Rattus norvegicus,Intermediate,,,10502,10116.0
,N,50597,,,In vivo,A,,CHEMBL877611,1,,BAO_0000218,3598,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,1,,,Rattus norvegicus,Expert,,,10503,10116.0
,N,50597,,,In vivo,A,,CHEMBL622064,1,,BAO_0000218,4216,Oral bioavailability of compound in Sprague Dawley rats,1,,,Rattus norvegicus,Intermediate,,,10504,10116.0
,N,50597,,,In vivo,A,,CHEMBL622065,1,,BAO_0000218,17839,Oral bioavailability of compound in rat,1,,,Rattus norvegicus,Intermediate,,,10505,10116.0
,N,50597,,,In vivo,A,,CHEMBL622066,1,,BAO_0000218,6570,Oral bioavailability in rat (dose 2 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10506,10116.0
,N,50597,,,In vivo,A,,CHEMBL622067,1,,BAO_0000218,5334,Oral bioavailability of compound in rat was determined,1,,,Rattus norvegicus,Intermediate,,,10507,10116.0
,N,50597,,,In vivo,A,,CHEMBL622068,1,,BAO_0000218,6886,Oral bioavailability of compound in rats,1,,,Rattus norvegicus,Intermediate,,,10508,10116.0
,N,50597,,,In vivo,A,,CHEMBL622069,1,,BAO_0000218,5210,Oral bioavailability of compound was determined in rats,1,,,Rattus norvegicus,Intermediate,,,10509,10116.0
,N,50597,,,In vivo,A,,CHEMBL624796,1,,BAO_0000218,4170,Oral bioavailability at a dose of 30 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,10510,10116.0
,N,50597,,,In vivo,A,,CHEMBL624797,1,,BAO_0000218,6028,Oral bioavailability in rat (dose 10 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10511,10116.0
,N,50597,,,In vivo,A,,CHEMBL623053,1,,BAO_0000218,6028,Oral bioavailability in rat (dose 10 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10512,10116.0
,N,50597,,,In vivo,A,,CHEMBL623054,1,,BAO_0000218,6078,Oral bioavailability evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,10513,10116.0
,N,50597,,,In vivo,A,,CHEMBL623055,1,,BAO_0000218,6168,Oral bioavailability in fasted rat,1,,,Rattus norvegicus,Intermediate,,,10514,10116.0
,N,50597,,,In vivo,A,,CHEMBL623056,1,,BAO_0000218,6168,Oral bioavailability in fed rat,1,,,Rattus norvegicus,Intermediate,,,10515,10116.0
,N,50597,,,In vivo,A,,CHEMBL623057,1,,BAO_0000218,5160,Oral bioavailability in rat (mature male) (dose 30 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10516,10116.0
,N,50597,,,In vivo,A,,CHEMBL623058,1,,BAO_0000218,6057,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10517,10116.0
,N,50597,,,In vivo,A,,CHEMBL623059,1,,BAO_0000218,6535,Oral bioavailability in rat (dose 10 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10518,10116.0
,N,50597,,,In vivo,A,,CHEMBL623060,1,,BAO_0000218,6535,Oral bioavailability in rat after administration of 10 mg/kg po,1,,,Rattus norvegicus,Intermediate,,,10519,10116.0
,N,50597,,,In vivo,A,,CHEMBL623061,1,,BAO_0000218,4194,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10520,10116.0
,N,50597,,,In vivo,A,,CHEMBL623062,1,,BAO_0000218,6230,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10521,10116.0
,N,50597,,,In vivo,A,,CHEMBL623063,1,,BAO_0000218,6619,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10522,10116.0
,N,50597,,,In vivo,A,,CHEMBL623064,1,,BAO_0000218,17607,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10523,10116.0
,N,50597,,,In vivo,A,,CHEMBL623065,1,,BAO_0000218,4942,Oral bioavailability in ratrs,1,,,Rattus norvegicus,Intermediate,,,10524,10116.0
,N,50597,,,In vivo,A,,CHEMBL623066,1,,BAO_0000218,4942,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10525,10116.0
,N,50597,,,In vivo,A,,CHEMBL623067,1,,BAO_0000218,6646,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10526,10116.0
,N,50597,,,In vivo,A,,CHEMBL623068,1,,BAO_0000218,5237,Oral bioavailability in rats was determined; High,1,,,Rattus norvegicus,Intermediate,,,10527,10116.0
,N,50597,,,In vivo,A,,CHEMBL623069,1,,BAO_0000218,6646,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10528,10116.0
,N,50597,,,In vivo,A,,CHEMBL623070,1,,BAO_0000218,4449,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10529,10116.0
,N,50597,,,In vivo,A,,CHEMBL623071,1,,BAO_0000218,6057,Oral bioavailability was calculated in rat,1,,,Rattus norvegicus,Intermediate,,,10530,10116.0
,N,50597,,,In vivo,A,,CHEMBL623072,1,,BAO_0000218,2552,Oral bioavailability,1,,,Rattus norvegicus,Intermediate,,,10531,10116.0
,N,50597,,,In vivo,A,,CHEMBL623073,1,,BAO_0000218,5496,Oral bioavailability,1,,,Rattus norvegicus,Intermediate,,,10532,10116.0
,N,50597,,,In vivo,A,,CHEMBL623074,1,,BAO_0000218,6484,Oral bioavailability,1,,,Rattus norvegicus,Intermediate,,,10533,10116.0
,N,50597,,,In vivo,A,,CHEMBL623075,1,,BAO_0000218,6485,Oral bioavailability,1,,,Rattus norvegicus,Intermediate,,,10534,10116.0
,N,50597,,,In vivo,A,,CHEMBL623076,1,,BAO_0000218,6616,Oral bioavailability after i.v. administration,1,,,Rattus norvegicus,Intermediate,,,10535,10116.0
,N,50597,,,In vivo,A,,CHEMBL623077,1,,BAO_0000218,4969,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10536,10116.0
,N,50597,,,In vivo,A,,CHEMBL623078,1,,BAO_0000218,5862,Oral bioavailability in rat (Sprague-Dawley),1,,,Rattus norvegicus,Intermediate,,,10537,10116.0
,N,50597,,,In vivo,A,,CHEMBL623079,1,,BAO_0000218,4514,Oral bioavailability in Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,10538,10116.0
,N,50597,,,In vivo,A,,CHEMBL623080,1,,BAO_0000218,4514,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10539,10116.0
,N,50597,,,In vivo,A,,CHEMBL623081,1,,BAO_0000218,4514,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10540,10116.0
,N,50597,,,In vivo,A,,CHEMBL623082,1,,BAO_0000218,5546,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,1,,,Rattus norvegicus,Intermediate,,,10541,10116.0
,N,50597,,,In vivo,A,,CHEMBL874400,1,,BAO_0000218,6168,Oral bioavailability in fasted rat,1,,,Rattus norvegicus,Intermediate,,,10542,10116.0
,N,50597,,,In vivo,A,,CHEMBL623083,1,,BAO_0000218,6168,Oral bioavailability in fed rat,1,,,Rattus norvegicus,Intermediate,,,10543,10116.0
,N,50597,,,In vivo,A,,CHEMBL623084,1,,BAO_0000218,3624,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10544,10116.0
,N,50597,,,In vivo,A,,CHEMBL623085,1,,BAO_0000218,5213,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10545,10116.0
,N,50597,,,In vivo,A,,CHEMBL623086,1,,BAO_0000218,5496,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10546,10116.0
,N,50597,,,In vivo,A,,CHEMBL623087,1,,BAO_0000218,5553,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10547,10116.0
,N,50597,,,In vivo,A,,CHEMBL623088,1,,BAO_0000218,5833,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10548,10116.0
,N,50597,,,In vivo,A,,CHEMBL623089,1,,BAO_0000218,5836,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10549,10116.0
,N,50597,,,In vivo,A,,CHEMBL623090,1,,BAO_0000218,5865,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10550,10116.0
,N,50597,,,In vivo,A,,CHEMBL623091,1,,BAO_0000218,5960,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10551,10116.0
,N,50597,,,In vivo,A,,CHEMBL623092,1,,BAO_0000218,6249,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10552,10116.0
,N,50597,,,In vivo,A,,CHEMBL623093,1,,BAO_0000218,6448,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10553,10116.0
,N,50597,,,In vivo,A,,CHEMBL874401,1,,BAO_0000218,6453,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10554,10116.0
,N,50597,,,In vivo,A,,CHEMBL623094,1,,BAO_0000218,6640,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10555,10116.0
,N,50597,,,In vivo,A,,CHEMBL623095,1,,BAO_0000218,17607,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10556,10116.0
,N,50597,,,In vivo,A,,CHEMBL623096,1,,BAO_0000218,5939,Oral bioavailability in rat after peroral administration at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10557,10116.0
,N,50597,,,In vivo,A,,CHEMBL624913,1,,BAO_0000218,5939,Oral bioavailability in rat after peroral administration at 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10558,10116.0
,N,50597,,,In vivo,A,,CHEMBL624914,1,,BAO_0000218,6281,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10559,10116.0
,N,50597,,,In vivo,A,,CHEMBL624915,1,,BAO_0000218,5874,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10560,10116.0
,N,50597,,,In vivo,A,,CHEMBL624916,1,,BAO_0000218,5213,Oral bioavailability in rat; Not measured,1,,,Rattus norvegicus,Intermediate,,,10561,10116.0
,N,50597,,,In vivo,A,,CHEMBL624917,1,,BAO_0000218,4964,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10562,10116.0
,N,50597,,,,A,,CHEMBL625157,1,,BAO_0000218,11020,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,1,,,Rattus norvegicus,Intermediate,,,10563,10116.0
,N,50597,,,,A,2107.0,CHEMBL625158,1,,BAO_0000218,6251,In vitro metabolic potential in rat liver microsomes,1,,Liver,Rattus norvegicus,Intermediate,,,10564,10116.0
,N,50597,,,In vivo,A,,CHEMBL625159,1,,BAO_0000218,1568,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",1,,,Rattus norvegicus,Intermediate,,,10565,10116.0
,N,50597,,,In vivo,A,,CHEMBL625160,1,,BAO_0000218,3032,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",1,,,Rattus norvegicus,Intermediate,,,10566,10116.0
,N,50597,,,In vivo,A,,CHEMBL625161,1,,BAO_0000218,3748,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,1,,,Rattus norvegicus,Intermediate,,,10567,10116.0
,N,50597,,,In vivo,A,,CHEMBL625162,1,,BAO_0000218,401,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10568,10116.0
,N,50597,,,In vivo,A,,CHEMBL625163,1,,BAO_0000218,6512,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10569,10116.0
,N,50597,,,In vivo,A,,CHEMBL625164,1,,BAO_0000218,17617,Oral bioavailability in rats at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10570,10116.0
,N,50597,,,In vivo,A,,CHEMBL625165,1,,BAO_0000218,6679,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,1,,,Rattus norvegicus,Intermediate,,,10571,10116.0
,N,50597,,,In vivo,A,,CHEMBL625166,1,,BAO_0000218,6742,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10572,10116.0
,N,50597,,,,A,,CHEMBL625167,1,,BAO_0000218,589,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,1,,,Rattus norvegicus,Intermediate,,,10573,10116.0
,N,50597,,,,A,,CHEMBL625168,1,,BAO_0000218,589,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,1,,,Rattus norvegicus,Intermediate,,,10574,10116.0
,N,50597,,,In vivo,A,,CHEMBL625169,1,,BAO_0000218,3185,Plasma clearance of the compound,1,,,Rattus norvegicus,Intermediate,,,10575,10116.0
,N,50597,,,In vivo,A,,CHEMBL626264,1,,BAO_0000218,17596,Plasma clearance at 10 mg/kg in rat upon intravenous administration,1,,,Rattus norvegicus,Intermediate,,,10576,10116.0
,N,50597,,,In vivo,A,,CHEMBL626265,1,,BAO_0000218,2713,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,1,,,Rattus norvegicus,Intermediate,,,10577,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626266,1,,BAO_0000218,12500,The compound was tested for plasma clearance in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,10578,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626267,1,,BAO_0000218,12500,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,1,,Plasma,Rattus norvegicus,Intermediate,,,10579,10116.0
,N,50597,,,,A,,CHEMBL626268,1,,BAO_0000218,2713,Plasma concentration upon oral administration of 1 mg/Kg in rats,1,,,Rattus norvegicus,Intermediate,,,10580,10116.0
,N,50597,,,,A,,CHEMBL626269,1,,BAO_0000218,1446,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,1,,,Rattus norvegicus,Intermediate,,,10581,10116.0
,N,50597,,,,A,,CHEMBL626270,1,,BAO_0000218,6227,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,1,,,Rattus norvegicus,Intermediate,,,10582,10116.0
,N,50597,,,,A,,CHEMBL626271,1,,BAO_0000218,4709,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10583,10116.0
,N,50597,,,,A,,CHEMBL626272,1,,BAO_0000218,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",1,,,Rattus norvegicus,Intermediate,,,10584,10116.0
,N,50597,,,,A,,CHEMBL626273,1,,BAO_0000218,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",1,,,Rattus norvegicus,Intermediate,,,10585,10116.0
,N,50597,,,,A,,CHEMBL875346,1,,BAO_0000218,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",1,,,Rattus norvegicus,Intermediate,,,10586,10116.0
,N,50597,,,,A,,CHEMBL626274,1,,BAO_0000218,5510,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",1,,,Rattus norvegicus,Intermediate,,,10587,10116.0
,N,50597,,,,A,,CHEMBL626275,1,,BAO_0000218,4514,Compound was tested for protein binding in rat plasma,1,,,Rattus norvegicus,Intermediate,,,10588,10116.0
,N,50597,,,,A,,CHEMBL624646,1,,BAO_0000218,2713,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,1,,,Rattus norvegicus,Intermediate,,,10589,10116.0
,N,50597,,,,A,,CHEMBL624647,1,,BAO_0000218,2713,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,1,,,Rattus norvegicus,Intermediate,,,10590,10116.0
,N,50597,,,,A,2107.0,CHEMBL624648,1,,BAO_0000218,5340,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,1,,Liver,Rattus norvegicus,Intermediate,,,10591,10116.0
,N,50597,,,,A,,CHEMBL624649,1,,BAO_0000218,12058,Area under curve ratio was determined (po/iv) in rat,1,,,Rattus norvegicus,Intermediate,,,10592,10116.0
,N,50597,,,,A,,CHEMBL624650,1,,BAO_0000218,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,1,,,Rattus norvegicus,Intermediate,,,10593,10116.0
,N,50597,,,,A,,CHEMBL624651,1,,BAO_0000218,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,1,,,Rattus norvegicus,Intermediate,,,10594,10116.0
,N,50597,,,,A,,CHEMBL624652,1,,BAO_0000218,11195,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,1,,,Rattus norvegicus,Intermediate,,,10595,10116.0
,N,50597,,,,A,,CHEMBL624653,1,,BAO_0000218,6495,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10596,10116.0
,N,50597,,,,A,,CHEMBL624654,1,,BAO_0000218,6078,Ratio of AUCbrain to AUCplasma,1,,,Rattus norvegicus,Intermediate,,,10597,10116.0
,N,50597,,,,A,,CHEMBL624655,1,,BAO_0000218,5656,Ratio of brain to plasma,1,,,Rattus norvegicus,Intermediate,,,10598,10116.0
,N,50597,,,,A,,CHEMBL624656,1,,BAO_0000218,4910,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,1,,,Rattus norvegicus,Intermediate,,,10599,10116.0
,N,50597,,,,A,,CHEMBL624657,1,,BAO_0000218,4910,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,1,,,Rattus norvegicus,Intermediate,,,10600,10116.0
,N,50597,,,,A,,CHEMBL624658,1,,BAO_0000218,4910,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,1,,,Rattus norvegicus,Intermediate,,,10601,10116.0
,N,50597,,,,A,,CHEMBL624659,1,,BAO_0000218,10130,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,1,,,Rattus norvegicus,Intermediate,,,10602,10116.0
,N,50597,,,,A,,CHEMBL624660,1,,BAO_0000218,10130,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,1,,,Rattus norvegicus,Intermediate,,,10603,10116.0
,N,50597,,,,A,,CHEMBL624661,1,,BAO_0000218,10130,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,1,,,Rattus norvegicus,Intermediate,,,10604,10116.0
,N,50597,,,,A,,CHEMBL624662,1,,BAO_0000218,5213,Steady state brain :blood ratio was determined,1,,,Rattus norvegicus,Intermediate,,,10605,10116.0
,N,50597,,,,A,,CHEMBL625199,1,,BAO_0000218,4910,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,1,,,Rattus norvegicus,Intermediate,,,10606,10116.0
,N,50597,,,,A,,CHEMBL625200,1,,BAO_0000218,4910,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,1,,,Rattus norvegicus,Intermediate,,,10607,10116.0
,N,50597,,,,A,,CHEMBL625201,1,,BAO_0000218,4910,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,1,,,Rattus norvegicus,Intermediate,,,10608,10116.0
,N,50597,,,,A,,CHEMBL625202,1,,BAO_0000218,4910,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,1,,,Rattus norvegicus,Intermediate,,,10609,10116.0
,N,50597,,,,A,,CHEMBL625203,1,,BAO_0000218,2083,Percentage recovery after 3h incubation with rat hapatocytes was determined,1,,,Rattus norvegicus,Intermediate,,,10610,10116.0
,N,50597,,,,A,,CHEMBL625204,1,,BAO_0000218,2082,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,1,,,Rattus norvegicus,Intermediate,,,10611,10116.0
,N,50597,,,,A,,CHEMBL625205,1,,BAO_0000218,2082,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,1,,,Rattus norvegicus,Intermediate,,,10612,10116.0
,N,50597,,,,A,,CHEMBL625206,1,,BAO_0000218,6351,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,10613,10116.0
,U,22224,,,,A,,CHEMBL625207,0,,BAO_0000019,14583,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",1,,,,Autocuration,,,10614,
,U,22224,,,,A,,CHEMBL625208,0,,BAO_0000019,14583,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,1,,,,Autocuration,,,10615,
,N,50587,495.0,,,A,,CHEMBL625209,1,,BAO_0000218,4608,In vivo absorption in Caco-2 cell line monolayers was determined,1,,,Homo sapiens,Intermediate,Caco-2,,10616,9606.0
,U,22229,,,,P,,CHEMBL625210,0,,BAO_0000100,13668,Calculated partition coefficient (clogP),1,,,,Autocuration,,,10617,
,N,50597,,,,A,,CHEMBL625211,1,,BAO_0000218,5669,Area under curve was determine after peroral administration at 10 mpk in Rat,1,,,Rattus norvegicus,Intermediate,,,10618,10116.0
,N,50797,,,,A,,CHEMBL625212,1,,BAO_0000218,5669,Area under curve was determine after peroral administration at 10 mpk in Rhesus,1,,,Macaca mulatta,Intermediate,,,10619,9544.0
,N,50597,,,,A,,CHEMBL625213,1,,BAO_0000218,5669,Area under curve was determine after peroral administration at 160 mpk in Rat,1,,,Rattus norvegicus,Intermediate,,,10620,10116.0
,N,50597,,,,A,,CHEMBL625214,1,,BAO_0000218,5669,Area under curve was determine after peroral administration at 20 mpk in Rat,1,,,Rattus norvegicus,Intermediate,,,10621,10116.0
,N,50597,,,,A,,CHEMBL874542,1,,BAO_0000218,5669,Area under curve was determine after peroral administration at 50 mpk in Rat,1,,,Rattus norvegicus,Intermediate,,,10622,10116.0
,U,22229,,,,P,,CHEMBL625215,0,,BAO_0000100,6472,Calculated partition coefficient (clogP) (AlogP),1,,,,Autocuration,,,10623,
,U,22224,,,,A,,CHEMBL625216,0,,BAO_0000019,15106,Activated partial thromboplastin time measured,1,,,,Autocuration,,,10624,
,U,22224,,,,P,,CHEMBL625217,0,,BAO_0000100,15207,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),1,,,,Autocuration,,,10625,
,U,22224,,,,P,,CHEMBL625218,0,,BAO_0000100,15207,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),1,,,,Autocuration,,,10626,
,N,50588,,,,A,1969.0,CHEMBL622864,1,,BAO_0000218,13941,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,1,,Plasma,Canis lupus familiaris,Intermediate,,,10627,9615.0
,N,50597,,,,A,1969.0,CHEMBL622865,1,,BAO_0000218,13941,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,1,,Plasma,Rattus norvegicus,Intermediate,,,10628,10116.0
,N,50597,,,,A,1969.0,CHEMBL622866,1,,BAO_0000218,13941,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,1,,Plasma,Rattus norvegicus,Intermediate,,,10629,10116.0
,N,50588,,,,A,1969.0,CHEMBL622867,1,,BAO_0000218,13941,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,1,,Plasma,Canis lupus familiaris,Intermediate,,,10630,9615.0
,N,50512,,,,A,1969.0,CHEMBL876808,1,,BAO_0000218,15240,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,1,,Plasma,Cavia porcellus,Intermediate,,,10631,10141.0
,U,22224,,,,A,955.0,CHEMBL627725,0,,BAO_0000019,10655,AUC in brain,1,,Brain,,Autocuration,,,10632,
,U,22224,,,,A,1977.0,CHEMBL627726,0,,BAO_0000019,10655,AUC in serum,1,,Serum,,Autocuration,,,10633,
,U,22224,,,,A,1969.0,CHEMBL627727,0,,BAO_0000019,6504,AUC was determined,1,,Plasma,,Autocuration,,,10634,
,U,22224,,,,A,1969.0,CHEMBL627728,0,,BAO_0000019,10615,AUC of the compound.,1,,Plasma,,Autocuration,,,10635,
,U,22224,,,,A,1969.0,CHEMBL627729,0,,BAO_0000019,10353,AUC value (0-4 hr),1,,Plasma,,Autocuration,,,10636,
,U,22224,,,,A,1969.0,CHEMBL627730,0,,BAO_0000019,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",1,,Plasma,,Autocuration,,,10637,
,U,22224,,,,A,1969.0,CHEMBL627731,0,,BAO_0000019,14907,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,1,,Plasma,,Autocuration,,,10638,
,U,22224,,,,A,1969.0,CHEMBL627732,0,,BAO_0000019,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",1,,Plasma,,Autocuration,,,10639,
,U,22224,,,,A,1969.0,CHEMBL627733,0,,BAO_0000019,14907,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",1,,Plasma,,Autocuration,,,10640,
,N,50597,,,,A,1969.0,CHEMBL627734,1,,BAO_0000218,16359,AUC(area under curve) was determined after intravenous administration in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,10641,10116.0
,N,50597,,,,A,1969.0,CHEMBL627735,1,,BAO_0000218,16359,AUC(area under curve) was determined after oral administration in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,10642,10116.0
,N,50512,,,,A,1969.0,CHEMBL627736,1,,BAO_0000218,15240,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,1,,Plasma,Cavia porcellus,Intermediate,,,10643,10141.0
,N,50597,,,,A,1969.0,CHEMBL876809,1,,BAO_0000218,15240,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,1,,Plasma,Rattus norvegicus,Intermediate,,,10644,10116.0
,U,22224,,,,A,,CHEMBL627737,0,,BAO_0000019,15469,Area Under Curve after oral dosing of 100 uM/Kg,1,,,,Autocuration,,,10645,
,U,22224,,,,A,,CHEMBL627738,0,,BAO_0000019,15469,Area Under Curve after oral dosing of 30 uM/Kg,1,,,,Autocuration,,,10646,
,U,22224,,,,A,,CHEMBL627739,0,,BAO_0000019,13520,Area Under Curve was measured by ploting the graph between concentration verses time,1,,,,Autocuration,,,10647,
,N,50588,,,,A,,CHEMBL626143,1,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,1,,,Canis lupus familiaris,Intermediate,,,10648,9615.0
,U,22224,,,,A,,CHEMBL626144,0,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,1,,,Simiiformes,Autocuration,,,10649,314293.0
,N,50592,,,,A,,CHEMBL626145,1,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,1,,,Oryctolagus cuniculus,Intermediate,,,10650,9986.0
,N,50597,,,,A,,CHEMBL626146,1,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,1,,,Rattus norvegicus,Intermediate,,,10651,10116.0
,N,50597,,,,A,178.0,CHEMBL626147,1,,BAO_0000218,12032,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,1,,Blood,Rattus norvegicus,Intermediate,,,10652,10116.0
,U,22224,,,,A,,CHEMBL626148,0,,BAO_0000019,10291,Area under curve (AUC) was determined,1,,,,Autocuration,,,10653,
,U,22224,,,,A,,CHEMBL626149,0,,BAO_0000218,5767,Area under curve (AUC) following ip administration at 1 mg/kg,1,,,,Autocuration,,,10654,
,U,22224,,,,A,,CHEMBL626150,0,,BAO_0000019,1434,Area under curve (AUC) was determined; ND is Not determined,1,,,,Autocuration,,,10655,
,N,50588,,,,A,,CHEMBL626151,1,,BAO_0000218,14925,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,1,,,Canis lupus familiaris,Intermediate,,,10656,9615.0
,N,50588,,,,A,,CHEMBL626152,1,,BAO_0000218,14925,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,1,,,Canis lupus familiaris,Intermediate,,,10657,9615.0
,N,50588,,,,A,,CHEMBL626153,1,,BAO_0000218,14925,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,1,,,Canis lupus familiaris,Intermediate,,,10658,9615.0
,U,22224,,,,A,,CHEMBL626154,0,,BAO_0000019,1434,Area under curve (AUR) was determined,1,,,,Autocuration,,,10659,
,U,22224,,,,A,,CHEMBL626155,0,,BAO_0000019,11883,Area under curve at 1 uM/dg administered intravenously,1,,,,Autocuration,,,10660,
,U,22224,,,,A,,CHEMBL626156,0,,BAO_0000019,11883,Area under curve at 10 uM/dg administered perorally,1,,,,Autocuration,,,10661,
,U,22224,,,,A,,CHEMBL626157,0,,BAO_0000019,11883,Area under curve at 2 uM/dg administered intravenously,1,,,,Autocuration,,,10662,
,U,22224,,,,A,,CHEMBL626158,0,,BAO_0000019,11883,Area under curve at 20 uM/dg administered perorally,1,,,,Autocuration,,,10663,
,N,50588,,,,A,,CHEMBL626159,1,,BAO_0000218,15233,Area under curve at a peroral dose of 3 mg/kg in dog,1,,,Canis lupus familiaris,Intermediate,,,10664,9615.0
,N,50597,,,,A,,CHEMBL626160,1,,BAO_0000218,15233,Area under curve at a peroral dose of 3 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10665,10116.0
,N,50588,,,,A,,CHEMBL626161,1,,BAO_0000218,15233,Area under curve at an iv dose of 1 mg/kg in dog,1,,,Canis lupus familiaris,Intermediate,,,10666,9615.0
,N,50597,,,,A,,CHEMBL626162,1,,BAO_0000218,15233,Area under curve at an iv dose of 1 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10667,10116.0
,U,22224,,,,A,,CHEMBL626163,0,,BAO_0000019,12978,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,1,,,,Autocuration,,,10668,
,U,22224,,,,A,,CHEMBL626164,0,,BAO_0000019,12978,Area under curve gives the effective duration for the angiotensin II antagonist effect.,1,,,,Autocuration,,,10669,
,N,50594,,,,A,,CHEMBL626165,1,,BAO_0000218,11355,Area under curve measured as conc vs time after intravenous administration to mice.,1,,,Mus musculus,Intermediate,,,10670,10090.0
,N,50594,,,,A,,CHEMBL626166,1,,BAO_0000218,11355,Area under curve measured as conc vs time after peroral administration to mice.,1,,,Mus musculus,Intermediate,,,10671,10090.0
,N,50588,,,,A,,CHEMBL626167,1,,BAO_0000218,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,1,,,Canis lupus familiaris,Intermediate,,,10672,9615.0
,N,50588,,,,A,,CHEMBL626168,1,,BAO_0000218,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,1,,,Canis lupus familiaris,Intermediate,,,10673,9615.0
,N,50588,,,,A,,CHEMBL877463,1,,BAO_0000218,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,1,,,Canis lupus familiaris,Intermediate,,,10674,9615.0
,N,50588,,,,A,,CHEMBL626169,1,,BAO_0000218,12923,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,1,,,Canis lupus familiaris,Intermediate,,,10675,9615.0
,N,50597,,,In vivo,A,948.0,CHEMBL626170,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,1,,Heart,Rattus norvegicus,Intermediate,,,10676,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL626171,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,1,,Heart,Rattus norvegicus,Intermediate,,,10677,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL626172,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,1,,Heart,Rattus norvegicus,Intermediate,,,10678,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL626173,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,1,,Heart,Rattus norvegicus,Intermediate,,,10679,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL626174,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,1,,Kidney,Rattus norvegicus,Intermediate,,,10680,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL626175,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,1,,Kidney,Rattus norvegicus,Intermediate,,,10681,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL626176,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,1,,Kidney,Rattus norvegicus,Intermediate,,,10682,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL626177,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,1,,Kidney,Rattus norvegicus,Intermediate,,,10683,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL622499,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,1,,Kidney,Rattus norvegicus,Intermediate,,,10684,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622500,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,1,,Liver,Rattus norvegicus,Intermediate,,,10685,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622501,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,1,,Liver,Rattus norvegicus,Intermediate,,,10686,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622502,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,1,,Liver,Rattus norvegicus,Intermediate,,,10687,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622503,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,1,,Liver,Rattus norvegicus,Intermediate,,,10688,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL877614,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,1,,Liver,Rattus norvegicus,Intermediate,,,10689,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624839,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,1,,Lung,Rattus norvegicus,Intermediate,,,10690,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624840,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,1,,Lung,Rattus norvegicus,Intermediate,,,10691,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624841,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,1,,Lung,Rattus norvegicus,Intermediate,,,10692,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL624842,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,1,,Lung,Rattus norvegicus,Intermediate,,,10693,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624843,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,10694,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624844,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,10695,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL624845,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,10696,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL621904,1,,BAO_0000218,17738,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,10697,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL621905,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,1,,Blood,Rattus norvegicus,Intermediate,,,10698,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL874382,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,1,,Blood,Rattus norvegicus,Intermediate,,,10699,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL621906,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,1,,Blood,Rattus norvegicus,Intermediate,,,10700,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL621907,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,1,,Brain,Rattus norvegicus,Intermediate,,,10701,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622096,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,1,,Brain,Rattus norvegicus,Intermediate,,,10702,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL622097,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,1,,Brain,Rattus norvegicus,Intermediate,,,10703,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL622098,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,1,,Heart,Rattus norvegicus,Intermediate,,,10704,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL622099,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,1,,Heart,Rattus norvegicus,Intermediate,,,10705,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL622100,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,1,,Heart,Rattus norvegicus,Intermediate,,,10706,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL622101,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,1,,Kidney,Rattus norvegicus,Intermediate,,,10707,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL622102,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,1,,Kidney,Rattus norvegicus,Intermediate,,,10708,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL622103,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,1,,Kidney,Rattus norvegicus,Intermediate,,,10709,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622104,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,1,,Liver,Rattus norvegicus,Intermediate,,,10710,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622105,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,1,,Liver,Rattus norvegicus,Intermediate,,,10711,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622106,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,1,,Liver,Rattus norvegicus,Intermediate,,,10712,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL622107,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,1,,Lung,Rattus norvegicus,Intermediate,,,10713,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL622108,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,1,,Lung,Rattus norvegicus,Intermediate,,,10714,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL622109,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,1,,Lung,Rattus norvegicus,Intermediate,,,10715,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL622110,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,10716,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL622111,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,10717,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL874383,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,10718,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL622112,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,1,,Zone of skin,Rattus norvegicus,Intermediate,,,10719,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL622113,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,1,,Zone of skin,Rattus norvegicus,Intermediate,,,10720,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL622114,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,1,,Zone of skin,Rattus norvegicus,Intermediate,,,10721,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL622115,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,1,,Spleen,Rattus norvegicus,Intermediate,,,10722,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL622116,1,,BAO_0000218,11195,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,1,,Spleen,Rattus norvegicus,Intermediate,,,10723,10116.0
,N,50597,,,In vivo,A,,CHEMBL622117,1,,BAO_0000218,6193,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10724,10116.0
,N,50597,,,In vivo,A,,CHEMBL622118,1,,BAO_0000218,6803,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10725,10116.0
,N,50597,,,In vivo,A,,CHEMBL622119,1,,BAO_0000218,6647,Oral bioavailability in rats at 6 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10726,10116.0
,N,50597,,,In vivo,A,,CHEMBL622120,1,,BAO_0000218,6647,Oral bioavailability in rat (dose 6 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10727,10116.0
,N,50597,,,In vivo,A,,CHEMBL622121,1,,BAO_0000218,6647,Oral bioavailability in rats at 6 mg/kg dose; Not tested,1,,,Rattus norvegicus,Intermediate,,,10728,10116.0
,N,50597,,,In vivo,A,,CHEMBL622122,1,,BAO_0000218,6640,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10729,10116.0
,N,50597,,,In vivo,A,,CHEMBL622123,1,,BAO_0000218,6641,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10730,10116.0
,N,50597,,,In vivo,A,,CHEMBL622124,1,,BAO_0000218,6641,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10731,10116.0
,N,50597,,,In vivo,A,,CHEMBL622125,1,,BAO_0000218,6642,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10732,10116.0
,N,50597,,,In vivo,A,,CHEMBL622126,1,,BAO_0000218,5472,Oral bioavailability,1,,,Rattus norvegicus,Intermediate,,,10733,10116.0
,N,50597,,,In vivo,A,,CHEMBL620455,1,,BAO_0000218,6141,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10734,10116.0
,N,50597,,,In vivo,A,,CHEMBL620456,1,,BAO_0000218,4390,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10735,10116.0
,N,50597,,,In vivo,A,,CHEMBL620457,1,,BAO_0000218,5472,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10736,10116.0
,N,50597,,,In vivo,A,,CHEMBL620458,1,,BAO_0000218,5472,Oral bioavailability was evaluated; Not tested,1,,,Rattus norvegicus,Intermediate,,,10737,10116.0
,N,50597,,,In vivo,A,,CHEMBL620459,1,,BAO_0000218,5438,Oral bioavailability,1,,,Rattus norvegicus,Intermediate,,,10738,10116.0
,N,50597,,,In vivo,A,,CHEMBL620460,1,,BAO_0000218,4883,Oral bioavailability in rat by oral dosing,1,,,Rattus norvegicus,Intermediate,,,10739,10116.0
,N,50597,,,In vivo,A,,CHEMBL620461,1,,BAO_0000218,1908,Oral bioavailability in rat (dose 10 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10740,10116.0
,N,50597,,,In vivo,A,,CHEMBL620462,1,,BAO_0000218,4853,Oral bioavailability in rat (Sprague-Dawley),1,,,Rattus norvegicus,Intermediate,,,10741,10116.0
,N,50597,,,In vivo,A,,CHEMBL620463,1,,BAO_0000218,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10742,10116.0
,N,50597,,,In vivo,A,,CHEMBL620464,1,,BAO_0000218,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10743,10116.0
,N,50597,,,In vivo,A,,CHEMBL620465,1,,BAO_0000218,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10744,10116.0
,N,50597,,,In vivo,A,,CHEMBL620466,1,,BAO_0000218,4853,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10745,10116.0
,N,50597,,,In vivo,A,,CHEMBL620467,1,,BAO_0000218,4853,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10746,10116.0
,N,50597,,,In vivo,A,,CHEMBL620468,1,,BAO_0000218,4853,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10747,10116.0
,N,50597,,,In vivo,A,,CHEMBL620469,1,,BAO_0000218,12873,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,1,,,Rattus norvegicus,Intermediate,,,10748,10116.0
,N,50597,,,In vivo,A,,CHEMBL620470,1,,BAO_0000218,12873,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,1,,,Rattus norvegicus,Intermediate,,,10749,10116.0
,N,50597,,,In vivo,A,,CHEMBL620471,1,,BAO_0000218,3169,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10750,10116.0
,N,50597,,,In vivo,A,,CHEMBL620472,1,,BAO_0000218,6305,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10751,10116.0
,N,50597,,,In vivo,A,,CHEMBL620473,1,,BAO_0000218,4762,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,1,,,Rattus norvegicus,Intermediate,,,10752,10116.0
,N,50597,,,In vivo,A,,CHEMBL620474,1,,BAO_0000218,17847,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10753,10116.0
,N,50597,,,In vivo,A,,CHEMBL620475,1,,BAO_0000218,6211,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10754,10116.0
,N,50597,,,In vivo,A,,CHEMBL620476,1,,BAO_0000218,6011,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10755,10116.0
,N,50597,,,In vivo,A,,CHEMBL620477,1,,BAO_0000218,6317,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10756,10116.0
,N,50597,,,In vivo,A,,CHEMBL620478,1,,BAO_0000218,6644,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,10757,10116.0
,N,50597,,,In vivo,A,,CHEMBL618768,1,,BAO_0000218,6644,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,10758,10116.0
,N,50597,,,In vivo,A,,CHEMBL618769,1,,BAO_0000218,6644,Oral bioavailability in rat after oral administration at 13 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,10759,10116.0
,N,50597,,,In vivo,A,,CHEMBL618770,1,,BAO_0000218,6644,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,10760,10116.0
,N,50597,,,In vivo,A,,CHEMBL618771,1,,BAO_0000218,6113,Oral bioavailability (dose 20 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10761,10116.0
,N,50597,,,In vivo,A,,CHEMBL618772,1,,BAO_0000218,5937,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10762,10116.0
,N,50597,,,In vivo,A,,CHEMBL618773,1,,BAO_0000218,5711,Oral bioavailability in rat at 10 mg/kg of the compound,1,,,Rattus norvegicus,Intermediate,,,10763,10116.0
,N,50597,,,In vivo,A,,CHEMBL875842,1,,BAO_0000218,17717,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,1,,,Rattus norvegicus,Intermediate,,,10764,10116.0
,N,50597,,,In vivo,A,,CHEMBL618774,1,,BAO_0000218,17717,Bioavailability in rat (dose 3 mg/kg i.v.),1,,,Rattus norvegicus,Intermediate,,,10765,10116.0
,N,50597,,,In vivo,A,,CHEMBL618775,1,,BAO_0000218,17717,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,1,,,Rattus norvegicus,Intermediate,,,10766,10116.0
,N,50597,,,In vivo,A,,CHEMBL618776,1,,BAO_0000218,17717,Oral bioavailability in rat (dose 60 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10767,10116.0
,N,50597,,,In vivo,A,,CHEMBL618777,1,,BAO_0000218,4722,Percent bioavailability (F) in rats after iv administration,1,,,Rattus norvegicus,Intermediate,,,10768,10116.0
,N,50597,,,In vivo,A,,CHEMBL618778,1,,BAO_0000218,4722,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10769,10116.0
,N,50597,,,In vivo,A,,CHEMBL618779,1,,BAO_0000218,4353,Bioavailability in rat (dose 5 uM/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10770,10116.0
,N,50597,,,In vivo,A,,CHEMBL618780,1,,BAO_0000218,15662,Oral bioavailability,1,,,Rattus norvegicus,Intermediate,,,10771,10116.0
,N,50597,,,In vivo,A,,CHEMBL618781,1,,BAO_0000218,4756,Bioavailability in rat (dose 2 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10772,10116.0
,N,50597,,,In vivo,A,,CHEMBL618782,1,,BAO_0000218,4756,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,1,,,Rattus norvegicus,Intermediate,,,10773,10116.0
,N,50597,,,In vivo,A,,CHEMBL618783,1,,BAO_0000218,3436,Oral bioavailability in rat (dose 20 mg/kg),1,,,Rattus norvegicus,Intermediate,,,10774,10116.0
,N,50597,,,In vivo,A,,CHEMBL618784,1,,BAO_0000218,17800,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10775,10116.0
,N,50597,,,In vivo,A,,CHEMBL618785,1,,BAO_0000218,15762,Percent oral bioavailability evaluated in rat,1,,,Rattus norvegicus,Intermediate,,,10776,10116.0
,N,50597,,,In vivo,A,,CHEMBL618786,1,,BAO_0000218,5089,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10777,10116.0
,N,50597,,,In vivo,A,,CHEMBL618787,1,,BAO_0000218,5089,Percent oral bioavailability in rat; Not determined,1,,,Rattus norvegicus,Intermediate,,,10778,10116.0
,N,50597,,,In vivo,A,,CHEMBL618788,1,,BAO_0000218,3185,Oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10779,10116.0
,N,50597,,,In vivo,A,,CHEMBL618789,1,,BAO_0000218,5145,Bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10780,10116.0
,N,50597,,,In vivo,A,,CHEMBL618790,1,,BAO_0000218,3457,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),1,,,Rattus norvegicus,Intermediate,,,10781,10116.0
,N,50597,,,In vivo,A,,CHEMBL618791,1,,BAO_0000218,3457,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),1,,,Rattus norvegicus,Intermediate,,,10782,10116.0
,N,50597,,,In vivo,A,,CHEMBL875843,1,,BAO_0000218,5983,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10783,10116.0
,N,50597,,,In vivo,A,,CHEMBL618792,1,,BAO_0000218,5739,Oral bioavailability in rat (dose 20 mg/kg p.o.),1,,,Rattus norvegicus,Intermediate,,,10784,10116.0
,N,50597,,,In vivo,A,,CHEMBL623395,1,,BAO_0000218,3579,Cmax at a dose of 30 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10785,10116.0
,U,22224,,,In vivo,A,,CHEMBL623396,0,,BAO_0000218,17788,Cmax in monkeys at a dose of 1 mg/kg,1,,,Simiiformes,Autocuration,,,10786,314293.0
,N,50597,,,In vivo,A,,CHEMBL623397,1,,BAO_0000218,14956,Cmax in rat,1,,,Rattus norvegicus,Intermediate,,,10787,10116.0
,N,50597,,,In vivo,A,,CHEMBL623398,1,,BAO_0000218,17788,Cmax in rats at a dose of 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,10788,10116.0
,N,50594,,,In vivo,A,,CHEMBL623399,1,,BAO_0000218,9750,Cmax was measured in mice after an oral dose of 50 mg/kg.,1,,,Mus musculus,Intermediate,,,10789,10090.0
,U,22224,,,In vivo,A,,CHEMBL623400,0,,BAO_0000218,12767,"Cmax value at a dose of 12.7 uM/kg, po",1,,,,Autocuration,,,10790,
,U,22224,,,In vivo,A,,CHEMBL623401,0,,BAO_0000218,12767,"Cmax value at a dose of 6.3 uM/kg, iv",1,,,,Autocuration,,,10791,
,U,22224,,,In vivo,A,,CHEMBL623402,0,,BAO_0000218,12767,"Cmax value at a dose of 7.1 uM/kg, iv",1,,,,Autocuration,,,10792,
,U,22224,,,In vivo,A,,CHEMBL623403,0,,BAO_0000218,12703,Cmax value of compound was determined after 1 hr,1,,,,Autocuration,,,10793,
,U,22224,,,In vivo,A,,CHEMBL623404,0,,BAO_0000218,15778,Cmax value of the compound,1,,,,Autocuration,,,10794,
,N,50597,,,In vivo,A,,CHEMBL625997,1,,BAO_0000218,12818,Cmax value administered intraintestinal in rats.,1,,,Rattus norvegicus,Intermediate,,,10795,10116.0
,N,50597,,,In vivo,A,,CHEMBL625998,1,,BAO_0000218,14964,Cmax value administered perorally was determined in rat; Not determined,1,,,Rattus norvegicus,Intermediate,,,10796,10116.0
,U,22224,,,In vivo,A,,CHEMBL625999,0,,BAO_0000218,15808,Cmax value at the dose of 2.3 mg/kg,1,,,,Autocuration,,,10797,
,U,22224,,,In vivo,A,,CHEMBL626000,0,,BAO_0000218,15808,Cmax value at the dose of 5 mg/kg,1,,,,Autocuration,,,10798,
,U,22224,,,In vivo,A,,CHEMBL626001,0,,BAO_0000218,15778,Cmax value in the period of 8 hr after dosing. ,1,,,,Autocuration,,,10799,
,U,22224,,,In vivo,A,,CHEMBL626002,0,,BAO_0000218,3715,Cmax value at a oral dose of 20 mg/kg; Not tested,1,,,,Autocuration,,,10800,
,U,22224,,,In vivo,A,,CHEMBL626003,0,,BAO_0000218,3715,Cmax value at a oral dose of 20 mg/kg,1,,,,Autocuration,,,10801,
,N,50597,,,In vivo,A,,CHEMBL626004,1,,BAO_0000218,1446,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1,,,Rattus norvegicus,Intermediate,,,10802,10116.0
,N,50512,,,In vivo,A,,CHEMBL626005,1,,BAO_0000218,15240,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,1,,,Cavia porcellus,Intermediate,,,10803,10141.0
,N,50597,,,In vivo,A,,CHEMBL626006,1,,BAO_0000218,15240,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,1,,,Rattus norvegicus,Intermediate,,,10804,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626007,1,,BAO_0000218,14810,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,1,,Plasma,Rattus norvegicus,Intermediate,,,10805,10116.0
,N,50594,,,In vivo,A,1969.0,CHEMBL626008,1,,BAO_0000218,14239,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,1,,Plasma,Mus musculus,Intermediate,,,10806,10090.0
,N,50588,,,In vivo,A,2107.0,CHEMBL626009,1,,BAO_0000218,12555,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,1,,Liver,Canis lupus familiaris,Intermediate,,,10807,9615.0
,N,50588,,,In vivo,A,,CHEMBL626010,1,,BAO_0000218,10754,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,1,,,Canis lupus familiaris,Intermediate,,,10808,9615.0
,N,50594,,,In vivo,A,178.0,CHEMBL626011,1,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,1,,Blood,Mus musculus,Intermediate,,,10809,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL626012,1,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,1,,Blood,Mus musculus,Intermediate,,,10810,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL626013,1,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,1,,Blood,Mus musculus,Intermediate,,,10811,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL626014,1,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,1,,Blood,Mus musculus,Intermediate,,,10812,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL877496,1,,BAO_0000218,10754,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,1,,Blood,Mus musculus,Intermediate,,,10813,10090.0
,N,50588,,,In vivo,F,,CHEMBL626015,1,,BAO_0000218,14600,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,1,,,Canis lupus familiaris,Intermediate,,,10814,9615.0
,N,50588,,,In vivo,F,,CHEMBL626016,1,,BAO_0000218,14600,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,1,,,Canis lupus familiaris,Intermediate,,,10815,9615.0
,N,50588,,,In vivo,F,,CHEMBL626017,1,,BAO_0000218,14600,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,1,,,Canis lupus familiaris,Intermediate,,,10816,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626018,1,,BAO_0000218,13543,Bioavailability as maximal plasma concentration in dogs,1,,Plasma,Canis lupus familiaris,Intermediate,,,10817,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626692,1,,BAO_0000218,13543,Bioavailability as maximal plasma concentration in dogs,1,,Plasma,Canis lupus familiaris,Intermediate,,,10818,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626693,1,,BAO_0000218,13543,Bioavailability as maximal plasma concentration in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,10819,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626694,0,,BAO_0000218,13543,Bioavailability as maximal plasma concentration in rats,1,,Plasma,Rattus norvegicus,Autocuration,,,10820,10116.0
,N,50588,,,In vivo,A,178.0,CHEMBL626695,1,,BAO_0000218,14600,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,Blood,Canis lupus familiaris,Intermediate,,,10821,9615.0
,N,50588,,,In vivo,A,178.0,CHEMBL626696,1,,BAO_0000218,14600,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,Blood,Canis lupus familiaris,Intermediate,,,10822,9615.0
,N,50588,,,In vivo,A,178.0,CHEMBL626697,1,,BAO_0000218,14600,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,Blood,Canis lupus familiaris,Intermediate,,,10823,9615.0
,N,50588,,,In vivo,A,178.0,CHEMBL626859,1,,BAO_0000218,14600,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,1,,Blood,Canis lupus familiaris,Intermediate,,,10824,9615.0
,N,50588,,,In vivo,A,178.0,CHEMBL626860,1,,BAO_0000218,14600,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,Blood,Canis lupus familiaris,Intermediate,,,10825,9615.0
,N,50588,,,In vivo,A,178.0,CHEMBL626861,1,,BAO_0000218,14600,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,1,,Blood,Canis lupus familiaris,Intermediate,,,10826,9615.0
,N,50597,,,In vivo,A,,CHEMBL626296,1,,BAO_0000218,14681,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,1,,,Rattus norvegicus,Intermediate,,,10827,10116.0
,U,22224,,,In vivo,A,,CHEMBL626297,0,,BAO_0000218,15905,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,1,,,,Autocuration,,,10828,
,U,22224,,,In vivo,A,1969.0,CHEMBL626298,0,,BAO_0000218,15905,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,1,,Plasma,,Autocuration,,,10829,
,N,50597,,,In vivo,A,1969.0,CHEMBL626299,1,,BAO_0000218,13304,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",1,,Plasma,Rattus norvegicus,Intermediate,,,10830,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626300,1,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,1,,Plasma,Rattus norvegicus,Intermediate,,,10831,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626301,1,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,1,,Plasma,Rattus norvegicus,Intermediate,,,10832,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626962,1,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,1,,Plasma,Rattus norvegicus,Intermediate,,,10833,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626963,1,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,1,,Plasma,Rattus norvegicus,Intermediate,,,10834,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626964,1,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,1,,Plasma,Rattus norvegicus,Intermediate,,,10835,10116.0
,N,100710,,,In vivo,A,1969.0,CHEMBL626965,1,,BAO_0000218,14839,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,1,,Plasma,Macaca fascicularis,Intermediate,,,10836,9541.0
,N,50594,,,In vivo,A,1969.0,CHEMBL626966,1,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,Plasma,Mus musculus,Intermediate,,,10837,10090.0
,N,50594,,,In vivo,A,1969.0,CHEMBL626967,1,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,Plasma,Mus musculus,Intermediate,,,10838,10090.0
,N,100710,,,In vivo,A,1969.0,CHEMBL626968,1,,BAO_0000218,14839,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,1,,Plasma,Macaca fascicularis,Intermediate,,,10839,9541.0
,N,50597,,,,A,948.0,CHEMBL626969,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,1,,Heart,Rattus norvegicus,Intermediate,,,10840,10116.0
,N,50597,,,,A,948.0,CHEMBL627126,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,1,,Heart,Rattus norvegicus,Intermediate,,,10841,10116.0
,N,50597,,,,A,948.0,CHEMBL631276,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,1,,Heart,Rattus norvegicus,Intermediate,,,10842,10116.0
,N,50597,,,,A,948.0,CHEMBL631277,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,1,,Heart,Rattus norvegicus,Intermediate,,,10843,10116.0
,N,50597,,,,A,948.0,CHEMBL631278,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,1,,Heart,Rattus norvegicus,Intermediate,,,10844,10116.0
,N,50597,,,,A,948.0,CHEMBL874457,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,1,,Heart,Rattus norvegicus,Intermediate,,,10845,10116.0
,N,50597,,,,A,948.0,CHEMBL631279,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,1,,Heart,Rattus norvegicus,Intermediate,,,10846,10116.0
,N,50597,,,,A,948.0,CHEMBL631280,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,1,,Heart,Rattus norvegicus,Intermediate,,,10847,10116.0
,N,50597,,,,A,948.0,CHEMBL631281,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,1,,Heart,Rattus norvegicus,Intermediate,,,10848,10116.0
,N,50597,,,,A,948.0,CHEMBL631968,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,1,,Heart,Rattus norvegicus,Intermediate,,,10849,10116.0
,N,50597,,,,A,948.0,CHEMBL631969,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,1,,Heart,Rattus norvegicus,Intermediate,,,10850,10116.0
,N,50597,,,,A,948.0,CHEMBL631970,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,1,,Heart,Rattus norvegicus,Intermediate,,,10851,10116.0
,N,50597,,,,A,948.0,CHEMBL631971,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,1,,Heart,Rattus norvegicus,Intermediate,,,10852,10116.0
,N,50597,,,,A,948.0,CHEMBL631972,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,1,,Heart,Rattus norvegicus,Intermediate,,,10853,10116.0
,N,50597,,,,A,948.0,CHEMBL630435,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,1,,Heart,Rattus norvegicus,Intermediate,,,10854,10116.0
,N,50597,,,,A,948.0,CHEMBL630436,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,1,,Heart,Rattus norvegicus,Intermediate,,,10855,10116.0
,N,50597,,,,A,948.0,CHEMBL630437,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,1,,Heart,Rattus norvegicus,Intermediate,,,10856,10116.0
,N,50597,,,,A,948.0,CHEMBL630438,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,1,,Heart,Rattus norvegicus,Intermediate,,,10857,10116.0
,N,50597,,,,A,948.0,CHEMBL630439,1,,BAO_0000218,8418,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,1,,Heart,Rattus norvegicus,Intermediate,,,10858,10116.0
,N,50597,,,,A,2113.0,CHEMBL630440,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,1,,Kidney,Rattus norvegicus,Intermediate,,,10859,10116.0
,N,50597,,,,A,2113.0,CHEMBL630441,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,1,,Kidney,Rattus norvegicus,Intermediate,,,10860,10116.0
,N,50597,,,,A,2113.0,CHEMBL630442,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,1,,Kidney,Rattus norvegicus,Intermediate,,,10861,10116.0
,N,50597,,,,A,2113.0,CHEMBL625234,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,1,,Kidney,Rattus norvegicus,Intermediate,,,10862,10116.0
,N,50597,,,,A,2113.0,CHEMBL625235,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,1,,Kidney,Rattus norvegicus,Intermediate,,,10863,10116.0
,N,50597,,,,A,2113.0,CHEMBL625236,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,1,,Kidney,Rattus norvegicus,Intermediate,,,10864,10116.0
,N,50597,,,,A,2113.0,CHEMBL625237,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,1,,Kidney,Rattus norvegicus,Intermediate,,,10865,10116.0
,N,50597,,,,A,2113.0,CHEMBL626125,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,1,,Kidney,Rattus norvegicus,Intermediate,,,10866,10116.0
,N,50597,,,,A,2113.0,CHEMBL626126,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,1,,Kidney,Rattus norvegicus,Intermediate,,,10867,10116.0
,N,50597,,,,A,2113.0,CHEMBL626127,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,1,,Kidney,Rattus norvegicus,Intermediate,,,10868,10116.0
,N,50597,,,,A,2113.0,CHEMBL626128,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,1,,Kidney,Rattus norvegicus,Intermediate,,,10869,10116.0
,N,50597,,,,A,2113.0,CHEMBL626129,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,1,,Kidney,Rattus norvegicus,Intermediate,,,10870,10116.0
,N,50597,,,,A,2113.0,CHEMBL626130,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,1,,Kidney,Rattus norvegicus,Intermediate,,,10871,10116.0
,N,50597,,,,A,2113.0,CHEMBL626131,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,1,,Kidney,Rattus norvegicus,Intermediate,,,10872,10116.0
,N,50597,,,,A,2113.0,CHEMBL626132,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,1,,Kidney,Rattus norvegicus,Intermediate,,,10873,10116.0
,N,50597,,,,A,2113.0,CHEMBL626752,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,1,,Kidney,Rattus norvegicus,Intermediate,,,10874,10116.0
,N,50597,,,,A,2113.0,CHEMBL626753,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,1,,Kidney,Rattus norvegicus,Intermediate,,,10875,10116.0
,N,50597,,,,A,2113.0,CHEMBL626754,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,1,,Kidney,Rattus norvegicus,Intermediate,,,10876,10116.0
,N,50597,,,,A,2113.0,CHEMBL626755,1,,BAO_0000218,8418,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,1,,Kidney,Rattus norvegicus,Intermediate,,,10877,10116.0
,N,50597,,,,A,2107.0,CHEMBL626756,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,1,,Liver,Rattus norvegicus,Intermediate,,,10878,10116.0
,N,50597,,,,A,2107.0,CHEMBL626757,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,1,,Liver,Rattus norvegicus,Intermediate,,,10879,10116.0
,N,50597,,,,A,2107.0,CHEMBL626758,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,1,,Liver,Rattus norvegicus,Intermediate,,,10880,10116.0
,N,50597,,,,A,2107.0,CHEMBL626759,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,1,,Liver,Rattus norvegicus,Intermediate,,,10881,10116.0
,N,50597,,,,A,2107.0,CHEMBL626760,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,1,,Liver,Rattus norvegicus,Intermediate,,,10882,10116.0
,N,50588,,,,A,,CHEMBL626394,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10883,9615.0
,N,50588,,,,A,,CHEMBL626395,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,10884,9615.0
,N,50588,,,,A,,CHEMBL626396,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10885,9615.0
,N,50588,,,,A,,CHEMBL626397,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,,,Canis lupus familiaris,Intermediate,,,10886,9615.0
,N,50588,,,,A,,CHEMBL626398,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,,,Canis lupus familiaris,Intermediate,,,10887,9615.0
,N,50588,,,,A,,CHEMBL626399,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10888,9615.0
,N,50597,,,,A,,CHEMBL874653,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,10889,10116.0
,N,50597,,,,A,,CHEMBL626400,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10890,10116.0
,N,50597,,,,A,,CHEMBL626401,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10891,10116.0
,N,50597,,,,A,,CHEMBL626402,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,10892,10116.0
,N,50597,,,,A,,CHEMBL626403,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,10893,10116.0
,N,50597,,,,A,,CHEMBL626404,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10894,10116.0
,N,50597,,,,A,,CHEMBL626405,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,10895,10116.0
,N,50597,,,,A,,CHEMBL625529,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10896,10116.0
,N,50597,,,,A,,CHEMBL625530,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10897,10116.0
,N,50597,,,,A,,CHEMBL625531,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,10898,10116.0
,N,50597,,,,A,,CHEMBL625532,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,10899,10116.0
,N,50597,,,,A,,CHEMBL625533,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10900,10116.0
,N,50597,,,,A,,CHEMBL875474,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,10901,10116.0
,N,50597,,,,A,,CHEMBL625534,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10902,10116.0
,N,50597,,,,A,,CHEMBL625535,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10903,10116.0
,N,50597,,,,A,,CHEMBL625536,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,10904,10116.0
,N,50597,,,,A,,CHEMBL625537,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,10905,10116.0
,N,50597,,,,A,,CHEMBL625538,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10906,10116.0
,N,50597,,,,A,,CHEMBL625539,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,10907,10116.0
,N,50597,,,,A,,CHEMBL625540,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10908,10116.0
,N,50597,,,,A,,CHEMBL625541,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10909,10116.0
,N,50597,,,,A,,CHEMBL625542,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,10910,10116.0
,N,50597,,,,A,,CHEMBL625543,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,10911,10116.0
,N,50597,,,,A,,CHEMBL625544,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,10912,10116.0
,N,50588,,,,A,,CHEMBL625545,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,10913,9615.0
,N,50588,,,,A,,CHEMBL625546,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10914,9615.0
,N,50588,,,,A,,CHEMBL625547,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,10915,9615.0
,N,50588,,,,A,,CHEMBL625548,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10916,9615.0
,N,50588,,,,A,,CHEMBL625549,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10917,9615.0
,N,50588,,,,A,,CHEMBL625550,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10918,9615.0
,N,50588,,,,A,,CHEMBL625551,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10919,9615.0
,N,50588,,,,A,,CHEMBL875475,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10920,9615.0
,N,50588,,,,A,,CHEMBL625552,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10921,9615.0
,N,50588,,,,A,,CHEMBL625553,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10922,9615.0
,N,50588,,,,A,,CHEMBL625554,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,,,Canis lupus familiaris,Intermediate,,,10923,9615.0
,N,50588,,,,A,,CHEMBL625555,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,,,Canis lupus familiaris,Intermediate,,,10924,9615.0
,N,50588,,,,A,,CHEMBL625556,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10925,9615.0
,N,50588,,,,A,,CHEMBL624986,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,10926,9615.0
,N,50588,,,,A,,CHEMBL624987,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,10927,9615.0
,N,50588,,,,A,,CHEMBL624988,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,,,Canis lupus familiaris,Intermediate,,,10928,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624989,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,1,,Artery,Canis lupus familiaris,Intermediate,,,10929,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624990,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,1,,Artery,Canis lupus familiaris,Intermediate,,,10930,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL874391,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,1,,Artery,Canis lupus familiaris,Intermediate,,,10931,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624991,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,1,,Artery,Canis lupus familiaris,Intermediate,,,10932,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624992,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,1,,Artery,Canis lupus familiaris,Intermediate,,,10933,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624993,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,1,,Artery,Canis lupus familiaris,Intermediate,,,10934,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624994,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,1,,Artery,Canis lupus familiaris,Intermediate,,,10935,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624995,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,1,,Artery,Canis lupus familiaris,Intermediate,,,10936,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624996,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,1,,Artery,Canis lupus familiaris,Intermediate,,,10937,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624997,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,1,,Artery,Canis lupus familiaris,Intermediate,,,10938,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624998,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,1,,Artery,Canis lupus familiaris,Intermediate,,,10939,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624999,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,1,,Artery,Canis lupus familiaris,Intermediate,,,10940,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL882955,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,1,,Artery,Canis lupus familiaris,Intermediate,,,10941,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL625000,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,1,,Artery,Canis lupus familiaris,Intermediate,,,10942,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL625001,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,1,,Artery,Canis lupus familiaris,Intermediate,,,10943,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL625089,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,1,,Artery,Canis lupus familiaris,Intermediate,,,10944,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL625090,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,1,,Artery,Canis lupus familiaris,Intermediate,,,10945,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL625091,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,1,,Artery,Canis lupus familiaris,Intermediate,,,10946,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL625092,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,1,,Artery,Canis lupus familiaris,Intermediate,,,10947,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL625093,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,1,,Artery,Canis lupus familiaris,Intermediate,,,10948,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL625094,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,1,,Artery,Canis lupus familiaris,Intermediate,,,10949,9615.0
,N,50588,,,In vivo,A,1637.0,CHEMBL625095,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,1,,Artery,Canis lupus familiaris,Intermediate,,,10950,9615.0
,N,50588,,,In vivo,A,,CHEMBL625096,1,,BAO_0000218,2249,Compound was evaluated for its bioavailability in the dogs,1,,,Canis lupus familiaris,Intermediate,,,10951,9615.0
,N,50597,,,In vivo,A,,CHEMBL625097,1,,BAO_0000218,2249,Compound was evaluated for its bioavailability in the rats,1,,,Rattus norvegicus,Intermediate,,,10952,10116.0
,U,22224,,,In vivo,A,,CHEMBL882956,0,,BAO_0000218,17515,Compound was evaluated for oral bioavailability,1,,,,Autocuration,,,10953,
,N,50597,,,In vivo,A,,CHEMBL625098,1,,BAO_0000218,14541,Compound was evaluated for percentage of Oral bioavailability in rats,1,,,Rattus norvegicus,Intermediate,,,10954,10116.0
,U,22224,,,In vivo,A,,CHEMBL625099,0,,BAO_0000218,12797,Bioavailability in guinea pig,1,,,Cavia porcellus,Autocuration,,,10955,10141.0
,N,50597,,,In vivo,A,,CHEMBL625100,1,,BAO_0000218,12797,Compound was evaluated for the oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10956,10116.0
,N,50588,,,In vivo,A,,CHEMBL625101,1,,BAO_0000218,12797,Compound was evaluated for the oral bioavailability in dog,1,,,Canis lupus familiaris,Intermediate,,,10957,9615.0
,N,50597,,,In vivo,A,,CHEMBL874396,1,,BAO_0000218,12797,Compound was evaluated for the oral bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10958,10116.0
,U,22224,,,In vivo,F,,CHEMBL625102,0,,BAO_0000218,11727,Bioavailability in dog (dosed i.v.),1,,,Canis lupus familiaris,Autocuration,,,10959,9615.0
,N,50588,,,In vivo,A,,CHEMBL625103,1,,BAO_0000218,13249,Compound was tested for in vivo bioavailability in dog,1,,,Canis lupus familiaris,Intermediate,,,10960,9615.0
,N,100712,,,In vivo,A,,CHEMBL625104,1,,BAO_0000218,13249,Compound was tested for in vivo bioavailability in hamsters,1,,,Cricetinae,Intermediate,,,10961,10026.0
,U,22224,,,In vivo,A,,CHEMBL625105,0,,BAO_0000218,13249,Compound was tested for in vivo bioavailability in monkey,1,,,Simiiformes,Autocuration,,,10962,314293.0
,N,50597,,,In vivo,A,,CHEMBL625106,1,,BAO_0000218,13249,Compound was tested for in vivo bioavailability in rat,1,,,Rattus norvegicus,Intermediate,,,10963,10116.0
,U,22224,,,In vivo,A,,CHEMBL625107,0,,BAO_0000218,9552,Oral bioavailability in mouse,1,,,Mus musculus,Autocuration,,,10964,10090.0
,N,50594,,,In vivo,A,,CHEMBL625108,1,,BAO_0000218,9552,Compound was tested for percent of oral bioavailability in mice; 56-74,1,,,Mus musculus,Intermediate,,,10965,10090.0
,U,22224,,,In vivo,A,,CHEMBL625109,0,,BAO_0000218,14839,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),1,,,Mus musculus,Autocuration,,,10966,10090.0
,U,22224,,,In vivo,A,,CHEMBL625110,0,,BAO_0000218,14839,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),1,,,Macaca fascicularis,Autocuration,,,10967,9541.0
,U,22224,,,In vivo,A,,CHEMBL625111,0,,BAO_0000218,14839,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),1,,,Macaca fascicularis,Autocuration,,,10968,9541.0
,N,50594,,,In vivo,A,,CHEMBL625112,1,,BAO_0000218,14839,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),1,,,Mus musculus,Intermediate,,,10969,10090.0
,N,50594,,,In vivo,A,,CHEMBL875334,1,,BAO_0000218,14839,Oral bioavailability in nude mice,1,,,Mus musculus,Intermediate,,,10970,10090.0
,U,22224,,,In vivo,A,,CHEMBL628617,0,,BAO_0000218,11219,Bioavailability in monkey (i.d. dosing),1,,,Primates,Autocuration,,,10971,9443.0
,U,22224,,,In vivo,A,,CHEMBL628618,0,,BAO_0000218,9552,Bioavailability in rat,1,,,Rattus norvegicus,Autocuration,,,10972,10116.0
,U,22224,,,In vivo,A,,CHEMBL628619,0,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,1,,,,Autocuration,,,10973,
,U,22224,,,In vivo,A,,CHEMBL628620,0,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,1,,,,Autocuration,,,10974,
,N,100710,,,In vivo,A,,CHEMBL628621,1,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,,,Macaca fascicularis,Intermediate,,,10975,9541.0
,N,100710,,,In vivo,A,,CHEMBL628622,1,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,,,Macaca fascicularis,Intermediate,,,10976,9541.0
,N,100710,,,In vivo,A,,CHEMBL628623,1,,BAO_0000218,14839,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",1,,,Macaca fascicularis,Intermediate,,,10977,9541.0
,N,100710,,,In vivo,A,1969.0,CHEMBL628624,1,,BAO_0000218,14839,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,1,,Plasma,Macaca fascicularis,Intermediate,,,10978,9541.0
,N,50594,,,In vivo,A,1969.0,CHEMBL628625,1,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,Plasma,Mus musculus,Intermediate,,,10979,10090.0
,N,100710,,,In vivo,A,1969.0,CHEMBL628626,1,,BAO_0000218,14839,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,1,,Plasma,Macaca fascicularis,Intermediate,,,10980,9541.0
,N,50594,,,In vivo,A,1969.0,CHEMBL627041,1,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,Plasma,Mus musculus,Intermediate,,,10981,10090.0
,N,50594,,,In vivo,A,1969.0,CHEMBL627042,1,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,Plasma,Mus musculus,Intermediate,,,10982,10090.0
,N,50594,,,In vivo,A,1969.0,CHEMBL627043,1,,BAO_0000218,14839,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,1,,Plasma,Mus musculus,Intermediate,,,10983,10090.0
,U,22224,,,In vivo,A,1969.0,CHEMBL627044,0,,BAO_0000218,13932,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,1,,Plasma,,Autocuration,,,10984,
,N,50594,,,In vivo,A,1969.0,CHEMBL627045,1,,BAO_0000218,11637,Cmax in mouse plasma,1,,Plasma,Mus musculus,Intermediate,,,10985,10090.0
,U,22224,,,In vivo,A,1969.0,CHEMBL627046,0,,BAO_0000218,11637,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,1,,Plasma,,Autocuration,,,10986,
,N,50597,,,In vivo,A,1969.0,CHEMBL627047,1,,BAO_0000218,13960,Maximal plasma concentration in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,10987,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627048,1,,BAO_0000218,15905,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,10988,10116.0
,N,50597,,,In vivo,A,,CHEMBL627049,1,,BAO_0000218,14062,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10989,10116.0
,N,50597,,,In vivo,A,,CHEMBL627050,1,,BAO_0000218,14062,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10990,10116.0
,N,50597,,,In vivo,A,,CHEMBL627051,1,,BAO_0000218,14062,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10991,10116.0
,N,50597,,,In vivo,A,,CHEMBL627052,1,,BAO_0000218,14062,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10992,10116.0
,N,50597,,,In vivo,A,,CHEMBL627053,1,,BAO_0000218,14062,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10993,10116.0
,N,50597,,,In vivo,A,,CHEMBL627054,1,,BAO_0000218,14062,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,10994,10116.0
,N,50594,,,In vivo,A,,CHEMBL627055,1,,BAO_0000218,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,,Mus musculus,Intermediate,,,10995,10090.0
,N,50594,,,In vivo,A,,CHEMBL627056,1,,BAO_0000218,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,1,,,Mus musculus,Intermediate,,,10996,10090.0
,N,50594,,,In vivo,A,,CHEMBL627057,1,,BAO_0000218,15011,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),1,,,Mus musculus,Intermediate,,,10997,10090.0
,N,50594,,,In vivo,A,,CHEMBL627058,1,,BAO_0000218,15011,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,1,,,Mus musculus,Intermediate,,,10998,10090.0
,N,50594,,,In vivo,A,,CHEMBL626211,1,,BAO_0000218,15011,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,1,,,Mus musculus,Intermediate,,,10999,10090.0
,U,22224,,,In vivo,A,,CHEMBL626212,0,,BAO_0000218,10291,Maximum Concentration of the compound.,1,,,,Autocuration,,,11000,
,N,50588,,,In vivo,A,,CHEMBL626213,1,,BAO_0000218,14599,Maximum Concentration was measured after iv administration into Beagle dog,1,,,Canis lupus familiaris,Intermediate,,,11001,9615.0
,N,50588,,,In vivo,A,,CHEMBL626214,1,,BAO_0000218,14599,Maximum Concentration was measured after iv administration into Beagle dog.,1,,,Canis lupus familiaris,Intermediate,,,11002,9615.0
,N,50588,,,In vivo,A,,CHEMBL626215,1,,BAO_0000218,14599,Maximum Concentration was measured after po administration into Beagle dog,1,,,Canis lupus familiaris,Intermediate,,,11003,9615.0
,N,50588,,,In vivo,A,,CHEMBL626216,1,,BAO_0000218,14599,Maximum Concentration was measured after po administration into Beagle dog.,1,,,Canis lupus familiaris,Intermediate,,,11004,9615.0
,U,22224,,,In vivo,A,178.0,CHEMBL626217,0,,BAO_0000218,12767,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,1,,Blood,,Autocuration,,,11005,
,U,22224,,,In vivo,A,178.0,CHEMBL626218,0,,BAO_0000218,12767,Maximum blood level reached after an iv dose of 12.2 uM/kg,1,,Blood,,Autocuration,,,11006,
,U,22224,,,In vivo,A,178.0,CHEMBL626219,0,,BAO_0000218,12767,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,1,,Blood,,Autocuration,,,11007,
,U,22224,,,In vivo,A,178.0,CHEMBL626220,0,,BAO_0000218,12767,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,1,,Blood,,Autocuration,,,11008,
,U,22224,,,In vivo,A,178.0,CHEMBL626221,0,,BAO_0000218,12767,Maximum blood level reached after an oral dose of 5.0 mg/kg,1,,Blood,,Autocuration,,,11009,
,U,22224,,,In vivo,A,178.0,CHEMBL626222,0,,BAO_0000218,12767,Maximum blood level reached at dose of 10.6 uM/kg orally,1,,Blood,,Autocuration,,,11010,
,N,50512,,,In vivo,A,,CHEMBL626223,1,,BAO_0000218,14706,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,1,,,Cavia porcellus,Intermediate,,,11011,10141.0
,N,50512,,,In vivo,A,,CHEMBL626224,1,,BAO_0000218,14706,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,1,,,Cavia porcellus,Intermediate,,,11012,10141.0
,N,50597,,,In vivo,A,955.0,CHEMBL626225,1,,BAO_0000218,14793,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,1,,Brain,Rattus norvegicus,Intermediate,,,11013,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL626226,1,,BAO_0000218,14793,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,1,,Brain,Rattus norvegicus,Intermediate,,,11014,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL626227,1,,BAO_0000218,14793,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,1,,Brain,Rattus norvegicus,Intermediate,,,11015,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL626228,1,,BAO_0000218,14793,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,1,,Brain,Rattus norvegicus,Intermediate,,,11016,10116.0
,N,50597,,,In vivo,A,,CHEMBL626229,1,,BAO_0000218,14793,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11017,10116.0
,N,50597,,,In vivo,A,,CHEMBL626921,1,,BAO_0000218,14793,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11018,10116.0
,N,50597,,,In vivo,A,,CHEMBL876793,1,,BAO_0000218,14793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11019,10116.0
,N,50597,,,In vivo,A,,CHEMBL625309,1,,BAO_0000218,14793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11020,10116.0
,N,50278,,,In vivo,A,,CHEMBL625310,1,,BAO_0000218,10524,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),1,,,Bacillus subtilis,Intermediate,,,11021,1423.0
,U,22224,,,In vivo,A,,CHEMBL625311,0,,BAO_0000218,11871,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,1,,,Simiiformes,Autocuration,,,11022,314293.0
,N,50597,,,In vivo,A,,CHEMBL625312,1,,BAO_0000218,11871,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11023,10116.0
,U,22224,,,In vivo,A,,CHEMBL625313,0,,BAO_0000218,3437,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,1,,,,Autocuration,,,11024,
,N,50594,,,In vivo,A,,CHEMBL625314,1,,BAO_0000218,12038,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,1,,,Mus musculus,Intermediate,,,11025,10090.0
,N,50597,,,In vivo,A,,CHEMBL625315,1,,BAO_0000218,12038,Maximum concentration in male rats after iv administration of 20 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11026,10116.0
,N,50597,,,,A,2107.0,CHEMBL625316,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,1,,Liver,Rattus norvegicus,Intermediate,,,11027,10116.0
,N,50597,,,,A,2107.0,CHEMBL625317,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,1,,Liver,Rattus norvegicus,Intermediate,,,11028,10116.0
,N,50597,,,,A,2107.0,CHEMBL625318,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,1,,Liver,Rattus norvegicus,Intermediate,,,11029,10116.0
,N,50597,,,,A,2107.0,CHEMBL625319,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,1,,Liver,Rattus norvegicus,Intermediate,,,11030,10116.0
,N,50597,,,,A,2107.0,CHEMBL625320,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,1,,Liver,Rattus norvegicus,Intermediate,,,11031,10116.0
,N,50597,,,,A,2107.0,CHEMBL625321,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,1,,Liver,Rattus norvegicus,Intermediate,,,11032,10116.0
,N,50597,,,,A,2107.0,CHEMBL625322,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,1,,Liver,Rattus norvegicus,Intermediate,,,11033,10116.0
,N,50597,,,,A,2107.0,CHEMBL876801,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,1,,Liver,Rattus norvegicus,Intermediate,,,11034,10116.0
,N,50597,,,,A,2107.0,CHEMBL625323,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,1,,Liver,Rattus norvegicus,Intermediate,,,11035,10116.0
,N,50597,,,,A,2107.0,CHEMBL625324,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,1,,Liver,Rattus norvegicus,Intermediate,,,11036,10116.0
,N,50597,,,,A,2107.0,CHEMBL625325,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,1,,Liver,Rattus norvegicus,Intermediate,,,11037,10116.0
,N,50597,,,,A,2107.0,CHEMBL625326,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,1,,Liver,Rattus norvegicus,Intermediate,,,11038,10116.0
,N,50597,,,,A,2107.0,CHEMBL625327,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,1,,Liver,Rattus norvegicus,Intermediate,,,11039,10116.0
,N,50597,,,,A,2107.0,CHEMBL625328,1,,BAO_0000218,8418,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,1,,Liver,Rattus norvegicus,Intermediate,,,11040,10116.0
,N,50597,,,,A,2048.0,CHEMBL625329,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,1,,Lung,Rattus norvegicus,Intermediate,,,11041,10116.0
,N,50597,,,,A,2048.0,CHEMBL625330,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,1,,Lung,Rattus norvegicus,Intermediate,,,11042,10116.0
,N,50597,,,,A,2048.0,CHEMBL627774,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,1,,Lung,Rattus norvegicus,Intermediate,,,11043,10116.0
,N,50597,,,,A,2048.0,CHEMBL627775,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,1,,Lung,Rattus norvegicus,Intermediate,,,11044,10116.0
,N,50597,,,,A,2048.0,CHEMBL627949,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,1,,Lung,Rattus norvegicus,Intermediate,,,11045,10116.0
,N,50597,,,,A,2048.0,CHEMBL627950,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,1,,Lung,Rattus norvegicus,Intermediate,,,11046,10116.0
,N,50597,,,,A,2048.0,CHEMBL627951,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,1,,Lung,Rattus norvegicus,Intermediate,,,11047,10116.0
,N,50597,,,,A,2048.0,CHEMBL627952,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,1,,Lung,Rattus norvegicus,Intermediate,,,11048,10116.0
,N,50597,,,,A,2048.0,CHEMBL627953,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,1,,Lung,Rattus norvegicus,Intermediate,,,11049,10116.0
,N,50597,,,,A,2048.0,CHEMBL627954,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,1,,Lung,Rattus norvegicus,Intermediate,,,11050,10116.0
,N,50597,,,,A,2048.0,CHEMBL627955,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,1,,Lung,Rattus norvegicus,Intermediate,,,11051,10116.0
,N,50597,,,,A,2048.0,CHEMBL627956,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,1,,Lung,Rattus norvegicus,Intermediate,,,11052,10116.0
,N,50597,,,,A,2048.0,CHEMBL876802,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,1,,Lung,Rattus norvegicus,Intermediate,,,11053,10116.0
,N,50597,,,,A,2048.0,CHEMBL627957,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,1,,Lung,Rattus norvegicus,Intermediate,,,11054,10116.0
,N,50597,,,,A,2048.0,CHEMBL627958,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,1,,Lung,Rattus norvegicus,Intermediate,,,11055,10116.0
,N,50597,,,,A,2048.0,CHEMBL627959,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,1,,Lung,Rattus norvegicus,Intermediate,,,11056,10116.0
,N,50597,,,,A,2048.0,CHEMBL627960,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,1,,Lung,Rattus norvegicus,Intermediate,,,11057,10116.0
,N,50597,,,,A,2048.0,CHEMBL627961,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,1,,Lung,Rattus norvegicus,Intermediate,,,11058,10116.0
,N,50597,,,,A,2048.0,CHEMBL627962,1,,BAO_0000218,8418,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,1,,Lung,Rattus norvegicus,Intermediate,,,11059,10116.0
,N,50597,,,,A,,CHEMBL627963,1,,BAO_0000218,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,,Rattus norvegicus,Intermediate,,,11060,10116.0
,N,50597,,,,A,,CHEMBL624759,1,,BAO_0000218,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,Rattus norvegicus,Intermediate,,,11061,10116.0
,N,50597,,,,A,,CHEMBL624760,1,,BAO_0000218,9796,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,,Rattus norvegicus,Intermediate,,,11062,10116.0
,N,50597,,,,A,,CHEMBL624761,1,,BAO_0000218,9796,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,Rattus norvegicus,Intermediate,,,11063,10116.0
,N,50597,,,,A,,CHEMBL877607,1,,BAO_0000218,9796,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,,Rattus norvegicus,Intermediate,,,11064,10116.0
,N,50597,,,,A,2107.0,CHEMBL624762,1,,BAO_0000218,9796,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,Liver,Rattus norvegicus,Intermediate,,,11065,10116.0
,N,50597,,,,A,2107.0,CHEMBL624763,1,,BAO_0000218,9796,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,,Liver,Rattus norvegicus,Intermediate,,,11066,10116.0
,N,50597,,,,A,2107.0,CHEMBL624764,1,,BAO_0000218,9796,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,Liver,Rattus norvegicus,Intermediate,,,11067,10116.0
,N,50597,,,,A,2107.0,CHEMBL624765,1,,BAO_0000218,9796,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,Liver,Rattus norvegicus,Intermediate,,,11068,10116.0
,N,50597,,,,A,2107.0,CHEMBL624766,1,,BAO_0000218,9796,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,Liver,Rattus norvegicus,Intermediate,,,11069,10116.0
,N,50588,,,,A,,CHEMBL624767,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11070,9615.0
,N,50588,,,,A,,CHEMBL624768,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,11071,9615.0
,N,50588,,,,A,,CHEMBL624769,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11072,9615.0
,N,50588,,,,A,,CHEMBL624770,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,,,Canis lupus familiaris,Intermediate,,,11073,9615.0
,N,50588,,,,A,,CHEMBL624771,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,,,Canis lupus familiaris,Intermediate,,,11074,9615.0
,N,50588,,,,A,,CHEMBL624772,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11075,9615.0
,N,50597,,,,A,,CHEMBL624773,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,11076,10116.0
,N,50597,,,,A,,CHEMBL624774,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11077,10116.0
,N,50597,,,,A,,CHEMBL624775,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11078,10116.0
,N,50597,,,,A,,CHEMBL624776,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,11079,10116.0
,N,50597,,,,A,,CHEMBL624777,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,11080,10116.0
,N,50597,,,,A,,CHEMBL624778,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11081,10116.0
,N,50597,,,,A,,CHEMBL624779,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,11082,10116.0
,N,50597,,,,A,,CHEMBL624780,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,11083,10116.0
,N,50597,,,,A,,CHEMBL624781,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,11084,10116.0
,N,50597,,,,A,,CHEMBL877608,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11085,10116.0
,N,50597,,,,A,,CHEMBL624782,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11086,10116.0
,N,50597,,,,A,,CHEMBL624783,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11087,10116.0
,N,50597,,,,A,,CHEMBL624784,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,11088,10116.0
,N,50597,,,,A,,CHEMBL624785,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11089,10116.0
,N,50597,,,,A,,CHEMBL624786,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11090,10116.0
,N,50597,,,,A,,CHEMBL624787,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,11091,10116.0
,N,50597,,,,A,,CHEMBL628676,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11092,10116.0
,N,50597,,,,A,,CHEMBL621842,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,11093,10116.0
,N,50597,,,,A,,CHEMBL621843,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11094,10116.0
,N,50597,,,,A,,CHEMBL623873,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11095,10116.0
,N,50597,,,,A,,CHEMBL623874,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,11096,10116.0
,N,50597,,,,A,,CHEMBL623875,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,11097,10116.0
,N,50597,,,,A,,CHEMBL623876,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,11098,10116.0
,N,50588,,,,A,,CHEMBL623877,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,11099,9615.0
,N,50588,,,,A,,CHEMBL623878,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11100,9615.0
,N,50588,,,,A,,CHEMBL623879,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,11101,9615.0
,N,50588,,,,A,,CHEMBL623880,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11102,9615.0
,N,50588,,,,A,,CHEMBL623881,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11103,9615.0
,N,50588,,,,A,,CHEMBL623957,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11104,9615.0
,N,50588,,,,A,,CHEMBL623958,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11105,9615.0
,N,50588,,,,A,,CHEMBL623959,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11106,9615.0
,N,50588,,,,A,,CHEMBL623960,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11107,9615.0
,N,50588,,,,A,,CHEMBL623961,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11108,9615.0
,N,50588,,,,A,,CHEMBL623962,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,,,Canis lupus familiaris,Intermediate,,,11109,9615.0
,N,50588,,,,A,,CHEMBL624676,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,,,Canis lupus familiaris,Intermediate,,,11110,9615.0
,N,50588,,,,A,,CHEMBL624677,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11111,9615.0
,N,50588,,,,A,,CHEMBL624678,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,11112,9615.0
,N,50588,,,,A,,CHEMBL624679,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11113,9615.0
,N,50588,,,,A,,CHEMBL624680,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,,,Canis lupus familiaris,Intermediate,,,11114,9615.0
,U,22224,,,In vivo,A,,CHEMBL624849,0,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,1,,,,Autocuration,,,11115,
,U,22224,,,In vivo,A,,CHEMBL624850,0,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,1,,,,Autocuration,,,11116,
,U,22224,,,In vivo,A,,CHEMBL874399,0,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,1,,,,Autocuration,,,11117,
,U,22224,,,In vivo,A,,CHEMBL624851,0,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,1,,,,Autocuration,,,11118,
,U,22224,,,In vivo,A,,CHEMBL624852,0,,BAO_0000218,11732,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,1,,,,Autocuration,,,11119,
,U,22224,,,In vivo,A,,CHEMBL624853,0,,BAO_0000218,13359,Oral bioavailability in rat (dose 10 mg/kg),1,,,Rattus norvegicus,Autocuration,,,11120,10116.0
,U,22224,,,In vivo,A,,CHEMBL624854,0,,BAO_0000218,16618,Oral bioavailability in rat (Sprague-Dawley),1,,,Rattus norvegicus,Autocuration,,,11121,10116.0
,U,22224,,,In vivo,A,,CHEMBL624855,0,,BAO_0000218,13960,Oral bioavailability in rat,1,,,Rattus norvegicus,Autocuration,,,11122,10116.0
,U,22224,,,In vivo,A,,CHEMBL624856,0,,BAO_0000218,13917,Oral bioavailability in rats was determined in vivo,1,,,Rattus norvegicus,Autocuration,,,11123,10116.0
,U,22224,,,In vivo,A,,CHEMBL882957,0,,BAO_0000218,14266,Oral bioavailability in dog,1,,,Canis lupus familiaris,Autocuration,,,11124,9615.0
,U,22224,,,In vivo,A,,CHEMBL624857,0,,BAO_0000218,12359,Oral bioavailability of compound in monkey,1,,,Simiiformes,Autocuration,,,11125,314293.0
,N,50597,,,In vivo,A,,CHEMBL622202,1,,BAO_0000218,12359,Oral bioavailability of compound in rat,1,,,Rattus norvegicus,Intermediate,,,11126,10116.0
,U,22224,,,In vivo,A,,CHEMBL622203,0,,BAO_0000218,12359,Bioavailability in rat of PMEA prodrug,1,,,Rattus norvegicus,Autocuration,,,11127,10116.0
,N,50597,,,In vivo,A,,CHEMBL625522,1,,BAO_0000218,12359,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,1,,,Rattus norvegicus,Intermediate,,,11128,10116.0
,U,22224,,,In vivo,A,,CHEMBL622868,0,,BAO_0000218,10791,Serum conc at 3 hours following 25 mg/kg dose,1,,,Macaca mulatta,Autocuration,,,11129,9544.0
,U,22224,,,In vivo,A,1088.0,CHEMBL622869,0,,BAO_0000218,10791,Urine conc 0-5 hours following 25 mg/kg dose,1,,Urine,Macaca mulatta,Autocuration,,,11130,9544.0
,U,22224,,,In vivo,A,1088.0,CHEMBL622870,0,,BAO_0000218,10791,Urine conc 0-24 hours following 25 mg/kg dose,1,,Urine,Macaca mulatta,Autocuration,,,11131,9544.0
,U,22224,,,In vivo,A,,CHEMBL622871,0,,BAO_0000218,138,Oral bioavailability in African green monkeys; 20-25,1,,,Chlorocebus aethiops,Autocuration,,,11132,9534.0
,N,100710,,,In vivo,A,,CHEMBL620560,1,,BAO_0000218,14521,Oral bioavailability in cynomolgus monkey.,1,,,Macaca fascicularis,Intermediate,,,11133,9541.0
,U,22224,,,In vivo,A,,CHEMBL620561,0,,BAO_0000218,13953,Oral bioavailability in dog,1,,,Canis lupus familiaris,Autocuration,,,11134,9615.0
,N,50588,,,In vivo,A,,CHEMBL620562,1,,BAO_0000218,12836,Oral bioavailability in dog at 10 mg/kg oral dose,1,,,Canis lupus familiaris,Intermediate,,,11135,9615.0
,N,100712,,,In vivo,A,,CHEMBL620563,1,,BAO_0000218,12836,Oral bioavailability in hamster at 10 mg/kg oral dose,1,,,Cricetinae,Intermediate,,,11136,10026.0
,N,50597,,,In vivo,A,,CHEMBL620564,1,,BAO_0000218,12836,Oral bioavailability in rat at 10 mg/kg oral dose,1,,,Rattus norvegicus,Intermediate,,,11137,10116.0
,U,22224,,,In vivo,A,,CHEMBL872265,0,,BAO_0000218,14521,Oral bioavailability in rat,1,,,Rattus norvegicus,Autocuration,,,11138,10116.0
,U,22224,,,In vivo,A,,CHEMBL620565,0,,BAO_0000218,13953,Oral bioavailability in rat,1,,,Rattus norvegicus,Autocuration,,,11139,10116.0
,U,22224,,,In vivo,A,,CHEMBL620566,0,,BAO_0000218,6799,Oral bioavailability,1,,,Eutheria,Autocuration,,,11140,9347.0
,U,22224,,,In vivo,A,,CHEMBL620567,0,,BAO_0000218,11311,Oral bioavailability was determined; range 49-102%,1,,,,Autocuration,,,11141,
,N,50588,,,In vivo,A,,CHEMBL620568,1,,BAO_0000218,4013,Oral bioavailability was determined in dogs,1,,,Canis lupus familiaris,Intermediate,,,11142,9615.0
,U,22224,,,In vivo,A,,CHEMBL620569,0,,BAO_0000218,4013,Oral bioavailability in rat,1,,,Rattus norvegicus,Autocuration,,,11143,10116.0
,U,22224,,,In vivo,A,,CHEMBL620570,0,,BAO_0000218,17591,Oral bioavailability,1,,,Eutheria,Autocuration,,,11144,9347.0
,U,22224,,,In vivo,A,,CHEMBL620571,0,,BAO_0000218,17591,Oral bioavailability was determined; Not orally available,1,,,,Autocuration,,,11145,
,N,50594,,,In vivo,A,,CHEMBL620572,1,,BAO_0000218,15011,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),1,,,Mus musculus,Intermediate,,,11146,10090.0
,U,22224,,,In vivo,A,,CHEMBL620573,0,,BAO_0000218,15011,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),1,,,Mus musculus,Autocuration,,,11147,10090.0
,U,22224,,,In vivo,A,,CHEMBL620574,0,,BAO_0000218,15011,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,1,,,Mus musculus,Autocuration,,,11148,10090.0
,U,22224,,,In vivo,A,,CHEMBL620575,0,,BAO_0000218,9552,Oral bioavailability in Rhesus monkey,1,,,Macaca mulatta,Autocuration,,,11149,9544.0
,U,22224,,,In vivo,A,,CHEMBL620576,0,,BAO_0000218,9552,Oral bioavailability in dog (female mongrel),1,,,Canis lupus familiaris,Autocuration,,,11150,9615.0
,U,22224,,,In vivo,A,,CHEMBL875846,0,,BAO_0000218,3639,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,1,,,,Autocuration,,,11151,
,U,22224,,,In vivo,A,,CHEMBL620577,0,,BAO_0000218,13397,Oral bioavailability in dog,1,,,Canis lupus familiaris,Autocuration,,,11152,9615.0
,U,22224,,,In vivo,A,,CHEMBL620578,0,,BAO_0000218,3031,Percentage Bioavailability was evaluated.,1,,,,Autocuration,,,11153,
,U,22224,,,In vivo,A,,CHEMBL620579,0,,BAO_0000218,12818,Bioavailability in rat administered i.d.,1,,,Rattus norvegicus,Autocuration,,,11154,10116.0
,U,22224,,,In vivo,A,,CHEMBL621248,0,,BAO_0000218,4847,Bioavailability,1,,,Eutheria,Autocuration,,,11155,9347.0
,U,22224,,,In vivo,A,,CHEMBL625390,0,,BAO_0000218,12421,Bioavailability in dog (male Beagle) i.v. administration,1,,,Canis lupus familiaris,Autocuration,,,11156,9615.0
,U,22224,,,In vivo,A,,CHEMBL625391,0,,BAO_0000218,11966,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",1,,,Rattus norvegicus,Autocuration,,,11157,10116.0
,U,22224,,,In vivo,A,,CHEMBL872266,0,,BAO_0000218,11218,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),1,,,Primates,Autocuration,,,11158,9443.0
,U,22224,,,In vivo,A,,CHEMBL625392,0,,BAO_0000218,13129,Oral bioavailability in rat (Sprague-Dawley) (male),1,,,Rattus norvegicus,Autocuration,,,11159,10116.0
,N,50597,,,In vivo,A,,CHEMBL625393,1,,BAO_0000218,12350,The oral bioavailability was measured on rats after oral administration,1,,,Rattus norvegicus,Intermediate,,,11160,10116.0
,N,50597,,,In vivo,A,,CHEMBL625394,1,,BAO_0000218,2231,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11161,10116.0
,N,50797,,,In vivo,A,,CHEMBL625395,1,,BAO_0000218,2231,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,1,,,Macaca mulatta,Intermediate,,,11162,9544.0
,U,22224,,,In vivo,A,,CHEMBL625396,0,,BAO_0000218,12187,Bioavailability in rat (dose 10 mg/kg i.d.),1,,,Rattus norvegicus,Autocuration,,,11163,10116.0
,U,22224,,,In vivo,A,,CHEMBL625397,0,,BAO_0000218,12421,Bioavailability in dog (male Beagle) i.v. administration,1,,,Canis lupus familiaris,Autocuration,,,11164,9615.0
,N,50594,,,In vivo,A,,CHEMBL625398,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11165,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL625399,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Blood,Mus musculus,Intermediate,,,11166,10090.0
,N,50594,,,In vivo,A,2037.0,CHEMBL626074,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Cerebellum,Mus musculus,Intermediate,,,11167,10090.0
,N,50594,,,In vivo,A,,CHEMBL626075,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11168,10090.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626076,1,,BAO_0000218,2231,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,11169,10116.0
,N,50797,,,In vivo,A,1969.0,CHEMBL626077,1,,BAO_0000218,2231,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,1,,Plasma,Macaca mulatta,Intermediate,,,11170,9544.0
,N,50597,,,In vivo,A,178.0,CHEMBL626078,1,,BAO_0000218,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),1,,Blood,Rattus norvegicus,Intermediate,,,11171,10116.0
,U,22224,,,In vivo,A,178.0,CHEMBL625846,0,,BAO_0000218,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),1,,Blood,,Autocuration,,,11172,
,U,22224,,,In vivo,A,178.0,CHEMBL625847,0,,BAO_0000218,12178,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),1,,Blood,,Autocuration,,,11173,
,N,50597,,,In vivo,A,,CHEMBL625848,1,,BAO_0000218,15633,Maximum concentration observed in rats at an oral dose of 50 mg/kg,1,,,Rattus norvegicus,Expert,,,11174,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625849,1,,BAO_0000218,14258,Maximum concentration of compound in plasma administered orally to rats,1,,Plasma,Rattus norvegicus,Intermediate,,,11175,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626023,1,,BAO_0000218,14224,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",1,,Plasma,Canis lupus familiaris,Intermediate,,,11176,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626024,1,,BAO_0000218,14224,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",1,,Plasma,Canis lupus familiaris,Intermediate,,,11177,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626025,1,,BAO_0000218,14224,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",1,,Plasma,Canis lupus familiaris,Intermediate,,,11178,9615.0
,U,22224,,,In vivo,A,,CHEMBL626026,0,,BAO_0000218,5566,Maximum concentration after 10 mg/kg by oral administration,1,,,,Autocuration,,,11179,
,U,22224,,,In vivo,A,,CHEMBL626027,0,,BAO_0000218,16935,Maximum concentration at a dose of 1.5 mg/kg,1,,,,Autocuration,,,11180,
,U,22224,,,In vivo,A,,CHEMBL626028,0,,BAO_0000218,16935,Maximum concentration at a dose of 2.0 mg/kg,1,,,,Autocuration,,,11181,
,N,50588,,,In vivo,A,1969.0,CHEMBL626029,1,,BAO_0000218,14224,Maximum concentration in dog plasma,1,,Plasma,Canis lupus familiaris,Intermediate,,,11182,9615.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626030,0,,BAO_0000218,12536,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,1,,Plasma,,Autocuration,,,11183,
,U,22224,,,In vivo,A,1969.0,CHEMBL626031,0,,BAO_0000218,12536,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,1,,Plasma,,Autocuration,,,11184,
,U,22224,,,In vivo,A,1969.0,CHEMBL626032,0,,BAO_0000218,12536,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,1,,Plasma,,Autocuration,,,11185,
,U,22224,,,In vivo,A,1969.0,CHEMBL626033,0,,BAO_0000218,12536,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,1,,Plasma,,Autocuration,,,11186,
,U,22224,,,In vivo,A,1969.0,CHEMBL626034,0,,BAO_0000218,12536,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,1,,Plasma,,Autocuration,,,11187,
,N,50588,,,In vivo,A,1969.0,CHEMBL626035,1,,BAO_0000218,9994,Maximum concentration in plasma after oral administration in dog (25 mg/kg),1,,Plasma,Canis lupus familiaris,Intermediate,,,11188,9615.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626036,0,,BAO_0000218,1434,Maximum concentration in plasma at Tmax,1,,Plasma,,Autocuration,,,11189,
,N,50588,,,In vivo,A,1969.0,CHEMBL626037,1,,BAO_0000218,12836,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,1,,Plasma,Canis lupus familiaris,Expert,,,11190,9615.0
,N,100712,,,In vivo,A,1969.0,CHEMBL626038,1,,BAO_0000218,12836,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,1,,Plasma,Cricetinae,Intermediate,,,11191,10026.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626039,1,,BAO_0000218,12836,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,1,,Plasma,Rattus norvegicus,Intermediate,,,11192,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626040,1,,BAO_0000218,12545,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,11193,10116.0
,N,50592,,,In vivo,A,1969.0,CHEMBL626041,1,,BAO_0000218,13856,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,1,,Plasma,Oryctolagus cuniculus,Intermediate,,,11194,9986.0
,U,22224,,,In vivo,A,,CHEMBL626042,0,,BAO_0000218,3550,Maximum concentration was calculated,1,,,,Autocuration,,,11195,
,U,22224,,,In vivo,A,,CHEMBL626043,0,,BAO_0000218,2632,Maximum concentration was calculated.,1,,,,Autocuration,,,11196,
,U,22224,,,In vivo,A,,CHEMBL626044,0,,BAO_0000218,5566,Maximum concentration at a peroral dose of 10 mg/kg,1,,,,Autocuration,,,11197,
,U,22224,,,In vivo,A,,CHEMBL626045,0,,BAO_0000218,11883,Maximum concentration of the drug at 10 uM/dg administered perorally,1,,,,Autocuration,,,11198,
,U,22224,,,In vivo,A,,CHEMBL626046,0,,BAO_0000218,11883,Maximum concentration of the drug at 2 uM/dg administered intravenously,1,,,,Autocuration,,,11199,
,N,50588,,,In vivo,A,1969.0,CHEMBL626047,1,,BAO_0000218,14122,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",1,,Plasma,Canis lupus familiaris,Intermediate,,,11200,9615.0
,N,100712,,,In vivo,A,1969.0,CHEMBL626048,1,,BAO_0000218,14122,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",1,,Plasma,Cricetinae,Intermediate,,,11201,10026.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626049,1,,BAO_0000218,14122,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",1,,Plasma,Rattus norvegicus,Intermediate,,,11202,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626050,1,,BAO_0000218,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,1,,Plasma,Rattus norvegicus,Intermediate,,,11203,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL874541,1,,BAO_0000218,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,1,,Plasma,Canis lupus familiaris,Intermediate,,,11204,9615.0
,N,100712,,,In vivo,A,1969.0,CHEMBL622826,1,,BAO_0000218,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,1,,Plasma,Cricetinae,Intermediate,,,11205,10026.0
,N,100712,,,In vivo,A,1969.0,CHEMBL622827,1,,BAO_0000218,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,1,,Plasma,Cricetinae,Intermediate,,,11206,10026.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622828,1,,BAO_0000218,12542,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,1,,Plasma,Rattus norvegicus,Intermediate,,,11207,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622829,1,,BAO_0000218,14080,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,1,,Plasma,Rattus norvegicus,Intermediate,,,11208,10116.0
,N,50597,,,In vivo,A,,CHEMBL876806,1,,BAO_0000218,11911,Maximum concentration reached following intravenous administration in male rat,1,,,Rattus norvegicus,Intermediate,,,11209,10116.0
,N,50588,,,In vivo,A,,CHEMBL622830,1,,BAO_0000218,13204,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,1,,,Canis lupus familiaris,Intermediate,,,11210,9615.0
,N,50597,,,In vivo,A,,CHEMBL622831,1,,BAO_0000218,13204,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,1,,,Rattus norvegicus,Intermediate,,,11211,10116.0
,N,50588,,,In vivo,A,,CHEMBL626794,1,,BAO_0000218,14346,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,1,,,Canis lupus familiaris,Intermediate,,,11212,9615.0
,N,50597,,,In vivo,A,,CHEMBL626795,1,,BAO_0000218,14346,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,11213,10116.0
,N,50597,,,In vivo,A,,CHEMBL626796,1,,BAO_0000218,14346,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,11214,10116.0
,N,50597,,,In vivo,A,,CHEMBL626797,1,,BAO_0000218,14346,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,1,,,Rattus norvegicus,Intermediate,,,11215,10116.0
,N,50597,,,In vivo,A,,CHEMBL626798,1,,BAO_0000218,14127,Maximum drug concentration is determined after oral dosing in rats.,1,,,Rattus norvegicus,Intermediate,,,11216,10116.0
,N,50588,,,In vivo,A,,CHEMBL626799,1,,BAO_0000218,14339,Maximum observed concentration in oral (5 mg/kg) fasted dogs,1,,,Canis lupus familiaris,Intermediate,,,11217,9615.0
,N,50588,,,In vivo,A,,CHEMBL626800,1,,BAO_0000218,14339,Maximum observed concentration in oral (5 mg/kg) fed dogs,1,,,Canis lupus familiaris,Intermediate,,,11218,9615.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626801,0,,BAO_0000218,13494,Maximum plasma concentration,1,,Plasma,,Autocuration,,,11219,
,N,50597,,,In vivo,A,1969.0,CHEMBL876816,1,,BAO_0000218,14925,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,1,,Plasma,Rattus norvegicus,Intermediate,,,11220,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626802,1,,BAO_0000218,14474,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,11221,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626803,1,,BAO_0000218,14474,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,1,,Plasma,Canis lupus familiaris,Intermediate,,,11222,9615.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626804,0,,BAO_0000218,13917,Maximum plasma concentration following oral administration of 30 umol/kg,1,,Plasma,,Autocuration,,,11223,
,N,50597,,,,A,1969.0,CHEMBL626805,1,,BAO_0000218,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,1,,Plasma,Rattus norvegicus,Intermediate,,,11224,10116.0
,N,50597,,,,A,1969.0,CHEMBL626309,1,,BAO_0000218,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,Plasma,Rattus norvegicus,Intermediate,,,11225,10116.0
,N,50597,,,,A,1969.0,CHEMBL626310,1,,BAO_0000218,9796,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,Plasma,Rattus norvegicus,Intermediate,,,11226,10116.0
,N,50597,,,,A,1969.0,CHEMBL626311,1,,BAO_0000218,9796,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,Plasma,Rattus norvegicus,Intermediate,,,11227,10116.0
,N,50597,,,,A,1969.0,CHEMBL626312,1,,BAO_0000218,9796,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,Plasma,Rattus norvegicus,Intermediate,,,11228,10116.0
,N,50597,,,,A,995.0,CHEMBL626313,1,,BAO_0000218,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,1,,Uterus,Rattus norvegicus,Intermediate,,,11229,10116.0
,N,50597,,,,A,995.0,CHEMBL626314,1,,BAO_0000218,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,1,,Uterus,Rattus norvegicus,Intermediate,,,11230,10116.0
,N,50597,,,,A,995.0,CHEMBL626315,1,,BAO_0000218,9796,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,1,,Uterus,Rattus norvegicus,Intermediate,,,11231,10116.0
,N,50597,,,,A,995.0,CHEMBL626316,1,,BAO_0000218,9796,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,1,,Uterus,Rattus norvegicus,Intermediate,,,11232,10116.0
,N,50597,,,,A,995.0,CHEMBL626317,1,,BAO_0000218,9796,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,1,,Uterus,Rattus norvegicus,Intermediate,,,11233,10116.0
,N,50597,,,,A,,CHEMBL626318,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,Rattus norvegicus,Intermediate,,,11234,10116.0
,N,50597,,,,A,,CHEMBL626319,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,Rattus norvegicus,Intermediate,,,11235,10116.0
,N,50597,,,,A,,CHEMBL626320,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,Rattus norvegicus,Intermediate,,,11236,10116.0
,N,50597,,,,A,,CHEMBL875053,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,Rattus norvegicus,Intermediate,,,11237,10116.0
,N,50597,,,,A,,CHEMBL626321,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,Rattus norvegicus,Intermediate,,,11238,10116.0
,N,50597,,,,A,,CHEMBL626322,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,Rattus norvegicus,Intermediate,,,11239,10116.0
,N,50597,,,,A,,CHEMBL626323,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,Rattus norvegicus,Intermediate,,,11240,10116.0
,N,50597,,,,A,,CHEMBL626324,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,Rattus norvegicus,Intermediate,,,11241,10116.0
,N,50597,,,,A,,CHEMBL626325,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,Rattus norvegicus,Intermediate,,,11242,10116.0
,N,50597,,,,A,,CHEMBL626326,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,Rattus norvegicus,Intermediate,,,11243,10116.0
,N,50597,,,,A,,CHEMBL626327,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),1,,,Rattus norvegicus,Intermediate,,,11244,10116.0
,N,50597,,,,A,,CHEMBL626328,1,,BAO_0000218,8363,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),1,,,Rattus norvegicus,Intermediate,,,11245,10116.0
,N,50597,,,,A,178.0,CHEMBL626329,1,,BAO_0000218,8684,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",1,,Blood,Rattus norvegicus,Intermediate,,,11246,10116.0
,N,50597,,,,A,178.0,CHEMBL626330,1,,BAO_0000218,8684,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",1,,Blood,Rattus norvegicus,Intermediate,,,11247,10116.0
,N,50597,,,,A,178.0,CHEMBL626331,1,,BAO_0000218,8684,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",1,,Blood,Rattus norvegicus,Intermediate,,,11248,10116.0
,N,50597,,,,A,178.0,CHEMBL626332,1,,BAO_0000218,8684,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",1,,Blood,Rattus norvegicus,Intermediate,,,11249,10116.0
,N,50597,,,,A,178.0,CHEMBL626333,1,,BAO_0000218,8684,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",1,,Blood,Rattus norvegicus,Intermediate,,,11250,10116.0
,N,50597,,,,A,178.0,CHEMBL626334,1,,BAO_0000218,8684,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",1,,Blood,Rattus norvegicus,Intermediate,,,11251,10116.0
,N,50597,,,,A,178.0,CHEMBL626335,1,,BAO_0000218,8684,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",1,,Blood,Rattus norvegicus,Intermediate,,,11252,10116.0
,N,50597,,,,A,178.0,CHEMBL624798,1,,BAO_0000218,8684,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",1,,Blood,Rattus norvegicus,Intermediate,,,11253,10116.0
,N,50597,,,,A,955.0,CHEMBL624799,1,,BAO_0000218,8684,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",1,,Brain,Rattus norvegicus,Intermediate,,,11254,10116.0
,N,50597,,,,A,955.0,CHEMBL624800,1,,BAO_0000218,8684,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",1,,Brain,Rattus norvegicus,Intermediate,,,11255,10116.0
,N,50597,,,,A,955.0,CHEMBL624801,1,,BAO_0000218,8684,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",1,,Brain,Rattus norvegicus,Intermediate,,,11256,10116.0
,N,50597,,,,A,955.0,CHEMBL624802,1,,BAO_0000218,8684,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",1,,Brain,Rattus norvegicus,Intermediate,,,11257,10116.0
,N,50597,,,,A,955.0,CHEMBL624803,1,,BAO_0000218,8684,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",1,,Brain,Rattus norvegicus,Intermediate,,,11258,10116.0
,N,50597,,,,A,955.0,CHEMBL624804,1,,BAO_0000218,8684,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",1,,Brain,Rattus norvegicus,Intermediate,,,11259,10116.0
,N,50597,,,,A,955.0,CHEMBL624805,1,,BAO_0000218,8684,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",1,,Brain,Rattus norvegicus,Intermediate,,,11260,10116.0
,N,50597,,,,A,955.0,CHEMBL624806,1,,BAO_0000218,8684,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",1,,Brain,Rattus norvegicus,Intermediate,,,11261,10116.0
,N,50597,,,,A,,CHEMBL624807,1,,BAO_0000218,8684,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11262,10116.0
,N,50597,,,,A,,CHEMBL624808,1,,BAO_0000218,8684,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11263,10116.0
,N,50597,,,,A,,CHEMBL624809,1,,BAO_0000218,8684,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11264,10116.0
,N,50597,,,,A,,CHEMBL624810,1,,BAO_0000218,8684,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11265,10116.0
,N,50597,,,,A,,CHEMBL877618,1,,BAO_0000218,8684,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11266,10116.0
,N,50597,,,,A,,CHEMBL624811,1,,BAO_0000218,8684,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11267,10116.0
,N,50597,,,,A,,CHEMBL624812,1,,BAO_0000218,8684,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11268,10116.0
,N,50597,,,,A,,CHEMBL624813,1,,BAO_0000218,8684,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11269,10116.0
,N,50597,,,,A,,CHEMBL624814,1,,BAO_0000218,8684,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11270,10116.0
,N,50597,,,,A,,CHEMBL624815,1,,BAO_0000218,8684,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11271,10116.0
,N,50597,,,,A,,CHEMBL624816,1,,BAO_0000218,8684,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11272,10116.0
,N,50597,,,,A,,CHEMBL624817,1,,BAO_0000218,8684,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11273,10116.0
,N,50588,,,,A,,CHEMBL624818,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11274,9615.0
,N,50588,,,,A,,CHEMBL624819,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,11275,9615.0
,N,50588,,,,A,,CHEMBL624820,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11276,9615.0
,N,50588,,,,A,,CHEMBL624821,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),1,,,Canis lupus familiaris,Intermediate,,,11277,9615.0
,N,50588,,,,A,,CHEMBL624822,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),1,,,Canis lupus familiaris,Intermediate,,,11278,9615.0
,N,50588,,,,A,,CHEMBL624823,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,11279,9615.0
,N,50212,,,,A,,CHEMBL624824,1,,BAO_0000218,15599,Observed diffusion coefficient in organic solvent for Escherichia coli,1,,,Escherichia coli,Intermediate,,,11280,562.0
,N,50597,,,,A,178.0,CHEMBL624825,1,,BAO_0000218,9614,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,Blood,Rattus norvegicus,Intermediate,,,11281,10116.0
,N,50597,,,,A,178.0,CHEMBL624826,1,,BAO_0000218,9614,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,11282,10116.0
,N,50597,,,,A,2081.0,CHEMBL876817,1,,BAO_0000218,9614,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,Cardiac atrium,Rattus norvegicus,Intermediate,,,11283,10116.0
,N,50597,,,,A,2081.0,CHEMBL624827,1,,BAO_0000218,9614,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,Cardiac atrium,Rattus norvegicus,Intermediate,,,11284,10116.0
,N,50597,,,,A,,CHEMBL624828,1,,BAO_0000218,9614,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,,Rattus norvegicus,Intermediate,,,11285,10116.0
,N,50597,,,,A,,CHEMBL624829,1,,BAO_0000218,9614,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,,Rattus norvegicus,Intermediate,,,11286,10116.0
,N,50597,,,,A,2107.0,CHEMBL624830,1,,BAO_0000218,9614,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,Liver,Rattus norvegicus,Intermediate,,,11287,10116.0
,N,50597,,,,A,2107.0,CHEMBL624831,1,,BAO_0000218,9614,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,11288,10116.0
,N,50597,,,,A,2081.0,CHEMBL624832,1,,BAO_0000218,9614,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,Cardiac atrium,Rattus norvegicus,Intermediate,,,11289,10116.0
,N,50597,,,,A,2081.0,CHEMBL624833,1,,BAO_0000218,9614,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,Cardiac atrium,Rattus norvegicus,Intermediate,,,11290,10116.0
,N,50597,,,,A,,CHEMBL624834,1,,BAO_0000218,9614,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,,Rattus norvegicus,Intermediate,,,11291,10116.0
,N,50597,,,,A,,CHEMBL624835,1,,BAO_0000218,9614,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,,Rattus norvegicus,Intermediate,,,11292,10116.0
,N,50597,,,,A,2106.0,CHEMBL624836,1,,BAO_0000218,9614,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",1,,Spleen,Rattus norvegicus,Intermediate,,,11293,10116.0
,N,50597,,,,A,2106.0,CHEMBL624837,1,,BAO_0000218,9614,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",1,,Spleen,Rattus norvegicus,Intermediate,,,11294,10116.0
,N,50597,,,,A,178.0,CHEMBL624838,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,1,,Blood,Rattus norvegicus,Intermediate,,,11295,10116.0
,N,50597,,,,A,178.0,CHEMBL622188,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,1,,Blood,Rattus norvegicus,Intermediate,,,11296,10116.0
,N,50597,,,,A,948.0,CHEMBL622189,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,1,,Heart,Rattus norvegicus,Intermediate,,,11297,10116.0
,N,50597,,,,A,948.0,CHEMBL622190,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,1,,Heart,Rattus norvegicus,Intermediate,,,11298,10116.0
,N,50597,,,,A,948.0,CHEMBL625170,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,1,,Heart,Rattus norvegicus,Intermediate,,,11299,10116.0
,N,50597,,,,A,2113.0,CHEMBL625171,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,1,,Kidney,Rattus norvegicus,Intermediate,,,11300,10116.0
,N,50597,,,,A,2113.0,CHEMBL625172,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,1,,Kidney,Rattus norvegicus,Intermediate,,,11301,10116.0
,N,50597,,,,A,2113.0,CHEMBL625173,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,1,,Kidney,Rattus norvegicus,Intermediate,,,11302,10116.0
,N,50597,,,,A,2107.0,CHEMBL625174,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,1,,Liver,Rattus norvegicus,Intermediate,,,11303,10116.0
,N,50597,,,,A,2107.0,CHEMBL625175,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,1,,Liver,Rattus norvegicus,Intermediate,,,11304,10116.0
,N,50597,,,,A,2107.0,CHEMBL625176,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,1,,Liver,Rattus norvegicus,Intermediate,,,11305,10116.0
,N,50597,,,,A,2048.0,CHEMBL625177,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,1,,Lung,Rattus norvegicus,Intermediate,,,11306,10116.0
,N,50597,,,,A,2048.0,CHEMBL625178,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,1,,Lung,Rattus norvegicus,Intermediate,,,11307,10116.0
,N,50597,,,,A,2048.0,CHEMBL625179,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,1,,Lung,Rattus norvegicus,Intermediate,,,11308,10116.0
,N,50597,,,,A,2048.0,CHEMBL625180,1,,BAO_0000218,9071,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,1,,Lung,Rattus norvegicus,Intermediate,,,11309,10116.0
,U,22224,,,,A,,CHEMBL625181,0,,BAO_0000218,10677,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",1,,,,Autocuration,,,11310,
,N,50594,,,,A,1088.0,CHEMBL625182,1,,BAO_0000218,9750,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,1,,Urine,Mus musculus,Intermediate,,,11311,10090.0
,N,50597,,,,A,,CHEMBL625183,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11312,10116.0
,N,50597,,,,A,,CHEMBL875848,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,,Rattus norvegicus,Intermediate,,,11313,10116.0
,N,50597,,,,A,,CHEMBL622260,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11314,10116.0
,N,50597,,,,A,,CHEMBL622261,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,,Rattus norvegicus,Intermediate,,,11315,10116.0
,N,50597,,,,A,,CHEMBL622262,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11316,10116.0
,N,50597,,,,A,2113.0,CHEMBL622263,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,Kidney,Rattus norvegicus,Intermediate,,,11317,10116.0
,N,50597,,,,A,2113.0,CHEMBL622418,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,Kidney,Rattus norvegicus,Intermediate,,,11318,10116.0
,N,50597,,,,A,2107.0,CHEMBL622419,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,Liver,Rattus norvegicus,Intermediate,,,11319,10116.0
,N,50594,,,In vivo,A,,CHEMBL623388,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11320,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL623389,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Liver,Mus musculus,Intermediate,,,11321,10090.0
,N,50594,,,In vivo,A,,CHEMBL623390,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11322,10090.0
,N,50594,,,In vivo,A,,CHEMBL623391,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11323,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL623392,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Blood,Mus musculus,Intermediate,,,11324,10090.0
,N,50594,,,In vivo,A,2037.0,CHEMBL623393,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Cerebellum,Mus musculus,Intermediate,,,11325,10090.0
,N,50594,,,In vivo,A,,CHEMBL623394,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11326,10090.0
,N,50594,,,In vivo,A,,CHEMBL618885,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11327,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL618886,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Liver,Mus musculus,Intermediate,,,11328,10090.0
,N,50594,,,In vivo,A,,CHEMBL618887,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11329,10090.0
,N,50594,,,In vivo,A,,CHEMBL619535,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11330,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL619536,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Blood,Mus musculus,Intermediate,,,11331,10090.0
,N,50594,,,In vivo,A,2037.0,CHEMBL619537,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Cerebellum,Mus musculus,Intermediate,,,11332,10090.0
,N,50594,,,In vivo,A,,CHEMBL619705,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11333,10090.0
,N,50594,,,In vivo,A,,CHEMBL619706,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11334,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL619707,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Liver,Mus musculus,Intermediate,,,11335,10090.0
,N,50594,,,In vivo,A,,CHEMBL619708,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11336,10090.0
,N,50594,,,In vivo,A,,CHEMBL625219,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11337,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL625220,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Blood,Mus musculus,Intermediate,,,11338,10090.0
,N,50594,,,In vivo,A,2037.0,CHEMBL625221,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Cerebellum,Mus musculus,Intermediate,,,11339,10090.0
,N,50594,,,In vivo,A,,CHEMBL625222,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11340,10090.0
,N,50594,,,In vivo,A,,CHEMBL625223,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11341,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL625224,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,Liver,Mus musculus,Intermediate,,,11342,10090.0
,N,50594,,,In vivo,A,,CHEMBL625225,1,,BAO_0000218,13256,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),1,,,Mus musculus,Intermediate,,,11343,10090.0
,N,50597,,,In vivo,A,178.0,CHEMBL625226,1,,BAO_0000218,8829,Biodistribution in Rat blood after 24 hours of iv administration,1,,Blood,Rattus norvegicus,Intermediate,,,11344,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625227,1,,BAO_0000218,8829,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,1,,Blood,Rattus norvegicus,Intermediate,,,11345,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625228,1,,BAO_0000218,8829,Biodistribution in Rat blood after 30 minutes of iv administration,1,,Blood,Rattus norvegicus,Intermediate,,,11346,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL875354,1,,BAO_0000218,8829,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,1,,Blood,Rattus norvegicus,Intermediate,,,11347,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625229,1,,BAO_0000218,8829,Biodistribution in Rat blood after 5 minutes of iv administration,1,,Blood,Rattus norvegicus,Intermediate,,,11348,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625230,1,,BAO_0000218,8829,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,1,,Blood,Rattus norvegicus,Intermediate,,,11349,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625231,1,,BAO_0000218,8829,Biodistribution in Rat heart after 24 hours of iv administration,1,,Heart,Rattus norvegicus,Intermediate,,,11350,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625900,1,,BAO_0000218,8829,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,1,,Heart,Rattus norvegicus,Intermediate,,,11351,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625901,1,,BAO_0000218,8829,Biodistribution in Rat heart after 30 minutes of iv administration,1,,Heart,Rattus norvegicus,Intermediate,,,11352,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625902,1,,BAO_0000218,8829,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,1,,Heart,Rattus norvegicus,Intermediate,,,11353,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625903,1,,BAO_0000218,8829,Biodistribution in Rat heart after 5 minutes of iv administration,1,,Heart,Rattus norvegicus,Intermediate,,,11354,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625904,1,,BAO_0000218,8829,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,1,,Heart,Rattus norvegicus,Intermediate,,,11355,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625905,1,,BAO_0000218,8829,Biodistribution in Rat liver after 24 hours of iv administration,1,,Liver,Rattus norvegicus,Intermediate,,,11356,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627861,1,,BAO_0000218,8829,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,1,,Liver,Rattus norvegicus,Intermediate,,,11357,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627862,1,,BAO_0000218,8829,Biodistribution in Rat liver after 30 minutes of iv administration,1,,Liver,Rattus norvegicus,Intermediate,,,11358,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627863,1,,BAO_0000218,8829,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,1,,Liver,Rattus norvegicus,Intermediate,,,11359,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627769,1,,BAO_0000218,8829,Biodistribution in Rat liver after 30 minutes of iv administration,1,,Liver,Rattus norvegicus,Intermediate,,,11360,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL627770,1,,BAO_0000218,13249,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,1,,Plasma,Canis lupus familiaris,Intermediate,,,11361,9615.0
,N,100710,,,In vivo,A,,CHEMBL627771,1,,BAO_0000218,13622,Cmax in cynomolgus monkey (PO dose),1,,,Macaca fascicularis,Intermediate,,,11362,9541.0
,N,50597,,,In vivo,A,,CHEMBL627772,1,,BAO_0000218,13622,Cmax in rat (PO dose),1,,,Rattus norvegicus,Intermediate,,,11363,10116.0
,N,50597,,,In vivo,A,,CHEMBL627773,1,,BAO_0000218,13622,Cmax in rat (PO dose),1,,,Rattus norvegicus,Intermediate,,,11364,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621922,1,,BAO_0000218,13494,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,11365,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621923,1,,BAO_0000218,12170,Cmax in rat plasma after oral dose (10 mg/kg),1,,Plasma,Rattus norvegicus,Intermediate,,,11366,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL621924,0,,BAO_0000218,12170,Cmax in plasma after oral dose (10 mg/kg),1,,Plasma,,Autocuration,,,11367,
,N,50588,,,In vivo,A,1969.0,CHEMBL621925,1,,BAO_0000218,17025,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,1,,Plasma,Canis lupus familiaris,Intermediate,,,11368,9615.0
,U,22224,,,In vivo,A,1969.0,CHEMBL621926,0,,BAO_0000218,17025,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,1,,Plasma,Simiiformes,Autocuration,,,11369,314293.0
,N,50592,,,In vivo,A,1969.0,CHEMBL621927,1,,BAO_0000218,17025,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,1,,Plasma,Oryctolagus cuniculus,Intermediate,,,11370,9986.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621928,1,,BAO_0000218,17025,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,1,,Plasma,Rattus norvegicus,Intermediate,,,11371,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621929,1,,BAO_0000218,14187,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,1,,Plasma,Rattus norvegicus,Intermediate,,,11372,10116.0
,N,50594,,,In vivo,A,1969.0,CHEMBL621930,1,,BAO_0000218,14816,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,1,,Plasma,Mus musculus,Intermediate,,,11373,10090.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621931,1,,BAO_0000218,17820,Maximum plasma concentration after oral dosing in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,11374,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL621932,0,,BAO_0000218,14380,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,1,,Plasma,,Autocuration,,,11375,
,U,22224,,,In vivo,A,1969.0,CHEMBL621933,0,,BAO_0000218,14380,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,1,,Plasma,,Autocuration,,,11376,
,N,50588,,,In vivo,A,1969.0,CHEMBL621934,1,,BAO_0000218,14691,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,1,,Plasma,Canis lupus familiaris,Intermediate,,,11377,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL621935,1,,BAO_0000218,14691,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,1,,Plasma,Canis lupus familiaris,Intermediate,,,11378,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL621936,1,,BAO_0000218,13375,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,11379,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL621937,0,,BAO_0000218,6236,Maximum plasma concentration was determined,1,,Plasma,,Autocuration,,,11380,
,U,22224,,,In vivo,A,1969.0,CHEMBL621938,0,,BAO_0000218,14380,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,,Plasma,,Autocuration,,,11381,
,U,22224,,,In vivo,A,1969.0,CHEMBL621939,0,,BAO_0000218,14380,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,,Plasma,,Autocuration,,,11382,
,U,22224,,,In vivo,A,1969.0,CHEMBL621940,0,,BAO_0000218,14380,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,1,,Plasma,,Autocuration,,,11383,
,U,22224,,,In vivo,A,1969.0,CHEMBL621941,0,,BAO_0000218,14380,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,1,,Plasma,,Autocuration,,,11384,
,U,22224,,,In vivo,A,1969.0,CHEMBL621942,0,,BAO_0000218,14380,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,1,,Plasma,,Autocuration,,,11385,
,U,22224,,,In vivo,A,1969.0,CHEMBL626178,0,,BAO_0000218,14380,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,1,,Plasma,,Autocuration,,,11386,
,U,22224,,,In vivo,A,1969.0,CHEMBL626179,0,,BAO_0000218,14380,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,1,,Plasma,,Autocuration,,,11387,
,U,22224,,,In vivo,A,1969.0,CHEMBL626180,0,,BAO_0000218,14380,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,1,,Plasma,,Autocuration,,,11388,
,N,50597,,,In vivo,A,1969.0,CHEMBL626181,1,,BAO_0000218,13622,Plasma Cmax in rat (PO dose),1,,Plasma,Rattus norvegicus,Intermediate,,,11389,10116.0
,N,50597,,,In vivo,A,,CHEMBL626182,1,,BAO_0000218,15372,Maximum serum concentration after po dose of 5.22 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,11390,10116.0
,N,50597,,,In vivo,A,,CHEMBL626183,1,,BAO_0000218,15372,Maximum serum concentration after po dose of 5.46 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,11391,10116.0
,N,50597,,,In vivo,A,,CHEMBL626184,1,,BAO_0000218,15372,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,11392,10116.0
,N,50597,,,In vivo,A,,CHEMBL626185,1,,BAO_0000218,15372,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,1,,,Rattus norvegicus,Intermediate,,,11393,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626186,1,,BAO_0000218,14925,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,1,,Plasma,Canis lupus familiaris,Intermediate,,,11394,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL877589,1,,BAO_0000218,14925,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,1,,Plasma,Canis lupus familiaris,Intermediate,,,11395,9615.0
,U,22224,,,In vivo,A,,CHEMBL626187,0,,BAO_0000218,11883,Maximum concentration of the drug at 1 uM/dg administered intravenously,1,,,,Autocuration,,,11396,
,U,22224,,,In vivo,A,,CHEMBL626188,0,,BAO_0000218,11883,Maximum concentration of the drug at 20 uM/dg administered perorally,1,,,,Autocuration,,,11397,
,U,22224,,,In vivo,A,,CHEMBL626189,0,,BAO_0000218,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,1,,,,Autocuration,,,11398,
,U,22224,,,In vivo,A,178.0,CHEMBL626855,0,,BAO_0000218,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,1,,Blood,,Autocuration,,,11399,
,U,22224,,,In vivo,A,178.0,CHEMBL623781,0,,BAO_0000218,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,1,,Blood,,Autocuration,,,11400,
,U,22224,,,In vivo,A,178.0,CHEMBL623782,0,,BAO_0000218,13391,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,1,,Blood,,Autocuration,,,11401,
,N,50597,,,In vivo,A,1969.0,CHEMBL623783,1,,BAO_0000218,16360,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,11402,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL623784,1,,BAO_0000218,3673,Cmax in dog plasma after 1mg/kg oral dose,1,,Plasma,Canis lupus familiaris,Intermediate,,,11403,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL623785,1,,BAO_0000218,14431,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,1,,Plasma,Canis lupus familiaris,Intermediate,,,11404,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623786,1,,BAO_0000218,14431,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,1,,Plasma,Rattus norvegicus,Intermediate,,,11405,10116.0
,N,50597,,,In vivo,A,,CHEMBL623787,1,,BAO_0000218,14964,Oral maximum concentration in rat,1,,,Rattus norvegicus,Intermediate,,,11406,10116.0
,N,50597,,,In vivo,A,,CHEMBL623788,1,,BAO_0000218,14964,Oral maximum concentration in rat,1,,,Rattus norvegicus,Intermediate,,,11407,10116.0
,N,50594,,,In vivo,A,1969.0,CHEMBL623789,1,,BAO_0000218,14209,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,1,,Plasma,Mus musculus,Intermediate,,,11408,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL623790,1,,BAO_0000218,11355,Peak concentration in blood after intravenous administration to mice,1,,Blood,Mus musculus,Intermediate,,,11409,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL623791,1,,BAO_0000218,11355,Peak concentration in blood after peroral administration to mice,1,,Blood,Mus musculus,Intermediate,,,11410,10090.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623792,1,,BAO_0000218,11966,Peak concentration in rat plasma was determined,1,,Plasma,Rattus norvegicus,Intermediate,,,11411,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL623793,0,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,1,,Plasma,Simiiformes,Autocuration,,,11412,314293.0
,N,50594,,,In vivo,A,1969.0,CHEMBL623794,1,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,1,,Plasma,Mus musculus,Intermediate,,,11413,10090.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623795,1,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,11414,10116.0
,N,50597,,,,A,,CHEMBL623796,1,,BAO_0000218,8684,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11415,10116.0
,N,50597,,,,A,,CHEMBL623797,1,,BAO_0000218,8684,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11416,10116.0
,N,50597,,,,A,,CHEMBL623798,1,,BAO_0000218,8684,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11417,10116.0
,N,50597,,,,A,,CHEMBL623799,1,,BAO_0000218,8684,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11418,10116.0
,N,50597,,,,A,160.0,CHEMBL624490,1,,BAO_0000218,8684,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",1,,Intestine,Rattus norvegicus,Intermediate,,,11419,10116.0
,N,50597,,,,A,160.0,CHEMBL624491,1,,BAO_0000218,8684,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",1,,Intestine,Rattus norvegicus,Intermediate,,,11420,10116.0
,N,50597,,,,A,160.0,CHEMBL624492,1,,BAO_0000218,8684,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",1,,Intestine,Rattus norvegicus,Intermediate,,,11421,10116.0
,N,50597,,,,A,160.0,CHEMBL624493,1,,BAO_0000218,8684,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",1,,Intestine,Rattus norvegicus,Intermediate,,,11422,10116.0
,N,50597,,,,A,160.0,CHEMBL877595,1,,BAO_0000218,8684,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",1,,Intestine,Rattus norvegicus,Intermediate,,,11423,10116.0
,N,50597,,,,A,160.0,CHEMBL624494,1,,BAO_0000218,8684,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",1,,Intestine,Rattus norvegicus,Intermediate,,,11424,10116.0
,N,50597,,,,A,160.0,CHEMBL624495,1,,BAO_0000218,8684,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",1,,Intestine,Rattus norvegicus,Intermediate,,,11425,10116.0
,N,50597,,,,A,160.0,CHEMBL624681,1,,BAO_0000218,8684,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",1,,Intestine,Rattus norvegicus,Intermediate,,,11426,10116.0
,N,50597,,,,A,,CHEMBL624682,1,,BAO_0000218,8684,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11427,10116.0
,N,50597,,,,A,,CHEMBL624683,1,,BAO_0000218,8684,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11428,10116.0
,N,50597,,,,A,,CHEMBL624684,1,,BAO_0000218,8684,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11429,10116.0
,N,50597,,,,A,,CHEMBL624685,1,,BAO_0000218,8684,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11430,10116.0
,N,50597,,,,A,,CHEMBL624686,1,,BAO_0000218,8684,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11431,10116.0
,N,50597,,,,A,,CHEMBL624687,1,,BAO_0000218,8684,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11432,10116.0
,N,50597,,,,A,,CHEMBL624688,1,,BAO_0000218,8684,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11433,10116.0
,N,50597,,,,A,,CHEMBL627161,1,,BAO_0000218,8684,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11434,10116.0
,N,50597,,,,A,,CHEMBL622127,1,,BAO_0000218,8684,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11435,10116.0
,N,50597,,,,A,,CHEMBL622128,1,,BAO_0000218,8684,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11436,10116.0
,N,50597,,,,A,,CHEMBL874384,1,,BAO_0000218,8684,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11437,10116.0
,N,50597,,,,A,,CHEMBL624898,1,,BAO_0000218,8684,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11438,10116.0
,N,50597,,,,A,,CHEMBL624899,1,,BAO_0000218,8684,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11439,10116.0
,N,50597,,,,A,,CHEMBL624900,1,,BAO_0000218,8684,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11440,10116.0
,N,50597,,,,A,,CHEMBL624901,1,,BAO_0000218,8684,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11441,10116.0
,N,50597,,,,A,,CHEMBL624902,1,,BAO_0000218,8684,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11442,10116.0
,N,50597,,,,A,,CHEMBL624903,1,,BAO_0000218,8684,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11443,10116.0
,N,50597,,,,A,,CHEMBL624904,1,,BAO_0000218,8684,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11444,10116.0
,N,50597,,,,A,,CHEMBL624905,1,,BAO_0000218,8684,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11445,10116.0
,N,50597,,,,A,,CHEMBL624906,1,,BAO_0000218,8684,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11446,10116.0
,N,50597,,,,A,,CHEMBL624907,1,,BAO_0000218,8684,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11447,10116.0
,N,50597,,,,A,,CHEMBL624908,1,,BAO_0000218,8684,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11448,10116.0
,N,50597,,,,A,,CHEMBL624909,1,,BAO_0000218,8684,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11449,10116.0
,N,50597,,,,A,,CHEMBL624910,1,,BAO_0000218,8684,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11450,10116.0
,N,50597,,,,A,2385.0,CHEMBL624911,1,,BAO_0000218,8684,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11451,10116.0
,N,50597,,,,A,2385.0,CHEMBL874388,1,,BAO_0000218,8684,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11452,10116.0
,N,50597,,,,A,2385.0,CHEMBL624912,1,,BAO_0000218,8684,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11453,10116.0
,N,50597,,,,A,2385.0,CHEMBL622930,1,,BAO_0000218,8684,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11454,10116.0
,N,50597,,,,A,2385.0,CHEMBL623121,1,,BAO_0000218,8684,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11455,10116.0
,N,50597,,,,A,2385.0,CHEMBL623122,1,,BAO_0000218,8684,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11456,10116.0
,N,50597,,,,A,2385.0,CHEMBL623123,1,,BAO_0000218,8684,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11457,10116.0
,N,50597,,,,A,2385.0,CHEMBL623124,1,,BAO_0000218,8684,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11458,10116.0
,N,50597,,,,A,,CHEMBL623125,1,,BAO_0000218,8684,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11459,10116.0
,N,50597,,,,A,,CHEMBL623126,1,,BAO_0000218,8684,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11460,10116.0
,N,50597,,,,A,,CHEMBL623127,1,,BAO_0000218,8684,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11461,10116.0
,N,50597,,,,A,,CHEMBL623128,1,,BAO_0000218,8684,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11462,10116.0
,N,50597,,,,A,,CHEMBL623129,1,,BAO_0000218,8684,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11463,10116.0
,N,50597,,,,A,,CHEMBL623130,1,,BAO_0000218,8684,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11464,10116.0
,N,50597,,,,A,,CHEMBL623131,1,,BAO_0000218,8684,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11465,10116.0
,N,50597,,,,A,,CHEMBL623132,1,,BAO_0000218,8684,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11466,10116.0
,N,50597,,,,A,2107.0,CHEMBL623133,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,Liver,Rattus norvegicus,Intermediate,,,11467,10116.0
,N,50597,,,,A,,CHEMBL623134,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11468,10116.0
,N,50597,,,,A,,CHEMBL874389,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11469,10116.0
,N,50597,,,,A,,CHEMBL623135,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,,Rattus norvegicus,Intermediate,,,11470,10116.0
,N,50597,,,,A,,CHEMBL623136,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11471,10116.0
,N,50597,,,,A,,CHEMBL623137,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,,Rattus norvegicus,Intermediate,,,11472,10116.0
,N,50597,,,,A,,CHEMBL623138,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11473,10116.0
,N,50597,,,,A,2113.0,CHEMBL623139,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,Kidney,Rattus norvegicus,Intermediate,,,11474,10116.0
,N,50597,,,,A,2113.0,CHEMBL623140,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,Kidney,Rattus norvegicus,Intermediate,,,11475,10116.0
,N,50597,,,,A,2107.0,CHEMBL623141,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,Liver,Rattus norvegicus,Intermediate,,,11476,10116.0
,N,50597,,,,A,2107.0,CHEMBL623142,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,Liver,Rattus norvegicus,Intermediate,,,11477,10116.0
,N,50597,,,,A,,CHEMBL623143,1,,BAO_0000218,8319,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11478,10116.0
,N,50594,,,,A,1088.0,CHEMBL623144,1,,BAO_0000218,14571,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,1,,Urine,Mus musculus,Intermediate,,,11479,10090.0
,N,50597,,,,A,1088.0,CHEMBL623405,1,,BAO_0000218,14571,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,1,,Urine,Rattus norvegicus,Intermediate,,,11480,10116.0
,N,50597,,,,A,,CHEMBL624074,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11481,10116.0
,N,50597,,,,A,,CHEMBL624075,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,,Rattus norvegicus,Intermediate,,,11482,10116.0
,N,50597,,,,A,,CHEMBL624076,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11483,10116.0
,N,50597,,,,A,,CHEMBL624077,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,,Rattus norvegicus,Intermediate,,,11484,10116.0
,N,50597,,,,A,,CHEMBL624078,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11485,10116.0
,N,50597,,,,A,2113.0,CHEMBL624079,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,Kidney,Rattus norvegicus,Intermediate,,,11486,10116.0
,N,50597,,,,A,2113.0,CHEMBL624261,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,Kidney,Rattus norvegicus,Intermediate,,,11487,10116.0
,N,50597,,,,A,,CHEMBL624262,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,,Rattus norvegicus,Intermediate,,,11488,10116.0
,N,50597,,,,A,,CHEMBL624263,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11489,10116.0
,N,50597,,,,A,,CHEMBL624264,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11490,10116.0
,N,50597,,,,A,,CHEMBL624265,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11491,10116.0
,N,50597,,,,A,,CHEMBL624266,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,1,,,Rattus norvegicus,Intermediate,,,11492,10116.0
,N,50597,,,,A,,CHEMBL624267,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11493,10116.0
,N,50597,,,,A,,CHEMBL624268,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,1,,,Rattus norvegicus,Intermediate,,,11494,10116.0
,N,50597,,,,A,,CHEMBL875227,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11495,10116.0
,N,50597,,,,A,2113.0,CHEMBL624269,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,1,,Kidney,Rattus norvegicus,Intermediate,,,11496,10116.0
,N,50597,,,,A,2113.0,CHEMBL624270,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,1,,Kidney,Rattus norvegicus,Intermediate,,,11497,10116.0
,N,50597,,,,A,,CHEMBL624271,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,1,,,Rattus norvegicus,Intermediate,,,11498,10116.0
,N,50597,,,,A,,CHEMBL624272,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11499,10116.0
,N,50597,,,,A,,CHEMBL624273,1,,BAO_0000218,8319,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,1,,,Rattus norvegicus,Intermediate,,,11500,10116.0
,N,50597,,,,A,1088.0,CHEMBL624274,1,,BAO_0000218,12064,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,1,,Urine,Rattus norvegicus,Intermediate,,,11501,10116.0
,N,50597,,,,A,1088.0,CHEMBL624275,1,,BAO_0000218,12064,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,1,,Urine,Rattus norvegicus,Intermediate,,,11502,10116.0
,N,50597,,,,A,1088.0,CHEMBL624276,1,,BAO_0000218,12064,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,1,,Urine,Rattus norvegicus,Intermediate,,,11503,10116.0
,N,50597,,,,A,1088.0,CHEMBL624277,1,,BAO_0000218,12038,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,1,,Urine,Rattus norvegicus,Intermediate,,,11504,10116.0
,U,22224,,,,A,,CHEMBL624278,0,,BAO_0000019,14314,% dose converted to 2-amino-5-chlorophenyl sulfate,1,,,,Autocuration,,,11505,
,U,22224,,,,A,,CHEMBL624279,0,,BAO_0000019,14314,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),1,,,,Autocuration,,,11506,
,N,50597,,,,A,1988.0,CHEMBL624280,1,,BAO_0000218,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",1,,Feces,Rattus norvegicus,Intermediate,,,11507,10116.0
,N,50597,,,,A,1988.0,CHEMBL624281,1,,BAO_0000218,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",1,,Feces,Rattus norvegicus,Intermediate,,,11508,10116.0
,N,50597,,,,A,1988.0,CHEMBL622933,1,,BAO_0000218,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",1,,Feces,Rattus norvegicus,Intermediate,,,11509,10116.0
,N,50597,,,,A,1988.0,CHEMBL622934,1,,BAO_0000218,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",1,,Feces,Rattus norvegicus,Intermediate,,,11510,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622935,1,,BAO_0000218,8829,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,1,,Liver,Rattus norvegicus,Intermediate,,,11511,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL622936,1,,BAO_0000218,8829,Biodistribution in Rat liver after 5 minutes of iv administration,1,,Liver,Rattus norvegicus,Intermediate,,,11512,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL875228,1,,BAO_0000218,8829,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,1,,Liver,Rattus norvegicus,Intermediate,,,11513,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL622937,1,,BAO_0000218,8829,Biodistribution in Rat lung after 24 hours of iv administration,1,,Lung,Rattus norvegicus,Intermediate,,,11514,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL622938,1,,BAO_0000218,8829,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,1,,Lung,Rattus norvegicus,Intermediate,,,11515,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL619736,1,,BAO_0000218,8829,Biodistribution in Rat lung after 30 minutes of iv administration,1,,Lung,Rattus norvegicus,Intermediate,,,11516,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625117,1,,BAO_0000218,8829,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,1,,Lung,Rattus norvegicus,Intermediate,,,11517,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625118,1,,BAO_0000218,8829,Biodistribution in Rat lung after 5 minutes of iv administration,1,,Lung,Rattus norvegicus,Intermediate,,,11518,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625119,1,,BAO_0000218,8829,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,1,,Lung,Rattus norvegicus,Intermediate,,,11519,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL625120,1,,BAO_0000218,14972,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",1,,Cerebellum,Rattus norvegicus,Intermediate,,,11520,10116.0
,N,50597,,,In vivo,A,,CHEMBL625121,1,,BAO_0000218,14972,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",1,,,Rattus norvegicus,Intermediate,,,11521,10116.0
,N,50597,,,In vivo,A,10000006.0,CHEMBL625122,1,,BAO_0000218,14972,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",1,,Thalamus,Rattus norvegicus,Intermediate,,,11522,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL622204,1,,BAO_0000218,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Blood,Rattus norvegicus,Intermediate,,,11523,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL877503,1,,BAO_0000218,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Blood,Rattus norvegicus,Intermediate,,,11524,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627127,1,,BAO_0000218,14608,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Blood,Rattus norvegicus,Intermediate,,,11525,10116.0
,U,22224,,,In vivo,A,10000000.0,CHEMBL627128,0,,BAO_0000218,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Hippocampus,,Autocuration,,,11526,
,U,22224,,,In vivo,A,10000000.0,CHEMBL627129,0,,BAO_0000218,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Hippocampus,,Autocuration,,,11527,
,U,22224,,,In vivo,A,10000000.0,CHEMBL627130,0,,BAO_0000218,14608,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Hippocampus,,Autocuration,,,11528,
,N,50597,,,In vivo,A,955.0,CHEMBL627131,1,,BAO_0000218,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Brain,Rattus norvegicus,Intermediate,,,11529,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL627132,1,,BAO_0000218,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Brain,Rattus norvegicus,Intermediate,,,11530,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL627133,1,,BAO_0000218,14608,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Brain,Rattus norvegicus,Intermediate,,,11531,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL627134,1,,BAO_0000218,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Cerebellum,Rattus norvegicus,Intermediate,,,11532,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL627135,1,,BAO_0000218,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Cerebellum,Rattus norvegicus,Intermediate,,,11533,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL627136,1,,BAO_0000218,14608,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Cerebellum,Rattus norvegicus,Intermediate,,,11534,10116.0
,N,50597,,,In vivo,A,,CHEMBL628435,1,,BAO_0000218,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,,Rattus norvegicus,Intermediate,,,11535,10116.0
,N,50597,,,In vivo,A,,CHEMBL628436,1,,BAO_0000218,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,,Rattus norvegicus,Intermediate,,,11536,10116.0
,N,50597,,,In vivo,A,,CHEMBL628437,1,,BAO_0000218,14608,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,,Rattus norvegicus,Intermediate,,,11537,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL628438,1,,BAO_0000218,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Heart,Rattus norvegicus,Intermediate,,,11538,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL628439,1,,BAO_0000218,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Heart,Rattus norvegicus,Intermediate,,,11539,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL628440,1,,BAO_0000218,14608,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Heart,Rattus norvegicus,Intermediate,,,11540,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL628441,1,,BAO_0000218,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Hippocampus,Rattus norvegicus,Intermediate,,,11541,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL628442,1,,BAO_0000218,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Hippocampus,Rattus norvegicus,Intermediate,,,11542,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL628443,1,,BAO_0000218,14608,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Hippocampus,Rattus norvegicus,Intermediate,,,11543,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL628444,1,,BAO_0000218,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Kidney,Rattus norvegicus,Intermediate,,,11544,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL628445,1,,BAO_0000218,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Kidney,Rattus norvegicus,Intermediate,,,11545,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL877504,1,,BAO_0000218,14608,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Kidney,Rattus norvegicus,Intermediate,,,11546,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL628446,1,,BAO_0000218,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Liver,Rattus norvegicus,Intermediate,,,11547,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL626874,1,,BAO_0000218,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Liver,Rattus norvegicus,Intermediate,,,11548,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL626875,1,,BAO_0000218,14608,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Liver,Rattus norvegicus,Intermediate,,,11549,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL626876,1,,BAO_0000218,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Lung,Rattus norvegicus,Intermediate,,,11550,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL626877,1,,BAO_0000218,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Lung,Rattus norvegicus,Intermediate,,,11551,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL626878,1,,BAO_0000218,14608,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Lung,Rattus norvegicus,Intermediate,,,11552,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL626879,1,,BAO_0000218,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11553,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626880,0,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,1,,Plasma,Simiiformes,Autocuration,,,11554,314293.0
,N,50594,,,In vivo,A,1969.0,CHEMBL626881,1,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,1,,Plasma,Mus musculus,Intermediate,,,11555,10090.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626882,1,,BAO_0000218,8918,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,11556,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626883,1,,BAO_0000218,14470,Peak plasma concentration was measured in dogs,1,,Plasma,Canis lupus familiaris,Intermediate,,,11557,9615.0
,N,50597,,,In vivo,A,,CHEMBL626884,1,,BAO_0000218,14393,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,Rattus norvegicus,Intermediate,,,11558,10116.0
,N,50597,,,In vivo,A,,CHEMBL626885,1,,BAO_0000218,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11559,10116.0
,N,50597,,,In vivo,A,,CHEMBL626886,1,,BAO_0000218,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11560,10116.0
,N,50597,,,In vivo,A,,CHEMBL626887,1,,BAO_0000218,14886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11561,10116.0
,N,50597,,,In vivo,A,,CHEMBL626888,1,,BAO_0000218,14393,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,Rattus norvegicus,Intermediate,,,11562,10116.0
,N,50588,,,In vivo,A,,CHEMBL626889,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,1,,,Canis lupus familiaris,Intermediate,,,11563,9615.0
,U,22224,,,In vivo,A,,CHEMBL626761,0,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,1,,,Simiiformes,Autocuration,,,11564,314293.0
,N,50588,,,In vivo,A,,CHEMBL626762,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,1,,,Canis lupus familiaris,Intermediate,,,11565,9615.0
,N,50588,,,In vivo,A,,CHEMBL626763,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,1,,,Canis lupus familiaris,Intermediate,,,11566,9615.0
,N,50597,,,In vivo,A,,CHEMBL626764,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,1,,,Rattus norvegicus,Intermediate,,,11567,10116.0
,N,50597,,,In vivo,A,,CHEMBL626765,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,1,,,Rattus norvegicus,Intermediate,,,11568,10116.0
,N,50588,,,In vivo,A,,CHEMBL626766,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,1,,,Canis lupus familiaris,Intermediate,,,11569,9615.0
,N,50597,,,In vivo,A,,CHEMBL626767,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,1,,,Rattus norvegicus,Intermediate,,,11570,10116.0
,N,50597,,,In vivo,A,,CHEMBL626768,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,1,,,Rattus norvegicus,Intermediate,,,11571,10116.0
,N,50588,,,In vivo,A,,CHEMBL626769,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,1,,,Canis lupus familiaris,Intermediate,,,11572,9615.0
,N,50588,,,In vivo,A,,CHEMBL874463,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,1,,,Canis lupus familiaris,Intermediate,,,11573,9615.0
,U,22224,,,In vivo,A,,CHEMBL626770,0,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,1,,,Simiiformes,Autocuration,,,11574,314293.0
,U,22224,,,In vivo,A,,CHEMBL626771,0,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,1,,,Simiiformes,Autocuration,,,11575,314293.0
,N,50597,,,In vivo,A,,CHEMBL626772,1,,BAO_0000218,13465,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,1,,,Rattus norvegicus,Intermediate,,,11576,10116.0
,N,100710,,,In vivo,A,,CHEMBL626773,1,,BAO_0000218,14731,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,1,,,Macaca fascicularis,Intermediate,,,11577,9541.0
,N,50594,,,In vivo,A,,CHEMBL626774,1,,BAO_0000218,14731,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,1,,,Mus musculus,Intermediate,,,11578,10090.0
,N,50588,,,In vivo,A,,CHEMBL626775,1,,BAO_0000218,13376,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,1,,,Canis lupus familiaris,Intermediate,,,11579,9615.0
,N,50588,,,In vivo,A,,CHEMBL626776,1,,BAO_0000218,13376,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,1,,,Canis lupus familiaris,Intermediate,,,11580,9615.0
,N,50597,,,In vivo,A,,CHEMBL626777,1,,BAO_0000218,14443,Maximum concentration (Cmax) in rat when administered orally,1,,,Rattus norvegicus,Intermediate,,,11581,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626778,0,,BAO_0000218,13465,Maximal concentration in monkey plasma after 25 mg/kg oral dose,1,,Plasma,Simiiformes,Autocuration,,,11582,314293.0
,U,22224,,,In vivo,A,,CHEMBL626779,0,,BAO_0000218,16359,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",1,,,Rattus norvegicus,Autocuration,,,11583,10116.0
,U,22224,,,In vivo,A,,CHEMBL626780,0,,BAO_0000218,16359,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",1,,,Rattus norvegicus,Autocuration,,,11584,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626781,0,,BAO_0000218,15618,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,1,,Plasma,,Autocuration,,,11585,
,N,50597,,,In vivo,A,,CHEMBL632164,1,,BAO_0000218,14554,Pharmacokinetic profile Cmax was evaluated in rats,1,,,Rattus norvegicus,Intermediate,,,11586,10116.0
,N,50588,,,In vivo,A,,CHEMBL632165,1,,BAO_0000218,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),1,,,Canis lupus familiaris,Intermediate,,,11587,9615.0
,N,50594,,,In vivo,A,,CHEMBL632166,1,,BAO_0000218,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),1,,,Mus musculus,Intermediate,,,11588,10090.0
,N,50588,,,In vivo,A,,CHEMBL632167,1,,BAO_0000218,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),1,,,Canis lupus familiaris,Intermediate,,,11589,9615.0
,N,50594,,,In vivo,A,,CHEMBL632168,1,,BAO_0000218,11537,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),1,,,Mus musculus,Intermediate,,,11590,10090.0
,U,22224,,,In vivo,A,1969.0,CHEMBL632169,0,,BAO_0000218,2021,Cmax in rat plasma,1,,Plasma,Rattus norvegicus,Autocuration,,,11591,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL632170,1,,BAO_0000218,5932,Cmax in dog plasma after 30mg/kg oral dose,1,,Plasma,Canis lupus familiaris,Intermediate,,,11592,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL632171,1,,BAO_0000218,5932,Cmax in rat plasma after 30mg/kg oral dose,1,,Plasma,Rattus norvegicus,Intermediate,,,11593,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL632172,1,,BAO_0000218,17320,Plasma level in rats at 30 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,11594,10116.0
,N,50594,,,In vivo,A,1969.0,CHEMBL632173,1,,BAO_0000218,15831,Tested for maximum plasma concentration in mice,1,,Plasma,Mus musculus,Intermediate,,,11595,10090.0
,N,50597,,,In vivo,A,,CHEMBL632174,1,,BAO_0000218,15078,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,11596,10116.0
,N,50597,,,In vivo,A,,CHEMBL632175,1,,BAO_0000218,14941,The Cmax values in female wistar rats.,1,,,Rattus norvegicus,Intermediate,,,11597,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL632176,1,,BAO_0000218,15343,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,1,,Plasma,Canis lupus familiaris,Intermediate,,,11598,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL632177,1,,BAO_0000218,15343,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,1,,Plasma,Rattus norvegicus,Intermediate,,,11599,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL632178,1,,BAO_0000218,14856,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,1,,Plasma,Rattus norvegicus,Intermediate,,,11600,10116.0
,N,50597,,,In vivo,A,,CHEMBL632179,1,,BAO_0000218,13129,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,1,,,Rattus norvegicus,Intermediate,,,11601,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL632180,1,,BAO_0000218,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,1,,Blood,Rattus norvegicus,Intermediate,,,11602,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL632181,1,,BAO_0000218,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,1,,Blood,Rattus norvegicus,Intermediate,,,11603,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL632182,1,,BAO_0000218,13098,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,1,,Blood,Rattus norvegicus,Intermediate,,,11604,10116.0
,U,22224,,,In vivo,A,178.0,CHEMBL632183,0,,BAO_0000218,15478,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,1,,Blood,Mus musculus,Autocuration,,,11605,10090.0
,N,50588,,,In vivo,A,,CHEMBL632184,1,,BAO_0000218,15341,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,1,,,Canis lupus familiaris,Intermediate,,,11606,9615.0
,N,50597,,,In vivo,A,,CHEMBL874470,1,,BAO_0000218,15341,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,1,,,Rattus norvegicus,Intermediate,,,11607,10116.0
,N,50597,,,,A,,CHEMBL631302,1,,BAO_0000218,8684,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11608,10116.0
,N,50597,,,,A,,CHEMBL631303,1,,BAO_0000218,8684,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11609,10116.0
,N,50597,,,,A,,CHEMBL631304,1,,BAO_0000218,8684,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11610,10116.0
,N,50597,,,,A,,CHEMBL631305,1,,BAO_0000218,8684,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11611,10116.0
,N,50597,,,,A,,CHEMBL631306,1,,BAO_0000218,8684,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11612,10116.0
,N,50597,,,,A,,CHEMBL631307,1,,BAO_0000218,8684,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11613,10116.0
,N,50597,,,,A,,CHEMBL631308,1,,BAO_0000218,8684,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11614,10116.0
,N,50597,,,,A,,CHEMBL625557,1,,BAO_0000218,8684,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",1,,,Rattus norvegicus,Intermediate,,,11615,10116.0
,N,50597,,,,A,2106.0,CHEMBL625558,1,,BAO_0000218,8684,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",1,,Spleen,Rattus norvegicus,Intermediate,,,11616,10116.0
,N,50597,,,,A,2106.0,CHEMBL625559,1,,BAO_0000218,8684,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",1,,Spleen,Rattus norvegicus,Intermediate,,,11617,10116.0
,N,50597,,,,A,2106.0,CHEMBL625560,1,,BAO_0000218,8684,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",1,,Spleen,Rattus norvegicus,Intermediate,,,11618,10116.0
,N,50597,,,,A,2106.0,CHEMBL625561,1,,BAO_0000218,8684,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",1,,Spleen,Rattus norvegicus,Intermediate,,,11619,10116.0
,N,50597,,,,A,2106.0,CHEMBL625562,1,,BAO_0000218,8684,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",1,,Spleen,Rattus norvegicus,Intermediate,,,11620,10116.0
,N,50597,,,,A,2106.0,CHEMBL875320,1,,BAO_0000218,8684,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",1,,Spleen,Rattus norvegicus,Intermediate,,,11621,10116.0
,N,50597,,,,A,2106.0,CHEMBL625563,1,,BAO_0000218,8684,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",1,,Spleen,Rattus norvegicus,Intermediate,,,11622,10116.0
,N,50597,,,,A,2106.0,CHEMBL625564,1,,BAO_0000218,8684,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",1,,Spleen,Rattus norvegicus,Intermediate,,,11623,10116.0
,N,50597,,,,A,995.0,CHEMBL625565,1,,BAO_0000218,8684,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",1,,Uterus,Rattus norvegicus,Intermediate,,,11624,10116.0
,N,50597,,,,A,995.0,CHEMBL625566,1,,BAO_0000218,8684,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",1,,Uterus,Rattus norvegicus,Intermediate,,,11625,10116.0
,N,50597,,,,A,995.0,CHEMBL625567,1,,BAO_0000218,8684,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",1,,Uterus,Rattus norvegicus,Intermediate,,,11626,10116.0
,N,50597,,,,A,995.0,CHEMBL625568,1,,BAO_0000218,8684,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",1,,Uterus,Rattus norvegicus,Intermediate,,,11627,10116.0
,N,50597,,,,A,995.0,CHEMBL628217,1,,BAO_0000218,8684,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",1,,Uterus,Rattus norvegicus,Intermediate,,,11628,10116.0
,N,50597,,,,A,995.0,CHEMBL628218,1,,BAO_0000218,8684,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",1,,Uterus,Rattus norvegicus,Intermediate,,,11629,10116.0
,N,50597,,,,A,995.0,CHEMBL628219,1,,BAO_0000218,8684,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",1,,Uterus,Rattus norvegicus,Intermediate,,,11630,10116.0
,N,50597,,,,A,995.0,CHEMBL628220,1,,BAO_0000218,8684,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",1,,Uterus,Rattus norvegicus,Intermediate,,,11631,10116.0
,U,22224,,,,A,,CHEMBL628221,0,,BAO_0000019,8926,Distribution in the blood after 120 min of intravenous administration,1,,,,Autocuration,,,11632,
,U,22224,,,,A,,CHEMBL628222,0,,BAO_0000019,8926,Distribution in the blood after 15 min of intravenous administration,1,,,,Autocuration,,,11633,
,U,22224,,,,A,,CHEMBL628223,0,,BAO_0000019,8926,Distribution in the blood after 30 min of intravenous administration,1,,,,Autocuration,,,11634,
,U,22224,,,,A,,CHEMBL628224,0,,BAO_0000019,8926,Distribution in the blood after 5 min of intravenous administration,1,,,,Autocuration,,,11635,
,U,22224,,,,A,,CHEMBL628225,0,,BAO_0000019,8926,Distribution in the blood after 60 min of intravenous administration,1,,,,Autocuration,,,11636,
,U,22224,,,,A,,CHEMBL628226,0,,BAO_0000019,8926,Distribution in the blood after 90 min of intravenous administration,1,,,,Autocuration,,,11637,
,U,22224,,,,A,,CHEMBL628227,0,,BAO_0000019,8926,Distribution in the bone after 120 min of intravenous administration,1,,,,Autocuration,,,11638,
,U,22224,,,,A,,CHEMBL875481,0,,BAO_0000019,8926,Distribution in the bone after 15 min of intravenous administration,1,,,,Autocuration,,,11639,
,U,22224,,,,A,,CHEMBL628228,0,,BAO_0000019,8926,Distribution in the bone after 30 min of intravenous administration,1,,,,Autocuration,,,11640,
,U,22224,,,,A,,CHEMBL628229,0,,BAO_0000019,8926,Distribution in the bone after 5 min of intravenous administration,1,,,,Autocuration,,,11641,
,U,22224,,,,A,,CHEMBL628230,0,,BAO_0000019,8926,Distribution in the bone after 60 min of intravenous administration,1,,,,Autocuration,,,11642,
,U,22224,,,,A,,CHEMBL628231,0,,BAO_0000019,8926,Distribution in the bone after 90 min of intravenous administration,1,,,,Autocuration,,,11643,
,U,22224,,,,A,,CHEMBL628232,0,,BAO_0000019,8926,Distribution in the heart after 120 min of intravenous administration,1,,,,Autocuration,,,11644,
,U,22224,,,,A,,CHEMBL628233,0,,BAO_0000019,8926,Distribution in the heart after 15 min of intravenous administration,1,,,,Autocuration,,,11645,
,U,22224,,,,A,,CHEMBL628234,0,,BAO_0000019,8926,Distribution in the heart after 30 min of intravenous administration,1,,,,Autocuration,,,11646,
,U,22224,,,,A,,CHEMBL628235,0,,BAO_0000019,8926,Distribution in the heart after 5 min of intravenous administration,1,,,,Autocuration,,,11647,
,U,22224,,,,A,,CHEMBL628236,0,,BAO_0000019,8926,Distribution in the heart after 60 min of intravenous administration,1,,,,Autocuration,,,11648,
,U,22224,,,,A,,CHEMBL628237,0,,BAO_0000019,8926,Distribution in the heart after 90 min of intravenous administration,1,,,,Autocuration,,,11649,
,U,22224,,,,A,,CHEMBL628238,0,,BAO_0000019,8926,Distribution in the kidneys after 120 min of intravenous administration,1,,,,Autocuration,,,11650,
,U,22224,,,,A,,CHEMBL628239,0,,BAO_0000019,8926,Distribution in the kidneys after 15 min of intravenous administration,1,,,,Autocuration,,,11651,
,U,22224,,,,A,,CHEMBL628240,0,,BAO_0000019,8926,Distribution in the kidneys after 30 min of intravenous administration,1,,,,Autocuration,,,11652,
,U,22224,,,,A,,CHEMBL628241,0,,BAO_0000019,8926,Distribution in the kidneys after 5 min of intravenous administration,1,,,,Autocuration,,,11653,
,U,22224,,,,A,,CHEMBL628242,0,,BAO_0000019,8926,Distribution in the kidneys after 60 min of intravenous administration,1,,,,Autocuration,,,11654,
,U,22224,,,,A,,CHEMBL875482,0,,BAO_0000019,8926,Distribution in the kidneys after 90 min of intravenous administration,1,,,,Autocuration,,,11655,
,U,22224,,,,A,,CHEMBL628243,0,,BAO_0000019,8926,Distribution in the liver after 120 min of intravenous administration,1,,,,Autocuration,,,11656,
,U,22224,,,,A,,CHEMBL628244,0,,BAO_0000019,8926,Distribution in the liver after 15 min of intravenous administration,1,,,,Autocuration,,,11657,
,U,22224,,,,A,,CHEMBL628245,0,,BAO_0000019,8926,Distribution in the liver after 30 min of intravenous administration,1,,,,Autocuration,,,11658,
,U,22224,,,,A,,CHEMBL628246,0,,BAO_0000019,8926,Distribution in the liver after 5 min of intravenous administration,1,,,,Autocuration,,,11659,
,U,22224,,,,A,,CHEMBL628247,0,,BAO_0000019,8926,Distribution in the liver after 60 min of intravenous administration,1,,,,Autocuration,,,11660,
,U,22224,,,,A,,CHEMBL628248,0,,BAO_0000019,8926,Distribution in the liver after 90 min of intravenous administration,1,,,,Autocuration,,,11661,
,U,22224,,,,A,,CHEMBL628249,0,,BAO_0000019,8926,Distribution in the lung after 120 min of intravenous administration,1,,,,Autocuration,,,11662,
,N,50594,,,,A,,CHEMBL625452,1,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",1,,,Mus musculus,Intermediate,,,11663,10090.0
,N,50594,,,,A,,CHEMBL625453,1,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",1,,,Mus musculus,Intermediate,,,11664,10090.0
,N,50594,,,,A,,CHEMBL625454,1,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",1,,,Mus musculus,Intermediate,,,11665,10090.0
,N,50594,,,,A,,CHEMBL623844,1,,BAO_0000218,14839,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",1,,,Mus musculus,Intermediate,,,11666,10090.0
,N,50597,,,,A,,CHEMBL623845,1,,BAO_0000218,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,1,,,Rattus norvegicus,Intermediate,,,11667,10116.0
,N,50597,,,,A,,CHEMBL623846,1,,BAO_0000218,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,1,,,Rattus norvegicus,Intermediate,,,11668,10116.0
,U,22224,,,,A,,CHEMBL623847,0,,BAO_0000218,12178,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,1,,,,Autocuration,,,11669,
,N,100710,,,,A,,CHEMBL623848,1,,BAO_0000218,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,,Macaca fascicularis,Intermediate,,,11670,9541.0
,N,100710,,,,A,,CHEMBL623849,1,,BAO_0000218,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,,,Macaca fascicularis,Intermediate,,,11671,9541.0
,N,100710,,,,A,,CHEMBL623850,1,,BAO_0000218,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,,Macaca fascicularis,Intermediate,,,11672,9541.0
,N,100710,,,,A,,CHEMBL623851,1,,BAO_0000218,12186,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,,,Macaca fascicularis,Intermediate,,,11673,9541.0
,U,22224,,,,A,,CHEMBL623852,0,,BAO_0000218,12187,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,1,,,Simiiformes,Autocuration,,,11674,314293.0
,N,50506,,,,A,,CHEMBL624551,1,,BAO_0000218,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,1,,,Mustela putorius furo,Intermediate,,,11675,9669.0
,N,50506,,,,A,,CHEMBL624552,1,,BAO_0000218,12187,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",1,,,Mustela putorius furo,Intermediate,,,11676,9669.0
,U,22224,,,,A,,CHEMBL624553,0,,BAO_0000218,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,1,,,Simiiformes,Autocuration,,,11677,314293.0
,U,22224,,,,A,,CHEMBL624554,0,,BAO_0000218,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,1,,,Simiiformes,Autocuration,,,11678,314293.0
,N,50597,,,,A,,CHEMBL624555,1,,BAO_0000218,12187,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,11679,10116.0
,N,50597,,,,A,,CHEMBL624741,1,,BAO_0000218,12187,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,,,Rattus norvegicus,Intermediate,,,11680,10116.0
,N,50588,,,,A,,CHEMBL624742,1,,BAO_0000218,14122,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",1,,,Canis lupus familiaris,Intermediate,,,11681,9615.0
,N,100712,,,,A,,CHEMBL624743,1,,BAO_0000218,14122,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",1,,,Cricetinae,Intermediate,,,11682,10026.0
,N,50597,,,,A,,CHEMBL877606,1,,BAO_0000218,14122,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",1,,,Rattus norvegicus,Intermediate,,,11683,10116.0
,U,22224,,,,A,,CHEMBL624744,0,,BAO_0000218,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,1,,,,Autocuration,,,11684,
,U,22224,,,,A,178.0,CHEMBL624745,0,,BAO_0000218,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,1,,Blood,,Autocuration,,,11685,
,U,22224,,,,A,178.0,CHEMBL624746,0,,BAO_0000218,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,1,,Blood,,Autocuration,,,11686,
,U,22224,,,,A,178.0,CHEMBL624747,0,,BAO_0000218,13391,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,1,,Blood,,Autocuration,,,11687,
,U,22224,,,,A,,CHEMBL624748,0,,BAO_0000019,16360,Oral absorption expressed as Area under curve was determined,1,,,,Autocuration,,,11688,
,N,50588,,,,A,,CHEMBL622504,1,,BAO_0000218,3673,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,1,,,Canis lupus familiaris,Intermediate,,,11689,9615.0
,N,50588,,,,A,,CHEMBL622505,1,,BAO_0000218,14122,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",1,,,Canis lupus familiaris,Intermediate,,,11690,9615.0
,N,100712,,,,A,,CHEMBL622506,1,,BAO_0000218,14122,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",1,,,Cricetinae,Intermediate,,,11691,10026.0
,N,100712,,,,A,,CHEMBL622507,1,,BAO_0000218,14122,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",1,,,Cricetinae,Intermediate,,,11692,10026.0
,N,50597,,,,A,,CHEMBL622508,1,,BAO_0000218,14122,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",1,,,Rattus norvegicus,Intermediate,,,11693,10116.0
,U,22224,,,,A,,CHEMBL622509,0,,BAO_0000019,13889,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,1,,,,Autocuration,,,11694,
,N,50597,,,,A,,CHEMBL622510,1,,BAO_0000218,14393,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,Rattus norvegicus,Intermediate,,,11695,10116.0
,N,50597,,,,A,,CHEMBL622511,1,,BAO_0000218,17279,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),1,,,Rattus norvegicus,Intermediate,,,11696,10116.0
,N,100710,,,,A,,CHEMBL622512,1,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,1,,,Macaca fascicularis,Intermediate,,,11697,9541.0
,N,100710,,,,A,,CHEMBL622513,1,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,1,,,Macaca fascicularis,Intermediate,,,11698,9541.0
,N,100710,,,,A,,CHEMBL622514,1,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,1,,,Macaca fascicularis,Intermediate,,,11699,9541.0
,N,50588,,,,A,,CHEMBL622515,1,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,1,,,Canis lupus familiaris,Intermediate,,,11700,9615.0
,N,50588,,,,A,,CHEMBL622516,1,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,1,,,Canis lupus familiaris,Intermediate,,,11701,9615.0
,N,50597,,,,A,,CHEMBL622517,1,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,11702,10116.0
,N,50597,,,,A,,CHEMBL622518,1,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,11703,10116.0
,N,50597,,,,A,,CHEMBL622519,1,,BAO_0000218,14548,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,11704,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL622520,1,,BAO_0000218,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11705,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL622521,1,,BAO_0000218,14608,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11706,10116.0
,N,50594,,,In vivo,A,14.0,CHEMBL625113,1,,BAO_0000218,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Zone of skin,Mus musculus,Intermediate,,,11707,10090.0
,N,50597,,,In vivo,A,14.0,CHEMBL625114,1,,BAO_0000218,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Zone of skin,Rattus norvegicus,Intermediate,,,11708,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL874397,1,,BAO_0000218,14608,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Zone of skin,Rattus norvegicus,Intermediate,,,11709,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL625115,1,,BAO_0000218,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Spleen,Rattus norvegicus,Intermediate,,,11710,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL625116,1,,BAO_0000218,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Spleen,Rattus norvegicus,Intermediate,,,11711,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL623932,1,,BAO_0000218,14608,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Spleen,Rattus norvegicus,Intermediate,,,11712,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL623933,1,,BAO_0000218,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Striatum,Rattus norvegicus,Intermediate,,,11713,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL623934,1,,BAO_0000218,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Striatum,Rattus norvegicus,Intermediate,,,11714,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL623935,1,,BAO_0000218,14608,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Striatum,Rattus norvegicus,Intermediate,,,11715,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL623936,1,,BAO_0000218,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,11716,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL623937,1,,BAO_0000218,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,11717,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL623938,1,,BAO_0000218,14608,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,11718,10116.0
,N,50594,,,,A,,CHEMBL623939,1,,BAO_0000218,15383,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,Mus musculus,Intermediate,,,11719,10090.0
,N,50594,,,,A,,CHEMBL623940,1,,BAO_0000218,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,,Mus musculus,Intermediate,,,11720,10090.0
,N,50594,,,,A,,CHEMBL623941,1,,BAO_0000218,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,,Mus musculus,Intermediate,,,11721,10090.0
,N,50594,,,,A,,CHEMBL627216,1,,BAO_0000218,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,Mus musculus,Intermediate,,,11722,10090.0
,N,50594,,,,A,,CHEMBL623942,1,,BAO_0000218,15383,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,Mus musculus,Intermediate,,,11723,10090.0
,N,50594,,,,A,955.0,CHEMBL618793,1,,BAO_0000218,15383,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,Brain,Mus musculus,Intermediate,,,11724,10090.0
,N,50594,,,,A,955.0,CHEMBL618794,1,,BAO_0000218,15383,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,Brain,Mus musculus,Intermediate,,,11725,10090.0
,N,50594,,,,A,955.0,CHEMBL618795,1,,BAO_0000218,15383,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,Brain,Mus musculus,Intermediate,,,11726,10090.0
,N,50594,,,,A,,CHEMBL618796,1,,BAO_0000218,15383,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,Mus musculus,Intermediate,,,11727,10090.0
,N,50594,,,,A,,CHEMBL618797,1,,BAO_0000218,15383,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,Mus musculus,Intermediate,,,11728,10090.0
,N,50594,,,,A,2113.0,CHEMBL618798,1,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,1,,Kidney,Mus musculus,Intermediate,,,11729,10090.0
,N,50594,,,,A,2113.0,CHEMBL618799,1,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,Kidney,Mus musculus,Intermediate,,,11730,10090.0
,N,50594,,,,A,2113.0,CHEMBL618800,1,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,Kidney,Mus musculus,Intermediate,,,11731,10090.0
,N,50594,,,,A,2113.0,CHEMBL618801,1,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,Kidney,Mus musculus,Intermediate,,,11732,10090.0
,N,50594,,,,A,2113.0,CHEMBL618802,1,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,Kidney,Mus musculus,Intermediate,,,11733,10090.0
,N,50594,,,,A,2113.0,CHEMBL618803,1,,BAO_0000218,15383,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,Kidney,Mus musculus,Intermediate,,,11734,10090.0
,N,50594,,,,A,2107.0,CHEMBL618804,1,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,1,,Liver,Mus musculus,Intermediate,,,11735,10090.0
,N,50594,,,,A,2107.0,CHEMBL618805,1,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,Liver,Mus musculus,Intermediate,,,11736,10090.0
,N,50594,,,,A,2107.0,CHEMBL618806,1,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,Liver,Mus musculus,Intermediate,,,11737,10090.0
,N,50594,,,,A,2107.0,CHEMBL618807,1,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,Liver,Mus musculus,Intermediate,,,11738,10090.0
,N,50594,,,,A,2107.0,CHEMBL618808,1,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,Liver,Mus musculus,Intermediate,,,11739,10090.0
,N,50594,,,,A,2107.0,CHEMBL618809,1,,BAO_0000218,15383,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,Liver,Mus musculus,Intermediate,,,11740,10090.0
,N,50594,,,,A,2385.0,CHEMBL618810,1,,BAO_0000218,15383,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,Muscle tissue,Mus musculus,Intermediate,,,11741,10090.0
,N,50594,,,,A,2385.0,CHEMBL618811,1,,BAO_0000218,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,1,,Muscle tissue,Mus musculus,Intermediate,,,11742,10090.0
,N,50594,,,,A,2385.0,CHEMBL875844,1,,BAO_0000218,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,Muscle tissue,Mus musculus,Intermediate,,,11743,10090.0
,N,50594,,,,A,2385.0,CHEMBL618812,1,,BAO_0000218,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,Muscle tissue,Mus musculus,Intermediate,,,11744,10090.0
,N,50594,,,,A,2385.0,CHEMBL618813,1,,BAO_0000218,15383,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,Muscle tissue,Mus musculus,Intermediate,,,11745,10090.0
,N,50594,,,,A,,CHEMBL618814,1,,BAO_0000218,15383,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,Mus musculus,Intermediate,,,11746,10090.0
,N,50594,,,,A,,CHEMBL618815,1,,BAO_0000218,15383,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,Mus musculus,Intermediate,,,11747,10090.0
,N,50594,,,,A,,CHEMBL618816,1,,BAO_0000218,15383,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,Mus musculus,Intermediate,,,11748,10090.0
,N,50594,,,,A,,CHEMBL618817,1,,BAO_0000218,15383,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,Mus musculus,Intermediate,,,11749,10090.0
,N,50594,,,,A,,CHEMBL620544,1,,BAO_0000218,15383,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,Mus musculus,Intermediate,,,11750,10090.0
,N,50597,,,In vivo,A,,CHEMBL626230,1,,BAO_0000218,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,1,,,Rattus norvegicus,Intermediate,,,11751,10116.0
,N,50597,,,In vivo,A,,CHEMBL626231,1,,BAO_0000218,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,1,,,Rattus norvegicus,Intermediate,,,11752,10116.0
,N,50597,,,In vivo,A,,CHEMBL626232,1,,BAO_0000218,15341,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,1,,,Rattus norvegicus,Intermediate,,,11753,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626233,1,,BAO_0000218,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,1,,Plasma,Canis lupus familiaris,Intermediate,,,11754,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626234,1,,BAO_0000218,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,1,,Plasma,Rattus norvegicus,Intermediate,,,11755,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL875341,1,,BAO_0000218,14906,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,1,,Plasma,Rattus norvegicus,Intermediate,,,11756,10116.0
,N,50587,,,In vivo,A,1969.0,CHEMBL626235,1,,BAO_0000218,14215,The maximum plasma concentration (100 mg/kg) administered orally in human,1,,Plasma,Homo sapiens,Intermediate,,,11757,9606.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626236,0,,BAO_0000218,14215,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,1,,Plasma,Callithrix,Autocuration,,,11758,9481.0
,U,22224,,,In vivo,A,1969.0,CHEMBL626237,0,,BAO_0000218,14215,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,1,,Plasma,Simiiformes,Autocuration,,,11759,314293.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626238,1,,BAO_0000218,14215,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,1,,Plasma,Canis lupus familiaris,Intermediate,,,11760,9615.0
,N,50587,,,In vivo,A,1969.0,CHEMBL622412,1,,BAO_0000218,14215,The maximum plasma concentration (200 mg/kg) administered orally in human,1,,Plasma,Homo sapiens,Intermediate,,,11761,9606.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623114,1,,BAO_0000218,14215,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,11762,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL623115,0,,BAO_0000218,14215,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,1,,Plasma,Callithrix,Autocuration,,,11763,9481.0
,U,22224,,,In vivo,A,1969.0,CHEMBL623116,0,,BAO_0000218,14215,The maximum plasma concentration (25 mg/kg) administered orally in monkey,1,,Plasma,Simiiformes,Autocuration,,,11764,314293.0
,U,22224,,,In vivo,A,1969.0,CHEMBL623117,0,,BAO_0000218,14215,The maximum plasma concentration (30 mg/kg) administered orally in dog,1,,Plasma,Canis lupus familiaris,Autocuration,,,11765,9615.0
,N,50587,,,In vivo,A,1969.0,CHEMBL623118,1,,BAO_0000218,14215,The maximum plasma concentration (400 mg/kg) administered orally in human,1,,Plasma,Homo sapiens,Intermediate,,,11766,9606.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623119,1,,BAO_0000218,14215,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,1,,Plasma,Rattus norvegicus,Intermediate,,,11767,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623120,1,,BAO_0000218,14215,The maximum plasma concentration (50 mg/kg) administered orally in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,11768,10116.0
,N,50587,,,In vivo,A,1969.0,CHEMBL623286,1,,BAO_0000218,14215,The maximum plasma concentration (800 mg/kg) administered orally in human,1,,Plasma,Homo sapiens,Intermediate,,,11769,9606.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623287,1,,BAO_0000218,14067,The maximum plasma concentration was measured on rats,1,,Plasma,Rattus norvegicus,Intermediate,,,11770,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623288,1,,BAO_0000218,12350,The maximum plasma concentration was measured on rats after oral administration,1,,Plasma,Rattus norvegicus,Intermediate,,,11771,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623289,1,,BAO_0000218,14813,Plasma drug Cmax in rat (PO dose),1,,Plasma,Rattus norvegicus,Intermediate,,,11772,10116.0
,U,22224,,,In vivo,A,,CHEMBL623290,0,,BAO_0000218,12536,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,1,,,,Autocuration,,,11773,
,N,50588,,,In vivo,A,1969.0,CHEMBL623291,1,,BAO_0000218,14169,maximum Plasma concentration in Dog was determined after Peroral administration,1,,Plasma,Canis lupus familiaris,Intermediate,,,11774,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623292,1,,BAO_0000218,14169,maximum Plasma concentration in Rats was determined after Peroral administration,1,,Plasma,Rattus norvegicus,Intermediate,,,11775,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL623293,1,,BAO_0000218,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,1,,Plasma,Canis lupus familiaris,Intermediate,,,11776,9615.0
,U,22224,,,In vivo,A,1969.0,CHEMBL623294,0,,BAO_0000218,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,1,,Plasma,Simiiformes,Autocuration,,,11777,314293.0
,N,50597,,,In vivo,A,1969.0,CHEMBL623295,1,,BAO_0000218,15604,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,11778,10116.0
,N,50594,,,In vivo,A,,CHEMBL623296,1,,BAO_0000218,14387,maximum concentration was measured when administered through oral route in mice,1,,,Mus musculus,Intermediate,,,11779,10090.0
,N,50594,,,,A,,CHEMBL875349,1,,BAO_0000218,15115,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,1,,,Mus musculus,Intermediate,,,11780,10090.0
,U,22224,,,,A,,CHEMBL623297,0,,BAO_0000019,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,1,,,Simiiformes,Autocuration,,,11781,314293.0
,U,22224,,,,A,,CHEMBL623298,0,,BAO_0000019,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,1,,,Simiiformes,Autocuration,,,11782,314293.0
,U,22224,,,,A,,CHEMBL623299,0,,BAO_0000019,15115,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,1,,,Simiiformes,Autocuration,,,11783,314293.0
,N,50597,,,,A,,CHEMBL623300,1,,BAO_0000218,16359,Pharmacokinetic parameter was evaluated in rats,1,,,Rattus norvegicus,Intermediate,,,11784,10116.0
,N,50594,,,,A,,CHEMBL623301,1,,BAO_0000218,12829,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,1,,,Mus musculus,Intermediate,,,11785,10090.0
,N,50594,,,,A,,CHEMBL623302,1,,BAO_0000218,12829,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,1,,,Mus musculus,Intermediate,,,11786,10090.0
,N,50594,,,,A,,CHEMBL623303,1,,BAO_0000218,12829,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,1,,,Mus musculus,Intermediate,,,11787,10090.0
,N,50594,,,,A,,CHEMBL623304,1,,BAO_0000218,12829,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,1,,,Mus musculus,Intermediate,,,11788,10090.0
,N,50594,,,,A,,CHEMBL623305,1,,BAO_0000218,12829,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,1,,,Mus musculus,Intermediate,,,11789,10090.0
,N,50597,,,,A,1969.0,CHEMBL623306,1,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,1,,Plasma,Rattus norvegicus,Intermediate,,,11790,10116.0
,N,50597,,,,A,1969.0,CHEMBL623307,1,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,1,,Plasma,Rattus norvegicus,Intermediate,,,11791,10116.0
,N,50597,,,,A,1969.0,CHEMBL623308,1,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,1,,Plasma,Rattus norvegicus,Intermediate,,,11792,10116.0
,N,50594,,,,A,1969.0,CHEMBL623309,1,,BAO_0000218,15137,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,1,,Plasma,Mus musculus,Intermediate,,,11793,10090.0
,N,50594,,,,A,,CHEMBL623310,1,,BAO_0000218,13509,Plasma Concentration after 120 min of oral administration to mice,1,,,Mus musculus,Intermediate,,,11794,10090.0
,N,50594,,,,A,,CHEMBL623311,1,,BAO_0000218,13509,Plasma Concentration after 30 min of oral administration to mice,1,,,Mus musculus,Intermediate,,,11795,10090.0
,N,100710,,,,A,,CHEMBL623312,1,,BAO_0000218,13509,Plasma Concentration after 60 min of oral administration to mice,1,,,Macaca fascicularis,Intermediate,,,11796,9541.0
,N,50594,,,,A,,CHEMBL875350,1,,BAO_0000218,13509,Plasma Concentration after 60 min of oral administration to mice; Not determined,1,,,Mus musculus,Intermediate,,,11797,10090.0
,N,50594,,,,A,,CHEMBL628635,1,,BAO_0000218,13509,Plasma Concentration after 90 min of oral administration to mice,1,,,Mus musculus,Intermediate,,,11798,10090.0
,N,50597,,,,A,,CHEMBL628636,1,,BAO_0000218,12064,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11799,10116.0
,N,50597,,,,A,,CHEMBL628637,1,,BAO_0000218,12064,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11800,10116.0
,N,50597,,,,A,,CHEMBL628058,1,,BAO_0000218,12064,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,1,,,Rattus norvegicus,Intermediate,,,11801,10116.0
,N,50597,,,,A,,CHEMBL628059,1,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,1,,,Rattus norvegicus,Intermediate,,,11802,10116.0
,N,50597,,,,A,,CHEMBL628060,1,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,1,,,Rattus norvegicus,Intermediate,,,11803,10116.0
,U,22224,,,,A,,CHEMBL628061,0,,BAO_0000019,8926,Distribution in the lung after 15 min of intravenous administration,1,,,,Autocuration,,,11804,
,U,22224,,,,A,,CHEMBL628062,0,,BAO_0000019,8926,Distribution in the lung after 30 min of intravenous administration,1,,,,Autocuration,,,11805,
,U,22224,,,,A,,CHEMBL628063,0,,BAO_0000019,8926,Distribution in the lung after 5 min of intravenous administration,1,,,,Autocuration,,,11806,
,U,22224,,,,A,,CHEMBL628064,0,,BAO_0000019,8926,Distribution in the lung after 60 min of intravenous administration,1,,,,Autocuration,,,11807,
,U,22224,,,,A,,CHEMBL628065,0,,BAO_0000019,8926,Distribution in the lung after 90 min of intravenous administration,1,,,,Autocuration,,,11808,
,U,22224,,,,A,2385.0,CHEMBL628066,0,,BAO_0000019,8926,Distribution in the muscle after 120 min of intravenous administration,1,,Muscle tissue,,Autocuration,,,11809,
,U,22224,,,,A,2385.0,CHEMBL628067,0,,BAO_0000019,8926,Distribution in the muscle after 15 min of intravenous administration,1,,Muscle tissue,,Autocuration,,,11810,
,N,50594,,,,A,2385.0,CHEMBL874646,1,,BAO_0000218,8926,Distribution in the muscle after 30 min of intravenous administration,1,,Muscle tissue,Mus musculus,Intermediate,,,11811,10090.0
,U,22224,,,,A,2385.0,CHEMBL628068,0,,BAO_0000019,8926,Distribution in the muscle after 5 min of intravenous administration,1,,Muscle tissue,,Autocuration,,,11812,
,U,22224,,,,A,2385.0,CHEMBL628069,0,,BAO_0000019,8926,Distribution in the muscle after 60 min of intravenous administration,1,,Muscle tissue,,Autocuration,,,11813,
,U,22224,,,,A,2385.0,CHEMBL628070,0,,BAO_0000019,8926,Distribution in the muscle after 90 min of intravenous administration,1,,Muscle tissue,,Autocuration,,,11814,
,U,22224,,,,A,2106.0,CHEMBL628071,0,,BAO_0000019,8926,Distribution in the spleen after 120 min of intravenous administration,1,,Spleen,,Autocuration,,,11815,
,U,22224,,,,A,2106.0,CHEMBL628072,0,,BAO_0000019,8926,Distribution in the spleen after 15 min of intravenous administration,1,,Spleen,,Autocuration,,,11816,
,U,22224,,,,A,2106.0,CHEMBL628073,0,,BAO_0000019,8926,Distribution in the spleen after 30 min of intravenous administration,1,,Spleen,,Autocuration,,,11817,
,U,22224,,,,A,2106.0,CHEMBL628074,0,,BAO_0000019,8926,Distribution in the spleen after 5 min of intravenous administration,1,,Spleen,,Autocuration,,,11818,
,U,22224,,,,A,2106.0,CHEMBL628075,0,,BAO_0000019,8926,Distribution in the spleen after 60 min of intravenous administration,1,,Spleen,,Autocuration,,,11819,
,U,22224,,,,A,2106.0,CHEMBL628076,0,,BAO_0000019,8926,Distribution in the spleen after 90 min of intravenous administration,1,,Spleen,,Autocuration,,,11820,
,N,50597,,,,A,1235.0,CHEMBL628077,1,,BAO_0000218,7570,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,1,,Adrenal cortex,Rattus norvegicus,Intermediate,,,11821,10116.0
,N,50597,,,,A,178.0,CHEMBL628078,1,,BAO_0000218,7570,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,1,,Blood,Rattus norvegicus,Intermediate,,,11822,10116.0
,N,50597,,,,A,2107.0,CHEMBL628079,1,,BAO_0000218,7570,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,1,,Liver,Rattus norvegicus,Intermediate,,,11823,10116.0
,N,50597,,,,A,992.0,CHEMBL628080,1,,BAO_0000218,7570,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,1,,Female gonad,Rattus norvegicus,Intermediate,,,11824,10116.0
,N,50597,,,,A,2046.0,CHEMBL628081,1,,BAO_0000218,7570,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,11825,10116.0
,N,50597,,,,A,1235.0,CHEMBL628082,1,,BAO_0000218,7570,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,1,,Adrenal cortex,Rattus norvegicus,Intermediate,,,11826,10116.0
,N,50597,,,,A,178.0,CHEMBL874647,1,,BAO_0000218,7570,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,1,,Blood,Rattus norvegicus,Intermediate,,,11827,10116.0
,N,50597,,,,A,2107.0,CHEMBL626406,1,,BAO_0000218,7570,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,1,,Liver,Rattus norvegicus,Intermediate,,,11828,10116.0
,N,50597,,,,A,992.0,CHEMBL626407,1,,BAO_0000218,7570,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,1,,Female gonad,Rattus norvegicus,Intermediate,,,11829,10116.0
,N,50597,,,,A,2046.0,CHEMBL626408,1,,BAO_0000218,7570,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,11830,10116.0
,N,50597,,,,A,178.0,CHEMBL626409,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",1,,Blood,Rattus norvegicus,Intermediate,,,11831,10116.0
,N,50597,,,,A,178.0,CHEMBL626410,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",1,,Blood,Rattus norvegicus,Intermediate,,,11832,10116.0
,N,50597,,,,A,178.0,CHEMBL626411,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",1,,Blood,Rattus norvegicus,Intermediate,,,11833,10116.0
,N,50597,,,,A,178.0,CHEMBL626412,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",1,,Blood,Rattus norvegicus,Intermediate,,,11834,10116.0
,N,50597,,,,A,178.0,CHEMBL626413,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",1,,Blood,Rattus norvegicus,Intermediate,,,11835,10116.0
,N,50597,,,,A,178.0,CHEMBL626414,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",1,,Blood,Rattus norvegicus,Intermediate,,,11836,10116.0
,N,50597,,,,A,178.0,CHEMBL626415,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",1,,Blood,Rattus norvegicus,Intermediate,,,11837,10116.0
,N,50597,,,,A,178.0,CHEMBL626416,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",1,,Blood,Rattus norvegicus,Intermediate,,,11838,10116.0
,N,50597,,,,A,178.0,CHEMBL627062,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",1,,Blood,Rattus norvegicus,Intermediate,,,11839,10116.0
,N,50597,,,,A,178.0,CHEMBL627063,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",1,,Blood,Rattus norvegicus,Intermediate,,,11840,10116.0
,N,50597,,,,A,178.0,CHEMBL627064,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",1,,Blood,Rattus norvegicus,Intermediate,,,11841,10116.0
,N,50597,,,,A,178.0,CHEMBL627227,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",1,,Blood,Rattus norvegicus,Intermediate,,,11842,10116.0
,N,50597,,,,A,178.0,CHEMBL627228,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",1,,Blood,Rattus norvegicus,Intermediate,,,11843,10116.0
,N,50597,,,,A,178.0,CHEMBL627229,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",1,,Blood,Rattus norvegicus,Intermediate,,,11844,10116.0
,N,50597,,,,A,178.0,CHEMBL625792,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",1,,Blood,Rattus norvegicus,Intermediate,,,11845,10116.0
,N,50597,,,,A,178.0,CHEMBL625793,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",1,,Blood,Rattus norvegicus,Intermediate,,,11846,10116.0
,N,50597,,,,A,178.0,CHEMBL625794,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",1,,Blood,Rattus norvegicus,Intermediate,,,11847,10116.0
,N,50597,,,,A,178.0,CHEMBL625795,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",1,,Blood,Rattus norvegicus,Intermediate,,,11848,10116.0
,N,50594,,,,A,,CHEMBL625796,1,,BAO_0000218,13792,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,1,,,Mus musculus,Intermediate,,,11849,10090.0
,N,50588,,,,A,,CHEMBL625797,1,,BAO_0000218,13376,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,1,,,Canis lupus familiaris,Intermediate,,,11850,9615.0
,N,50588,,,,A,,CHEMBL625798,1,,BAO_0000218,13376,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,1,,,Canis lupus familiaris,Intermediate,,,11851,9615.0
,U,22224,,,,A,,CHEMBL875613,0,,BAO_0000218,14380,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,,,,Autocuration,,,11852,
,U,22224,,,,A,,CHEMBL625799,0,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,1,,,,Autocuration,,,11853,
,U,22224,,,,A,,CHEMBL625800,0,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,1,,,,Autocuration,,,11854,
,U,22224,,,,A,,CHEMBL625801,0,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,1,,,,Autocuration,,,11855,
,U,22224,,,,A,,CHEMBL625802,0,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,1,,,,Autocuration,,,11856,
,U,22224,,,,A,,CHEMBL625803,0,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,1,,,,Autocuration,,,11857,
,U,22224,,,,A,,CHEMBL625804,0,,BAO_0000019,14380,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,1,,,,Autocuration,,,11858,
,U,22224,,,,A,,CHEMBL622530,0,,BAO_0000218,14380,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,1,,,,Autocuration,,,11859,
,N,50594,,,,A,,CHEMBL622531,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,1,,,Mus musculus,Intermediate,,,11860,10090.0
,N,50594,,,,A,,CHEMBL622532,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,,,Mus musculus,Intermediate,,,11861,10090.0
,N,50594,,,,A,,CHEMBL623176,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11862,10090.0
,N,50594,,,,A,,CHEMBL623177,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),1,,,Mus musculus,Intermediate,,,11863,10090.0
,N,50594,,,,A,,CHEMBL623178,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,,,Mus musculus,Intermediate,,,11864,10090.0
,N,50594,,,,A,,CHEMBL623179,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,1,,,Mus musculus,Intermediate,,,11865,10090.0
,N,50594,,,,A,,CHEMBL623180,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),1,,,Mus musculus,Intermediate,,,11866,10090.0
,N,50594,,,,A,,CHEMBL623181,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11867,10090.0
,N,50594,,,,A,,CHEMBL624131,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11868,10090.0
,N,50594,,,,A,,CHEMBL624132,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),1,,,Mus musculus,Intermediate,,,11869,10090.0
,N,50594,,,,A,,CHEMBL624133,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11870,10090.0
,N,50594,,,,A,,CHEMBL624846,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,1,,,Mus musculus,Intermediate,,,11871,10090.0
,N,50594,,,,A,,CHEMBL624847,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11872,10090.0
,N,50594,,,,A,,CHEMBL624848,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11873,10090.0
,N,50594,,,,A,,CHEMBL625012,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),1,,,Mus musculus,Intermediate,,,11874,10090.0
,N,50594,,,,A,,CHEMBL625013,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11875,10090.0
,N,50594,,,,A,,CHEMBL625014,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,1,,,Mus musculus,Intermediate,,,11876,10090.0
,N,50594,,,,A,,CHEMBL625015,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),1,,,Mus musculus,Intermediate,,,11877,10090.0
,N,50594,,,,A,,CHEMBL625016,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11878,10090.0
,N,50594,,,,A,,CHEMBL625017,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,1,,,Mus musculus,Intermediate,,,11879,10090.0
,N,50594,,,,A,,CHEMBL625018,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11880,10090.0
,N,50594,,,,A,,CHEMBL625019,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11881,10090.0
,N,50594,,,,A,,CHEMBL625020,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,11882,10090.0
,N,50594,,,,A,,CHEMBL625021,1,,BAO_0000218,13701,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,1,,,Mus musculus,Intermediate,,,11883,10090.0
,N,50597,,,,A,,CHEMBL625022,1,,BAO_0000218,14393,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,Rattus norvegicus,Intermediate,,,11884,10116.0
,N,50594,,,,A,,CHEMBL625023,1,,BAO_0000218,14731,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,1,,,Mus musculus,Intermediate,,,11885,10090.0
,N,100710,,,,A,,CHEMBL625024,1,,BAO_0000218,14731,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,1,,,Macaca fascicularis,Intermediate,,,11886,9541.0
,N,100710,,,,A,,CHEMBL627626,1,,BAO_0000218,14731,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,1,,,Macaca fascicularis,Intermediate,,,11887,9541.0
,U,22224,,,,A,955.0,CHEMBL627627,0,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,1,,Brain,,Autocuration,,,11888,
,U,22224,,,,A,1977.0,CHEMBL627628,0,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,1,,Serum,,Autocuration,,,11889,
,U,22224,,,,A,955.0,CHEMBL627629,0,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,1,,Brain,,Autocuration,,,11890,
,U,22224,,,,A,1977.0,CHEMBL627630,0,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,1,,Serum,,Autocuration,,,11891,
,U,22224,,,,A,,CHEMBL627631,0,,BAO_0000019,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),1,,,,Autocuration,,,11892,
,U,22224,,,,A,,CHEMBL629515,0,,BAO_0000218,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),1,,,,Autocuration,,,11893,
,N,50594,,,,A,2106.0,CHEMBL629516,1,,BAO_0000218,15383,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,Spleen,Mus musculus,Intermediate,,,11894,10090.0
,N,50594,,,,A,2106.0,CHEMBL629517,1,,BAO_0000218,15383,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,Spleen,Mus musculus,Intermediate,,,11895,10090.0
,N,50594,,,,A,2106.0,CHEMBL629518,1,,BAO_0000218,15383,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,Spleen,Mus musculus,Intermediate,,,11896,10090.0
,N,50594,,,,A,,CHEMBL877499,1,,BAO_0000218,15383,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,1,,,Mus musculus,Intermediate,,,11897,10090.0
,N,50594,,,,A,,CHEMBL629519,1,,BAO_0000218,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,1,,,Mus musculus,Intermediate,,,11898,10090.0
,N,50594,,,,A,,CHEMBL629520,1,,BAO_0000218,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,1,,,Mus musculus,Intermediate,,,11899,10090.0
,N,50594,,,,A,,CHEMBL629521,1,,BAO_0000218,15383,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,1,,,Mus musculus,Intermediate,,,11900,10090.0
,N,50594,,,,A,,CHEMBL629522,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),1,,,Mus musculus,Intermediate,,,11901,10090.0
,N,50594,,,,A,,CHEMBL629523,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),1,,,Mus musculus,Intermediate,,,11902,10090.0
,N,50594,,,,A,,CHEMBL629524,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),1,,,Mus musculus,Intermediate,,,11903,10090.0
,N,50594,,,,A,,CHEMBL629525,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),1,,,Mus musculus,Intermediate,,,11904,10090.0
,N,50594,,,,A,,CHEMBL629526,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),1,,,Mus musculus,Intermediate,,,11905,10090.0
,N,50594,,,,A,,CHEMBL629527,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),1,,,Mus musculus,Intermediate,,,11906,10090.0
,N,50594,,,,A,,CHEMBL629528,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),1,,,Mus musculus,Intermediate,,,11907,10090.0
,N,50594,,,,A,,CHEMBL629529,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),1,,,Mus musculus,Intermediate,,,11908,10090.0
,N,50594,,,,A,,CHEMBL629530,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),1,,,Mus musculus,Intermediate,,,11909,10090.0
,N,50594,,,,A,,CHEMBL629531,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),1,,,Mus musculus,Intermediate,,,11910,10090.0
,N,50594,,,,A,,CHEMBL628656,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),1,,,Mus musculus,Intermediate,,,11911,10090.0
,N,50594,,,,A,,CHEMBL628657,1,,BAO_0000218,14439,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),1,,,Mus musculus,Intermediate,,,11912,10090.0
,N,50597,,,In vivo,A,,CHEMBL628658,1,,BAO_0000218,13751,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,11913,10116.0
,N,50597,,,In vivo,A,,CHEMBL628659,1,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,11914,10116.0
,N,50597,,,In vivo,A,,CHEMBL877500,1,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,11915,10116.0
,N,50597,,,In vivo,A,,CHEMBL628660,1,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,11916,10116.0
,N,50597,,,In vivo,A,,CHEMBL628661,1,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,11917,10116.0
,N,50597,,,In vivo,A,,CHEMBL628662,1,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,11918,10116.0
,N,50597,,,In vivo,A,,CHEMBL628663,1,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,11919,10116.0
,N,50597,,,In vivo,A,,CHEMBL628664,1,,BAO_0000218,13751,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,11920,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628665,1,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,11921,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628666,1,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,11922,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628667,1,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,11923,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628668,1,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,11924,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628669,1,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,11925,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628670,1,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,11926,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL628671,1,,BAO_0000218,13751,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,Blood,Rattus norvegicus,Intermediate,,,11927,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL628672,1,,BAO_0000218,13751,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,Bone,Rattus norvegicus,Intermediate,,,11928,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL630300,1,,BAO_0000218,13751,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,Bone,Rattus norvegicus,Intermediate,,,11929,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL629787,1,,BAO_0000218,13751,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,Bone,Rattus norvegicus,Intermediate,,,11930,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL629788,1,,BAO_0000218,13751,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,Bone,Rattus norvegicus,Intermediate,,,11931,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629789,1,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,11932,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629790,1,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,11933,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629791,1,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,11934,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629792,1,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,11935,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629793,1,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,11936,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629794,1,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,11937,10116.0
,N,50597,,,,A,,CHEMBL874459,1,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,1,,,Rattus norvegicus,Intermediate,,,11938,10116.0
,N,50597,,,,A,,CHEMBL629795,1,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,1,,,Rattus norvegicus,Intermediate,,,11939,10116.0
,N,50597,,,,A,,CHEMBL629796,1,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,1,,,Rattus norvegicus,Intermediate,,,11940,10116.0
,N,50597,,,,A,,CHEMBL629797,1,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,1,,,Rattus norvegicus,Intermediate,,,11941,10116.0
,N,50597,,,,A,,CHEMBL629798,1,,BAO_0000218,10677,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,1,,,Rattus norvegicus,Intermediate,,,11942,10116.0
,N,50597,,,In vivo,A,2369.0,CHEMBL629799,1,,BAO_0000218,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Adrenal gland,Rattus norvegicus,Intermediate,,,11943,10116.0
,N,50597,,,In vivo,A,2369.0,CHEMBL629800,1,,BAO_0000218,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Adrenal gland,Rattus norvegicus,Intermediate,,,11944,10116.0
,N,50597,,,In vivo,A,2369.0,CHEMBL629801,1,,BAO_0000218,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Adrenal gland,Rattus norvegicus,Intermediate,,,11945,10116.0
,N,50597,,,In vivo,A,2369.0,CHEMBL629802,1,,BAO_0000218,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,1,,Adrenal gland,Rattus norvegicus,Intermediate,,,11946,10116.0
,N,50597,,,In vivo,A,2369.0,CHEMBL629803,1,,BAO_0000218,10911,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Adrenal gland,Rattus norvegicus,Intermediate,,,11947,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL629804,1,,BAO_0000218,10911,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Blood,Rattus norvegicus,Intermediate,,,11948,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL629805,1,,BAO_0000218,10911,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Blood,Rattus norvegicus,Intermediate,,,11949,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL629806,1,,BAO_0000218,10911,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,,Blood,Rattus norvegicus,Intermediate,,,11950,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL629807,1,,BAO_0000218,10911,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Blood,Rattus norvegicus,Intermediate,,,11951,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL629808,1,,BAO_0000218,10911,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Blood,Rattus norvegicus,Intermediate,,,11952,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629809,1,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Brain,Rattus norvegicus,Intermediate,,,11953,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629810,1,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Brain,Rattus norvegicus,Intermediate,,,11954,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629811,1,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,,Brain,Rattus norvegicus,Intermediate,,,11955,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629812,1,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Brain,Rattus norvegicus,Intermediate,,,11956,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629813,1,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,1,,Brain,Rattus norvegicus,Intermediate,,,11957,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL874460,1,,BAO_0000218,10911,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Brain,Rattus norvegicus,Intermediate,,,11958,10116.0
,N,50597,,,In vivo,A,,CHEMBL629814,1,,BAO_0000218,10911,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,,Rattus norvegicus,Intermediate,,,11959,10116.0
,N,50597,,,In vivo,A,,CHEMBL629815,1,,BAO_0000218,10911,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,,Rattus norvegicus,Intermediate,,,11960,10116.0
,N,50597,,,In vivo,A,,CHEMBL629816,1,,BAO_0000218,10911,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,,Rattus norvegicus,Intermediate,,,11961,10116.0
,N,50597,,,In vivo,A,,CHEMBL629817,1,,BAO_0000218,10911,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,,Rattus norvegicus,Intermediate,,,11962,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL626643,1,,BAO_0000218,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Kidney,Rattus norvegicus,Intermediate,,,11963,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL626644,1,,BAO_0000218,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Kidney,Rattus norvegicus,Intermediate,,,11964,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL626806,1,,BAO_0000218,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Kidney,Rattus norvegicus,Intermediate,,,11965,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL626807,1,,BAO_0000218,10911,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Kidney,Rattus norvegicus,Intermediate,,,11966,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627261,1,,BAO_0000218,10911,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Liver,Rattus norvegicus,Intermediate,,,11967,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627262,1,,BAO_0000218,10911,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Liver,Rattus norvegicus,Intermediate,,,11968,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627263,1,,BAO_0000218,10911,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Liver,Rattus norvegicus,Intermediate,,,11969,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627264,1,,BAO_0000218,10911,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Liver,Rattus norvegicus,Intermediate,,,11970,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627265,1,,BAO_0000218,10911,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Lung,Rattus norvegicus,Intermediate,,,11971,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627266,1,,BAO_0000218,10911,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Lung,Rattus norvegicus,Intermediate,,,11972,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627267,1,,BAO_0000218,10911,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Lung,Rattus norvegicus,Intermediate,,,11973,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627268,1,,BAO_0000218,10911,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Lung,Rattus norvegicus,Intermediate,,,11974,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627269,1,,BAO_0000218,10911,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11975,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627270,1,,BAO_0000218,10911,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,11976,10116.0
,N,50597,,,,A,,CHEMBL627271,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",1,,,Rattus norvegicus,Intermediate,,,11977,10116.0
,N,50597,,,,A,,CHEMBL627946,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",1,,,Rattus norvegicus,Intermediate,,,11978,10116.0
,N,50597,,,,A,,CHEMBL875472,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",1,,,Rattus norvegicus,Intermediate,,,11979,10116.0
,N,50597,,,,A,,CHEMBL627947,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",1,,,Rattus norvegicus,Intermediate,,,11980,10116.0
,N,50597,,,,A,,CHEMBL627948,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",1,,,Rattus norvegicus,Intermediate,,,11981,10116.0
,N,50597,,,,A,,CHEMBL628113,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",1,,,Rattus norvegicus,Intermediate,,,11982,10116.0
,N,50597,,,,A,,CHEMBL628114,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",1,,,Rattus norvegicus,Intermediate,,,11983,10116.0
,N,50597,,,,A,,CHEMBL628115,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",1,,,Rattus norvegicus,Intermediate,,,11984,10116.0
,N,50597,,,,A,,CHEMBL628116,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",1,,,Rattus norvegicus,Intermediate,,,11985,10116.0
,N,50597,,,,A,,CHEMBL628117,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",1,,,Rattus norvegicus,Intermediate,,,11986,10116.0
,N,50597,,,,A,,CHEMBL628118,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",1,,,Rattus norvegicus,Intermediate,,,11987,10116.0
,N,50597,,,,A,,CHEMBL628119,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",1,,,Rattus norvegicus,Intermediate,,,11988,10116.0
,N,50597,,,,A,,CHEMBL628120,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",1,,,Rattus norvegicus,Intermediate,,,11989,10116.0
,N,50597,,,,A,,CHEMBL628121,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",1,,,Rattus norvegicus,Intermediate,,,11990,10116.0
,N,50597,,,,A,,CHEMBL628122,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",1,,,Rattus norvegicus,Intermediate,,,11991,10116.0
,N,50597,,,,A,,CHEMBL627297,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",1,,,Rattus norvegicus,Intermediate,,,11992,10116.0
,N,50597,,,,A,,CHEMBL627298,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",1,,,Rattus norvegicus,Intermediate,,,11993,10116.0
,N,50597,,,,A,,CHEMBL627299,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",1,,,Rattus norvegicus,Intermediate,,,11994,10116.0
,N,50597,,,,A,,CHEMBL627300,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",1,,,Rattus norvegicus,Intermediate,,,11995,10116.0
,N,50597,,,,A,,CHEMBL627301,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",1,,,Rattus norvegicus,Intermediate,,,11996,10116.0
,N,50597,,,,A,,CHEMBL627302,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",1,,,Rattus norvegicus,Intermediate,,,11997,10116.0
,N,50597,,,,A,,CHEMBL627303,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",1,,,Rattus norvegicus,Intermediate,,,11998,10116.0
,N,50597,,,,A,,CHEMBL627304,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",1,,,Rattus norvegicus,Intermediate,,,11999,10116.0
,N,50597,,,,A,,CHEMBL627305,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",1,,,Rattus norvegicus,Intermediate,,,12000,10116.0
,N,50597,,,,A,,CHEMBL627306,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",1,,,Rattus norvegicus,Intermediate,,,12001,10116.0
,N,50597,,,,A,,CHEMBL623982,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",1,,,Rattus norvegicus,Intermediate,,,12002,10116.0
,N,50597,,,,A,,CHEMBL623983,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",1,,,Rattus norvegicus,Intermediate,,,12003,10116.0
,N,50597,,,,A,,CHEMBL623984,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",1,,,Rattus norvegicus,Intermediate,,,12004,10116.0
,N,50597,,,,A,,CHEMBL623985,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",1,,,Rattus norvegicus,Intermediate,,,12005,10116.0
,N,50597,,,,A,,CHEMBL623986,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",1,,,Rattus norvegicus,Intermediate,,,12006,10116.0
,N,50597,,,,A,,CHEMBL623987,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",1,,,Rattus norvegicus,Intermediate,,,12007,10116.0
,N,50597,,,,A,,CHEMBL623988,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",1,,,Rattus norvegicus,Intermediate,,,12008,10116.0
,N,50597,,,,A,,CHEMBL623989,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",1,,,Rattus norvegicus,Intermediate,,,12009,10116.0
,N,50597,,,,A,,CHEMBL622215,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",1,,,Rattus norvegicus,Intermediate,,,12010,10116.0
,N,50597,,,,A,,CHEMBL622216,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",1,,,Rattus norvegicus,Intermediate,,,12011,10116.0
,N,50597,,,,A,,CHEMBL877481,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",1,,,Rattus norvegicus,Intermediate,,,12012,10116.0
,U,22224,,,,A,,CHEMBL622217,0,,BAO_0000218,16359,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),1,,,,Autocuration,,,12013,
,N,50594,,,,A,,CHEMBL622218,1,,BAO_0000218,13701,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),1,,,Mus musculus,Intermediate,,,12014,10090.0
,N,50597,,,,A,,CHEMBL622219,1,,BAO_0000218,14554,Pharmacokinetic profile AUC was evaluated in rats,1,,,Rattus norvegicus,Intermediate,,,12015,10116.0
,U,22224,,,,A,,CHEMBL622220,0,,BAO_0000019,6241,Pharmacokinetic property (Area under curve),1,,,,Autocuration,,,12016,
,N,50588,,,,A,,CHEMBL622221,1,,BAO_0000218,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",1,,,Canis lupus familiaris,Intermediate,,,12017,9615.0
,N,50594,,,,A,,CHEMBL622222,1,,BAO_0000218,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",1,,,Mus musculus,Intermediate,,,12018,10090.0
,N,50588,,,,A,,CHEMBL622223,1,,BAO_0000218,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",1,,,Canis lupus familiaris,Intermediate,,,12019,9615.0
,N,50594,,,,A,,CHEMBL622224,1,,BAO_0000218,11537,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",1,,,Mus musculus,Intermediate,,,12020,10090.0
,U,22224,,,,A,,CHEMBL622225,0,,BAO_0000019,13118,Plasma concentration (AUC) was determined,1,,,,Autocuration,,,12021,
,U,22224,,,,A,,CHEMBL622226,0,,BAO_0000019,13118,Plasma concentration (AUC) was determined; Not detectable,1,,,,Autocuration,,,12022,
,N,50512,,,,A,,CHEMBL624154,1,,BAO_0000218,9562,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),1,,,Cavia porcellus,Intermediate,,,12023,10141.0
,N,50597,,,,A,,CHEMBL624155,1,,BAO_0000218,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,12024,10116.0
,N,50597,,,,A,,CHEMBL624156,1,,BAO_0000218,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,1,,,Rattus norvegicus,Intermediate,,,12025,10116.0
,N,50597,,,,A,,CHEMBL624157,1,,BAO_0000218,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,1,,,Rattus norvegicus,Intermediate,,,12026,10116.0
,N,50597,,,,A,,CHEMBL624158,1,,BAO_0000218,10363,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,12027,10116.0
,N,50597,,,,A,,CHEMBL624159,1,,BAO_0000218,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,1,,,Rattus norvegicus,Intermediate,,,12028,10116.0
,N,50597,,,,A,,CHEMBL624160,1,,BAO_0000218,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,1,,,Rattus norvegicus,Intermediate,,,12029,10116.0
,N,50597,,,,A,,CHEMBL624161,1,,BAO_0000218,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,1,,,Rattus norvegicus,Intermediate,,,12030,10116.0
,N,50597,,,,A,,CHEMBL624162,1,,BAO_0000218,12504,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,1,,,Rattus norvegicus,Intermediate,,,12031,10116.0
,N,50588,,,,A,,CHEMBL624163,1,,BAO_0000218,13317,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,1,,,Canis lupus familiaris,Intermediate,,,12032,9615.0
,N,50597,,,,A,,CHEMBL624164,1,,BAO_0000218,15078,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,12033,10116.0
,N,50597,,,,A,,CHEMBL624165,1,,BAO_0000218,14941,The AUC(0-infinity) values in female wistar rats.,1,,,Rattus norvegicus,Intermediate,,,12034,10116.0
,N,50597,,,,A,,CHEMBL624166,1,,BAO_0000218,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,12035,10116.0
,N,50597,,,,A,,CHEMBL624167,1,,BAO_0000218,15078,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",1,,,Rattus norvegicus,Intermediate,,,12036,10116.0
,N,50597,,,,A,,CHEMBL624168,1,,BAO_0000218,14941,The AUC(0-t)values in female wistar rats.,1,,,Rattus norvegicus,Intermediate,,,12037,10116.0
,N,50597,,,,A,,CHEMBL624169,1,,BAO_0000218,14067,The Area under the concentration time curve of compound was measured on rats,1,,,Rattus norvegicus,Intermediate,,,12038,10116.0
,N,50587,,,,A,,CHEMBL624170,1,,BAO_0000218,14215,The area under curve (100 mg/kg) administered orally in humans,1,,,Homo sapiens,Intermediate,,,12039,9606.0
,U,22224,,,,A,,CHEMBL624171,0,,BAO_0000218,14215,The area under curve (12.5 mg/kg) administered intravenously in marmoset,1,,,Callithrix,Autocuration,,,12040,9481.0
,U,22224,,,,A,,CHEMBL624172,0,,BAO_0000218,14215,The area under curve (12.5 mg/kg) administered intravenously in monkey,1,,,Simiiformes,Autocuration,,,12041,314293.0
,N,50588,,,,A,,CHEMBL624173,1,,BAO_0000218,14215,The area under curve (15 mg/kg) administered intravenously in dog,1,,,Canis lupus familiaris,Intermediate,,,12042,9615.0
,N,50587,,,,A,,CHEMBL877488,1,,BAO_0000218,14215,The area under curve (200 mg/kg) administered orally in humans,1,,,Homo sapiens,Intermediate,,,12043,9606.0
,N,50597,,,,A,,CHEMBL624174,1,,BAO_0000218,14215,The area under curve (25 mg/kg) administered intravenously in rat,1,,,Rattus norvegicus,Intermediate,,,12044,10116.0
,U,22224,,,,A,,CHEMBL624175,0,,BAO_0000218,14215,The area under curve (25 mg/kg) administered orally in marmoset,1,,,Callithrix,Autocuration,,,12045,9481.0
,U,22224,,,,A,,CHEMBL624176,0,,BAO_0000218,14215,The area under curve (25 mg/kg) administered orally in monkey,1,,,Simiiformes,Autocuration,,,12046,314293.0
,N,50588,,,,A,,CHEMBL624177,1,,BAO_0000218,14215,The area under curve (30 mg/kg) administered orally in dog,1,,,Canis lupus familiaris,Intermediate,,,12047,9615.0
,N,50587,,,,A,,CHEMBL624178,1,,BAO_0000218,14215,The area under curve (400 mg/kg) administered orally in humans,1,,,Homo sapiens,Intermediate,,,12048,9606.0
,N,50597,,,,A,,CHEMBL624179,1,,BAO_0000218,14215,The area under curve (50 mg/kg) administered orally in fasted rat,1,,,Rattus norvegicus,Intermediate,,,12049,10116.0
,N,50597,,,,A,,CHEMBL627689,1,,BAO_0000218,14215,The area under curve (50 mg/kg) administered orally in rat,1,,,Rattus norvegicus,Intermediate,,,12050,10116.0
,N,50587,,,,A,,CHEMBL627690,1,,BAO_0000218,14215,The area under curve (800 mg/kg) administered orally in humans,1,,,Homo sapiens,Intermediate,,,12051,9606.0
,U,22224,,,,A,,CHEMBL627691,0,,BAO_0000019,11324,The compound was evaluated for area under the curve,1,,,,Autocuration,,,12052,
,U,22224,,,,A,,CHEMBL627692,0,,BAO_0000019,11324,The compound was evaluated for area under the curve in marmosets,1,,,Callithrix,Autocuration,,,12053,9481.0
,U,22224,,,,A,,CHEMBL627693,0,,BAO_0000019,11324,The compound was evaluated for area under the curve in marmosets,1,,,Callithrix,Autocuration,,,12054,9481.0
,N,50597,,,,A,,CHEMBL627694,1,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,,,Rattus norvegicus,Intermediate,,,12055,10116.0
,N,50597,,,,A,,CHEMBL627695,1,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,1,,,Rattus norvegicus,Intermediate,,,12056,10116.0
,U,22224,,,,A,,CHEMBL627696,0,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),1,,,,Autocuration,,,12057,
,N,50597,,,,A,,CHEMBL627697,1,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,,,Rattus norvegicus,Intermediate,,,12058,10116.0
,N,50597,,,,A,,CHEMBL627698,1,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,1,,,Rattus norvegicus,Intermediate,,,12059,10116.0
,N,50597,,,,A,,CHEMBL627699,1,,BAO_0000218,13875,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,1,,,Rattus norvegicus,Intermediate,,,12060,10116.0
,N,50597,,,,A,,CHEMBL627700,1,,BAO_0000218,13807,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,1,,,Rattus norvegicus,Intermediate,,,12061,10116.0
,N,50597,,,,A,,CHEMBL627701,1,,BAO_0000218,14127,Total drug exposure is determined after oral dosing in rats.,1,,,Rattus norvegicus,Intermediate,,,12062,10116.0
,U,22224,,,,A,,CHEMBL627702,0,,BAO_0000218,15116,Total drug exposure (5 mg/kg) when administered intravenously,1,,,,Autocuration,,,12063,
,U,22224,,,,A,,CHEMBL627703,0,,BAO_0000218,15116,Total drug exposure (5 mg/kg) when administered orally,1,,,,Autocuration,,,12064,
,U,22224,,,,A,,CHEMBL626873,0,,BAO_0000218,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,1,,,Simiiformes,Autocuration,,,12065,314293.0
,N,50597,,,,A,,CHEMBL629583,1,,BAO_0000218,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,1,,,Rattus norvegicus,Intermediate,,,12066,10116.0
,N,50588,,,,A,,CHEMBL629584,1,,BAO_0000218,15604,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,1,,,Canis lupus familiaris,Intermediate,,,12067,9615.0
,N,50588,,,,A,,CHEMBL629585,1,,BAO_0000218,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,1,,,Canis lupus familiaris,Intermediate,,,12068,9615.0
,N,50597,,,In vivo,A,955.0,CHEMBL629586,1,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,12069,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL629587,1,,BAO_0000218,13751,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,Brain,Rattus norvegicus,Intermediate,,,12070,10116.0
,N,50597,,,In vivo,A,,CHEMBL629588,1,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,12071,10116.0
,N,50597,,,In vivo,A,,CHEMBL629589,1,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,12072,10116.0
,N,50597,,,In vivo,A,,CHEMBL629590,1,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,12073,10116.0
,N,50597,,,In vivo,A,,CHEMBL629591,1,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,12074,10116.0
,N,50597,,,In vivo,A,,CHEMBL629592,1,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,12075,10116.0
,N,50597,,,In vivo,A,,CHEMBL629593,1,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,12076,10116.0
,N,50597,,,In vivo,A,,CHEMBL629594,1,,BAO_0000218,13751,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,12077,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL629595,1,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,12078,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL630290,1,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,12079,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL627137,1,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,12080,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL627138,1,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,12081,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL627139,1,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,12082,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL627140,1,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,12083,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL627141,1,,BAO_0000218,13751,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,Heart,Rattus norvegicus,Intermediate,,,12084,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627142,1,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,12085,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627143,1,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,12086,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL874449,1,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,12087,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627144,1,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,12088,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627145,1,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,12089,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627146,1,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,12090,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627147,1,,BAO_0000218,13751,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,Kidney,Rattus norvegicus,Intermediate,,,12091,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627148,1,,BAO_0000218,13751,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,12092,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627149,1,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,12093,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL632160,1,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,12094,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL632161,1,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,12095,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL632162,1,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,12096,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL632163,1,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,12097,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL874469,1,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,12098,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627182,1,,BAO_0000218,13751,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,Lung,Rattus norvegicus,Intermediate,,,12099,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627183,1,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12100,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627184,1,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12101,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627185,1,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12102,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627186,1,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12103,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627187,1,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12104,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627188,1,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12105,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627189,1,,BAO_0000218,13751,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12106,10116.0
,N,50597,,,In vivo,A,,CHEMBL627190,1,,BAO_0000218,13751,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,,Rattus norvegicus,Intermediate,,,12107,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627191,1,,BAO_0000218,13751,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,12108,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627192,1,,BAO_0000218,13751,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,12109,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627193,1,,BAO_0000218,13751,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,12110,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL874590,1,,BAO_0000218,10911,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12111,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627194,1,,BAO_0000218,10911,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12112,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627195,1,,BAO_0000218,10911,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12113,10116.0
,N,50597,,,In vivo,A,992.0,CHEMBL627196,1,,BAO_0000218,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Female gonad,Rattus norvegicus,Intermediate,,,12114,10116.0
,N,50597,,,In vivo,A,992.0,CHEMBL627197,1,,BAO_0000218,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Female gonad,Rattus norvegicus,Intermediate,,,12115,10116.0
,N,50597,,,In vivo,A,992.0,CHEMBL627198,1,,BAO_0000218,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Female gonad,Rattus norvegicus,Intermediate,,,12116,10116.0
,N,50597,,,In vivo,A,992.0,CHEMBL627199,1,,BAO_0000218,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,1,,Female gonad,Rattus norvegicus,Intermediate,,,12117,10116.0
,N,50597,,,In vivo,A,992.0,CHEMBL627200,1,,BAO_0000218,10911,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Female gonad,Rattus norvegicus,Intermediate,,,12118,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627201,1,,BAO_0000218,10911,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Plasma,Rattus norvegicus,Intermediate,,,12119,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627202,1,,BAO_0000218,10911,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Plasma,Rattus norvegicus,Intermediate,,,12120,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627203,1,,BAO_0000218,10911,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Plasma,Rattus norvegicus,Intermediate,,,12121,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627204,1,,BAO_0000218,10911,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Plasma,Rattus norvegicus,Intermediate,,,12122,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL627205,1,,BAO_0000218,10911,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Spleen,Rattus norvegicus,Intermediate,,,12123,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL627206,1,,BAO_0000218,10911,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Spleen,Rattus norvegicus,Intermediate,,,12124,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL627207,1,,BAO_0000218,10911,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Spleen,Rattus norvegicus,Intermediate,,,12125,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL627208,1,,BAO_0000218,10911,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Spleen,Rattus norvegicus,Intermediate,,,12126,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL627209,1,,BAO_0000218,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12127,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL627210,1,,BAO_0000218,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12128,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL627211,1,,BAO_0000218,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12129,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL627212,1,,BAO_0000218,10911,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12130,10116.0
,N,50597,,,In vivo,A,995.0,CHEMBL627213,1,,BAO_0000218,10911,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,1,,Uterus,Rattus norvegicus,Intermediate,,,12131,10116.0
,N,50597,,,In vivo,A,995.0,CHEMBL626599,1,,BAO_0000218,10911,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,1,,Uterus,Rattus norvegicus,Intermediate,,,12132,10116.0
,N,50597,,,In vivo,A,995.0,CHEMBL626600,1,,BAO_0000218,10911,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,1,,Uterus,Rattus norvegicus,Intermediate,,,12133,10116.0
,N,50597,,,In vivo,A,995.0,CHEMBL626601,1,,BAO_0000218,10911,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,1,,Uterus,Rattus norvegicus,Intermediate,,,12134,10116.0
,U,22224,,,,A,,CHEMBL627484,0,,BAO_0000019,8081,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,1,,,,Autocuration,,,12135,
,N,100710,,,,A,1969.0,CHEMBL627485,1,,BAO_0000218,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),1,,Plasma,Macaca fascicularis,Intermediate,,,12136,9541.0
,N,100710,,,,A,1969.0,CHEMBL628147,1,,BAO_0000218,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,1,,Plasma,Macaca fascicularis,Intermediate,,,12137,9541.0
,N,100710,,,,A,1969.0,CHEMBL628148,1,,BAO_0000218,17248,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,1,,Plasma,Macaca fascicularis,Intermediate,,,12138,9541.0
,N,50588,,,,A,1969.0,CHEMBL628149,1,,BAO_0000218,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),1,,Plasma,Canis lupus familiaris,Intermediate,,,12139,9615.0
,N,50588,,,,A,1969.0,CHEMBL628150,1,,BAO_0000218,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,1,,Plasma,Canis lupus familiaris,Intermediate,,,12140,9615.0
,N,50588,,,,A,1969.0,CHEMBL628318,1,,BAO_0000218,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,1,,Plasma,Canis lupus familiaris,Intermediate,,,12141,9615.0
,N,50588,,,,A,1969.0,CHEMBL628319,1,,BAO_0000218,17248,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,1,,Plasma,Canis lupus familiaris,Intermediate,,,12142,9615.0
,N,50588,,,,A,,CHEMBL875609,1,,BAO_0000218,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",1,,,Canis lupus familiaris,Intermediate,,,12143,9615.0
,U,22224,,,,A,,CHEMBL628320,0,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,1,,,,Autocuration,,,12144,
,U,22224,,,,A,,CHEMBL628321,0,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,1,,,,Autocuration,,,12145,
,U,22224,,,,A,,CHEMBL628322,0,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,1,,,,Autocuration,,,12146,
,U,22224,,,,A,,CHEMBL628323,0,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,1,,,,Autocuration,,,12147,
,U,22224,,,,A,,CHEMBL628324,0,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,1,,,,Autocuration,,,12148,
,U,22224,,,,A,,CHEMBL628325,0,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,1,,,,Autocuration,,,12149,
,U,22224,,,,A,,CHEMBL628326,0,,BAO_0000019,7040,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,1,,,,Autocuration,,,12150,
,N,50588,,,,A,1236.0,CHEMBL628327,1,,BAO_0000218,9614,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",1,,Adrenal medulla,Canis lupus familiaris,Intermediate,,,12151,9615.0
,N,50588,,,,A,1236.0,CHEMBL628328,1,,BAO_0000218,9614,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",1,,Adrenal medulla,Canis lupus familiaris,Intermediate,,,12152,9615.0
,N,50588,,,,A,178.0,CHEMBL628329,1,,BAO_0000218,9614,"Concentration of compound in blood of dog 1, after administering intravenously",1,,Blood,Canis lupus familiaris,Intermediate,,,12153,9615.0
,N,50597,,,,A,2107.0,CHEMBL628330,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",1,,Liver,Rattus norvegicus,Intermediate,,,12154,10116.0
,N,50597,,,,A,2107.0,CHEMBL628331,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",1,,Liver,Rattus norvegicus,Intermediate,,,12155,10116.0
,N,50597,,,,A,2107.0,CHEMBL628332,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",1,,Liver,Rattus norvegicus,Intermediate,,,12156,10116.0
,N,50597,,,,A,2107.0,CHEMBL628333,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",1,,Liver,Rattus norvegicus,Intermediate,,,12157,10116.0
,N,50597,,,,A,2107.0,CHEMBL628334,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",1,,Liver,Rattus norvegicus,Intermediate,,,12158,10116.0
,N,50597,,,,A,2107.0,CHEMBL628335,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",1,,Liver,Rattus norvegicus,Intermediate,,,12159,10116.0
,N,50597,,,,A,2107.0,CHEMBL628336,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",1,,Liver,Rattus norvegicus,Intermediate,,,12160,10116.0
,N,50597,,,,A,2107.0,CHEMBL628337,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",1,,Liver,Rattus norvegicus,Intermediate,,,12161,10116.0
,N,50597,,,,A,2107.0,CHEMBL628338,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",1,,Liver,Rattus norvegicus,Intermediate,,,12162,10116.0
,N,50597,,,,A,2107.0,CHEMBL875610,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",1,,Liver,Rattus norvegicus,Intermediate,,,12163,10116.0
,N,50597,,,,A,2107.0,CHEMBL628339,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",1,,Liver,Rattus norvegicus,Intermediate,,,12164,10116.0
,N,50597,,,,A,2107.0,CHEMBL628340,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",1,,Liver,Rattus norvegicus,Intermediate,,,12165,10116.0
,N,50597,,,,A,2107.0,CHEMBL628341,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",1,,Liver,Rattus norvegicus,Intermediate,,,12166,10116.0
,N,50597,,,,A,2107.0,CHEMBL622214,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",1,,Liver,Rattus norvegicus,Intermediate,,,12167,10116.0
,N,50597,,,,A,2107.0,CHEMBL623167,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",1,,Liver,Rattus norvegicus,Intermediate,,,12168,10116.0
,N,50597,,,,A,2107.0,CHEMBL623168,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",1,,Liver,Rattus norvegicus,Intermediate,,,12169,10116.0
,N,50597,,,,A,2107.0,CHEMBL623169,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",1,,Liver,Rattus norvegicus,Intermediate,,,12170,10116.0
,N,50597,,,,A,2107.0,CHEMBL623170,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",1,,Liver,Rattus norvegicus,Intermediate,,,12171,10116.0
,N,50597,,,,A,2048.0,CHEMBL627224,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",1,,Lung,Rattus norvegicus,Intermediate,,,12172,10116.0
,N,50597,,,,A,2048.0,CHEMBL875634,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",1,,Lung,Rattus norvegicus,Intermediate,,,12173,10116.0
,N,50597,,,,A,2048.0,CHEMBL627225,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",1,,Lung,Rattus norvegicus,Intermediate,,,12174,10116.0
,N,50597,,,,A,2048.0,CHEMBL627226,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",1,,Lung,Rattus norvegicus,Intermediate,,,12175,10116.0
,N,50597,,,,A,2048.0,CHEMBL626083,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",1,,Lung,Rattus norvegicus,Intermediate,,,12176,10116.0
,N,50597,,,,A,2048.0,CHEMBL626084,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",1,,Lung,Rattus norvegicus,Intermediate,,,12177,10116.0
,N,50597,,,,A,2048.0,CHEMBL626085,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",1,,Lung,Rattus norvegicus,Intermediate,,,12178,10116.0
,N,50597,,,,A,2048.0,CHEMBL626086,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",1,,Lung,Rattus norvegicus,Intermediate,,,12179,10116.0
,N,50597,,,,A,2048.0,CHEMBL626087,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",1,,Lung,Rattus norvegicus,Intermediate,,,12180,10116.0
,N,50597,,,,A,2048.0,CHEMBL626088,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",1,,Lung,Rattus norvegicus,Intermediate,,,12181,10116.0
,N,50597,,,,A,2048.0,CHEMBL626089,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",1,,Lung,Rattus norvegicus,Intermediate,,,12182,10116.0
,N,50597,,,,A,2048.0,CHEMBL626090,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",1,,Lung,Rattus norvegicus,Intermediate,,,12183,10116.0
,N,50597,,,,A,2048.0,CHEMBL626091,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",1,,Lung,Rattus norvegicus,Intermediate,,,12184,10116.0
,N,50597,,,,A,2048.0,CHEMBL626092,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",1,,Lung,Rattus norvegicus,Intermediate,,,12185,10116.0
,N,50597,,,,A,2048.0,CHEMBL626093,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",1,,Lung,Rattus norvegicus,Intermediate,,,12186,10116.0
,N,50597,,,,A,2048.0,CHEMBL626094,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",1,,Lung,Rattus norvegicus,Intermediate,,,12187,10116.0
,N,50597,,,,A,2048.0,CHEMBL626095,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",1,,Lung,Rattus norvegicus,Intermediate,,,12188,10116.0
,N,50597,,,,A,2048.0,CHEMBL626096,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",1,,Lung,Rattus norvegicus,Intermediate,,,12189,10116.0
,U,22224,,,,A,,CHEMBL626097,0,,BAO_0000218,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,1,,,Simiiformes,Autocuration,,,12190,314293.0
,N,50597,,,,A,,CHEMBL626098,1,,BAO_0000218,15604,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,1,,,Rattus norvegicus,Intermediate,,,12191,10116.0
,U,22224,,,,A,1969.0,CHEMBL626099,0,,BAO_0000218,1806,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,1,,Plasma,,Autocuration,,,12192,
,U,22224,,,,A,1969.0,CHEMBL626100,0,,BAO_0000218,1806,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,1,,Plasma,,Autocuration,,,12193,
,N,50588,,,,A,1969.0,CHEMBL626101,1,,BAO_0000218,17237,AUC 0-inf in dog,1,,Plasma,Canis lupus familiaris,Intermediate,,,12194,9615.0
,N,50512,,,,A,1969.0,CHEMBL626102,1,,BAO_0000218,17237,AUC 0-inf in guinea pig,1,,Plasma,Cavia porcellus,Intermediate,,,12195,10141.0
,N,50588,,,,A,1969.0,CHEMBL626103,1,,BAO_0000218,17237,AUC 0-t in dog,1,,Plasma,Canis lupus familiaris,Intermediate,,,12196,9615.0
,N,50512,,,,A,1969.0,CHEMBL628391,1,,BAO_0000218,17237,AUC 0-t in guinea pig,1,,Plasma,Cavia porcellus,Intermediate,,,12197,10141.0
,N,50597,,,,A,,CHEMBL628392,1,,BAO_0000218,15194,The compound was tested for brain to plasma partition in rat,1,,,Rattus norvegicus,Intermediate,,,12198,10116.0
,N,50597,,,,A,,CHEMBL628393,1,,BAO_0000218,15194,The compound was tested for brain to plasma partition in rat.,1,,,Rattus norvegicus,Intermediate,,,12199,10116.0
,U,22224,,,,A,178.0,CHEMBL628394,0,,BAO_0000019,8787,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,1,,Blood,,Autocuration,,,12200,
,N,50588,,,,A,,CHEMBL628395,1,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,1,,,Canis lupus familiaris,Intermediate,,,12201,9615.0
,U,22224,,,,A,,CHEMBL628396,0,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,1,,,Simiiformes,Autocuration,,,12202,314293.0
,N,50592,,,,A,,CHEMBL628397,1,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,1,,,Oryctolagus cuniculus,Intermediate,,,12203,9986.0
,N,50597,,,,A,,CHEMBL628398,1,,BAO_0000218,17025,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,1,,,Rattus norvegicus,Intermediate,,,12204,10116.0
,N,50797,,,,A,,CHEMBL628399,1,,BAO_0000218,4236,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,1,,,Macaca mulatta,Intermediate,,,12205,9544.0
,N,50588,,,,A,,CHEMBL628400,1,,BAO_0000218,15343,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,1,,,Canis lupus familiaris,Intermediate,,,12206,9615.0
,N,50597,,,,A,,CHEMBL874907,1,,BAO_0000218,15343,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,12207,10116.0
,U,22224,,,,A,,CHEMBL628401,0,,BAO_0000019,17720,Area under curve of the compound was determined,1,,,,Autocuration,,,12208,
,U,22224,,,,A,1969.0,CHEMBL628402,0,,BAO_0000218,17788,AUC in monkeys at a dose of 1 mg/kg,1,,Plasma,Simiiformes,Autocuration,,,12209,314293.0
,N,50597,,,,A,1969.0,CHEMBL628403,1,,BAO_0000218,17788,AUC in rats at a dose of 1 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,12210,10116.0
,U,22224,,,,A,,CHEMBL628404,0,,BAO_0000019,8778,Compound was evaluated for the overall absorbance loss at pH of 2,1,,,,Autocuration,,,12211,
,U,22224,,,,A,,CHEMBL628405,0,,BAO_0000019,8778,Compound was evaluated for the overall absorbance loss at pH of 4,1,,,,Autocuration,,,12212,
,U,22224,,,,A,,CHEMBL628406,0,,BAO_0000019,8778,Compound was evaluated for the overall absorbance loss at pH of 7,1,,,,Autocuration,,,12213,
,N,50597,,,,A,,CHEMBL628407,1,,BAO_0000218,2249,Compound was evaluated for its absorption in the rats,1,,,Rattus norvegicus,Intermediate,,,12214,10116.0
,N,50597,,,,A,1088.0,CHEMBL628408,1,,BAO_0000218,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,1,,Urine,Rattus norvegicus,Intermediate,,,12215,10116.0
,N,50597,,,,A,1088.0,CHEMBL629171,1,,BAO_0000218,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,1,,Urine,Rattus norvegicus,Intermediate,,,12216,10116.0
,N,50597,,,,A,1088.0,CHEMBL629172,1,,BAO_0000218,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,1,,Urine,Rattus norvegicus,Intermediate,,,12217,10116.0
,N,50597,,,,A,1088.0,CHEMBL629173,1,,BAO_0000218,8881,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,1,,Urine,Rattus norvegicus,Intermediate,,,12218,10116.0
,N,50597,,,,A,,CHEMBL629174,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum,1,,,Rattus norvegicus,Intermediate,,,12219,10116.0
,N,50597,,,,A,,CHEMBL629175,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 10-17,1,,,Rattus norvegicus,Intermediate,,,12220,10116.0
,N,50597,,,,A,,CHEMBL629176,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 10-18,1,,,Rattus norvegicus,Intermediate,,,12221,10116.0
,N,50597,,,,A,,CHEMBL629177,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 10-19,1,,,Rattus norvegicus,Intermediate,,,12222,10116.0
,N,50597,,,,A,,CHEMBL629178,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 12-15,1,,,Rattus norvegicus,Intermediate,,,12223,10116.0
,N,50597,,,,A,,CHEMBL631869,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 13-19,1,,,Rattus norvegicus,Intermediate,,,12224,10116.0
,N,50597,,,,A,,CHEMBL631870,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 14-17,1,,,Rattus norvegicus,Intermediate,,,12225,10116.0
,N,50597,,,,A,,CHEMBL631871,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 15-18,1,,,Rattus norvegicus,Intermediate,,,12226,10116.0
,N,50597,,,,A,,CHEMBL631872,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 2-5,1,,,Rattus norvegicus,Intermediate,,,12227,10116.0
,U,22224,,,,A,2116.0,CHEMBL875775,0,,BAO_0000221,15286,In vitro percent permeability into rat ileum; Range is 23-42,1,,Ileum,,Autocuration,,,12228,
,N,50597,,,,A,,CHEMBL631873,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 28-36,1,,,Rattus norvegicus,Intermediate,,,12229,10116.0
,N,50597,,,,A,,CHEMBL631874,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 29-35,1,,,Rattus norvegicus,Intermediate,,,12230,10116.0
,N,50597,,,,A,,CHEMBL631875,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 46-66,1,,,Rattus norvegicus,Intermediate,,,12231,10116.0
,N,50597,,,,A,,CHEMBL631876,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 50-68,1,,,Rattus norvegicus,Intermediate,,,12232,10116.0
,N,50597,,,,A,,CHEMBL631877,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; Range is 78-81,1,,,Rattus norvegicus,Intermediate,,,12233,10116.0
,N,50597,,,,A,,CHEMBL631878,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,1,,,Rattus norvegicus,Intermediate,,,12234,10116.0
,N,50597,,,,A,,CHEMBL631879,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; nd indicates not detected,1,,,Rattus norvegicus,Intermediate,,,12235,10116.0
,N,50597,,,,A,,CHEMBL631880,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; nt indicates not detected,1,,,Rattus norvegicus,Intermediate,,,12236,10116.0
,N,50597,,,,A,,CHEMBL631881,1,,BAO_0000218,15286,In vitro percent permeability into rat ileum; nt indicates not tested,1,,,Rattus norvegicus,Intermediate,,,12237,10116.0
,N,50597,,,,A,,CHEMBL631882,1,,BAO_0000218,13770,Compound was tested for oral absorption in bile-duct cannulated rats,1,,,Rattus norvegicus,Intermediate,,,12238,10116.0
,N,50597,,,,A,,CHEMBL630749,1,,BAO_0000218,13770,Compound was tested for oral absorption in bile-duct cannulated rats.,1,,,Rattus norvegicus,Intermediate,,,12239,10116.0
,N,50587,,,,A,,CHEMBL630750,1,,BAO_0000218,5202,Oral absorption using Caco-2 cell monolayers.,1,,,Homo sapiens,Intermediate,,,12240,9606.0
,N,50587,,,,A,,CHEMBL630253,1,,BAO_0000218,14920,Percent of the drug absorbed after administration to humans was determined,1,,,Homo sapiens,Intermediate,,,12241,9606.0
,N,50597,,,,A,1969.0,CHEMBL630254,1,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12242,10116.0
,N,50597,,,,A,1969.0,CHEMBL630255,1,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12243,10116.0
,N,50597,,,,A,1969.0,CHEMBL630256,1,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12244,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL875781,1,,BAO_0000218,13751,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,12245,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL630257,1,,BAO_0000218,13751,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,12246,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL630258,1,,BAO_0000218,13751,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",1,,Liver,Rattus norvegicus,Intermediate,,,12247,10116.0
,N,50597,,,,A,,CHEMBL630259,1,,BAO_0000218,15807,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",1,,,Rattus norvegicus,Intermediate,,,12248,10116.0
,N,50597,,,,A,2435.0,CHEMBL630260,1,,BAO_0000218,15807,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",1,,Striatum,Rattus norvegicus,Intermediate,,,12249,10116.0
,N,50597,,,,A,2435.0,CHEMBL630261,1,,BAO_0000218,15807,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",1,,Striatum,Rattus norvegicus,Intermediate,,,12250,10116.0
,N,50597,,,,A,,CHEMBL630262,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,1,,,Rattus norvegicus,Intermediate,,,12251,10116.0
,N,50597,,,,A,,CHEMBL630263,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,1,,,Rattus norvegicus,Intermediate,,,12252,10116.0
,N,50597,,,,A,,CHEMBL630264,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,1,,,Rattus norvegicus,Intermediate,,,12253,10116.0
,N,50597,,,,A,,CHEMBL630265,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,1,,,Rattus norvegicus,Intermediate,,,12254,10116.0
,N,50597,,,,A,,CHEMBL630266,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,1,,,Rattus norvegicus,Intermediate,,,12255,10116.0
,N,50597,,,,A,2113.0,CHEMBL630267,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,1,,Kidney,Rattus norvegicus,Intermediate,,,12256,10116.0
,N,50597,,,,A,2113.0,CHEMBL630268,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,1,,Kidney,Rattus norvegicus,Intermediate,,,12257,10116.0
,N,50597,,,,A,,CHEMBL630269,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,1,,,Rattus norvegicus,Intermediate,,,12258,10116.0
,N,50597,,,,A,,CHEMBL630270,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,1,,,Rattus norvegicus,Intermediate,,,12259,10116.0
,N,50597,,,,A,2048.0,CHEMBL630141,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,1,,Lung,Rattus norvegicus,Intermediate,,,12260,10116.0
,N,50597,,,,A,2048.0,CHEMBL630142,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,1,,Lung,Rattus norvegicus,Intermediate,,,12261,10116.0
,N,50597,,,,A,2385.0,CHEMBL630143,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12262,10116.0
,N,50597,,,,A,2385.0,CHEMBL630144,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12263,10116.0
,N,50597,,,,A,2367.0,CHEMBL630145,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,1,,Prostate gland,Rattus norvegicus,Intermediate,,,12264,10116.0
,N,50597,,,,A,2367.0,CHEMBL630146,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,1,,Prostate gland,Rattus norvegicus,Intermediate,,,12265,10116.0
,N,50597,,,,A,,CHEMBL630147,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,1,,,Rattus norvegicus,Intermediate,,,12266,10116.0
,N,50597,,,,A,,CHEMBL630148,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,1,,,Rattus norvegicus,Intermediate,,,12267,10116.0
,N,50597,,,,A,,CHEMBL630149,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,1,,,Rattus norvegicus,Intermediate,,,12268,10116.0
,N,50597,,,,A,2106.0,CHEMBL630150,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,1,,Spleen,Rattus norvegicus,Intermediate,,,12269,10116.0
,N,50597,,,,A,2106.0,CHEMBL630151,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,1,,Spleen,Rattus norvegicus,Intermediate,,,12270,10116.0
,N,50597,,,,A,2046.0,CHEMBL632031,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12271,10116.0
,N,50597,,,,A,2046.0,CHEMBL632032,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12272,10116.0
,N,50597,,,,A,,CHEMBL632033,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,1,,,Rattus norvegicus,Intermediate,,,12273,10116.0
,N,50597,,,,A,,CHEMBL632034,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,1,,,Rattus norvegicus,Intermediate,,,12274,10116.0
,N,50597,,,,A,2385.0,CHEMBL632035,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12275,10116.0
,N,50597,,,,A,,CHEMBL632036,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,1,,,Rattus norvegicus,Intermediate,,,12276,10116.0
,N,50597,,,,A,2046.0,CHEMBL632037,1,,BAO_0000218,14950,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12277,10116.0
,N,50597,,,,A,178.0,CHEMBL632038,1,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12278,10116.0
,N,50597,,,,A,178.0,CHEMBL632039,1,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12279,10116.0
,N,50597,,,,A,178.0,CHEMBL632040,1,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12280,10116.0
,N,50597,,,,A,178.0,CHEMBL632041,1,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12281,10116.0
,N,50588,,,,A,178.0,CHEMBL632042,1,,BAO_0000218,9614,"Concentration of compound in blood of dog 2, after administering intravenously",1,,Blood,Canis lupus familiaris,Intermediate,,,12282,9615.0
,N,50588,,,,A,,CHEMBL632043,1,,BAO_0000218,9614,"Concentration of compound in left ventricle of dog 1, after administering intravenously",1,,,Canis lupus familiaris,Intermediate,,,12283,9615.0
,N,50588,,,,A,,CHEMBL632044,1,,BAO_0000218,9614,"Concentration of compound in left ventricle of dog 2, after administering intravenously",1,,,Canis lupus familiaris,Intermediate,,,12284,9615.0
,N,50588,,,,A,2107.0,CHEMBL632045,1,,BAO_0000218,9614,"Concentration of compound in liver of dog 1, after administering intravenously",1,,Liver,Canis lupus familiaris,Intermediate,,,12285,9615.0
,N,50588,,,,A,2107.0,CHEMBL632046,1,,BAO_0000218,9614,"Concentration of compound in liver of dog 2, after administering intravenously",1,,Liver,Canis lupus familiaris,Intermediate,,,12286,9615.0
,N,50588,,,,A,2048.0,CHEMBL632047,1,,BAO_0000218,9614,"Concentration of compound in lung of dog 1, after administering intravenously",1,,Lung,Canis lupus familiaris,Intermediate,,,12287,9615.0
,N,50588,,,,A,2048.0,CHEMBL632048,1,,BAO_0000218,9614,"Concentration of compound in lung of dog 2, after administering intravenously",1,,Lung,Canis lupus familiaris,Intermediate,,,12288,9615.0
,N,50588,,,,A,2385.0,CHEMBL632049,1,,BAO_0000218,9614,"Concentration of compound in muscle of dog 1, after administering intravenously",1,,Muscle tissue,Canis lupus familiaris,Intermediate,,,12289,9615.0
,N,50588,,,,A,2385.0,CHEMBL876418,1,,BAO_0000218,9614,"Concentration of compound in muscle of dog 2, after administering intravenously",1,,Muscle tissue,Canis lupus familiaris,Intermediate,,,12290,9615.0
,N,50588,,,,A,2106.0,CHEMBL632050,1,,BAO_0000218,9614,"Concentration of compound in spleen of dog 1,after administering intravenously",1,,Spleen,Canis lupus familiaris,Intermediate,,,12291,9615.0
,N,50588,,,,A,2106.0,CHEMBL632051,1,,BAO_0000218,9614,"Concentration of compound in spleen of dog 2, after administering intravenously",1,,Spleen,Canis lupus familiaris,Intermediate,,,12292,9615.0
,U,22224,,,,F,,CHEMBL632052,0,,BAO_0000218,10353,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,1,,,,Autocuration,,,12293,
,U,22224,,,,F,,CHEMBL632053,0,,BAO_0000218,10353,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,1,,,,Autocuration,,,12294,
,U,22224,,,,A,,CHEMBL632054,0,,BAO_0000218,10353,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,1,,,,Autocuration,,,12295,
,U,22224,,,,F,,CHEMBL632055,0,,BAO_0000218,10353,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,1,,,,Autocuration,,,12296,
,U,22224,,,,F,,CHEMBL631181,0,,BAO_0000218,10353,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,1,,,,Autocuration,,,12297,
,U,22224,,,,A,,CHEMBL631182,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,1,,,,Autocuration,,,12298,
,U,22224,,,,A,,CHEMBL631183,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,1,,,,Autocuration,,,12299,
,U,22224,,,,A,,CHEMBL631184,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,,,,Autocuration,,,12300,
,U,22224,,,,A,,CHEMBL629774,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,,,,Autocuration,,,12301,
,U,22224,,,,A,,CHEMBL629775,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,,,,Autocuration,,,12302,
,U,22224,,,,A,,CHEMBL876549,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,,,,Autocuration,,,12303,
,U,22224,,,,A,,CHEMBL628172,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,,,,Autocuration,,,12304,
,U,22224,,,,A,,CHEMBL628173,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,1,,,,Autocuration,,,12305,
,U,22224,,,,A,,CHEMBL628174,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,1,,,,Autocuration,,,12306,
,U,22224,,,,A,,CHEMBL628175,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,1,,,,Autocuration,,,12307,
,U,22224,,,,A,,CHEMBL628176,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,1,,,,Autocuration,,,12308,
,U,22224,,,,A,,CHEMBL628177,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,1,,,,Autocuration,,,12309,
,U,22224,,,,A,,CHEMBL628178,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,,,,Autocuration,,,12310,
,U,22224,,,,A,,CHEMBL628179,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,1,,,,Autocuration,,,12311,
,U,22224,,,,A,,CHEMBL628180,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,1,,,,Autocuration,,,12312,
,U,22224,,,,A,,CHEMBL628181,0,,BAO_0000218,9196,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,1,,,,Autocuration,,,12313,
,U,22224,,,,A,,CHEMBL628182,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,,,,Autocuration,,,12314,
,U,22224,,,,A,,CHEMBL628183,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,,,,Autocuration,,,12315,
,U,22224,,,,A,,CHEMBL628184,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,1,,,,Autocuration,,,12316,
,U,22224,,,,A,,CHEMBL628185,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,,,,Autocuration,,,12317,
,U,22224,,,,A,,CHEMBL875617,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,,,,Autocuration,,,12318,
,U,22224,,,,A,,CHEMBL628186,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,1,,,,Autocuration,,,12319,
,U,22224,,,,A,,CHEMBL628187,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,,,,Autocuration,,,12320,
,U,22224,,,,A,,CHEMBL628188,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,1,,,,Autocuration,,,12321,
,U,22224,,,,A,,CHEMBL628189,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,1,,,,Autocuration,,,12322,
,U,22224,,,,A,,CHEMBL628190,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,1,,,,Autocuration,,,12323,
,U,22224,,,,A,,CHEMBL628191,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,1,,,,Autocuration,,,12324,
,U,22224,,,,A,,CHEMBL626513,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,1,,,,Autocuration,,,12325,
,N,50597,,,,A,2046.0,CHEMBL626514,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12326,10116.0
,N,50597,,,,A,2046.0,CHEMBL626515,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12327,10116.0
,N,50597,,,,A,2046.0,CHEMBL626516,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12328,10116.0
,N,50597,,,,A,2046.0,CHEMBL626517,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12329,10116.0
,N,50597,,,,A,2046.0,CHEMBL626518,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12330,10116.0
,N,50597,,,,A,2046.0,CHEMBL626519,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12331,10116.0
,N,50597,,,,A,2046.0,CHEMBL626520,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12332,10116.0
,N,50597,,,,A,2046.0,CHEMBL626521,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12333,10116.0
,N,50597,,,,A,2046.0,CHEMBL626522,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12334,10116.0
,N,50597,,,,A,2046.0,CHEMBL626523,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12335,10116.0
,N,50597,,,,A,2046.0,CHEMBL626524,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12336,10116.0
,N,50597,,,,A,2046.0,CHEMBL626688,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12337,10116.0
,N,50597,,,,A,2046.0,CHEMBL626689,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12338,10116.0
,N,50597,,,,A,2046.0,CHEMBL626690,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12339,10116.0
,N,50597,,,,A,2046.0,CHEMBL626691,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12340,10116.0
,N,50597,,,,A,2046.0,CHEMBL627319,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12341,10116.0
,N,50597,,,,A,2046.0,CHEMBL624052,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12342,10116.0
,N,50597,,,,A,2046.0,CHEMBL624053,1,,BAO_0000218,8608,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12343,10116.0
,N,50597,,,,A,,CHEMBL624054,1,,BAO_0000218,8085,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,Rattus norvegicus,Intermediate,,,12344,10116.0
,N,50597,,,,A,,CHEMBL624055,1,,BAO_0000218,8085,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,Rattus norvegicus,Intermediate,,,12345,10116.0
,N,50597,,,,A,,CHEMBL624056,1,,BAO_0000218,8085,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,,Rattus norvegicus,Intermediate,,,12346,10116.0
,N,50597,,,,A,995.0,CHEMBL624057,1,,BAO_0000218,8085,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,Uterus,Rattus norvegicus,Intermediate,,,12347,10116.0
,N,50597,,,,A,995.0,CHEMBL622281,1,,BAO_0000218,8085,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,Uterus,Rattus norvegicus,Intermediate,,,12348,10116.0
,N,50597,,,,A,995.0,CHEMBL622282,1,,BAO_0000218,8085,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,Uterus,Rattus norvegicus,Intermediate,,,12349,10116.0
,N,50597,,,,A,995.0,CHEMBL622283,1,,BAO_0000218,8085,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,Uterus,Rattus norvegicus,Intermediate,,,12350,10116.0
,N,50597,,,,A,995.0,CHEMBL622284,1,,BAO_0000218,8085,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,Uterus,Rattus norvegicus,Intermediate,,,12351,10116.0
,N,50597,,,,A,995.0,CHEMBL622285,1,,BAO_0000218,8085,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,Uterus,Rattus norvegicus,Intermediate,,,12352,10116.0
,N,50597,,,,A,995.0,CHEMBL622286,1,,BAO_0000218,8085,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,1,,Uterus,Rattus norvegicus,Intermediate,,,12353,10116.0
,U,22224,,,,P,,CHEMBL622287,0,,BAO_0000100,7657,Distribution coefficient (D %) between octanol and buffer of pH 7.4,1,,,,Autocuration,,,12354,
,N,50594,,,,A,,CHEMBL622288,1,,BAO_0000218,8935,Partition coefficient (logD7.4),1,,,Mus musculus,Intermediate,,,12355,10090.0
,N,50594,,,,A,,CHEMBL622289,1,,BAO_0000218,13792,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",1,,,Mus musculus,Intermediate,,,12356,10090.0
,N,50594,,,,A,955.0,CHEMBL622290,1,,BAO_0000218,13792,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",1,,Brain,Mus musculus,Intermediate,,,12357,10090.0
,N,50594,,,,A,,CHEMBL622291,1,,BAO_0000218,13792,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,1,,,Mus musculus,Intermediate,,,12358,10090.0
,N,50594,,,,A,955.0,CHEMBL622292,1,,BAO_0000218,13792,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,1,,Brain,Mus musculus,Intermediate,,,12359,10090.0
,N,50594,,,,A,,CHEMBL622293,1,,BAO_0000218,13792,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",1,,,Mus musculus,Intermediate,,,12360,10090.0
,N,50594,,,,A,955.0,CHEMBL622294,1,,BAO_0000218,13792,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",1,,Brain,Mus musculus,Intermediate,,,12361,10090.0
,N,50594,,,,A,,CHEMBL622295,1,,BAO_0000218,13792,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,1,,,Mus musculus,Intermediate,,,12362,10090.0
,N,50597,,,,A,955.0,CHEMBL622296,1,,BAO_0000218,13792,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,1,,Brain,Rattus norvegicus,Intermediate,,,12363,10116.0
,N,50597,,,,A,1969.0,CHEMBL874409,1,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12364,10116.0
,N,50597,,,,A,1969.0,CHEMBL622297,1,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12365,10116.0
,N,50597,,,,A,1969.0,CHEMBL622298,1,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12366,10116.0
,N,50597,,,,A,1969.0,CHEMBL622299,1,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12367,10116.0
,N,50597,,,,A,1969.0,CHEMBL622300,1,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12368,10116.0
,N,50597,,,,A,1969.0,CHEMBL622301,1,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12369,10116.0
,N,50597,,,,A,1969.0,CHEMBL622302,1,,BAO_0000218,14103,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12370,10116.0
,N,50597,,,,A,1969.0,CHEMBL622303,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12371,10116.0
,N,50597,,,,A,1969.0,CHEMBL622304,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12372,10116.0
,N,50597,,,,A,1969.0,CHEMBL622305,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,12373,10116.0
,N,50597,,,,A,1969.0,CHEMBL622306,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12374,10116.0
,N,50597,,,,A,1969.0,CHEMBL626864,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,12375,10116.0
,N,50597,,,,A,1969.0,CHEMBL626865,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12376,10116.0
,N,50597,,,,A,1969.0,CHEMBL626866,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,12377,10116.0
,N,50597,,,,A,1969.0,CHEMBL626867,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12378,10116.0
,N,50597,,,,A,1969.0,CHEMBL626868,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12379,10116.0
,N,50597,,,,A,1969.0,CHEMBL626869,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,12380,10116.0
,N,50597,,,,A,1969.0,CHEMBL626870,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12381,10116.0
,N,50597,,,,A,1969.0,CHEMBL626871,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,12382,10116.0
,N,50597,,,,A,1969.0,CHEMBL626872,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12383,10116.0
,N,50597,,,,A,1969.0,CHEMBL632185,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,1,,Plasma,Rattus norvegicus,Intermediate,,,12384,10116.0
,N,50597,,,,A,1969.0,CHEMBL632186,1,,BAO_0000218,14103,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,12385,10116.0
,U,22224,,,,A,,CHEMBL629310,0,,BAO_0000019,12904,Amount of acetic acid produced by the compound,1,,,,Autocuration,,,12386,
,U,22224,,,,A,,CHEMBL629311,0,,BAO_0000019,12904,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,1,,,,Autocuration,,,12387,
,N,50597,,,,A,,CHEMBL629312,1,,BAO_0000218,9663,Log of (Cbrain/Cblood) in rats,1,,,Rattus norvegicus,Intermediate,,,12388,10116.0
,U,22224,,,,A,,CHEMBL629313,0,,BAO_0000221,7652,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),1,,,,Autocuration,,,12389,
,U,22224,,,,A,,CHEMBL629314,0,,BAO_0000221,7652,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),1,,,,Autocuration,,,12390,
,U,22224,,,,A,,CHEMBL629315,0,,BAO_0000221,7652,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),1,,,,Autocuration,,,12391,
,U,22224,,,,B,,CHEMBL629316,0,,BAO_0000219,7652,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),1,,,,Autocuration,,,12392,
,U,22224,,,,A,,CHEMBL629317,0,,BAO_0000221,7652,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),1,,,,Autocuration,,,12393,
,U,22224,,,,A,,CHEMBL629318,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),1,,,,Autocuration,,,12394,
,U,22224,,,,A,,CHEMBL877497,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),1,,,,Autocuration,,,12395,
,U,22224,,,,A,,CHEMBL629319,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),1,,,,Autocuration,,,12396,
,U,22224,,,,A,,CHEMBL629320,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),1,,,,Autocuration,,,12397,
,U,22224,,,,A,,CHEMBL629496,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),1,,,,Autocuration,,,12398,
,U,22224,,,,A,,CHEMBL629497,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),1,,,,Autocuration,,,12399,
,U,22224,,,,A,,CHEMBL629498,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),1,,,,Autocuration,,,12400,
,U,22224,,,,A,,CHEMBL629499,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),1,,,,Autocuration,,,12401,
,U,22224,,,,A,,CHEMBL629500,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),1,,,,Autocuration,,,12402,
,U,22224,,,,A,,CHEMBL629501,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),1,,,,Autocuration,,,12403,
,U,22224,,,,A,,CHEMBL629502,0,,BAO_0000019,7652,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),1,,,,Autocuration,,,12404,
,U,22224,,,In vivo,F,,CHEMBL629503,0,,BAO_0000218,8267,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,1,,,,Autocuration,,,12405,
,N,50588,,,,A,,CHEMBL629504,1,,BAO_0000218,8267,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,1,,,Canis lupus familiaris,Intermediate,,,12406,9615.0
,U,22224,,,,A,,CHEMBL629505,0,,BAO_0000019,14479,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,1,,,,Autocuration,,,12407,
,U,22224,,,,A,,CHEMBL629506,0,,BAO_0000019,17515,Compound was evaluated for total body clearance,1,,,,Autocuration,,,12408,
,U,22224,,,,A,,CHEMBL629507,0,,BAO_0000019,17515,Compound was evaluated for volume of distribution at steady state,1,,,,Autocuration,,,12409,
,U,22224,,,,A,,CHEMBL877498,0,,BAO_0000019,8142,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,1,,,,Autocuration,,,12410,
,U,22224,,,,A,,CHEMBL629508,0,,BAO_0000019,14849,Percentage of the diamine which is monoprotonated at pH 7.4,1,,,,Autocuration,,,12411,
,U,22224,,,,A,,CHEMBL629509,0,,BAO_0000019,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,1,,,,Autocuration,,,12412,
,N,50597,,,,A,178.0,CHEMBL629510,1,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12413,10116.0
,N,50597,,,,A,178.0,CHEMBL629511,1,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12414,10116.0
,N,50597,,,,A,178.0,CHEMBL629512,1,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12415,10116.0
,N,50597,,,,A,178.0,CHEMBL629513,1,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12416,10116.0
,N,50597,,,,A,178.0,CHEMBL629514,1,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12417,10116.0
,N,50597,,,,A,178.0,CHEMBL628447,1,,BAO_0000218,8631,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12418,10116.0
,N,50597,,,,A,178.0,CHEMBL628448,1,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12419,10116.0
,N,50597,,,,A,178.0,CHEMBL628449,1,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12420,10116.0
,N,50597,,,,A,178.0,CHEMBL631119,1,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12421,10116.0
,N,50597,,,,A,178.0,CHEMBL631120,1,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12422,10116.0
,N,50597,,,,A,178.0,CHEMBL631121,1,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12423,10116.0
,N,50597,,,,A,178.0,CHEMBL874458,1,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,1,,Blood,Rattus norvegicus,Intermediate,,,12424,10116.0
,N,50597,,,,A,178.0,CHEMBL631122,1,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12425,10116.0
,N,50597,,,,A,178.0,CHEMBL631123,1,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12426,10116.0
,N,50597,,,,A,178.0,CHEMBL631124,1,,BAO_0000218,8631,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12427,10116.0
,N,50597,,,,A,178.0,CHEMBL631125,1,,BAO_0000218,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12428,10116.0
,N,50597,,,,A,178.0,CHEMBL631290,1,,BAO_0000218,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12429,10116.0
,N,50597,,,,A,178.0,CHEMBL631291,1,,BAO_0000218,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12430,10116.0
,N,50597,,,,A,178.0,CHEMBL631292,1,,BAO_0000218,8631,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12431,10116.0
,N,50597,,,,A,178.0,CHEMBL631293,1,,BAO_0000218,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12432,10116.0
,N,50597,,,,A,178.0,CHEMBL631294,1,,BAO_0000218,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12433,10116.0
,N,50597,,,,A,178.0,CHEMBL631295,1,,BAO_0000218,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12434,10116.0
,N,50597,,,,A,178.0,CHEMBL631296,1,,BAO_0000218,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12435,10116.0
,N,50597,,,,A,178.0,CHEMBL631297,1,,BAO_0000218,8631,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,1,,Blood,Rattus norvegicus,Intermediate,,,12436,10116.0
,U,22224,,,,A,,CHEMBL631298,0,,BAO_0000218,10263,Maximum biodistribution (Bmax) was determined.,1,,,,Autocuration,,,12437,
,N,50594,,,,A,,CHEMBL631299,1,,BAO_0000218,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,1,,,Mus musculus,Intermediate,,,12438,10090.0
,N,50594,,,,A,,CHEMBL631300,1,,BAO_0000218,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,1,,,Mus musculus,Intermediate,,,12439,10090.0
,N,50594,,,,A,,CHEMBL631301,1,,BAO_0000218,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,1,,,Mus musculus,Intermediate,,,12440,10090.0
,N,50594,,,,A,,CHEMBL630291,1,,BAO_0000218,12364,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,1,,,Mus musculus,Intermediate,,,12441,10090.0
,U,22224,,,,A,,CHEMBL630292,0,,BAO_0000218,14793,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,1,,,,Autocuration,,,12442,
,U,22224,,,,A,,CHEMBL630293,0,,BAO_0000218,14793,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,1,,,,Autocuration,,,12443,
,U,22224,,,,A,,CHEMBL630294,0,,BAO_0000218,14793,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,1,,,,Autocuration,,,12444,
,U,22224,,,,A,,CHEMBL630295,0,,BAO_0000218,14793,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,1,,,,Autocuration,,,12445,
,U,22224,,,,A,,CHEMBL630296,0,,BAO_0000218,14793,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,1,,,,Autocuration,,,12446,
,U,22224,,,,A,,CHEMBL626782,0,,BAO_0000218,14793,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,1,,,,Autocuration,,,12447,
,U,22224,,,,A,,CHEMBL626783,0,,BAO_0000218,14793,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,1,,,,Autocuration,,,12448,
,U,22224,,,,A,,CHEMBL626784,0,,BAO_0000218,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,1,,,,Autocuration,,,12449,
,U,22224,,,,A,,CHEMBL626785,0,,BAO_0000218,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,1,,,,Autocuration,,,12450,
,U,22224,,,,A,,CHEMBL626786,0,,BAO_0000218,14793,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,1,,,,Autocuration,,,12451,
,U,22224,,,,A,,CHEMBL626787,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,,,,Autocuration,,,12452,
,U,22224,,,,A,,CHEMBL626788,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,1,,,,Autocuration,,,12453,
,U,22224,,,,A,,CHEMBL625927,0,,BAO_0000218,9196,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,1,,,,Autocuration,,,12454,
,N,50597,,,,A,178.0,CHEMBL625928,1,,BAO_0000218,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12455,10116.0
,N,50597,,,,A,178.0,CHEMBL625929,1,,BAO_0000218,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,Blood,Rattus norvegicus,Intermediate,,,12456,10116.0
,N,50597,,,,A,178.0,CHEMBL625930,1,,BAO_0000218,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,1,,Blood,Rattus norvegicus,Intermediate,,,12457,10116.0
,N,50597,,,,A,178.0,CHEMBL625931,1,,BAO_0000218,8374,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",1,,Blood,Rattus norvegicus,Intermediate,,,12458,10116.0
,N,50597,,,,A,178.0,CHEMBL627230,1,,BAO_0000218,8374,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,1,,Blood,Rattus norvegicus,Intermediate,,,12459,10116.0
,N,50597,,,,A,178.0,CHEMBL627231,1,,BAO_0000218,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12460,10116.0
,N,50597,,,,A,178.0,CHEMBL627232,1,,BAO_0000218,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,Blood,Rattus norvegicus,Intermediate,,,12461,10116.0
,N,50597,,,,A,178.0,CHEMBL627233,1,,BAO_0000218,8374,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,1,,Blood,Rattus norvegicus,Intermediate,,,12462,10116.0
,N,50597,,,,A,178.0,CHEMBL875470,1,,BAO_0000218,8374,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12463,10116.0
,N,50597,,,,A,178.0,CHEMBL627234,1,,BAO_0000218,8374,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12464,10116.0
,N,50597,,,,A,178.0,CHEMBL627235,1,,BAO_0000218,8374,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12465,10116.0
,N,50597,,,,A,178.0,CHEMBL627236,1,,BAO_0000218,8374,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12466,10116.0
,N,50597,,,,A,178.0,CHEMBL627237,1,,BAO_0000218,8374,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12467,10116.0
,N,50597,,,,A,178.0,CHEMBL627238,1,,BAO_0000218,8374,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12468,10116.0
,N,50597,,,,A,178.0,CHEMBL627239,1,,BAO_0000218,8374,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12469,10116.0
,N,50597,,,,A,178.0,CHEMBL627240,1,,BAO_0000218,8374,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12470,10116.0
,N,50597,,,,A,178.0,CHEMBL627241,1,,BAO_0000218,8374,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12471,10116.0
,N,50597,,,,A,178.0,CHEMBL627242,1,,BAO_0000218,8374,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12472,10116.0
,N,50597,,,,A,178.0,CHEMBL627243,1,,BAO_0000218,8374,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,1,,Blood,Rattus norvegicus,Intermediate,,,12473,10116.0
,N,50597,,,,A,178.0,CHEMBL627244,1,,BAO_0000218,8374,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,Blood,Rattus norvegicus,Intermediate,,,12474,10116.0
,N,50597,,,,A,178.0,CHEMBL627245,1,,BAO_0000218,8374,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12475,10116.0
,N,50597,,,,A,178.0,CHEMBL627246,1,,BAO_0000218,8374,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12476,10116.0
,N,50597,,,,A,178.0,CHEMBL627247,1,,BAO_0000218,8374,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12477,10116.0
,N,50597,,,,A,178.0,CHEMBL627248,1,,BAO_0000218,8374,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12478,10116.0
,N,50597,,,,A,178.0,CHEMBL627249,1,,BAO_0000218,8374,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12479,10116.0
,N,50597,,,,A,178.0,CHEMBL625569,1,,BAO_0000218,8374,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12480,10116.0
,N,50597,,,,A,178.0,CHEMBL625570,1,,BAO_0000218,8374,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12481,10116.0
,N,50597,,,,A,178.0,CHEMBL625571,1,,BAO_0000218,8374,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12482,10116.0
,N,50597,,,,A,178.0,CHEMBL625572,1,,BAO_0000218,8374,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,Blood,Rattus norvegicus,Intermediate,,,12483,10116.0
,N,50597,,,,A,178.0,CHEMBL625573,1,,BAO_0000218,8374,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,Blood,Rattus norvegicus,Intermediate,,,12484,10116.0
,N,50597,,,,A,178.0,CHEMBL625574,1,,BAO_0000218,8374,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,1,,Blood,Rattus norvegicus,Intermediate,,,12485,10116.0
,N,50597,,,,A,178.0,CHEMBL626245,1,,BAO_0000218,8374,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,1,,Blood,Rattus norvegicus,Intermediate,,,12486,10116.0
,N,50597,,,,A,178.0,CHEMBL626246,1,,BAO_0000218,8374,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12487,10116.0
,U,22224,,,,A,,CHEMBL626247,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,,,,Autocuration,,,12488,
,U,22224,,,,A,,CHEMBL626248,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,,,,Autocuration,,,12489,
,U,22224,,,,A,,CHEMBL626249,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,1,,,,Autocuration,,,12490,
,U,22224,,,,A,,CHEMBL626420,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,,,,Autocuration,,,12491,
,U,22224,,,,A,,CHEMBL626421,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,1,,,,Autocuration,,,12492,
,U,22224,,,,A,,CHEMBL626422,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,1,,,,Autocuration,,,12493,
,U,22224,,,,A,,CHEMBL626423,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,,,,Autocuration,,,12494,
,U,22224,,,,A,,CHEMBL626424,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,,,,Autocuration,,,12495,
,N,50588,,,,A,,CHEMBL626425,1,,BAO_0000218,12023,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,1,,,Canis lupus familiaris,Intermediate,,,12496,9615.0
,N,50597,,,,A,,CHEMBL875476,1,,BAO_0000218,12023,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,1,,,Rattus norvegicus,Intermediate,,,12497,10116.0
,N,100710,,,,A,,CHEMBL626426,1,,BAO_0000218,12023,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,1,,,Macaca fascicularis,Intermediate,,,12498,9541.0
,U,22224,,,,P,,CHEMBL626427,0,,BAO_0000100,10580,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,1,,,,Autocuration,,,12499,
,U,22224,,,,P,,CHEMBL626428,0,,BAO_0000100,10580,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,1,,,,Autocuration,,,12500,
,U,22224,,,,A,,CHEMBL626429,0,,BAO_0000019,16032,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,1,,,,Autocuration,,,12501,
,U,22224,,,,A,1088.0,CHEMBL625025,0,,BAO_0000019,16032,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,1,,Urine,,Autocuration,,,12502,
,N,50597,,,,A,178.0,CHEMBL625026,1,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12503,10116.0
,N,50597,,,,A,178.0,CHEMBL625027,1,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12504,10116.0
,N,50597,,,,A,178.0,CHEMBL874410,1,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12505,10116.0
,N,50597,,,,A,178.0,CHEMBL625028,1,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12506,10116.0
,N,50597,,,,A,178.0,CHEMBL625029,1,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12507,10116.0
,N,50597,,,,A,178.0,CHEMBL625030,1,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12508,10116.0
,N,50597,,,,A,178.0,CHEMBL625031,1,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12509,10116.0
,N,50597,,,,A,178.0,CHEMBL625032,1,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12510,10116.0
,N,50597,,,,A,178.0,CHEMBL625033,1,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12511,10116.0
,N,50597,,,,A,178.0,CHEMBL625034,1,,BAO_0000218,8594,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12512,10116.0
,N,50597,,,,A,948.0,CHEMBL624872,1,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12513,10116.0
,N,50597,,,,A,948.0,CHEMBL624873,1,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12514,10116.0
,N,50597,,,,A,948.0,CHEMBL624874,1,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12515,10116.0
,N,50597,,,,A,948.0,CHEMBL624875,1,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12516,10116.0
,N,50597,,,,A,948.0,CHEMBL624876,1,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12517,10116.0
,N,50597,,,,A,948.0,CHEMBL624877,1,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12518,10116.0
,N,50597,,,,A,948.0,CHEMBL624878,1,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12519,10116.0
,N,50597,,,,A,948.0,CHEMBL624879,1,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12520,10116.0
,N,50597,,,,A,948.0,CHEMBL624880,1,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12521,10116.0
,N,50597,,,,A,948.0,CHEMBL624881,1,,BAO_0000218,8594,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12522,10116.0
,N,50597,,,,A,948.0,CHEMBL624882,1,,BAO_0000218,8594,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",1,,Heart,Rattus norvegicus,Intermediate,,,12523,10116.0
,N,50597,,,,A,2113.0,CHEMBL624883,1,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12524,10116.0
,N,50597,,,,A,2113.0,CHEMBL624884,1,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12525,10116.0
,N,50597,,,,A,2113.0,CHEMBL624885,1,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12526,10116.0
,N,50597,,,,A,2113.0,CHEMBL624886,1,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12527,10116.0
,N,50597,,,,A,2113.0,CHEMBL624887,1,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12528,10116.0
,N,50597,,,,A,2113.0,CHEMBL624888,1,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12529,10116.0
,N,50597,,,,A,2113.0,CHEMBL624889,1,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12530,10116.0
,N,50597,,,,A,2113.0,CHEMBL624890,1,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12531,10116.0
,N,50597,,,,A,2113.0,CHEMBL621964,1,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12532,10116.0
,N,50597,,,,A,2113.0,CHEMBL621965,1,,BAO_0000218,8594,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12533,10116.0
,N,50597,,,,A,2107.0,CHEMBL621966,1,,BAO_0000218,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12534,10116.0
,N,50597,,,,A,2107.0,CHEMBL621967,1,,BAO_0000218,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12535,10116.0
,N,50597,,,,A,2107.0,CHEMBL622164,1,,BAO_0000218,8594,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12536,10116.0
,U,22224,,,,A,,CHEMBL623097,0,,BAO_0000019,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),1,,,,Autocuration,,,12537,
,U,22224,,,,A,,CHEMBL623098,0,,BAO_0000019,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),1,,,,Autocuration,,,12538,
,U,22224,,,,A,,CHEMBL623099,0,,BAO_0000019,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,1,,,,Autocuration,,,12539,
,U,22224,,,,A,,CHEMBL623100,0,,BAO_0000019,7653,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,1,,,,Autocuration,,,12540,
,N,50597,,,,A,,CHEMBL628673,1,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",1,,,Rattus norvegicus,Intermediate,,,12541,10116.0
,N,50597,,,,A,,CHEMBL628674,1,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",1,,,Rattus norvegicus,Intermediate,,,12542,10116.0
,N,50597,,,,A,,CHEMBL628675,1,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",1,,,Rattus norvegicus,Intermediate,,,12543,10116.0
,N,50597,,,,A,,CHEMBL627644,1,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",1,,,Rattus norvegicus,Intermediate,,,12544,10116.0
,N,50597,,,,A,,CHEMBL627645,1,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",1,,,Rattus norvegicus,Intermediate,,,12545,10116.0
,N,50597,,,,A,,CHEMBL627646,1,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",1,,,Rattus norvegicus,Intermediate,,,12546,10116.0
,N,50597,,,,A,,CHEMBL627647,1,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",1,,,Rattus norvegicus,Intermediate,,,12547,10116.0
,N,50597,,,,A,,CHEMBL627648,1,,BAO_0000218,9104,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",1,,,Rattus norvegicus,Intermediate,,,12548,10116.0
,N,50597,,,,A,,CHEMBL627649,1,,BAO_0000218,12902,Free level in rat plasma,1,,,Rattus norvegicus,Intermediate,,,12549,10116.0
,U,22224,,,,A,,CHEMBL628313,0,,BAO_0000019,6614,Level reaching in blood plasma of rat or human was determined,1,,,,Autocuration,,,12550,
,N,50597,,,,A,,CHEMBL628314,1,,BAO_0000218,9663,Log (Cbrain/Cblood) in rats,1,,,Rattus norvegicus,Intermediate,,,12551,10116.0
,U,22224,,,,A,,CHEMBL628315,0,,BAO_0000019,17658,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,1,,,,Autocuration,,,12552,
,U,22224,,,,A,,CHEMBL628316,0,,BAO_0000019,17658,Mean percentage of compound transport through membrane; expressed as membrane transport,1,,,,Autocuration,,,12553,
,U,22224,,,,A,,CHEMBL628317,0,,BAO_0000218,14314,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,1,,,,Autocuration,,,12554,
,U,22224,,,,A,,CHEMBL628473,0,,BAO_0000019,7385,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,1,,,,Autocuration,,,12555,
,U,22224,,,,A,,CHEMBL628474,0,,BAO_0000019,7385,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",1,,,,Autocuration,,,12556,
,U,22224,,,,A,,CHEMBL628475,0,,BAO_0000019,7385,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,1,,,,Autocuration,,,12557,
,U,22224,,,,A,,CHEMBL628476,0,,BAO_0000019,1329,Net water uptake by a carrier mediated transport (%cm) mechanism,1,,,,Autocuration,,,12558,
,U,22224,,,,A,,CHEMBL628477,0,,BAO_0000218,12187,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,1,,,Simiiformes,Autocuration,,,12559,314293.0
,N,50506,,,,A,,CHEMBL628478,1,,BAO_0000218,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,1,,,Mustela putorius furo,Intermediate,,,12560,9669.0
,N,50506,,,,A,,CHEMBL628479,1,,BAO_0000218,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",1,,,Mustela putorius furo,Intermediate,,,12561,9669.0
,U,22224,,,,A,,CHEMBL628480,0,,BAO_0000218,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,1,,,Simiiformes,Autocuration,,,12562,314293.0
,U,22224,,,,A,,CHEMBL628481,0,,BAO_0000218,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",1,,,Simiiformes,Autocuration,,,12563,314293.0
,N,50597,,,,A,,CHEMBL628482,1,,BAO_0000218,12187,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,12564,10116.0
,N,50597,,,,A,,CHEMBL628483,1,,BAO_0000218,12187,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,,,Rattus norvegicus,Intermediate,,,12565,10116.0
,N,50597,,,,A,1969.0,CHEMBL628484,1,,BAO_0000218,9278,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",1,,Plasma,Rattus norvegicus,Intermediate,,,12566,10116.0
,N,50597,,,,A,1969.0,CHEMBL628485,1,,BAO_0000218,9278,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,,Plasma,Rattus norvegicus,Intermediate,,,12567,10116.0
,N,100710,,,,A,1969.0,CHEMBL628486,1,,BAO_0000218,9278,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",1,,Plasma,Macaca fascicularis,Intermediate,,,12568,9541.0
,N,50587,,,,A,1969.0,CHEMBL628487,1,,BAO_0000218,9278,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",1,,Plasma,Homo sapiens,Intermediate,,,12569,9606.0
,N,50597,,,,A,1969.0,CHEMBL628488,1,,BAO_0000218,9278,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",1,,Plasma,Rattus norvegicus,Intermediate,,,12570,10116.0
,N,50597,,,,A,1969.0,CHEMBL628489,1,,BAO_0000218,9278,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,,Plasma,Rattus norvegicus,Intermediate,,,12571,10116.0
,N,50597,,,,A,1969.0,CHEMBL628490,1,,BAO_0000218,9278,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",1,,Plasma,Rattus norvegicus,Intermediate,,,12572,10116.0
,N,100710,,,,A,,CHEMBL628491,1,,BAO_0000218,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,,Macaca fascicularis,Intermediate,,,12573,9541.0
,N,100710,,,,A,,CHEMBL877507,1,,BAO_0000218,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,1,,,Macaca fascicularis,Intermediate,,,12574,9541.0
,U,22224,,,,A,,CHEMBL628492,0,,BAO_0000218,12186,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,1,,,,Autocuration,,,12575,
,U,22224,,,,A,,CHEMBL628493,0,,BAO_0000019,12041,% metabolized in monkey S-9 after 2 hours (10 ug/mL),1,,,Simiiformes,Autocuration,,,12576,314293.0
,U,22224,,,,A,,CHEMBL628494,0,,BAO_0000019,12041,% metabolized in monkey S-9 after 2 hours (1 ug/ml),1,,,Simiiformes,Autocuration,,,12577,314293.0
,U,22224,,,,A,,CHEMBL628495,0,,BAO_0000019,12041,% metabolized in monkey S-9 after 2 hours (10 ug/ml),1,,,Simiiformes,Autocuration,,,12578,314293.0
,N,50587,,,,A,,CHEMBL628496,1,,BAO_0000218,6737,Permeability in Caco-2 assay at 10E-6,1,,,Homo sapiens,Intermediate,,,12579,9606.0
,U,22224,,,,A,955.0,CHEMBL628497,0,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,1,,Brain,,Autocuration,,,12580,
,U,22224,,,,A,955.0,CHEMBL628498,0,,BAO_0000218,13758,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,1,,Brain,,Autocuration,,,12581,
,U,22224,,,,A,,CHEMBL628499,0,,BAO_0000019,5676,Plasma protein binding was determined,1,,,,Autocuration,,,12582,
,U,22224,,,,A,,CHEMBL627656,0,,BAO_0000218,14793,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,1,,,,Autocuration,,,12583,
,U,22224,,,,A,,CHEMBL627657,0,,BAO_0000218,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,1,,,,Autocuration,,,12584,
,U,22224,,,,A,,CHEMBL626808,0,,BAO_0000218,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,1,,,,Autocuration,,,12585,
,U,22224,,,,A,,CHEMBL626809,0,,BAO_0000218,14793,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,1,,,,Autocuration,,,12586,
,U,22224,,,,A,,CHEMBL626810,0,,BAO_0000218,14793,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,1,,,,Autocuration,,,12587,
,U,22224,,,,A,,CHEMBL626811,0,,BAO_0000218,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,1,,,,Autocuration,,,12588,
,U,22224,,,,A,,CHEMBL874465,0,,BAO_0000218,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,1,,,,Autocuration,,,12589,
,U,22224,,,,A,,CHEMBL626812,0,,BAO_0000218,14793,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,1,,,,Autocuration,,,12590,
,U,22224,,,,A,,CHEMBL626813,0,,BAO_0000218,14793,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,1,,,,Autocuration,,,12591,
,U,22224,,,,A,,CHEMBL626814,0,,BAO_0000218,14793,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,1,,,,Autocuration,,,12592,
,U,22224,,,,A,,CHEMBL626815,0,,BAO_0000019,14000,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,1,,,,Autocuration,,,12593,
,U,22224,,,,A,,CHEMBL628566,0,,BAO_0000019,5948,Partition coefficient (logP),1,,,,Autocuration,,,12594,
,U,22229,,,,P,,CHEMBL628567,0,,BAO_0000100,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),1,,,,Autocuration,,,12595,
,U,22229,,,,P,,CHEMBL628568,0,,BAO_0000100,10778,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12596,
,N,50588,,,In vivo,A,,CHEMBL628569,1,,BAO_0000218,17237,C max in dog,1,,,Canis lupus familiaris,Intermediate,,,12597,9615.0
,N,50512,,,In vivo,A,,CHEMBL628570,1,,BAO_0000218,17237,C max in guinea pig,1,,,Cavia porcellus,Intermediate,,,12598,10141.0
,U,22224,,,In vivo,A,,CHEMBL628571,0,,BAO_0000218,2809,C max value was evaluated,1,,,,Autocuration,,,12599,
,U,22224,,,In vivo,A,,CHEMBL628572,0,,BAO_0000218,11954,Cmax value after oral dose of 0.1 mg//kg,1,,,,Autocuration,,,12600,
,U,22224,,,In vivo,A,,CHEMBL628573,0,,BAO_0000218,11954,Cmax value after oral dose of 0.3 mg/kg,1,,,,Autocuration,,,12601,
,U,22224,,,In vivo,A,,CHEMBL628574,0,,BAO_0000218,11954,Cmax value after oral dose of 1 mg/kg,1,,,,Autocuration,,,12602,
,U,22224,,,In vivo,A,,CHEMBL628575,0,,BAO_0000218,11954,Cmax value after oral dose of 10 mg/kg,1,,,,Autocuration,,,12603,
,U,22224,,,In vivo,A,,CHEMBL628576,0,,BAO_0000218,11954,Cmax value after oral dose of 23.4 mg/kg,1,,,,Autocuration,,,12604,
,U,22224,,,In vivo,A,,CHEMBL628577,0,,BAO_0000218,11954,Cmax value after oral dose of 3 mg/kg,1,,,,Autocuration,,,12605,
,U,22224,,,In vivo,A,,CHEMBL628578,0,,BAO_0000218,11954,Cmax value after oral dose of 3.87 mg/kg,1,,,,Autocuration,,,12606,
,N,50588,,,In vivo,A,,CHEMBL874466,1,,BAO_0000218,12768,Cmax value in female Beagle dogs,1,,,Canis lupus familiaris,Intermediate,,,12607,9615.0
,N,50597,,,In vivo,A,,CHEMBL628579,1,,BAO_0000218,12768,Cmax value in male rats,1,,,Rattus norvegicus,Intermediate,,,12608,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL628580,1,,BAO_0000218,12780,Cmax value in rat plasma when administered 20 mg/kg perorally,1,,Plasma,Rattus norvegicus,Intermediate,,,12609,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL628581,1,,BAO_0000218,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,,Plasma,Canis lupus familiaris,Intermediate,,,12610,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL628582,1,,BAO_0000218,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,,Plasma,Canis lupus familiaris,Intermediate,,,12611,9615.0
,N,50588,,,,A,,CHEMBL628583,1,,BAO_0000218,17025,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,1,,,Canis lupus familiaris,Intermediate,,,12612,9615.0
,U,22224,,,,A,,CHEMBL625782,0,,BAO_0000218,17025,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,1,,,Simiiformes,Autocuration,,,12613,314293.0
,N,50592,,,,A,,CHEMBL625783,1,,BAO_0000218,17025,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,1,,,Oryctolagus cuniculus,Intermediate,,,12614,9986.0
,N,50597,,,,A,,CHEMBL625784,1,,BAO_0000218,17025,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,1,,,Rattus norvegicus,Intermediate,,,12615,10116.0
,N,50797,,,,A,1969.0,CHEMBL625785,1,,BAO_0000218,4236,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,1,,Plasma,Macaca mulatta,Intermediate,,,12616,9544.0
,N,50597,,,,A,,CHEMBL625786,1,,BAO_0000218,15791,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,1,,,Rattus norvegicus,Intermediate,,,12617,10116.0
,U,22224,,,,A,,CHEMBL874467,0,,BAO_0000019,11149,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,1,,,,Autocuration,,,12618,
,N,50588,,,,A,,CHEMBL625787,1,,BAO_0000218,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",1,,,Canis lupus familiaris,Intermediate,,,12619,9615.0
,N,50677,,,,A,,CHEMBL625964,1,,BAO_0000218,15778,cytotoxicity against HIV protease enzyme.,1,,,Human immunodeficiency virus,Intermediate,,,12620,12721.0
,N,50594,,,,A,,CHEMBL625965,1,,BAO_0000218,12745,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,1,,,Mus musculus,Intermediate,,,12621,10090.0
,N,50594,,,,A,,CHEMBL625966,1,,BAO_0000218,12745,Apparent clearance in mice after oral administration of 100 mg/kg of dose,1,,,Mus musculus,Intermediate,,,12622,10090.0
,N,50588,,,In vivo,A,1969.0,CHEMBL625967,1,,BAO_0000218,13941,The plasma clearance in dog.,1,,Plasma,Canis lupus familiaris,Intermediate,,,12623,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625968,1,,BAO_0000218,13941,The plasma clearance in rat.,1,,Plasma,Rattus norvegicus,Intermediate,,,12624,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625969,1,,BAO_0000218,16449,Clearance from plasma in male Sprague-Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,12625,10116.0
,N,100710,,,In vivo,A,1969.0,CHEMBL625970,1,,BAO_0000218,16449,Clearance from plasma in male cynomolgus monkeys,1,,Plasma,Macaca fascicularis,Intermediate,,,12626,9541.0
,N,50588,,,In vivo,A,1969.0,CHEMBL625971,1,,BAO_0000218,14224,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",1,,Plasma,Canis lupus familiaris,Intermediate,,,12627,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL625972,1,,BAO_0000218,14224,Clearance of compound in dog plasma,1,,Plasma,Canis lupus familiaris,Intermediate,,,12628,9615.0
,N,50587,,,In vivo,A,1969.0,CHEMBL625973,1,,BAO_0000218,14224,Clearance of compound in human plasma,1,,Plasma,Homo sapiens,Intermediate,,,12629,9606.0
,N,50588,,,In vivo,A,,CHEMBL625974,1,,BAO_0000218,14317,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,1,,,Canis lupus familiaris,Intermediate,,,12630,9615.0
,N,50588,,,In vivo,A,,CHEMBL625975,1,,BAO_0000218,14317,Clearance of compound when administered intravenously as an individual dose to a single dog.,1,,,Canis lupus familiaris,Intermediate,,,12631,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL625976,1,,BAO_0000218,14224,"Clearance (10 mg/kg, intravenously) in dog plasma",1,,Plasma,Canis lupus familiaris,Intermediate,,,12632,9615.0
,N,50588,,,In vivo,A,,CHEMBL625977,1,,BAO_0000218,17237,Clearance value in dog,1,,,Canis lupus familiaris,Intermediate,,,12633,9615.0
,N,50512,,,In vivo,A,,CHEMBL625978,1,,BAO_0000218,17237,Clearance value in guinea pig,1,,,Cavia porcellus,Intermediate,,,12634,10141.0
,N,50597,,,In vivo,A,,CHEMBL874468,1,,BAO_0000218,14187,Clearance values in rats after iv administration.,1,,,Rattus norvegicus,Intermediate,,,12635,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL625421,0,,BAO_0000218,4806,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,1,,Plasma,,Autocuration,,,12636,
,N,50592,,,In vivo,A,,CHEMBL625422,1,,BAO_0000218,15025,In vivo clearance (5 mg/kg) was determined in rabbits,1,,,Oryctolagus cuniculus,Intermediate,,,12637,9986.0
,N,50597,,,In vivo,A,,CHEMBL625423,1,,BAO_0000218,13197,Plasma Clearance rate was determined for the compound in rats,1,,,Rattus norvegicus,Intermediate,,,12638,10116.0
,U,22224,,,In vivo,A,,CHEMBL625424,0,,BAO_0000218,13197,Plasma Clearance rate was determined for the compound in squirrel monkeys,1,,,Saimiri,Autocuration,,,12639,9520.0
,N,50597,,,In vivo,A,,CHEMBL625425,1,,BAO_0000218,13960,Plasma clearance in rat,1,,,Rattus norvegicus,Intermediate,,,12640,10116.0
,U,22224,,,In vivo,A,,CHEMBL625426,0,,BAO_0000218,17820,Plasma clearance of the compound,1,,,,Autocuration,,,12641,
,N,50512,,,In vivo,A,,CHEMBL625427,1,,BAO_0000218,14706,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,1,,,Cavia porcellus,Intermediate,,,12642,10141.0
,N,50512,,,In vivo,A,,CHEMBL625428,1,,BAO_0000218,14706,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,1,,,Cavia porcellus,Intermediate,,,12643,10141.0
,U,22224,,,In vivo,A,,CHEMBL625429,0,,BAO_0000218,6504,Plasma clearance was determined,1,,,,Autocuration,,,12644,
,N,50588,,,In vivo,A,,CHEMBL625430,1,,BAO_0000218,14925,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,1,,,Canis lupus familiaris,Intermediate,,,12645,9615.0
,N,50597,,,In vivo,A,,CHEMBL625431,1,,BAO_0000218,13197,Plasma clearance rate was determined for the compound in rats,1,,,Rattus norvegicus,Intermediate,,,12646,10116.0
,U,22224,,,In vivo,A,,CHEMBL627307,0,,BAO_0000218,13197,Plasma clearance rate was determined for the compound in squirrel monkeys,1,,,Saimiri,Autocuration,,,12647,9520.0
,U,22224,,,In vivo,A,,CHEMBL627308,0,,BAO_0000218,3437,Slow clearance (CL) was determined,1,,,,Autocuration,,,12648,
,U,22224,,,,A,,CHEMBL627309,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,1,,,,Autocuration,,,12649,
,U,22224,,,,A,,CHEMBL627310,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,1,,,,Autocuration,,,12650,
,U,22224,,,,A,,CHEMBL627311,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,1,,,,Autocuration,,,12651,
,U,22224,,,,A,,CHEMBL627312,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,1,,,,Autocuration,,,12652,
,U,22224,,,,A,,CHEMBL627313,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,1,,,,Autocuration,,,12653,
,U,22224,,,,A,,CHEMBL627314,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,1,,,,Autocuration,,,12654,
,U,22224,,,,A,,CHEMBL627315,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,1,,,,Autocuration,,,12655,
,U,22224,,,,A,,CHEMBL627316,0,,BAO_0000218,9196,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,,,,Autocuration,,,12656,
,U,22224,,,,A,,CHEMBL627317,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,1,,,,Autocuration,,,12657,
,U,22224,,,,A,,CHEMBL627318,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,1,,,,Autocuration,,,12658,
,U,22224,,,,A,,CHEMBL627999,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,1,,,,Autocuration,,,12659,
,U,22224,,,,A,,CHEMBL628000,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,1,,,,Autocuration,,,12660,
,U,22224,,,,A,,CHEMBL628001,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,1,,,,Autocuration,,,12661,
,U,22224,,,,A,,CHEMBL628002,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,1,,,,Autocuration,,,12662,
,U,22224,,,,A,,CHEMBL625610,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,1,,,,Autocuration,,,12663,
,U,22224,,,,A,,CHEMBL625611,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,1,,,,Autocuration,,,12664,
,U,22224,,,,A,,CHEMBL625612,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,1,,,,Autocuration,,,12665,
,U,22224,,,,A,,CHEMBL625613,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,1,,,,Autocuration,,,12666,
,U,22224,,,,A,,CHEMBL875479,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,1,,,,Autocuration,,,12667,
,U,22224,,,,A,,CHEMBL625614,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,1,,,,Autocuration,,,12668,
,U,22224,,,,A,,CHEMBL625615,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,1,,,,Autocuration,,,12669,
,U,22224,,,,A,,CHEMBL626302,0,,BAO_0000218,9196,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,1,,,,Autocuration,,,12670,
,N,50597,,,,A,178.0,CHEMBL626303,1,,BAO_0000218,8374,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12671,10116.0
,N,50597,,,,A,178.0,CHEMBL627420,1,,BAO_0000218,8374,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,1,,Blood,Rattus norvegicus,Intermediate,,,12672,10116.0
,N,50597,,,,A,,CHEMBL627421,1,,BAO_0000218,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,1,,,Rattus norvegicus,Intermediate,,,12673,10116.0
,N,50597,,,,A,,CHEMBL625695,1,,BAO_0000218,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,1,,,Rattus norvegicus,Intermediate,,,12674,10116.0
,N,50597,,,,A,,CHEMBL625696,1,,BAO_0000218,13477,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,1,,,Rattus norvegicus,Intermediate,,,12675,10116.0
,N,50594,,,,A,955.0,CHEMBL875606,1,,BAO_0000218,10009,Distribution of compound in mice brain was measured after 1 hr,1,,Brain,Mus musculus,Intermediate,,,12676,10090.0
,N,50594,,,,A,955.0,CHEMBL625697,1,,BAO_0000218,10009,Distribution of compound in mice brain was measured after 24 hr r,1,,Brain,Mus musculus,Intermediate,,,12677,10090.0
,N,50594,,,,A,955.0,CHEMBL625698,1,,BAO_0000218,10009,Distribution of compound in mice brain was measured after 2 hr,1,,Brain,Mus musculus,Intermediate,,,12678,10090.0
,N,50594,,,,A,955.0,CHEMBL625699,1,,BAO_0000218,10009,Distribution of compound in mice brain was measured after 3 hr,1,,Brain,Mus musculus,Intermediate,,,12679,10090.0
,N,50594,,,,A,955.0,CHEMBL625700,1,,BAO_0000218,10009,Distribution of compound in mice brain was measured after 6 hr,1,,Brain,Mus musculus,Intermediate,,,12680,10090.0
,N,50594,,,,A,,CHEMBL625701,1,,BAO_0000218,10009,Distribution of compound in mice liver was measured after 1 hr,1,,,Mus musculus,Intermediate,,,12681,10090.0
,N,50594,,,,A,,CHEMBL625702,1,,BAO_0000218,10009,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,1,,,Mus musculus,Intermediate,,,12682,10090.0
,N,50594,,,,A,,CHEMBL625703,1,,BAO_0000218,10009,Distribution of compound in mice liver was measured after 2 hr,1,,,Mus musculus,Intermediate,,,12683,10090.0
,N,50594,,,,A,,CHEMBL625704,1,,BAO_0000218,10009,Distribution of compound in mice liver was measured after 3 hr,1,,,Mus musculus,Intermediate,,,12684,10090.0
,N,50594,,,,A,,CHEMBL625705,1,,BAO_0000218,10009,Distribution of compound in mice liver was measured after 6 hr,1,,,Mus musculus,Intermediate,,,12685,10090.0
,N,50588,,,,A,1236.0,CHEMBL625706,1,,BAO_0000218,8170,Distribution in dog adrenal medulla 30 min after administration.,1,,Adrenal medulla,Canis lupus familiaris,Intermediate,,,12686,9615.0
,N,50588,,,,A,1236.0,CHEMBL625707,1,,BAO_0000218,8170,Distribution in dog adrenal medulla 72 hours after administration.,1,,Adrenal medulla,Canis lupus familiaris,Intermediate,,,12687,9615.0
,N,50588,,,,A,,CHEMBL625708,1,,BAO_0000218,8170,Distribution in female dog Ovary 24 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12688,9615.0
,N,50588,,,,A,,CHEMBL625709,1,,BAO_0000218,8170,Distribution in female dog Ovary 72 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12689,9615.0
,N,50588,,,,A,,CHEMBL624180,1,,BAO_0000218,8170,Distribution in female dog adipose 24 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12690,9615.0
,N,50588,,,,A,,CHEMBL624181,1,,BAO_0000218,8170,Distribution in female dog adipose 72 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12691,9615.0
,N,50588,,,,A,1235.0,CHEMBL624182,1,,BAO_0000218,8170,Distribution in female dog adrenal cortex 72 hours after administration.,1,,Adrenal cortex,Canis lupus familiaris,Intermediate,,,12692,9615.0
,N,50588,,,,A,1235.0,CHEMBL624183,1,,BAO_0000218,8170,Distribution in female dog adrenal cortex 72 hours after administration.,1,,Adrenal cortex,Canis lupus familiaris,Intermediate,,,12693,9615.0
,N,50597,,,,A,2107.0,CHEMBL624184,1,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12694,10116.0
,N,50597,,,,A,2107.0,CHEMBL877489,1,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12695,10116.0
,N,50597,,,,A,2107.0,CHEMBL624185,1,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12696,10116.0
,N,50597,,,,A,2107.0,CHEMBL624186,1,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12697,10116.0
,N,50597,,,,A,2107.0,CHEMBL624187,1,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12698,10116.0
,N,50597,,,,A,2107.0,CHEMBL624188,1,,BAO_0000218,8594,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12699,10116.0
,N,50597,,,,A,2048.0,CHEMBL624189,1,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12700,10116.0
,N,50597,,,,A,2048.0,CHEMBL624190,1,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12701,10116.0
,N,50597,,,,A,2048.0,CHEMBL624191,1,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12702,10116.0
,N,50597,,,,A,2048.0,CHEMBL624192,1,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12703,10116.0
,N,50597,,,,A,2048.0,CHEMBL624193,1,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12704,10116.0
,N,50597,,,,A,2048.0,CHEMBL624194,1,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12705,10116.0
,N,50597,,,,A,2048.0,CHEMBL624891,1,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12706,10116.0
,N,50597,,,,A,2048.0,CHEMBL624892,1,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12707,10116.0
,N,50597,,,,A,2048.0,CHEMBL624893,1,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12708,10116.0
,N,50597,,,,A,2048.0,CHEMBL627632,1,,BAO_0000218,8594,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12709,10116.0
,N,50597,,,,A,,CHEMBL627633,1,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12710,10116.0
,N,50597,,,,A,,CHEMBL627634,1,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12711,10116.0
,N,50597,,,,A,,CHEMBL627635,1,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,,Rattus norvegicus,Intermediate,,,12712,10116.0
,N,50597,,,,A,,CHEMBL627636,1,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12713,10116.0
,N,50597,,,,A,,CHEMBL626816,1,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,,Rattus norvegicus,Intermediate,,,12714,10116.0
,N,50597,,,,A,,CHEMBL626817,1,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12715,10116.0
,N,50597,,,,A,,CHEMBL626818,1,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,,Rattus norvegicus,Intermediate,,,12716,10116.0
,N,50597,,,,A,,CHEMBL626819,1,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12717,10116.0
,N,50597,,,,A,,CHEMBL626820,1,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,,Rattus norvegicus,Intermediate,,,12718,10116.0
,N,50597,,,,A,,CHEMBL626821,1,,BAO_0000218,8594,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12719,10116.0
,N,50597,,,,A,2046.0,CHEMBL626822,1,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12720,10116.0
,N,50597,,,,A,2046.0,CHEMBL626823,1,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12721,10116.0
,N,50597,,,,A,2046.0,CHEMBL626824,1,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12722,10116.0
,N,50597,,,,A,2046.0,CHEMBL626825,1,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12723,10116.0
,N,50597,,,,A,2046.0,CHEMBL626826,1,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12724,10116.0
,N,50597,,,,A,2046.0,CHEMBL626827,1,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12725,10116.0
,N,50597,,,,A,2046.0,CHEMBL626828,1,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12726,10116.0
,N,50597,,,,A,2046.0,CHEMBL626829,1,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12727,10116.0
,N,50597,,,,A,2046.0,CHEMBL626830,1,,BAO_0000218,8594,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12728,10116.0
,N,50597,,,,A,,CHEMBL627150,1,,BAO_0000218,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,,Rattus norvegicus,Intermediate,,,12729,10116.0
,N,50597,,,,A,,CHEMBL627151,1,,BAO_0000218,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12730,10116.0
,N,50597,,,,A,,CHEMBL627152,1,,BAO_0000218,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,1,,,Rattus norvegicus,Intermediate,,,12731,10116.0
,N,50597,,,,A,,CHEMBL627153,1,,BAO_0000218,8594,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12732,10116.0
,U,22224,,,,A,,CHEMBL627154,0,,BAO_0000019,12904,Rate of acetate production by the compound was determined,1,,,,Autocuration,,,12733,
,U,22224,,,,A,,CHEMBL627155,0,,BAO_0000019,12904,Rate of acetate production by the compound was determined; Not determined,1,,,,Autocuration,,,12734,
,U,22224,,,,A,,CHEMBL627156,0,,BAO_0000019,3730,Rate of hydrolysis of nitrocefin by compound was evaluated in water,1,,,,Autocuration,,,12735,
,U,22224,,,,A,,CHEMBL627157,0,,BAO_0000019,3627,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,1,,,,Autocuration,,,12736,
,N,50592,,,,A,,CHEMBL627158,1,,BAO_0000218,13799,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,1,,,Oryctolagus cuniculus,Intermediate,,,12737,9986.0
,N,50592,,,,A,1969.0,CHEMBL627159,1,,BAO_0000218,13799,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,1,,Plasma,Oryctolagus cuniculus,Intermediate,,,12738,9986.0
,N,50594,,,,A,,CHEMBL627160,1,,BAO_0000218,13799,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,1,,,Mus musculus,Intermediate,,,12739,10090.0
,N,50597,,,,A,,CHEMBL628540,1,,BAO_0000218,13799,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,1,,,Rattus norvegicus,Intermediate,,,12740,10116.0
,N,50597,,,,A,1969.0,CHEMBL628541,1,,BAO_0000218,13799,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,1,,Plasma,Rattus norvegicus,Intermediate,,,12741,10116.0
,N,50597,,,,A,1969.0,CHEMBL628542,1,,BAO_0000218,13799,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,1,,Plasma,Rattus norvegicus,Intermediate,,,12742,10116.0
,U,22229,,,,P,,CHEMBL628543,0,,BAO_0000100,6629,Solubility after at a pH 1.2,1,,,,Autocuration,,,12743,
,U,22229,,,,P,,CHEMBL628544,0,,BAO_0000100,6629,Solubility after at pH 1.2,1,,,,Autocuration,,,12744,
,U,22229,,,,P,,CHEMBL628545,0,,BAO_0000100,6629,Solubility after injection of water,1,,,,Autocuration,,,12745,
,U,22224,,,,A,,CHEMBL628546,0,,BAO_0000019,14000,Statistical significance of IC 50 values; Expressed as R value,1,,,,Autocuration,,,12746,
,U,22224,,,,A,,CHEMBL874455,0,,BAO_0000019,8267,Systemic availability with respect to methyldopa was determined,1,,,,Autocuration,,,12747,
,N,50597,,,,A,,CHEMBL628547,1,,BAO_0000218,13799,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,1,,,Rattus norvegicus,Intermediate,,,12748,10116.0
,N,50597,,,,A,1969.0,CHEMBL628548,1,,BAO_0000218,13799,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,1,,Plasma,Rattus norvegicus,Intermediate,,,12749,10116.0
,N,50592,,,,A,1988.0,CHEMBL628549,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",1,,Feces,Oryctolagus cuniculus,Intermediate,,,12750,9986.0
,N,50592,,,,A,1988.0,CHEMBL628550,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",1,,Feces,Oryctolagus cuniculus,Intermediate,,,12751,9986.0
,N,50592,,,,A,1988.0,CHEMBL628551,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",1,,Feces,Oryctolagus cuniculus,Intermediate,,,12752,9986.0
,N,50592,,,,A,1088.0,CHEMBL628552,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12753,9986.0
,N,50592,,,,A,1088.0,CHEMBL628553,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12754,9986.0
,N,50592,,,,A,1088.0,CHEMBL628554,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12755,9986.0
,N,50592,,,,A,1088.0,CHEMBL628555,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12756,9986.0
,N,50592,,,,A,1088.0,CHEMBL628556,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12757,9986.0
,N,50592,,,,A,2113.0,CHEMBL628557,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",1,,Kidney,Oryctolagus cuniculus,Intermediate,,,12758,9986.0
,N,50592,,,,A,1988.0,CHEMBL628558,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",1,,Feces,Oryctolagus cuniculus,Intermediate,,,12759,9986.0
,N,50592,,,,A,1988.0,CHEMBL628559,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",1,,Feces,Oryctolagus cuniculus,Intermediate,,,12760,9986.0
,N,50592,,,,A,1988.0,CHEMBL628560,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",1,,Feces,Oryctolagus cuniculus,Intermediate,,,12761,9986.0
,N,50592,,,,A,1088.0,CHEMBL874456,1,,BAO_0000218,7132,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12762,9986.0
,N,50592,,,,A,1988.0,CHEMBL628561,1,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",1,,Feces,Oryctolagus cuniculus,Intermediate,,,12763,9986.0
,N,50592,,,,A,1988.0,CHEMBL628562,1,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",1,,Feces,Oryctolagus cuniculus,Intermediate,,,12764,9986.0
,N,50592,,,,A,1088.0,CHEMBL628563,1,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12765,9986.0
,N,50592,,,,A,1088.0,CHEMBL628564,1,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12766,9986.0
,N,50592,,,,A,1088.0,CHEMBL628565,1,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12767,9986.0
,N,50592,,,,A,1088.0,CHEMBL631248,1,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12768,9986.0
,N,50592,,,,A,1088.0,CHEMBL631249,1,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",1,,Urine,Oryctolagus cuniculus,Intermediate,,,12769,9986.0
,N,50592,,,,A,2113.0,CHEMBL627214,1,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",1,,Kidney,Oryctolagus cuniculus,Intermediate,,,12770,9986.0
,N,50592,,,,A,1988.0,CHEMBL874591,1,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",1,,Feces,Oryctolagus cuniculus,Intermediate,,,12771,9986.0
,N,50592,,,,A,1988.0,CHEMBL627215,1,,BAO_0000218,7132,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",1,,Feces,Oryctolagus cuniculus,Intermediate,,,12772,9986.0
,N,50592,,,,A,1988.0,CHEMBL625471,1,,BAO_0000218,7132,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,1,,Feces,Oryctolagus cuniculus,Intermediate,,,12773,9986.0
,N,50592,,,,A,,CHEMBL625472,1,,BAO_0000218,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,1,,,Oryctolagus cuniculus,Intermediate,,,12774,9986.0
,N,50592,,,,A,,CHEMBL625473,1,,BAO_0000218,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,1,,,Oryctolagus cuniculus,Intermediate,,,12775,9986.0
,N,50588,,,In vivo,A,,CHEMBL625474,1,,BAO_0000218,13317,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,1,,,Canis lupus familiaris,Intermediate,,,12776,9615.0
,N,50588,,,In vivo,A,,CHEMBL625475,1,,BAO_0000218,15341,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,1,,,Canis lupus familiaris,Intermediate,,,12777,9615.0
,N,50597,,,In vivo,A,,CHEMBL625476,1,,BAO_0000218,15341,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,1,,,Rattus norvegicus,Intermediate,,,12778,10116.0
,N,50597,,,In vivo,A,,CHEMBL625477,1,,BAO_0000218,15341,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,1,,,Rattus norvegicus,Intermediate,,,12779,10116.0
,N,50597,,,In vivo,A,,CHEMBL625478,1,,BAO_0000218,15341,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,1,,,Rattus norvegicus,Intermediate,,,12780,10116.0
,N,50597,,,In vitro,A,,CHEMBL625479,1,,BAO_0000218,12801,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,1,,esophageal tunica muscularis mucosae,Rattus norvegicus,Intermediate,,,12781,10116.0
,N,50597,,,In vitro,A,,CHEMBL625480,1,,BAO_0000218,12801,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,1,,esophageal tunica muscularis mucosae,Rattus norvegicus,Intermediate,,,12782,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625481,1,,BAO_0000218,14856,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,1,,Plasma,Rattus norvegicus,Intermediate,,,12783,10116.0
,N,50597,,,In vivo,A,,CHEMBL625482,1,,BAO_0000218,14062,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,12784,10116.0
,N,50597,,,In vivo,A,,CHEMBL625483,1,,BAO_0000218,14062,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,12785,10116.0
,N,50597,,,In vivo,A,,CHEMBL625484,1,,BAO_0000218,14062,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,12786,10116.0
,N,50597,,,In vivo,A,,CHEMBL625485,1,,BAO_0000218,14062,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,12787,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL625486,1,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,1,,Plasma,Canis lupus familiaris,Intermediate,,,12788,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625487,1,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,12789,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625488,1,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,12790,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625489,1,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,12791,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625490,1,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,12792,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL625491,1,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,1,,Plasma,Canis lupus familiaris,Intermediate,,,12793,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625492,1,,BAO_0000218,14346,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,1,,Plasma,Rattus norvegicus,Intermediate,,,12794,10116.0
,N,50587,,,In vivo,A,1969.0,CHEMBL625493,1,,BAO_0000218,15711,plasma clearance in human,1,,Plasma,Homo sapiens,Intermediate,,,12795,9606.0
,N,50597,,,In vivo,A,,CHEMBL625494,1,,BAO_0000218,14886,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,1,,,Rattus norvegicus,Intermediate,,,12796,10116.0
,N,50597,,,In vivo,A,,CHEMBL625495,1,,BAO_0000218,14886,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,1,,,Rattus norvegicus,Intermediate,,,12797,10116.0
,N,50597,,,In vivo,A,,CHEMBL625496,1,,BAO_0000218,14886,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,1,,,Rattus norvegicus,Intermediate,,,12798,10116.0
,U,22229,,,,P,,CHEMBL625497,0,,BAO_0000100,4115,1-Octanol/water partition coefficient measured at 7.4,1,,,,Autocuration,,,12799,
,U,22229,,,,P,,CHEMBL625498,0,,BAO_0000100,13733,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12800,
,U,22224,,,,A,,CHEMBL625499,0,,BAO_0000019,12102,Partition coefficient (logP),1,,,,Autocuration,,,12801,
,U,22229,,,,P,,CHEMBL625500,0,,BAO_0000100,12676,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12802,
,U,22229,,,,P,,CHEMBL625501,0,,BAO_0000100,13733,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12803,
,U,22229,,,,P,,CHEMBL625502,0,,BAO_0000100,13740,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12804,
,U,22229,,,,P,,CHEMBL625503,0,,BAO_0000100,12766,Calculated partition coefficient (clogP) (relative to BAY K 8644),1,,,,Autocuration,,,12805,
,U,22229,,,,P,,CHEMBL625504,0,,BAO_0000100,2764,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12806,
,U,22229,,,,P,,CHEMBL625505,0,,BAO_0000100,12355,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12807,
,U,22229,,,,P,,CHEMBL625506,0,,BAO_0000100,11314,Calculated partition coefficient of the compound,1,,,,Autocuration,,,12808,
,U,22224,,,,A,,CHEMBL625507,0,,BAO_0000019,12706,Partition coefficient (logP),1,,,,Autocuration,,,12809,
,U,22229,,,,P,,CHEMBL625508,0,,BAO_0000100,12645,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12810,
,U,22229,,,,P,,CHEMBL625509,0,,BAO_0000100,13668,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12811,
,U,22229,,,,P,,CHEMBL625510,0,,BAO_0000100,12819,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12812,
,U,22229,,,,P,,CHEMBL883125,0,,BAO_0000100,13668,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12813,
,U,22229,,,,P,,CHEMBL625511,0,,BAO_0000100,13017,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12814,
,U,22224,,,,A,,CHEMBL874650,0,,BAO_0000019,2448,Partition coefficient of the compound,1,,,,Autocuration,,,12815,
,U,22224,,,,A,,CHEMBL625512,0,,BAO_0000019,11526,Partition coefficient of the compound,1,,,,Autocuration,,,12816,
,U,22224,,,,A,,CHEMBL625513,0,,BAO_0000019,12426,Partition coefficient of compound was determined,1,,,,Autocuration,,,12817,
,U,22224,,,,A,,CHEMBL625514,0,,BAO_0000019,2448,Partition coefficient was determined,1,,,,Autocuration,,,12818,
,U,22229,,,,P,,CHEMBL625515,0,,BAO_0000100,12001,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12819,
,U,22229,,,,P,,CHEMBL625516,0,,BAO_0000100,12426,partition coefficient of compound was determined,1,,,,Autocuration,,,12820,
,N,50588,,,In vivo,A,,CHEMBL625517,1,,BAO_0000218,13204,The total body administered intravenously in dog,1,,,Canis lupus familiaris,Intermediate,,,12821,9615.0
,N,50597,,,In vivo,A,,CHEMBL625518,1,,BAO_0000218,13204,The total body administered intravenously in rats,1,,,Rattus norvegicus,Intermediate,,,12822,10116.0
,N,50594,,,,A,,CHEMBL625519,1,,BAO_0000218,13889,Time taken for the administration to female NIH mice weighing 25-30 g.,1,,,Mus musculus,Intermediate,,,12823,10090.0
,U,22224,,,,A,,CHEMBL625520,0,,BAO_0000019,13889,Time taken for the administration,1,,,,Autocuration,,,12824,
,N,50588,,,In vivo,A,,CHEMBL874651,1,,BAO_0000218,17025,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,1,,,Canis lupus familiaris,Intermediate,,,12825,9615.0
,U,22224,,,In vivo,A,,CHEMBL625521,0,,BAO_0000218,17025,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,1,,,Simiiformes,Autocuration,,,12826,314293.0
,N,50592,,,In vivo,A,,CHEMBL623171,1,,BAO_0000218,17025,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,1,,,Oryctolagus cuniculus,Intermediate,,,12827,9986.0
,N,50597,,,In vivo,A,,CHEMBL623853,1,,BAO_0000218,17025,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,1,,,Rattus norvegicus,Intermediate,,,12828,10116.0
,U,22224,,,,A,,CHEMBL623854,0,,BAO_0000019,15067,Plasma clearance for the compound was determined.,1,,,,Autocuration,,,12829,
,U,22224,,,,P,,CHEMBL874405,0,,BAO_0000100,3091,CLog P value of the compound,1,,,,Autocuration,,,12830,
,U,22229,,,,P,,CHEMBL623855,0,,BAO_0000100,15592,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12831,
,U,22229,,,,P,,CHEMBL623856,0,,BAO_0000100,14738,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12832,
,U,22224,,,,P,,CHEMBL623857,0,,BAO_0000100,14738,ClogP value of the compound; nd ='no data',1,,,,Autocuration,,,12833,
,U,22224,,,,P,,CHEMBL623858,0,,BAO_0000100,14738,ClogP value of the compound; nd ='not determined',1,,,,Autocuration,,,12834,
,U,22224,,,,P,,CHEMBL623859,0,,BAO_0000100,6076,CLog P was determined,1,,,,Autocuration,,,12835,
,U,22229,,,,P,,CHEMBL839829,0,,BAO_0000100,17840,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12836,
,U,22224,,,,A,,CHEMBL623860,0,,BAO_0000019,13589,CLogP was calculated,1,,,,Autocuration,,,12837,
,U,22224,,,,A,,CHEMBL623861,0,,BAO_0000019,17655,CLogP value was determined,1,,,,Autocuration,,,12838,
,U,22224,,,,A,,CHEMBL623862,0,,BAO_0000019,5867,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,1,,,,Autocuration,,,12839,
,U,22229,,,,P,,CHEMBL874406,0,,BAO_0000100,5867,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12840,
,U,22229,,,,P,,CHEMBL623863,0,,BAO_0000100,10783,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12841,
,U,22229,,,,P,,CHEMBL624021,0,,BAO_0000100,14849,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12842,
,N,50588,,,,A,1236.0,CHEMBL624022,1,,BAO_0000218,8170,Distribution in female dog adrenal medulla 24 hours after administration.,1,,Adrenal medulla,Canis lupus familiaris,Intermediate,,,12843,9615.0
,N,50588,,,,A,1236.0,CHEMBL624023,1,,BAO_0000218,8170,Distribution in female dog adrenal medulla 72 hours after administration.,1,,Adrenal medulla,Canis lupus familiaris,Intermediate,,,12844,9615.0
,N,50588,,,,A,,CHEMBL624024,1,,BAO_0000218,8170,Distribution in female dog bile 24 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12845,9615.0
,N,50588,,,,A,,CHEMBL624025,1,,BAO_0000218,8170,Distribution in female dog bile 72 hr after administration.,1,,,Canis lupus familiaris,Intermediate,,,12846,9615.0
,N,50588,,,,A,,CHEMBL624026,1,,BAO_0000218,8170,Distribution in female dog blood 24 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12847,9615.0
,N,50588,,,,A,,CHEMBL624027,1,,BAO_0000218,8170,Distribution in female dog blood 72 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12848,9615.0
,N,50588,,,,A,,CHEMBL624028,1,,BAO_0000218,8170,Distribution in female dog heart 24 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12849,9615.0
,N,50588,,,,A,,CHEMBL624029,1,,BAO_0000218,8170,Distribution in female dog heart 72 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12850,9615.0
,N,50588,,,,A,,CHEMBL624030,1,,BAO_0000218,8170,Distribution in female dog kidney 24 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12851,9615.0
,N,50588,,,,A,,CHEMBL624031,1,,BAO_0000218,8170,Distribution in female dog kidney 72 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12852,9615.0
,N,50588,,,,A,160.0,CHEMBL624032,1,,BAO_0000218,8170,Distribution in female dog large intestine 24 hours after administration.,1,,Intestine,Canis lupus familiaris,Intermediate,,,12853,9615.0
,N,50588,,,,A,160.0,CHEMBL874407,1,,BAO_0000218,8170,Distribution in female dog large intestine 72 hours after administration.,1,,Intestine,Canis lupus familiaris,Intermediate,,,12854,9615.0
,N,50588,,,,A,,CHEMBL624033,1,,BAO_0000218,8170,Distribution in female dog liver 24 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12855,9615.0
,N,50588,,,,A,,CHEMBL624034,1,,BAO_0000218,8170,Distribution in female dog liver 72 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12856,9615.0
,N,50588,,,,A,,CHEMBL624035,1,,BAO_0000218,8170,Distribution in female dog lung 24 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12857,9615.0
,N,50588,,,,A,,CHEMBL624036,1,,BAO_0000218,8170,Distribution in female dog lung 72 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12858,9615.0
,N,50588,,,,A,2385.0,CHEMBL624037,1,,BAO_0000218,8170,Distribution in female dog muscle 24 hours after administration.,1,,Muscle tissue,Canis lupus familiaris,Intermediate,,,12859,9615.0
,N,50588,,,,A,2385.0,CHEMBL624038,1,,BAO_0000218,8170,Distribution in female dog muscle 72 hours after administration.,1,,Muscle tissue,Canis lupus familiaris,Intermediate,,,12860,9615.0
,N,50588,,,,A,,CHEMBL624039,1,,BAO_0000218,8170,Distribution in female dog pancreas 24 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12861,9615.0
,N,50588,,,,A,,CHEMBL624040,1,,BAO_0000218,8170,Distribution in female dog pancreas 72 hours after administration.,1,,,Canis lupus familiaris,Intermediate,,,12862,9615.0
,N,50588,,,,A,160.0,CHEMBL624041,1,,BAO_0000218,8170,Distribution in female dog small intestine 24 hours after administration.,1,,Intestine,Canis lupus familiaris,Intermediate,,,12863,9615.0
,N,50588,,,,A,160.0,CHEMBL624042,1,,BAO_0000218,8170,Distribution in female dog small intestine 72 hours after administration.,1,,Intestine,Canis lupus familiaris,Intermediate,,,12864,9615.0
,N,50588,,,,A,2106.0,CHEMBL624043,1,,BAO_0000218,8170,Distribution in female dog spleen 24 hours after administration.,1,,Spleen,Canis lupus familiaris,Intermediate,,,12865,9615.0
,N,50588,,,,A,2106.0,CHEMBL624044,1,,BAO_0000218,8170,Distribution in female dog spleen 72 hours after administration.,1,,Spleen,Canis lupus familiaris,Intermediate,,,12866,9615.0
,N,50588,,,,A,945.0,CHEMBL624045,1,,BAO_0000218,8170,Distribution in female dog stomach 24 hours after administration.,1,,Stomach,Canis lupus familiaris,Intermediate,,,12867,9615.0
,N,50588,,,,A,945.0,CHEMBL624046,1,,BAO_0000218,8170,Distribution in female dog stomach 72 hours after administration.,1,,Stomach,Canis lupus familiaris,Intermediate,,,12868,9615.0
,N,50588,,,,A,2046.0,CHEMBL624047,1,,BAO_0000218,8170,Distribution in female dog thyroid 24 hours after administration.,1,,Thyroid gland,Canis lupus familiaris,Intermediate,,,12869,9615.0
,N,50588,,,,A,2046.0,CHEMBL624048,1,,BAO_0000218,8170,Distribution in female dog thyroid 72 hours after administration.,1,,Thyroid gland,Canis lupus familiaris,Intermediate,,,12870,9615.0
,N,50588,,,,A,1088.0,CHEMBL874408,1,,BAO_0000218,8170,Distribution in female dog urine 24 hours after administration.,1,,Urine,Canis lupus familiaris,Intermediate,,,12871,9615.0
,N,50588,,,,A,1088.0,CHEMBL624049,1,,BAO_0000218,8170,Distribution in female dog urine 72 hr after administration.,1,,Urine,Canis lupus familiaris,Intermediate,,,12872,9615.0
,U,22224,,,,A,1969.0,CHEMBL624050,0,,BAO_0000218,14283,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,1,,Plasma,,Autocuration,,,12873,
,U,22224,,,,A,,CHEMBL624051,0,,BAO_0000019,5623,Plasma concentration at 7 hr after intravenous dosing,1,,,,Autocuration,,,12874,
,N,50597,,,,A,,CHEMBL623278,1,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,1,,,Rattus norvegicus,Intermediate,,,12875,10116.0
,N,50597,,,,A,,CHEMBL623279,1,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,1,,,Rattus norvegicus,Intermediate,,,12876,10116.0
,N,50597,,,,A,,CHEMBL623280,1,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 1 hr in rats,1,,,Rattus norvegicus,Intermediate,,,12877,10116.0
,N,50597,,,,A,,CHEMBL623963,1,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 2 hr in rats,1,,,Rattus norvegicus,Intermediate,,,12878,10116.0
,N,50597,,,,A,,CHEMBL623964,1,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 4 hr in rats,1,,,Rattus norvegicus,Intermediate,,,12879,10116.0
,N,50597,,,,A,,CHEMBL623965,1,,BAO_0000218,13477,Plasma concentration of 3 mg/kg iv after 6 hr in rats,1,,,Rattus norvegicus,Intermediate,,,12880,10116.0
,N,50597,,,,A,,CHEMBL623966,1,,BAO_0000218,13477,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,1,,,Rattus norvegicus,Intermediate,,,12881,10116.0
,N,50597,,,,A,,CHEMBL874415,1,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,1,,,Rattus norvegicus,Intermediate,,,12882,10116.0
,N,50597,,,,A,,CHEMBL623967,1,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,1,,,Rattus norvegicus,Intermediate,,,12883,10116.0
,N,50597,,,,A,,CHEMBL623968,1,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,1,,,Rattus norvegicus,Intermediate,,,12884,10116.0
,N,50597,,,,A,,CHEMBL623969,1,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,1,,,Rattus norvegicus,Intermediate,,,12885,10116.0
,N,50597,,,,A,,CHEMBL628409,1,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,1,,,Rattus norvegicus,Intermediate,,,12886,10116.0
,N,50597,,,,A,,CHEMBL628410,1,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,1,,,Rattus norvegicus,Intermediate,,,12887,10116.0
,N,50597,,,,A,,CHEMBL628411,1,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,1,,,Rattus norvegicus,Intermediate,,,12888,10116.0
,N,50597,,,,A,,CHEMBL628412,1,,BAO_0000218,13477,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,1,,,Rattus norvegicus,Intermediate,,,12889,10116.0
,U,22224,,,,A,,CHEMBL628413,0,,BAO_0000019,12553,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,1,,,,Autocuration,,,12890,
,U,22224,,,,A,1969.0,CHEMBL628414,0,,BAO_0000019,14548,The concentration in plasmat; Not determined,1,,Plasma,,Autocuration,,,12891,
,N,50597,,,,A,,CHEMBL628415,1,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in blood,1,,,Rattus norvegicus,Intermediate,,,12892,10116.0
,N,50597,,,,A,,CHEMBL628416,1,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in brown fat,1,,,Rattus norvegicus,Intermediate,,,12893,10116.0
,N,50597,,,,A,,CHEMBL628417,1,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in heart,1,,,Rattus norvegicus,Intermediate,,,12894,10116.0
,N,50597,,,,A,2107.0,CHEMBL874908,1,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in liver,1,,Liver,Rattus norvegicus,Intermediate,,,12895,10116.0
,N,50597,,,,A,,CHEMBL628418,1,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in plasma,1,,,Rattus norvegicus,Intermediate,,,12896,10116.0
,N,50597,,,,A,2385.0,CHEMBL628419,1,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,12897,10116.0
,N,50597,,,,A,,CHEMBL628420,1,,BAO_0000218,14393,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,1,,,Rattus norvegicus,Intermediate,,,12898,10116.0
,U,22224,,,,A,,CHEMBL628421,0,,BAO_0000019,1629,Water solubility at 37 degree C.,1,,,,Autocuration,,,12899,
,U,22229,,,,P,,CHEMBL626726,0,,BAO_0000100,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,1,,,,Autocuration,,,12900,
,U,22229,,,,P,,CHEMBL626727,0,,BAO_0000100,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,1,,,,Autocuration,,,12901,
,N,50597,,,,A,178.0,CHEMBL626728,1,,BAO_0000218,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12902,10116.0
,N,50597,,,,A,178.0,CHEMBL626729,1,,BAO_0000218,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12903,10116.0
,N,50597,,,,A,178.0,CHEMBL626730,1,,BAO_0000218,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12904,10116.0
,N,50597,,,,A,178.0,CHEMBL626731,1,,BAO_0000218,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12905,10116.0
,N,50597,,,,A,178.0,CHEMBL626732,1,,BAO_0000218,8594,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,Blood,Rattus norvegicus,Intermediate,,,12906,10116.0
,N,50597,,,,A,948.0,CHEMBL626733,1,,BAO_0000218,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12907,10116.0
,N,50597,,,,A,948.0,CHEMBL626734,1,,BAO_0000218,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12908,10116.0
,N,50597,,,,A,948.0,CHEMBL626735,1,,BAO_0000218,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12909,10116.0
,N,50597,,,,A,948.0,CHEMBL874909,1,,BAO_0000218,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12910,10116.0
,N,50597,,,,A,948.0,CHEMBL626736,1,,BAO_0000218,8594,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,Heart,Rattus norvegicus,Intermediate,,,12911,10116.0
,N,50597,,,,A,2113.0,CHEMBL626737,1,,BAO_0000218,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12912,10116.0
,N,50597,,,,A,2113.0,CHEMBL630999,1,,BAO_0000218,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12913,10116.0
,N,50597,,,,A,2113.0,CHEMBL631000,1,,BAO_0000218,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12914,10116.0
,N,50597,,,,A,2113.0,CHEMBL631001,1,,BAO_0000218,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12915,10116.0
,N,50597,,,,A,2113.0,CHEMBL631002,1,,BAO_0000218,8594,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,Kidney,Rattus norvegicus,Intermediate,,,12916,10116.0
,N,50597,,,,A,2107.0,CHEMBL631003,1,,BAO_0000218,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12917,10116.0
,N,50597,,,,A,2107.0,CHEMBL631004,1,,BAO_0000218,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12918,10116.0
,N,50597,,,,A,2107.0,CHEMBL631005,1,,BAO_0000218,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12919,10116.0
,N,50597,,,,A,2107.0,CHEMBL631006,1,,BAO_0000218,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12920,10116.0
,N,50597,,,,A,2107.0,CHEMBL631007,1,,BAO_0000218,8594,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,Liver,Rattus norvegicus,Intermediate,,,12921,10116.0
,N,50597,,,,A,2048.0,CHEMBL631008,1,,BAO_0000218,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12922,10116.0
,N,50597,,,,A,2048.0,CHEMBL631009,1,,BAO_0000218,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12923,10116.0
,N,50597,,,,A,2048.0,CHEMBL631010,1,,BAO_0000218,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12924,10116.0
,N,50597,,,,A,2048.0,CHEMBL631011,1,,BAO_0000218,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12925,10116.0
,N,50597,,,,A,2048.0,CHEMBL631012,1,,BAO_0000218,8594,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,Lung,Rattus norvegicus,Intermediate,,,12926,10116.0
,N,50597,,,,A,2046.0,CHEMBL630271,1,,BAO_0000218,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12927,10116.0
,N,50597,,,,A,2046.0,CHEMBL630272,1,,BAO_0000218,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12928,10116.0
,N,50597,,,,A,2046.0,CHEMBL630273,1,,BAO_0000218,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12929,10116.0
,N,50597,,,,A,2046.0,CHEMBL630274,1,,BAO_0000218,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12930,10116.0
,N,50597,,,,A,2046.0,CHEMBL630275,1,,BAO_0000218,8594,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,12931,10116.0
,N,50597,,,,A,,CHEMBL875782,1,,BAO_0000218,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12932,10116.0
,N,50597,,,,A,,CHEMBL630276,1,,BAO_0000218,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12933,10116.0
,N,50597,,,,A,,CHEMBL630277,1,,BAO_0000218,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12934,10116.0
,N,50597,,,,A,,CHEMBL630278,1,,BAO_0000218,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12935,10116.0
,N,50597,,,,A,,CHEMBL630279,1,,BAO_0000218,8594,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,1,,,Rattus norvegicus,Intermediate,,,12936,10116.0
,U,22224,,,,A,,CHEMBL630280,0,,BAO_0000019,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,1,,,,Autocuration,,,12937,
,U,22224,,,,A,,CHEMBL630281,0,,BAO_0000019,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,,,,Autocuration,,,12938,
,N,50592,,,,A,,CHEMBL630282,1,,BAO_0000218,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,1,,,Oryctolagus cuniculus,Intermediate,,,12939,9986.0
,N,50592,,,,A,,CHEMBL630283,1,,BAO_0000218,7132,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,1,,,Oryctolagus cuniculus,Intermediate,,,12940,9986.0
,U,22224,,,,A,,CHEMBL630284,0,,BAO_0000019,5797,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),1,,,,Autocuration,,,12941,
,U,22224,,,,A,,CHEMBL630285,0,,BAO_0000019,7849,Alkylating activity was determined,1,,,,Autocuration,,,12942,
,U,22224,,Microsomes,,A,,CHEMBL630286,0,,BAO_0000251,14220,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),1,,,,Autocuration,,,12943,
,N,50592,,,,A,,CHEMBL630069,1,,BAO_0000218,8650,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",1,,,Oryctolagus cuniculus,Intermediate,,,12944,9986.0
,N,50592,,,,A,,CHEMBL630070,1,,BAO_0000218,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",1,,,Oryctolagus cuniculus,Intermediate,,,12945,9986.0
,N,50592,,,,A,,CHEMBL630071,1,,BAO_0000218,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",1,,,Oryctolagus cuniculus,Intermediate,,,12946,9986.0
,N,50592,,,,A,,CHEMBL630072,1,,BAO_0000218,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",1,,,Oryctolagus cuniculus,Intermediate,,,12947,9986.0
,N,50592,,,,A,,CHEMBL875110,1,,BAO_0000218,8650,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",1,,,Oryctolagus cuniculus,Intermediate,,,12948,9986.0
,N,50597,,,,A,,CHEMBL630073,1,,BAO_0000218,7116,Compound was tested for antidiuretic activity in rats,1,,,Rattus norvegicus,Intermediate,,,12949,10116.0
,U,22224,,,,A,,CHEMBL630074,0,,BAO_0000019,14131,Compound was tested for inactivation kinetic values,1,,,,Autocuration,,,12950,
,U,22224,,,In vivo,A,,CHEMBL630075,0,,BAO_0000218,7415,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,1,,,,Autocuration,,,12951,
,U,22224,,,,A,,CHEMBL630076,0,,BAO_0000019,13178,Dissociation rate calculated from the first-order equation using the t1/2 value,1,,,,Autocuration,,,12952,
,U,22229,,,,P,,CHEMBL630077,0,,BAO_0000100,8815,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,1,,,,Autocuration,,,12953,
,U,22229,,,,P,,CHEMBL630078,0,,BAO_0000100,1450,Aqueous solubility was measured,1,,,,Autocuration,,,12954,
,U,22229,,,,P,,CHEMBL630079,0,,BAO_0000100,1450,Aqueous solubility was measured at a pH 4,1,,,,Autocuration,,,12955,
,U,22229,,,,P,,CHEMBL630080,0,,BAO_0000100,1450,Aqueous solubility (pH 7),1,,,,Autocuration,,,12956,
,U,22229,,,,P,,CHEMBL630081,0,,BAO_0000100,1450,Aqueous solubility was measured at a pH 9,1,,,,Autocuration,,,12957,
,U,22224,,,,A,,CHEMBL630082,0,,BAO_0000019,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",1,,,,Autocuration,,,12958,
,U,22224,,,,A,,CHEMBL630083,0,,BAO_0000019,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",1,,,,Autocuration,,,12959,
,U,22224,,,,A,,CHEMBL630084,0,,BAO_0000019,12711,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",1,,,,Autocuration,,,12960,
,U,22229,,,,P,,CHEMBL629198,0,,BAO_0000100,15032,Aqueous solubility of the compound,1,,,,Autocuration,,,12961,
,U,22229,,,,P,,CHEMBL629199,0,,BAO_0000100,9964,Aqueous solubility at 37 degree Celsius at pH 7.38,1,,,,Autocuration,,,12962,
,U,22229,,,,P,,CHEMBL629200,0,,BAO_0000100,14962,Aqueous solubility in pH 7.4 phosphate buffer,1,,,,Autocuration,,,12963,
,N,50588,,,,A,,CHEMBL629201,1,,BAO_0000218,12487,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,1,,,Canis lupus familiaris,Intermediate,,,12964,9615.0
,N,50588,,,,A,,CHEMBL629202,1,,BAO_0000218,12487,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,1,,,Canis lupus familiaris,Intermediate,,,12965,9615.0
,N,50587,,,,A,,CHEMBL875111,1,,BAO_0000218,10026,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,1,,,Homo sapiens,Intermediate,,,12966,9606.0
,N,50587,,,,A,,CHEMBL629203,1,,BAO_0000218,10026,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,1,,,Homo sapiens,Intermediate,,,12967,9606.0
,N,50587,,,,A,,CHEMBL629204,1,,BAO_0000218,10026,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,1,,,Homo sapiens,Intermediate,,,12968,9606.0
,N,50587,,,,A,,CHEMBL629205,1,,BAO_0000218,10026,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,1,,,Homo sapiens,Intermediate,,,12969,9606.0
,N,50587,,,,A,,CHEMBL629206,1,,BAO_0000218,10026,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,1,,,Homo sapiens,Intermediate,,,12970,9606.0
,U,22224,,,,A,,CHEMBL631185,0,,BAO_0000019,10026,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,1,,,,Autocuration,,,12971,
,N,50597,,,,A,,CHEMBL631186,1,,BAO_0000218,7415,Compound was evaluated for the average bile flow rat in rats,1,,,Rattus norvegicus,Intermediate,,,12972,10116.0
,N,50592,,,,A,,CHEMBL631187,1,,BAO_0000218,17025,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",1,,,Oryctolagus cuniculus,Intermediate,,,12973,9986.0
,N,50592,,,,A,,CHEMBL631188,1,,BAO_0000218,17025,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",1,,,Oryctolagus cuniculus,Intermediate,,,12974,9986.0
,U,22224,,,,A,,CHEMBL876419,0,,BAO_0000019,10184,Average half life period was determined,1,,,,Autocuration,,,12975,
,U,22224,,,,A,,CHEMBL631189,0,,BAO_0000019,10184,Average half life period was determined,1,,,,Autocuration,,,12976,
,N,50602,,,,A,,CHEMBL631190,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,1,,,Human herpesvirus 1,Intermediate,,,12977,10298.0
,N,50602,,,,A,,CHEMBL631191,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,1,,,Human herpesvirus 1,Intermediate,,,12978,10298.0
,N,50602,,,,A,,CHEMBL631192,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,1,,,Human herpesvirus 1,Intermediate,,,12979,10298.0
,N,50602,,,,A,,CHEMBL632400,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,1,,,Human herpesvirus 1,Intermediate,,,12980,10298.0
,N,50602,,,,A,,CHEMBL630564,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,1,,,Human herpesvirus 1,Intermediate,,,12981,10298.0
,N,50602,,,,A,,CHEMBL630565,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,1,,,Human herpesvirus 1,Intermediate,,,12982,10298.0
,N,50602,,,,A,,CHEMBL630566,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,1,,,Human herpesvirus 1,Intermediate,,,12983,10298.0
,N,50602,,,,A,,CHEMBL631229,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,1,,,Human herpesvirus 1,Intermediate,,,12984,10298.0
,N,50602,,,,A,,CHEMBL631230,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,1,,,Human herpesvirus 1,Intermediate,,,12985,10298.0
,U,22229,,,,P,,CHEMBL876428,0,,BAO_0000100,6030,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12986,
,U,22229,,,,P,,CHEMBL631231,0,,BAO_0000100,6147,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12987,
,U,22229,,,,P,,CHEMBL631232,0,,BAO_0000100,14556,Calculated partition coefficient (clogP) (MacLogP),1,,,,Autocuration,,,12988,
,U,22224,,,,A,,CHEMBL631233,0,,BAO_0000019,768,Hydrophilicity was determined,1,,,,Autocuration,,,12989,
,U,22229,,,,P,,CHEMBL631234,0,,BAO_0000100,14452,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12990,
,U,22224,,,,A,,CHEMBL883126,0,,BAO_0000019,5237,Increased absorption was determined,1,,,,Autocuration,,,12991,
,U,22224,,,,P,,CHEMBL631235,0,,BAO_0000100,14378,Lipophilicity value was evaluated,1,,,,Autocuration,,,12992,
,U,22224,,,,P,,CHEMBL631236,0,,BAO_0000100,14418,Log P value of the compound.,1,,,,Autocuration,,,12993,
,U,22224,,,,A,,CHEMBL631237,0,,BAO_0000019,5249,Partition coefficient of compound was determined,1,,,,Autocuration,,,12994,
,U,22229,,,,P,,CHEMBL631238,0,,BAO_0000100,14621,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12995,
,U,22229,,,,P,,CHEMBL876429,0,,BAO_0000100,12542,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12996,
,U,22224,,,,A,,CHEMBL631414,0,,BAO_0000019,12542,Partition coefficient was measured by medchem software; Not calculated,1,,,,Autocuration,,,12997,
,U,22224,,,,P,,CHEMBL631415,0,,BAO_0000100,12542,Partition coefficient was measured by octanol-water using standard shake-flask method,1,,,,Autocuration,,,12998,
,U,22229,,,,P,,CHEMBL631416,0,,BAO_0000100,15462,Calculated partition coefficient (clogP),1,,,,Autocuration,,,12999,
,U,22224,,,,A,,CHEMBL631417,0,,BAO_0000019,14884,Partition coefficient (logP),1,,,,Autocuration,,,13000,
,U,22229,,,,P,,CHEMBL631418,0,,BAO_0000100,16526,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13001,
,U,22229,,,,P,,CHEMBL631419,0,,BAO_0000100,13693,The Octanol/Water partition coefficient CLogP,1,,,,Autocuration,,,13002,
,U,22224,,,,A,,CHEMBL631420,0,,BAO_0000019,13693,The pharmacokinetic parameter C Log p was reported,1,,,,Autocuration,,,13003,
,U,22229,,,,P,,CHEMBL631421,0,,BAO_0000100,13779,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13004,
,U,22229,,,,P,,CHEMBL631422,0,,BAO_0000100,14772,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13005,
,U,22229,,,,P,,CHEMBL631423,0,,BAO_0000100,14393,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13006,
,N,50597,,,In vivo,A,1969.0,CHEMBL876430,1,,BAO_0000218,14793,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,13007,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL631424,1,,BAO_0000218,14793,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,13008,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL631425,1,,BAO_0000218,13744,Compound was administered intravenously in dog to evaluate plasma clearance values,1,,Plasma,Canis lupus familiaris,Intermediate,,,13009,9615.0
,U,22224,,,In vivo,A,1969.0,CHEMBL631426,0,,BAO_0000218,13744,Compound was administered intravenously in monkey to evaluate plasma clearance values,1,,Plasma,Simiiformes,Autocuration,,,13010,314293.0
,N,50594,,,In vivo,A,1969.0,CHEMBL631427,1,,BAO_0000218,13744,Compound was administered intravenously in mouse to evaluate plasma clearance values,1,,Plasma,Mus musculus,Intermediate,,,13011,10090.0
,N,50588,,,In vivo,A,1969.0,CHEMBL631428,1,,BAO_0000218,13207,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,1,,Plasma,Canis lupus familiaris,Intermediate,,,13012,9615.0
,N,50797,,Microsomes,In vitro,A,2107.0,CHEMBL631429,1,,BAO_0000218,5669,Intrinsic clearance in Rhesus liver microsome,1,,Liver,Macaca mulatta,Intermediate,,,13013,9544.0
,N,50588,,Microsomes,In vitro,A,2107.0,CHEMBL631430,1,,BAO_0000218,5669,Intrinsic clearance in dog liver microsome,1,,Liver,Canis lupus familiaris,Intermediate,,,13014,9615.0
,N,50597,,Microsomes,In vitro,A,2107.0,CHEMBL631431,1,,BAO_0000218,5669,Intrinsic clearance in rat liver microsome,1,,Liver,Rattus norvegicus,Intermediate,,,13015,10116.0
,N,50797,,,In vivo,A,1969.0,CHEMBL631432,1,,BAO_0000218,4853,Low plasma clearance was calculated in rhesus monkey,1,,Plasma,Macaca mulatta,Intermediate,,,13016,9544.0
,N,50588,,,In vivo,A,,CHEMBL631433,1,,BAO_0000218,16452,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,1,,,Canis lupus familiaris,Intermediate,,,13017,9615.0
,U,22224,,,In vivo,A,,CHEMBL631434,0,,BAO_0000218,11954,Plasma clearance after intravenous dose of 0.3 mg/kg,1,,,,Autocuration,,,13018,
,U,22224,,,In vivo,A,,CHEMBL631435,0,,BAO_0000218,11954,Plasma clearance after intravenous dose of 1 mg/kg,1,,,,Autocuration,,,13019,
,U,22224,,,In vivo,A,,CHEMBL631436,0,,BAO_0000218,11954,Plasma clearance after intravenous dose of 3 mg/kg,1,,,,Autocuration,,,13020,
,U,22224,,,In vivo,A,,CHEMBL631437,0,,BAO_0000218,11954,Plasma clearance after intravenous dose of 3.87 mg/kg,1,,,,Autocuration,,,13021,
,N,50597,,,In vivo,A,,CHEMBL631438,1,,BAO_0000218,5669,Plasma clearance after peroral administration at 10 mpk in Rat,1,,,Rattus norvegicus,Intermediate,,,13022,10116.0
,N,50797,,,In vivo,A,,CHEMBL876431,1,,BAO_0000218,5669,Plasma clearance after peroral administration at 10 mpk in Rhesus,1,,,Macaca mulatta,Intermediate,,,13023,9544.0
,N,50588,,,In vivo,A,,CHEMBL631439,1,,BAO_0000218,5669,Plasma clearance after peroral administration at 10 mpk in dog,1,,,Canis lupus familiaris,Intermediate,,,13024,9615.0
,N,50597,,,In vivo,A,,CHEMBL631440,1,,BAO_0000218,13662,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,1,,,Rattus norvegicus,Intermediate,,,13025,10116.0
,U,22224,,,,A,,CHEMBL631441,0,,BAO_0000019,8272,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),1,,,,Autocuration,,,13026,
,U,22224,,,,A,,CHEMBL631442,0,,BAO_0000019,13410,Critical Micellar concentration was determined,1,,,,Autocuration,,,13027,
,U,22224,,,,A,,CHEMBL626525,0,,BAO_0000019,13410,Critical Micellar concentration of the compound. was determined,1,,,,Autocuration,,,13028,
,U,22224,,,,A,,CHEMBL627168,0,,BAO_0000019,12628,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,1,,,,Autocuration,,,13029,
,U,22224,,,,A,,CHEMBL875618,0,,BAO_0000019,9675,Critical micellar concentration was measured in water by the dye solubilization method,1,,,,Autocuration,,,13030,
,U,22224,,,,B,,CHEMBL626612,0,,BAO_0000019,12628,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,1,,,,Autocuration,,,13031,
,U,22224,,,,A,,CHEMBL626613,0,,BAO_0000019,12766,CMR value (relative to BAY K 8644),1,,,,Autocuration,,,13032,
,U,22224,,,,A,,CHEMBL626614,0,,BAO_0000019,7849,Carbamoylating activity was determined,1,,,,Autocuration,,,13033,
,U,22224,,,,A,,CHEMBL626615,0,,BAO_0000218,12187,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,1,,,Simiiformes,Autocuration,,,13034,314293.0
,U,22224,,,,A,,CHEMBL626616,0,,BAO_0000019,2040,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,1,,,,Autocuration,,,13035,
,U,22224,,,,A,,CHEMBL626617,0,,BAO_0000019,2040,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,1,,,,Autocuration,,,13036,
,N,50588,,,In vivo,A,1969.0,CHEMBL626618,1,,BAO_0000218,14180,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,1,,Plasma,Canis lupus familiaris,Intermediate,,,13037,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626619,1,,BAO_0000218,14180,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,1,,Plasma,Rattus norvegicus,Intermediate,,,13038,10116.0
,N,50588,,,In vivo,A,,CHEMBL626620,1,,BAO_0000218,14474,"Clearance rate at 0.46 mg/kg, iv, in dogs",1,,,Canis lupus familiaris,Intermediate,,,13039,9615.0
,N,50597,,,In vivo,A,,CHEMBL626621,1,,BAO_0000218,14474,"Clearance rate at 5.5 mg/kg, iv, in rat",1,,,Rattus norvegicus,Intermediate,,,13040,10116.0
,N,100710,,,In vivo,A,,CHEMBL626622,1,,BAO_0000218,14548,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,1,,,Macaca fascicularis,Intermediate,,,13041,9541.0
,N,100710,,,In vivo,A,,CHEMBL626623,1,,BAO_0000218,14548,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,1,,,Macaca fascicularis,Intermediate,,,13042,9541.0
,N,50588,,,In vivo,A,,CHEMBL626624,1,,BAO_0000218,14548,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,1,,,Canis lupus familiaris,Intermediate,,,13043,9615.0
,N,50597,,,In vivo,A,,CHEMBL626625,1,,BAO_0000218,14548,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,13044,10116.0
,N,50597,,,Ex vivo,A,2107.0,CHEMBL626626,1,,BAO_0000218,6125,Clearance rate constant using isolated perfused rat liver (IPRL) assay,1,,Liver,Rattus norvegicus,Intermediate,,,13045,10116.0
,U,22224,,,In vivo,A,,CHEMBL626627,0,,BAO_0000218,6874,Tested for the total clearance of the compound,1,,,,Autocuration,,,13046,
,N,50588,,,In vivo,A,,CHEMBL626628,1,,BAO_0000218,15343,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,1,,,Canis lupus familiaris,Intermediate,,,13047,9615.0
,U,22224,,,In vivo,A,,CHEMBL626629,0,,BAO_0000218,6236,Total body clearance was determined,1,,,,Autocuration,,,13048,
,N,50597,,,,A,,CHEMBL626630,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13049,10116.0
,N,50597,,,,A,,CHEMBL626631,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13050,10116.0
,U,22229,,,,P,,CHEMBL626632,0,,BAO_0000100,8194,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,1,,,,Autocuration,,,13051,
,U,22229,,,,P,,CHEMBL626633,0,,BAO_0000100,8194,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,1,,,,Autocuration,,,13052,
,U,22229,,,,P,,CHEMBL626634,0,,BAO_0000100,8194,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,1,,,,Autocuration,,,13053,
,U,22229,,,,P,,CHEMBL626635,0,,BAO_0000100,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,1,,,,Autocuration,,,13054,
,U,22229,,,,P,,CHEMBL626636,0,,BAO_0000100,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,1,,,,Autocuration,,,13055,
,U,22229,,,,P,,CHEMBL626637,0,,BAO_0000100,8194,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,1,,,,Autocuration,,,13056,
,N,50339,,,,A,,CHEMBL626638,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),1,,,Pneumocystis carinii,Intermediate,,,13057,4754.0
,N,50339,,,,A,,CHEMBL626639,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,1,,,Pneumocystis carinii,Intermediate,,,13058,4754.0
,N,50339,,,,A,,CHEMBL626640,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,1,,,Pneumocystis carinii,Intermediate,,,13059,4754.0
,N,50339,,,,A,,CHEMBL626641,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,1,,,Pneumocystis carinii,Intermediate,,,13060,4754.0
,N,50339,,,,A,,CHEMBL627272,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,1,,,Pneumocystis carinii,Intermediate,,,13061,4754.0
,N,50339,,,,A,,CHEMBL627273,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,1,,,Pneumocystis carinii,Intermediate,,,13062,4754.0
,N,50339,,,,A,,CHEMBL627441,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),1,,,Pneumocystis carinii,Intermediate,,,13063,4754.0
,N,50339,,,,A,,CHEMBL628355,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),1,,,Pneumocystis carinii,Intermediate,,,13064,4754.0
,N,50339,,,,A,,CHEMBL628356,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),1,,,Pneumocystis carinii,Intermediate,,,13065,4754.0
,N,50339,,,,A,,CHEMBL628357,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),1,,,Pneumocystis carinii,Intermediate,,,13066,4754.0
,N,50339,,,,A,,CHEMBL628358,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),1,,,Pneumocystis carinii,Intermediate,,,13067,4754.0
,N,50339,,,,A,,CHEMBL622307,1,,BAO_0000218,13273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),1,,,Pneumocystis carinii,Intermediate,,,13068,4754.0
,U,22224,,,,A,,CHEMBL622527,0,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,1,,,,Autocuration,,,13069,
,U,22224,,,,A,,CHEMBL622528,0,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,1,,,,Autocuration,,,13070,
,U,22224,,,,A,,CHEMBL622529,0,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,1,,,,Autocuration,,,13071,
,U,22224,,,,A,,CHEMBL622992,0,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,1,,,,Autocuration,,,13072,
,U,22224,,,,A,,CHEMBL622993,0,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,1,,,,Autocuration,,,13073,
,U,22224,,,,A,,CHEMBL622994,0,,BAO_0000019,13118,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,1,,,,Autocuration,,,13074,
,N,50597,,,,A,,CHEMBL622995,1,,BAO_0000218,10633,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",1,,,Rattus norvegicus,Intermediate,,,13075,10116.0
,N,50597,,,,A,,CHEMBL622996,1,,BAO_0000218,10633,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",1,,,Rattus norvegicus,Intermediate,,,13076,10116.0
,N,50597,,,,A,,CHEMBL622997,1,,BAO_0000218,10633,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",1,,,Rattus norvegicus,Intermediate,,,13077,10116.0
,N,50597,,,,A,,CHEMBL622998,1,,BAO_0000218,10633,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",1,,,Rattus norvegicus,Intermediate,,,13078,10116.0
,U,22224,,,,A,,CHEMBL622999,0,,BAO_0000218,5767,Cp max following ip administration at 1 mg/kg,1,,,,Autocuration,,,13079,
,U,22224,,,In vivo,A,1969.0,CHEMBL623000,0,,BAO_0000218,3302,Maximum concentration in plasma was reported at 0.5 hour,1,,Plasma,,Autocuration,,,13080,
,U,22224,,,In vivo,A,1969.0,CHEMBL623001,0,,BAO_0000218,3302,Maximum concentration in plasma was reported at 2 hour,1,,Plasma,,Autocuration,,,13081,
,N,50594,,,,A,,CHEMBL623002,1,,BAO_0000218,12467,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,1,,,Mus musculus,Intermediate,,,13082,10090.0
,U,22229,,,,P,,CHEMBL623003,0,,BAO_0000100,11778,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),1,,,,Autocuration,,,13083,
,U,22224,,,,A,,CHEMBL623004,0,,BAO_0000019,4321,Steady state concentration was evaluated,1,,,,Autocuration,,,13084,
,U,22224,,,,A,,CHEMBL623005,0,,BAO_0000019,14884,Partition coefficient (logP),1,,,,Autocuration,,,13085,
,U,22224,,,,A,,CHEMBL623006,0,,BAO_0000019,15234,Partition coefficient (logD7.4),1,,,,Autocuration,,,13086,
,N,50597,,,In vivo,A,2107.0,CHEMBL623007,1,,BAO_0000218,14198,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,1,,Liver,Rattus norvegicus,Intermediate,,,13087,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL623008,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,1,,Bone,Rattus norvegicus,Intermediate,,,13088,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL876654,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13089,10116.0
,N,50597,,,In vivo,A,,CHEMBL623009,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13090,10116.0
,N,50597,,,In vivo,A,,CHEMBL623010,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13091,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL623011,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,1,,Heart,Rattus norvegicus,Intermediate,,,13092,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL623012,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,1,,Intestine,Rattus norvegicus,Intermediate,,,13093,10116.0
,U,22224,,,,A,,CHEMBL623013,0,,BAO_0000019,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,1,,,,Autocuration,,,13094,
,U,22224,,,,A,,CHEMBL623014,0,,BAO_0000019,8151,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,,,,Autocuration,,,13095,
,U,22224,,,,A,1088.0,CHEMBL623015,0,,BAO_0000019,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,1,,Urine,,Autocuration,,,13096,
,U,22224,,,,A,1088.0,CHEMBL623016,0,,BAO_0000019,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,1,,Urine,,Autocuration,,,13097,
,U,22224,,,,A,1088.0,CHEMBL624858,0,,BAO_0000019,8151,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,1,,Urine,,Autocuration,,,13098,
,N,50597,,,,A,,CHEMBL624859,1,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,1,,,Rattus norvegicus,Intermediate,,,13099,10116.0
,N,50597,,,,A,,CHEMBL624860,1,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,13100,10116.0
,N,50597,,,,A,,CHEMBL624861,1,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,,,Rattus norvegicus,Intermediate,,,13101,10116.0
,N,50597,,,,A,,CHEMBL624862,1,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,1,,,Rattus norvegicus,Intermediate,,,13102,10116.0
,N,50597,,,,A,,CHEMBL624863,1,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,1,,,Rattus norvegicus,Intermediate,,,13103,10116.0
,N,50597,,,,A,,CHEMBL876655,1,,BAO_0000218,8151,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,1,,,Rattus norvegicus,Intermediate,,,13104,10116.0
,N,50588,,,,A,,CHEMBL624864,1,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,1,,,Canis lupus familiaris,Intermediate,,,13105,9615.0
,N,50588,,,,A,,CHEMBL624865,1,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,1,,,Canis lupus familiaris,Intermediate,,,13106,9615.0
,N,50588,,,,A,,CHEMBL624866,1,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,,,Canis lupus familiaris,Intermediate,,,13107,9615.0
,N,50588,,,,F,,CHEMBL624867,1,,BAO_0000218,6996,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,1,,,Canis lupus familiaris,Expert,,,13108,9615.0
,N,50588,,,,A,,CHEMBL624868,1,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,1,,,Canis lupus familiaris,Intermediate,,,13109,9615.0
,N,50588,,,,A,,CHEMBL628450,1,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,1,,,Canis lupus familiaris,Intermediate,,,13110,9615.0
,N,50588,,,,A,,CHEMBL628451,1,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,1,,,Canis lupus familiaris,Intermediate,,,13111,9615.0
,N,50588,,,,A,,CHEMBL628452,1,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,1,,,Canis lupus familiaris,Intermediate,,,13112,9615.0
,N,50588,,,,A,,CHEMBL628453,1,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,,,Canis lupus familiaris,Intermediate,,,13113,9615.0
,N,50588,,,,A,,CHEMBL628454,1,,BAO_0000218,6996,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,1,,,Canis lupus familiaris,Intermediate,,,13114,9615.0
,N,50588,,,,A,,CHEMBL628455,1,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,1,,,Canis lupus familiaris,Intermediate,,,13115,9615.0
,N,50588,,,,A,,CHEMBL628456,1,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,1,,,Canis lupus familiaris,Intermediate,,,13116,9615.0
,N,50588,,,,A,,CHEMBL628457,1,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,1,,,Canis lupus familiaris,Intermediate,,,13117,9615.0
,N,50588,,,,A,,CHEMBL877505,1,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,1,,,Canis lupus familiaris,Intermediate,,,13118,9615.0
,N,50588,,,,A,,CHEMBL628458,1,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,1,,,Canis lupus familiaris,Intermediate,,,13119,9615.0
,N,50588,,,,A,,CHEMBL628459,1,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,1,,,Canis lupus familiaris,Intermediate,,,13120,9615.0
,N,50588,,,,A,,CHEMBL628460,1,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,1,,,Canis lupus familiaris,Intermediate,,,13121,9615.0
,N,50588,,,,A,,CHEMBL628461,1,,BAO_0000218,6996,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,1,,,Canis lupus familiaris,Intermediate,,,13122,9615.0
,U,22224,,,,B,,CHEMBL628462,0,,BAO_0000218,6996,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",1,,,,Autocuration,,,13123,
,N,50588,,,,A,,CHEMBL628463,1,,BAO_0000218,6996,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,,Canis lupus familiaris,Intermediate,,,13124,9615.0
,N,50597,,,,F,,CHEMBL625666,1,,BAO_0000218,6996,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",1,,,Rattus norvegicus,Expert,,,13125,10116.0
,U,22224,,,,B,,CHEMBL625667,0,,BAO_0000218,6996,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,,,Autocuration,,,13126,
,N,50597,,,,A,,CHEMBL625668,1,,BAO_0000218,6996,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,,Rattus norvegicus,Expert,,,13127,10116.0
,N,50597,,,,A,,CHEMBL625669,1,,BAO_0000218,6996,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,1,,,Rattus norvegicus,Intermediate,,,13128,10116.0
,U,22224,,,,A,,CHEMBL625670,0,,BAO_0000019,7114,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,1,,,,Autocuration,,,13129,
,N,50597,,,,A,,CHEMBL625671,1,,BAO_0000218,7114,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,1,,,Rattus norvegicus,Intermediate,,,13130,10116.0
,N,50602,,,,A,,CHEMBL625672,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,1,,,Human herpesvirus 1,Intermediate,,,13131,10298.0
,N,50602,,,,A,,CHEMBL625673,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,1,,,Human herpesvirus 1,Intermediate,,,13132,10298.0
,N,50602,,,,A,,CHEMBL625674,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,1,,,Human herpesvirus 1,Intermediate,,,13133,10298.0
,N,50602,,,,A,,CHEMBL625675,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,1,,,Human herpesvirus 1,Intermediate,,,13134,10298.0
,N,50602,,,,A,,CHEMBL627637,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,1,,,Human herpesvirus 1,Intermediate,,,13135,10298.0
,N,50602,,,,A,,CHEMBL627638,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,1,,,Human herpesvirus 1,Intermediate,,,13136,10298.0
,N,50602,,,,A,,CHEMBL627639,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,1,,,Human herpesvirus 1,Intermediate,,,13137,10298.0
,N,50602,,,,A,,CHEMBL627640,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,1,,,Human herpesvirus 1,Intermediate,,,13138,10298.0
,N,50602,,,,A,,CHEMBL627641,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,1,,,Human herpesvirus 1,Intermediate,,,13139,10298.0
,N,50602,,,,A,,CHEMBL627642,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,1,,,Human herpesvirus 1,Intermediate,,,13140,10298.0
,N,50602,,,,A,,CHEMBL877506,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,1,,,Human herpesvirus 1,Intermediate,,,13141,10298.0
,N,50594,,,,A,,CHEMBL627275,1,,BAO_0000218,8613,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,1,,,Mus musculus,Intermediate,,,13142,10090.0
,N,50506,,,,A,,CHEMBL627643,1,,BAO_0000218,11219,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",1,,,Mustela putorius furo,Intermediate,,,13143,9669.0
,N,50506,,,,A,,CHEMBL631246,1,,BAO_0000218,11219,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",1,,,Mustela putorius furo,Intermediate,,,13144,9669.0
,N,50506,,,,A,,CHEMBL631247,1,,BAO_0000218,11219,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",1,,,Mustela putorius furo,Intermediate,,,13145,9669.0
,N,50506,,,,A,,CHEMBL629532,1,,BAO_0000218,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,1,,,Mustela putorius furo,Intermediate,,,13146,9669.0
,N,50506,,,,A,,CHEMBL629533,1,,BAO_0000218,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,1,,,Mustela putorius furo,Intermediate,,,13147,9669.0
,N,50506,,,,A,,CHEMBL629534,1,,BAO_0000218,11219,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,1,,,Mustela putorius furo,Intermediate,,,13148,9669.0
,N,50506,,,,A,,CHEMBL629535,1,,BAO_0000218,11219,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,1,,,Mustela putorius furo,Intermediate,,,13149,9669.0
,U,22224,,,,A,,CHEMBL625932,0,,BAO_0000019,14837,Pharmacokinetic parameter :drug bound to plasma was reported,1,,,,Autocuration,,,13150,
,U,22224,,,,A,,CHEMBL625933,0,,BAO_0000019,14837,compound was evaluated for drug bound in plasma,1,,,,Autocuration,,,13151,
,N,50597,,,,A,,CHEMBL625934,1,,BAO_0000218,15343,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,1,,,Rattus norvegicus,Intermediate,,,13152,10116.0
,U,22224,,,,A,,CHEMBL625935,0,,BAO_0000218,13761,Bioavailability,1,,,Eutheria,Autocuration,,,13153,9347.0
,N,50597,,,,A,,CHEMBL625936,1,,BAO_0000218,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,1,,,Rattus norvegicus,Intermediate,,,13154,10116.0
,N,50597,,,,A,,CHEMBL625937,1,,BAO_0000218,14810,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,1,,,Rattus norvegicus,Intermediate,,,13155,10116.0
,N,50588,,,,A,,CHEMBL625938,1,,BAO_0000218,13249,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,1,,,Canis lupus familiaris,Intermediate,,,13156,9615.0
,N,50597,,,,A,1970.0,CHEMBL625939,1,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,1,,Bile,Rattus norvegicus,Intermediate,,,13157,10116.0
,N,50597,,,,A,1970.0,CHEMBL625940,1,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,1,,Bile,Rattus norvegicus,Intermediate,,,13158,10116.0
,N,50597,,,,A,1970.0,CHEMBL874464,1,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,1,,Bile,Rattus norvegicus,Intermediate,,,13159,10116.0
,N,50597,,,,A,1970.0,CHEMBL625941,1,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,1,,Bile,Rattus norvegicus,Intermediate,,,13160,10116.0
,N,50597,,,,A,1970.0,CHEMBL625942,1,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,1,,Bile,Rattus norvegicus,Intermediate,,,13161,10116.0
,N,50597,,,,A,1970.0,CHEMBL625943,1,,BAO_0000218,9267,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,1,,Bile,Rattus norvegicus,Intermediate,,,13162,10116.0
,N,50587,,,,A,1977.0,CHEMBL625944,1,,BAO_0000218,15549,In vitro protein binding in human serum at 5 ug/ml,1,,Serum,Homo sapiens,Intermediate,,,13163,9606.0
,U,22224,,,,A,,CHEMBL625945,0,,BAO_0000019,10929,Serum protein binding ability was measured,1,,,,Autocuration,,,13164,
,U,22224,,,,A,,CHEMBL625946,0,,BAO_0000019,15444,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),1,,,,Autocuration,,,13165,
,U,22224,,,In vivo,A,,CHEMBL625947,0,,BAO_0000218,12860,Oral bioavailability in dog,1,,,Canis lupus familiaris,Autocuration,,,13166,9615.0
,N,50597,,,In vivo,A,,CHEMBL625948,1,,BAO_0000218,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,1,,,Rattus norvegicus,Intermediate,,,13167,10116.0
,U,22224,,,In vivo,A,,CHEMBL625949,0,,BAO_0000218,15173,Absolute oral bioavailability at an iv dose of 14 mg/kg,1,,,,Autocuration,,,13168,
,U,22224,,,In vivo,A,,CHEMBL625950,0,,BAO_0000218,15173,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,1,,,,Autocuration,,,13169,
,U,22224,,,In vivo,A,,CHEMBL625951,0,,BAO_0000218,15173,Oral bioavailability (dose 15 mg/kg i.v.),1,,,Eutheria,Autocuration,,,13170,9347.0
,U,22224,,,In vivo,A,,CHEMBL625952,0,,BAO_0000218,15173,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,1,,,,Autocuration,,,13171,
,U,22224,,,In vivo,A,,CHEMBL625953,0,,BAO_0000218,15173,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,1,,,,Autocuration,,,13172,
,U,22224,,,In vivo,A,,CHEMBL625954,0,,BAO_0000218,15173,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,1,,,,Autocuration,,,13173,
,U,22224,,,In vivo,A,,CHEMBL882959,0,,BAO_0000218,15173,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,1,,,,Autocuration,,,13174,
,N,50588,,,In vivo,A,,CHEMBL625955,1,,BAO_0000218,11767,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,1,,,Canis lupus familiaris,Intermediate,,,13175,9615.0
,U,22224,,,In vivo,A,,CHEMBL625956,0,,BAO_0000218,11219,Bioavailability in ferret,1,,,Mustela putorius furo,Autocuration,,,13176,9669.0
,N,100710,,,In vivo,A,,CHEMBL625957,1,,BAO_0000218,12186,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,1,,,Macaca fascicularis,Intermediate,,,13177,9541.0
,N,50597,,,,A,,CHEMBL625958,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13178,10116.0
,N,50597,,,,A,,CHEMBL625959,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13179,10116.0
,N,50597,,,,A,,CHEMBL626642,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13180,10116.0
,N,50597,,,,A,,CHEMBL631330,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13181,10116.0
,N,50597,,,,A,,CHEMBL631331,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13182,10116.0
,N,50597,,,,A,,CHEMBL631332,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,,,Rattus norvegicus,Intermediate,,,13183,10116.0
,N,50597,,,,A,,CHEMBL631333,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13184,10116.0
,N,50597,,,,A,,CHEMBL632018,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13185,10116.0
,N,50597,,,,A,,CHEMBL632019,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13186,10116.0
,N,50597,,,,A,,CHEMBL632020,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13187,10116.0
,N,50597,,,,A,,CHEMBL632021,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13188,10116.0
,N,50597,,,,A,,CHEMBL632022,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13189,10116.0
,N,50597,,,,A,,CHEMBL632023,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13190,10116.0
,N,50597,,,,A,,CHEMBL632024,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13191,10116.0
,N,50597,,,,A,,CHEMBL874472,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13192,10116.0
,N,50597,,,,A,,CHEMBL632025,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13193,10116.0
,N,50597,,,,A,,CHEMBL632026,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13194,10116.0
,N,50597,,,,A,,CHEMBL632027,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13195,10116.0
,N,50597,,,,A,,CHEMBL632028,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13196,10116.0
,N,50597,,,,A,,CHEMBL626430,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13197,10116.0
,N,50597,,,,A,,CHEMBL626431,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13198,10116.0
,N,50597,,,,A,,CHEMBL626432,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13199,10116.0
,N,50597,,,,A,,CHEMBL626433,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13200,10116.0
,N,50597,,,,A,,CHEMBL626434,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13201,10116.0
,N,50597,,,,A,,CHEMBL627280,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13202,10116.0
,N,50597,,,,A,,CHEMBL627281,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13203,10116.0
,N,50597,,,,A,,CHEMBL627282,1,,BAO_0000218,11510,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13204,10116.0
,U,22224,,,,A,,CHEMBL627283,0,,BAO_0000019,7199,Total body clearance was measured at given dose,1,,,,Autocuration,,,13205,
,U,22224,,,,A,,CHEMBL627284,0,,BAO_0000218,7199,Total body clearance was measured at given dose.,1,,,,Autocuration,,,13206,
,N,50597,,,,A,,CHEMBL627285,1,,BAO_0000218,7095,Metabolic clearance from the body in rat,1,,,Rattus norvegicus,Intermediate,,,13207,10116.0
,U,22224,,,In vivo,A,,CHEMBL627286,0,,BAO_0000218,7095,Renal clearance from the body,1,,,,Autocuration,,,13208,
,N,50597,,,In vivo,A,,CHEMBL875477,1,,BAO_0000218,7095,Renal clearance from the body in rat,1,,,Rattus norvegicus,Intermediate,,,13209,10116.0
,N,50597,,,In vivo,A,,CHEMBL627287,1,,BAO_0000218,12528,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,13210,10116.0
,N,50588,,,In vivo,A,,CHEMBL627288,1,,BAO_0000218,12528,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,1,,,Canis lupus familiaris,Intermediate,,,13211,9615.0
,N,50597,,,,A,,CHEMBL627289,1,,BAO_0000218,7095,Total clearance from the body in rat,1,,,Rattus norvegicus,Intermediate,,,13212,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627290,1,,BAO_0000218,14223,Clearance into cortex from rat plasma or PBS,1,,Plasma,Rattus norvegicus,Intermediate,,,13213,10116.0
,U,22224,,,In vivo,A,,CHEMBL627291,0,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,1,,,,Autocuration,,,13214,
,U,22224,,,In vivo,A,,CHEMBL627292,0,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,1,,,,Autocuration,,,13215,
,U,22224,,,In vivo,A,,CHEMBL627293,0,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,1,,,,Autocuration,,,13216,
,U,22224,,,In vivo,A,,CHEMBL627294,0,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,1,,,,Autocuration,,,13217,
,U,22224,,,In vivo,A,,CHEMBL875478,0,,BAO_0000218,13569,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,1,,,,Autocuration,,,13218,
,U,22224,,,In vivo,A,,CHEMBL627295,0,,BAO_0000218,13979,Clearance was determined,1,,,,Autocuration,,,13219,
,N,50594,,,In vivo,A,,CHEMBL627296,1,,BAO_0000218,14315,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,1,,,Mus musculus,Intermediate,,,13220,10090.0
,N,50592,,,In vivo,A,,CHEMBL626119,1,,BAO_0000218,14315,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,1,,,Oryctolagus cuniculus,Intermediate,,,13221,9986.0
,N,50597,,,In vivo,A,,CHEMBL626120,1,,BAO_0000218,14315,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,1,,,Rattus norvegicus,Intermediate,,,13222,10116.0
,N,50597,,,In vivo,A,,CHEMBL626121,1,,BAO_0000218,12174,Clearance in rat after iv dose (100 ug/kg),1,,,Rattus norvegicus,Intermediate,,,13223,10116.0
,U,22224,,,In vivo,A,,CHEMBL626122,0,,BAO_0000218,12797,Clearance in guinea pig,1,,,Cavia porcellus,Autocuration,,,13224,10141.0
,N,50597,,,In vivo,A,,CHEMBL626123,1,,BAO_0000218,12797,Compound was evaluated for clearance in rat,1,,,Rattus norvegicus,Intermediate,,,13225,10116.0
,N,50588,,,In vivo,A,,CHEMBL623456,1,,BAO_0000218,12797,Compound was evaluated for the clearance in dog,1,,,Canis lupus familiaris,Intermediate,,,13226,9615.0
,N,50597,,,In vivo,A,,CHEMBL623457,1,,BAO_0000218,12797,Compound was evaluated for the clearance in rat,1,,,Rattus norvegicus,Intermediate,,,13227,10116.0
,N,50597,,,In vivo,A,,CHEMBL623458,1,,BAO_0000218,11500,Compound was tested in vivo for clearance after iv administration in the rat,1,,,Rattus norvegicus,Intermediate,,,13228,10116.0
,U,22224,,,In vivo,A,,CHEMBL623459,0,,BAO_0000218,15173,IV clearance determined at an iv dose of 14 mg/kg,1,,,,Autocuration,,,13229,
,U,22224,,,In vivo,A,,CHEMBL875484,0,,BAO_0000218,15173,IV clearance determined at an iv dose of 15.2 mg/kg,1,,,,Autocuration,,,13230,
,U,22224,,,In vivo,A,,CHEMBL623460,0,,BAO_0000218,15173,IV clearance determined at an iv dose of 15 mg/kg,1,,,,Autocuration,,,13231,
,U,22224,,,In vivo,A,,CHEMBL623461,0,,BAO_0000218,15173,IV clearance determined at an peroral dose of 30 mg/kg.,1,,,,Autocuration,,,13232,
,U,22224,,,In vivo,A,,CHEMBL623462,0,,BAO_0000218,15173,IV clearance determined at an peroral dose of 30.2 mg/kg.,1,,,,Autocuration,,,13233,
,U,22224,,,In vivo,A,,CHEMBL627386,0,,BAO_0000218,15173,IV clearance determined at an peroral dose of 30.3 mg/kg.,1,,,,Autocuration,,,13234,
,N,50597,,,In vivo,A,2113.0,CHEMBL627387,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,1,,Kidney,Rattus norvegicus,Intermediate,,,13235,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627388,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,1,,Liver,Rattus norvegicus,Intermediate,,,13236,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627389,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,1,,Lung,Rattus norvegicus,Intermediate,,,13237,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627390,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13238,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627391,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,1,,Plasma,Rattus norvegicus,Intermediate,,,13239,10116.0
,N,50597,,,In vivo,A,,CHEMBL627392,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13240,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL627393,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,1,,Spleen,Rattus norvegicus,Intermediate,,,13241,10116.0
,N,50597,,,In vivo,A,3126.0,CHEMBL627394,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,1,,Trachea,Rattus norvegicus,Intermediate,,,13242,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL627395,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,1,,Bone,Rattus norvegicus,Intermediate,,,13243,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL875485,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13244,10116.0
,N,50597,,,In vivo,A,,CHEMBL627396,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13245,10116.0
,N,50597,,,In vivo,A,,CHEMBL627397,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13246,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL627398,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,1,,Heart,Rattus norvegicus,Intermediate,,,13247,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL627399,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,1,,Bone,Rattus norvegicus,Intermediate,,,13248,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627400,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,1,,Kidney,Rattus norvegicus,Intermediate,,,13249,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627401,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,1,,Liver,Rattus norvegicus,Intermediate,,,13250,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627402,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,1,,Lung,Rattus norvegicus,Intermediate,,,13251,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL627403,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13252,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL627404,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,1,,Plasma,Rattus norvegicus,Intermediate,,,13253,10116.0
,N,50597,,,In vivo,A,,CHEMBL623101,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13254,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL877480,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,1,,Spleen,Rattus norvegicus,Intermediate,,,13255,10116.0
,N,50597,,,In vivo,A,3126.0,CHEMBL623102,1,,BAO_0000218,14198,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,1,,Trachea,Rattus norvegicus,Intermediate,,,13256,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL623103,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,1,,Bone,Rattus norvegicus,Intermediate,,,13257,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL623104,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13258,10116.0
,N,50597,,,In vivo,A,,CHEMBL623105,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13259,10116.0
,N,50597,,,In vivo,A,,CHEMBL623106,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13260,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL623107,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,1,,Heart,Rattus norvegicus,Intermediate,,,13261,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL623108,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,1,,Intestine,Rattus norvegicus,Intermediate,,,13262,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL623109,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,1,,Kidney,Rattus norvegicus,Intermediate,,,13263,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL623110,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,1,,Liver,Rattus norvegicus,Intermediate,,,13264,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL623111,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,1,,Lung,Rattus norvegicus,Intermediate,,,13265,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL625060,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13266,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625061,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,1,,Plasma,Rattus norvegicus,Intermediate,,,13267,10116.0
,N,50597,,,In vivo,A,,CHEMBL625062,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13268,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL625063,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,1,,Spleen,Rattus norvegicus,Intermediate,,,13269,10116.0
,N,50597,,,In vivo,A,3126.0,CHEMBL625064,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,1,,Trachea,Rattus norvegicus,Intermediate,,,13270,10116.0
,N,50597,,,In vivo,A,10000001.0,CHEMBL625065,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,1,,Bone,Rattus norvegicus,Intermediate,,,13271,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL625066,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13272,10116.0
,N,50597,,,In vivo,A,,CHEMBL625067,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13273,10116.0
,N,50597,,,In vivo,A,,CHEMBL625068,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13274,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL622159,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,1,,Heart,Rattus norvegicus,Intermediate,,,13275,10116.0
,N,50597,,,In vivo,A,160.0,CHEMBL622160,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,1,,Intestine,Rattus norvegicus,Intermediate,,,13276,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL622161,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,1,,Kidney,Rattus norvegicus,Intermediate,,,13277,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL622162,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,1,,Lung,Rattus norvegicus,Intermediate,,,13278,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL622163,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13279,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622313,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,1,,Plasma,Rattus norvegicus,Intermediate,,,13280,10116.0
,N,50597,,,In vivo,A,,CHEMBL622314,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,1,,,Rattus norvegicus,Intermediate,,,13281,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL622315,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,1,,Spleen,Rattus norvegicus,Intermediate,,,13282,10116.0
,N,50597,,,In vivo,A,3126.0,CHEMBL622316,1,,BAO_0000218,14198,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,1,,Trachea,Rattus norvegicus,Intermediate,,,13283,10116.0
,N,50212,,,,A,,CHEMBL877486,1,,BAO_0000218,15599,Normal diffusion coefficient in water for Escherichia coli,1,,,Escherichia coli,Intermediate,,,13284,562.0
,U,22224,,,,A,,CHEMBL622317,0,,BAO_0000019,8204,Average max percent decrease in RVR (renal vascular resistance) was determined,1,,,,Autocuration,,,13285,
,U,22224,,,,A,,CHEMBL622318,0,,BAO_0000019,8204,Average max percent decrease in RVR (renal vascular resistance) was determined.,1,,,,Autocuration,,,13286,
,U,22224,,,,A,,CHEMBL622319,0,,BAO_0000019,6154,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,1,,,,Autocuration,,,13287,
,U,22224,,,,A,,CHEMBL622320,0,,BAO_0000019,6154,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,1,,,,Autocuration,,,13288,
,U,22224,,,,A,,CHEMBL622321,0,,BAO_0000019,6154,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,1,,,,Autocuration,,,13289,
,U,22224,,,,A,,CHEMBL622322,0,,BAO_0000019,6154,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,1,,,,Autocuration,,,13290,
,U,22224,,,,A,,CHEMBL622323,0,,BAO_0000019,7114,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,1,,,,Autocuration,,,13291,
,N,50597,,,,A,,CHEMBL622324,1,,BAO_0000218,7114,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,1,,,Rattus norvegicus,Intermediate,,,13292,10116.0
,N,50588,,,,A,1088.0,CHEMBL622325,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13293,9615.0
,N,50588,,,,A,1088.0,CHEMBL622326,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13294,9615.0
,N,50588,,,,A,1088.0,CHEMBL877487,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13295,9615.0
,N,50588,,,,A,1088.0,CHEMBL622327,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13296,9615.0
,N,50588,,,,A,1088.0,CHEMBL622328,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13297,9615.0
,N,50588,,,,A,1088.0,CHEMBL622329,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13298,9615.0
,N,50588,,,,A,1088.0,CHEMBL622330,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13299,9615.0
,N,50588,,,,A,1088.0,CHEMBL622331,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13300,9615.0
,N,50588,,,,A,1088.0,CHEMBL622332,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13301,9615.0
,N,50588,,,,A,1088.0,CHEMBL622333,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13302,9615.0
,U,22224,,,,A,1088.0,CHEMBL627658,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13303,314293.0
,U,22224,,,,A,1088.0,CHEMBL630428,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13304,314293.0
,U,22224,,,,A,1088.0,CHEMBL630429,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13305,314293.0
,U,22224,,,,A,1088.0,CHEMBL630430,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13306,314293.0
,U,22224,,,,A,1088.0,CHEMBL630431,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13307,314293.0
,N,50597,,,,A,1088.0,CHEMBL630432,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13308,10116.0
,N,50597,,,,A,1088.0,CHEMBL630433,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13309,10116.0
,N,50597,,,,A,1088.0,CHEMBL630434,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13310,10116.0
,N,50597,,,,A,1088.0,CHEMBL629372,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13311,10116.0
,N,50597,,,,A,1088.0,CHEMBL629553,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13312,10116.0
,N,50597,,,,A,1088.0,CHEMBL629554,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13313,10116.0
,N,50597,,,,A,1088.0,CHEMBL874447,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13314,10116.0
,N,50597,,,,A,1088.0,CHEMBL629555,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13315,10116.0
,N,50597,,,,A,1088.0,CHEMBL629556,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13316,10116.0
,N,50597,,,,A,1088.0,CHEMBL629557,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13317,10116.0
,N,50597,,,,A,1088.0,CHEMBL629558,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13318,10116.0
,N,50597,,,,A,1088.0,CHEMBL629559,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13319,10116.0
,N,50597,,,,A,1088.0,CHEMBL629560,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13320,10116.0
,N,50588,,,,A,1088.0,CHEMBL629561,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13321,9615.0
,N,50588,,,,A,1088.0,CHEMBL629562,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13322,9615.0
,N,50588,,,,A,1088.0,CHEMBL629563,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13323,9615.0
,N,50588,,,,A,1088.0,CHEMBL629564,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13324,9615.0
,N,50588,,,,A,1088.0,CHEMBL629565,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13325,9615.0
,N,50588,,,,A,1088.0,CHEMBL629566,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13326,9615.0
,N,50588,,,,A,1088.0,CHEMBL629567,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13327,9615.0
,N,50588,,,,A,1088.0,CHEMBL629568,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13328,9615.0
,N,50588,,,,A,1088.0,CHEMBL629569,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13329,9615.0
,N,50588,,,,A,1088.0,CHEMBL629570,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13330,9615.0
,U,22224,,,,A,1088.0,CHEMBL629571,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13331,314293.0
,U,22224,,,In vivo,A,,CHEMBL629572,0,,BAO_0000218,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,1,,,Rattus norvegicus,Autocuration,,,13332,10116.0
,U,22224,,,In vivo,A,,CHEMBL629573,0,,BAO_0000218,12170,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,1,,,Rattus norvegicus,Autocuration,,,13333,10116.0
,U,22224,,,In vivo,A,,CHEMBL629574,0,,BAO_0000218,4985,Bioavailability (dose 20 mg/kg),1,,,Eutheria,Autocuration,,,13334,9347.0
,U,22224,,,In vivo,A,,CHEMBL629575,0,,BAO_0000218,15145,Bioavailability in dog,1,,,Canis lupus familiaris,Autocuration,,,13335,9615.0
,U,22224,,,In vivo,A,,CHEMBL874448,0,,BAO_0000218,14080,Bioavailability in rat (Sprague-Dawley) (male),1,,,Rattus norvegicus,Autocuration,,,13336,10116.0
,U,22224,,,In vivo,A,,CHEMBL629576,0,,BAO_0000218,11219,Bioavailability in monkey (dose 10 mg/kg i.d.),1,,,Primates,Autocuration,,,13337,9443.0
,U,22224,,,In vivo,A,,CHEMBL629577,0,,BAO_0000218,15145,Bioavailability in rat,1,,,Rattus norvegicus,Autocuration,,,13338,10116.0
,U,22224,,,In vivo,A,,CHEMBL629578,0,,BAO_0000218,15145,Bioavailability in rat,1,,,Rattus norvegicus,Autocuration,,,13339,10116.0
,U,22224,,,In vivo,A,,CHEMBL629579,0,,BAO_0000218,1202,Bioavailability in dog (dose 3.0 mg/kg p.o.),1,,,Canis lupus familiaris,Autocuration,,,13340,9615.0
,U,22224,,,In vivo,A,,CHEMBL882958,0,,BAO_0000218,1202,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,1,,,Canis lupus familiaris,Autocuration,,,13341,9615.0
,N,50505,,,In vivo,A,,CHEMBL629580,1,,BAO_0000218,1202,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,1,,,Pan troglodytes,Intermediate,,,13342,9598.0
,U,22224,,,In vivo,A,,CHEMBL629581,0,,BAO_0000218,4026,Bioavailability,1,,,Eutheria,Autocuration,,,13343,9347.0
,U,22224,,,In vivo,A,,CHEMBL629582,0,,BAO_0000218,1492,Bioavailability in squirrel monkey,1,,,Saimiri,Autocuration,,,13344,9520.0
,N,50588,,,In vivo,A,,CHEMBL628522,1,,BAO_0000218,12793,Bioavailability was evaluated in dog,1,,,Canis lupus familiaris,Intermediate,,,13345,9615.0
,N,100712,,,In vivo,A,,CHEMBL625432,1,,BAO_0000218,12793,Bioavailability was evaluated in hamster,1,,,Cricetinae,Intermediate,,,13346,10026.0
,U,22224,,,In vivo,A,,CHEMBL625433,0,,BAO_0000218,12793,Bioavailability in rat,1,,,Rattus norvegicus,Autocuration,,,13347,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625434,1,,BAO_0000218,14793,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,1,,Plasma,Rattus norvegicus,Intermediate,,,13348,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL625435,1,,BAO_0000218,14793,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,1,,Plasma,Rattus norvegicus,Intermediate,,,13349,10116.0
,U,22224,,,In vivo,A,,CHEMBL625436,0,,BAO_0000218,14793,Bioavailability in rat (dose 10 mg/kg p.o.),1,,,Rattus norvegicus,Autocuration,,,13350,10116.0
,N,100710,,,In vivo,A,,CHEMBL874588,1,,BAO_0000218,14731,Bioavailability was measured in cynomolgus monkeys.,1,,,Macaca fascicularis,Intermediate,,,13351,9541.0
,N,50594,,,In vivo,A,,CHEMBL625437,1,,BAO_0000218,14731,Bioavailability was measured in nude mice.,1,,,Mus musculus,Intermediate,,,13352,10090.0
,U,22224,,,In vivo,A,,CHEMBL625438,0,,BAO_0000218,12187,Bioavailability in ferret (dose 10 mg/kg i.d.),1,,,Mustela putorius furo,Autocuration,,,13353,9669.0
,U,22224,,,In vivo,A,,CHEMBL625439,0,,BAO_0000218,12187,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),1,,,Simiiformes,Autocuration,,,13354,314293.0
,U,22224,,,In vivo,A,,CHEMBL625440,0,,BAO_0000218,12187,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",1,,,Simiiformes,Autocuration,,,13355,314293.0
,U,22224,,,In vivo,A,,CHEMBL625441,0,,BAO_0000218,12187,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),1,,,Simiiformes,Autocuration,,,13356,314293.0
,U,22224,,,In vivo,A,,CHEMBL625442,0,,BAO_0000218,12187,Bioavailability in rat (dose 10 mg/kg i.d.),1,,,Rattus norvegicus,Autocuration,,,13357,10116.0
,N,50597,,,In vivo,A,,CHEMBL625443,1,,BAO_0000218,12187,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",1,,,Rattus norvegicus,Intermediate,,,13358,10116.0
,U,22224,,,In vivo,A,,CHEMBL625444,0,,BAO_0000218,17431,Bioavailability was determined; extremely poor,1,,,,Autocuration,,,13359,
,N,50594,,,In vivo,A,,CHEMBL625445,1,,BAO_0000218,13318,% bioavailability in mice after oral administration of prodrug,1,,,Mus musculus,Intermediate,,,13360,10090.0
,N,50588,,,In vivo,A,,CHEMBL625446,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,1,,,Canis lupus familiaris,Intermediate,,,13361,9615.0
,N,50588,,,In vivo,A,,CHEMBL882960,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,1,,,Canis lupus familiaris,Intermediate,,,13362,9615.0
,N,50588,,,In vivo,A,,CHEMBL625447,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,1,,,Canis lupus familiaris,Intermediate,,,13363,9615.0
,N,50588,,,In vivo,A,,CHEMBL625448,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,1,,,Canis lupus familiaris,Intermediate,,,13364,9615.0
,N,50588,,,In vivo,A,,CHEMBL625449,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,1,,,Canis lupus familiaris,Intermediate,,,13365,9615.0
,N,50588,,,In vivo,A,,CHEMBL874589,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),1,,,Canis lupus familiaris,Intermediate,,,13366,9615.0
,N,50588,,,In vivo,A,,CHEMBL625450,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,1,,,Canis lupus familiaris,Intermediate,,,13367,9615.0
,N,50588,,,In vivo,A,,CHEMBL625451,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,1,,,Canis lupus familiaris,Intermediate,,,13368,9615.0
,N,50588,,,In vivo,A,,CHEMBL626584,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,1,,,Canis lupus familiaris,Intermediate,,,13369,9615.0
,N,50588,,,In vivo,A,,CHEMBL626585,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,1,,,Canis lupus familiaris,Intermediate,,,13370,9615.0
,N,50588,,,In vivo,A,,CHEMBL626586,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,1,,,Canis lupus familiaris,Intermediate,,,13371,9615.0
,N,50588,,,In vivo,A,,CHEMBL626587,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,1,,,Canis lupus familiaris,Intermediate,,,13372,9615.0
,N,50588,,,In vivo,A,,CHEMBL626588,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,1,,,Canis lupus familiaris,Intermediate,,,13373,9615.0
,N,50588,,,In vivo,A,,CHEMBL626589,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,1,,,Canis lupus familiaris,Intermediate,,,13374,9615.0
,N,50588,,,In vivo,A,,CHEMBL626590,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,1,,,Canis lupus familiaris,Intermediate,,,13375,9615.0
,N,50588,,,In vivo,A,,CHEMBL626591,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,1,,,Canis lupus familiaris,Intermediate,,,13376,9615.0
,N,50588,,,In vivo,A,,CHEMBL627181,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,1,,,Canis lupus familiaris,Intermediate,,,13377,9615.0
,N,50588,,,In vivo,A,,CHEMBL628083,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,1,,,Canis lupus familiaris,Intermediate,,,13378,9615.0
,U,22224,,,In vivo,A,,CHEMBL628084,0,,BAO_0000218,15173,IV clearance determined at an peroral dose of 15 mg/kg.,1,,,,Autocuration,,,13379,
,N,50064,,,In vivo,F,,CHEMBL628085,1,,BAO_0000218,7732,Mouse oral clearance was measured against Hymenolepiasis nana.,1,,,Hymenolepis nana,Expert,,,13380,102285.0
,N,50545,,,In vivo,F,,CHEMBL628086,1,,BAO_0000218,7732,Mouse oral clearance was measured against Nematospiroides dubius,1,,,Heligmosomoides polygyrus,Expert,,,13381,6339.0
,U,22224,,,In vivo,F,,CHEMBL628087,0,,BAO_0000218,7732,Mouse oral clearance was measured against N. dubius; NT is Not Tested,1,,,,Autocuration,,,13382,
,N,50594,,,In vivo,A,,CHEMBL628088,1,,BAO_0000218,7732,Mouse oral clearance was measured against N. nana; NT is Not Tested,1,,,Mus musculus,Intermediate,,,13383,10090.0
,U,22224,,,In vivo,B,,CHEMBL628089,0,,BAO_0000218,7732,Mouse oral clearance was measured against N. nana; NT is Not Tested,1,,,,Autocuration,,,13384,
,U,22224,,,In vivo,A,,CHEMBL628090,0,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,1,,,,Autocuration,,,13385,
,U,22224,,,In vivo,A,,CHEMBL628091,0,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,1,,,,Autocuration,,,13386,
,U,22224,,,In vivo,A,,CHEMBL628092,0,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,1,,,,Autocuration,,,13387,
,U,22224,,,In vivo,A,,CHEMBL628093,0,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,1,,,,Autocuration,,,13388,
,U,22224,,,In vivo,A,,CHEMBL875607,0,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,1,,,,Autocuration,,,13389,
,U,22224,,,In vivo,A,,CHEMBL625710,0,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,1,,,,Autocuration,,,13390,
,U,22224,,,In vivo,A,,CHEMBL625711,0,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,1,,,,Autocuration,,,13391,
,U,22224,,,In vivo,A,,CHEMBL625712,0,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,1,,,,Autocuration,,,13392,
,U,22224,,,In vivo,A,,CHEMBL625713,0,,BAO_0000218,8328,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,1,,,,Autocuration,,,13393,
,N,50588,,,In vivo,A,,CHEMBL625714,1,,BAO_0000218,13376,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,1,,,Canis lupus familiaris,Intermediate,,,13394,9615.0
,N,50797,,,In vivo,A,,CHEMBL625715,1,,BAO_0000218,13477,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,1,,,Macaca mulatta,Intermediate,,,13395,9544.0
,N,50597,,,In vivo,A,,CHEMBL625716,1,,BAO_0000218,13477,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,1,,,Rattus norvegicus,Intermediate,,,13396,10116.0
,N,50597,,,In vivo,A,,CHEMBL625717,1,,BAO_0000218,13477,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,1,,,Rattus norvegicus,Intermediate,,,13397,10116.0
,N,50597,,,In vivo,A,,CHEMBL625718,1,,BAO_0000218,13313,Plasma clearance was determined for the compound in rats,1,,,Rattus norvegicus,Intermediate,,,13398,10116.0
,N,50597,,,In vivo,A,,CHEMBL625719,1,,BAO_0000218,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,1,,,Rattus norvegicus,Intermediate,,,13399,10116.0
,N,50597,,,In vivo,A,,CHEMBL625720,1,,BAO_0000218,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,1,,,Rattus norvegicus,Intermediate,,,13400,10116.0
,N,50597,,,In vivo,A,,CHEMBL625721,1,,BAO_0000218,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,1,,,Rattus norvegicus,Intermediate,,,13401,10116.0
,N,50597,,,In vivo,A,,CHEMBL625722,1,,BAO_0000218,12504,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,1,,,Rattus norvegicus,Intermediate,,,13402,10116.0
,N,50597,,,In vivo,A,,CHEMBL625723,1,,BAO_0000218,13129,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,1,,,Rattus norvegicus,Intermediate,,,13403,10116.0
,N,50545,,,In vivo,A,,CHEMBL625724,1,,BAO_0000218,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,1,,,Heligmosomoides polygyrus,Intermediate,,,13404,6339.0
,N,50545,,,In vivo,A,,CHEMBL625725,1,,BAO_0000218,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,1,,,Heligmosomoides polygyrus,Intermediate,,,13405,6339.0
,N,50545,,,In vivo,A,,CHEMBL625726,1,,BAO_0000218,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,1,,,Heligmosomoides polygyrus,Intermediate,,,13406,6339.0
,N,50545,,,In vivo,A,,CHEMBL875608,1,,BAO_0000218,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,1,,,Heligmosomoides polygyrus,Intermediate,,,13407,6339.0
,N,50545,,,In vivo,A,,CHEMBL625727,1,,BAO_0000218,7732,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,1,,,Heligmosomoides polygyrus,Intermediate,,,13408,6339.0
,U,22224,,,In vivo,A,1088.0,CHEMBL625728,0,,BAO_0000218,9278,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,1,,Urine,Rattus norvegicus,Autocuration,,,13409,10116.0
,U,22224,,,In vivo,A,,CHEMBL625729,0,,BAO_0000218,9278,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,1,,,Rattus norvegicus,Autocuration,,,13410,10116.0
,U,22224,,,In vivo,A,,CHEMBL625730,0,,BAO_0000218,9278,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,1,,,Rattus norvegicus,Autocuration,,,13411,10116.0
,U,22224,,,In vivo,A,1088.0,CHEMBL625731,0,,BAO_0000218,9278,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,1,,Urine,Rattus norvegicus,Autocuration,,,13412,10116.0
,U,22224,,,In vivo,A,1088.0,CHEMBL626417,0,,BAO_0000218,9278,Urinary clearance was determined in rat at 25 mg/kg os dosage,1,,Urine,Rattus norvegicus,Autocuration,,,13413,10116.0
,N,50587,,,In vivo,A,1088.0,CHEMBL626418,1,,BAO_0000218,9278,Urinary clearance was determined at 100 mg/kg oral dosage in human,1,,Urine,Homo sapiens,Intermediate,,,13414,9606.0
,N,50588,,,In vivo,A,1088.0,CHEMBL626419,1,,BAO_0000218,9278,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,1,,Urine,Canis lupus familiaris,Intermediate,,,13415,9615.0
,N,50588,,,In vivo,A,1969.0,CHEMBL626592,1,,BAO_0000218,5932,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,1,,Plasma,Canis lupus familiaris,Intermediate,,,13416,9615.0
,N,50597,,,In vivo,A,1969.0,CHEMBL626593,1,,BAO_0000218,5932,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,1,,Plasma,Rattus norvegicus,Intermediate,,,13417,10116.0
,N,50597,,,In vivo,A,,CHEMBL626594,1,,BAO_0000218,5182,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,1,,,Rattus norvegicus,Intermediate,,,13418,10116.0
,N,50588,,,In vivo,A,,CHEMBL625035,1,,BAO_0000218,10499,Clearance rate in dogs,1,,,Canis lupus familiaris,Intermediate,,,13419,9615.0
,U,22224,,,In vitro,A,,CHEMBL625036,0,,BAO_0000019,6051,Compound was measured for intrinsic clearance,1,,,,Autocuration,,,13420,
,U,22229,,,,P,,CHEMBL625037,0,,BAO_0000100,17508,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13421,
,U,22229,,,,P,,CHEMBL625038,0,,BAO_0000100,6228,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13422,
,U,22229,,,,P,,CHEMBL625039,0,,BAO_0000100,6231,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13423,
,U,22229,,,,P,,CHEMBL625040,0,,BAO_0000100,17740,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13424,
,U,22229,,,,P,,CHEMBL625041,0,,BAO_0000100,6495,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13425,
,U,22229,,,,P,,CHEMBL625042,0,,BAO_0000100,2171,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13426,
,U,22224,,,,A,,CHEMBL874411,0,,BAO_0000019,3255,Partition coefficient of the compound,1,,,,Autocuration,,,13427,
,U,22224,,,,A,,CHEMBL625043,0,,BAO_0000019,6821,Permeability,1,,,,Autocuration,,,13428,
,U,22229,,,,P,,CHEMBL625044,0,,BAO_0000100,2685,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13429,
,U,22224,,,,A,,CHEMBL625045,0,,BAO_0000019,17584,Partition coefficient (logD),1,,,,Autocuration,,,13430,
,U,22229,,,,P,,CHEMBL625046,0,,BAO_0000100,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),1,,,,Autocuration,,,13431,
,U,22229,,,,P,,CHEMBL625047,0,,BAO_0000100,13824,Calculated partition coefficient (clogP) (CLOGP3 V3.4),1,,,,Autocuration,,,13432,
,U,22229,,,,P,,CHEMBL625048,0,,BAO_0000100,16479,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13433,
,U,22229,,,,P,,CHEMBL625049,0,,BAO_0000100,11997,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13434,
,U,22229,,,,P,,CHEMBL625050,0,,BAO_0000100,2988,Calculated logarithm of partition coefficient (P) was determined,1,,,,Autocuration,,,13435,
,U,22229,,,,P,,CHEMBL625051,0,,BAO_0000100,931,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13436,
,U,22229,,,,P,,CHEMBL874412,0,,BAO_0000100,4381,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13437,
,U,22229,,,,P,,CHEMBL625052,0,,BAO_0000100,4397,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13438,
,U,22229,,,,P,,CHEMBL625053,0,,BAO_0000100,5889,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13439,
,U,22224,,,,A,,CHEMBL623250,0,,BAO_0000019,6154,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,1,,,,Autocuration,,,13440,
,U,22224,,,,A,,CHEMBL623251,0,,BAO_0000019,6154,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,1,,,,Autocuration,,,13441,
,U,22224,,,,A,,CHEMBL623252,0,,BAO_0000019,6154,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,1,,,,Autocuration,,,13442,
,U,22224,,,,A,,CHEMBL623253,0,,BAO_0000019,6154,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,1,,,,Autocuration,,,13443,
,U,22224,,,,A,,CHEMBL623254,0,,BAO_0000019,6154,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,1,,,,Autocuration,,,13444,
,U,22224,,,,A,,CHEMBL623255,0,,BAO_0000019,6154,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,1,,,,Autocuration,,,13445,
,U,22224,,,,A,,CHEMBL626831,0,,BAO_0000019,6887,Percent degradation of compound at a pH of 1 over a 18 hr period,1,,,,Autocuration,,,13446,
,U,22224,,,,A,,CHEMBL877494,0,,BAO_0000019,6887,Percent degradation of compound at pH of 1 over an 18 hr period,1,,,,Autocuration,,,13447,
,U,22224,,,,A,,CHEMBL626832,0,,BAO_0000019,14116,Delta Logarithm of Partition Coefficient value was determined.,1,,,,Autocuration,,,13448,
,U,22224,,,,A,,CHEMBL626833,0,,BAO_0000019,11137,Delta logPoct-cyc,1,,,,Autocuration,,,13449,
,U,22224,,,,P,,CHEMBL626834,0,,BAO_0000100,7230,Lipophilicity estimated on reversed phase TLC,1,,,,Autocuration,,,13450,
,U,22224,,,,A,,CHEMBL626835,0,,BAO_0000019,15741,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,1,,,,Autocuration,,,13451,
,U,22224,,,,A,,CHEMBL626836,0,,BAO_0000019,9663,Delta logPoct-cyc,1,,,,Autocuration,,,13452,
,U,22229,,,,P,,CHEMBL626837,0,,BAO_0000100,9663,Change in logarithm of partition coefficient of the compound,1,,,,Autocuration,,,13453,
,U,22224,,,,A,,CHEMBL626838,0,,BAO_0000019,13807,Delta logD (pH 6.5),1,,,,Autocuration,,,13454,
,U,22224,,,,P,,CHEMBL626839,0,,BAO_0000100,13807,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",1,,,,Autocuration,,,13455,
,U,22224,,,,A,,CHEMBL626840,0,,BAO_0000019,17425,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,1,,,,Autocuration,,,13456,
,U,22224,,,,A,,CHEMBL626841,0,,BAO_0000019,12143,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),1,,,,Autocuration,,,13457,
,U,22224,,,,A,,CHEMBL626842,0,,BAO_0000219,12608,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,1,,,,Autocuration,,,13458,
,U,22224,,,,A,,CHEMBL626843,0,,BAO_0000219,12608,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,1,,,,Autocuration,,,13459,
,N,50597,,,,A,,CHEMBL626844,1,,BAO_0000218,8649,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,1,,,Rattus norvegicus,Intermediate,,,13460,10116.0
,N,50597,,,,A,,CHEMBL877495,1,,BAO_0000218,8649,Amount of deuterium retained was reported after normal workup in rats,1,,,Rattus norvegicus,Intermediate,,,13461,10116.0
,N,50597,,,,A,,CHEMBL626845,1,,BAO_0000218,8649,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,1,,,Rattus norvegicus,Intermediate,,,13462,10116.0
,N,50597,,,,A,,CHEMBL626846,1,,BAO_0000218,8649,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,1,,,Rattus norvegicus,Intermediate,,,13463,10116.0
,N,50597,,,,A,,CHEMBL626847,1,,BAO_0000218,8649,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,1,,,Rattus norvegicus,Intermediate,,,13464,10116.0
,N,50597,,,,A,,CHEMBL628677,1,,BAO_0000218,8649,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,1,,,Rattus norvegicus,Intermediate,,,13465,10116.0
,N,50597,,,,A,,CHEMBL628678,1,,BAO_0000218,8649,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,1,,,Rattus norvegicus,Intermediate,,,13466,10116.0
,U,22224,,,,A,,CHEMBL628679,0,,BAO_0000019,9659,Compound was subjected to electrochemical oxidation,1,,,,Autocuration,,,13467,
,U,22224,,,,A,,CHEMBL628680,0,,BAO_0000019,9659,Compound was subjected to photochemical oxidation,1,,,,Autocuration,,,13468,
,U,22224,,,,A,,CHEMBL628681,0,,BAO_0000019,9659,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,1,,,,Autocuration,,,13469,
,U,22224,,,,A,,CHEMBL628682,0,,BAO_0000019,9659,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,1,,,,Autocuration,,,13470,
,U,22224,,,,A,,CHEMBL628683,0,,BAO_0000019,9659,Oxidation of compound by methemoglobin in presence of hydroperoxide,1,,,,Autocuration,,,13471,
,N,50597,,,,A,,CHEMBL628684,1,,BAO_0000218,9607,Percent diffusion through fuzzy rat skin after 48 h of incubation,1,,,Rattus norvegicus,Intermediate,,,13472,10116.0
,U,22229,,,,P,,CHEMBL877501,0,,BAO_0000100,7057,Dissociation constant (pKa),1,,,,Autocuration,,,13473,
,U,22224,,,,P,,CHEMBL628685,0,,BAO_0000100,7057,Dissociation constant value of the compound; ND means not determined.,1,,,,Autocuration,,,13474,
,N,50597,,,,A,178.0,CHEMBL628686,1,,BAO_0000218,7911,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,1,,Blood,Rattus norvegicus,Intermediate,,,13475,10116.0
,N,50597,,,,A,178.0,CHEMBL628687,1,,BAO_0000218,7911,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,Blood,Rattus norvegicus,Intermediate,,,13476,10116.0
,N,50597,,,,A,,CHEMBL628688,1,,BAO_0000218,7911,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,1,,,Rattus norvegicus,Intermediate,,,13477,10116.0
,N,50597,,,,A,,CHEMBL628689,1,,BAO_0000218,7911,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,,Rattus norvegicus,Intermediate,,,13478,10116.0
,N,50597,,,,A,2107.0,CHEMBL628690,1,,BAO_0000218,7911,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,1,,Liver,Rattus norvegicus,Intermediate,,,13479,10116.0
,N,50597,,,,A,2107.0,CHEMBL629363,1,,BAO_0000218,7911,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,1,,Liver,Rattus norvegicus,Intermediate,,,13480,10116.0
,N,50597,,,,A,2106.0,CHEMBL629364,1,,BAO_0000218,7911,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,1,,Spleen,Rattus norvegicus,Intermediate,,,13481,10116.0
,N,50597,,,,A,2106.0,CHEMBL629365,1,,BAO_0000218,7911,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,Spleen,Rattus norvegicus,Intermediate,,,13482,10116.0
,N,50597,,,,A,,CHEMBL629366,1,,BAO_0000218,7911,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,1,,,Rattus norvegicus,Intermediate,,,13483,10116.0
,N,50597,,,,A,1088.0,CHEMBL629367,1,,BAO_0000218,7911,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,1,,Urine,Rattus norvegicus,Intermediate,,,13484,10116.0
,N,50597,,,,A,1988.0,CHEMBL629368,1,,BAO_0000218,7911,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,1,,Feces,Rattus norvegicus,Intermediate,,,13485,10116.0
,N,50597,,,,A,1088.0,CHEMBL877502,1,,BAO_0000218,7911,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,1,,Urine,Rattus norvegicus,Intermediate,,,13486,10116.0
,N,50594,,,,A,2037.0,CHEMBL629369,1,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,1,,Cerebellum,Mus musculus,Intermediate,,,13487,10090.0
,N,50594,,,,A,955.0,CHEMBL629370,1,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,1,,Brain,Mus musculus,Intermediate,,,13488,10090.0
,U,22224,,,,A,1088.0,CHEMBL629371,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13489,314293.0
,U,22224,,,,A,1088.0,CHEMBL626276,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13490,314293.0
,U,22224,,,,A,1088.0,CHEMBL626277,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13491,314293.0
,U,22224,,,,A,1088.0,CHEMBL631250,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13492,314293.0
,N,50597,,,,A,1088.0,CHEMBL631251,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13493,10116.0
,N,50597,,,,A,1088.0,CHEMBL631252,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13494,10116.0
,N,50597,,,,A,1088.0,CHEMBL631253,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13495,10116.0
,N,50597,,,,A,1088.0,CHEMBL631254,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13496,10116.0
,N,50597,,,,A,1088.0,CHEMBL631255,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13497,10116.0
,N,50597,,,,A,1088.0,CHEMBL631256,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13498,10116.0
,N,50597,,,,A,1088.0,CHEMBL631257,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13499,10116.0
,N,50597,,,,A,1088.0,CHEMBL628009,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13500,10116.0
,N,50597,,,,A,1088.0,CHEMBL628010,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13501,10116.0
,N,50597,,,,A,1088.0,CHEMBL628011,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13502,10116.0
,N,50597,,,,A,1088.0,CHEMBL628012,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13503,10116.0
,N,50597,,,,A,1088.0,CHEMBL628013,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13504,10116.0
,N,50597,,,,A,1088.0,CHEMBL628014,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13505,10116.0
,N,50588,,,,A,1088.0,CHEMBL628015,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13506,9615.0
,N,50588,,,,A,1088.0,CHEMBL628016,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13507,9615.0
,N,50588,,,,A,1088.0,CHEMBL874461,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13508,9615.0
,N,50588,,,,A,1088.0,CHEMBL628017,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13509,9615.0
,N,50588,,,,A,1088.0,CHEMBL628018,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13510,9615.0
,N,50588,,,,A,1088.0,CHEMBL628019,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13511,9615.0
,N,50588,,,,A,1088.0,CHEMBL628020,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13512,9615.0
,N,50588,,,,A,1088.0,CHEMBL628021,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13513,9615.0
,N,50588,,,,A,1088.0,CHEMBL628022,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13514,9615.0
,N,50588,,,,A,1088.0,CHEMBL628023,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",1,,Urine,Canis lupus familiaris,Intermediate,,,13515,9615.0
,U,22224,,,,A,1088.0,CHEMBL628024,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13516,314293.0
,U,22224,,,,A,1088.0,CHEMBL628025,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13517,314293.0
,U,22224,,,,A,1088.0,CHEMBL628026,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13518,314293.0
,U,22224,,,,A,1088.0,CHEMBL628027,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13519,314293.0
,U,22224,,,,A,1088.0,CHEMBL628028,0,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",1,,Urine,Simiiformes,Autocuration,,,13520,314293.0
,N,50597,,,,A,1088.0,CHEMBL628029,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13521,10116.0
,N,50597,,,,A,1088.0,CHEMBL628030,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13522,10116.0
,N,50597,,,,A,1088.0,CHEMBL628031,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13523,10116.0
,N,50597,,,,A,1088.0,CHEMBL628032,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13524,10116.0
,N,50597,,,,A,1088.0,CHEMBL628033,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13525,10116.0
,N,50597,,,,A,1088.0,CHEMBL628034,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13526,10116.0
,N,50597,,,,A,1088.0,CHEMBL628035,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13527,10116.0
,N,50597,,,,A,1088.0,CHEMBL628036,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13528,10116.0
,N,50597,,,,A,1088.0,CHEMBL874462,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13529,10116.0
,N,50588,,,In vivo,A,,CHEMBL628037,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,1,,,Canis lupus familiaris,Intermediate,,,13530,9615.0
,N,50588,,,In vivo,A,,CHEMBL628123,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,1,,,Canis lupus familiaris,Intermediate,,,13531,9615.0
,N,50588,,,In vivo,A,,CHEMBL628124,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,1,,,Canis lupus familiaris,Intermediate,,,13532,9615.0
,N,50588,,,In vivo,A,,CHEMBL628125,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,1,,,Canis lupus familiaris,Intermediate,,,13533,9615.0
,N,50588,,,In vivo,A,,CHEMBL628126,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,1,,,Canis lupus familiaris,Intermediate,,,13534,9615.0
,N,50588,,,In vivo,A,,CHEMBL628127,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),1,,,Canis lupus familiaris,Intermediate,,,13535,9615.0
,N,50588,,,In vivo,A,,CHEMBL628128,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,1,,,Canis lupus familiaris,Intermediate,,,13536,9615.0
,N,50588,,,In vivo,A,,CHEMBL628129,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,1,,,Canis lupus familiaris,Intermediate,,,13537,9615.0
,N,50588,,,In vivo,A,,CHEMBL628130,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,1,,,Canis lupus familiaris,Intermediate,,,13538,9615.0
,N,50588,,,In vivo,A,,CHEMBL628131,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,1,,,Canis lupus familiaris,Intermediate,,,13539,9615.0
,N,50588,,,In vivo,A,,CHEMBL628132,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,1,,,Canis lupus familiaris,Intermediate,,,13540,9615.0
,N,50588,,,In vivo,A,,CHEMBL628133,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,1,,,Canis lupus familiaris,Intermediate,,,13541,9615.0
,N,50588,,,In vivo,A,,CHEMBL628134,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,1,,,Canis lupus familiaris,Intermediate,,,13542,9615.0
,N,50588,,,In vivo,A,,CHEMBL628135,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,1,,,Canis lupus familiaris,Intermediate,,,13543,9615.0
,N,50588,,,In vivo,A,,CHEMBL628136,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,1,,,Canis lupus familiaris,Intermediate,,,13544,9615.0
,N,50588,,,In vivo,A,,CHEMBL628137,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,1,,,Canis lupus familiaris,Intermediate,,,13545,9615.0
,N,50588,,,In vivo,A,,CHEMBL628138,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,1,,,Canis lupus familiaris,Intermediate,,,13546,9615.0
,N,50588,,,In vivo,A,,CHEMBL628139,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,1,,,Canis lupus familiaris,Intermediate,,,13547,9615.0
,N,50588,,,In vivo,A,,CHEMBL628140,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,1,,,Canis lupus familiaris,Intermediate,,,13548,9615.0
,N,50588,,,In vivo,A,,CHEMBL628141,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,1,,,Canis lupus familiaris,Intermediate,,,13549,9615.0
,N,50588,,,In vivo,A,,CHEMBL628142,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,1,,,Canis lupus familiaris,Intermediate,,,13550,9615.0
,N,50588,,,In vivo,A,,CHEMBL628143,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,1,,,Canis lupus familiaris,Intermediate,,,13551,9615.0
,N,50588,,,In vivo,A,,CHEMBL628144,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,1,,,Canis lupus familiaris,Intermediate,,,13552,9615.0
,N,50588,,,In vivo,A,,CHEMBL628145,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,1,,,Canis lupus familiaris,Intermediate,,,13553,9615.0
,N,50588,,,In vivo,A,,CHEMBL628146,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,1,,,Canis lupus familiaris,Intermediate,,,13554,9615.0
,N,50588,,,In vivo,A,,CHEMBL625355,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,1,,,Canis lupus familiaris,Intermediate,,,13555,9615.0
,N,50588,,,In vivo,A,,CHEMBL625356,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,1,,,Canis lupus familiaris,Intermediate,,,13556,9615.0
,N,50588,,,In vivo,A,,CHEMBL625357,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,1,,,Canis lupus familiaris,Intermediate,,,13557,9615.0
,N,50588,,,In vivo,A,,CHEMBL625527,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,1,,,Canis lupus familiaris,Intermediate,,,13558,9615.0
,N,50588,,,In vivo,A,,CHEMBL875473,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),1,,,Canis lupus familiaris,Intermediate,,,13559,9615.0
,N,50588,,,In vivo,A,,CHEMBL625528,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,1,,,Canis lupus familiaris,Intermediate,,,13560,9615.0
,N,50597,,,In vivo,A,,CHEMBL626304,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,1,,,Rattus norvegicus,Intermediate,,,13561,10116.0
,N,50588,,,In vivo,A,1637.0,CHEMBL624138,1,,BAO_0000218,9025,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,1,,Artery,Canis lupus familiaris,Intermediate,,,13562,9615.0
,U,22229,,,,P,,CHEMBL624139,0,,BAO_0000100,6448,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13563,
,U,22229,,,,P,,CHEMBL624140,0,,BAO_0000100,17221,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13564,
,U,22229,,,,P,,CHEMBL624141,0,,BAO_0000100,6545,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13565,
,U,22229,,,,P,,CHEMBL624142,0,,BAO_0000100,577,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13566,
,U,22229,,,,P,,CHEMBL624143,0,,BAO_0000100,6285,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13567,
,U,22229,,,,P,,CHEMBL624144,0,,BAO_0000100,6500,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13568,
,U,22229,,,,P,,CHEMBL624145,0,,BAO_0000100,6716,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13569,
,U,22229,,,,P,,CHEMBL624146,0,,BAO_0000100,13658,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13570,
,U,22229,,,,P,,CHEMBL624147,0,,BAO_0000100,6549,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13571,
,U,22229,,,,P,,CHEMBL883123,0,,BAO_0000100,14685,Calculated partition coefficient (clogP) (MacLogP),1,,,,Autocuration,,,13572,
,U,22224,,,,A,,CHEMBL624148,0,,BAO_0000019,6893,Partition coefficient (logP),1,,,,Autocuration,,,13573,
,U,22224,,,,A,,CHEMBL874416,0,,BAO_0000019,3687,Kinetic parameter was determined,1,,,,Autocuration,,,13574,
,U,22229,,,,P,,CHEMBL624149,0,,BAO_0000100,4207,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13575,
,U,22229,,,,P,,CHEMBL624150,0,,BAO_0000100,4626,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13576,
,U,22224,,,,P,,CHEMBL624151,0,,BAO_0000100,1021,Lipophilicity was determined,1,,,,Autocuration,,,13577,
,U,22224,,,,P,,CHEMBL624152,0,,BAO_0000100,3777,Lipophilicity was determined,1,,,,Autocuration,,,13578,
,U,22224,,,,P,,CHEMBL622139,0,,BAO_0000100,17533,Lipophilicity was determined,1,,,,Autocuration,,,13579,
,U,22229,,,,P,,CHEMBL622140,0,,BAO_0000100,6524,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13580,
,U,22224,,,,P,,CHEMBL622141,0,,BAO_0000100,17533,Lipophilicity was determined,1,,,,Autocuration,,,13581,
,U,22224,,,,P,,CHEMBL622142,0,,BAO_0000100,6480,Lipophilicity in octanol-water,1,,,,Autocuration,,,13582,
,U,22229,,,,P,,CHEMBL622143,0,,BAO_0000100,17606,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13583,
,U,22229,,,,P,,CHEMBL622144,0,,BAO_0000100,6863,Octanol-water partition coefficient was determined,1,,,,Autocuration,,,13584,
,U,22224,,,,A,,CHEMBL877473,0,,BAO_0000019,1356,Partition coefficient (logP),1,,,,Autocuration,,,13585,
,U,22229,,,,P,,CHEMBL622145,0,,BAO_0000100,3326,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13586,
,U,22224,,,,A,,CHEMBL622146,0,,BAO_0000019,1356,Partition coefficient was determined; ND means not determined,1,,,,Autocuration,,,13587,
,U,22229,,,,P,,CHEMBL622147,0,,BAO_0000100,12984,Calculated partition coefficient (clogP),1,,,,Autocuration,,,13588,
,U,22224,,,,A,,CHEMBL622148,0,,BAO_0000019,17363,Partition coefficient of the compound,1,,,,Autocuration,,,13589,
,U,22224,,,,A,,CHEMBL883124,0,,BAO_0000019,6827,Permeability was determined,1,,,,Autocuration,,,13590,
,U,22229,,,,P,,CHEMBL622149,0,,BAO_0000100,261,The compound was evaluated for the partition coefficient,1,,,,Autocuration,,,13591,
,U,22224,,,,A,,CHEMBL622150,0,,BAO_0000019,2685,Partition coefficient (logP),1,,,,Autocuration,,,13592,
,U,22224,,,,P,,CHEMBL622151,0,,BAO_0000100,414,The lipophilicity was reported,1,,,,Autocuration,,,13593,
,U,22229,,,,P,,CHEMBL622152,0,,BAO_0000100,15769,logarithm of the octanol-water partition coefficient for the compound,1,,,,Autocuration,,,13594,
,U,22224,,,,A,,CHEMBL622153,0,,BAO_0000019,17248,Clogp value was determined,1,,,,Autocuration,,,13595,
,U,22224,,,In vivo,A,,CHEMBL877474,0,,BAO_0000218,16935,Clp at a dose of 1.5 mg/kg,1,,,,Autocuration,,,13596,
,U,22224,,,In vivo,A,,CHEMBL622154,0,,BAO_0000218,16935,Clp at a dose of 2.0 mg/kg,1,,,,Autocuration,,,13597,
,U,22224,,,In vivo,A,1969.0,CHEMBL622155,0,,BAO_0000218,14832,"Clp, plasma clearance at a dose of 10 mg/kg",1,,Plasma,,Autocuration,,,13598,
,U,22224,,,In vivo,A,1969.0,CHEMBL622156,0,,BAO_0000218,14832,"Clp, plasma clearance at a dose of 50 mg/kg",1,,Plasma,,Autocuration,,,13599,
,N,50597,,,In vivo,A,1969.0,CHEMBL622157,1,,BAO_0000218,2399,Compound was tested for plasma clearance in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,13600,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622158,1,,BAO_0000218,2399,Compound was tested for plasma clearance in rat; Not determined,1,,Plasma,Rattus norvegicus,Intermediate,,,13601,10116.0
,N,50597,,,In vivo,A,,CHEMBL622807,1,,BAO_0000218,6227,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,13602,10116.0
,N,50797,,,In vivo,A,,CHEMBL622808,1,,BAO_0000218,6227,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,1,,,Macaca mulatta,Intermediate,,,13603,9544.0
,U,22224,,,In vivo,A,,CHEMBL622809,0,,BAO_0000218,5623,Plasma clearance by iv administration at a dose 0.003 ug/mL,1,,,,Autocuration,,,13604,
,U,22224,,,In vivo,A,,CHEMBL622810,0,,BAO_0000218,4854,Plasma clearance determined,1,,,,Autocuration,,,13605,
,N,100712,,,In vivo,A,,CHEMBL876653,1,,BAO_0000218,4493,Plasma clearance after iv administration at 3 mg/kg in hamster,1,,,Cricetinae,Intermediate,,,13606,10026.0
,N,100712,,,In vivo,A,,CHEMBL622811,1,,BAO_0000218,4493,Plasma clearance after iv administration at 4 mg/kg in hamster,1,,,Cricetinae,Intermediate,,,13607,10026.0
,N,50597,,,In vivo,A,,CHEMBL622986,1,,BAO_0000218,14956,Rate of clearance in rat was determined,1,,,Rattus norvegicus,Intermediate,,,13608,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622987,1,,BAO_0000218,15372,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,13609,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622988,1,,BAO_0000218,15372,Total plasma clearance after iv dose of 5.10 mg/kg in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,13610,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622989,1,,BAO_0000218,15372,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,13611,10116.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622990,1,,BAO_0000218,15372,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,1,,Plasma,Rattus norvegicus,Intermediate,,,13612,10116.0
,U,22224,,,In vivo,A,1969.0,CHEMBL622991,0,,BAO_0000218,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,1,,Plasma,Simiiformes,Autocuration,,,13613,314293.0
,N,50597,,,In vivo,A,1969.0,CHEMBL622227,1,,BAO_0000218,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,1,,Plasma,Rattus norvegicus,Intermediate,,,13614,10116.0
,N,50588,,,In vivo,A,1969.0,CHEMBL622228,1,,BAO_0000218,15604,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,1,,Plasma,Canis lupus familiaris,Intermediate,,,13615,9615.0
,N,50597,,,In vivo,A,,CHEMBL622229,1,,BAO_0000218,14964,Clpl value in rat,1,,,Rattus norvegicus,Intermediate,,,13616,10116.0
,N,50512,,,In vivo,A,,CHEMBL622230,1,,BAO_0000218,15240,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,1,,,Cavia porcellus,Intermediate,,,13617,10141.0
,N,50597,,,In vivo,A,,CHEMBL622231,1,,BAO_0000218,16449,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,1,,,Rattus norvegicus,Intermediate,,,13618,10116.0
,N,100710,,,In vivo,A,,CHEMBL622232,1,,BAO_0000218,16449,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,1,,,Macaca fascicularis,Intermediate,,,13619,9541.0
,U,22224,,,In vivo,A,,CHEMBL622233,0,,BAO_0000218,12902,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,1,,,,Autocuration,,,13620,
,U,22224,,,In vivo,A,,CHEMBL622234,0,,BAO_0000218,12902,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,1,,,,Autocuration,,,13621,
,U,22224,,,In vivo,A,,CHEMBL622235,0,,BAO_0000218,12902,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,1,,,,Autocuration,,,13622,
,U,22224,,,In vivo,A,,CHEMBL622236,0,,BAO_0000218,12902,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,1,,,,Autocuration,,,13623,
,U,22224,,,In vivo,A,,CHEMBL622237,0,,BAO_0000218,12902,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,1,,,,Autocuration,,,13624,
,U,22224,,,In vivo,A,,CHEMBL877482,0,,BAO_0000218,12902,Cmax in minutes at a po dose of 10.0(pmol/g/h).,1,,,,Autocuration,,,13625,
,U,22224,,,In vivo,A,,CHEMBL622238,0,,BAO_0000218,12902,Cmax in minutes at a po dose of 20.0(pmol/g/h).,1,,,,Autocuration,,,13626,
,U,22224,,,In vivo,A,,CHEMBL622239,0,,BAO_0000218,12902,Cmax in minutes at a po dose of 40.0(pmol/g/h).,1,,,,Autocuration,,,13627,
,U,22224,,,In vivo,A,178.0,CHEMBL622240,0,,BAO_0000218,11149,Cmax was calculated as maximum concentration reached in the blood,1,,Blood,,Autocuration,,,13628,
,U,22224,,,In vivo,A,178.0,CHEMBL622241,0,,BAO_0000218,11149,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,1,,Blood,,Autocuration,,,13629,
,N,50597,,,In vivo,A,,CHEMBL631013,1,,BAO_0000218,5669,Cmax was determine after peroral administration at 10 mpk in Rat,1,,,Rattus norvegicus,Intermediate,,,13630,10116.0
,N,50797,,,In vivo,A,,CHEMBL631014,1,,BAO_0000218,5669,Cmax was determine after peroral administration at 10 mpk in Rhesus,1,,,Macaca mulatta,Intermediate,,,13631,9544.0
,N,50588,,,In vivo,A,,CHEMBL631015,1,,BAO_0000218,5669,Cmax was determine after peroral administration at 10 mpk in dog,1,,,Canis lupus familiaris,Intermediate,,,13632,9615.0
,N,50597,,,In vivo,A,,CHEMBL631016,1,,BAO_0000218,5669,Cmax was determine after peroral administration at 160 mpk in Rat,1,,,Rattus norvegicus,Intermediate,,,13633,10116.0
,N,50597,,,In vivo,A,,CHEMBL631017,1,,BAO_0000218,5669,Cmax was determine after peroral administration at 20 mpk in Rat,1,,,Rattus norvegicus,Intermediate,,,13634,10116.0
,N,50597,,,In vivo,A,,CHEMBL631018,1,,BAO_0000218,5669,Cmax was determine after peroral administration at 50 mpk in Rat,1,,,Rattus norvegicus,Intermediate,,,13635,10116.0
,U,22224,,,In vivo,A,,CHEMBL631019,0,,BAO_0000218,4236,Cmax was determined,1,,,,Autocuration,,,13636,
,N,50594,,,,A,955.0,CHEMBL875761,1,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,1,,Brain,Mus musculus,Intermediate,,,13637,10090.0
,N,50594,,,,A,955.0,CHEMBL631020,1,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,1,,Brain,Mus musculus,Intermediate,,,13638,10090.0
,N,50594,,,,A,955.0,CHEMBL631669,1,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,1,,Brain,Mus musculus,Intermediate,,,13639,10090.0
,N,50594,,,,A,955.0,CHEMBL631670,1,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,1,,Brain,Mus musculus,Intermediate,,,13640,10090.0
,N,50594,,,,A,2435.0,CHEMBL631671,1,,BAO_0000218,13792,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,1,,Striatum,Mus musculus,Intermediate,,,13641,10090.0
,N,50597,,,,A,178.0,CHEMBL631672,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,1,,Blood,Rattus norvegicus,Intermediate,,,13642,10116.0
,N,50597,,,,A,178.0,CHEMBL631673,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,1,,Blood,Rattus norvegicus,Intermediate,,,13643,10116.0
,N,50597,,,,A,178.0,CHEMBL631856,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,1,,Blood,Rattus norvegicus,Intermediate,,,13644,10116.0
,N,50597,,,,A,178.0,CHEMBL631857,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,1,,Blood,Rattus norvegicus,Intermediate,,,13645,10116.0
,N,50597,,,,A,178.0,CHEMBL631858,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,1,,Blood,Rattus norvegicus,Intermediate,,,13646,10116.0
,N,50597,,,,A,178.0,CHEMBL631859,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,1,,Blood,Rattus norvegicus,Intermediate,,,13647,10116.0
,N,50597,,,,A,178.0,CHEMBL631860,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,1,,Blood,Rattus norvegicus,Intermediate,,,13648,10116.0
,N,50597,,,,A,178.0,CHEMBL631861,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,1,,Blood,Rattus norvegicus,Intermediate,,,13649,10116.0
,N,50597,,,,A,178.0,CHEMBL631862,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,1,,Blood,Rattus norvegicus,Intermediate,,,13650,10116.0
,N,50597,,,,A,178.0,CHEMBL631863,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,1,,Blood,Rattus norvegicus,Intermediate,,,13651,10116.0
,N,50597,,,,A,178.0,CHEMBL631864,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,1,,Blood,Rattus norvegicus,Intermediate,,,13652,10116.0
,N,50597,,,,A,178.0,CHEMBL631865,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,1,,Blood,Rattus norvegicus,Intermediate,,,13653,10116.0
,N,50597,,,,A,178.0,CHEMBL631866,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,1,,Blood,Rattus norvegicus,Intermediate,,,13654,10116.0
,N,50597,,,,A,178.0,CHEMBL629360,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,1,,Blood,Rattus norvegicus,Intermediate,,,13655,10116.0
,N,50597,,,,A,178.0,CHEMBL629361,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,1,,Blood,Rattus norvegicus,Intermediate,,,13656,10116.0
,N,50597,,,,A,178.0,CHEMBL629362,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,1,,Blood,Rattus norvegicus,Intermediate,,,13657,10116.0
,N,50597,,,,A,178.0,CHEMBL630740,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,1,,Blood,Rattus norvegicus,Intermediate,,,13658,10116.0
,N,50597,,,,A,178.0,CHEMBL630741,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,1,,Blood,Rattus norvegicus,Intermediate,,,13659,10116.0
,N,50597,,,,A,178.0,CHEMBL630742,1,,BAO_0000218,8418,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,1,,Blood,Rattus norvegicus,Intermediate,,,13660,10116.0
,N,50597,,,,A,,CHEMBL630743,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,1,,,Rattus norvegicus,Intermediate,,,13661,10116.0
,N,50597,,,,A,,CHEMBL630744,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,1,,,Rattus norvegicus,Intermediate,,,13662,10116.0
,N,50597,,,,A,,CHEMBL630745,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,1,,,Rattus norvegicus,Intermediate,,,13663,10116.0
,N,50597,,,,A,,CHEMBL630746,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,1,,,Rattus norvegicus,Intermediate,,,13664,10116.0
,N,50597,,,,A,,CHEMBL630747,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,1,,,Rattus norvegicus,Intermediate,,,13665,10116.0
,N,50597,,,,A,,CHEMBL630748,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,1,,,Rattus norvegicus,Intermediate,,,13666,10116.0
,N,50597,,,,A,,CHEMBL632056,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,1,,,Rattus norvegicus,Intermediate,,,13667,10116.0
,N,50597,,,,A,,CHEMBL632057,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,1,,,Rattus norvegicus,Intermediate,,,13668,10116.0
,N,50597,,,,A,,CHEMBL632058,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,1,,,Rattus norvegicus,Intermediate,,,13669,10116.0
,N,50597,,,,A,,CHEMBL632059,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,1,,,Rattus norvegicus,Intermediate,,,13670,10116.0
,N,50597,,,,A,,CHEMBL632060,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,1,,,Rattus norvegicus,Intermediate,,,13671,10116.0
,N,50597,,,,A,,CHEMBL632061,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,1,,,Rattus norvegicus,Intermediate,,,13672,10116.0
,N,50597,,,,A,,CHEMBL629207,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,1,,,Rattus norvegicus,Intermediate,,,13673,10116.0
,N,50597,,,,A,,CHEMBL629208,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,1,,,Rattus norvegicus,Intermediate,,,13674,10116.0
,N,50597,,,,A,,CHEMBL629209,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,1,,,Rattus norvegicus,Intermediate,,,13675,10116.0
,N,50597,,,,A,,CHEMBL629210,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,1,,,Rattus norvegicus,Intermediate,,,13676,10116.0
,N,50597,,,,A,,CHEMBL629211,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,1,,,Rattus norvegicus,Intermediate,,,13677,10116.0
,N,50597,,,,A,,CHEMBL629212,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,1,,,Rattus norvegicus,Intermediate,,,13678,10116.0
,N,50597,,,,A,,CHEMBL629213,1,,BAO_0000218,8418,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,1,,,Rattus norvegicus,Intermediate,,,13679,10116.0
,N,50597,,,,A,1088.0,CHEMBL629214,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13680,10116.0
,N,50597,,,,A,1088.0,CHEMBL629215,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13681,10116.0
,N,50597,,,,A,1088.0,CHEMBL635154,1,,BAO_0000218,8133,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",1,,Urine,Rattus norvegicus,Intermediate,,,13682,10116.0
,N,50597,,,,A,,CHEMBL629216,1,,BAO_0000218,6996,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13683,10116.0
,N,50597,,,,A,,CHEMBL629217,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,13684,10116.0
,N,50597,,,,A,,CHEMBL629218,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13685,10116.0
,N,50597,,,,A,,CHEMBL629219,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13686,10116.0
,N,50597,,,,A,,CHEMBL629220,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,13687,10116.0
,N,50597,,,,A,,CHEMBL629221,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,13688,10116.0
,N,50597,,,,A,,CHEMBL631127,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13689,10116.0
,N,50597,,,,A,,CHEMBL631128,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,13690,10116.0
,N,50597,,,,A,,CHEMBL631129,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13691,10116.0
,N,50597,,,,A,,CHEMBL631130,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13692,10116.0
,N,50597,,,,A,,CHEMBL631131,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,13693,10116.0
,N,50597,,,,A,,CHEMBL631132,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,13694,10116.0
,N,50597,,,,A,,CHEMBL631133,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13695,10116.0
,N,50597,,,,A,,CHEMBL631134,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,13696,10116.0
,N,50597,,,,A,,CHEMBL875120,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13697,10116.0
,N,50597,,,,A,,CHEMBL631135,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13698,10116.0
,N,50597,,,,A,,CHEMBL631136,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,13699,10116.0
,N,50597,,,,A,,CHEMBL631137,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,13700,10116.0
,N,50597,,,,A,,CHEMBL631138,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13701,10116.0
,N,50597,,,,A,,CHEMBL631139,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,1,,,Rattus norvegicus,Intermediate,,,13702,10116.0
,N,50597,,,,A,,CHEMBL631140,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13703,10116.0
,N,50597,,,,A,,CHEMBL631141,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13704,10116.0
,N,50597,,,,A,,CHEMBL631142,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),1,,,Rattus norvegicus,Intermediate,,,13705,10116.0
,N,50597,,,,A,,CHEMBL631143,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),1,,,Rattus norvegicus,Intermediate,,,13706,10116.0
,N,50597,,,,A,,CHEMBL631144,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),1,,,Rattus norvegicus,Intermediate,,,13707,10116.0
,N,50588,,,,A,,CHEMBL631145,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,13708,9615.0
,N,50588,,,,A,,CHEMBL631146,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13709,9615.0
,N,50588,,,,A,,CHEMBL631147,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,13710,9615.0
,N,50588,,,,A,,CHEMBL631148,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13711,9615.0
,N,50588,,,,A,,CHEMBL631149,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13712,9615.0
,N,50588,,,,A,,CHEMBL631150,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13713,9615.0
,N,50588,,,,A,,CHEMBL631151,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13714,9615.0
,N,50588,,,,A,,CHEMBL631152,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13715,9615.0
,N,50588,,,,A,,CHEMBL631443,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13716,9615.0
,N,50588,,,,A,,CHEMBL631444,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13717,9615.0
,N,50588,,,,A,,CHEMBL631445,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),1,,,Canis lupus familiaris,Intermediate,,,13718,9615.0
,N,50588,,,,A,,CHEMBL631446,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),1,,,Canis lupus familiaris,Intermediate,,,13719,9615.0
,N,50588,,,,A,,CHEMBL631447,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13720,9615.0
,N,50588,,,,A,,CHEMBL631448,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13721,9615.0
,N,50588,,,,A,,CHEMBL631449,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,1,,,Canis lupus familiaris,Intermediate,,,13722,9615.0
,N,50588,,,,A,,CHEMBL631450,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),1,,,Canis lupus familiaris,Intermediate,,,13723,9615.0
,N,50588,,,,A,,CHEMBL629724,1,,BAO_0000218,6996,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),1,,,Canis lupus familiaris,Intermediate,,,13724,9615.0
,N,50594,,,In vivo,A,14.0,CHEMBL629725,1,,BAO_0000218,9716,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,Zone of skin,Mus musculus,Intermediate,,,13725,10090.0
,N,50594,,,In vivo,A,14.0,CHEMBL629726,1,,BAO_0000218,9716,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,Zone of skin,Mus musculus,Intermediate,,,13726,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL629727,1,,BAO_0000218,9716,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,Spleen,Mus musculus,Intermediate,,,13727,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL630404,1,,BAO_0000218,9716,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,Spleen,Mus musculus,Intermediate,,,13728,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL630405,1,,BAO_0000218,9716,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,Spleen,Mus musculus,Intermediate,,,13729,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL630406,1,,BAO_0000218,9716,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,Spleen,Mus musculus,Intermediate,,,13730,10090.0
,N,50594,,,In vivo,A,945.0,CHEMBL630407,1,,BAO_0000218,9716,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,Stomach,Mus musculus,Intermediate,,,13731,10090.0
,N,50594,,,In vivo,A,945.0,CHEMBL630573,1,,BAO_0000218,9716,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,Stomach,Mus musculus,Intermediate,,,13732,10090.0
,N,50594,,,In vivo,A,945.0,CHEMBL630574,1,,BAO_0000218,9716,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,Stomach,Mus musculus,Intermediate,,,13733,10090.0
,N,50594,,,In vivo,A,945.0,CHEMBL630575,1,,BAO_0000218,9716,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,Stomach,Mus musculus,Intermediate,,,13734,10090.0
,N,50594,,,In vivo,A,,CHEMBL630576,1,,BAO_0000218,9716,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,Mus musculus,Intermediate,,,13735,10090.0
,N,50594,,,In vivo,A,,CHEMBL630577,1,,BAO_0000218,9716,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,Mus musculus,Intermediate,,,13736,10090.0
,N,50594,,,In vivo,A,,CHEMBL630578,1,,BAO_0000218,9716,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,Mus musculus,Intermediate,,,13737,10090.0
,N,50594,,,In vivo,A,,CHEMBL630579,1,,BAO_0000218,9716,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",1,,,Mus musculus,Intermediate,,,13738,10090.0
,N,50594,,,,A,2113.0,CHEMBL630580,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),1,,Kidney,Mus musculus,Intermediate,,,13739,10090.0
,N,50594,,,,A,2113.0,CHEMBL630581,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,1,,Kidney,Mus musculus,Intermediate,,,13740,10090.0
,N,50594,,,,A,2113.0,CHEMBL630582,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),1,,Kidney,Mus musculus,Intermediate,,,13741,10090.0
,N,50594,,,,A,,CHEMBL630583,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,1,,,Mus musculus,Intermediate,,,13742,10090.0
,N,50594,,,,A,,CHEMBL630584,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),1,,,Mus musculus,Intermediate,,,13743,10090.0
,N,50594,,,,A,,CHEMBL630585,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,1,,,Mus musculus,Intermediate,,,13744,10090.0
,N,50594,,,,A,,CHEMBL630586,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),1,,,Mus musculus,Intermediate,,,13745,10090.0
,N,50594,,,,A,,CHEMBL630587,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,1,,,Mus musculus,Intermediate,,,13746,10090.0
,N,50594,,,,A,,CHEMBL630588,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),1,,,Mus musculus,Intermediate,,,13747,10090.0
,N,50594,,,,A,,CHEMBL630589,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,1,,,Mus musculus,Intermediate,,,13748,10090.0
,N,50594,,,,A,,CHEMBL630590,1,,BAO_0000218,12192,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),1,,,Mus musculus,Intermediate,,,13749,10090.0
,U,22224,,,,A,1988.0,CHEMBL630591,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in feces at 24 h,1,,Feces,,Autocuration,,,13750,
,U,22224,,,,A,1988.0,CHEMBL630592,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),1,,Feces,,Autocuration,,,13751,
,U,22224,,,,A,,CHEMBL630593,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,1,,,,Autocuration,,,13752,
,U,22224,,,,A,,CHEMBL630594,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),1,,,,Autocuration,,,13753,
,U,22224,,,,A,1088.0,CHEMBL630595,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),1,,Urine,,Autocuration,,,13754,
,U,22224,,,,A,1088.0,CHEMBL630596,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),1,,Urine,,Autocuration,,,13755,
,U,22224,,,,A,1088.0,CHEMBL630597,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 0-24 h,1,,Urine,,Autocuration,,,13756,
,U,22224,,,,A,1088.0,CHEMBL630598,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),1,,Urine,,Autocuration,,,13757,
,U,22224,,,,A,1088.0,CHEMBL630599,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 0-4 h,1,,Urine,,Autocuration,,,13758,
,U,22224,,,,A,1088.0,CHEMBL630600,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),1,,Urine,,Autocuration,,,13759,
,U,22224,,,,A,1088.0,CHEMBL630601,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 4-24 h,1,,Urine,,Autocuration,,,13760,
,U,22224,,,,A,1088.0,CHEMBL630602,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),1,,Urine,,Autocuration,,,13761,
,U,22224,,,,A,1088.0,CHEMBL630603,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),1,,Urine,,Autocuration,,,13762,
,U,22224,,,,A,1088.0,CHEMBL630604,0,,BAO_0000019,12192,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),1,,Urine,,Autocuration,,,13763,
,N,50597,,,In vivo,A,178.0,CHEMBL624869,1,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,13764,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL624870,1,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,13765,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL623189,1,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Blood,Rattus norvegicus,Intermediate,,,13766,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL623190,1,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,13767,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL623191,1,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,13768,10116.0
,N,50597,,,In vivo,A,,CHEMBL623192,1,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,13769,10116.0
,N,50597,,,In vivo,A,,CHEMBL623193,1,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,13770,10116.0
,N,50597,,,In vivo,A,,CHEMBL623194,1,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,Rattus norvegicus,Intermediate,,,13771,10116.0
,N,50597,,,In vivo,A,,CHEMBL623195,1,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,13772,10116.0
,N,50597,,,In vivo,A,,CHEMBL623196,1,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,13773,10116.0
,N,50597,,,,A,,CHEMBL623197,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,1,,,Rattus norvegicus,Intermediate,,,13774,10116.0
,N,50597,,,,A,,CHEMBL623198,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,,Rattus norvegicus,Intermediate,,,13775,10116.0
,N,50597,,,,A,,CHEMBL623199,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,1,,,Rattus norvegicus,Intermediate,,,13776,10116.0
,N,50597,,,,A,2385.0,CHEMBL623200,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13777,10116.0
,N,50597,,,,A,2385.0,CHEMBL623201,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13778,10116.0
,N,50597,,,,A,2385.0,CHEMBL623202,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13779,10116.0
,N,50597,,,,A,2385.0,CHEMBL623203,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13780,10116.0
,N,50597,,,,A,2385.0,CHEMBL623204,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13781,10116.0
,N,50597,,,,A,2385.0,CHEMBL623205,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13782,10116.0
,N,50597,,,,A,2385.0,CHEMBL623206,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13783,10116.0
,N,50597,,,,A,2385.0,CHEMBL623207,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13784,10116.0
,N,50597,,,,A,2385.0,CHEMBL623208,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13785,10116.0
,N,50597,,,,A,2385.0,CHEMBL623209,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13786,10116.0
,N,50597,,,,A,2385.0,CHEMBL623210,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13787,10116.0
,N,50597,,,,A,,CHEMBL623211,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,1,,,Rattus norvegicus,Intermediate,,,13788,10116.0
,N,50597,,,,A,995.0,CHEMBL623212,1,,BAO_0000218,11836,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,1,,Uterus,Rattus norvegicus,Intermediate,,,13789,10116.0
,U,22224,,,,A,,CHEMBL623213,0,,BAO_0000019,12640,Tested in vitro for intrinsic activity relative to quinpirole,1,,,,Autocuration,,,13790,
,U,22224,,,,A,,CHEMBL623214,0,,BAO_0000019,14218,"Relative ion enhancement, determined in pulsed ultrafiltration",1,,,,Autocuration,,,13791,
,U,22224,,,,A,,CHEMBL623215,0,,BAO_0000019,11296,% ionization at the pH 7.4 at 37 degree Centigrade,1,,,,Autocuration,,,13792,
,U,22224,,,,A,,CHEMBL623216,0,,BAO_0000019,10929,Percentage ionization was measured,1,,,,Autocuration,,,13793,
,N,50591,,,,A,,CHEMBL623217,1,,BAO_0000218,13841,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,1,,,Bos taurus,Intermediate,,,13794,9913.0
,U,22224,,,,A,,CHEMBL623218,0,,BAO_0000019,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,1,,,,Autocuration,,,13795,
,U,22224,,,,A,,CHEMBL623913,0,,BAO_0000019,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,1,,,,Autocuration,,,13796,
,U,22224,,,,A,,CHEMBL623914,0,,BAO_0000019,10431,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,1,,,,Autocuration,,,13797,
,U,22229,,,,P,,CHEMBL623915,0,,BAO_0000100,8826,Compound was evaluated for the partition coefficient in octanol/water,1,,,,Autocuration,,,13798,
,U,22229,,,,P,,CHEMBL624080,0,,BAO_0000100,8826,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),1,,,,Autocuration,,,13799,
,U,22224,,,,A,,CHEMBL624081,0,,BAO_0000019,9884,Equilibrium constant measured by the pulse radiolysis at pH 7,1,,,,Autocuration,,,13800,
,N,50587,,,,A,,CHEMBL624082,1,,BAO_0000218,9827,In vitro hydrolytic rate constant determined in human blood,1,,,Homo sapiens,Intermediate,,,13801,9606.0
,N,50587,,,,A,,CHEMBL625054,1,,BAO_0000218,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,1,,,Homo sapiens,Intermediate,,,13802,9606.0
,U,22224,,,,A,,CHEMBL877485,0,,BAO_0000019,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,1,,,,Autocuration,,,13803,
,N,50594,,,,A,,CHEMBL625055,1,,BAO_0000218,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,1,,,Mus musculus,Intermediate,,,13804,10090.0
,N,50594,,,,A,,CHEMBL625056,1,,BAO_0000218,10009,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,1,,,Mus musculus,Intermediate,,,13805,10090.0
,N,50587,,,,A,,CHEMBL625057,1,,BAO_0000218,10009,In vitro oxidation of compound in presence of human plasma,1,,,Homo sapiens,Intermediate,,,13806,9606.0
,U,22224,,,,A,,CHEMBL625058,0,,BAO_0000019,10009,In vitro oxidation of compound in presence of hydrogen peroxide,1,,,,Autocuration,,,13807,
,N,50594,,,,A,,CHEMBL625059,1,,BAO_0000218,10009,In vitro oxidation of compound in presence of mouse brain homogenate,1,,,Mus musculus,Intermediate,,,13808,10090.0
,N,50594,,,,A,,CHEMBL629536,1,,BAO_0000218,10009,In vitro oxidation of compound in presence of mouse liver homogenate,1,,,Mus musculus,Intermediate,,,13809,10090.0
,N,50597,,,,A,,CHEMBL629537,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13810,10116.0
,N,50597,,,,A,,CHEMBL629538,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13811,10116.0
,N,50597,,,,A,,CHEMBL629539,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13812,10116.0
,N,50597,,,,A,,CHEMBL874445,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13813,10116.0
,N,50597,,,,A,,CHEMBL629540,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13814,10116.0
,N,50597,,,,A,,CHEMBL629541,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13815,10116.0
,N,50597,,,,A,,CHEMBL629542,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13816,10116.0
,N,50597,,,,A,,CHEMBL630243,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,,,Rattus norvegicus,Intermediate,,,13817,10116.0
,N,50597,,,,A,,CHEMBL630244,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13818,10116.0
,N,50597,,,,A,,CHEMBL630245,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13819,10116.0
,N,50597,,,,A,,CHEMBL630246,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13820,10116.0
,N,50597,,,,A,,CHEMBL630247,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13821,10116.0
,N,50597,,,,A,,CHEMBL630248,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13822,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL630249,1,,BAO_0000218,13100,Biodistribution in rat blood at 240 minutes after dose administration.,1,,Blood,Rattus norvegicus,Intermediate,,,13823,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL630250,1,,BAO_0000218,13100,Biodistribution in rat blood at 30 minutes after dose administration.,1,,Blood,Rattus norvegicus,Intermediate,,,13824,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL630251,1,,BAO_0000218,13100,Biodistribution in rat blood at 360 minutes after dose administration.,1,,Blood,Rattus norvegicus,Intermediate,,,13825,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL630252,1,,BAO_0000218,13100,Biodistribution in rat blood at 3 hr after dose administration.,1,,Blood,Rattus norvegicus,Intermediate,,,13826,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL630408,1,,BAO_0000218,13100,Biodistribution in rat blood at 60 minutes after dose administration.,1,,Blood,Rattus norvegicus,Intermediate,,,13827,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL630409,1,,BAO_0000218,13100,Biodistribution in rat cerebellum at 120 minutes after dose administration.,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13828,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL874446,1,,BAO_0000218,13100,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13829,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL630410,1,,BAO_0000218,13100,Biodistribution in rat cerebellum at 15 minutes after dose administration.,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13830,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL630411,1,,BAO_0000218,13100,Biodistribution in rat cerebellum at 240 minutes after dose administration.,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13831,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL630412,1,,BAO_0000218,13100,Biodistribution in rat cerebellum at 30 minutes after dose administration.,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13832,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL630413,1,,BAO_0000218,13100,Biodistribution in rat cerebellum at 360 minutes after dose administration.,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13833,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL630414,1,,BAO_0000218,13100,Biodistribution in rat cerebellum at 3 hr after dose administration.,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13834,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL630415,1,,BAO_0000218,13100,Biodistribution in rat cerebellum at 60 minutes after dose administration.,1,,Cerebellum,Rattus norvegicus,Intermediate,,,13835,10116.0
,N,50597,,,In vivo,A,,CHEMBL630416,1,,BAO_0000218,13100,Biodistribution in rat cortex at 120 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,13836,10116.0
,N,50597,,,In vivo,A,,CHEMBL630417,1,,BAO_0000218,13100,Biodistribution in rat cortex at 1440 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,13837,10116.0
,N,50597,,,In vivo,A,,CHEMBL630418,1,,BAO_0000218,13100,Biodistribution in rat cortex at 15 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,13838,10116.0
,N,50597,,,In vivo,A,,CHEMBL630419,1,,BAO_0000218,13100,Biodistribution in rat cortex at 240 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,13839,10116.0
,N,50597,,,In vivo,A,,CHEMBL630420,1,,BAO_0000218,13100,Biodistribution in rat cortex at 30 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,13840,10116.0
,N,50597,,,In vivo,A,,CHEMBL630421,1,,BAO_0000218,13100,Biodistribution in rat cortex at 360 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,13841,10116.0
,N,50597,,,In vivo,A,,CHEMBL630422,1,,BAO_0000218,13100,Biodistribution in rat cortex at 3 hr after dose administration.,1,,,Rattus norvegicus,Intermediate,,,13842,10116.0
,N,50597,,,In vivo,A,,CHEMBL630423,1,,BAO_0000218,13100,Biodistribution in rat cortex at 60 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,13843,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL630424,1,,BAO_0000218,13100,Biodistribution in rat heart at 120 minutes after dose administration.,1,,Heart,Rattus norvegicus,Intermediate,,,13844,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL630425,1,,BAO_0000218,13100,Biodistribution in rat heart at 15 minutes after dose administration.,1,,Heart,Rattus norvegicus,Intermediate,,,13845,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL629462,1,,BAO_0000218,13100,Biodistribution in rat heart at 240 minutes after dose administration.,1,,Heart,Rattus norvegicus,Intermediate,,,13846,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL630426,1,,BAO_0000218,13100,Biodistribution in rat heart at 30 minutes after dose administration.,1,,Heart,Rattus norvegicus,Intermediate,,,13847,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL630427,1,,BAO_0000218,13100,Biodistribution in rat heart at 360 minutes after dose administration.,1,,Heart,Rattus norvegicus,Intermediate,,,13848,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625877,1,,BAO_0000218,13100,Biodistribution in rat heart at 3 hr after dose administration.,1,,Heart,Rattus norvegicus,Intermediate,,,13849,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625878,1,,BAO_0000218,13100,Biodistribution in rat heart at 60 minutes after dose administration.,1,,Heart,Rattus norvegicus,Intermediate,,,13850,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL625879,1,,BAO_0000218,13100,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,1,,Hippocampus,Rattus norvegicus,Intermediate,,,13851,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL625880,1,,BAO_0000218,13100,Biodistribution in rat hippocampus at 240 minutes after dose administration.,1,,Hippocampus,Rattus norvegicus,Intermediate,,,13852,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL625881,1,,BAO_0000218,13100,Biodistribution in rat hippocampus at 30 minutes after dose administration.,1,,Hippocampus,Rattus norvegicus,Intermediate,,,13853,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL625882,1,,BAO_0000218,13100,Biodistribution in rat hippocampus at 360 minutes after dose administration.,1,,Hippocampus,Rattus norvegicus,Intermediate,,,13854,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL625883,1,,BAO_0000218,13100,Biodistribution in rat hippocampus at 15 minutes after dose administration.,1,,Hippocampus,Rattus norvegicus,Intermediate,,,13855,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL625884,1,,BAO_0000218,13100,Biodistribution in rat kidney at 120 minutes after dose administration.,1,,Kidney,Rattus norvegicus,Intermediate,,,13856,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL625885,1,,BAO_0000218,13100,Biodistribution in rat kidney at 1440 minutes after dose administration.,1,,Kidney,Rattus norvegicus,Intermediate,,,13857,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL628649,1,,BAO_0000218,13100,Biodistribution in rat kidney at 15 minutes after dose administration.,1,,Kidney,Rattus norvegicus,Intermediate,,,13858,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL628650,1,,BAO_0000218,13100,Biodistribution in rat kidney at 240 minutes after dose administration.,1,,Kidney,Rattus norvegicus,Intermediate,,,13859,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL628651,1,,BAO_0000218,13100,Biodistribution in rat kidney at 30 minutes after dose administration.,1,,Kidney,Rattus norvegicus,Intermediate,,,13860,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL628652,1,,BAO_0000218,13100,Biodistribution in rat kidney at 360 minutes after dose administration.,1,,Kidney,Rattus norvegicus,Intermediate,,,13861,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL628653,1,,BAO_0000218,13100,Biodistribution in rat kidney at 60 minutes after dose administration.,1,,Kidney,Rattus norvegicus,Intermediate,,,13862,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL628654,1,,BAO_0000218,13100,Biodistribution in rat liver at 120 minutes after dose administration.,1,,Liver,Rattus norvegicus,Intermediate,,,13863,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL628655,1,,BAO_0000218,13100,Biodistribution in rat liver at 1440 minutes after dose administration.,1,,Liver,Rattus norvegicus,Intermediate,,,13864,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625238,1,,BAO_0000218,13100,Biodistribution in rat liver at 15 minutes after dose administration.,1,,Liver,Rattus norvegicus,Intermediate,,,13865,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625239,1,,BAO_0000218,13100,Biodistribution in rat liver at 240 minutes after dose administration.,1,,Liver,Rattus norvegicus,Intermediate,,,13866,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625240,1,,BAO_0000218,13100,Biodistribution in rat liver at 30 minutes after dose administration.,1,,Liver,Rattus norvegicus,Intermediate,,,13867,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625241,1,,BAO_0000218,13100,Biodistribution in rat liver at 360 minutes after dose administration.,1,,Liver,Rattus norvegicus,Intermediate,,,13868,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625242,1,,BAO_0000218,13100,Biodistribution in rat liver at 60 minutes after dose administration.,1,,Liver,Rattus norvegicus,Intermediate,,,13869,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL874587,1,,BAO_0000218,13100,Biodistribution in rat lung at 120 minutes after dose administration.,1,,Lung,Rattus norvegicus,Intermediate,,,13870,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625405,1,,BAO_0000218,13100,Biodistribution in rat lung at 1440 minutes after dose administration.,1,,Lung,Rattus norvegicus,Intermediate,,,13871,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625406,1,,BAO_0000218,13100,Biodistribution in rat lung at 15 minutes after dose administration.,1,,Lung,Rattus norvegicus,Intermediate,,,13872,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625407,1,,BAO_0000218,13100,Biodistribution in rat lung at 240 minutes after dose administration.,1,,Lung,Rattus norvegicus,Intermediate,,,13873,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625408,1,,BAO_0000218,13100,Biodistribution in rat lung at 30 minutes after dose administration.,1,,Lung,Rattus norvegicus,Intermediate,,,13874,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625409,1,,BAO_0000218,13100,Biodistribution in rat lung at 360 minutes after dose administration.,1,,Lung,Rattus norvegicus,Intermediate,,,13875,10116.0
,N,50597,,,,A,1515.0,CHEMBL625410,1,,BAO_0000218,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,1,,Thoracic aorta,Rattus norvegicus,Intermediate,,,13876,10116.0
,N,50597,,,,A,1515.0,CHEMBL625411,1,,BAO_0000218,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,1,,Thoracic aorta,Rattus norvegicus,Intermediate,,,13877,10116.0
,N,50597,,,,A,1515.0,CHEMBL625412,1,,BAO_0000218,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,1,,Thoracic aorta,Rattus norvegicus,Intermediate,,,13878,10116.0
,N,50597,,,,A,1515.0,CHEMBL625413,1,,BAO_0000218,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,1,,Thoracic aorta,Rattus norvegicus,Intermediate,,,13879,10116.0
,N,50597,,,,A,1515.0,CHEMBL625414,1,,BAO_0000218,12361,Percent of maximal contractile response to compound in rat thoracic aorta strips v,1,,Thoracic aorta,Rattus norvegicus,Intermediate,,,13880,10116.0
,N,50597,,,,A,1515.0,CHEMBL625415,1,,BAO_0000218,12361,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,1,,Thoracic aorta,Rattus norvegicus,Intermediate,,,13881,10116.0
,N,50597,,,,A,1515.0,CHEMBL625416,1,,BAO_0000218,12361,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,1,,Thoracic aorta,Rattus norvegicus,Intermediate,,,13882,10116.0
,N,50597,,,,A,1088.0,CHEMBL625417,1,,BAO_0000218,12712,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,1,,Urine,Rattus norvegicus,Intermediate,,,13883,10116.0
,N,50597,,,,A,1988.0,CHEMBL625418,1,,BAO_0000218,7415,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,1,,Feces,Rattus norvegicus,Intermediate,,,13884,10116.0
,N,50597,,,,A,1088.0,CHEMBL625419,1,,BAO_0000218,7415,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,1,,Urine,Rattus norvegicus,Intermediate,,,13885,10116.0
,N,50597,,,,A,,CHEMBL625420,1,,BAO_0000218,7415,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,1,,,Rattus norvegicus,Intermediate,,,13886,10116.0
,N,50597,,,,A,,CHEMBL626996,1,,BAO_0000218,7415,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,1,,,Rattus norvegicus,Intermediate,,,13887,10116.0
,N,50597,,,,A,1988.0,CHEMBL626997,1,,BAO_0000218,7415,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",1,,Feces,Rattus norvegicus,Intermediate,,,13888,10116.0
,N,50597,,,,A,1088.0,CHEMBL626998,1,,BAO_0000218,7415,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",1,,Urine,Rattus norvegicus,Intermediate,,,13889,10116.0
,N,50597,,,,A,,CHEMBL626999,1,,BAO_0000218,7415,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",1,,,Rattus norvegicus,Intermediate,,,13890,10116.0
,N,50594,,,,A,,CHEMBL627000,1,,BAO_0000218,8050,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,1,,,Mus musculus,Intermediate,,,13891,10090.0
,N,50594,,,,A,,CHEMBL627001,1,,BAO_0000218,8050,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,1,,,Mus musculus,Intermediate,,,13892,10090.0
,N,50594,,,,A,,CHEMBL627002,1,,BAO_0000218,8050,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,1,,,Mus musculus,Intermediate,,,13893,10090.0
,N,50594,,,,A,,CHEMBL627003,1,,BAO_0000218,8050,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,1,,,Mus musculus,Intermediate,,,13894,10090.0
,N,50594,,,,A,1088.0,CHEMBL627004,1,,BAO_0000218,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,1,,Urine,Mus musculus,Intermediate,,,13895,10090.0
,N,50594,,,,A,1088.0,CHEMBL627005,1,,BAO_0000218,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,1,,Urine,Mus musculus,Intermediate,,,13896,10090.0
,N,50594,,,,A,1088.0,CHEMBL874594,1,,BAO_0000218,8050,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,1,,Urine,Mus musculus,Intermediate,,,13897,10090.0
,N,50594,,,,A,1088.0,CHEMBL627006,1,,BAO_0000218,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,1,,Urine,Mus musculus,Intermediate,,,13898,10090.0
,N,50594,,,,A,1088.0,CHEMBL627007,1,,BAO_0000218,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,1,,Urine,Mus musculus,Intermediate,,,13899,10090.0
,N,50594,,,,A,1088.0,CHEMBL627884,1,,BAO_0000218,8050,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,1,,Urine,Mus musculus,Intermediate,,,13900,10090.0
,N,50594,,,,A,1088.0,CHEMBL627885,1,,BAO_0000218,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,1,,Urine,Mus musculus,Intermediate,,,13901,10090.0
,N,50594,,,,A,1088.0,CHEMBL627886,1,,BAO_0000218,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,1,,Urine,Mus musculus,Intermediate,,,13902,10090.0
,N,50594,,,,A,1088.0,CHEMBL627887,1,,BAO_0000218,8050,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,1,,Urine,Mus musculus,Intermediate,,,13903,10090.0
,N,50594,,,,A,1088.0,CHEMBL627888,1,,BAO_0000218,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,1,,Urine,Mus musculus,Intermediate,,,13904,10090.0
,N,50594,,,,A,1088.0,CHEMBL628057,1,,BAO_0000218,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,1,,Urine,Mus musculus,Intermediate,,,13905,10090.0
,N,50594,,,,A,1088.0,CHEMBL627405,1,,BAO_0000218,8050,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,1,,Urine,Mus musculus,Intermediate,,,13906,10090.0
,N,50588,,,,A,1088.0,CHEMBL627406,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13907,9615.0
,N,50588,,,,A,1088.0,CHEMBL627407,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13908,9615.0
,N,50588,,,,A,1088.0,CHEMBL627408,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13909,9615.0
,N,50588,,,,A,1088.0,CHEMBL627409,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13910,9615.0
,N,50588,,,,A,1088.0,CHEMBL875486,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13911,9615.0
,N,50588,,,,A,1088.0,CHEMBL627410,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13912,9615.0
,N,50588,,,,A,1088.0,CHEMBL627411,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13913,9615.0
,N,50588,,,,A,1088.0,CHEMBL627412,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13914,9615.0
,N,50588,,,,A,1088.0,CHEMBL627413,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13915,9615.0
,N,50588,,,,A,1088.0,CHEMBL627414,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13916,9615.0
,N,50588,,,,A,1088.0,CHEMBL627415,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13917,9615.0
,N,50588,,,,A,1088.0,CHEMBL627416,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13918,9615.0
,N,50588,,,,A,1088.0,CHEMBL627417,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13919,9615.0
,N,50588,,,,A,1088.0,CHEMBL627418,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13920,9615.0
,N,50588,,,,A,1088.0,CHEMBL627419,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13921,9615.0
,N,50588,,,,A,1088.0,CHEMBL627320,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13922,9615.0
,N,50588,,,,A,1088.0,CHEMBL627321,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,13923,9615.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627322,1,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,13924,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627323,1,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,13925,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627491,1,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Kidney,Rattus norvegicus,Intermediate,,,13926,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627492,1,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,13927,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL627493,1,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,13928,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627494,1,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,13929,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627495,1,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,13930,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627496,1,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Liver,Rattus norvegicus,Intermediate,,,13931,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627497,1,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,13932,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL627498,1,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,13933,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627499,1,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,13934,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627500,1,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,13935,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL627501,1,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Lung,Rattus norvegicus,Intermediate,,,13936,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625616,1,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,13937,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625617,1,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,13938,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL625618,1,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13939,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL625619,1,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13940,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL625620,1,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13941,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL625621,1,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13942,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL625622,1,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,13943,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL625788,1,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,13944,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL625789,1,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,13945,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL625790,1,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Spleen,Rattus norvegicus,Intermediate,,,13946,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL625791,1,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,13947,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL622334,1,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,13948,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL622335,1,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,13949,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL622336,1,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,13950,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL622337,1,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Thyroid gland,Rattus norvegicus,Intermediate,,,13951,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL622338,1,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,13952,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL622339,1,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,13953,10116.0
,N,50597,,,In vivo,A,,CHEMBL624153,1,,BAO_0000218,12017,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,13954,10116.0
,N,50597,,,In vivo,A,,CHEMBL628430,1,,BAO_0000218,12017,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,13955,10116.0
,N,50597,,,In vivo,A,,CHEMBL628431,1,,BAO_0000218,12017,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,Rattus norvegicus,Intermediate,,,13956,10116.0
,N,50597,,,In vivo,A,,CHEMBL628432,1,,BAO_0000218,12017,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,13957,10116.0
,N,50597,,,In vivo,A,,CHEMBL628433,1,,BAO_0000218,12017,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,13958,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL628434,1,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,Spleen,Rattus norvegicus,Intermediate,,,13959,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL626789,1,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,Spleen,Rattus norvegicus,Intermediate,,,13960,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL626790,1,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",1,,Spleen,Rattus norvegicus,Intermediate,,,13961,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL626791,1,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,Spleen,Rattus norvegicus,Intermediate,,,13962,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL626792,1,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,Spleen,Rattus norvegicus,Intermediate,,,13963,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL626793,1,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,Spleen,Rattus norvegicus,Intermediate,,,13964,10116.0
,N,50597,,,,A,,CHEMBL627436,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13965,10116.0
,N,50597,,,,A,,CHEMBL627437,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13966,10116.0
,N,50597,,,,A,,CHEMBL627438,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13967,10116.0
,N,50597,,,,A,,CHEMBL627439,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13968,10116.0
,N,50597,,,,A,,CHEMBL627440,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13969,10116.0
,N,50597,,,,A,,CHEMBL627602,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13970,10116.0
,N,50597,,,,A,,CHEMBL627603,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13971,10116.0
,N,50597,,,,A,,CHEMBL627604,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13972,10116.0
,N,50597,,,,A,,CHEMBL627605,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13973,10116.0
,N,50597,,,,A,,CHEMBL627606,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13974,10116.0
,N,50597,,,,A,,CHEMBL627607,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13975,10116.0
,N,50597,,,,A,,CHEMBL627608,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13976,10116.0
,N,50597,,,,A,,CHEMBL627609,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13977,10116.0
,N,50597,,,,A,,CHEMBL627610,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13978,10116.0
,N,50597,,,,A,,CHEMBL627611,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13979,10116.0
,N,50597,,,,A,,CHEMBL627612,1,,BAO_0000218,11510,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,,,Rattus norvegicus,Intermediate,,,13980,10116.0
,U,22229,,,,P,,CHEMBL627613,0,,BAO_0000100,8362,Octanol:water partition coefficient is evaluated,1,,,,Autocuration,,,13981,
,U,22224,,,,P,,CHEMBL627614,0,,BAO_0000100,8257,Partition coefficient in 1-octanol/water system,1,,,,Autocuration,,,13982,
,U,22224,,,,P,,CHEMBL627615,0,,BAO_0000100,8257,Partition coefficient in 1-octanol/water system measured using radio active compounds,1,,,,Autocuration,,,13983,
,U,22224,,,,P,,CHEMBL627616,0,,BAO_0000100,9468,Partition coefficient in octanol/water system was determined,1,,,,Autocuration,,,13984,
,U,22224,,,,P,,CHEMBL627617,0,,BAO_0000100,9468,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,1,,,,Autocuration,,,13985,
,U,22224,,,,A,,CHEMBL627618,0,,BAO_0000019,10568,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,1,,,,Autocuration,,,13986,
,U,22224,,,,A,,CHEMBL627619,0,,BAO_0000019,10568,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",1,,,,Autocuration,,,13987,
,U,22224,,,,A,,CHEMBL627620,0,,BAO_0000019,15359,Pseudo-first-order rate constant of the compound,1,,,,Autocuration,,,13988,
,U,22224,,,,A,,CHEMBL627621,0,,BAO_0000019,15359,Pseudo-first-order rate constant with 1-min time point,1,,,,Autocuration,,,13989,
,U,22224,,,,A,,CHEMBL627622,0,,BAO_0000019,15359,Pseudo-first-order rate constant without 1-min time point,1,,,,Autocuration,,,13990,
,U,22224,,,,A,,CHEMBL627623,0,,BAO_0000019,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,1,,,,Autocuration,,,13991,
,U,22224,,,,A,,CHEMBL627624,0,,BAO_0000019,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,1,,,,Autocuration,,,13992,
,U,22224,,,,A,,CHEMBL627625,0,,BAO_0000019,10431,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,1,,,,Autocuration,,,13993,
,U,22224,,,,A,,CHEMBL628523,0,,BAO_0000019,15704,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,1,,,,Autocuration,,,13994,
,U,22224,,,,A,,CHEMBL628524,0,,BAO_0000019,15287,The alkaline hydrolysis second order rate constant(K OH) of the compound,1,,,,Autocuration,,,13995,
,U,22224,,,,A,,CHEMBL628525,0,,BAO_0000019,7516,The efflux rate constant of the compound,1,,,,Autocuration,,,13996,
,U,22224,,,,A,,CHEMBL625732,0,,BAO_0000019,12973,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,1,,,,Autocuration,,,13997,
,U,22224,,,,A,,CHEMBL625733,0,,BAO_0000019,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,1,,,,Autocuration,,,13998,
,U,22224,,,,F,,CHEMBL625734,0,,BAO_0000019,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,1,,,,Autocuration,,,13999,
,U,22224,,,,A,,CHEMBL625913,0,,BAO_0000019,12973,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,1,,,,Autocuration,,,14000,
,U,22224,,,,A,,CHEMBL625914,0,,BAO_0000019,8696,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,1,,,,Autocuration,,,14001,
,U,22224,,,,A,,CHEMBL625915,0,,BAO_0000019,15052,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,1,,,,Autocuration,,,14002,
,U,22224,,,,A,,CHEMBL625916,0,,BAO_0000019,15052,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,1,,,,Autocuration,,,14003,
,U,22224,,,,A,,CHEMBL625917,0,,BAO_0000019,10503,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),1,,,,Autocuration,,,14004,
,U,22224,,,,A,,CHEMBL625918,0,,BAO_0000019,8354,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14005,
,U,22224,,,,A,,CHEMBL625919,0,,BAO_0000019,8354,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14006,
,U,22224,,,,A,,CHEMBL625920,0,,BAO_0000019,8354,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14007,
,U,22224,,,,A,,CHEMBL874453,0,,BAO_0000019,8354,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14008,
,U,22224,,,,A,,CHEMBL625921,0,,BAO_0000019,8354,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14009,
,U,22224,,,,A,,CHEMBL625922,0,,BAO_0000019,10503,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,1,,,,Autocuration,,,14010,
,U,22224,,,,A,,CHEMBL625923,0,,BAO_0000019,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14011,
,U,22224,,,,A,,CHEMBL625924,0,,BAO_0000019,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14012,
,U,22224,,,,A,,CHEMBL625925,0,,BAO_0000019,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14013,
,U,22224,,,,A,,CHEMBL625926,0,,BAO_0000019,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14014,
,N,50597,,,In vivo,A,2048.0,CHEMBL627704,1,,BAO_0000218,13100,Biodistribution in rat lung at 60 minutes after dose administration.,1,,Lung,Rattus norvegicus,Intermediate,,,14015,10116.0
,N,50597,,,In vivo,A,,CHEMBL627705,1,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,14016,10116.0
,N,50597,,,In vivo,A,,CHEMBL627706,1,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,14017,10116.0
,N,50597,,,In vivo,A,,CHEMBL627707,1,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,14018,10116.0
,N,50597,,,In vivo,A,,CHEMBL627708,1,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,14019,10116.0
,N,50597,,,In vivo,A,,CHEMBL628361,1,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,14020,10116.0
,N,50597,,,In vivo,A,,CHEMBL628362,1,,BAO_0000218,13100,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,1,,,Rattus norvegicus,Intermediate,,,14021,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL628363,1,,BAO_0000218,13100,Biodistribution in rat striatum at 120 minutes after dose administration.,1,,Striatum,Rattus norvegicus,Intermediate,,,14022,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL628364,1,,BAO_0000218,13100,Biodistribution in rat striatum at 1440 minutes after dose administration.,1,,Striatum,Rattus norvegicus,Intermediate,,,14023,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL628365,1,,BAO_0000218,13100,Biodistribution in rat striatum at 15 minutes after dose administration.,1,,Striatum,Rattus norvegicus,Intermediate,,,14024,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL874454,1,,BAO_0000218,13100,Biodistribution in rat striatum at 240 minutes after dose administration.,1,,Striatum,Rattus norvegicus,Intermediate,,,14025,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL628531,1,,BAO_0000218,13100,Biodistribution in rat striatum at 30 minutes after dose administration.,1,,Striatum,Rattus norvegicus,Intermediate,,,14026,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL628532,1,,BAO_0000218,13100,Biodistribution in rat striatum at 360 minutes after dose administration.,1,,Striatum,Rattus norvegicus,Intermediate,,,14027,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL628533,1,,BAO_0000218,13100,Biodistribution in rat striatum at 3 hr after dose administration.,1,,Striatum,Rattus norvegicus,Intermediate,,,14028,10116.0
,N,50597,,,In vivo,A,2435.0,CHEMBL628534,1,,BAO_0000218,13100,Biodistribution in rat striatum at 60 minutes after dose administration.,1,,Striatum,Rattus norvegicus,Intermediate,,,14029,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL628535,1,,BAO_0000218,13100,Biodistribution in rat thyroid at 120 minutes after dose administration.,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,14030,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL628536,1,,BAO_0000218,13100,Biodistribution in rat thyroid at 1440 minutes after dose administration.,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,14031,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL628537,1,,BAO_0000218,13100,Biodistribution in rat thyroid at 15 minutes after dose administration.,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,14032,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL628538,1,,BAO_0000218,13100,Biodistribution in rat thyroid at 240 minutes after dose administration.,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,14033,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL628539,1,,BAO_0000218,13100,Biodistribution in rat thyroid at 30 minutes after dose administration.,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,14034,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL630297,1,,BAO_0000218,13100,Biodistribution in rat thyroid at 360 minutes after dose administration.,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,14035,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL630298,1,,BAO_0000218,13100,Biodistribution in rat thyroid at 60 minutes after dose administration.,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,14036,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL630299,1,,BAO_0000218,13100,Biodistribution in rest of brain of rat 120 minutes after dose administration.,1,,Brain,Rattus norvegicus,Intermediate,,,14037,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL628094,1,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,1,,Brain,Rattus norvegicus,Intermediate,,,14038,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL628095,1,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,1,,Brain,Rattus norvegicus,Intermediate,,,14039,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL874648,1,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,1,,Brain,Rattus norvegicus,Intermediate,,,14040,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL628096,1,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,1,,Brain,Rattus norvegicus,Intermediate,,,14041,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL628097,1,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,1,,Brain,Rattus norvegicus,Intermediate,,,14042,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL628098,1,,BAO_0000218,13100,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,1,,Brain,Rattus norvegicus,Intermediate,,,14043,10116.0
,U,22224,,,,A,,CHEMBL628099,0,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",1,,,,Autocuration,,,14044,
,U,22224,,,,A,,CHEMBL628100,0,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",1,,,,Autocuration,,,14045,
,U,22224,,,,A,,CHEMBL628101,0,,BAO_0000019,13331,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),1,,,,Autocuration,,,14046,
,U,22224,,,,A,,CHEMBL628102,0,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",1,,,,Autocuration,,,14047,
,U,22224,,,,A,,CHEMBL628103,0,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",1,,,,Autocuration,,,14048,
,U,22224,,,,A,,CHEMBL628104,0,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",1,,,,Autocuration,,,14049,
,U,22224,,,,A,,CHEMBL628105,0,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",1,,,,Autocuration,,,14050,
,U,22224,,,,A,,CHEMBL628106,0,,BAO_0000019,13331,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",1,,,,Autocuration,,,14051,
,N,50597,,,,A,1088.0,CHEMBL628107,1,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,1,,Urine,Rattus norvegicus,Intermediate,,,14052,10116.0
,U,22224,,,,F,1088.0,CHEMBL628108,0,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,1,,Urine,,Autocuration,,,14053,
,N,50597,,,,A,1088.0,CHEMBL628109,1,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,1,,Urine,Rattus norvegicus,Intermediate,,,14054,10116.0
,U,22224,,,,F,1088.0,CHEMBL625299,0,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,1,,Urine,,Autocuration,,,14055,
,N,50597,,,,A,1088.0,CHEMBL625300,1,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,1,,Urine,Rattus norvegicus,Intermediate,,,14056,10116.0
,N,50597,,,,A,1088.0,CHEMBL625301,1,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,1,,Urine,Rattus norvegicus,Intermediate,,,14057,10116.0
,N,50597,,,,A,1088.0,CHEMBL625302,1,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,1,,Urine,Rattus norvegicus,Intermediate,,,14058,10116.0
,N,50597,,,,A,1088.0,CHEMBL874649,1,,BAO_0000218,10086,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,1,,Urine,Rattus norvegicus,Intermediate,,,14059,10116.0
,N,50597,,,,A,,CHEMBL625303,1,,BAO_0000218,13248,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,1,,,Rattus norvegicus,Intermediate,,,14060,10116.0
,N,50597,,,,A,,CHEMBL625463,1,,BAO_0000218,13248,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,1,,,Rattus norvegicus,Intermediate,,,14061,10116.0
,N,50587,,,,A,2107.0,CHEMBL625464,1,,BAO_0000218,14527,In vitro metabolism in human liver microsomes,1,,Liver,Homo sapiens,Intermediate,,,14062,9606.0
,N,50587,,,,A,,CHEMBL625465,1,,BAO_0000218,3008,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,1,,,Homo sapiens,Intermediate,,,14063,9606.0
,N,50588,,,,A,1088.0,CHEMBL625466,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14064,9615.0
,N,50588,,,,A,1088.0,CHEMBL625467,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14065,9615.0
,N,50597,,,,A,1088.0,CHEMBL625468,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14066,10116.0
,N,50597,,,,A,1088.0,CHEMBL625469,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14067,10116.0
,N,50597,,,,A,1088.0,CHEMBL625470,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14068,10116.0
,N,50597,,,,A,1088.0,CHEMBL632418,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14069,10116.0
,N,50597,,,,A,1088.0,CHEMBL627250,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14070,10116.0
,N,50597,,,,A,1088.0,CHEMBL627251,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14071,10116.0
,N,50597,,,,A,1088.0,CHEMBL627252,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14072,10116.0
,N,50597,,,,A,1088.0,CHEMBL627253,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14073,10116.0
,N,50597,,,,A,1088.0,CHEMBL627254,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14074,10116.0
,N,50597,,,,A,1088.0,CHEMBL875471,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14075,10116.0
,N,50597,,,,A,1088.0,CHEMBL627255,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14076,10116.0
,N,50597,,,,A,1088.0,CHEMBL627256,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14077,10116.0
,N,50597,,,,A,1088.0,CHEMBL627257,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14078,10116.0
,N,50597,,,,A,1088.0,CHEMBL627258,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14079,10116.0
,N,50597,,,,A,1088.0,CHEMBL627259,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14080,10116.0
,N,50597,,,,A,1088.0,CHEMBL627260,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14081,10116.0
,N,50597,,,,A,1088.0,CHEMBL623256,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14082,10116.0
,N,50597,,,,A,1088.0,CHEMBL874413,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14083,10116.0
,N,50597,,,,A,1088.0,CHEMBL623257,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14084,10116.0
,N,50597,,,,A,1088.0,CHEMBL623258,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14085,10116.0
,N,50597,,,,A,1088.0,CHEMBL623259,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14086,10116.0
,N,50597,,,,A,1088.0,CHEMBL623260,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14087,10116.0
,N,50597,,,,A,1088.0,CHEMBL623261,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14088,10116.0
,N,50597,,,,A,1088.0,CHEMBL623262,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14089,10116.0
,N,50597,,,,A,1088.0,CHEMBL623263,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14090,10116.0
,N,50597,,,,A,1088.0,CHEMBL623264,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14091,10116.0
,N,50597,,,,A,1088.0,CHEMBL623265,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14092,10116.0
,N,50597,,,,A,1088.0,CHEMBL623266,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14093,10116.0
,N,50597,,,,A,1088.0,CHEMBL623267,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14094,10116.0
,N,50597,,,,A,1088.0,CHEMBL623268,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14095,10116.0
,N,50597,,,,A,1088.0,CHEMBL623269,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14096,10116.0
,N,50597,,,,A,1088.0,CHEMBL623270,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14097,10116.0
,N,50597,,,,A,1088.0,CHEMBL623271,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14098,10116.0
,N,50597,,,,A,1088.0,CHEMBL623272,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14099,10116.0
,N,50597,,,,A,1088.0,CHEMBL623273,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14100,10116.0
,N,50597,,,,A,1088.0,CHEMBL623274,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14101,10116.0
,N,50597,,,,A,1088.0,CHEMBL874414,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14102,10116.0
,N,50597,,,,A,1088.0,CHEMBL623275,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14103,10116.0
,N,50597,,,,A,1088.0,CHEMBL629150,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14104,10116.0
,N,50597,,,,A,1088.0,CHEMBL623276,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14105,10116.0
,N,50597,,,,A,1088.0,CHEMBL623277,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14106,10116.0
,N,50597,,,,A,1088.0,CHEMBL623112,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14107,10116.0
,N,50597,,,,A,1088.0,CHEMBL623113,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14108,10116.0
,N,50597,,,,A,1088.0,CHEMBL623800,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14109,10116.0
,N,50597,,,,A,1088.0,CHEMBL623801,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14110,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL623802,1,,BAO_0000218,12017,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",1,,Spleen,Rattus norvegicus,Intermediate,,,14111,10116.0
,N,50597,,,In vivo,A,995.0,CHEMBL623803,1,,BAO_0000218,12017,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Uterus,Rattus norvegicus,Intermediate,,,14112,10116.0
,N,50597,,,In vivo,A,995.0,CHEMBL623970,1,,BAO_0000218,12017,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Uterus,Rattus norvegicus,Intermediate,,,14113,10116.0
,N,50597,,,In vivo,A,995.0,CHEMBL623971,1,,BAO_0000218,12017,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Uterus,Rattus norvegicus,Intermediate,,,14114,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL623972,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),1,,Blood,Rattus norvegicus,Intermediate,,,14115,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL623973,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),1,,Blood,Rattus norvegicus,Intermediate,,,14116,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL623974,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),1,,Blood,Rattus norvegicus,Intermediate,,,14117,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL623975,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),1,,Blood,Rattus norvegicus,Intermediate,,,14118,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL623976,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),1,,Brain,Rattus norvegicus,Intermediate,,,14119,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL623977,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),1,,Brain,Rattus norvegicus,Intermediate,,,14120,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL623978,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),1,,Brain,Rattus norvegicus,Intermediate,,,14121,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL623979,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),1,,Brain,Rattus norvegicus,Intermediate,,,14122,10116.0
,N,50597,,,In vivo,A,,CHEMBL623980,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),1,,,Rattus norvegicus,Intermediate,,,14123,10116.0
,N,50597,,,In vivo,A,,CHEMBL623981,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),1,,,Rattus norvegicus,Intermediate,,,14124,10116.0
,N,50597,,,In vivo,A,,CHEMBL626278,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),1,,,Rattus norvegicus,Intermediate,,,14125,10116.0
,N,50597,,,In vivo,A,,CHEMBL626279,1,,BAO_0000218,14045,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),1,,,Rattus norvegicus,Intermediate,,,14126,10116.0
,N,50594,,,In vivo,A,,CHEMBL626280,1,,BAO_0000218,14045,Biodistribution in mice bladder plus excreted urine was determined,1,,,Mus musculus,Intermediate,,,14127,10090.0
,N,50594,,,,A,,CHEMBL626281,1,,BAO_0000218,14045,"Percentage biodistribution in mouse blood, 10 minutes post injection",1,,,Mus musculus,Intermediate,,,14128,10090.0
,N,50594,,,,A,,CHEMBL626282,1,,BAO_0000218,14045,"Percentage biodistribution in mouse blood, 30 minutes post injection",1,,,Mus musculus,Intermediate,,,14129,10090.0
,N,50594,,,,A,,CHEMBL626283,1,,BAO_0000218,14045,"Percentage biodistribution in mouse blood, 5 minutes post injection",1,,,Mus musculus,Intermediate,,,14130,10090.0
,N,50594,,,,A,,CHEMBL626284,1,,BAO_0000218,14045,"Percentage biodistribution in mouse blood, 60 minutes post injection",1,,,Mus musculus,Intermediate,,,14131,10090.0
,N,50594,,,,A,955.0,CHEMBL626285,1,,BAO_0000218,14045,"Percentage biodistribution in mouse brain, 10 minutes post injection",1,,Brain,Mus musculus,Intermediate,,,14132,10090.0
,N,50594,,,,A,955.0,CHEMBL626286,1,,BAO_0000218,14045,"Percentage biodistribution in mouse brain, 30 minutes post injection",1,,Brain,Mus musculus,Intermediate,,,14133,10090.0
,N,50594,,,,A,955.0,CHEMBL626287,1,,BAO_0000218,14045,"Percentage biodistribution in mouse brain, 5 minutes post injection",1,,Brain,Mus musculus,Intermediate,,,14134,10090.0
,N,50594,,,,A,955.0,CHEMBL626288,1,,BAO_0000218,14045,"Percentage biodistribution in mouse brain, 60 minutes post injection",1,,Brain,Mus musculus,Intermediate,,,14135,10090.0
,N,50594,,,,A,,CHEMBL626289,1,,BAO_0000218,14045,"Percentage biodistribution in mouse heart, 10 minutes post injection",1,,,Mus musculus,Intermediate,,,14136,10090.0
,N,50594,,,,A,,CHEMBL626290,1,,BAO_0000218,14045,"Percentage biodistribution in mouse heart, 30 minutes post injection",1,,,Mus musculus,Intermediate,,,14137,10090.0
,N,50594,,,,A,,CHEMBL626291,1,,BAO_0000218,14045,"Percentage biodistribution in mouse heart, 5 minutes post injection",1,,,Mus musculus,Intermediate,,,14138,10090.0
,N,50594,,,,A,,CHEMBL839888,1,,BAO_0000218,14045,"Percentage biodistribution in mouse heart, 60 minutes post injection",1,,,Mus musculus,Intermediate,,,14139,10090.0
,N,50594,,,,A,160.0,CHEMBL626292,1,,BAO_0000218,14045,"Percentage biodistribution in mouse intestine, 10 minutes post injection",1,,Intestine,Mus musculus,Intermediate,,,14140,10090.0
,N,50594,,,,A,160.0,CHEMBL626293,1,,BAO_0000218,14045,"Percentage biodistribution in mouse intestine, 30 minutes post injection",1,,Intestine,Mus musculus,Intermediate,,,14141,10090.0
,N,50594,,,,A,160.0,CHEMBL626294,1,,BAO_0000218,14045,"Percentage biodistribution in mouse intestine, 5 minutes post injection",1,,Intestine,Mus musculus,Intermediate,,,14142,10090.0
,N,50594,,,,A,160.0,CHEMBL626295,1,,BAO_0000218,14045,"Percentage biodistribution in mouse intestine, 60 minutes post injection",1,,Intestine,Mus musculus,Intermediate,,,14143,10090.0
,N,50594,,,,A,2107.0,CHEMBL627659,1,,BAO_0000218,14045,"Percentage biodistribution in mouse liver, 10 minutes post injection",1,,Liver,Mus musculus,Intermediate,,,14144,10090.0
,N,50594,,,,A,2107.0,CHEMBL627660,1,,BAO_0000218,14045,"Percentage biodistribution in mouse liver, 30 minutes of post injection",1,,Liver,Mus musculus,Intermediate,,,14145,10090.0
,N,50594,,,,A,2107.0,CHEMBL627661,1,,BAO_0000218,14045,"Percentage biodistribution in mouse liver, 5 minutes post injection",1,,Liver,Mus musculus,Intermediate,,,14146,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL627662,1,,BAO_0000218,14045,Biodistribution in mice liver at 60 minutes of post injection,1,,Liver,Mus musculus,Intermediate,,,14147,10090.0
,N,50594,,,In vivo,A,2048.0,CHEMBL627663,1,,BAO_0000218,14045,Biodistribution in mice lungs at 10 min of post injection,1,,Lung,Mus musculus,Intermediate,,,14148,10090.0
,N,50594,,,,A,,CHEMBL627664,1,,BAO_0000218,14045,"Percentage biodistribution in mouse lung, 30 minutes post injection",1,,,Mus musculus,Intermediate,,,14149,10090.0
,N,50594,,,,A,,CHEMBL627665,1,,BAO_0000218,14045,"Percentage biodistribution in mousee lung, 5 minutes post injection",1,,,Mus musculus,Intermediate,,,14150,10090.0
,N,50594,,,In vivo,A,2048.0,CHEMBL627666,1,,BAO_0000218,14045,Biodistribution in mice lungs at 60 min of post injection,1,,Lung,Mus musculus,Intermediate,,,14151,10090.0
,N,50594,,,,A,2106.0,CHEMBL627667,1,,BAO_0000218,14045,Percentage biodistribution in mouse spleen,1,,Spleen,Mus musculus,Intermediate,,,14152,10090.0
,N,50594,,,,A,945.0,CHEMBL627668,1,,BAO_0000218,14045,Percentage biodistribution in mouse stomach,1,,Stomach,Mus musculus,Intermediate,,,14153,10090.0
,N,50594,,,,A,1088.0,CHEMBL627669,1,,BAO_0000218,11745,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,1,,Urine,Mus musculus,Intermediate,,,14154,10090.0
,U,22224,,,In vivo,A,1255.0,CHEMBL627670,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,1,,Urinary bladder,,Autocuration,,,14155,
,U,22224,,,In vivo,A,178.0,CHEMBL627671,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,1,,Blood,,Autocuration,,,14156,
,U,22224,,,In vivo,A,1474.0,CHEMBL627672,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,1,,Bone element,,Autocuration,,,14157,
,U,22224,,,In vivo,A,,CHEMBL627673,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,1,,,,Autocuration,,,14158,
,U,22224,,,In vivo,A,2113.0,CHEMBL627674,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,1,,Kidney,,Autocuration,,,14159,
,U,22224,,,In vivo,A,2107.0,CHEMBL627675,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,1,,Liver,,Autocuration,,,14160,
,U,22224,,,In vivo,A,2048.0,CHEMBL627676,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,1,,Lung,,Autocuration,,,14161,
,U,22224,,,In vivo,A,2385.0,CHEMBL627677,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,1,,Muscle tissue,,Autocuration,,,14162,
,U,22224,,,,A,,CHEMBL627678,0,,BAO_0000019,8354,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14163,
,N,50597,,,,A,1977.0,CHEMBL627679,1,,BAO_0000218,7095,Affinity for protein binding expressed as association constant in fresh rat serum,1,,Serum,Rattus norvegicus,Intermediate,,,14164,10116.0
,U,22224,,,,A,,CHEMBL627680,0,,BAO_0000019,12185,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,1,,,,Autocuration,,,14165,
,U,22224,,,,A,,CHEMBL627681,0,,BAO_0000019,12185,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,1,,,,Autocuration,,,14166,
,U,22224,,,,A,,CHEMBL627682,0,,BAO_0000019,12185,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,1,,,,Autocuration,,,14167,
,U,22224,,,,A,,CHEMBL627683,0,,BAO_0000019,12185,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,1,,,,Autocuration,,,14168,
,U,22224,,,,A,,CHEMBL627684,0,,BAO_0000019,12686,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,1,,,,Autocuration,,,14169,
,U,22224,,,,A,,CHEMBL874441,0,,BAO_0000019,12686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",1,,,,Autocuration,,,14170,
,U,22224,,,,A,,CHEMBL627685,0,,BAO_0000019,12686,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,1,,,,Autocuration,,,14171,
,U,22224,,,,A,,CHEMBL627686,0,,BAO_0000019,12686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",1,,,,Autocuration,,,14172,
,U,22224,,,,A,,CHEMBL627687,0,,BAO_0000019,8057,Apparent rate constant Koff for inactivation of dTMP synthase.,1,,,,Autocuration,,,14173,
,U,22224,,,,A,,CHEMBL627688,0,,BAO_0000019,15778,The irreversible inhibitor activity by second order rate equation.,1,,,,Autocuration,,,14174,
,N,50597,,,,A,,CHEMBL628038,1,,BAO_0000218,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,14175,10116.0
,N,50597,,,,A,,CHEMBL628039,1,,BAO_0000218,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,1,,,Rattus norvegicus,Intermediate,,,14176,10116.0
,N,50597,,,,A,,CHEMBL628040,1,,BAO_0000218,12375,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,1,,,Rattus norvegicus,Intermediate,,,14177,10116.0
,U,22224,,,,A,,CHEMBL628041,0,,BAO_0000019,13588,Dissociation rate calculated from the first-order equation using t1/2 value,1,,,,Autocuration,,,14178,
,U,22224,,,,A,,CHEMBL630226,0,,BAO_0000019,15039,The compound was tested for Binding constant against DNA,1,,,,Autocuration,,,14179,
,U,22224,,,,A,,CHEMBL628042,0,,BAO_0000019,9500,First order rate constant for cyclization of the compound,1,,,,Autocuration,,,14180,
,U,22224,,,,A,,CHEMBL625232,0,,BAO_0000019,10014,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,1,,,,Autocuration,,,14181,
,U,22224,,,,A,,CHEMBL625233,0,,BAO_0000019,10014,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,1,,,,Autocuration,,,14182,
,U,22224,,,,A,,CHEMBL625979,0,,BAO_0000019,568,Hydrolysis rate constant was determined,1,,,,Autocuration,,,14183,
,U,22224,,,,A,,CHEMBL625980,0,,BAO_0000019,10026,Observed first order rate constant,1,,,,Autocuration,,,14184,
,U,22224,,,,A,,CHEMBL625981,0,,BAO_0000019,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,1,,,,Autocuration,,,14185,
,U,22224,,,,A,,CHEMBL625982,0,,BAO_0000019,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,1,,,,Autocuration,,,14186,
,U,22224,,,,A,,CHEMBL625983,0,,BAO_0000019,9680,Second-order rate constant for attack on PNPA at 25 degree Centigrade,1,,,,Autocuration,,,14187,
,U,22224,,,,A,,CHEMBL625984,0,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14188,
,U,22224,,,,A,,CHEMBL625985,0,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14189,
,U,22224,,,,A,,CHEMBL625986,0,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14190,
,U,22224,,,,A,,CHEMBL625987,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14191,
,U,22224,,,,A,,CHEMBL625988,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14192,
,U,22224,,,,A,,CHEMBL625989,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14193,
,U,22224,,,,A,,CHEMBL625990,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14194,
,U,22224,,,,A,,CHEMBL625991,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14195,
,U,22224,,,,A,,CHEMBL625992,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14196,
,U,22224,,,,A,,CHEMBL625993,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14197,
,U,22224,,,,A,,CHEMBL631973,0,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14198,
,U,22224,,,,A,,CHEMBL632143,0,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14199,
,U,22224,,,,A,,CHEMBL632144,0,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14200,
,U,22224,,,,A,,CHEMBL632145,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14201,
,U,22224,,,,A,,CHEMBL632146,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14202,
,U,22224,,,,A,,CHEMBL632147,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14203,
,U,22224,,,,A,,CHEMBL632148,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14204,
,U,22224,,,,A,,CHEMBL632149,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14205,
,U,22224,,,,A,,CHEMBL632150,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14206,
,U,22224,,,,A,,CHEMBL632151,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14207,
,N,50587,,,,A,,CHEMBL632152,1,,BAO_0000218,3008,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,1,,,Homo sapiens,Intermediate,,,14208,9606.0
,N,50587,,,,A,,CHEMBL632153,1,,BAO_0000218,4509,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,1,,,Homo sapiens,Intermediate,,,14209,9606.0
,N,50587,,,,A,,CHEMBL632154,1,,BAO_0000218,4509,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,1,,,Homo sapiens,Intermediate,,,14210,9606.0
,N,50602,,,,A,,CHEMBL632155,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,1,,,Human herpesvirus 1,Intermediate,,,14211,10298.0
,N,50602,,,,A,,CHEMBL632156,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,1,,,Human herpesvirus 1,Intermediate,,,14212,10298.0
,N,50602,,,,A,,CHEMBL632157,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,1,,,Human herpesvirus 1,Intermediate,,,14213,10298.0
,N,50602,,,,A,,CHEMBL632158,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,1,,,Human herpesvirus 1,Intermediate,,,14214,10298.0
,N,50602,,,,A,,CHEMBL632159,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,1,,,Human herpesvirus 1,Intermediate,,,14215,10298.0
,N,50602,,,,A,,CHEMBL626305,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,1,,,Human herpesvirus 1,Intermediate,,,14216,10298.0
,N,50602,,,,A,,CHEMBL626306,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,1,,,Human herpesvirus 1,Intermediate,,,14217,10298.0
,N,50602,,,,A,,CHEMBL626307,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,1,,,Human herpesvirus 1,Intermediate,,,14218,10298.0
,N,50602,,,,A,,CHEMBL626308,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,1,,,Human herpesvirus 1,Intermediate,,,14219,10298.0
,N,50602,,,,A,,CHEMBL626479,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,1,,,Human herpesvirus 1,Intermediate,,,14220,10298.0
,N,50602,,,,A,,CHEMBL626480,1,,BAO_0000218,8613,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,1,,,Human herpesvirus 1,Intermediate,,,14221,10298.0
,U,22229,,,,P,,CHEMBL626481,0,,BAO_0000100,6021,Calculated partition coefficient (clogP) (MlogP),1,,,,Autocuration,,,14222,
,U,22224,,,,A,,CHEMBL626482,0,,BAO_0000019,9348,Equipotent potent ratio relative to carbachol (nicotinic activity),1,,,,Autocuration,,,14223,
,N,50588,,,,A,,CHEMBL626483,1,,BAO_0000218,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",1,,,Canis lupus familiaris,Intermediate,,,14224,9615.0
,N,50588,,,,A,,CHEMBL626484,1,,BAO_0000218,15592,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",1,,,Canis lupus familiaris,Intermediate,,,14225,9615.0
,U,22229,,,,P,,CHEMBL626485,0,,BAO_0000100,15592,Solubility at pH 7.4 in micro g/mL;NA denotes available,1,,,,Autocuration,,,14226,
,U,22229,,,,P,,CHEMBL626486,0,,BAO_0000100,15592,Solubility at pH 7.4 in micro g/mL;NA denotes not available,1,,,,Autocuration,,,14227,
,U,22229,,,,P,,CHEMBL626487,0,,BAO_0000100,15592,Solubility at pH 7.4 in ug/mL;NA denotes not available,1,,,,Autocuration,,,14228,
,N,50588,,,In vivo,A,1969.0,CHEMBL626488,1,,BAO_0000218,15592,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,1,,Plasma,Canis lupus familiaris,Intermediate,,,14229,9615.0
,N,50597,,,,A,1977.0,CHEMBL626489,1,,BAO_0000218,7095,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,1,,Serum,Rattus norvegicus,Intermediate,,,14230,10116.0
,U,22224,,,,A,,CHEMBL626490,0,,BAO_0000019,16618,Area under the MAP curve measured over 5 min; ND means Not determined,1,,,,Autocuration,,,14231,
,U,22224,,,,P,,CHEMBL626491,0,,BAO_0000100,16835,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,1,,,,Autocuration,,,14232,
,U,22229,,,,P,,CHEMBL626492,0,,BAO_0000100,15284,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,1,,,,Autocuration,,,14233,
,U,22224,,,,A,,CHEMBL626493,0,,BAO_0000019,15750,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,1,,,,Autocuration,,,14234,
,N,50597,,,In vivo,A,,CHEMBL626494,1,,BAO_0000218,16618,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,1,,,Rattus norvegicus,Intermediate,,,14235,10116.0
,U,22224,,,In vivo,A,,CHEMBL626495,0,,BAO_0000218,16618,Half life after oral tested,1,,,,Autocuration,,,14236,
,N,50597,,,,A,1969.0,CHEMBL626496,1,,BAO_0000218,15812,Half life was determined in plasma of rat; NT indicates not tested,1,,Plasma,Rattus norvegicus,Intermediate,,,14237,10116.0
,N,50597,,,In vivo,A,,CHEMBL626497,1,,BAO_0000218,16618,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,1,,,Rattus norvegicus,Intermediate,,,14238,10116.0
,U,22224,,,In vivo,A,,CHEMBL626498,0,,BAO_0000218,16618,Oral bioavailability after oral tested,1,,,,Autocuration,,,14239,
,N,50597,,,,A,,CHEMBL626499,1,,BAO_0000218,13098,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),1,,,Rattus norvegicus,Intermediate,,,14240,10116.0
,N,50597,,,,A,,CHEMBL626500,1,,BAO_0000218,13098,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),1,,,Rattus norvegicus,Intermediate,,,14241,10116.0
,N,50597,,,,A,1969.0,CHEMBL626501,1,,BAO_0000218,15812,half life was determined in plasma of rat; NT indicates not tested,1,,Plasma,Rattus norvegicus,Intermediate,,,14242,10116.0
,N,50597,,,,A,1969.0,CHEMBL626502,1,,BAO_0000218,15812,half life was determined in plasma of rat; NT means not tested,1,,Plasma,Rattus norvegicus,Intermediate,,,14243,10116.0
,N,50597,,,,A,,CHEMBL626503,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,1,,,Rattus norvegicus,Intermediate,,,14244,10116.0
,N,50597,,,,A,,CHEMBL626504,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); inactive,1,,,Rattus norvegicus,Intermediate,,,14245,10116.0
,N,50597,,,,A,,CHEMBL626505,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,1,,,Rattus norvegicus,Intermediate,,,14246,10116.0
,N,50597,,,,A,,CHEMBL626506,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,1,,,Rattus norvegicus,Intermediate,,,14247,10116.0
,N,50597,,,,A,,CHEMBL626507,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,1,,,Rattus norvegicus,Intermediate,,,14248,10116.0
,N,50597,,,,A,,CHEMBL626508,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,1,,,Rattus norvegicus,Intermediate,,,14249,10116.0
,N,50597,,,,A,,CHEMBL626509,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,1,,,Rattus norvegicus,Intermediate,,,14250,10116.0
,N,50597,,,,A,,CHEMBL875480,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,1,,,Rattus norvegicus,Intermediate,,,14251,10116.0
,N,50597,,,,A,,CHEMBL626510,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,1,,,Rattus norvegicus,Intermediate,,,14252,10116.0
,N,50597,,,,A,,CHEMBL626511,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,1,,,Rattus norvegicus,Intermediate,,,14253,10116.0
,N,50597,,,,A,,CHEMBL626512,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,1,,,Rattus norvegicus,Intermediate,,,14254,10116.0
,N,50597,,,,A,,CHEMBL628208,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,1,,,Rattus norvegicus,Intermediate,,,14255,10116.0
,N,50597,,,,A,,CHEMBL628209,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,1,,,Rattus norvegicus,Intermediate,,,14256,10116.0
,N,50597,,,,A,,CHEMBL628210,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,1,,,Rattus norvegicus,Intermediate,,,14257,10116.0
,N,50597,,,,A,,CHEMBL628211,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,1,,,Rattus norvegicus,Intermediate,,,14258,10116.0
,N,50597,,,,A,,CHEMBL628212,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,1,,,Rattus norvegicus,Intermediate,,,14259,10116.0
,N,50597,,,,A,,CHEMBL628213,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,1,,,Rattus norvegicus,Intermediate,,,14260,10116.0
,N,50597,,,,A,1088.0,CHEMBL628214,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14261,10116.0
,N,50597,,,,A,1088.0,CHEMBL628215,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14262,10116.0
,N,50597,,,,A,1088.0,CHEMBL628216,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14263,10116.0
,N,50597,,,,A,1088.0,CHEMBL626595,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14264,10116.0
,N,50597,,,,A,1088.0,CHEMBL626596,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14265,10116.0
,N,50597,,,,A,1088.0,CHEMBL626597,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14266,10116.0
,N,50597,,,,A,1088.0,CHEMBL626598,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14267,10116.0
,N,50597,,,,A,1088.0,CHEMBL622242,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14268,10116.0
,N,50597,,,,A,1088.0,CHEMBL622243,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14269,10116.0
,N,50597,,,,A,1088.0,CHEMBL622244,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14270,10116.0
,N,50597,,,,A,1088.0,CHEMBL622245,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14271,10116.0
,N,50597,,,,A,1088.0,CHEMBL622246,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14272,10116.0
,N,50597,,,,A,1088.0,CHEMBL622247,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14273,10116.0
,N,50597,,,,A,1088.0,CHEMBL622248,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14274,10116.0
,N,50597,,,,A,1088.0,CHEMBL877483,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14275,10116.0
,N,50597,,,,A,1088.0,CHEMBL622249,1,,BAO_0000218,12582,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14276,10116.0
,N,50588,,,,A,1088.0,CHEMBL622250,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14277,9615.0
,N,50588,,,,A,1088.0,CHEMBL622251,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14278,9615.0
,N,50588,,,,A,1088.0,CHEMBL622252,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14279,9615.0
,N,50588,,,,A,1088.0,CHEMBL622253,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14280,9615.0
,N,50588,,,,A,1088.0,CHEMBL622254,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14281,9615.0
,N,50588,,,,A,1088.0,CHEMBL622255,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14282,9615.0
,N,50588,,,,A,1088.0,CHEMBL622256,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14283,9615.0
,N,50588,,,,A,1088.0,CHEMBL622257,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14284,9615.0
,N,50588,,,,A,1088.0,CHEMBL622258,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14285,9615.0
,N,50588,,,,A,1088.0,CHEMBL622259,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14286,9615.0
,N,50588,,,,A,1088.0,CHEMBL622927,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14287,9615.0
,N,50588,,,,A,1088.0,CHEMBL622928,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14288,9615.0
,N,50588,,,,A,1088.0,CHEMBL622929,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14289,9615.0
,N,50588,,,,A,1088.0,CHEMBL623182,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14290,9615.0
,N,50588,,,,A,1088.0,CHEMBL623183,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14291,9615.0
,N,50597,,,,A,1088.0,CHEMBL623184,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14292,10116.0
,N,50597,,,,A,1088.0,CHEMBL623185,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14293,10116.0
,N,50597,,,,A,1088.0,CHEMBL877484,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14294,10116.0
,N,50597,,,,A,1088.0,CHEMBL627274,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14295,10116.0
,N,50597,,,,A,1088.0,CHEMBL623186,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14296,10116.0
,N,50597,,,,A,1088.0,CHEMBL623187,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14297,10116.0
,N,50597,,,,A,1088.0,CHEMBL623188,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14298,10116.0
,N,50597,,,,A,1088.0,CHEMBL628055,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14299,10116.0
,N,50597,,,,A,1088.0,CHEMBL628056,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14300,10116.0
,N,50597,,,,A,1088.0,CHEMBL628200,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14301,10116.0
,N,50597,,,,A,1088.0,CHEMBL628201,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14302,10116.0
,N,50597,,,,A,1088.0,CHEMBL628202,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14303,10116.0
,N,50597,,,,A,1088.0,CHEMBL628203,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14304,10116.0
,N,50597,,,,A,1088.0,CHEMBL628204,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14305,10116.0
,N,50597,,,,A,1088.0,CHEMBL628205,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14306,10116.0
,N,50597,,,,A,1088.0,CHEMBL628206,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14307,10116.0
,U,22224,,,In vivo,A,2367.0,CHEMBL628207,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),1,,Prostate gland,,Autocuration,,,14308,
,U,22224,,,In vivo,A,2367.0,CHEMBL627220,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,1,,Prostate gland,,Autocuration,,,14309,
,U,22224,,,In vivo,A,2385.0,CHEMBL627221,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,1,,Muscle tissue,,Autocuration,,,14310,
,U,22224,,,In vivo,A,2367.0,CHEMBL627222,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),1,,Prostate gland,,Autocuration,,,14311,
,U,22224,,,In vivo,A,,CHEMBL627223,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,1,,,,Autocuration,,,14312,
,U,22224,,,In vivo,A,2385.0,CHEMBL632062,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,1,,Muscle tissue,,Autocuration,,,14313,
,U,22224,,,In vivo,A,2106.0,CHEMBL632063,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,1,,Spleen,,Autocuration,,,14314,
,U,22224,,,In vivo,A,1255.0,CHEMBL632064,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,1,,Urinary bladder,,Autocuration,,,14315,
,U,22224,,,In vivo,A,178.0,CHEMBL632065,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,1,,Blood,,Autocuration,,,14316,
,U,22224,,,In vivo,A,1474.0,CHEMBL632066,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,1,,Bone element,,Autocuration,,,14317,
,U,22224,,,In vivo,A,,CHEMBL632067,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,1,,,,Autocuration,,,14318,
,U,22224,,,In vivo,A,2113.0,CHEMBL629188,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,1,,Kidney,,Autocuration,,,14319,
,U,22224,,,In vivo,A,2107.0,CHEMBL629189,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,1,,Liver,,Autocuration,,,14320,
,U,22224,,,In vivo,A,2048.0,CHEMBL629190,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,1,,Lung,,Autocuration,,,14321,
,U,22224,,,In vivo,A,2385.0,CHEMBL629191,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,1,,Muscle tissue,,Autocuration,,,14322,
,U,22224,,,In vivo,A,2367.0,CHEMBL629192,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),1,,Prostate gland,,Autocuration,,,14323,
,U,22224,,,In vivo,A,2385.0,CHEMBL629193,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,1,,Muscle tissue,,Autocuration,,,14324,
,U,22224,,,In vivo,A,2367.0,CHEMBL629194,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),1,,Prostate gland,,Autocuration,,,14325,
,U,22224,,,In vivo,A,,CHEMBL629195,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,1,,,,Autocuration,,,14326,
,U,22224,,,In vivo,A,2385.0,CHEMBL629373,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,1,,Muscle tissue,,Autocuration,,,14327,
,U,22224,,,In vivo,A,2106.0,CHEMBL629374,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,1,,Spleen,,Autocuration,,,14328,
,U,22224,,,In vivo,A,2367.0,CHEMBL629375,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,1,,Prostate gland,,Autocuration,,,14329,
,U,22224,,,In vivo,A,1255.0,CHEMBL629376,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,1,,Urinary bladder,,Autocuration,,,14330,
,U,22224,,,In vivo,A,178.0,CHEMBL629377,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,1,,Blood,,Autocuration,,,14331,
,U,22224,,,In vivo,A,1474.0,CHEMBL629378,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,1,,Bone element,,Autocuration,,,14332,
,U,22224,,,In vivo,A,,CHEMBL629379,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,1,,,,Autocuration,,,14333,
,U,22224,,,In vivo,A,2113.0,CHEMBL629151,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,1,,Kidney,,Autocuration,,,14334,
,U,22224,,,In vivo,A,2107.0,CHEMBL629152,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,1,,Liver,,Autocuration,,,14335,
,U,22224,,,In vivo,A,2048.0,CHEMBL629153,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,1,,Lung,,Autocuration,,,14336,
,U,22224,,,In vivo,A,2385.0,CHEMBL629154,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,1,,Muscle tissue,,Autocuration,,,14337,
,U,22224,,,In vivo,A,2367.0,CHEMBL629155,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),1,,Prostate gland,,Autocuration,,,14338,
,U,22224,,,In vivo,A,2367.0,CHEMBL629156,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,1,,Prostate gland,,Autocuration,,,14339,
,U,22224,,,In vivo,A,2385.0,CHEMBL629157,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,1,,Muscle tissue,,Autocuration,,,14340,
,U,22224,,,In vivo,A,2367.0,CHEMBL629158,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),1,,Prostate gland,,Autocuration,,,14341,
,U,22224,,,In vivo,A,,CHEMBL629159,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,1,,,,Autocuration,,,14342,
,U,22224,,,In vivo,A,2385.0,CHEMBL629160,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,1,,Muscle tissue,,Autocuration,,,14343,
,U,22224,,,In vivo,A,2106.0,CHEMBL629161,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,1,,Spleen,,Autocuration,,,14344,
,U,22224,,,In vivo,A,1255.0,CHEMBL629162,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,1,,Urinary bladder,,Autocuration,,,14345,
,U,22224,,,In vivo,A,178.0,CHEMBL629163,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,1,,Blood,,Autocuration,,,14346,
,U,22224,,,In vivo,A,1474.0,CHEMBL629164,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,1,,Bone element,,Autocuration,,,14347,
,U,22224,,,In vivo,A,,CHEMBL629165,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,1,,,,Autocuration,,,14348,
,U,22224,,,In vivo,A,2107.0,CHEMBL629166,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,1,,Liver,,Autocuration,,,14349,
,U,22224,,,In vivo,A,2048.0,CHEMBL629167,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,1,,Lung,,Autocuration,,,14350,
,U,22224,,,In vivo,A,2385.0,CHEMBL629168,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,1,,Muscle tissue,,Autocuration,,,14351,
,U,22224,,,,A,,CHEMBL629169,0,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,1,,,,Autocuration,,,14352,
,U,22224,,,,A,,CHEMBL629170,0,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,1,,,,Autocuration,,,14353,
,U,22224,,,,A,,CHEMBL631153,0,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,1,,,,Autocuration,,,14354,
,U,22224,,,,A,,CHEMBL875121,0,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,1,,,,Autocuration,,,14355,
,U,22224,,,,A,,CHEMBL631154,0,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,1,,,,Autocuration,,,14356,
,U,22224,,,,A,,CHEMBL631155,0,,BAO_0000019,2193,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,1,,,,Autocuration,,,14357,
,U,22224,,,,A,,CHEMBL631156,0,,BAO_0000019,568,Hydrolysis rate constant was determined,1,,,,Autocuration,,,14358,
,U,22224,,,,A,,CHEMBL631157,0,,BAO_0000019,9680,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",1,,,,Autocuration,,,14359,
,U,22224,,,,A,,CHEMBL631158,0,,BAO_0000019,9680,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",1,,,,Autocuration,,,14360,
,U,22224,,,,A,,CHEMBL631159,0,,BAO_0000019,9680,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",1,,,,Autocuration,,,14361,
,U,22224,,,,A,,CHEMBL631160,0,,BAO_0000019,10026,Observed second order rate constant,1,,,,Autocuration,,,14362,
,U,22224,,,,A,,CHEMBL631161,0,,BAO_0000019,10281,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,1,,,,Autocuration,,,14363,
,U,22224,,,,A,,CHEMBL631162,0,,BAO_0000019,10014,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,1,,,,Autocuration,,,14364,
,U,22224,,,,A,,CHEMBL630313,0,,BAO_0000019,10014,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,1,,,,Autocuration,,,14365,
,U,22224,,,,A,,CHEMBL630314,0,,BAO_0000019,9680,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",1,,,,Autocuration,,,14366,
,U,22224,,,,A,,CHEMBL630315,0,,BAO_0000019,9680,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",1,,,,Autocuration,,,14367,
,U,22224,,,,A,,CHEMBL630316,0,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14368,
,U,22224,,,,A,,CHEMBL630986,0,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14369,
,U,22224,,,,A,,CHEMBL630987,0,,BAO_0000019,13028,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14370,
,U,22224,,,,A,,CHEMBL630988,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14371,
,U,22224,,,,A,,CHEMBL630989,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14372,
,U,22224,,,,A,,CHEMBL630990,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14373,
,U,22224,,,,A,,CHEMBL630991,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14374,
,U,22224,,,,A,,CHEMBL630992,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14375,
,U,22224,,,,A,,CHEMBL630993,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14376,
,U,22224,,,,A,,CHEMBL630994,0,,BAO_0000019,13028,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,1,,,,Autocuration,,,14377,
,N,50597,,,,A,,CHEMBL630995,1,,BAO_0000218,10014,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,1,,,Rattus norvegicus,Intermediate,,,14378,10116.0
,U,22224,,,,A,,CHEMBL629252,0,,BAO_0000019,9962,Association constant for compound at 31 degree C was determined,1,,,,Autocuration,,,14379,
,U,22224,,,,A,,CHEMBL629253,0,,BAO_0000019,12029,Calculated antagonist equilibrium dissociation constant of the compound,1,,,,Autocuration,,,14380,
,U,22224,,,,A,,CHEMBL629944,0,,BAO_0000019,12029,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,1,,,,Autocuration,,,14381,
,N,50512,,,,A,3126.0,CHEMBL629945,1,,BAO_0000218,10583,Dissociation constants vs LTE4 on guinea pig trachea,1,,Trachea,Cavia porcellus,Intermediate,,,14382,10141.0
,U,22224,,,,A,,CHEMBL629946,0,,BAO_0000019,568,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",1,,,,Autocuration,,,14383,
,U,22224,,,,A,,CHEMBL629947,0,,BAO_0000019,568,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",1,,,,Autocuration,,,14384,
,U,22224,,,,A,,CHEMBL629948,0,,BAO_0000019,568,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",1,,,,Autocuration,,,14385,
,U,22224,,,,A,,CHEMBL856024,0,,BAO_0000019,568,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",1,,,,Autocuration,,,14386,
,U,22224,,,,A,,CHEMBL629949,0,,BAO_0000019,7493,Affinity constant KD value was derived from TMP,1,,,,Autocuration,,,14387,
,U,22224,,,,A,,CHEMBL629950,0,,BAO_0000019,8371,Apparent dissociation (binding) rate constant was evaluated,1,,,,Autocuration,,,14388,
,U,22224,,,,P,,CHEMBL630127,0,,BAO_0000100,13114,Dissociation constant (KD) of the compound,1,,,,Autocuration,,,14389,
,U,22224,,,,P,,CHEMBL630128,0,,BAO_0000100,15515,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,1,,,,Autocuration,,,14390,
,U,22224,,,,P,,CHEMBL630129,0,,BAO_0000100,522,Dissociation constant from ESR titration experiments,1,,,,Autocuration,,,14391,
,U,22224,,,,,,CHEMBL630130,0,,BAO_0000019,13888,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),1,,,,Autocuration,,,14392,
,U,22224,,,,P,,CHEMBL875234,0,,BAO_0000100,2616,Dissociation constant was evaluated.,1,,,,Autocuration,,,14393,
,U,22224,,,,P,,CHEMBL630131,0,,BAO_0000100,3798,Dissociation constant was reported,1,,,,Autocuration,,,14394,
,N,50597,,,,A,,CHEMBL630132,1,,BAO_0000218,8731,Dissociation constant was determined in rat pituitary cells.,1,,,Rattus norvegicus,Intermediate,,,14395,10116.0
,U,22224,,,,A,,CHEMBL630133,0,,BAO_0000019,11892,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,1,,,,Autocuration,,,14396,
,U,22224,,,,A,,CHEMBL630134,0,,BAO_0000019,11892,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,1,,,,Autocuration,,,14397,
,U,22224,,,,A,,CHEMBL630135,0,,BAO_0000019,2582,Equilibrium dissociation constant of the compound,1,,,,Autocuration,,,14398,
,U,22224,,,,A,,CHEMBL630136,0,,BAO_0000019,11892,Equilibrium dissociation constant was determined,1,,,,Autocuration,,,14399,
,U,22224,,,,A,,CHEMBL630137,0,,BAO_0000019,13396,Kinetic constant KD was evaluated,1,,,,Autocuration,,,14400,
,U,22224,,,,A,,CHEMBL630138,0,,BAO_0000019,603,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,1,,,,Autocuration,,,14401,
,U,22224,,,,A,,CHEMBL630139,0,,BAO_0000019,15673,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,1,,,,Autocuration,,,14402,
,U,22224,,,,A,,CHEMBL630140,0,,BAO_0000019,10368,Rate constant for hydrolysis in aqueous acetone.,1,,,,Autocuration,,,14403,
,U,22224,,,,A,,CHEMBL875235,0,,BAO_0000019,14228,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,1,,,,Autocuration,,,14404,
,N,50597,,,,A,,CHEMBL876439,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,1,,,Rattus norvegicus,Intermediate,,,14405,10116.0
,N,50597,,,,A,,CHEMBL630605,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,1,,,Rattus norvegicus,Intermediate,,,14406,10116.0
,N,50597,,,,A,,CHEMBL630606,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,1,,,Rattus norvegicus,Intermediate,,,14407,10116.0
,N,50597,,,,A,,CHEMBL630607,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,1,,,Rattus norvegicus,Intermediate,,,14408,10116.0
,N,50597,,,,A,,CHEMBL630608,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,1,,,Rattus norvegicus,Intermediate,,,14409,10116.0
,N,50597,,,,A,,CHEMBL630609,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,1,,,Rattus norvegicus,Intermediate,,,14410,10116.0
,N,50597,,,,A,,CHEMBL630610,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,1,,,Rattus norvegicus,Intermediate,,,14411,10116.0
,N,50597,,,,A,,CHEMBL630611,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,1,,,Rattus norvegicus,Intermediate,,,14412,10116.0
,N,50597,,,,A,,CHEMBL629552,1,,BAO_0000218,11510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,1,,,Rattus norvegicus,Intermediate,,,14413,10116.0
,N,50597,,,,A,,CHEMBL629733,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14414,10116.0
,N,50597,,,,A,,CHEMBL629734,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14415,10116.0
,N,50597,,,,A,,CHEMBL629735,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14416,10116.0
,N,50597,,,,A,,CHEMBL629736,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14417,10116.0
,N,50597,,,,A,,CHEMBL629737,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14418,10116.0
,N,50597,,,,A,,CHEMBL629738,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14419,10116.0
,N,50597,,,,A,,CHEMBL629739,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14420,10116.0
,N,50597,,,,A,,CHEMBL629740,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,1,,,Rattus norvegicus,Intermediate,,,14421,10116.0
,N,50597,,,,A,,CHEMBL629741,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14422,10116.0
,N,50597,,,,A,,CHEMBL629742,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14423,10116.0
,N,50597,,,,A,,CHEMBL629743,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14424,10116.0
,N,50597,,,,A,,CHEMBL629744,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14425,10116.0
,N,50597,,,,A,,CHEMBL629745,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14426,10116.0
,N,50597,,,,A,,CHEMBL629746,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14427,10116.0
,N,50597,,,,A,,CHEMBL629747,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14428,10116.0
,N,50597,,,,A,,CHEMBL629748,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14429,10116.0
,N,50597,,,,A,,CHEMBL629749,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14430,10116.0
,N,50597,,,,A,,CHEMBL629750,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14431,10116.0
,N,50597,,,,A,,CHEMBL629751,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14432,10116.0
,N,50597,,,,A,,CHEMBL629752,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14433,10116.0
,N,50597,,,,A,,CHEMBL629753,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14434,10116.0
,N,50597,,,,A,,CHEMBL629754,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14435,10116.0
,N,50597,,,,A,,CHEMBL629755,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14436,10116.0
,N,50597,,,,A,,CHEMBL629756,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14437,10116.0
,N,50597,,,,A,,CHEMBL629757,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14438,10116.0
,N,50597,,,,A,,CHEMBL629758,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14439,10116.0
,N,50597,,,,A,,CHEMBL629759,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14440,10116.0
,N,50597,,,,A,,CHEMBL629760,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14441,10116.0
,N,50597,,,,A,,CHEMBL876443,1,,BAO_0000218,11510,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,1,,,Rattus norvegicus,Intermediate,,,14442,10116.0
,N,50588,,,,A,,CHEMBL629761,1,,BAO_0000218,8310,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,1,,,Canis lupus familiaris,Intermediate,,,14443,9615.0
,N,50588,,,,A,,CHEMBL629762,1,,BAO_0000218,8310,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,1,,,Canis lupus familiaris,Intermediate,,,14444,9615.0
,N,50594,,,,A,,CHEMBL629763,1,,BAO_0000218,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14445,10090.0
,N,50594,,,,A,,CHEMBL629764,1,,BAO_0000218,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14446,10090.0
,N,50594,,,,A,,CHEMBL629765,1,,BAO_0000218,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14447,10090.0
,N,50594,,,,A,,CHEMBL629766,1,,BAO_0000218,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14448,10090.0
,N,50594,,,,A,,CHEMBL629767,1,,BAO_0000218,8310,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14449,10090.0
,N,50588,,,,A,,CHEMBL629768,1,,BAO_0000218,8310,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,1,,,Canis lupus familiaris,Intermediate,,,14450,9615.0
,N,50594,,,,A,,CHEMBL629769,1,,BAO_0000218,8310,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14451,10090.0
,N,50588,,,,A,,CHEMBL629770,1,,BAO_0000218,8310,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,1,,,Canis lupus familiaris,Intermediate,,,14452,9615.0
,N,50588,,,,A,,CHEMBL629771,1,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,1,,,Canis lupus familiaris,Intermediate,,,14453,9615.0
,N,50594,,,,A,,CHEMBL629772,1,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14454,10090.0
,N,50594,,,,A,,CHEMBL629773,1,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14455,10090.0
,N,50594,,,,A,,CHEMBL625455,1,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14456,10090.0
,N,50594,,,,A,,CHEMBL625456,1,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14457,10090.0
,N,50594,,,,A,,CHEMBL625457,1,,BAO_0000218,8310,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,1,,,Mus musculus,Intermediate,,,14458,10090.0
,N,50597,,,,A,1088.0,CHEMBL625458,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14459,10116.0
,N,50597,,,,A,1088.0,CHEMBL625459,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14460,10116.0
,N,50597,,,,A,1088.0,CHEMBL875483,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14461,10116.0
,N,50597,,,,A,1088.0,CHEMBL634779,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14462,10116.0
,N,50597,,,,A,1088.0,CHEMBL625460,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14463,10116.0
,N,50597,,,,A,1088.0,CHEMBL626117,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14464,10116.0
,N,50597,,,,A,1088.0,CHEMBL626118,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14465,10116.0
,N,50597,,,,A,1088.0,CHEMBL628342,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14466,10116.0
,N,50597,,,,A,1088.0,CHEMBL628343,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14467,10116.0
,N,50597,,,,A,1088.0,CHEMBL628344,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14468,10116.0
,N,50597,,,,A,1088.0,CHEMBL628345,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14469,10116.0
,N,50597,,,,A,1088.0,CHEMBL628346,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14470,10116.0
,N,50597,,,,A,1088.0,CHEMBL628347,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14471,10116.0
,N,50597,,,,A,1088.0,CHEMBL628348,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14472,10116.0
,N,50597,,,,A,1088.0,CHEMBL628349,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14473,10116.0
,N,50597,,,,A,1088.0,CHEMBL875611,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14474,10116.0
,N,50597,,,,A,1088.0,CHEMBL628350,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14475,10116.0
,N,50597,,,,A,1088.0,CHEMBL628351,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14476,10116.0
,N,50597,,,,A,1088.0,CHEMBL628352,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14477,10116.0
,N,50597,,,,A,1088.0,CHEMBL628353,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14478,10116.0
,N,50597,,,,A,1088.0,CHEMBL628354,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14479,10116.0
,N,50597,,,,A,1088.0,CHEMBL626667,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14480,10116.0
,N,50597,,,,A,1088.0,CHEMBL626668,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14481,10116.0
,N,50597,,,,A,1088.0,CHEMBL626669,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14482,10116.0
,N,50597,,,,A,1088.0,CHEMBL626670,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14483,10116.0
,N,50597,,,,A,1088.0,CHEMBL626671,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14484,10116.0
,N,50597,,,,A,1088.0,CHEMBL626672,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14485,10116.0
,N,50597,,,,A,1088.0,CHEMBL626673,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14486,10116.0
,N,50597,,,,A,1088.0,CHEMBL626674,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14487,10116.0
,N,50597,,,,A,1088.0,CHEMBL626675,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14488,10116.0
,N,50597,,,,A,1088.0,CHEMBL626676,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14489,10116.0
,N,50597,,,,A,1088.0,CHEMBL626677,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14490,10116.0
,N,50597,,,,A,1088.0,CHEMBL626678,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14491,10116.0
,N,50597,,,,A,1088.0,CHEMBL626679,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14492,10116.0
,N,50597,,,,A,1088.0,CHEMBL875612,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14493,10116.0
,N,50597,,,,A,1088.0,CHEMBL626680,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14494,10116.0
,N,50597,,,,A,1088.0,CHEMBL626681,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14495,10116.0
,N,50597,,,,A,1088.0,CHEMBL626682,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14496,10116.0
,N,50597,,,,A,1088.0,CHEMBL626683,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14497,10116.0
,N,50597,,,,A,1088.0,CHEMBL626684,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14498,10116.0
,N,50597,,,,A,1088.0,CHEMBL626685,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14499,10116.0
,N,50597,,,,A,1088.0,CHEMBL626686,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14500,10116.0
,N,50597,,,,A,1088.0,CHEMBL626687,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14501,10116.0
,N,50597,,,,A,1088.0,CHEMBL624978,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14502,10116.0
,N,50597,,,,A,1088.0,CHEMBL624979,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14503,10116.0
,N,50597,,,,A,1088.0,CHEMBL624980,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14504,10116.0
,N,50597,,,,A,1088.0,CHEMBL624981,1,,BAO_0000218,12582,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14505,10116.0
,N,50588,,,,A,1088.0,CHEMBL624982,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14506,9615.0
,U,22224,,,In vivo,A,2367.0,CHEMBL627564,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),1,,Prostate gland,,Autocuration,,,14507,
,U,22224,,,In vivo,A,2367.0,CHEMBL627565,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),1,,Prostate gland,,Autocuration,,,14508,
,U,22224,,,In vivo,A,,CHEMBL627566,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,1,,,,Autocuration,,,14509,
,U,22224,,,In vivo,A,2385.0,CHEMBL627567,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,1,,Muscle tissue,,Autocuration,,,14510,
,U,22224,,,In vivo,A,2106.0,CHEMBL627568,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,1,,Spleen,,Autocuration,,,14511,
,U,22224,,,In vivo,A,2113.0,CHEMBL627569,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,1,,Kidney,,Autocuration,,,14512,
,U,22224,,,In vivo,A,1255.0,CHEMBL627570,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,1,,Urinary bladder,,Autocuration,,,14513,
,U,22224,,,In vivo,A,178.0,CHEMBL627571,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,1,,Blood,,Autocuration,,,14514,
,U,22224,,,In vivo,A,1474.0,CHEMBL627572,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,1,,Bone element,,Autocuration,,,14515,
,U,22224,,,In vivo,A,,CHEMBL627573,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,1,,,,Autocuration,,,14516,
,U,22224,,,In vivo,A,2113.0,CHEMBL627574,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,1,,Kidney,,Autocuration,,,14517,
,U,22224,,,In vivo,A,2107.0,CHEMBL627575,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,1,,Liver,,Autocuration,,,14518,
,U,22224,,,In vivo,A,2048.0,CHEMBL627576,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,1,,Lung,,Autocuration,,,14519,
,U,22224,,,In vivo,A,2385.0,CHEMBL627577,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,1,,Muscle tissue,,Autocuration,,,14520,
,U,22224,,,In vivo,A,2367.0,CHEMBL627578,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),1,,Prostate gland,,Autocuration,,,14521,
,U,22224,,,In vivo,A,2367.0,CHEMBL627579,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,1,,Prostate gland,,Autocuration,,,14522,
,U,22224,,,In vivo,A,2385.0,CHEMBL627580,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,1,,Muscle tissue,,Autocuration,,,14523,
,U,22224,,,In vivo,A,2367.0,CHEMBL627581,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),1,,Prostate gland,,Autocuration,,,14524,
,U,22224,,,In vivo,A,,CHEMBL627582,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,1,,,,Autocuration,,,14525,
,U,22224,,,In vivo,A,2385.0,CHEMBL627583,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,1,,Muscle tissue,,Autocuration,,,14526,
,U,22224,,,In vivo,A,2106.0,CHEMBL627584,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,1,,Spleen,,Autocuration,,,14527,
,U,22224,,,In vivo,A,2367.0,CHEMBL627585,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,1,,Prostate gland,,Autocuration,,,14528,
,U,22224,,,In vivo,A,2385.0,CHEMBL627586,0,,BAO_0000218,13257,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,1,,Muscle tissue,,Autocuration,,,14529,
,N,50597,,,In vivo,A,,CHEMBL627587,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,1,,,Rattus norvegicus,Intermediate,,,14530,10116.0
,N,50597,,,In vivo,A,,CHEMBL627588,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,,,Rattus norvegicus,Intermediate,,,14531,10116.0
,N,50597,,,In vivo,A,,CHEMBL628250,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,1,,,Rattus norvegicus,Intermediate,,,14532,10116.0
,N,50597,,,In vivo,A,,CHEMBL628251,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,,,Rattus norvegicus,Intermediate,,,14533,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL628252,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,1,,Hippocampus,Rattus norvegicus,Intermediate,,,14534,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL628253,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,,Hippocampus,Rattus norvegicus,Intermediate,,,14535,10116.0
,N,50597,,,In vivo,A,1898.0,CHEMBL628254,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,1,,Hypothalamus,Rattus norvegicus,Intermediate,,,14536,10116.0
,N,50597,,,In vivo,A,1898.0,CHEMBL877493,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,1,,Hypothalamus,Rattus norvegicus,Intermediate,,,14537,10116.0
,N,50597,,,In vivo,A,,CHEMBL628255,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,,,Rattus norvegicus,Intermediate,,,14538,10116.0
,N,50597,,,In vivo,A,,CHEMBL628256,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,,,Rattus norvegicus,Intermediate,,,14539,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL628257,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,,Hippocampus,Rattus norvegicus,Intermediate,,,14540,10116.0
,N,50597,,,In vivo,A,1898.0,CHEMBL628258,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,1,,Hypothalamus,Rattus norvegicus,Intermediate,,,14541,10116.0
,N,50597,,,In vivo,A,,CHEMBL628259,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,1,,,Rattus norvegicus,Intermediate,,,14542,10116.0
,N,50597,,,In vivo,A,,CHEMBL628429,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,1,,,Rattus norvegicus,Intermediate,,,14543,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL626862,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,1,,Hippocampus,Rattus norvegicus,Intermediate,,,14544,10116.0
,N,50597,,,In vivo,A,1898.0,CHEMBL626863,1,,BAO_0000218,15413,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,1,,Hypothalamus,Rattus norvegicus,Intermediate,,,14545,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL625886,1,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,1,,Cerebellum,Rattus norvegicus,Intermediate,,,14546,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL625887,1,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,1,,Cerebellum,Rattus norvegicus,Intermediate,,,14547,10116.0
,N,50597,,,In vivo,A,,CHEMBL625888,1,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat cortex,1,,,Rattus norvegicus,Intermediate,,,14548,10116.0
,N,50597,,,In vivo,A,,CHEMBL625889,1,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,1,,,Rattus norvegicus,Intermediate,,,14549,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL625890,1,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,1,,Hippocampus,Rattus norvegicus,Intermediate,,,14550,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL625891,1,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,1,,Hippocampus,Rattus norvegicus,Intermediate,,,14551,10116.0
,N,50597,,,In vivo,A,1898.0,CHEMBL625892,1,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,1,,Hypothalamus,Rattus norvegicus,Intermediate,,,14552,10116.0
,N,50597,,,In vivo,A,1898.0,CHEMBL625893,1,,BAO_0000218,15413,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,1,,Hypothalamus,Rattus norvegicus,Intermediate,,,14553,10116.0
,N,50597,,,In vivo,A,2037.0,CHEMBL625894,1,,BAO_0000218,15413,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,1,,Cerebellum,Rattus norvegicus,Intermediate,,,14554,10116.0
,N,50597,,,In vivo,A,,CHEMBL625895,1,,BAO_0000218,15413,Biodistribution of the [18F]-radiolabeled compound in rat cortex,1,,,Rattus norvegicus,Intermediate,,,14555,10116.0
,U,22224,,,,A,,CHEMBL625896,0,,BAO_0000019,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,1,,,,Autocuration,,,14556,
,U,22224,,,,A,,CHEMBL625897,0,,BAO_0000019,568,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",1,,,,Autocuration,,,14557,
,U,22224,,,,A,,CHEMBL625898,0,,BAO_0000019,568,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",1,,,,Autocuration,,,14558,
,U,22224,,,,A,,CHEMBL625899,0,,BAO_0000019,568,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",1,,,,Autocuration,,,14559,
,U,22224,,,,A,,CHEMBL626124,0,,BAO_0000019,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,1,,,,Autocuration,,,14560,
,N,50212,,,,A,,CHEMBL628500,1,,BAO_0000218,7624,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,1,,,Escherichia coli,Intermediate,,,14561,562.0
,N,50597,,,,A,,CHEMBL857856,1,,BAO_0000218,7624,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",1,,,Rattus norvegicus,Intermediate,,,14562,10116.0
,N,50597,,,,A,,CHEMBL628501,1,,BAO_0000218,7624,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",1,,,Rattus norvegicus,Intermediate,,,14563,10116.0
,U,22224,,,,A,,CHEMBL628502,0,,BAO_0000019,4643,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",1,,,,Autocuration,,,14564,
,U,22224,,,,A,,CHEMBL628503,0,,BAO_0000019,11532,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,1,,,,Autocuration,,,14565,
,U,22224,,,,A,,CHEMBL628504,0,,BAO_0000019,11018,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,1,,,,Autocuration,,,14566,
,U,22224,,,,A,,CHEMBL628505,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",1,,,,Autocuration,,,14567,
,U,22224,,,,A,,CHEMBL874452,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",1,,,,Autocuration,,,14568,
,U,22224,,,,A,,CHEMBL628506,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",1,,,,Autocuration,,,14569,
,U,22224,,,,A,,CHEMBL628507,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",1,,,,Autocuration,,,14570,
,U,22224,,,,A,,CHEMBL628508,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",1,,,,Autocuration,,,14571,
,U,22224,,,,A,,CHEMBL628509,0,,BAO_0000019,8949,Michaelis constant (KM) was evaluated,1,,,,Autocuration,,,14572,
,U,22224,,,,A,,CHEMBL628510,0,,BAO_0000019,12404,Reaction rate parameter value for phosphate with transfer with respect to ATP,1,,,,Autocuration,,,14573,
,U,22224,,,,B,,CHEMBL628511,0,,BAO_0000019,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase I,1,,,,Autocuration,,,14574,
,U,22224,,,,B,,CHEMBL628512,0,,BAO_0000019,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase II,1,,,,Autocuration,,,14575,
,U,22224,,,,B,,CHEMBL628513,0,,BAO_0000019,7625,Substrate concentration for half maximal velocity was reported for rat hexokinase III,1,,,,Autocuration,,,14576,
,U,22224,,,,B,,CHEMBL628514,0,,BAO_0000019,7625,Substrate concentration for half maximal velocity was reported for yeast hexokinase,1,,,,Autocuration,,,14577,
,U,22224,,,,A,,CHEMBL628515,0,,BAO_0000019,12908,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,1,,,,Autocuration,,,14578,
,U,22224,,,,A,,CHEMBL628516,0,,BAO_0000019,10368,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,1,,,,Autocuration,,,14579,
,U,22224,,,,A,,CHEMBL628517,0,,BAO_0000019,13108,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),1,,,,Autocuration,,,14580,
,U,22224,,,,A,,CHEMBL628518,0,,BAO_0000019,13108,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),1,,,,Autocuration,,,14581,
,U,22224,,,,A,,CHEMBL628519,0,,BAO_0000019,15217,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,1,,,,Autocuration,,,14582,
,U,22224,,,,A,,CHEMBL628520,0,,BAO_0000019,15217,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,1,,,,Autocuration,,,14583,
,U,22224,,,,A,,CHEMBL628521,0,,BAO_0000019,10933,Binding constant was determined,1,,,,Autocuration,,,14584,
,U,22224,,,,A,,CHEMBL630443,0,,BAO_0000019,2363,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,1,,,,Autocuration,,,14585,
,U,22224,,,,A,,CHEMBL630444,0,,BAO_0000019,2363,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,1,,,,Autocuration,,,14586,
,U,22224,,,,A,,CHEMBL857732,0,,BAO_0000019,2276,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,1,,,,Autocuration,,,14587,
,U,22224,,,,P,,CHEMBL630445,0,,BAO_0000100,14915,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,1,,,,Autocuration,,,14588,
,U,22224,,,,A,,CHEMBL630446,0,,BAO_0000019,8847,Catalytic rate constant of the compound,1,,,,Autocuration,,,14589,
,U,22224,,,,B,,CHEMBL630447,0,,BAO_0000019,15357,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,1,,,,Autocuration,,,14590,
,U,22224,,,,A,,CHEMBL630448,0,,BAO_0000019,2869,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),1,,,,Autocuration,,,14591,
,U,22224,,,,A,,CHEMBL630449,0,,BAO_0000019,3484,Catalytic rate constant against phospholipase A2 was determined,1,,,,Autocuration,,,14592,
,U,22224,,,,A,,CHEMBL630450,0,,BAO_0000019,1373,"Compound was evaluated for catalytic constant, Kcat",1,,,,Autocuration,,,14593,
,U,22224,,,,A,,CHEMBL630451,0,,BAO_0000019,8142,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,1,,,,Autocuration,,,14594,
,U,22224,,,,A,,CHEMBL630452,0,,BAO_0000019,14131,Kcat calculated from 0.693/T1/2,1,,,,Autocuration,,,14595,
,U,22224,,,,A,,CHEMBL630453,0,,BAO_0000019,17269,Kcat was determined,1,,,,Autocuration,,,14596,
,U,22224,,,,A,,CHEMBL630454,0,,BAO_0000019,3485,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,1,,,,Autocuration,,,14597,
,U,22224,,,,A,,CHEMBL630455,0,,BAO_0000019,3485,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,1,,,,Autocuration,,,14598,
,U,22224,,,,A,,CHEMBL631487,0,,BAO_0000019,3485,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,1,,,,Autocuration,,,14599,
,U,22224,,,,A,,CHEMBL631488,0,,BAO_0000019,5962,Kcat value was determined,1,,,,Autocuration,,,14600,
,U,22224,,,,A,,CHEMBL876440,0,,BAO_0000019,3133,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,1,,,,Autocuration,,,14601,
,U,22224,,,,A,,CHEMBL631489,0,,BAO_0000019,3133,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,1,,,,Autocuration,,,14602,
,U,22224,,,,A,,CHEMBL857742,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",1,,,,Autocuration,,,14603,
,U,22224,,,,A,,CHEMBL631490,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",1,,,,Autocuration,,,14604,
,U,22224,,,,A,,CHEMBL631491,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",1,,,,Autocuration,,,14605,
,U,22224,,,,A,,CHEMBL631492,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",1,,,,Autocuration,,,14606,
,U,22224,,,,A,,CHEMBL631493,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",1,,,,Autocuration,,,14607,
,U,22224,,,,A,,CHEMBL631494,0,,BAO_0000019,4892,Kinetic parameter for rate of conversion to PABA was determined,1,,,,Autocuration,,,14608,
,U,22224,,,,A,,CHEMBL631495,0,,BAO_0000019,3133,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,1,,,,Autocuration,,,14609,
,N,50597,,,,A,1988.0,CHEMBL631496,1,,BAO_0000218,11488,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",1,,Feces,Rattus norvegicus,Intermediate,,,14610,10116.0
,N,50597,,,,A,1088.0,CHEMBL631497,1,,BAO_0000218,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",1,,Urine,Rattus norvegicus,Intermediate,,,14611,10116.0
,N,50597,,,,A,1088.0,CHEMBL631498,1,,BAO_0000218,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",1,,Urine,Rattus norvegicus,Intermediate,,,14612,10116.0
,N,50597,,,,A,1088.0,CHEMBL629776,1,,BAO_0000218,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",1,,Urine,Rattus norvegicus,Intermediate,,,14613,10116.0
,N,50597,,,,A,1088.0,CHEMBL629777,1,,BAO_0000218,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",1,,Urine,Rattus norvegicus,Intermediate,,,14614,10116.0
,N,50597,,,,A,1088.0,CHEMBL629778,1,,BAO_0000218,11488,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",1,,Urine,Rattus norvegicus,Intermediate,,,14615,10116.0
,N,50597,,,,A,,CHEMBL630456,1,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14616,10116.0
,N,50597,,,,A,,CHEMBL630457,1,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14617,10116.0
,N,50597,,,,A,,CHEMBL630458,1,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14618,10116.0
,N,50597,,,,A,,CHEMBL630459,1,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14619,10116.0
,N,50597,,,,A,,CHEMBL630460,1,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14620,10116.0
,N,50597,,,,A,,CHEMBL876550,1,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14621,10116.0
,N,50597,,,,A,,CHEMBL630461,1,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14622,10116.0
,N,50597,,,,A,,CHEMBL630462,1,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14623,10116.0
,N,50597,,,,A,,CHEMBL630463,1,,BAO_0000218,11488,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14624,10116.0
,N,50597,,,,A,,CHEMBL630464,1,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14625,10116.0
,N,50597,,,,A,,CHEMBL630465,1,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14626,10116.0
,N,50597,,,,A,,CHEMBL630466,1,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14627,10116.0
,N,50597,,,,A,,CHEMBL630467,1,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14628,10116.0
,N,50597,,,,A,,CHEMBL630633,1,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14629,10116.0
,N,50597,,,,A,,CHEMBL630634,1,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14630,10116.0
,N,50597,,,,A,,CHEMBL630635,1,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14631,10116.0
,N,50597,,,,A,,CHEMBL630636,1,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14632,10116.0
,N,50597,,,,A,,CHEMBL630637,1,,BAO_0000218,11488,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,1,,,Rattus norvegicus,Intermediate,,,14633,10116.0
,N,50592,,,,A,1988.0,CHEMBL630638,1,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",1,,Feces,Oryctolagus cuniculus,Intermediate,,,14634,9986.0
,N,50592,,,,A,1988.0,CHEMBL630639,1,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",1,,Feces,Oryctolagus cuniculus,Intermediate,,,14635,9986.0
,N,50592,,,,A,1988.0,CHEMBL630640,1,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",1,,Feces,Oryctolagus cuniculus,Intermediate,,,14636,9986.0
,N,50592,,,,A,1988.0,CHEMBL876551,1,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",1,,Feces,Oryctolagus cuniculus,Intermediate,,,14637,9986.0
,N,50592,,,,A,1088.0,CHEMBL630641,1,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",1,,Urine,Oryctolagus cuniculus,Intermediate,,,14638,9986.0
,N,50592,,,,A,1088.0,CHEMBL630642,1,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,14639,9986.0
,N,50592,,,,A,1088.0,CHEMBL630643,1,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,14640,9986.0
,N,50592,,,,A,1088.0,CHEMBL630644,1,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,14641,9986.0
,N,50592,,,,A,1088.0,CHEMBL630645,1,,BAO_0000218,7132,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,14642,9986.0
,N,50592,,,,A,1988.0,CHEMBL625599,1,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",1,,Feces,Oryctolagus cuniculus,Intermediate,,,14643,9986.0
,N,50592,,,,A,1988.0,CHEMBL625600,1,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",1,,Feces,Oryctolagus cuniculus,Intermediate,,,14644,9986.0
,N,50592,,,,A,1988.0,CHEMBL625601,1,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",1,,Feces,Oryctolagus cuniculus,Intermediate,,,14645,9986.0
,N,50592,,,,A,1988.0,CHEMBL625602,1,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",1,,Feces,Oryctolagus cuniculus,Intermediate,,,14646,9986.0
,N,50592,,,,A,1088.0,CHEMBL627470,1,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",1,,Urine,Oryctolagus cuniculus,Intermediate,,,14647,9986.0
,N,50592,,,,A,1088.0,CHEMBL627471,1,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,14648,9986.0
,N,50592,,,,A,1088.0,CHEMBL627472,1,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,14649,9986.0
,N,50592,,,,A,1088.0,CHEMBL627473,1,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,14650,9986.0
,N,50592,,,,A,1088.0,CHEMBL627474,1,,BAO_0000218,7132,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",1,,Urine,Oryctolagus cuniculus,Intermediate,,,14651,9986.0
,N,50597,,,In vivo,A,178.0,CHEMBL627475,1,,BAO_0000218,13925,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Blood,Rattus norvegicus,Intermediate,,,14652,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL627476,1,,BAO_0000218,13925,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Blood,Rattus norvegicus,Intermediate,,,14653,10116.0
,N,50588,,,,A,1088.0,CHEMBL627477,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14654,9615.0
,N,50588,,,,A,1088.0,CHEMBL627478,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14655,9615.0
,N,50588,,,,A,1088.0,CHEMBL627479,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14656,9615.0
,N,50588,,,,A,1088.0,CHEMBL627480,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14657,9615.0
,N,50588,,,,A,1088.0,CHEMBL627481,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14658,9615.0
,N,50588,,,,A,1088.0,CHEMBL627482,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14659,9615.0
,N,50588,,,,A,1088.0,CHEMBL627483,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14660,9615.0
,N,50588,,,,A,1088.0,CHEMBL875636,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14661,9615.0
,N,50588,,,,A,1088.0,CHEMBL625764,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14662,9615.0
,N,50588,,,,A,1088.0,CHEMBL625765,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14663,9615.0
,N,50588,,,,A,1088.0,CHEMBL625766,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14664,9615.0
,N,50588,,,,A,1088.0,CHEMBL625767,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14665,9615.0
,N,50588,,,,A,1088.0,CHEMBL625768,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14666,9615.0
,N,50588,,,,A,1088.0,CHEMBL625769,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14667,9615.0
,N,50588,,,,A,1088.0,CHEMBL625770,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14668,9615.0
,N,50588,,,,A,1088.0,CHEMBL625771,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14669,9615.0
,N,50588,,,,A,1088.0,CHEMBL625772,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14670,9615.0
,N,50588,,,,A,1088.0,CHEMBL625773,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,1,,Urine,Canis lupus familiaris,Intermediate,,,14671,9615.0
,N,50597,,,,A,1088.0,CHEMBL625774,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14672,10116.0
,N,50597,,,,A,1088.0,CHEMBL625775,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14673,10116.0
,N,50597,,,,A,1088.0,CHEMBL625776,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14674,10116.0
,N,50597,,,,A,1088.0,CHEMBL625777,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14675,10116.0
,N,50597,,,,A,1088.0,CHEMBL625778,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14676,10116.0
,N,50597,,,,A,1088.0,CHEMBL625779,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14677,10116.0
,N,50597,,,,A,1088.0,CHEMBL625780,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14678,10116.0
,N,50597,,,,A,1088.0,CHEMBL625781,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14679,10116.0
,N,50597,,,,A,1088.0,CHEMBL875637,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14680,10116.0
,N,50597,,,,A,1088.0,CHEMBL626473,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14681,10116.0
,N,50597,,,,A,1088.0,CHEMBL626474,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14682,10116.0
,N,50597,,,,A,1088.0,CHEMBL626475,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14683,10116.0
,N,50597,,,,A,1088.0,CHEMBL626476,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14684,10116.0
,N,50597,,,,A,1088.0,CHEMBL634397,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14685,10116.0
,N,50597,,,,A,1088.0,CHEMBL626477,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14686,10116.0
,N,50597,,,,A,1088.0,CHEMBL631069,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14687,10116.0
,N,50597,,,,A,1088.0,CHEMBL631070,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14688,10116.0
,N,50597,,,,A,1088.0,CHEMBL631071,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14689,10116.0
,N,50597,,,,A,1088.0,CHEMBL631072,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14690,10116.0
,N,50597,,,,A,1088.0,CHEMBL631073,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14691,10116.0
,N,50597,,,,A,1088.0,CHEMBL631074,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14692,10116.0
,N,50597,,,,A,1088.0,CHEMBL631075,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14693,10116.0
,N,50597,,,,A,1088.0,CHEMBL631725,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14694,10116.0
,N,50597,,,,A,1088.0,CHEMBL631726,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14695,10116.0
,N,50597,,,,A,1088.0,CHEMBL631727,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14696,10116.0
,N,50597,,,,A,1088.0,CHEMBL631728,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14697,10116.0
,N,50597,,,,A,1088.0,CHEMBL631729,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14698,10116.0
,N,50597,,,,A,1088.0,CHEMBL631730,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14699,10116.0
,N,50597,,,,A,1088.0,CHEMBL631731,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14700,10116.0
,N,50597,,,,A,1088.0,CHEMBL631910,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14701,10116.0
,N,50597,,,In vivo,A,10000000.0,CHEMBL631911,1,,BAO_0000218,15413,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,1,,Hippocampus,Rattus norvegicus,Intermediate,,,14702,10116.0
,N,50597,,,In vivo,A,1898.0,CHEMBL631912,1,,BAO_0000218,15413,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,1,,Hypothalamus,Rattus norvegicus,Intermediate,,,14703,10116.0
,N,50597,,,In vivo,A,1898.0,CHEMBL631913,1,,BAO_0000218,15413,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,1,,Hypothalamus,Rattus norvegicus,Intermediate,,,14704,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL631914,1,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,14705,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL631915,1,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,14706,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL875778,1,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Blood,Rattus norvegicus,Intermediate,,,14707,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL631916,1,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,14708,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL631917,1,,BAO_0000218,12017,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,14709,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL631918,1,,BAO_0000218,12017,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,14710,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL631919,1,,BAO_0000218,12017,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,14711,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL631920,1,,BAO_0000218,12017,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Blood,Rattus norvegicus,Intermediate,,,14712,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL631921,1,,BAO_0000218,12017,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,14713,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL631922,1,,BAO_0000218,12017,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Blood,Rattus norvegicus,Intermediate,,,14714,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL631923,1,,BAO_0000218,12017,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Blood,Rattus norvegicus,Intermediate,,,14715,10116.0
,N,50597,,,In vivo,A,,CHEMBL631924,1,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,14716,10116.0
,N,50597,,,In vivo,A,,CHEMBL630234,1,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,14717,10116.0
,N,50597,,,In vivo,A,,CHEMBL630235,1,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,Rattus norvegicus,Intermediate,,,14718,10116.0
,N,50597,,,In vivo,A,,CHEMBL630236,1,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,14719,10116.0
,N,50597,,,In vivo,A,,CHEMBL630237,1,,BAO_0000218,12017,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,14720,10116.0
,N,50597,,,In vivo,A,,CHEMBL630238,1,,BAO_0000218,12017,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,14721,10116.0
,N,50597,,,In vivo,A,,CHEMBL630239,1,,BAO_0000218,12017,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,14722,10116.0
,N,50597,,,In vivo,A,,CHEMBL630303,1,,BAO_0000218,12017,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,,Rattus norvegicus,Intermediate,,,14723,10116.0
,N,50597,,,In vivo,A,,CHEMBL630304,1,,BAO_0000218,12017,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,14724,10116.0
,N,50597,,,In vivo,A,,CHEMBL630305,1,,BAO_0000218,12017,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,,Rattus norvegicus,Intermediate,,,14725,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL630306,1,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,14726,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL630307,1,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,14727,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL630308,1,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Kidney,Rattus norvegicus,Intermediate,,,14728,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL630309,1,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,14729,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL629309,1,,BAO_0000218,12017,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,14730,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL629993,1,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,14731,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL629994,1,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,14732,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL629995,1,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Kidney,Rattus norvegicus,Intermediate,,,14733,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL631993,1,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,14734,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL631994,1,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,14735,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL631995,1,,BAO_0000218,12017,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Kidney,Rattus norvegicus,Intermediate,,,14736,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL631996,1,,BAO_0000218,12017,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Liver,Rattus norvegicus,Intermediate,,,14737,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL631997,1,,BAO_0000218,12017,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,14738,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL631998,1,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,14739,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL631999,1,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,14740,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL632000,1,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Liver,Rattus norvegicus,Intermediate,,,14741,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL632001,1,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,14742,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL874424,1,,BAO_0000218,12017,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,14743,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL632002,1,,BAO_0000218,12017,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,14744,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL632003,1,,BAO_0000218,12017,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,14745,10116.0
,U,22224,,,,A,,CHEMBL632004,0,,BAO_0000019,3133,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,1,,,,Autocuration,,,14746,
,U,22224,,,,A,,CHEMBL632005,0,,BAO_0000019,2742,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,1,,,,Autocuration,,,14747,
,U,22224,,,,A,,CHEMBL632006,0,,BAO_0000019,2742,Compound was tested for amidase rate in the presence of N62C screen enzyme,1,,,,Autocuration,,,14748,
,U,22224,,,,A,,CHEMBL632007,0,,BAO_0000019,2742,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,1,,,,Autocuration,,,14749,
,U,22224,,,,A,,CHEMBL632008,0,,BAO_0000019,2742,Compound was tested for amidase rate in the presence of S166C screen enzyme,1,,,,Autocuration,,,14750,
,U,22224,,,,A,,CHEMBL632009,0,,BAO_0000019,2742,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,1,,,,Autocuration,,,14751,
,U,22224,,,,A,,CHEMBL632010,0,,BAO_0000019,2742,Compound was tested for esterase rate in the presence of N62C screen enzyme,1,,,,Autocuration,,,14752,
,U,22224,,,,A,,CHEMBL857750,0,,BAO_0000019,2742,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,1,,,,Autocuration,,,14753,
,U,22224,,,,A,,CHEMBL632011,0,,BAO_0000019,2742,Compound was tested for esterase rate in the presence of S166C screen enzyme,1,,,,Autocuration,,,14754,
,U,22224,,,,A,,CHEMBL632012,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,,,,Autocuration,,,14755,
,U,22224,,,,A,,CHEMBL632013,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,,,,Autocuration,,,14756,
,U,22224,,,,A,,CHEMBL632014,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",1,,,,Autocuration,,,14757,
,U,22224,,,,A,,CHEMBL629622,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,,,,Autocuration,,,14758,
,U,22224,,,,A,,CHEMBL629623,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",1,,,,Autocuration,,,14759,
,U,22224,,,,A,,CHEMBL629624,0,,BAO_0000019,2276,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",1,,,,Autocuration,,,14760,
,U,22224,,,,A,,CHEMBL629625,0,,BAO_0000019,17269,Ratio of Kcat to that of Km was determined,1,,,,Autocuration,,,14761,
,U,22224,,,,A,,CHEMBL629626,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",1,,,,Autocuration,,,14762,
,U,22224,,,,A,,CHEMBL629627,0,,BAO_0000019,2276,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",1,,,,Autocuration,,,14763,
,U,22224,,,,A,,CHEMBL629628,0,,BAO_0000019,15917,"Compound was evaluated for constant, Kd",1,,,,Autocuration,,,14764,
,U,22224,,,,A,,CHEMBL629629,0,,BAO_0000019,10933,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,1,,,,Autocuration,,,14765,
,U,22224,,,,A,,CHEMBL629630,0,,BAO_0000019,10933,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,1,,,,Autocuration,,,14766,
,U,22224,,,,A,,CHEMBL856030,0,,BAO_0000019,14293,Dissociation Constant of compound determined,1,,,,Autocuration,,,14767,
,U,22224,,,,B,,CHEMBL629631,0,,BAO_0000019,6698,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,1,,,,Autocuration,,,14768,
,U,22224,,,,B,,CHEMBL629632,0,,BAO_0000019,6698,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,1,,,,Autocuration,,,14769,
,U,22224,,,,P,,CHEMBL629633,0,,BAO_0000100,4318,Dissociation constant of compound with Fructose was determined,1,,,,Autocuration,,,14770,
,U,22224,,,,P,,CHEMBL629634,0,,BAO_0000100,4318,Dissociation constant of compound with Fructose was determined; Not determined,1,,,,Autocuration,,,14771,
,U,22224,,,,P,,CHEMBL629635,0,,BAO_0000100,4318,Dissociation constant of compound with Lactulose was determined,1,,,,Autocuration,,,14772,
,U,22224,,,,P,,CHEMBL629636,0,,BAO_0000100,4318,Dissociation constant of compound with Lactulose was determined; Not determined,1,,,,Autocuration,,,14773,
,U,22224,,,,P,,CHEMBL629637,0,,BAO_0000100,14959,Dissociation constant of the Compound,1,,,,Autocuration,,,14774,
,U,22224,,,,P,,CHEMBL629638,0,,BAO_0000100,5913,Dissociation constant by non-linear regression analysis,1,,,,Autocuration,,,14775,
,U,22224,,,,P,,CHEMBL629639,0,,BAO_0000100,14218,Dissociation constant was determined,1,,,,Autocuration,,,14776,
,U,22224,,,,P,,CHEMBL629640,0,,BAO_0000100,10689,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,1,,,,Autocuration,,,14777,
,U,22224,,,,P,,CHEMBL629641,0,,BAO_0000100,13925,Dissociation constant was determined,1,,,,Autocuration,,,14778,
,U,22224,,,,P,,CHEMBL631344,0,,BAO_0000100,16359,Dissociation constant was determined,1,,,,Autocuration,,,14779,
,N,50597,,,,A,2385.0,CHEMBL631345,1,,BAO_0000218,10944,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14780,10116.0
,U,22224,,,,A,,CHEMBL631346,0,,BAO_0000019,11080,The dissociation constant determined by fluorescence displacement assay,1,,,,Autocuration,,,14781,
,U,22224,,,,A,,CHEMBL631524,0,,BAO_0000019,17805,kd value surface plasmon resonance (SPR) method,1,,,,Autocuration,,,14782,
,N,50597,,,,A,2385.0,CHEMBL631525,1,,BAO_0000218,10944,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14783,10116.0
,U,22224,,,,F,,CHEMBL631526,0,,BAO_0000019,16645,First dissociation constant of the binding of compound to V30M TTR,1,,,,Autocuration,,,14784,
,U,22224,,,,F,,CHEMBL631527,0,,BAO_0000019,16645,Second dissociation constant of the binding of compound to V30M TTR,1,,,,Autocuration,,,14785,
,U,22224,,,,A,,CHEMBL631528,0,,BAO_0000019,7793,"Compound was evaluated for equilibrium constant, Ke",1,,,,Autocuration,,,14786,
,U,22224,,,,A,1898.0,CHEMBL631529,0,,BAO_0000019,12199,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,1,,Hypothalamus,,Autocuration,,,14787,
,U,22224,,,,A,1898.0,CHEMBL631530,0,,BAO_0000019,12199,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,1,,Hypothalamus,,Autocuration,,,14788,
,U,22224,,,,A,,CHEMBL631531,0,,BAO_0000019,9680,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,1,,,,Autocuration,,,14789,
,U,22224,,,,A,,CHEMBL631532,0,,BAO_0000019,9680,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,1,,,,Autocuration,,,14790,
,U,22224,,,,A,,CHEMBL631533,0,,BAO_0000019,9680,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,1,,,,Autocuration,,,14791,
,N,50594,,,,A,,CHEMBL876552,1,,BAO_0000218,13758,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,,Mus musculus,Intermediate,,,14792,10090.0
,N,50594,,,,A,,CHEMBL631534,1,,BAO_0000218,13758,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,1,,,Mus musculus,Intermediate,,,14793,10090.0
,N,50594,,,,A,,CHEMBL631535,1,,BAO_0000218,13758,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,,Mus musculus,Intermediate,,,14794,10090.0
,N,50594,,,,A,,CHEMBL631536,1,,BAO_0000218,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,,Mus musculus,Intermediate,,,14795,10090.0
,N,50594,,,,A,,CHEMBL631537,1,,BAO_0000218,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,1,,,Mus musculus,Intermediate,,,14796,10090.0
,N,50594,,,,A,,CHEMBL631538,1,,BAO_0000218,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,1,,,Mus musculus,Intermediate,,,14797,10090.0
,N,50594,,,,A,,CHEMBL631539,1,,BAO_0000218,13758,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,1,,,Mus musculus,Intermediate,,,14798,10090.0
,N,50594,,,,A,,CHEMBL631540,1,,BAO_0000218,13758,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,1,,,Mus musculus,Intermediate,,,14799,10090.0
,N,50597,,,,A,,CHEMBL625637,1,,BAO_0000218,14393,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,Rattus norvegicus,Intermediate,,,14800,10116.0
,N,50597,,,,A,,CHEMBL625638,1,,BAO_0000218,14393,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,1,,,Rattus norvegicus,Intermediate,,,14801,10116.0
,N,50597,,,,A,,CHEMBL625639,1,,BAO_0000218,15078,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",1,,,Rattus norvegicus,Intermediate,,,14802,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL625640,1,,BAO_0000218,13925,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Brain,Rattus norvegicus,Intermediate,,,14803,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL625641,1,,BAO_0000218,13925,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Brain,Rattus norvegicus,Intermediate,,,14804,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625642,1,,BAO_0000218,13925,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Heart,Rattus norvegicus,Intermediate,,,14805,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625643,1,,BAO_0000218,13925,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Heart,Rattus norvegicus,Intermediate,,,14806,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL625644,1,,BAO_0000218,13925,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Kidney,Rattus norvegicus,Intermediate,,,14807,10116.0
,N,50597,,,In vivo,A,2113.0,CHEMBL625645,1,,BAO_0000218,13925,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Kidney,Rattus norvegicus,Intermediate,,,14808,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625646,1,,BAO_0000218,13925,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Liver,Rattus norvegicus,Intermediate,,,14809,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625647,1,,BAO_0000218,13925,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Liver,Rattus norvegicus,Intermediate,,,14810,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625648,1,,BAO_0000218,13925,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Lung,Rattus norvegicus,Intermediate,,,14811,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL625649,1,,BAO_0000218,13925,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,1,,Lung,Rattus norvegicus,Intermediate,,,14812,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL625650,1,,BAO_0000218,13925,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14813,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL625651,1,,BAO_0000218,13925,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14814,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL625652,1,,BAO_0000218,13925,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Zone of skin,Rattus norvegicus,Intermediate,,,14815,10116.0
,N,50597,,,In vivo,A,14.0,CHEMBL625653,1,,BAO_0000218,13925,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Zone of skin,Rattus norvegicus,Intermediate,,,14816,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL625654,1,,BAO_0000218,13925,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Spleen,Rattus norvegicus,Intermediate,,,14817,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL625655,1,,BAO_0000218,13925,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,1,,Spleen,Rattus norvegicus,Intermediate,,,14818,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625656,1,,BAO_0000218,9712,Biodistribution of Compound in rat blood after 15 minutes of administration,1,,Blood,Rattus norvegicus,Intermediate,,,14819,10116.0
,N,50597,,,In vivo,A,178.0,CHEMBL625657,1,,BAO_0000218,9712,Biodistribution of Compound in rat blood after 2 minutes of administration,1,,Blood,Rattus norvegicus,Intermediate,,,14820,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL625658,1,,BAO_0000218,9712,Biodistribution of Compound in rat brain after 15 minutes of administration,1,,Brain,Rattus norvegicus,Intermediate,,,14821,10116.0
,N,50597,,,In vivo,A,955.0,CHEMBL625659,1,,BAO_0000218,9712,Biodistribution of Compound in rat brain after 2 minutes of administration,1,,Brain,Rattus norvegicus,Intermediate,,,14822,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625660,1,,BAO_0000218,9712,Biodistribution of Compound in rat heart after 15 minutes of administration,1,,Heart,Rattus norvegicus,Intermediate,,,14823,10116.0
,N,50597,,,In vivo,A,948.0,CHEMBL625661,1,,BAO_0000218,9712,Biodistribution of Compound in rat heart after 2 minutes of administration,1,,Heart,Rattus norvegicus,Intermediate,,,14824,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625662,1,,BAO_0000218,9712,Biodistribution of Compound in rat liver after 15 minutes of administration,1,,Liver,Rattus norvegicus,Intermediate,,,14825,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL625663,1,,BAO_0000218,9712,Biodistribution of Compound in rat liver after 2 minutes of administration,1,,Liver,Rattus norvegicus,Intermediate,,,14826,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL875621,1,,BAO_0000218,9712,Biodistribution of Compound in rat lung after 15 minutes of administration,1,,Lung,Rattus norvegicus,Intermediate,,,14827,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL628382,1,,BAO_0000218,9712,Biodistribution of Compound in rat lung after 2 minutes of administration,1,,Lung,Rattus norvegicus,Intermediate,,,14828,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL628383,1,,BAO_0000218,9712,Biodistribution of Compound in rat muscle after 15 minutes of administration,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14829,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL628384,1,,BAO_0000218,9712,Biodistribution of Compound in rat muscle after 2 minutes of administration,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14830,10116.0
,N,50597,,,,A,,CHEMBL628385,1,,BAO_0000218,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,1,,,Rattus norvegicus,Intermediate,,,14831,10116.0
,N,50597,,,,A,,CHEMBL875753,1,,BAO_0000218,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,1,,,Rattus norvegicus,Intermediate,,,14832,10116.0
,N,50597,,,,A,,CHEMBL628386,1,,BAO_0000218,13925,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,1,,,Rattus norvegicus,Intermediate,,,14833,10116.0
,N,50597,,,,A,,CHEMBL628387,1,,BAO_0000218,6941,Organ distribution in rat blood 2 minutes after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14834,10116.0
,N,50597,,,,A,,CHEMBL628388,1,,BAO_0000218,6941,Organ distribution in rat blood 2 hr after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14835,10116.0
,N,50597,,,,A,,CHEMBL628389,1,,BAO_0000218,6941,Organ distribution in rat blood 30 minutes after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14836,10116.0
,N,50597,,,,A,,CHEMBL632756,1,,BAO_0000218,6941,Organ distribution in rat blood 30 min after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14837,10116.0
,N,50597,,,,A,,CHEMBL628390,1,,BAO_0000218,6941,Organ distribution in rat brain 2 minutes after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14838,10116.0
,N,50597,,,,A,,CHEMBL631811,1,,BAO_0000218,6941,Organ distribution in rat brain 2 hr after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14839,10116.0
,N,50597,,,,A,,CHEMBL631812,1,,BAO_0000218,6941,Organ distribution in rat brain 30 minutes after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14840,10116.0
,N,50597,,,,A,,CHEMBL631813,1,,BAO_0000218,6941,Organ distribution in rat heart 2 minutes after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14841,10116.0
,N,50597,,,,A,,CHEMBL631814,1,,BAO_0000218,6941,Organ distribution in rat heart 2 hr after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14842,10116.0
,N,50597,,,,A,,CHEMBL631815,1,,BAO_0000218,6941,Organ distribution in rat heart 30 minutes after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14843,10116.0
,N,50597,,,,A,,CHEMBL631816,1,,BAO_0000218,6941,Organ distribution in rat kidney 2 minutes after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14844,10116.0
,N,50597,,,,A,,CHEMBL875758,1,,BAO_0000218,6941,Organ distribution in rat kidney 2 hr after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14845,10116.0
,N,50597,,,,A,,CHEMBL631817,1,,BAO_0000218,6941,Organ distribution in rat kidney 30 minutes after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14846,10116.0
,N,50597,,,,A,2107.0,CHEMBL631818,1,,BAO_0000218,6941,Organ distribution in rat liver 2 minutes after intravenous injection,1,,Liver,Rattus norvegicus,Intermediate,,,14847,10116.0
,N,50597,,,,A,2107.0,CHEMBL631819,1,,BAO_0000218,6941,Organ distribution in rat liver 2 hr after intravenous injection,1,,Liver,Rattus norvegicus,Intermediate,,,14848,10116.0
,N,50597,,,,A,2107.0,CHEMBL631820,1,,BAO_0000218,6941,Organ distribution in rat liver 30 minutes after intravenous injection,1,,Liver,Rattus norvegicus,Intermediate,,,14849,10116.0
,N,50597,,,,A,,CHEMBL631821,1,,BAO_0000218,6941,Organ distribution in rat lung 2 minutes after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14850,10116.0
,N,50597,,,,A,,CHEMBL631822,1,,BAO_0000218,6941,Organ distribution in rat lung 2 hr after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14851,10116.0
,N,50597,,,,A,,CHEMBL631823,1,,BAO_0000218,6941,Organ distribution in rat lung 30 minutes after intravenous injection,1,,,Rattus norvegicus,Intermediate,,,14852,10116.0
,N,50597,,,,A,2385.0,CHEMBL631824,1,,BAO_0000218,6941,Organ distribution in rat muscle 2 minutes after intravenous injection,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14853,10116.0
,N,50597,,,,A,2385.0,CHEMBL631825,1,,BAO_0000218,6941,Organ distribution in rat muscle 2 hr after intravenous injection,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14854,10116.0
,N,50597,,,,A,2385.0,CHEMBL631826,1,,BAO_0000218,6941,Organ distribution in rat muscle 30 minutes after intravenous injection,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14855,10116.0
,N,50594,,,In vivo,A,,CHEMBL631827,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),1,,,Mus musculus,Intermediate,,,14856,10090.0
,N,50594,,,In vivo,A,,CHEMBL631828,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),1,,,Mus musculus,Intermediate,,,14857,10090.0
,N,50594,,,In vivo,A,,CHEMBL631829,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),1,,,Mus musculus,Intermediate,,,14858,10090.0
,N,50597,,,,A,1088.0,CHEMBL875759,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14859,10116.0
,N,50597,,,,A,1088.0,CHEMBL631830,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14860,10116.0
,N,50597,,,,A,1088.0,CHEMBL631831,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14861,10116.0
,N,50597,,,,A,1088.0,CHEMBL631832,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14862,10116.0
,N,50597,,,,A,1088.0,CHEMBL631833,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14863,10116.0
,N,50597,,,,A,1088.0,CHEMBL631834,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14864,10116.0
,N,50597,,,,A,1088.0,CHEMBL631835,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14865,10116.0
,N,50597,,,,A,1088.0,CHEMBL631836,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14866,10116.0
,N,50597,,,,A,1088.0,CHEMBL631837,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14867,10116.0
,N,50597,,,,A,1088.0,CHEMBL631838,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14868,10116.0
,N,50597,,,,A,1088.0,CHEMBL631839,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14869,10116.0
,N,50597,,,,A,1088.0,CHEMBL631840,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14870,10116.0
,N,50597,,,,A,1088.0,CHEMBL631841,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14871,10116.0
,N,50597,,,,A,1088.0,CHEMBL631842,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14872,10116.0
,N,50597,,,,A,1088.0,CHEMBL631843,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14873,10116.0
,N,50597,,,,A,1088.0,CHEMBL631844,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14874,10116.0
,N,50597,,,,A,1088.0,CHEMBL631845,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14875,10116.0
,N,50597,,,,A,1088.0,CHEMBL631846,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14876,10116.0
,N,50597,,,,A,1088.0,CHEMBL875760,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14877,10116.0
,N,50597,,,,A,1088.0,CHEMBL632199,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14878,10116.0
,N,50597,,,,A,1088.0,CHEMBL631847,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14879,10116.0
,N,50597,,,,A,1088.0,CHEMBL631848,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14880,10116.0
,N,50597,,,,A,1088.0,CHEMBL628707,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14881,10116.0
,N,50597,,,,A,1088.0,CHEMBL628708,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14882,10116.0
,N,50597,,,,A,1088.0,CHEMBL628709,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14883,10116.0
,N,50597,,,,A,1088.0,CHEMBL628710,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14884,10116.0
,N,50597,,,,A,1088.0,CHEMBL628711,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14885,10116.0
,N,50597,,,,A,1088.0,CHEMBL628712,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14886,10116.0
,N,50597,,,,A,1088.0,CHEMBL628713,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14887,10116.0
,N,50597,,,,A,1088.0,CHEMBL628714,1,,BAO_0000218,12582,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,1,,Urine,Rattus norvegicus,Intermediate,,,14888,10116.0
,N,50597,,,,A,,CHEMBL628715,1,,BAO_0000218,7415,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",1,,,Rattus norvegicus,Intermediate,,,14889,10116.0
,U,22224,,,,A,,CHEMBL629179,0,,BAO_0000019,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,1,,,,Autocuration,,,14890,
,U,22224,,,,A,,CHEMBL629180,0,,BAO_0000019,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,1,,,,Autocuration,,,14891,
,U,22224,,,,A,,CHEMBL875108,0,,BAO_0000019,7313,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,1,,,,Autocuration,,,14892,
,U,22224,,,,A,1235.0,CHEMBL629181,0,,BAO_0000019,7570,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,1,,Adrenal cortex,,Autocuration,,,14893,
,U,22224,,,,A,1235.0,CHEMBL629182,0,,BAO_0000019,7570,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,1,,Adrenal cortex,,Autocuration,,,14894,
,U,22224,,,,A,,CHEMBL629183,0,,BAO_0000019,7570,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,1,,,,Autocuration,,,14895,
,U,22224,,,,A,,CHEMBL629184,0,,BAO_0000019,7570,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,1,,,,Autocuration,,,14896,
,U,22224,,,,A,1235.0,CHEMBL629185,0,,BAO_0000019,7570,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,1,,Adrenal cortex,,Autocuration,,,14897,
,U,22224,,,,A,1235.0,CHEMBL629186,0,,BAO_0000019,7570,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,1,,Adrenal cortex,,Autocuration,,,14898,
,U,22224,,,,A,,CHEMBL629187,0,,BAO_0000019,7570,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,1,,,,Autocuration,,,14899,
,U,22224,,,,A,,CHEMBL629887,0,,BAO_0000019,7570,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,1,,,,Autocuration,,,14900,
,U,22224,,,,A,,CHEMBL629888,0,,BAO_0000019,7570,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,1,,,,Autocuration,,,14901,
,U,22224,,,,A,,CHEMBL629889,0,,BAO_0000019,7570,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,1,,,,Autocuration,,,14902,
,U,22224,,,,A,1235.0,CHEMBL629890,0,,BAO_0000019,7570,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,1,,Adrenal cortex,,Autocuration,,,14903,
,U,22224,,,,A,,CHEMBL629891,0,,BAO_0000019,7570,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,1,,,,Autocuration,,,14904,
,U,22224,,,,A,,CHEMBL629892,0,,BAO_0000019,7570,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,1,,,,Autocuration,,,14905,
,U,22224,,,,A,1235.0,CHEMBL629893,0,,BAO_0000019,7570,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,1,,Adrenal cortex,,Autocuration,,,14906,
,U,22224,,,,A,,CHEMBL629894,0,,BAO_0000019,7570,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,1,,,,Autocuration,,,14907,
,U,22224,,,,A,,CHEMBL629895,0,,BAO_0000019,7570,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,1,,,,Autocuration,,,14908,
,U,22224,,,In vivo,A,,CHEMBL875109,0,,BAO_0000218,14122,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",1,,,Canis lupus familiaris,Autocuration,,,14909,9615.0
,U,22224,,,In vivo,A,,CHEMBL629896,0,,BAO_0000218,16449,Absolute bioavailability in male cynomolgus monkeys,1,,,Macaca fascicularis,Autocuration,,,14910,9541.0
,U,22224,,,In vivo,A,,CHEMBL629897,0,,BAO_0000218,16449,Absolute bioavailability in maleSprague-Dawley rats,1,,,Rattus norvegicus,Autocuration,,,14911,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL629898,1,,BAO_0000218,12017,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Liver,Rattus norvegicus,Intermediate,,,14912,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL630057,1,,BAO_0000218,12017,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,14913,10116.0
,N,50597,,,In vivo,A,2107.0,CHEMBL630058,1,,BAO_0000218,12017,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Liver,Rattus norvegicus,Intermediate,,,14914,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL630059,1,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,14915,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL630060,1,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,14916,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL630061,1,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Lung,Rattus norvegicus,Intermediate,,,14917,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL630062,1,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,14918,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL630063,1,,BAO_0000218,12017,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,14919,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL630064,1,,BAO_0000218,12017,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,14920,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL630065,1,,BAO_0000218,12017,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,14921,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL630066,1,,BAO_0000218,12017,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Lung,Rattus norvegicus,Intermediate,,,14922,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL630067,1,,BAO_0000218,12017,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,14923,10116.0
,N,50597,,,In vivo,A,2048.0,CHEMBL630068,1,,BAO_0000218,12017,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Lung,Rattus norvegicus,Intermediate,,,14924,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL631113,1,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14925,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL631114,1,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14926,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL631115,1,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14927,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL631116,1,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14928,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL630528,1,,BAO_0000218,12017,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14929,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL630529,1,,BAO_0000218,12017,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14930,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL630530,1,,BAO_0000218,12017,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14931,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL630531,1,,BAO_0000218,12017,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14932,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL630532,1,,BAO_0000218,12017,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14933,10116.0
,N,50597,,,In vivo,A,2385.0,CHEMBL630533,1,,BAO_0000218,12017,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Muscle tissue,Rattus norvegicus,Intermediate,,,14934,10116.0
,N,50594,,,In vivo,A,178.0,CHEMBL630534,1,,BAO_0000218,15045,Biodistribution in normal mice blood after 120 hr,1,,Blood,Mus musculus,Intermediate,,,14935,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL630535,1,,BAO_0000218,15045,Biodistribution in normal mice blood after 24 hr,1,,Blood,Mus musculus,Intermediate,,,14936,10090.0
,N,50594,,,In vivo,A,178.0,CHEMBL630536,1,,BAO_0000218,15045,Biodistribution in normal mice blood after 4 hr,1,,Blood,Mus musculus,Intermediate,,,14937,10090.0
,N,50594,,,In vivo,A,10000001.0,CHEMBL630537,1,,BAO_0000218,15045,Biodistribution in normal mice bone after 120 hr,1,,Bone,Mus musculus,Intermediate,,,14938,10090.0
,N,50594,,,In vivo,A,10000001.0,CHEMBL630538,1,,BAO_0000218,15045,Biodistribution in normal mice bone after 24 hr,1,,Bone,Mus musculus,Intermediate,,,14939,10090.0
,N,50594,,,In vivo,A,10000001.0,CHEMBL630539,1,,BAO_0000218,15045,Biodistribution in normal mice bone after 4 hr,1,,Bone,Mus musculus,Intermediate,,,14940,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL630540,1,,BAO_0000218,15045,Biodistribution in normal mice heart after 120 hr,1,,Heart,Mus musculus,Intermediate,,,14941,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL630541,1,,BAO_0000218,15045,Biodistribution in normal mice heart after 24 hr,1,,Heart,Mus musculus,Intermediate,,,14942,10090.0
,N,50594,,,In vivo,A,948.0,CHEMBL630542,1,,BAO_0000218,15045,Biodistribution in normal mice heart after 4 hr,1,,Heart,Mus musculus,Intermediate,,,14943,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL630543,1,,BAO_0000218,15045,Biodistribution in normal mice kidney after 120 hr,1,,Kidney,Mus musculus,Intermediate,,,14944,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL630544,1,,BAO_0000218,15045,Biodistribution in normal mice kidney after 24 hr,1,,Kidney,Mus musculus,Intermediate,,,14945,10090.0
,N,50594,,,In vivo,A,2113.0,CHEMBL630545,1,,BAO_0000218,15045,Biodistribution in normal mice kidney after 4 hr,1,,Kidney,Mus musculus,Intermediate,,,14946,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL630546,1,,BAO_0000218,15045,Biodistribution in normal mice liver after 120 hr,1,,Liver,Mus musculus,Intermediate,,,14947,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL630547,1,,BAO_0000218,15045,Biodistribution in normal mice liver after 24 hr,1,,Liver,Mus musculus,Intermediate,,,14948,10090.0
,N,50594,,,In vivo,A,2107.0,CHEMBL630548,1,,BAO_0000218,15045,Biodistribution in normal mice liver after 4 hr,1,,Liver,Mus musculus,Intermediate,,,14949,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL630549,1,,BAO_0000218,15045,Biodistribution in normal mice spleen after 120 hr,1,,Spleen,Mus musculus,Intermediate,,,14950,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL630550,1,,BAO_0000218,15045,Biodistribution in normal mice spleen after 24 hr,1,,Spleen,Mus musculus,Intermediate,,,14951,10090.0
,N,50594,,,In vivo,A,2106.0,CHEMBL876426,1,,BAO_0000218,15045,Biodistribution in normal mice spleen after 4 hr,1,,Spleen,Mus musculus,Intermediate,,,14952,10090.0
,N,50597,,,In vivo,A,2106.0,CHEMBL630551,1,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,14953,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL630552,1,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,14954,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL630553,1,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Spleen,Rattus norvegicus,Intermediate,,,14955,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL630554,1,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,14956,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL630555,1,,BAO_0000218,12017,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,14957,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL630556,1,,BAO_0000218,12017,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,14958,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL630557,1,,BAO_0000218,12017,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,14959,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL630558,1,,BAO_0000218,12017,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),1,,Spleen,Rattus norvegicus,Intermediate,,,14960,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL630559,1,,BAO_0000218,12017,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,14961,10116.0
,N,50597,,,In vivo,A,2106.0,CHEMBL630560,1,,BAO_0000218,12017,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Spleen,Rattus norvegicus,Intermediate,,,14962,10116.0
,N,50597,,,In vivo,A,2046.0,CHEMBL876427,1,,BAO_0000218,12017,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,1,,Thyroid gland,Rattus norvegicus,Intermediate,,,14963,10116.0
,N,50597,,,,A,,CHEMBL630561,1,,BAO_0000218,14941,The Kel values in female wistar rats.,1,,,Rattus norvegicus,Intermediate,,,14964,10116.0
,U,22224,,,,A,,CHEMBL630562,0,,BAO_0000019,4646,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,1,,,,Autocuration,,,14965,
,U,22224,,,,A,,CHEMBL630563,0,,BAO_0000019,8847,Hydrolysis rate constant of the compound,1,,,,Autocuration,,,14966,
,U,22229,,,,P,,CHEMBL629673,0,,BAO_0000100,11778,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,1,,,,Autocuration,,,14967,
,U,22224,,,,A,,CHEMBL629674,0,,BAO_0000019,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",1,,,,Autocuration,,,14968,
,U,22224,,,,A,,CHEMBL629675,0,,BAO_0000019,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",1,,,,Autocuration,,,14969,
,U,22224,,,,A,,CHEMBL629676,0,,BAO_0000019,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",1,,,,Autocuration,,,14970,
,U,22224,,,,A,,CHEMBL629677,0,,BAO_0000019,2363,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",1,,,,Autocuration,,,14971,
,U,22224,,,,A,,CHEMBL629678,0,,BAO_0000019,8371,Apparent inactivation rate constant was evaluated,1,,,,Autocuration,,,14972,
,U,22224,,,,A,,CHEMBL629679,0,,BAO_0000019,14883,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,1,,,,Autocuration,,,14973,
,U,22224,,,,A,,CHEMBL629680,0,,BAO_0000019,14883,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,1,,,,Autocuration,,,14974,
,U,22224,,,,A,,CHEMBL629681,0,,BAO_0000019,4643,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,1,,,,Autocuration,,,14975,
,U,22224,,,,A,,CHEMBL629682,0,,BAO_0000019,3519,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,1,,,,Autocuration,,,14976,
,U,22224,,,,A,,CHEMBL629683,0,,BAO_0000019,10600,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,1,,,,Autocuration,,,14977,
,U,22224,,,,F,,CHEMBL629684,0,,BAO_0000019,8501,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,1,,,,Autocuration,,,14978,
,U,22224,,,,P,,CHEMBL629685,0,,BAO_0000100,8505,Dissociation constant was determined,1,,,,Autocuration,,,14979,
,U,22224,,,,P,,CHEMBL629686,0,,BAO_0000100,9778,Dissociation constant was determined,1,,,,Autocuration,,,14980,
,U,22224,,,,P,,CHEMBL872932,0,,BAO_0000100,9778,Dissociation constant at pH 7.4,1,,,,Autocuration,,,14981,
,U,22224,,,,P,,CHEMBL629687,0,,BAO_0000100,9778,Dissociation constant in presence of 1 mM dithiothreitol,1,,,,Autocuration,,,14982,
,U,22224,,,,A,,CHEMBL872931,0,,BAO_0000019,13007,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,1,,,,Autocuration,,,14983,
,U,22224,,,,A,,CHEMBL628151,0,,BAO_0000019,13007,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,1,,,,Autocuration,,,14984,
,U,22224,,,,A,,CHEMBL628152,0,,BAO_0000019,13007,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,1,,,,Autocuration,,,14985,
,U,22224,,,,A,,CHEMBL628153,0,,BAO_0000019,13007,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,1,,,,Autocuration,,,14986,
,U,22224,,,,A,,CHEMBL628154,0,,BAO_0000019,11482,Kinetic constant for aromatization of androstenedione,1,,,,Autocuration,,,14987,
,U,22224,,,,A,,CHEMBL628155,0,,BAO_0000019,11482,Kinetic constant for aromatization of testosterone,1,,,,Autocuration,,,14988,
,U,22224,,,,A,,CHEMBL628156,0,,BAO_0000019,2303,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,1,,,,Autocuration,,,14989,
,U,22224,,,,A,,CHEMBL628157,0,,BAO_0000019,11964,Local inhibition constant was determined,1,,,,Autocuration,,,14990,
,N,50347,,,,A,,CHEMBL857533,1,,BAO_0000218,3140,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,1,,,Saccharomyces cerevisiae,Intermediate,,,14991,4932.0
,U,22224,,,,P,,CHEMBL628158,0,,BAO_0000100,10650,Dissociation constant value of the compound,1,,,,Autocuration,,,14992,
,U,22224,,,,A,964.0,CHEMBL628159,0,,BAO_0000019,4667,In vitro permeability through cornea without epithelium,1,,Cornea,,Autocuration,,,14993,
,U,22224,,,,A,964.0,CHEMBL875616,0,,BAO_0000019,4667,In vitro permeability through intact cornea,1,,Cornea,,Autocuration,,,14994,
,N,50592,,,,A,964.0,CHEMBL628160,1,,BAO_0000218,9199,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,1,,Cornea,Oryctolagus cuniculus,Intermediate,,,14995,9986.0
,U,22224,,,,A,,CHEMBL628161,0,,BAO_0000019,11966,Rate of enzyme inactivation for the compound was determined,1,,,,Autocuration,,,14996,
,U,22224,,,,A,964.0,CHEMBL628162,0,,BAO_0000019,4667,In vitro permeability through cornea without epithelium,1,,Cornea,,Autocuration,,,14997,
,U,22224,,,,A,964.0,CHEMBL628163,0,,BAO_0000019,4667,In vitro permeability through intact cornea,1,,Cornea,,Autocuration,,,14998,
,U,22224,,,,A,,CHEMBL628164,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,14999,
,U,22224,,,,A,,CHEMBL628165,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15000,
,U,22224,,,,A,,CHEMBL628166,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15001,
,U,22224,,,,A,,CHEMBL628167,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15002,
,U,22224,,,,A,,CHEMBL628168,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15003,
,U,22224,,,,A,,CHEMBL628169,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15004,
,U,22224,,,,A,,CHEMBL628170,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15005,
,U,22224,,,,A,,CHEMBL628171,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15006,
,U,22224,,,,A,,CHEMBL627434,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15007,
,U,22224,,,,A,,CHEMBL627435,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15008,
,U,22224,,,,A,,CHEMBL628110,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15009,
,U,22224,,,,A,,CHEMBL628111,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15010,
,U,22224,,,,A,,CHEMBL628112,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15011,
,U,22224,,,,A,,CHEMBL628260,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15012,
,U,22224,,,,A,,CHEMBL628261,0,,BAO_0000019,8354,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",1,,,,Autocuration,,,15013,
,N,50594,,,In vivo,A,,CHEMBL628262,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),1,,,Mus musculus,Intermediate,,,15014,10090.0
,N,50587,,,In vivo,A,,CHEMBL628263,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,1,,,Homo sapiens,Intermediate,,,15015,9606.0
,N,50594,,,In vivo,A,,CHEMBL628264,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),1,,,Mus musculus,Intermediate,,,15016,10090.0
,N,50594,,,In vivo,A,,CHEMBL628265,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),1,,,Mus musculus,Intermediate,,,15017,10090.0
,N,50594,,,In vivo,A,,CHEMBL628266,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),1,,,Mus musculus,Intermediate,,,15018,10090.0
,N,50594,,,In vivo,A,,CHEMBL628267,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),1,,,Mus musculus,Intermediate,,,15019,10090.0
,N,50594,,,In vivo,A,,CHEMBL628268,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,1,,,Mus musculus,Intermediate,,,15020,10090.0
,N,50594,,,In vivo,A,,CHEMBL628269,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),1,,,Mus musculus,Intermediate,,,15021,10090.0
,N,50594,,,In vivo,A,,CHEMBL628270,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),1,,,Mus musculus,Intermediate,,,15022,10090.0
,N,50594,,,In vivo,A,,CHEMBL628271,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),1,,,Mus musculus,Intermediate,,,15023,10090.0
,N,50594,,,In vivo,A,,CHEMBL628272,1,,BAO_0000218,14439,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),1,,,Mus musculus,Intermediate,,,15024,10090.0
